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I.  EXPLANATORY NOTE TO THE READER 
The following notes will assist you in navigating around this study. 
Hill and Knowlton (H&K) was commissioned by the Directorate-General responsible 
for  Health  and  Consumer Protection  of the  European Commission  (DG  Sanco)  to 
carry out a pan-European study on nutritional, health and ethical claims. This study 
was undertaken in the second half of 1999 and completed in early 2000. 
The objective of the study was to provide comprehensive data on the legislation, rules 
and  practices  in  place.  In  addition,  the  study  was  to  seek  the  direct  views  of all 
interested stakeholders, namely regulators, industry and,  in particular, consumers, to 
assess  whether  there  are  problems  of misleading  claims  endangering  consumer 
protection. 
The research was carried out in  order to  examine whether and, how, the Misleading 
Advertising Directive (84/450) could be used to  resolve the problems encountered as 
a result of such claims (it should be noted that a study on green claims has already 
been  completed).  More  specifically,  it  looked  at  whether  the  Directive  could  be 
amended to  secure higher consumer protection, thereby creating a framework for all 
types  of claims.  DG  Sanco  is  fully  aware  that  nutritional  and  health  claims  are 
"vertically" regulated by the Nutritional Labelling Directive 90/496 and the Labelling, 
Presentation and  Advertising of Foodstuffs  Directive 791112  respectively (although 
this  Directive's  reference,  since  its  consolidation,  is  now  2000113).  Hence,  the 
challenge to  find a way of "horizontally'' regulating all  types of claims.  Thereafter, 
further changes to current legislation could follow, based on the individual type(s) of 
claim(s). 
H&K interviewed over 200 stakeholders (logged into the database of contacts) across 
the  15 Member States, the United States, Canada and at the EU level (Brussels-based 
organisations). H&K has tried its best to  seek the views of as  many stakeholders as 
possible and would like to thank all those who very kindly participated and apologise 
to those which may have been left out.  Whilst every effort has been made to  ensure 
that  the  study  reads  correctly  in  English,  please  note  that  many  sections  were 
undertaken  by  non-native  English  mother-tongue  persons.  DG  Sanco  also  made 
available to  H&K the answers received in reply to the questionnaire they sent out to 
the Member States in 1988 as a first initial assessment of the situation. 
The focus  was to  study not only what is  in  place and how  it is  working but,  more 
importantly,  what  developments  are  taking  place  and  what  are  the  views  of the 
stakeholders, in particular consumers. The findings of  the study have led us to make a 
number of recommendations aimed at ensuring better regulation of claims at  the EU 
level to  guarantee consumer protection and to  establis a clearer regulatory framework 
in which industry can operate. 
If one  agrees  with the  analysis that  claims  must be better regulated at EU  level,  a 
number of specific horizontal and vertical solutions need to be put in place. This will 
require the Misleading Advertising Directive to  be amended to  introduce across the 
board measures. But also, amendments to Directives 90/496 (nutritional labelling) and 
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(  ,- \  .  I. to  79/112 (food labelling), defining what is  a foodstuff in the context of the general 
review on foodlaw, and providing an EU-wide information campaign. 
There are six main sections to the study, including the Explanatory Note. 
The Analysis  and  Recommendations provides a  global view of the  whole study, 
divided into the following sections: 
A.  Analysis (main findings) 
1.  Consumers and Consumer Protection 
2.  Member State Legislation and Definitions 
a.  Nutritional Claims 
b.  Health Claims 
c.  Ethical Claims 
d.  Definitions 
3.  Voluntary Codes of  Practice 
4.  Verification Systems 
a.  Substantiation 
b.  Pre-Clearance 
c.  Post-Clearance 
d.  Legal Persons Entitled to Take Legal Action 
e.  Burden of  Proof 
f.  Applicable Penalties 
5.  Trade Barriers 
6.  Means of  Communication 
7.  Case Law 
8.  Statistics 
B.  Recommendations 
1.  Horizontal Approach- Amending the Misleading Advertising Directive 
2.  Vertical Legislation- Amending 79/112 and 90/496 
3.  Other Measures 
The Comparative Analysis brings together all  relevant information obtained from 
the 15  Member States, the US, Canada and the European Union/Brussels, grouping it 
under a number of  subject categories (see below). 
The  Country  Reports  provide  the  detailed  factual  information  as  to  what  is 
happening on the ground. We have reviewed all  15  Member States, the US, Canada 
and the European Union level. The following structure has been used for each country 
report: each sub-section covers each of the three claims (i) nutritional; (ii) health; and 
(iii) ethical claims. 
I.  Executive Summary 
This  section,  which reflects the  standard structure of the  individual country 
reports  as  well  as  focusing  specifically  on  consumer  protection,  aims  to 
provide  an overview,  containing all  the  key information,  together with our 
initial assessment of  what the key stakeholders would like to see. 
II.  Member State Policy 
The purpose of this section is to provide information in Member States' laws 
and regulations, their current policy thinking and their plans and wishes for the 
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stakeholders; namely consumer organisations, the enforcement authorities and 
industry. 
A.  Definition of Claims 
One  of the  key  problems  is  the  lack  of definitions,  legal  or not,  in 
particular  with  regard  to  health  and  ethical  claims  and  assessing 
whether there is any commonality. 
B.  Legislation in Place 
We examine the regulatory framework, the legislation in place, most of 
which  is  implementing  EU  Directives,  and  assessing  whether  they 
conform. 
C.  Existing Prohibitions, Restrictions and Exemptions 
D.  Policy Developments and Stakeholders' Positions 
This is one of the most important sections as it provides details of the 
main  stakeholders'  positions  on  the  current  situation  and  their 
intentions (policy orientations and/or proposals), whether they wish to 
see further regulation and whether this would be at EU level. 
III.  Voluntary Instruments 
To  assess  why and how voluntary agreements/codes of conduct have  come 
about - do they suggest that legislation is insufficient/no longer appropriate. 
A.  Voluntary Instruments in Place 
B.  Definitions used in Voluntary Instruments 
C.  Existing Prohibitions, Restrictions and Exemptions 
D.  Voluntary Instruments Accepted/Recognised by the Authorities 
IV.  Verifications Systems 
To assess what systems are in place and, secondly, whether they are effective 
in contributing to consumer protection. 
A.  Criteria for Substantiating Claims 
B.  Legal/  Administrative Systems for Verifying Claims 
C.  Pre-Clearance Rules/Guidelines 
D.  Post-Clearance Rules/Guidelines 
E.  Legal Persons entitled to Take Legal Action 
F.  Burden of Proof 
G.  Applicable Penalties 
V.  Case Law 
To  assess  what  case  law  exists  in  order  to  provide  an  assessment  of the 
misleading  claims  which  exist  and  to  assess  how  courts  interpret  EU  and 
national legislation on claims. 
VI.  Means of Communication 
This section aims at assessing whether legislation on claims differs depending 
on the way claims are communicated, e.g., radio/labelling, etc. 
VII.  Statistics on Claims 
This  part  was  supposed  to  provide  data  on  misleading  claims  although, 
unfortunately, this information is virtually non-existent. 
VIII.  Annexes 
Each  Country  Report  is  backed-up  by  all  relevant  information  which  is 
contained  in  the  Annexes,  which  are  not  part  of this  report  due  to  the 
enormous quantity of  paper. These were submitted in a separate set of  binders. 
However, each country report contains a full list of  the annexes submitted. 
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200 persons from Government/  Administrations, consumer organisations, industry and 
other  interested/relevant  partie  and  whose  details  are  contained  in  an  Access 
Database. 
ACRONYMS INDEX 
To guide you through the study, we provide below the full names of  the most referred 
to organisations: 
•  BEUC, The European Consumer Association 
•  CIAA, Confederation of  the Food and Drink Industries of  the EU 
•  Codex, Codex Alimentarius 
•  Eurocoop, The Association of  European Consumer Cooperatives 
•  EHPM, The European Health Product Manufacturers' Association 
•  Eurocommerce, The European Retailer Association 
•  ILSI, International Life Sciences Institute 
•  EASA, European Advertising Standards Alliance 
•  FLO, Fairtrade Labelling Organizations International 
•  EJC, European Court of  Justice 
•  EFLA, European Food Law Association 
•  FUFUOSE,  The  European  Commission  Concerted Action  on Functional  Food 
Science in Europe 
•  CEEREAL, The European Breakfast Cereal Association 
•  EFT  A, The European Fair Trade Association 
•  EURA  TEX, The European Apparel and Textile Organisation 
•  ETUF:TCL,  The  European  Trade  Union  Federation  of Textiles,  Clothing  and 
Leather 
•  ILO, International Labour Organisation 
* * * 
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In this section, we provide in part A an overall analysis of the key findings and in part 
B we spell out our suggested recommendations. There is  some repetition as we felt it 
important to recap on the key findings  in order to  explain the reasoning behind the 
recommendations proposed. 
A.  ANALYSIS 
1.  CONSUMERS AND CONSUMER PROTECTION 
Do nutritional, health and ethical claims create consumer protection problems? For 
consumer organisations they do and many regulators share this view. 
Whilst there are no available statistics as to how many claims exist, few would dispute 
the  fact  that  there  is  a  proliferation  of  claims  being  made  today.  Consumer 
organisations go from the premise that as soon as a misleading claim has been made, 
the damage  has effectively been done,  undermining consumer protection.  Also,  the 
legislation in place or the lack of a clear regulatory framework has led to  misleading 
claims being made. Whilst there is not a plethora of evidence on misleading claims, it 
is evident that the Member States' enforcement authorities are very often called upon 
to  negotiate  with the  makers of claims  in  order to  stop  misleading claims.  Hence, 
consumer organisations are calling for proper and effective control. 
Consumer organisations, not surprisingly, are  less  well  resourced than industry and 
less well informed about the issue of claims than are the regulators. We interviewed 
all  the major consumer organisations throughout Europe and what is  striking is  that 
only a few are fully briefed on the issue and have defined positions. To date, BEUC is 
studying the issue of claims (and health claims in particular) intensively, but does not 
as  yet  have  an  officially  published  position.  For  consumer  organisations,  this  is 
becoming one of  the key concerns as it relates to the bigger picture of food safety. The 
most  organised  of consumer  groups  are  in  the  Nordic  countries,  Germany  and 
especially in the UK, where the  associations have clearly defined positions and are 
active in seeking changes to protect the consumer. 
As  to  the  three categories of claims, consumer organisations agree that whilst it  is 
health claims which are creating the greatest problems, a closer look at nutritional and 
ethical claims is essential. 
As to  health claims, the crucial factor into why misleading claims come about is  the 
outdated and unclear legal framework. Member States interpret Directive 79/112 and 
its Article 2 either more liberally or restrictively, leading to industry making claims, 
which are acceptable in  one country but not in another (see below barriers to  trade 
section). 
Consumer organisations are calling for checks and balances to be introduced. Nobody 
disagrees  with  this  principle.  It is  the  how,  which  tends  to  pit  industry  against 
consumers. It is up to  the regulators to find a solution and according to  the research, 
virtually all stakeholders, and consumer associations in particular, agree that this is an 
issue to be resolved at the EU level. 
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have been set-up, often as a  stopgap, until further legislation is  adopted.  Consumer 
associations have been following the developments surrounding the different national 
voluntary agreements which have been put in place,  not least the  recent and much 
awaited UK Joint Health Claims initiative, where they acted as  equal representatives. 
The consumer contribution to  these  initiatives has  certainly been welcomed by the 
parties concerned as  regulators and industry agree that a tripartite balance is  needed 
(see Voluntary Agreement section below). 
As to nutritional claims, consumer organisations, particularly in the UK, make a valid 
point about the need for further clarification and the need for further substantiation. 
Industry in several Member States also suggest that additional guidelines are required. 
Ethical claims, from a consumer protection angle, do not currently pose a problem in 
that there are very few being used. Nevertheless, consumer groups are concerned for 
the future, as  there is general agreement that their use will proliferate and, thus, lead 
to  misleading  claims  being  made.  Hence,  consumer organisations  argue  that  they 
should also  be appropriately regulated.  The European Commission concluded in  its 
Communication on  Fair Trade of November  1999  that there was  a need to  further 
study and review how fair trade claims and labels are currently substantiated, verified 
and controlled. It also concluded that the Directive on Misleading Advertising "could 
be considered as  an instrument for ex-post verification and control in order to  ensure 
adequate protection for consumers". 
In  summary,  consumer  organisations  across  Europe  are  calling  for  strict  EU 
legislation to introduce: pre-clearance of any claims; precise substantiation criteria to 
allow a claim to be used; reinforced post verification systems; a shift in the burden of 
proof onto the shoulders of the maker of the claim; and better consumer information 
about the relationship between diet and health. These points are developed below. 
2.  MEMBER STATE LEGISLATION AND DEFINITIONS 
The first point to make is that there is no legal definition of what a "claim" is at either 
national or EU level. Codex Alimentarius does nevertheless provide a definition of a 
claim for the food sector. The EU Misleading Advertising Directive 84/450 does not 
directly refer  to  claims,  but it  is  generally acknowledged that claims  fall  under its 
scope. 
a.  Nutritional Claims 
As regards nutritional claims, all definitions are, by and large, the same and follow the 
Codex  guidelines,  which  define  four  different  types  of claims  (nutrient  content, 
comparative,  nutrient  function  and  claims  related  to  dietary  guidelines  of healthy 
diets).  There  is  quite  a  large  consensus  that  these  should be  now  annexed  to  the 
Nutritional Labelling Directive. 
There are also three countries where voluntary codes/guidelines have been set-up to 
provide  further  information to  industry,  namely in Denmark,  Finland,  and the  UK, 
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order to provide consumers with truthful information. 
Another example is the Co-operative wholesale Society (CWS) in the UK, which has 
developed  its  own  code  of practice  for  labelling  of pre-packed  foods  for  both 
nutritional  and health claims.  The views of the  CWS are  that the  lack of detailed 
provisions could lead to the potential misleading consumers. 
It is  our opinion  that  there  is  a  need  to  clarify  the  EU  Directive  on  nutritional 
labelling. As a first step, one should consider annexing the Codex guidelines tot he 
Directive.  Secondly, nutrient content claims must be clearly defined in terms of the 
quantitative  level  of the  nutrient  present,  be  consistent  between  products,  and  be 
meaningful to consumers. 
b.  Health Claims 
Without  a  doubt,  health  claims  pose  the  major problem  and  the  major challenge. 
Health claims are interpreted differently:  either a more liberal regime such as  in the 
UK or a restrictive/to the  letter of the law such as  in Germany and Italy.  Also, the 
various  developments  taking  place  throughout  Europe  (e.g.,  the  establishment  of 
voluntary codes of conduct)  are  clearly indicative of the  need to  establish a  better 
regulatory framework. 
The draft April 1999 Codex Alimentarius guidelines on the use of enhanced function 
claims and reduction of disease risk claims (even if they go further than the allowed 
scope  of Directive  791112)  have  received  wide  support  from  both  industry  and 
Member States authorities. 
Also,  the  developments  across  the  Atlantic  in  both  the  US  and  Canada  are 
demonstrative of  the liberal approach to health claims gaining ground. 
With  the  acknowledged  relationship  between  diet  and  health,  industry  has  been 
innovative, introducing new foods and a range of fortified foods.  However, Directive 
79/112 effectively puts the brake on innovation at a time when consumers are asking 
for quality and healthy food products. There is perhaps a case to be made for allowing 
"'enhanced  function  claims" and '""disease  risk reduction claims", albeit with proper 
controls". 
The European Commission announced in its White Paper on Food Safety that it will 
look into the question of nutritional claims and functional claims. Unfortunately it is 
not clear what is meant by 'functional claims'. More clarity could have been achieved, 
if the Commission had adopted the terms currently used in international fora such as 
the Codex Alimentarius and Council of Europe i.e.  "enhanced function claims"  and 
"disease risk reduction claims. 
The voluntary codes/agreements set-up in Sweden, Spain, The Netherlands (already in 
operation) and in  Belgium and in  the UK (both expected to  become operational  in 
2000)  is  a  clear demonstration of how regulators,  industry and,  to  a  large  extent, 
consumers  have come together to  pave the  way forward.  The  definitions,  criteria, 
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viewed as a blue print for what should be done at EU level. 
Whilst nutrition claims are defined by Directive 90/496 on nutrition labelling, there is 
no  definition of health claims.  In  order to  be able  to  make claims  that go  beyond 
'normal'  nutrition  claims  (as  defined  by  Directive  90/496),  there  seems  to  be  a 
tendency by industry to make claims that lie between nutrition claims (as defined by 
Directive 90/496)  and the  prohibition set  out under Directive  79/112.  This  legally 
somewhat undefined zone (at least at EU level) is further complicated by the fact that 
Member States  interpret differently the  prohibition set  out under Directive 791112. 
Hence, the need for the EU to legislate on health claims. 
As to  the advantages of health claims for consumers, it is  our opinion, based on the 
research carried out, that industry, regulators and even consumer organisations agree 
that health claims can be of benefit to  the consumer. This is  reflected in the liberal 
regimes of several EU  countries; the growing number of voluntary agreements that 
allow for health claims to be made; the developments in Codex and the April  1999 
draft guidelines which propose to allow health claims; and generally the widespread 
movement  in  the  US  and  Canada to  allow  certain health  claims.  The issue  is  not 
whether to allow claims or not, it is how to control them and make sure that they do 
not mislead the consumer. 
We are not suggesting the liberalisation of health claims. We are suggesting, instead, 
that by amending Directive 79/112 to allow health claims and to open-up the types of 
health claims, which can be made, this will create a proper regulatory framework for 
industry to work with.  With it, of course, one must introduce the proper checks and 
balances to guarantee consumer protection. 
The main demands of  the stakeholders (majority view) are the following: 
i.  Consumer Organisations 
•  They are  calling for  action,  preferably at  the  EU  level,  although this  does  not 
preclude action/measures at national level; 
•  They would prefer criteria for substantiation to be developed instead of a positive 
or negative list of  health claims; 
•  They want pre-clearance for all claims; 
•  They want the supervision/control of claims once on the market to  be tightened 
and want the enforcement bodies to  be more aware and bring cases to  court in 
order to guarantee consumer protection; 
•  They want the burden of proof to lie with the maker of the claim in order to allow 
for a more equitable and cheaper prosecution; 
•  They wish  to  see  the  EU  setting-up  an  information  campaign  to  educate  and 
inform consumers on the advantages of  diet and health; and 
•  They believe that current legislation is inadequate and/or incorrectly enforced and 
are, therefore, seeking change. 
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I ii.  Regulators 
•  Virtually  all  Member  States  (perhaps  Spain  and  Belgium  are  somewhat  more 
reluctant, and possibly The Netherlands does not see a great need)  agree that it 
should  be  at  the  EU  level  that  the  problems  surrounding  health  claims  are 
resolved; 
•  The large majority of Member States have expressed the need to amend Directive 
79/112 in order to meet current requirements; 
•  They consider Codex draft guidelines  as  the  way forward  in  order to  introduce 
new types of  claims; 
•  They accept that perhaps a definition of a foodstuff should be elaborated to avoid 
the problem of  borderline cases; 
•  They realise that they need to consider: 
•  allowing enhanced function and disease risk reductions claims; 
•  drawing-up a positive list of generic claims; 
•  introducing  pre-clearance  generally  or  introducing  pre-clearance  for 
innovative claims; and 
•  reviewing the criteria to establish what type of  claim can be made. 
•  They view  the  voluntary  codes/agreements  as  a  step  in  the  right  direction  but 
ultimately wish to see legislation in place. 
iii.  Industry 
•  They view the EU as the best level to create a clear regulatory environment; 
•  Whilst  ideally  industry  would  like  to  see  self-regulation  as  the  way  forward, 
basing itself on  the voluntary codes now in place,  industry is  also realistic  and 
accepts that a code might not be able to work in each country (Italy and Germany 
for legal reasons) and the fact that regulators and consumers favour legislation; 
•  In addition, industry is calling for: 
•  An  amendment to  79/112, (and Directive 65/65) and Article 2 to  allow new 
types  of claims,  in  particular  disease  risk  reduction  claims  and  enhanced 
function claims; 
•  The consideration of a clear set of criteria under which a claim can be made; 
and 
•  No pre-clearance, but well defined post clearance verifications. This is one of 
the most fundamental issues and agreement on a way forward would go a long 
towards finding a compromise between what industry and consumers want. It 
is  our  opm10n  that  industry's  stance  on  pre-clearance  is  being 
reviewed/discussed and, hence, they may adopt a more realistic approach. 
•  Retailers and other industry-related interests favour only enhanced function claims 
and call for criteria to be drawn-up under which conditions a claim can be made (a 
positive list is possible). 
•  The advertising industry in general favours self-regulation. 
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Ethical claims, which are generally seen to  cover labour related working conditions 
and are a fairly new type of labelling, have only appeared on products in the last few 
years. Furthermore, there is currently no direct legislation or legal definition in any of 
the Member States. Nevertheless, each Member State has legislation which indirectly 
applies  to  ethical  claims,  most  often  due  to  national  implementation  of the  EU 
Directive on Misleading Advertising. 
It must be said that,  currently, consumer groups do not see a problem in  the use of 
ehtical claims, mostly because so  few  are being used.  Nevertheless, consumers and 
many of the other stakeholders agree that they should be regulated in order to  avoid 
problems and guarantee consumer protection in the future, given the expectation that 
they  will  proliferate.  Amongst  the  stakeholders  that  do  not  perceive  a  need  for 
regulation on ethical claims is the retail sector. 
It is  important to note that two countries (Belgian and Italy) are drafting legislation. 
Four  other  Member  States  (Denmark,  France,  Portugal,  and  Sweden)  have  seen 
developments signalling a call to regulate ethical claims in some form. The other nine 
Member States have not considered the issue and, hence, have no defined position. 
Voluntary agreements/codes of conduct are being set-up for ethical claims. The most 
well known one is  the Fairtrade Labelling Organisations International (FLO), which 
does not have a claim as  such but a fairtrade  label, which could be/is associated by 
consumers with certain ethical standards. 
On  the  whole,  consumer  organisations  have  not  developed  a  defined 
viewpoint/position  on  ethical  claims.  Suffice  to  say  that  they  want  them  to  be 
controlled,  like  any  other  claim,  via  the  right  channels.  By  contrast,  as  a  whole, 
industry does not perceive ethical claims to  be  an issue,  as  they are very limited in 
use, and believe that the market will regulate their use. 
d.  Definitions 
Currently there exists no legal definition of what a "claim" is.  In order to clarify this 
aspect  of  the  Misleading  Advertising  Directive,  we  would  recommend  the 
introduction of a definition of claims.  In the  light of policy developments and based 
on the stakeholders' position, we also consider necessary a definition of: 
•  a health claim; 
•  a foodstuff; and 
•  an ethical claim. 
3.  VOLUNTARY CODES OF PRACTICE 
It is  indicative that where there  is  clear legislation, there are virtually no  voluntary 
codes  of practice,  but  where  legislation  is  non-existent,  i.e.,  on  ethical  claims,  or 
where  legislation  is  perceived to  be  outdated or no  longer appropriate,  i.e.,  health 
claims,  the  proliferation  of voluntary  initiatives  is  considerable.  The  exception  is 
perhaps Sweden where the industry-led voluntary agreement emanated from the view 
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to implement the Swedish dietary recommendations. 
With regard to nutritional claims, only Denmark has a voluntary agreement in place. 
In Finland and the UK, the relevant authorities issue clarification guidelines. This is 
indicative of the need to provide industry further information as to what they can and 
cannot  do  and,  hence,  raises  the  issue  as  to  whether  this  might  cause  consumer 
protection problems. 
With regard to  health claims, several voluntary agreements are  in  place and/or are 
being planned. Sweden is home to the oldest code of conduct on health claims, which 
entered into force in 1990. Spain and The Netherlands have codes already in place and 
in Belgium and the UK codes are being finalised. 
The UK code is an example of a possible way forward on how to create a framework 
for health claims. The majority of stakeholders in the UK are hoping that the Joint 
Health Claims Initiative (JHCI) will provide the necessary framework for regulating 
health claims. However, a number of  the participants believe that it is a stopgap until a 
proper legislative framework, which should emanate at the EU level, is established. 
The JHCI can claim that all interested parties (government, enforcement authorities, 
consumers and industry) participated actively and they are now hoping that it will 
come  into  force  in  2000.  A  Code  Administration  body,  made  up  of a  Council 
(representing all key stakeholders), a Secretariat and an expert authority will manage 
the  JHCI.  Consumers,  especially,  hope that  the  Food Standards  Agency will  take 
responsibility. The initiative promotes a pre-market advice/pre-vetting system, which 
suggests  the  exercise  of due  diligence,  applied  to  health  claims  in  all  means  of 
communications, with the overriding principle that the likely consumer perception of 
the health claim is  paramount. The Code administration body will develop a list of 
generic  health  claims,  to  be  approved  by  the  Expert  authority,  to  be  reviewed 
regularly. A system of innovative claims will also be established. Whilst not legally 
binding, it promises to deliver. 
The Swedish code is  another blue print for what could be done at the EU level.  It 
ensures  that  health  claims  must  be  based  on  the  importance  of the  product  in  a 
balanced diet,  and must be in  line  with official  Swedish dietary recommendations. 
The claim must consist of two parts:  A:  information on diet-health relationship:  B: 
followed by information on the composition of the product. To be noted is that the 
two  main  Swedish  consumer  organisations  support  the  voluntary  code  and  have 
pronounced themselves in favour of the  updating of this  code concerning product-
specific physiological claims. 
Interestingly,  the  consumer  organisations  have  been  involved  to  a  degree  in  the 
elaboration of these voluntary agreements.  In  the  UK and Sweden,  they have been 
partners in the elaboration of the codes and are supportive on the whole. Admittedly, 
in the UK, the consumer organisations wanted a system of pre-clearance, which was 
finally  not  retained  in  the  code.  Consumers  were also  active  in  the  draft  Belgian 
voluntary code, but are currently hesitating to join. The Dutch Consumer Association 
was (and is)  involved in  the elaboration of the  Dutch Advertising Code and on the 
Code of  Practice on Health Benefits Claims. 
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Conseil  National  de  !'Alimentation,  following  an  extensive  and  broad-based 
consultation process, including consumers, provides a valuable insight into  how the 
major  stakeholders  in  France  would  like  to  address  the  issue  in  the  future  at  the 
European level.  Some of the  12  key points of the recommendation are  in line with 
consumer wishes. 
Due to  the fact  that  more  and  more stakeholders consider that some health claims 
should be allowed, such codes have proliferated across the EU, thus giving a different 
interpretation  to  Directive  791112,  in  effect  broadening  its  scope  and  by default 
defining a health claim. The voluntary agreements, by their nature,  do  not however 
have effective and/or binding sanctions. Nevertheless, all set out detailed criteria for 
substantiation. 
As  to  ethical  claims,  being the  most recent  type  of claims  made, numerous  codes 
exist.  These  codes  do  not  specifically deal  with  claims,  but rather  set-up  labelling 
initiatives and  set out certain criteria that have to  be respected,  in  order to  use  the 
logo/symbol  of these  labelling  initiatives.  These  are  mostly  fair  trade  labelling 
initiatives. 
There exist also a number of voluntary agreements on advertising in general in nearly 
all  Member States,  which are  aimed at providing a sort of voluntary framework to 
keep advertising within accepted moral and ethical boundaries. 
The  question  can  be  raised  as  to  how  far  the  proliferation  of national  voluntary 
agreements (in particular in the area of health claims) does not lead to different levels 
of consumer protection within the EU, as  well as  to  the creation of new barriers to 
trade.  Another  possibility  would  be  to  model  consumer  protection  in  the  area  of 
claims after the new approach in harmonisation used for technical legislation, i.e.  EU 
legislation only establishes the general principles and essential requirements. For the 
technical  details,  reference  is  made  to  standards  due  to  be  established  by 
standardisation institutes (e.g. CEN), following a mandate from the Commission. As 
in  the  technical  area  under  this  scenario,  if standards  are  met,  there  would  be  a 
presumption that the claims used are in conformity with the essential requirements for 
claims as set out in an amended Misleading Advertising Directive. 
4.  VERIFICATION SYSTEMS 
Verification systems encompass, from our perspective, five components, which hold 
the  key to  how  any type  of claim can be  better regulated,  via  amendments  to  the 
Misleading  Advertising  Directive.  This  is  also  the  key  to  guaranteeing  increased 
consumer protection. 
a.  Substantiation 
Consumer organisations have clearly called for increased substantiation of claims and, 
in recent initiatives, the voluntary codes have developed explicitly detailed criteria. 
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set out in Directive 90/496 on Nutritional Labelling, i.e. whenever a nutritional claim 
is  made  nutritional  labelling  becomes  compulsory.  In  some  countries  additional 
guidelines (e.g. Finland) and/or legal requirements exist as to the composition of the 
product which have to  be respected, in order to be able to  make certain nutritional 
claims (e.g. UK, Germany). 
Regarding health claims, in many cases, criteria for substantiating them do not exist 
by law,  as  health  claims  are  simply not  allowed,  or criteria only apply  for  some 
exceptions,  which  are  allowed  for  foodstuffs  for  particular  nutritional  uses 
(P ARNUTS). In these cases, a manufacturer has most often to  submit the label and 
information  on  the  composition  of the  product.  In  some  Member  States  and,  in 
particular,  in  those  where  a  pre-clearance  for health claims  exist (Austria,  France) 
criteria have been set out for substantiating claims. Here again, in general the label 
and information on the composition of the product has to be submitted. Furthermore, 
some countries also require scientific data to be submitted (e.g., France). 
All  voluntary  instruments  on  health  claims  require,  in  general,  the  submission of 
scientific  evidence.  The voluntary instruments define  very often in more detail  the 
criteria that the scientific evidence has to fulfill. Most interesting in this respect is the 
CIAA code on health claims, which lists a large number of criteria that have to be met 
in order to substantiate a claim. 
Substantiation criteria for ethical claims only exist in the voluntary agreements. Fair 
trade  labelling  schemes  apply,  in  general,  the  criteria  set  out  by the  Fair Trade 
Labeling  Organisation  (FLO).  These  criteria  are  normally:  purchase  only  from 
accepted sources; payment of a premium in  addition to  the market price; respect of 
minimum labour standards; etc. 
It is  clear that  a  substantiation  system  needs  to  be elaborated  as  one  of the  pre-
conditions for allowing claims. We would recommend introducing into the Misleading 
Advertising Directive (for example in the form of an Annex) a number of criteria that 
need to be fulfilled in view of  the substantiation of  claims. It is clear that for the use of 
health claims more detailed criteria as to the scientific substantiation should be set out. 
This has been done in a number of  voluntary codes on health claims. In our view, such 
detailed  criteria  could  be  addressed  under  Directive  79/112  and/or  through  the 
elaboration of  technical standards. 
b.  Pre-Clearance 
While in most Member States no pre-clearance rules apply by law, there exist in most 
of  them  informal  pre-clearance  rules,  whereby  companies  can  ask  their  local 
enforcement authorities to  verify in how far the claims that the producer wants to  use 
may be considered lawful. This informal procedure, however, offers no guarantees but 
according to the enforcement authorities enables them to stop many misleading claims 
being used. 
In  some Member States, which rely on self-regulatory instruments such as  the UK, 
Ireland and The Netherlands, more formalised pre-clearance rules exist but, which are 
equally not set out by law. 
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code  introduces  the  possibility  for  companies  to  ask  for  pre-market  advice  for 
innovative health claims.  Whilst the  opinion of the  JHCI will  have  no  legal  right, 
companies  which  receive  a  positive  answer  from  the  JHCI,  may be  looked  upon 
favourably by the courts should a case arise. Acting upon pre-market advice suggests 
the exercise of "due diligence". The courts may take this into account in the event of 
any legal challenge to the health claim under the Food Safety Act. 
Systems  of  pre-clearance  have  been  set  up  in  France  and  Austria,  whereby 
authorisation from the relevant administrations are needed, in order to be able to make 
health claims. By contrast, in Germany pre-clearance is considered censorship and is, 
therefore, not applied. 
Consumer associations are  widely in favour of pre-clearance with regard to  health 
claims in order to ensure that only truthful and non-misleading claims are being used. 
Their view  is  that once  a misleading  claim  has been made,  the  damage has  been 
done,  even  if the  claim  is  then  pulled  off the  market.  By contrast,  industry,  has 
indicated that it was in general opposed to pre-clearance procedures, as: 
•  these would delay the placing on the market of  a product; 
•  it was not possible to copyright final food products and/or the claim made; 
•  industry was worried that confidentiality was not ensured during an a priori 
approval procedure; and 
•  it was unproportional to introduce a strict system of  pre-clearance. 
Suffice  to  say that if pre-clearance were  to  be  introduced,  it  would  most  probably 
avoid to a large extent misleading claims coming onto the market. Nevertheless, this is 
one of the major stumbling blocks between industry and consumers.  Hence, the pre-
clearance system will  have to  accommodate  industry's needs  for  a quick,  efficient, 
confidential system. Here lies one of the greatest difficulties that the EU Commission 
will have to face. 
Whilst one could envisage making use of the European Food Authority that has been 
announced in  the  White  Paper on Food Safety as  the  authority responsible  for  pre-
clearance,  this  has  two  disadvantages.  Firstly,  the  European  Food  Authority would 
only  be  a  possible  way  forward  for  claims  made  on  foodstuffs  and  secondly,  the 
European  Food  Authority  as  envisaged  by  the  White  Paper  would  not  have  any 
regulatory powers. This means that whilst the evaluation of claims could be done by 
the  European Food Authority,  the  final  decision to  allow a claim or not  would still 
have to be taken by the European Commission. 
c.  Post Clearance 
Post-clearance is,  in  general, undertaken by the relevant health or food  inspection 
services.  In  some countries  also  the  authorities  dealing with trading standards  arc 
responsible for post-clearance (e.g., UK, Portugal). 
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mostly in the framework of voluntary codes on advertising (e.g.  Germany, Greece, 
Italy, Ireland, etc.). It seems that competitors quite often make use of  these systems. 
Consumer associations and regulators/enforcement bodies are critical of how difficult 
post verification is.  Hence,  if pre-clearance could be  introduced,  this would already 
make post-clearance less of  a burden. 
Nevertheless,  better  systems  need  to  be  put  in  place  to  assist  the  enforcement 
authorities in carrying-out their post clearance checks. Interlinked with this issue is, of 
course, the crucial issues of who is entitled to take legal action, the burden of proof-
on whose shoulders does it lie - and what applicable sanctions can be levied.  These 
points are developed in the next sections. 
d.  Legal Persons Entitled to Take Legal Action 
In  all  Member  States,  the  authorities,  companies  and  consumer  associatiOns  are 
entitled to  take legal action.  The only exception is  Austria, where so  far  consumer 
associations  are  not  allowed  to  take  legal  action.  Nevertheless,  the  Austrian  Law 
against Unfair Competition is currently being revised, in order to give consumers the 
right to take legal action. There are a few countries (Austria and Germany), which do 
not allow the  individual consumer to  take legal action, but they do  not see this  as 
having led to any problems in terms of  consumer protection. 
We  consider  that  no  clarifications/changes  need  to  be  made  to  the  Misleading 
Advertising Directive with regard to the legal persons entitled to take legal action. 
e.  Burden of Proof 
The  burden  of proof lies,  in  a  maJonty  of Member  States,  with  the  plaintiff. 
Nevertheless, some Member States have established a system whereby the burden of 
proof lies  with  the  maker  of the  claim,  in  the  case  that  the  authorities  start  an 
investigation. The latter is  reflected in  the  Misleading Advertising Directive, which 
empowers,  under  certain  circumstances,  national  courts  and  administrations  to 
require  advertisers  to  furnish  evidence  as  to  the  accuracy  of factual  claims  in 
advertising. 
It is only in the Nordic countries that the burden of proof lies clearly with the maker 
of the  claim.  In  Germany,  it  was  reported  that  the  burden  of proof is  creating 
problems for consumer associations wishing to pursue cases in front of the courts, as 
they  do  not  have  the  means  of paying  an  expert  who  could  provide  an  opinion 
testifying that a certain claim could not be scientifically proven. 
Also, the enforcement authorities, in particular in the  UK,  have highlighted the fact 
that taking a manufacturer to court requires enormous resources, which they do not 
have. Hence, unless they are  1  00% confident of their case, they will not go to court, 
but rather enter into negotiations with the maker of the claim to  try and resolve the 
issue out of court. This process can take considerable time and the claim can still be 
on the market whilst the negotiations are going on. It is difficult to indicate what the 
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numerous. 
Clearly,  in those countries where the burden of proof lies  with the  plaintiff,  there 
seem  to  exist  problems  in  terms  of bringing  cases  to  the  courts.  Consumer 
associations are unanimously in favour of a reversal of  the burden of  proof and even 
industry, in general, seems to  agree that a manufacturer needs to  be able to justify 
nutritional and health claims with scientific evidence. 
In essence, we believe that a modification of  the rules on burden of  proof, as set out in 
the  Misleading Advertising Directive,  should take  place.  All  arguments  taken into 
account, the optimal solution is, in our view, a reversal of the burden of proof, i.e. it 
would be up to the maker of the claim to prove that his/her claim is  non-misleading 
and truthful.  Nevertheless, a reversal of the burden of proof may be considered by 
some  Member  States  as  a  profound  intervention  by  the  EU  into  its  basic  legal 
principles. In this case, we consider as second best option to make the reversal of the 
burden of proof dependant as to whether the producer has fulfilled certain criteria set 
out  in  an  amended  Directive  on  Misleading  Advertising,  whilst  at  the  same  time 
requiring the maker of the claim to provide all useful documentation and information 
so that the plaintiff can avail himself of  concrete facts to prove his case. 
f.  Applicable Penalties 
In  all  Member  States  fines  and/or  imprisonment  are  foreseen  as  penalties  for 
misleading advertising and/or non-respect of food  labelling rules.  Nevertheless,  in 
some Member States the penalties/fines seem to be less stringent than in others. The 
Misleading Advertising Directive only foresees that Member States set up a system 
which allows for the cessation of  the misleading advertising. 
In order to guarantee the same level of  consumer protection in all Member States with 
regard to  the  sanctioning of misleading claims, one option could be  to  introduce a 
provision  into  the  Misleading  Advertising  Directive,  requiring  Member  States  to 
introduce effective and dissuasive sanctions against the use of  misleading claims. 
5.  TRADE BARRIERS 
Barriers to trade are not seen to give rise to consumer protection problems. 
Nevertheless,  manufacturers  are  experiencing trade  barrier problems as  a  result of 
health  claims.  Some  problems  were  reported  for  nutritional  claims  where  the 
reference values  for  making a nutritional claim differ between Member States,  but 
none for ethical claims. 
It is  interesting to  note that barriers to  trade were mentioned in  those countries that 
have  a  very strict interpretation of health claims (e.g.,  Austria,  Italy)  and  in  those 
countries  that  have  a  pre-clearance  system  in  place  (e.g.  Austria,  France). 
Furthermore,  some  barriers  to  trade  were  reported  by the  authorities,  where  food 
supplements being imported from other countries are often categorised as  medicinal 
products (e.g., Germany, UK). In general, and quite logically, barriers to trade seem to 
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appear between countries that share the same language, e.g., Austria and Germany, or 
the Flemish part of  Belgium and The Netherlands. 
Industry indicated that often these barriers to  trade would not be visible,  as  industry 
tended to  modify its  labelling from  one  country to  another, instead of going to  the 
courts.  Barriers to  trade seem to  be generated mainly by the  different interpretation 
that Member State authorities give to  the ban spelled out in  Article  2 of Directive 
79/112,  i.e.  the  prevention,  treatment  and  curing  of disease,  as  well  as  to  the 
development of  voluntary agreements on health claims. 
An amendment to  the Misleading Advertising Directive will  not resolve these trade 
barrier problems. In our view, these problems could essentially be resolved through an 
amendment of the  Labelling Directive 79/112.  It would be necessary to  clarify the 
scope of its  Article 2 and align it  with the developments taking place within Codex 
Alimentarius, as well as national voluntary codes on health claims. 
6.  MEANS OF COMMUNICATION 
Claims can be made through different means of communication. The most common 
means are the labelling of the product and advertising. The countries studied do not 
differentiate between legislation applicable to  labelling and legislation applicable to 
advertising. In addition to the legislation, self-regulatory rules apply to advertising in 
certain  instances,  but  none  exist  for  labelling.  This,  however,  does  not  reflect  a 
difference between the means of communication, since national legislation remains 
applicable to both labelling and advertising. 
On many occasions, the Internet has been described as a potential source of  problems 
because of  the quasi-impossibility of  monitoring the claims made on the web, as well 
as  the  difficulty of controling electronic  commerce of products bearing prohibited 
claims.  However, policy thinking on this  issue is  still at a very early stage and no 
country has taken measures that would apply specifically to the Internet. 
It is unclear whether the scope of the Misleading Advertising Directive encompasses 
all  means  of communication and,  in  particular,  claims made  on  labelling (on-pack 
claims). All national legislation is  based on the principle that a uniform set of rules 
should apply whatever the means of communication used. We, therefore, recommend 
that the Directive be amended so that it clearly applies not only to advertising but also 
to labelling. 
7.  CASELAW 
Whilst case  law  on  claims - virtually all  were  on  health claims - were  identified, 
these are limited for three reasons: 
1.  There seems to be in many Member States a tradition of  resolving disputes outside 
the courts on an informal basis.  In particular, in countries which rely heavily on 
self-regulation (e.g. the UK), disputes tend to be resolved outside the legal system. 
2.  In  some countries, there seems to be a problem for consumer associations and/or 
local  authorities  to  bring  cases  before  the  courts.  This  is  due  to  a  number of 
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judgement as a result of  the burden ofproofbeing on the plaintiff. 
3.  In  countries  with a  strict  legislation  and  interpretation  of health  claims  by the 
authorities, producers tend to clarify with the enforcement authorities beforehand, 
in an informal way, in how far there may be objections by the authorities on the 
use of  a certain claim. 
Although it  is  difficult to  draw general  conclusions from  the limited case law that 
exists, it seems that courts tend,  in general,  to  adopt a rather strict interpretation of 
health. 
The European Court of Justice (ECJ) has ruled on a number of cases, which concern 
the classification of medicines. It is  in this context that the Court has also looked at 
health  claims.  The  rulings  indicate  that  the  ECJ  gives  a  broad  interpretation  to 
Directive  65/65  on  medicinal  products,  i.e.  a  product  recommended,  as  having 
prophylactic or therapeutic properties is  a medicinal product, even if it  is  generally 
regarded  as  a  foodstuff.  In  a  more  recent  case,  the  ECJ  seems  to  consider  that  a 
control system for claims as foreseen under the Misleading Advertising Directive (i.e. 
that  courts  and  administrations  can  ask  advertisers  to  furnish  evidence  as  to  the 
accuracy of factual  claims, taking into  account the  legitimate interest of the parties 
involved) is a viable way of  controlling claims. 
In a number of Member States, disputes are more often resolved in an informal way 
outside the courts. In order to make such a system work in all Member States, it may 
be considered to introduce in the Misleading Advertising Directive a similar system 
as  foreseen under Directive 98/27  on Injunctions for  the Protection of Consumers' 
Interests. This Directive foresees that the party that intends to seek an injunction can 
only start this procedure if it has tried to achieve the cessation of the infringement in 
consultation with either the  defendant or with both the  defendant and a  qualified 
entity (i.e. public bodies and organisations whose purpose it is  to protect collective 
interests of  consumers). 
8.  STATISTICS 
As to the availability of statistics providing an overview of the complaints that have 
been submitted by consumers to the authorities, courts or out-of-court bodies, as well 
as  the  number of claims  made,  little  information  was  available  from  either  the 
authorities  or consumer/industry associations.  We  sumtnarise below  the  available 
country information: 
Austria 
In Austria a pre-clearance for claims applies.  According to the Federal Chancellery, 
the claims for which an authorisation is requested most frequently are claims in line 
with  current  trends  (i.e.  staying  fit,  losing  weight)  such  as  "reduces  weight"  or 
"encourages digestion".  On average  1,000 to  2,000 authorisations are requested per 
year and about two-thirds are granted after modification (which is often substantial). 
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According to  the National Food Agency (NFA),  there have not been any 
decisions  or  court  cases  on  an  inappropriate  use  of health  claims  in 
foodstuffs  since  1995  (before  1995  the  Consumer Ombudsman  had  the 
responsibility for the market control of claims).  Since  1995, the NF A has 
passed comments  on  unsuitable claims  in  ten  instances.  However,  in  all 
these  cases  the  claims  have  been  corrected  without  further  action  and, 
therefore, the NF  A is  not willing to  list them. There have also been a few 
cases where health claims have been used in  an  inappropriate way in  the 
marketing of  dietary supplements. 
Germany 
One  of the  best  sources  proved  to  be  the  Centre  for  the  Fight  against  Unlawful 
Competition. The Centre received, in  1998, a total of 21, 190  complaints relating to 
unlawful competition Out of these, the Centre estimates that around 1  ,300 complaints 
concerned health and disease related advertising.  More specifically concerning food-
related  claims,  the  Centre  estimates  that around  100  complaints  are  received  each 
year, of which only three concern complaints on nutritional claims. The rest concern 
health claims where the complaints were mostly settled out of  court. 
Another  very  useful  source  proved to  be  the  Consumer Protection  Association  in 
Berlin. It has a database that goes back to  1  992 and tracks all the letters it has sent to 
companies  asking  for  declarations  for  forbearance.  The  Consumer  Protection 
Association  indicated  that  its  database  contains  around  150  such  admonitions 
covering  health  related  advertising,  of which  80  concern  advertising  for  slimming 
products. 
The German Advertising Council also has  some statistics regarding complaints that 
are being submitted. In 1997, the number of complaints received concerning foodstuff 
advertising  was  23.  But  this  number  went  down  to  eight  in  1998.  The  statistics, 
unfortunately, do  not reveal  how far these  claims concerned health claims or other 
sorts of  complaints related to food advertising. 
Italy 
Real  statistics  on  nutritional  and  health  claims  were  not  available.  However,  the 
Antitrust Authority responsible for misleading advertising has published some data. 
In the period 1992-1997, the Antitrust Authority analysed a growing number of cases 
related to misleading advertising. The number of  cases which have been recognised as 
misleading increased from  1992, where 35% of the  cases analysed turned out to  be 
misleading, to 73% in 1996, with more than 350 cases examined. 
The areas which presented the highest rates of misleading advertising per number of 
cases analysed in the period May 1992-April 1997 are: 
•  Instructions and publishing, with more than  150  cases analysed and around 67% 
of the cases found misleading; 
•  Trade, with more than 130 cases, and around 69%> found misleading; 
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misleading; 
•  Tourism and travel, with 60 cases, and 38o/o found misleading 
•  Food, with 42 cases and only 14o/o found misleading. 
Portugal 
The Portuguese consumer association (DECO) indicated the following statistics on 
labelling for cases where the association was invited to mediate in 1998 and 1999: 
Complaints 1998  Nr. of  complaints 
Nutritional labeling  90 
Health-related labeling  96 
Ethical labeling  14 
Complaints 1999  Nr. of  complaints 
Nutritional labeling  92 
Health related labeling  74 
Ethical labeling  27 
For most of the cases,  the problem was related to  the fact  that the  labelling was 
written in other languages than Portuguese. A smaller number of complaints relate to 
the  omission  or  incorrect  use  of information.  Most  of the  cases  are  still  under 
investigation by the competent authorities. 
Sweden 
The Consumer Agency receives  approximately 200  complaints annually relating to 
claims; mostly these complaints concern dietary supplements and natural remedies. 
No further  information is  available.  Out of approximately 200 complaints annually 
approximately 75  concern dietary supplements, approximately 40 slimming products 
and  only  a  limited  number  concern  nutritional/health  claims  for  ordinary  food 
products. 
United Kingdom 
The  local  Welsh  Authorities  on  Trading  Standards  carried  out  a  study  to  assess 
whether claims comply inter alia with the Food Labelling Regulations of 1996. This 
study would  seem to  imply that  a  number of claims  are  being made  that,  in  the 
judgement of  the local authorities, are unlawful. 
Two other studies  examining nutritional  and health claims made on food  products 
have been carried out by the Food Commission, which point to  the need for further 
regulation to prevent consumers being misled. 
In  conclusion,  whilst there  is  not a  considerable body of evidence as  statistics  are 
concerned, nevertheless what statistical  information exists clearly points to  the  fact 
that claims are being made, which are deemed misleading. 
* * * 
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 1.  Horizontal Approach - Amending the misleading Advertising Directive 
a.  Definitions used in Misleading Advertising Directive 
Currently  there  exists  no  legal  definition  of what  a  "claim"  is.  The  Misleading 
Advertising Directive  84/450  does  not directly  refer to  claims,  but  it  is  generally 
acknowledged that claims fall  under its  scope.  In order to clarify this  aspect of the 
Directive, we recommend to introduce a definition of claims, under Article 2 as point 
4.  Based on an analysis of the definitions used in national legislation and voluntary 
agreements, we suggest the following type of  definition: 
"A claim is any direct or indirect statement, symbol, suggestion, implication or 
any other form of communication (including the brand name) that a good has 
particular  characteristics  relating  to  its  origin,  properties,  effect,  nature, 
method of  production, processing, composition or any other quality". 
b.  Scope of the Misleading Advertising Directive 
It is unclear whether the scope of the Misleading Advertising Directive encompasses 
all  means of communication and,  in  particular,  claims made  on labelling (on-pack 
claims). All national legislation is based on the principle that a uniform set of rules 
should apply whatever the means of  communication used. 
We recommend that the Directive be amended so that it clearly applies to labelling. 
This could, for example, be done by introducing a provision which would state that 
the non-respect of labelling legislation should be considered misleading advertising. 
This would also be in line with the fact that, on a national level, misleading claims are 
often  judged  by  the  courts  on  the  basis  of  the  national  rules  on  misleading 
advertising/unfair competition. 
c.  Substantiation of Claims 
We  would recommend  introducing into  the  Misleading Advertising Directive (for 
example in the form of an Annex) a number of criteria that need to  be fulfilled in 
view  of the  substantiation  of claims.  This  seems  in  particular  necessary,  as  an 
increased use of health claims can be expected over the  coming years and,  so  far, 
criteria on the substantiation of  health claims are only listed in voluntary instruments. 
Similarly,  with  regard  to  ethical  claims,  criteria  are  mostly  set  out  in  fair  trade 
labelling schemes, but no  criteria for  substantiation of ethical claims are  fixed  by 
law. 
In order to ensure a high level of consumer protection, it may be worth considering 
introducing  the  following  criteria  into  a  possible  Annex  of  the  Misleading 
Advertising Directive: 
Claims must be: 
•  True and not misleading; 
•  Clear and understandable; 
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•  Complete (indicate, for example, for health claims on food the dosage required, 
the effect over time, etc.); 
•  Precise  and  not  using  extrapolations/generalisations  (eventually  claims  using 
words such as "implies", "suggests" etc. should be considered misleading); 
•  Objective  (e.g.  not  evoke  fears,  or if testimonials  are  used  must  provide  an 
objective image of  the effects that a product claims to have); 
•  Substantiated, verifiable and documented; 
•  Supported by evidence if the  claim is  based on  the  composition/quality of the 
product. 
We have limited the criteria of scientific evidence to  those claims that are based on 
the composition/quality of the product for the following reasons: 
•  Firstly,  it would evidently be possible to  indicate that scientific  evidence,  as  a 
criteria, should only apply to health claims. But in this case a definition of health 
claims would need to be inserted in the Misleading Advertising Directive. It can 
in our view, be questioned as to how far a definition of 'health claims' should not 
be left to 'vertical' legislation, i.e. Directive 791112. 
•  Secondly, it  is  clear that certain ethical claims, such as  'produced without child 
labour', cannot be based on evidence, as they are not based on the composition of 
the product or the quality of  the product. 
•  Thirdly, some ethical claims, notably the fair trade claims, for which some fair 
trade  labelling  schemes  require  the  respect  of  certain  environmental 
requirements,  would,  with  this  approach,  fall  under  the  obligation  of sound 
evidence. This approach would also encompass nutritional and green claims. 
•  Fourthly, this  solution also  automatically eliminates any disputes as  to whether 
specific claims fall under the chosen definition of health claims and whether for 
these specific claims scientific evidence was, therefore, needed or not. 
d.  Pre-Clearance 
The following are possible options: 
Pre-clearance for all claims 
The advantage of a pre-clearance system for all claims is that it would ensure that 
in  most  cases  only  truthful  and  non-misleading  claims  are  made.  The 
disadvantages of such a pre-clearance system is  that it is,  from  an  administrative 
point of view, very burdensome (and raises the  question of whether an EU  level 
pre-clearance authority would need to be established, in order to avoid barriers to 
trade  due  to  differing pre-clearance advice in  the  Member States).  Furthermore, 
even  under  a  pre-clearance  system  it  cannot  be  excluded  that  some  economic 
operators  may  make  misleading  claims.  Finally,  even  pre-clearance  from  a 
government authority, does not give  I  OOo/o  assurance to  an economic operator that 
a court may not find the claim unlawful. 
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need to be established) 
A second option is  to  establish an  EU  list of generic  claims  for  which no  pre-
clearance is  needed, whilst for all  other claims (new/innovative) pre-clearance is 
needed. The establishment of such a generic list could in our view only be done via 
Directive 791112  on the Labelling of Foodstuffs.  It  also raises the question as  to 
how far a list of generic ethical claims could be established and as to how far this 
could be added to the Misleading Advertising Directive. 
Notification procedure (similar to the one set up under the Directive for Particular 
Nutritional Uses 891398) 
A third option would be to introduce a notification procedure such as the one under 
Directive  89/398  on  Foodstuffs  for  Particular  Nutritional  Uses,  whereby  an 
operator has to notify the authorities of  the placing on the market of  a foodstuff for 
particular nutritional uses. The advantage for companies would be that they could 
put their product on the market immediately without having to await approval as in 
option a).  The disadvantage of this system seems to be that it may prove difficult 
for  national  authorities,  from  an  administrative  point  of view,  to  check  all 
labels/claims used.  This could partly be overcome if,  at the same time,  a generic 
list of  claims was established for which no notification was required. 
Assumption of  due diligence in case of  voluntary pre-clearance 
A  fourth  option  would  be  to  encourage  operators  to  submit,  either  in  the 
framework  of a  voluntary  agreement  or in  the  framework  of an  administrative 
body,  the  claim  that  he/she  wants  to  make  for  pre-clearance.  Companies  that 
follow this pre-clearance procedure could then be considered to have exercised due 
diligence. The courts may take this into account in the event of  any legal challenge 
to  the  claims.  The disadvantage of this  solution  is  that  in  some Member States 
(Germany, Italy, Austria), due to  the legal systems, courts may be tempted not to 
take  such  voluntary  pre-clearance  into  account,  in  particular  where  such  pre-
clearance is  carried out within the  framework of a voluntary agreement to which 
the authorities are not a party.  Such voluntary ageements could be considered as 
not being 'binding enough' to trigger an assumption of  due diligence. 
Reversal of  the burden of  proof, so that the maker of  the claim bears the burden 
A  fifth  possible way forward  would be  to  counterbalance the  absence  of a  pre-
clearance system by reversing the burden of proof so  that the maker of the claim 
would have to  prove the  non-misleading character and truthfulness of the  claim. 
This seems to be a possible way forward, although the dissuasive effect of  reversing 
the burden of proof would need to be examined in more detail. It has, nevertheless, 
the  advantage that  it  would not  impose any new burdens from  an administrative 
point of view. 
Weighing the advantages and disadvantages of  all these options (for further details see 
section Comparative Analysis - Existence of Pre-Clearance and Post-Clearance), and 
in  light of the diverging views of consumers and industry, the most viable solutions 
.  . 
are m our vtew: 
•  a system of  notification; and/or 
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I •  the  model  of assumption  of due  diligence  in  case  of voluntary pre-
clearance; and/or 
•  the reversal of  the burden of  proof. 
All three options allow for  increased consumer protection, whilst at the same time 
keeping the  administrative burden within reasonable  limits.  Furthermore,  all  three 
options seem to be compatible with voluntary instruments on claims. In particular the 
model  of voluntary pre-clearance,  as  well  as  the  reversal  of the  burden of proof 
concept seem to be systems which could apply to all types of  claims. 
e.  Post-Clearance 
i.  Burden of Proof 
In  those countries where the burden of proof lies with the plaintiff,  there seem to 
exist  problems  in  terms  of bringing  cases  to  the  courts,  notably  as  consumer 
associations  do  not  have  the  means  of paying  an  expert  who  could  provide  an 
opinion proving that a certain claim could not be scientifically proven. Therefore, we 
believe  that  a  modification  of the  rules  on  burden  of proof,  as  set  out  in  the 
Misleading Advertising Directive, should take place. 
Different options appear to be possible: 
•  To  impose on the producer the obligation to  provide all useful documentation 
and information so that the plaintiff can avail himself of concrete facts to prove 
his case. 
•  To  make  the  producer  bear  the  costs  of an  expert  opm10n  under  certain 
circumstances, e.g. on condition that the victim reimburses the costs in the event 
of  failure. 
•  To make the reversal of  the burden of  proof dependant as to whether the producer 
has  fulfilled  certain  criteria  set  out  in  an  amended  Directive  on  Misleading 
Advertising. The Directive could, for example, set out certain criteria applying to 
claims, in order to be considered non-misleading (for further details on this point 
see Substantiation of  Claims below). If a manufacturer has fulfilled these criteria, 
the burden of  proof would remain with the plaintiff. 
•  To reverse the burden of  proof. 
All arguments taken into account, the optimal solution is in our view a reversal of  the 
burden of proof, i.e. it would be up to the maker of the claim to proove that his/her 
claim is non-misleading and truthful. 
Nevertheless, a reversal of  the burden of proof may be considered by some Member 
States as  a profound intervention by the EU  into  its  basic  legal  principles.  In  this 
case, we consider as  second best option to make the reversal of the burden of proof 
dependant  as  to  whether  the  producer has  fulfilled  certain  criteria  set  out  in  an 
amended Directive on Misleading Advertising, whilst at the same time requiring the 
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plaintiff can avail himself of concrete facts to prove his case. 
ii.  Applicable Penalties 
In order to guarantee the same level of  consumer protection in all Member States with 
regard  to  the  sanctioning of misleading claims,  one option could be  to  introduce a 
provision  into  the  Misleading  Advertising  Directive,  requiring  Member  States  to 
introduce effective and dissuasive sanctions against the use of  misleading claims. 
f.  Out-of-Court Settlement 
Since,  in  a  number  of Member  States,  disputes  are  often  being  resolved  in  an 
informal  way  outside  the  courts,  it  would  be  interesting  to  see  if this  could  be 
introduced in all Member States. For example, along the lines of  a system as foreseen 
under Directive 98/27 on Injunctions for the Protection of Consumer Interests. The 
Directive foresees that the party that intends to seek an injunction can only start this 
procedure if it has tried to  achieve the cessation of the infringement in consultation 
with  either  the  defendant,  or with both  the  defendant  and  a  qualified  entity  (i.e. 
public bodies and organisations whose purpose it is to protect the collective interests 
of  consumers). 
g.  Technical Standards for Claims 
The  question  can  be  raised  as  to  how  far  the  proliferation  of national  voluntary 
agreements (in particular in the area of health claims) does not lead to different levels 
of consumer protection within the EU, as well as  to  the creation of new barriers to 
trade. Whilst one could argue for a European voluntary agreement for example in the 
area of  health claims or ethical claims, the problem is that: 
•  The  means  of surveillance  and  sanctions  of voluntary  agreements  are  rather 
limited; 
•  Voluntary agreements may not work in some countries for legal reasons (notably 
Italy and Germany); and 
•  If not all relevant parties sign up to a voluntary agreement, it will lack broad social 
legitimization. 
One could, therefore, argue that legislation might be the right way forward. 
Another possibility would be to model consumer protection in the area of claims on 
the new approach in harmonisation used for technical legislation, i.e.  EU legislation 
only establishes the  general principles and essential requirements. For the technical 
details,  reference  is  made  to  standards  due  to  be  established  by  standardisation 
institutes (e.g. CEN), following a mandate from the Commission. As in the technical 
area under this scenario, if standards are met, there would be a presumption that the 
claims used are in conformity with the essential requirements for claims as set out in 
an amended Misleading Advertising Directive. 
The voluntary instruments that have been developed at national level could be used as 
a source of inspiration and a link could be established whereby, for example, certain 
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have been developed. In this way, national voluntary instruments that work well could 
continue to exist (although some amendments may be needed). 
The  advantage  of this  approach  is  that  standardisation  is  probably  an  easier  way 
forward  than  exhaustive  legislation  and,  on  the  other hand,  it  has  a  greater  legal 
authority (in particular if developed under Commission surveillance and with a clear 
mandate) than voluntary instruments. 
It is clear that the standardisation approach will need to resolve a number of issues, in 
order to become a viable and functioning option: 
•  Funds will need to be made available by the EU for setting standards in the area of 
claims; 
•  An 'education process' amongst the standards institutes will be necessary to switch 
their culture from being essentially focused on technical/scientific aspects to  the 
less  precise and clear cut area of claims (standardisation institutes have already 
some experience in this area, e.g. ISO standard 14021  on green claims); and 
•  Ways  and  means  will  have  to  be  found  to  enable  consumer  associations  to 
participate adequately and equally with industry in the standardisation work. 
2.  Vertical Legislation- Amending 79/112 and 90/496 
A  number of proposals  are made,  which will  need  to  be addressed under the  two 
vertical  Directives  regulating  nutritional  labelling  (90/496)  and  food  labelling 
(79/112). 
a.  Revision of 79/112 
•  A definition of health claims is  needed,  in order to  overcome, on the one hand, 
currently existing barriers to trade and, on the other, to address the question of the 
use  of enhanced  function  and  disease  risk  reduction  claims.  This  needs  to  be 
addressed, in our view, via the Food Labelling Directive (79/112). 
•  It is  clear, that for the  use of health claims, more detailed criteria should be set 
with  regard  to  scientific  substantiation.  This  has  been  done  in  a  number  of 
voluntary codes  on health claims.  In  our view,  such criteria would need  to  be 
addressed in another legal framework, e.g. via Directive 79/112. 
•  The  Codex  Alimentarius  draft  April  1999  guidelines  on  the  use  of enhanced 
function claims and reduction of disease risk claims (even if they go further than 
the  allowed  scope  of Directive 79/112)  have  received  wide  support from  both 
industry and Member States authorities and even from certain consumer groups. 
Hence,  an  amendment to  79/112  and,  in particular,  to  Article 2,  (and Directive 
65/65) to allow these types of  claims may be considered. 
•  The consideration of a  clear set of criteria under  which a  health  claim  can be 
made. For example, a positive list of  generic claims. 
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This Directive could be amended to  include, in an Annex, the Codex guidelines for 
use of  nutritional claims, which define four different types of claims (nutrient content, 
comparative, nutrient function and claims related to dietary guidelines of healthy diets 
to  provide  additional  clarity,  as  well  as  ensuring  that  nutrient  content  claims  are 
clearly defined in terms of the quantitative level of the nutrient present, be consistent 
between products, and be meaningful to consumers. 
3.  Other Measures 
a.  Food Law Framework Directive 
The  definition  of a  foodstuff is  much  needed  and  should  come  in  a  Framework 
Directive on food law. This would have the purpose of clearly defining what is  and 
what  is  not  a  foodstuff;  thereby  reducing  the  problem  of borderline  cases  with 
pharmaceutical products as defined under Directive 65/65. 
b.  Information Campaign 
Consumer organisations wish to  see the EU setting-up an  information campaign to 
educate and inform consumers on the link between diet and health. 
c.  Ethical Labelling 
A definition of ethical claims should be addressed in any future legislation on ethical 
labelling, if  such legislation is to be considered necessary in the medium term. 
* * * 
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A.  DEFINITIONS,  LEGISLATION,  POLICY  DEVELOPMENTS  AND 
STAKEHOLDERS' POSITIONS 
1.  Comments 
•  In  the following we examine (i) the definitions given to  all  three types of claim; 
(ii) the legislation in place and how it differs to that of the EU Directives; and (iii) 
the  policy  developments  and  positions  of  the  major  stakeholders,  namely 
government/responsible  Ministries,  consumer  organisations  and  industry  (to  a 
very large degree the food and beverage industry, but also retailers). 
A.  Definitions and Legislation 
•  The first point to make is that there is no legal definition of what a "claim'' is at 
either national or EU level. However, Codex Alimentarius defines a claim for the 
food  sector.  The EU  Misleading Advertising Directive 84/450 does not directly 
refer to  claims, but it is generally acknowledged that claims fall under its  scope. 
The  Misleading  Advertising  Directive  can  be  seen  as  providing  for  certain 
restrictions and prohibitions, as  it defines in Article 2  (2) misleading advertising 
as: 
" ...  any advertising which in any way, including its presentation, deceives or is 
likely to deceive the persons to whom it is addressed or whom it reaches and 
which,  by reason of its  deceptive nature,  is  likely to  affect their economic 
behaviour  or  which,  for  those  reasons,  injures  or  is  likely  to  injure  a 
competitor" 
a.  Nutritional Claims 
•  Nutritional claims are defined in law, both at EU and national level, in compliance 
with Directive 90/496 on the Nutrition Labelling for Foodstuffs, article 1, para. 4 
(b) as: 
"any  representation  and  any advertising  message  which  states,  suggests  or 
implies that a foodstuff has particular nutrition properties due to  the  energy 
(calorific value) it provides; provides at a reduced or increased rate or;  does 
not  provide;  and/or due  to  the  nutrients  it  contains;  contains  in  reduced or 
increased  proportions  or;  does  not  contain.  A  reference  to  qualities  or 
quantities of a nutrient does not constitute a nutrition claim in  so far as  it is 
required by legislation". 
•  All definitions are by and large the same and follow the Codex guidelines, except 
for Ireland, Germany and The Netherlands, which are more restrictive. 
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•  Health  claims  are  defined  in  terms  of what  they  cannot  do,  establishing  a 
prohibition for  certain types of health-related claims.  As  such,  there  is  no  legal 
definition of what is  a health claim. Due· to  the increasing unclarity of Directive 
79/112  on  the  Labelling  Presentation, and  Advertising  of  Foodstuffs  and 
specifically Article 2, paragraph 1 (b) codified version, which reads : 
"1. The labelling and methods used must not: 
[ ... ] 
(b) subject to Community provisions applicable to natural mineral waters and 
foodstuffs for particular nutritional uses, attribute to any foodstuff the property 
of preventing, treating or curing a human disease, or refer to such properties." 
Health claims are interpreted differently (either a more liberal regime such as 
in the UK or a restrictive/to the letter of the law such as in Germany and Italy) 
throughout the EU. 
•  There are also a number of developments, which have added to  the debate as to 
the definition of  health claims: 
•  Certain Member States, such as the UK, have an unofficial definition which is 
commonly accepted; 
•  the more liberal definitions coming from the US and Canada~ 
•  the recent work in the Codex Alimentarius, which has defined a health claim 
and  come  up  with  draft  guidelines  on  allowed  claims  (enhanced  function 
claims and reduction of disease risk claims, the  latter going further than the 
allowed scope of  Directive 79/112) and their specific definitions; and 
•  the various voluntary agreements/codes of practice in several Member States 
(Belgium,  The  Netherlands,  Spain,  Sweden,  and  UK)  have  developed 
definitions  of a  health  claim,  which  are  usually  broader  in  its  scope  than 
Directive 79/112. 
•  As  to  the  variations  with  regard  to  the  definition  of a  health  claim,  there  are 
widespread differences.  Six  countries have a more restrictive approach, namely 
Austria,  Belgium, Germany, Italy,  Luxembourg, Portugal, whilst three countries 
have  a more liberal approach namely Finland,  France,  UK and the  other seven 
tend to take a middle ground between the two. 
c.  Ethical Claims 
•  With regard to  ethical claims, there is  no direct legislation or legal definition in 
any of  the Member States. Nevertheless, each Member State has legislation which 
indirectly applies to  ethical claims, most often due to national implementation of 
the EU Directive on Misleading Advertising. 
•  Ethical  claims - whatever they cover exactly (there  are  differing views  but in 
essence  they  cover  labour-related  working  conditions)  are  a  fairly  new 
phenomenon/type of labelling, which have only appeared on products in the last 
few years. 
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B.  Policy Developments and the Positions of the Major Stakeholders 
a.  Nutritional Claims 
•  Interestingly,  policy  thinking  and  developments  in  the  Member  States  clearly 
demonstrate that on nutritional claims, as a whole, most stakeholders are generally 
satisfied with the current legislative environment. It has to  be noted that the UK 
consumer organisations are  the  exception as  they are  seeking further  restrictive 
rules,  wishing to  see criteria for  absolute  and relative  claims, a  full  supporting 
nutritional panel and a set of  standard criteria for healthy eating symbols. 
•  The  key  development  is  the  discussions  on  the  Codex  Guidelines  for  use  of 
nutrition  claims,  which  define  four  different  types  of claims  (nutrient  content, 
comparative, nutrient function and claims related to  dietary guidelines of healthy 
diets).  There  is  quite  a  large  consensus  that  these  should  be  annexed  to  the 
Nutritional Labelling Directive. 
•  There are also three countries where voluntary codes/guidelines have been set-up 
to  provide further information to industry, namely in  Denmark, Finland, and the 
UK,  such as  the  UK F  AC  guidelines, perhaps demonstrating the need to  better 
assist  industry  in  order  to  provide  consumers  with  better/legal/truthful 
information.  Another  example  is  the  Co-operative  Wholesale  Society  (CWS) 
which has developed its own code of  practice for labelling of  pre-packed foods for 
both nutritional  and health claims.  The  views  of the  CWS  are  that  the  lack  of 
detailed provisions could lead to the potential of  misleading consumers. 
b.  Health Claims 
•  Health claims, without a doubt, pose the biggest problem and the major challenge. 
The  various  and  numerous  developments  taking  place  throughout  Europe  are 
clearly  indicative  of the  need  to  establish  a  better  regulatory  framework.  The 
Codex  Alimentarius  draft  April  1999  guidelines  recommending  the  use  of 
enhanced function claims and reduction of disease risk claims have received wide 
support from both industry and Member States authorities and even from  certain 
consumer groups. Also, the developments across the Atlantic in both the  US  and 
Canada are demonstrative of the liberal approach to health claims gaining ground. 
•  The  voluntary  codes/agreements  set-up  in  Sweden,  Spain,  The  Netherlands 
(already in  operation) and in  Belgium and in  the  UK (both expected to become 
operational  in  2000)  and  the  EU  level  one  developed  by the  CIAA  (adopted 
September 1999) is  a clear demonstration of how regulators,  industry and,  to  a 
large  extent,  consumers  have  come  together  to  pave  the  way  forward.  The 
definitions,  criteria,  verification  systems  established  in  these  voluntary 
codes/agreements should be viewed as a blue print for what should be done at EU 
level. 
•  Below, we list the key demands of the stakeholders. Many of these will of course 
form the basis for our recommendations. Please note that some issues, such as the 
voluntary  codes/agreements,  the  verification  systems  (pre-and  post-clearance, 
burden of proof, sanctions), means of communications, case law, barriers to trade, 
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therefore, this section must be seen in the overall context: 
i.  Regulators 
•  Virtually  all  Member  States  (perhaps  Spain  and  Belgium  are  somewhat  more 
reticent  and  possibly The Netherlands  does  not  see  a  great need)  agree  that  it 
should  be  at  the  EU  level  that  the  problems  surrounding  health  claims  are 
resolved; 
•  The large majority of Member States have expressed the need to amend Directive 
791112 in order to meet current requirements; 
•  They consider Codex draft guidelines as the way forward in order to  introduce a 
more liberal regime; 
•  They accept that perhaps, a definition of a foodstuff should be elaborated to avoid 
the problem of  borderline cases; 
•  They realise that they need to consider: 
* allowing enhanced function and disease risk reductions claims; 
* drawing-up a positive list of  generic claims; 
*  introducing  pre-clearance  and/or  introducing  pre-clearance  for  innovative 
claims; and 
* reviewing the criteria to establish what type of  claim can be made. 
•  They view  the  voluntary  codes/agreements  as  a  step  in  the  right direction  but 
ultimately wish to see legislation in place. 
ii.  Consumer Organisations 
•  They are  calling for  action,  preferably at  the  EU  level,  although this  does  not 
mean that nothing should be done at national level; 
•  They prefer criteria for substantiation to be developed as opposed to a positive or 
negative list of  health claims; 
•  They want pre-clearance for all claims; 
•  They want the supervision/control of  claims once on the market to be tightened to 
guarantee consumer protection; 
•  They want the burden of  proof to lie with the maker of  the claim in order to allow 
easier, cheaper prosecution; 
•  They would like to see an amendment to the Misleading Advertising Directive to 
include distance selling and electronic commerce; and 
•  They wish  to  see  the  EU  setting-up  an  information  campaign  to  educate  and 
inform consumers on the link between diet and health. 
iii.  Industry 
•  Industry is  of the view that the EU is  the  best level to  create a clear regulatory 
environment. Whilst ideally industry would like to see self-regulation as  the way 
forward, industry is realistic that a code might not be able to work in each country 
(Italy and Germany for legal reasons) and the fact that regulators and consumers 
favour legislation. 
•  In addition, industry is calling for: 
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•  The introduction of a more liberal regime; 
•  An amendment to 79/112 (and Directive 65/65), and Article 2 in particular to 
allow  new  types  of claims,  in  particular  disease  risk  reduction  claims  and 
enhanced function claims; 
•  The consideration of  a clear set of  criteria under which a claim can be made; 
•  No pre-clearance, but well defined post clearance verifications; 
•  A voluntary code/agreement to  create the necessary framework (German and 
Italian industry would probably oppose this). 
•  Retailers and other industry-related interests favour only enhanced function claims 
and call for criteria to be drawn-up under which conditions a claim can be made (a 
positive list is possible). 
•  The Advertising industry calls for self-regulation. 
c.  Ethical Claims 
•  With regard to  ethical claims, whilst there is  no  real  perceived problem, a large 
number of stakeholders (retailers are perhaps overall  against)  tend to  agree that 
they  should  be  regulated  in  order  to  avoid  problems  and  guarantee  consumer 
protection in the future, given that the expectation is that they will proliferate. The 
European Parliament has called for a social label, together with a code of conduct 
for  European  businesses  that  should  comprise  existing  minimum  applicable 
international standards. 
•  Only two countries, Belgian and Italy, are drafting legislation. In Belgium, there is 
a  consensus  that  a  regulatory  framework  is  required,  which  has  led  to  two 
proposals: one for the promotion of socially responsible production with a label 
(ILO  standards)  and  one  for  adding  labelling/advertising  provisions  with  an 
ethical notion to  the  unfair competition and consumer information law.  In  Italy, 
the  Parliament is  adopting a  law  on  the  certification of social  conformity (and 
label) of  products produced without the use of  child labour. 
•  As with health claims, voluntary agreements/codes of  conduct are being set-up for 
ethical claims. The most well known one is the Fairtrade Labelling Organisations 
International (FLO),  which does not have a claim as  such but a fairtrade  label, 
which could be/is associated by consumers with certain ethical standards. Whilst 
there is no question of lack of consumer protection, there is nevertheless the view 
that an independent verification system should be carried out. 
•  In  addition to  Belgium and  Italy,  four  other Member States  (Denmark,  France, 
Portugal, and Sweden) have seen developments signalling a call to regulate ethical 
claims  in  some  form.  The  other  nine  Member  States  are  not  against  doing 
anything; they simply have not considered the issue and, hence, have no position. 
•  On  the  whole  consumer  organisations  have  not  developed  a  defined 
viewpoint/position on  ethical claims.  Suffice  to  say  that  they want them  to  be 
regulated,  like  any other claim, via the right channels.  By contrast, as  a whole, 
industry do not perceive ethical claims to be an issue, as their use is limited. 
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definitions  used  and  legislation  in  place  and,  secondly,  a  table  which  gives  an 
overview of  policy developments and the stakeholders' positions. 
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i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
n
o
t
 
a
l
l
o
w
 
c
l
a
i
m
s
 
o
n
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
c
e
r
t
a
i
n
 
p
r
o
h
i
b
i
t
i
o
n
s
,
 
e
s
t
a
b
l
i
s
h
i
n
g
 
a
 
m
o
r
e
 
r
e
s
t
r
i
c
t
i
v
e
 
i
n
t
e
r
p
r
e
t
a
t
i
o
n
.
 
C
o
u
l
d
 
a
l
l
o
w
 
n
u
t
r
i
e
n
t
s
.
 
c
e
r
t
a
i
n
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
(
a
s
 
d
e
f
i
n
e
d
 
b
y
 
C
o
d
e
x
)
 
b
u
t
 
d
o
e
s
 
n
o
t
 
p
e
r
m
i
t
 
d
i
s
e
a
s
e
s
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
.
 
G
r
e
e
c
e
 
C
o
n
f
o
r
m
s
 
t
o
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
,
 
b
u
t
 
C
o
d
e
 
p
r
o
v
i
d
e
s
 
t
h
e
 
n
o
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
 
t
e
r
m
s
 
o
f
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
p
r
o
h
i
b
i
t
i
o
n
s
 
a
n
d
 
r
e
s
p
e
c
t
s
,
 
w
o
r
d
 
f
o
r
 
w
o
r
d
,
 
A
r
t
i
c
l
e
 
2
 
o
f
 
7
9
/
1
 
1
2
.
 
I
r
e
l
a
n
d
 
C
o
n
f
o
r
m
s
 
t
o
 
E
U
 
l
a
w
,
 
b
u
t
 
s
t
r
i
c
t
e
r
 
t
h
a
n
 
C
o
n
f
o
r
m
s
 
t
o
 
E
U
 
7
9
/
1
1
2
,
 
w
o
r
d
 
f
o
r
 
w
o
r
d
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
C
o
d
e
x
 
a
s
 
c
l
a
i
m
s
 
r
e
l
a
t
e
d
 
t
o
 
d
i
e
t
a
r
y
 
g
u
i
d
e
l
i
n
e
s
 
o
r
 
h
e
a
l
t
h
y
 
d
i
e
t
s
 
a
r
e
 
n
o
t
 
a
l
l
o
w
e
d
.
 
I
t
a
l
y
 
D
e
f
i
n
i
t
i
o
n
 
i
d
e
n
t
i
c
a
l
 
t
o
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
b
u
t
 
c
o
n
f
o
r
m
s
 
t
o
 
E
U
 
7
9
/
1
1
2
,
 
a
l
t
h
o
u
g
h
 
a
 
m
o
r
e
 
r
e
s
t
r
i
c
t
i
v
e
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
a
p
p
r
o
a
c
h
 
i
s
 
a
d
o
p
t
e
d
.
 
T
h
e
y
 
d
o
 
n
o
t
 
a
c
c
e
p
t
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
r
e
 
v
e
r
y
 
l
i
m
i
t
e
d
.
 
L
u
x
e
m
b
o
u
r
g
 
D
e
f
i
n
i
t
i
o
n
 
i
d
e
n
t
i
c
a
l
 
t
o
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
.
 
H
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
b
a
n
n
e
d
.
 
C
o
n
f
o
r
m
s
 
t
o
 
E
U
 
7
9
/
1
1
2
,
 
a
l
t
h
o
u
g
h
 
a
 
m
o
r
e
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
r
e
s
t
r
i
c
t
i
v
e
 
a
p
p
r
o
a
c
h
 
i
s
 
a
d
o
p
t
e
d
.
 
T
h
e
y
 
d
o
 
n
o
t
 
a
c
c
e
p
t
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
r
e
 
v
e
r
y
 
l
i
m
i
t
e
d
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
3
8
 C
o
u
n
t
r
y
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
N
e
t
h
e
r
l
a
n
d
s
 
D
e
f
i
n
i
t
i
o
n
 
s
a
m
e
 
a
s
 
E
U
 
9
0
/
4
9
6
,
 
b
u
t
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
b
u
t
 
b
a
n
n
e
d
 
u
n
d
e
r
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
D
e
f
i
n
i
t
i
o
n
 
i
d
e
n
t
i
c
a
l
 
t
o
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
s
o
m
e
w
h
a
t
 
m
o
r
e
 
r
e
s
t
r
i
c
t
i
v
e
.
 
E
U
.
 
P
o
r
t
u
g
a
l
 
D
e
f
i
n
i
t
i
o
n
 
s
a
m
e
 
a
s
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
a
n
d
 
b
a
n
n
e
d
 
u
n
d
e
r
 
a
n
d
 
c
o
n
f
o
r
m
s
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
,
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
a
l
t
h
o
u
g
h
 
a
 
m
o
r
e
 
r
e
s
t
r
i
c
t
i
v
e
 
a
p
p
r
o
a
c
h
 
i
s
 
a
d
o
p
t
e
d
.
 
T
h
e
y
 
d
o
 
n
o
t
 
a
c
c
e
p
t
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
r
e
 
v
e
r
y
 
l
i
m
i
t
e
d
.
 
S
p
a
i
n
 
D
e
f
i
n
i
t
i
o
n
 
s
a
m
e
 
a
s
 
E
U
 
9
0
/
4
9
6
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
a
n
d
 
b
a
n
n
e
d
 
u
n
d
e
r
 
a
n
d
 
c
o
n
f
o
r
m
s
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
S
w
e
d
e
n
 
D
e
f
i
n
i
t
i
o
n
 
s
a
m
e
 
a
s
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
 
+
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
a
n
d
 
b
a
n
n
e
d
 
u
n
d
e
r
 
a
n
d
 
c
o
n
f
o
r
m
s
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
1
1
1
2
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
K
e
y
h
o
l
e
 
t
r
a
d
e
m
a
r
k
 
s
y
m
b
o
l
 
t
o
 
d
e
f
i
n
e
 
S
w
e
d
i
s
h
 
F
o
o
d
 
A
c
t
 
d
e
f
i
n
e
s
 
f
o
o
d
s
t
u
f
f
.
 
c
e
r
t
a
i
n
 
p
r
o
d
u
c
t
s
.
 
U
K
 
D
e
f
i
n
i
t
i
o
n
 
s
a
m
e
 
a
s
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
.
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
a
n
d
 
b
a
n
n
e
d
 
u
n
d
e
r
 
a
n
d
 
c
o
n
f
o
r
m
s
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
,
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
a
l
t
h
o
u
g
h
 
t
h
e
r
e
 
i
s
 
a
 
g
e
n
e
r
a
l
l
y
 
a
c
c
e
p
t
e
d
 
d
e
f
i
n
i
t
i
o
n
.
 
u
s
 
L
i
s
t
 
o
f
 
l
 
0
 
a
u
t
h
o
r
i
s
e
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
A
l
l
o
w
s
 
s
t
r
u
c
t
u
r
e
 
a
n
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
(
s
a
m
e
 
a
s
 
t
h
e
 
E
u
r
o
p
e
a
n
 
t
e
r
m
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
)
.
 
C
a
n
a
d
a
 
D
e
f
i
n
i
t
i
o
n
 
o
f
 
a
 
n
u
t
r
i
e
n
t
 
c
o
n
t
e
n
t
 
c
l
a
i
m
 
(
a
n
d
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
b
u
t
 
a
 
d
i
f
f
e
r
e
n
c
e
 
i
s
 
m
a
d
e
 
b
e
t
w
e
e
n
 
t
h
e
r
a
p
e
u
t
i
c
 
a
n
d
 
r
i
s
k
 
N
o
 
d
e
f
i
n
i
t
i
o
n
 
o
r
 
s
p
e
c
i
f
i
c
 
l
e
g
i
s
l
a
t
i
o
n
.
 
c
o
m
p
a
r
a
t
i
v
e
 
c
l
a
i
m
s
)
 
a
r
e
 
t
h
e
 
s
a
m
e
 
a
s
 
C
o
d
e
x
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
w
h
i
c
h
 
a
r
e
 
b
a
n
n
e
d
 
a
n
d
 
s
t
r
u
c
t
u
r
e
,
 
a
n
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
,
 
b
u
t
 
n
o
t
 
l
e
g
a
l
l
y
 
e
n
f
o
r
c
e
a
b
l
e
 
w
h
i
c
h
 
a
r
e
 
a
l
l
o
w
e
d
,
 
b
u
t
 
t
h
e
r
e
 
i
s
 
a
 
l
e
g
i
s
l
a
t
i
v
e
 
f
r
a
m
e
w
o
r
k
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
3
9
 2
.
b
)
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
P
o
l
i
c
y
 
D
e
v
e
l
o
p
m
e
n
t
s
 
a
n
d
 
S
t
a
k
e
h
o
l
d
e
r
s
'
 
P
o
s
i
t
i
o
n
s
 
C
o
u
n
t
r
y
 
E
U
 
A
u
s
t
r
i
a
 
B
e
l
g
i
u
m
 
D
e
n
m
a
r
k
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
D
i
s
c
u
s
s
i
o
n
 
a
b
o
u
t
 
C
o
d
e
x
 
G
u
i
d
e
l
i
n
e
s
 
f
o
r
 
u
s
e
 
o
f
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
w
h
i
c
h
 
d
e
f
i
n
e
 
4
 
d
i
f
f
e
r
e
n
t
 
t
y
p
e
s
 
o
f
 
c
l
a
i
m
s
 
(
n
u
t
r
i
e
n
t
 
c
o
n
t
e
n
t
,
 
c
o
m
p
a
r
a
t
i
v
e
,
 
n
u
t
r
i
e
n
t
 
f
u
n
c
t
i
o
n
 
a
n
d
 
c
l
a
i
m
s
 
r
e
l
a
t
e
d
 
t
o
 
d
t
e
t
a
r
y
 
g
u
i
d
e
l
i
n
e
s
 
o
f
 
h
e
a
l
t
h
y
 
d
i
e
t
s
,
 
t
o
 
b
e
 
a
n
n
e
x
e
d
 
t
o
 
N
u
t
r
i
t
i
o
n
a
l
 
L
a
b
e
l
l
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
X
 
N
o
 
n
e
e
d
 
f
o
r
 
r
e
v
i
s
i
o
n
,
 
e
x
c
e
p
t
 
f
o
r
 
a
l
l
o
w
i
n
g
 
o
t
h
e
r
 
s
u
b
s
t
a
n
c
e
s
 
n
o
t
 
c
u
r
r
e
n
t
l
y
 
l
i
s
t
e
d
.
 
X
 
N
o
 
p
l
a
n
s
 
t
o
 
c
h
a
n
g
e
 
t
h
e
 
l
a
w
.
 
D
a
n
i
s
h
 
F
o
o
d
 
D
i
r
e
c
t
o
r
a
t
e
 
a
c
c
e
p
t
s
 
n
e
e
d
 
t
o
 
a
l
l
o
w
 
n
u
t
r
i
e
n
t
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
i
n
 
a
c
c
o
r
d
a
n
c
e
 
w
i
t
h
 
C
o
d
e
x
.
 
U
n
d
e
r
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
,
 
t
h
e
 
S
-
L
a
b
e
l
 
d
e
v
e
l
o
p
e
d
 
t
o
 
i
n
d
i
c
a
t
e
 
p
r
o
d
u
c
t
s
 
l
o
w
 
i
n
 
f
a
t
 
o
r
 
s
u
g
a
r
.
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
D
r
a
f
t
 
C
o
d
e
x
 
G
u
i
d
e
l
i
n
e
s
 
r
e
c
o
m
m
e
n
d
 
t
h
e
 
u
s
e
 
o
f
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
r
e
d
u
c
t
i
o
n
 
o
f
 
d
i
s
e
a
s
e
 
r
i
s
k
 
c
l
a
i
m
s
.
 
E
u
r
o
p
e
a
n
 
P
a
r
l
i
a
m
e
n
t
 
b
a
c
k
s
 
t
h
i
s
 
p
o
s
i
t
i
o
n
 
a
s
 
d
o
e
s
 
t
h
e
 
f
o
o
d
 
i
n
d
u
s
t
r
y
 
a
t
 
l
a
r
g
e
,
 
c
a
l
l
i
n
g
 
f
o
r
 
a
n
 
a
m
e
n
d
m
e
n
t
 
t
o
 
7
9
1
1
1
2
 
(
a
n
d
 
D
i
r
e
c
t
i
v
e
 
6
5
/
6
5
)
 
a
n
d
 
A
r
t
i
c
l
e
 
2
 
t
o
 
a
l
l
o
w
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
.
 
R
e
t
a
i
l
e
r
s
 
a
n
d
 
o
t
h
e
r
 
i
n
d
u
s
t
r
y
-
r
e
l
a
t
e
d
 
i
n
t
e
r
e
s
t
s
 
f
a
v
o
u
r
 
o
n
l
y
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
c
a
l
l
 
f
o
r
 
c
r
i
t
e
r
i
a
 
t
o
 
b
e
 
d
r
a
w
n
-
u
p
 
u
n
d
e
r
 
w
h
i
c
h
 
c
o
n
d
i
t
i
o
n
s
 
a
 
c
l
a
i
m
 
c
a
n
 
b
e
 
m
a
d
e
 
(
a
 
p
o
s
i
t
i
v
e
 
l
i
s
t
 
i
s
 
p
o
s
s
i
b
l
e
)
.
 
C
o
n
s
u
m
e
r
s
 
w
a
n
t
 
s
t
r
i
c
t
 
l
e
g
i
s
l
a
t
i
o
n
,
 
n
o
 
p
o
s
i
t
i
v
e
 
o
r
 
n
e
g
a
t
i
v
e
 
l
i
s
t
,
 
b
u
t
 
i
n
s
t
e
a
d
 
c
r
i
t
e
r
i
a
 
t
o
 
e
n
s
u
r
e
 
t
h
a
t
 
o
n
l
y
 
t
r
u
e
 
a
n
d
 
n
o
n
-
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
 
a
r
e
 
m
a
d
e
.
 
T
h
e
 
a
d
v
e
r
t
i
s
i
n
g
 
i
n
d
u
s
t
r
y
 
c
a
l
l
s
 
f
o
r
 
s
e
l
f
-
r
e
g
u
l
a
t
i
o
n
.
 
A
u
t
h
o
r
i
t
i
e
s
 
c
o
n
c
e
d
e
 
t
h
a
t
 
c
e
r
t
a
i
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
a
l
l
o
w
e
d
,
 
c
o
m
b
i
n
e
d
 
w
i
t
h
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
T
h
i
s
 
i
s
 
b
a
c
k
e
d
-
u
p
 
b
y
 
i
n
d
u
s
t
r
y
 
w
h
i
c
h
 
v
i
e
w
s
 
l
e
g
i
s
l
a
t
i
o
n
 
a
s
 
f
a
r
 
t
o
o
 
s
t
r
i
c
t
 
(
e
v
e
n
 
a
g
a
i
n
s
t
 
E
U
 
l
a
w
)
 
a
n
d
 
c
a
l
l
 
f
o
r
 
p
h
y
s
i
o
l
o
g
i
c
a
l
 
c
l
a
i
m
s
 
t
o
 
b
e
 
a
l
l
o
w
e
d
.
 
C
o
n
s
u
m
e
r
s
 
a
r
e
,
 
h
o
w
e
v
e
r
,
 
o
p
p
o
s
e
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
s
e
e
k
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
A
u
t
h
o
r
i
t
i
e
s
 
a
c
c
e
p
t
 
t
h
a
t
 
f
o
l
l
o
w
i
n
g
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
t
h
e
r
e
 
i
s
 
a
 
n
e
e
d
 
t
o
 
r
e
v
i
s
e
 
t
h
e
 
l
a
w
 
t
o
 
a
c
c
e
p
t
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
.
 
T
h
e
 
i
n
d
u
s
t
r
y
 
v
i
e
w
s
 
c
u
r
r
e
n
t
 
r
u
l
e
s
 
a
s
 
t
o
o
 
r
e
s
t
r
i
c
t
i
v
e
,
 
c
a
l
l
i
n
g
 
f
o
r
 
r
e
v
i
s
i
o
n
 
a
s
 
a
b
o
v
e
 
a
s
 
w
e
l
l
 
a
s
 
c
a
l
l
i
n
g
 
f
o
r
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
t
o
 
b
e
 
r
o
l
l
e
d
-
o
u
t
 
a
c
r
o
s
s
 
E
u
r
o
p
e
.
 
C
o
n
s
u
m
e
r
s
 
a
r
e
,
 
h
o
w
e
v
e
r
,
 
s
c
e
p
t
i
c
a
l
.
 
D
a
n
i
s
h
 
G
o
v
e
r
n
m
e
n
t
 
a
c
c
e
p
t
s
 
n
e
e
d
 
t
o
 
h
a
v
e
 
w
i
d
e
r
 
a
p
p
l
i
c
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
t
o
 
a
c
c
e
p
t
 
r
e
d
u
c
t
i
o
n
 
o
f
 
d
i
s
e
a
s
e
 
r
i
s
k
 
c
l
a
i
m
s
 
b
u
t
 
n
o
t
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
(
p
h
y
s
i
o
l
o
g
i
c
a
l
 
c
l
a
i
m
s
)
 
a
n
d
 
a
c
c
e
p
t
s
 
U
S
/
S
w
e
d
i
s
h
 
m
o
d
e
l
 
t
h
a
t
 
a
n
y
 
c
l
a
i
m
 
r
e
l
a
t
i
n
g
 
t
o
 
a
 
s
p
e
c
i
f
i
c
 
f
o
o
d
 
p
r
o
d
u
c
t
 
i
s
 
p
l
a
c
e
d
 
i
n
 
t
h
e
 
c
o
n
t
e
x
t
 
o
f
t
h
e
 
t
o
t
a
l
 
d
i
e
t
 
a
n
d
 
f
a
v
o
u
r
s
 
E
U
 
a
c
t
i
o
n
 
a
n
d
 
m
e
a
s
u
r
e
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
E
u
r
o
p
e
a
n
 
P
a
r
l
i
a
m
e
n
t
 
c
a
l
l
e
d
 
f
o
r
 
S
o
c
i
a
l
 
L
a
b
e
l
 
t
o
 
e
n
s
u
r
e
 
e
x
i
s
t
i
n
g
 
m
i
n
i
m
u
m
 
a
p
p
l
i
c
a
b
l
e
 
i
n
t
e
r
n
a
t
i
o
n
a
l
 
s
t
a
n
d
a
r
d
s
.
 
D
G
 
d
e
v
e
l
o
p
m
e
n
t
 
I
s
 
f
i
n
a
l
i
s
i
n
g
 
a
 
C
o
m
m
u
n
i
c
a
t
i
o
n
 
o
n
 
F
a
i
r
 
T
r
a
d
e
.
 
E
u
r
o
c
o
m
m
e
r
c
e
 
i
s
 
a
g
a
i
n
s
t
 
l
e
g
i
s
l
a
t
i
o
n
,
 
a
s
 
t
h
e
y
 
w
i
l
l
 
n
o
t
 
o
f
t
e
n
 
b
e
 
u
s
e
d
,
 
t
h
e
 
d
i
f
f
i
c
u
l
t
y
 
o
f
 
e
n
s
u
r
i
n
g
 
c
o
m
p
l
e
t
e
 
v
e
r
a
c
i
t
y
 
a
n
d
 
m
a
r
k
e
t
 
w
i
l
l
 
r
e
g
u
l
a
t
e
 
f
a
l
s
e
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
i
t
s
e
l
f
.
 
N
o
t
 
a
n
 
i
s
s
u
e
 
f
o
r
 
B
E
U
C
.
 
X
 
N
o
t
h
i
n
g
 
e
n
v
i
s
a
g
e
d
.
 
C
o
n
s
e
n
s
u
s
 
t
h
a
t
 
a
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
 
i
s
 
r
e
q
u
i
r
e
d
 
-
t
w
o
 
p
r
o
p
o
s
a
l
s
 
o
n
 
t
h
e
 
t
a
b
l
e
:
 
o
n
e
 
f
o
r
 
t
h
e
 
p
r
o
m
o
t
i
o
n
 
o
f
 
s
o
c
i
a
l
l
y
 
r
e
s
p
o
n
s
i
b
l
e
 
p
r
o
d
u
c
t
i
o
n
 
w
i
t
h
 
a
 
l
a
b
e
l
 
(
I
L
O
 
s
t
a
n
d
a
r
d
s
)
 
a
n
d
 
o
n
e
 
f
o
r
 
a
d
d
i
n
g
 
l
a
b
e
l
l
i
n
g
/
a
d
v
e
r
t
i
s
i
n
g
 
p
r
o
v
i
s
i
o
n
s
 
w
i
t
h
 
a
n
 
e
t
h
i
c
a
l
 
n
o
t
i
o
n
 
t
o
 
t
h
e
 
u
n
f
a
i
r
 
c
o
m
p
e
t
i
t
i
o
n
 
a
n
d
 
c
o
n
s
u
m
e
r
 
i
n
f
o
r
m
a
t
i
o
n
 
l
a
w
.
 
N
G
O
s
 
a
r
e
 
t
h
e
 
d
r
i
v
i
n
g
 
f
o
r
c
e
 
G
o
v
e
r
n
m
e
n
t
 
c
a
l
l
i
n
g
 
f
o
r
 
e
f
f
e
c
t
i
v
e
 
d
e
f
i
n
i
t
i
o
n
 
a
n
d
 
n
e
w
 
l
a
b
e
l
l
i
n
g
 
s
y
s
t
e
m
 
a
t
 
E
U
 
l
e
v
e
l
.
 
4
0
 C
o
u
n
t
r
y
 
F
i
n
l
a
n
d
 
F
r
a
n
c
e
 
G
e
r
m
a
n
y
 
G
r
e
e
c
e
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
X
 
S
t
a
k
e
h
o
l
d
e
r
s
 
a
g
r
e
e
 
t
h
a
t
 
t
h
e
r
e
 
i
s
 
n
o
 
n
e
e
d
 
t
o
 
m
a
k
e
 
c
h
a
n
g
e
s
 
t
o
 
t
h
e
 
l
a
w
,
 
b
u
t
 
a
r
e
 
w
o
r
k
i
n
g
 
o
n
 
g
u
i
d
e
l
i
n
e
s
 
f
o
r
 
t
h
e
 
u
s
e
 
o
f
 
n
u
t
r
i
t
i
o
n
a
l
 
d
e
c
l
a
r
a
t
i
o
n
s
 
a
n
d
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
d
u
e
 
i
n
 
A
u
t
u
m
n
 
1
9
9
9
.
 
X
 
T
h
e
r
e
 
i
s
 
n
o
 
i
n
d
i
c
a
t
i
o
n
 
t
h
a
t
 
a
n
y
 
c
h
a
n
g
e
s
 
s
h
o
u
l
d
 
b
e
 
m
a
d
e
.
 
X
 
C
u
r
r
e
n
t
 
l
e
g
i
s
l
a
t
i
o
n
 
1
s
 
d
e
e
m
e
d
 
s
a
t
i
s
f
a
c
t
o
r
y
 
a
n
d
 
n
o
 
i
n
i
t
i
a
t
i
v
e
s
 
a
r
e
 
p
l
a
n
n
e
d
,
 
e
x
c
e
p
t
 
f
o
r
 
t
h
e
 
r
e
v
i
e
w
 
o
f
 
t
h
e
 
1
5
%
 
R
D
A
 
v
a
l
u
e
.
 
X
 
N
o
 
c
h
a
n
g
e
s
 
p
l
a
n
n
e
d
.
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
G
o
v
e
r
n
m
e
n
t
 
a
n
d
 
i
n
d
u
s
t
r
y
 
f
a
v
o
u
r
 
a
 
m
o
r
e
 
l
i
b
e
r
a
l
 
r
e
g
i
m
e
 
a
s
 
p
e
r
 
C
o
d
e
x
,
 
a
n
d
 
w
i
s
h
 
f
o
r
 
E
U
 
f
r
a
m
e
w
o
r
k
 
a
c
c
e
p
t
i
n
g
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
.
 
G
o
v
e
r
n
m
e
n
t
 
f
a
v
o
u
r
s
 
e
x
p
l
i
c
i
t
 
l
i
s
t
 
o
f
 
a
c
c
e
p
t
a
b
l
e
 
a
n
d
 
p
r
o
h
i
b
i
t
e
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
I
n
d
u
s
t
r
y
 
i
s
 
s
e
e
k
i
n
g
 
a
c
c
e
p
t
a
n
c
e
 
o
f
 
d
i
s
e
a
s
e
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
b
u
t
 
N
F
 
A
 
c
o
n
s
i
d
e
r
s
 
t
h
a
t
 
a
n
 
a
m
e
n
d
m
e
n
t
 
I
S
 
n
e
e
d
e
d
 
o
f
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
C
o
n
s
u
m
e
r
s
 
f
e
a
r
 
i
n
t
r
o
d
u
c
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
s
p
e
c
i
f
i
c
 
c
l
a
i
m
s
 
f
o
r
 
p
r
o
d
u
c
t
s
 
a
n
d
,
 
t
h
e
r
e
f
o
r
e
,
 
c
a
l
l
 
f
o
r
 
t
h
e
 
S
w
e
d
i
s
h
 
a
p
p
r
o
a
c
h
 
a
n
d
 
q
u
e
s
t
i
o
n
 
l
a
c
k
 
o
f
 
s
u
p
e
r
v
i
s
i
o
n
 
a
n
d
 
c
o
n
t
r
o
l
 
o
f
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
J
u
n
e
 
1
9
9
8
 
C
o
n
s
e
i
l
 
N
 
a
 
t
i
o
n
a
!
 
d
e
 
L
'
 
A
l
i
m
e
n
t
a
t
i
o
n
 
O
p
i
n
i
o
n
 
(
b
a
c
k
b
o
n
e
 
o
f
 
F
r
e
n
c
h
 
t
h
i
n
k
i
n
g
)
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
e
l
a
b
o
r
a
t
e
s
 
1
2
 
c
o
n
d
i
t
i
o
n
s
 
t
o
 
b
e
 
m
e
t
 
i
n
 
o
r
d
e
r
 
t
o
 
a
c
c
e
p
t
 
t
h
e
 
d
e
v
e
l
o
p
m
e
n
t
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
T
h
e
 
f
i
r
s
t
 
b
a
n
s
 
t
h
e
r
a
p
e
u
t
i
c
 
c
l
a
i
m
s
,
 
b
u
t
 
a
l
l
o
w
s
 
d
i
s
e
a
s
e
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
,
 
c
l
a
i
m
s
 
s
u
g
g
e
s
t
i
n
g
 
a
 
c
o
n
t
r
i
b
u
t
i
o
n
 
t
o
 
t
h
e
 
g
e
n
e
r
a
l
 
h
e
a
l
t
h
 
c
o
n
d
i
t
i
o
n
 
a
n
d
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
f
u
n
c
t
i
o
n
a
l
 
c
l
a
i
m
s
.
 
M
o
s
t
 
s
t
a
k
e
h
o
l
d
e
r
s
 
w
a
n
t
 
E
U
 
f
r
a
m
e
w
o
r
k
.
 
I
n
d
u
s
t
r
y
 
i
s
 
d
i
s
s
a
t
i
s
f
i
e
d
 
w
i
t
h
 
t
h
e
 
v
i
s
a
 
P
P
 
p
r
o
c
e
d
u
r
e
 
f
o
r
 
a
u
t
h
o
r
i
s
i
n
g
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
c
o
n
s
u
m
e
r
s
 
w
a
n
t
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
t
o
 
b
e
 
e
x
t
e
n
d
e
d
 
t
o
 
d
i
s
t
a
n
c
e
 
s
e
l
l
i
n
g
 
a
n
d
 
e
l
e
c
t
r
o
n
i
c
 
c
o
m
m
e
r
c
e
.
 
A
u
t
h
o
r
i
t
i
e
s
 
v
i
e
w
 
c
u
r
r
e
n
t
 
s
i
t
u
a
t
i
o
n
 
a
s
 
s
a
t
i
s
f
a
c
t
o
r
y
,
 
b
u
t
 
d
u
e
 
t
o
 
t
h
e
 
p
r
o
b
l
e
m
 
o
f
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
,
 
t
h
e
 
E
U
 
n
e
e
d
s
 
t
o
 
d
e
f
i
n
e
 
"
f
o
o
d
s
t
u
f
f
'
 
b
e
f
o
r
e
 
l
e
g
i
s
l
a
t
i
n
g
 
b
y
 
a
m
e
n
d
i
n
g
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
T
h
e
y
 
c
o
u
l
d
 
e
n
v
i
s
a
g
e
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
,
 
b
u
t
 
w
o
u
l
d
 
i
n
t
e
n
s
i
f
y
 
b
o
r
d
e
r
l
i
n
e
 
p
r
o
b
l
e
m
s
 
w
i
t
h
 
p
h
a
r
m
a
c
e
u
t
i
c
a
l
s
.
 
C
o
n
s
u
m
e
r
s
 
b
e
l
i
e
v
e
 
E
U
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
n
e
c
e
s
s
a
r
y
 
d
u
e
 
t
o
 
i
n
c
r
e
a
s
e
 
o
f
 
f
u
n
c
t
i
o
n
a
l
 
f
o
o
d
s
,
 
f
o
o
d
 
s
u
p
p
l
e
m
e
n
t
s
 
a
n
d
 
p
r
o
b
i
o
t
i
c
 
f
o
o
d
s
t
u
f
f
s
.
 
I
n
d
u
s
t
r
y
 
w
i
s
h
e
s
 
t
o
 
b
e
 
a
b
l
e
 
t
o
 
m
a
k
e
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
b
e
l
i
e
v
e
 
t
h
e
 
b
e
s
t
 
w
a
y
 
f
o
r
w
a
r
d
 
i
s
 
t
o
 
a
m
e
n
d
 
D
i
r
e
c
t
i
v
e
 
7
9
1
1
1
2
.
 
T
h
e
y
 
a
l
s
o
 
s
e
e
 
t
h
e
 
n
e
e
d
 
t
o
 
d
e
f
i
n
e
 
w
h
a
t
 
a
 
f
o
o
d
s
t
u
f
f
 
i
s
.
 
V
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
a
r
e
 
n
o
t
 
p
e
r
c
e
i
v
e
d
 
a
s
 
a
 
v
i
a
b
l
e
 
w
a
y
 
t
o
 
a
d
d
r
e
s
s
 
t
h
e
 
i
s
s
u
e
 
i
n
 
G
e
r
m
a
n
y
.
 
A
l
l
 
s
t
a
k
e
h
o
l
d
e
r
s
 
f
a
v
o
u
r
 
E
U
 
a
c
t
i
o
n
 
t
o
 
r
e
s
o
l
v
e
 
p
r
o
b
l
e
m
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
,
 
a
n
d
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
.
 
I
n
d
u
s
t
r
y
 
f
a
v
o
u
r
s
 
t
h
e
 
C
I
A
A
 
V
o
l
u
n
t
a
r
y
 
C
o
d
e
 
a
n
d
 
c
o
n
s
u
m
e
r
s
 
g
e
n
e
r
a
l
l
y
 
b
e
l
i
e
v
e
 
t
h
a
t
 
m
o
r
e
 
p
r
o
t
e
c
t
i
o
n
 
i
s
 
r
e
q
u
i
r
e
d
 
w
i
t
h
 
t
h
e
 
p
r
o
l
i
f
e
r
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
T
h
e
 
a
d
v
e
r
t
i
s
i
n
g
 
i
n
d
u
s
t
r
y
 
i
s
 
a
g
a
i
n
s
t
 
a
n
y
 
E
U
 
i
n
v
o
l
v
e
m
e
n
t
 
o
r
 
a
m
e
n
d
m
e
n
t
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
a
n
d
 
o
p
t
 
i
n
s
t
e
a
d
 
f
o
r
 
s
e
l
f
-
r
e
g
u
l
a
t
i
o
n
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
-
2
0
0
0
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
X
 
G
o
v
e
r
n
m
e
n
t
 
h
a
s
 
n
o
t
 
c
o
n
s
i
d
e
r
e
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
n
o
r
 
d
o
e
s
 
i
t
 
p
l
a
n
 
t
o
.
 
H
o
w
e
v
e
r
,
 
t
h
e
 
C
o
n
s
u
m
e
r
 
A
g
e
n
c
y
 
w
i
l
l
 
m
a
k
e
 
i
t
 
a
 
p
r
i
o
r
i
t
y
 
i
n
 
2
0
0
0
.
 
T
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
v
i
e
w
 
t
h
e
 
n
e
e
d
 
t
o
 
e
s
t
a
b
l
i
s
h
 
f
r
a
m
e
w
o
r
k
 
a
t
 
e
i
t
h
e
r
 
E
U
 
o
r
 
i
n
t
e
r
n
a
t
i
o
n
a
l
 
l
e
v
e
l
,
 
a
s
 
t
h
e
y
 
d
o
 
n
o
t
 
s
e
e
 
t
h
e
m
s
e
l
v
e
s
 
a
s
 
c
o
m
p
e
t
e
n
t
.
 
T
h
e
 
c
a
m
p
a
i
g
n
 
"
d
e
 
I
'
 
e
t
h
i
q
u
e
 
s
u
r
 
I
'
 
e
t
i
q
u
e
t
t
e
"
 
h
a
s
 
c
o
n
s
i
d
e
r
a
b
l
y
 
h
e
i
g
h
t
e
n
e
d
 
a
w
a
r
e
n
e
s
s
 
o
f
 
t
h
e
 
i
s
s
u
e
.
 
X
 
T
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
d
o
 
n
o
t
 
h
a
v
e
 
a
 
p
o
s
i
t
i
o
n
,
 
c
o
n
s
u
m
e
r
s
 
w
i
s
h
 
t
o
 
s
e
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
t
o
 
b
e
 
s
h
i
f
t
e
d
 
t
o
 
t
h
e
 
m
a
n
u
f
a
c
t
u
r
e
r
 
f
o
r
 
a
l
l
 
c
l
a
i
m
s
 
a
n
d
 
i
n
d
u
s
t
r
y
 
d
o
 
n
o
t
 
s
e
c
 
t
h
e
 
n
e
e
d
 
t
o
 
l
e
g
i
s
l
a
t
e
.
 
X
 
N
o
 
d
e
v
e
l
o
p
m
e
n
t
s
 
t
o
 
s
p
e
a
k
 
o
f
.
 
4
1
 C
o
u
n
t
r
y
 
I
r
e
l
a
n
d
 
I
t
a
l
y
 
L
u
x
e
m
b
o
u
r
g
 
N
e
t
h
e
r
l
a
n
d
s
 
P
o
r
t
u
g
a
l
 
S
p
a
i
n
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
X
 
L
e
g
i
s
l
a
t
i
o
n
 
i
s
 
w
o
r
k
i
n
g
 
w
e
l
l
 
a
n
d
 
n
o
 
n
e
e
d
 
f
o
r
 
r
e
v
i
e
w
.
 
I
n
d
u
s
t
r
y
 
i
s
,
 
h
o
w
e
v
e
r
,
 
c
a
l
l
i
n
g
 
f
o
r
 
c
l
a
r
i
f
i
c
a
t
i
o
n
 
a
s
 
t
o
 
w
h
a
t
 
t
y
p
e
s
 
o
f
 
c
l
a
i
m
s
 
c
a
n
 
b
e
 
m
a
d
e
.
 
X
 
T
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
a
r
e
 
n
o
t
 
s
a
t
i
s
f
i
e
d
 
w
i
t
h
 
t
h
e
 
c
u
r
r
e
n
t
 
l
a
w
 
a
l
t
h
o
u
g
h
 
t
h
e
y
 
w
o
u
l
d
 
l
i
k
e
 
f
u
r
t
h
e
r
 
p
r
e
v
e
n
t
i
v
e
 
m
e
a
s
u
r
e
s
 
t
o
 
b
e
 
i
n
t
r
o
d
u
c
e
d
.
 
I
n
d
u
s
t
r
y
 
i
s
 
s
a
t
i
s
f
i
e
d
.
 
X
 
N
o
 
l
e
g
i
s
l
a
t
i
v
e
 
c
h
a
n
g
e
s
 
a
r
c
 
f
o
r
e
s
e
e
n
.
 
X
 
C
u
r
r
e
n
t
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
s
a
t
i
s
f
a
c
t
o
r
y
 
a
n
d
 
s
t
a
k
e
h
o
l
d
e
r
s
 
s
e
e
 
n
o
 
n
e
e
d
 
f
o
r
 
c
h
a
n
g
e
.
 
S
o
m
e
 
p
o
l
i
c
y
 
d
e
v
e
l
o
p
m
e
n
t
s
 
r
e
l
a
t
i
n
g
 
t
o
 
d
i
f
f
e
r
e
n
t
 
t
y
p
e
s
 
o
f
 
f
a
t
s
.
 
X
 
A
l
l
 
s
t
a
k
e
h
o
l
d
e
r
s
 
v
i
e
w
 
c
u
r
r
e
n
t
 
l
e
g
i
s
l
a
t
i
o
n
 
a
s
 
s
a
t
i
s
f
a
c
t
o
r
y
.
 
X
 
S
t
a
k
e
h
o
l
d
e
r
s
 
s
e
e
 
n
o
 
n
e
e
d
 
t
o
 
a
m
e
n
d
 
l
e
g
i
s
l
a
t
i
o
n
,
 
d
e
e
m
e
d
 
s
a
t
i
s
f
a
c
t
o
r
y
,
 
a
l
t
h
o
u
g
h
 
o
p
e
n
 
t
o
 
e
x
t
e
n
d
i
n
g
 
t
h
e
 
l
i
s
t
 
o
f
 
a
l
l
o
w
a
b
l
e
 
c
l
a
i
m
s
 
i
n
 
t
h
e
 
e
v
e
n
t
 
o
f
 
n
e
w
 
n
u
t
r
i
e
n
t
s
.
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
T
h
e
 
F
S
A
I
 
v
i
e
w
s
 
t
h
a
t
 
t
h
e
 
E
U
 
s
h
o
u
l
d
 
c
l
a
r
i
f
y
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
,
 
m
a
k
i
n
g
 
r
e
f
e
r
e
n
c
e
 
t
o
 
D
i
r
e
c
t
i
v
e
 
6
5
/
6
5
,
 
s
h
o
u
l
d
 
i
s
s
u
e
 
a
 
p
o
s
i
t
i
v
e
 
l
i
s
t
 
o
f
 
c
l
a
i
m
s
 
(
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
c
e
 
s
u
c
h
 
a
s
 
t
h
e
 
U
S
 
F
D
A
)
,
 
w
a
n
t
s
 
t
o
 
s
e
e
 
p
r
e
-
v
e
t
t
i
n
g
/
c
l
e
a
r
a
n
c
e
 
a
n
d
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
t
o
 
b
e
 
p
l
a
c
e
d
 
o
n
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
I
n
d
u
s
t
r
y
 
s
e
e
k
s
 
c
l
a
r
i
f
i
c
a
t
i
o
n
,
 
p
o
s
i
t
i
v
e
/
g
e
n
e
r
i
c
 
l
i
s
t
 
o
f
 
a
l
l
o
w
e
d
 
c
l
a
i
m
s
 
a
n
d
 
p
r
o
m
o
t
e
s
 
s
e
l
f
-
r
e
g
u
l
a
t
i
o
n
 
a
l
o
n
g
 
t
h
e
 
l
i
n
e
s
 
o
f
 
t
h
e
 
U
K
 
J
H
C
I
.
 
C
o
n
s
u
m
e
r
s
 
w
a
n
t
 
t
h
e
 
E
U
 
t
o
 
l
a
u
n
c
h
 
i
n
f
o
r
m
a
t
i
o
n
 
c
a
m
p
a
i
g
n
 
t
o
 
e
n
h
a
n
c
e
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
a
n
d
 
a
w
a
r
e
n
e
s
s
.
 
X
 
S
t
a
k
e
h
o
l
d
e
r
s
 
d
o
 
n
o
t
 
s
e
e
 
t
h
e
 
n
e
e
d
 
t
o
 
c
h
a
n
g
e
 
t
h
e
 
l
a
w
,
 
a
l
t
h
o
u
g
h
 
i
f
 
c
h
a
n
g
e
s
 
a
r
e
 
t
o
 
b
e
 
m
a
d
e
 
i
t
 
s
h
o
u
l
d
 
b
e
 
a
t
 
E
U
 
l
e
v
e
l
.
 
T
h
e
y
 
w
o
u
l
d
 
a
l
s
o
 
c
o
n
s
i
d
e
r
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
I
n
d
u
s
t
r
y
 
f
a
v
o
u
r
s
 
a
m
e
n
d
i
n
g
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
 
t
o
 
l
i
b
e
r
a
l
i
s
e
 
t
h
e
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
 
a
n
d
 
i
s
 
o
p
p
o
s
e
d
 
t
o
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
X
 
N
o
 
l
e
g
i
s
l
a
t
i
v
e
 
c
h
a
n
g
e
 
i
s
 
f
o
r
e
s
e
e
n
,
 
a
l
t
h
o
u
g
h
 
s
t
a
k
e
h
o
l
d
e
r
s
 
g
e
n
e
r
a
l
l
y
 
a
g
r
e
e
 
t
h
a
t
 
t
h
e
 
d
e
v
e
l
o
p
m
e
n
t
 
o
f
 
a
 
s
o
u
n
d
 
r
e
g
u
l
a
t
o
r
y
 
e
n
v
i
r
o
n
m
e
n
t
 
s
h
o
u
l
d
 
b
e
 
e
s
t
a
b
l
i
s
h
e
d
 
a
t
 
E
U
 
l
e
v
e
l
.
 
C
o
n
s
u
m
e
r
s
 
a
r
e
 
i
n
 
f
a
v
o
u
r
 
o
f
 
c
o
n
t
r
o
l
 
a
t
 
E
U
 
l
e
v
e
l
.
 
X
 
A
t
 
h
o
m
e
,
 
a
l
l
 
s
t
a
k
e
h
o
l
d
e
r
s
 
v
i
e
w
 
c
u
r
r
e
n
t
 
l
e
g
i
s
l
a
t
i
o
n
 
a
s
 
s
a
t
i
s
f
a
c
t
o
r
y
,
 
s
u
p
p
o
r
t
i
n
g
 
s
e
l
f
-
r
e
g
u
l
a
t
i
o
n
 
a
s
 
i
n
 
t
h
e
 
c
a
s
e
 
o
f
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
s
.
 
T
h
e
 
s
t
a
k
e
h
o
l
d
e
r
s
 
a
c
c
e
p
t
 
t
h
a
t
 
c
h
a
n
g
e
s
 
a
r
e
 
n
e
e
d
e
d
 
t
o
 
s
o
r
t
 
o
u
t
 
t
h
e
 
p
r
o
b
l
e
m
 
o
f
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
,
 
b
e
s
t
 
r
e
s
o
l
v
e
d
 
a
t
 
E
U
 
l
e
v
e
l
.
 
I
n
d
u
s
t
r
y
 
i
s
 
c
a
l
l
i
n
g
 
f
o
r
 
t
h
e
 
a
c
c
e
p
t
a
n
c
e
 
o
f
 
d
i
s
e
a
s
e
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
w
o
u
l
d
 
l
i
k
e
 
t
o
 
s
e
e
 
i
n
 
p
l
a
c
e
 
a
n
 
E
U
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
t
o
 
c
r
e
a
t
e
 
a
n
 
a
p
p
r
o
p
r
i
a
t
e
 
f
r
a
m
e
w
o
r
k
 
t
o
 
o
p
e
r
a
t
e
 
i
n
.
 
C
o
n
s
u
m
e
r
s
 
w
i
s
h
 
f
o
r
 
t
h
e
 
p
r
o
b
l
e
m
 
o
f
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
 
t
o
 
b
e
 
r
e
s
o
l
v
e
d
 
a
t
 
E
U
 
l
e
v
e
l
,
 
a
s
 
w
e
l
l
 
a
s
 
f
o
r
 
t
h
e
 
E
U
 
t
o
 
a
s
s
i
s
t
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
i
n
 
p
r
o
v
i
d
i
n
g
 
g
u
i
d
a
n
c
e
 
o
n
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
c
l
a
i
m
s
.
 
X
 
N
o
 
l
e
g
i
s
l
a
t
i
v
e
 
o
r
 
p
o
l
i
c
y
 
c
h
a
n
g
e
s
 
a
r
e
 
p
l
a
n
n
e
d
.
 
T
h
e
r
e
 
i
s
 
n
o
 
d
e
b
a
t
e
 
o
n
 
t
h
e
 
i
s
s
u
e
.
 
I
n
d
u
s
t
r
y
 
w
o
u
l
d
 
l
i
k
e
 
t
o
 
s
e
e
 
a
 
m
o
r
e
 
l
i
b
e
r
a
l
 
r
e
g
i
m
e
 
a
n
d
 
i
s
 
l
o
o
k
i
n
g
 
t
o
 
t
h
e
 
E
U
 
l
e
v
e
l
 
t
o
 
c
r
e
a
t
e
 
a
 
p
r
o
p
e
r
 
r
e
g
u
l
a
t
o
r
y
 
e
n
v
i
r
o
n
m
e
n
t
.
 
C
o
n
s
u
m
e
r
s
 
f
a
v
o
u
r
 
c
l
e
a
r
l
y
 
d
e
f
i
n
e
d
 
r
u
l
e
s
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
c
l
a
i
m
s
.
 
X
 
W
h
i
l
s
t
 
s
t
a
k
e
h
o
l
d
e
r
s
 
a
r
e
 
n
o
t
 
p
l
a
n
n
i
n
g
 
t
o
 
a
m
e
n
d
 
l
e
g
i
s
l
a
t
i
o
n
,
 
t
h
e
r
e
 
i
s
 
a
 
n
e
e
d
 
t
o
 
a
c
c
o
m
m
o
d
a
t
e
 
n
e
w
 
t
y
p
e
s
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
G
o
v
e
r
n
m
e
n
t
 
m
i
g
h
t
 
n
o
t
 
w
a
n
t
 
E
U
 
i
n
v
o
l
v
e
m
e
n
t
.
 
I
n
d
u
s
t
r
y
 
h
a
s
 
i
t
s
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
a
n
d
 
s
u
p
p
o
r
t
s
 
C
I
A
A
 
C
o
d
e
 
i
n
 
c
o
m
b
i
n
a
t
i
o
n
 
w
i
t
h
 
C
o
d
e
x
 
w
o
r
k
.
 
C
o
n
s
u
m
e
r
s
 
w
e
l
c
o
m
e
 
E
U
 
i
n
i
t
i
a
t
i
v
e
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
-
2
0
0
0
 
-
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
X
 
N
o
 
d
e
v
e
l
o
p
m
e
n
t
s
 
t
o
 
s
p
e
a
k
 
o
f
.
 
A
l
t
h
o
u
g
h
 
c
o
n
s
e
n
s
u
s
 
t
h
a
t
 
i
n
d
e
p
e
n
d
e
n
t
 
c
h
e
c
k
s
 
s
h
o
u
l
d
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
i
n
 
t
h
e
 
f
u
t
u
r
e
 
w
i
t
h
 
t
h
e
 
p
r
o
l
i
f
e
r
a
t
i
o
n
 
o
f
 
s
u
c
h
 
c
l
a
i
m
s
.
 
T
h
e
 
I
t
a
l
i
a
n
 
P
a
r
l
i
a
m
e
n
t
 
i
s
 
a
d
o
p
t
i
n
g
 
a
 
l
a
w
 
o
n
 
t
h
e
 
c
e
r
t
i
f
i
c
a
t
i
o
n
 
o
f
 
s
o
c
i
a
l
 
c
o
n
f
o
r
m
i
t
y
 
(
a
n
d
 
l
a
b
e
l
)
 
o
f
 
p
r
o
d
u
c
t
s
 
p
r
o
d
u
c
e
d
 
w
i
t
h
o
u
t
 
t
h
e
 
u
s
e
 
o
f
 
c
h
i
l
d
 
l
a
b
o
u
r
.
 
I
n
d
u
s
t
r
y
 
i
s
 
o
p
p
o
s
e
d
.
 
X
 
N
o
 
d
e
v
e
l
o
p
m
e
n
t
s
 
t
o
 
s
p
e
a
k
 
o
f
.
 
X
 
N
o
 
d
e
v
e
l
o
p
m
e
n
t
s
 
t
o
 
r
e
p
o
r
t
 
a
n
d
 
n
o
 
d
e
f
i
n
e
d
 
p
o
s
i
t
i
o
n
s
 
e
x
c
e
p
t
 
t
h
a
t
 
i
n
d
u
s
t
r
y
 
p
r
e
f
e
r
s
 
s
e
l
f
-
r
e
g
u
l
a
t
i
o
n
.
 
C
o
n
s
u
m
e
r
s
 
a
r
e
 
c
a
l
l
i
n
g
 
f
o
r
 
t
h
e
 
i
n
t
r
o
d
u
c
t
i
o
n
 
o
f
 
a
 
m
e
c
h
a
n
i
s
m
 
t
o
 
s
u
p
e
r
v
i
s
e
 
t
h
e
 
u
s
e
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
e
i
t
h
e
r
 
v
i
a
 
l
e
g
i
s
l
a
t
i
o
n
 
o
r
 
c
o
d
e
 
o
f
 
c
o
n
d
u
c
t
.
 
X
 
N
o
 
r
e
a
l
 
i
n
t
e
r
e
s
t
 
f
r
o
m
 
a
u
t
h
o
r
i
t
i
e
s
 
a
n
d
 
c
o
n
s
u
m
e
r
s
 
w
o
u
l
d
 
l
i
k
e
 
t
o
 
s
e
e
 
E
U
 
f
r
a
m
e
w
o
r
k
.
 
4
2
 C
o
u
n
t
r
y
 
S
w
e
d
e
n
 
U
K
 
u
s
 
C
a
n
a
d
a
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
X
 
S
t
a
k
e
h
o
l
d
e
r
s
 
a
r
e
 
s
a
t
i
s
f
i
e
d
 
w
i
t
h
 
c
u
r
r
e
n
t
 
l
e
g
i
s
l
a
t
i
o
n
.
 
X
 
G
o
v
e
r
n
m
e
n
t
 
d
o
c
s
 
n
o
t
 
p
e
r
c
e
i
v
e
 
a
 
n
e
e
d
 
t
o
 
r
e
v
i
e
w
 
l
e
g
i
s
l
a
t
i
o
n
,
 
a
l
t
h
o
u
g
h
 
F
 
A
C
 
g
u
i
d
e
l
i
n
e
s
 
o
n
 
u
s
e
 
a
r
c
 
r
e
g
u
l
a
r
l
y
 
u
p
d
a
t
e
d
.
 
H
o
w
e
v
e
r
,
 
c
o
n
s
u
m
e
r
 
o
r
g
a
n
i
s
a
t
i
o
n
s
 
a
r
e
 
s
e
e
k
i
n
g
 
f
u
r
t
h
e
r
 
r
e
s
t
r
i
c
t
i
v
e
 
r
u
l
e
s
,
 
w
i
s
h
i
n
g
 
t
o
 
s
e
c
 
c
r
i
t
e
r
i
a
 
f
o
r
 
a
b
s
o
l
u
t
e
 
a
n
d
 
r
e
l
a
t
i
v
e
 
c
l
a
i
m
s
,
 
a
 
f
u
l
l
 
s
u
p
p
o
r
t
i
n
g
 
n
u
t
r
i
t
i
o
n
a
l
 
p
a
n
e
l
 
a
n
d
 
a
 
s
e
t
 
o
f
 
s
t
a
n
d
a
r
d
 
c
r
i
t
e
r
i
a
 
f
o
r
 
h
e
a
l
t
h
y
 
e
a
t
i
n
g
 
s
y
m
b
o
l
s
.
 
I
n
d
u
s
t
r
y
 
s
e
e
m
s
 
t
o
 
i
n
d
i
c
a
t
e
 
t
h
a
t
 
r
e
g
u
l
a
r
 
c
l
a
r
i
f
i
c
a
t
i
o
n
 
u
p
d
a
t
e
s
 
a
r
e
 
n
e
c
e
s
s
a
r
y
.
 
A
l
s
o
,
 
C
W
S
 
h
a
s
 
s
e
t
-
u
p
 
a
 
C
o
d
e
 
f
o
r
 
c
o
n
s
u
m
e
r
 
l
a
b
e
l
l
i
n
g
 
c
l
a
r
i
t
y
.
:
.
 
C
u
r
r
e
n
t
 
r
e
g
u
l
a
t
o
r
y
 
s
y
s
t
e
m
 
w
o
r
k
i
n
g
 
w
e
l
l
.
 
H
e
a
l
t
h
 
C
a
n
a
d
a
 
w
o
u
l
d
 
l
i
k
e
 
t
o
 
r
e
g
u
l
a
t
e
 
a
l
l
 
n
u
t
r
i
e
n
t
 
c
o
n
t
e
n
t
 
c
l
a
i
m
s
,
 
b
u
t
 
i
n
d
u
s
t
r
y
 
i
s
 
o
p
p
o
s
e
d
 
s
e
e
k
i
n
g
 
n
o
n
-
r
e
g
u
l
a
t
o
r
y
 
m
e
a
s
u
r
e
s
.
 
C
o
m
p
o
s
i
t
i
o
n
a
l
 
c
r
i
t
e
r
i
a
 
a
r
e
 
u
n
d
e
r
 
r
e
v
i
e
w
 
f
o
r
 
n
u
t
r
i
e
n
t
 
c
o
n
t
e
n
t
 
c
l
a
i
m
s
.
 
X
=
 
N
o
 
n
e
e
d
 
t
o
 
c
h
a
n
g
e
 
c
u
r
r
e
n
t
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
 
=
 
G
e
n
e
r
a
l
 
n
e
e
d
 
t
o
 
c
h
a
n
g
e
 
c
u
r
r
e
n
t
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
S
t
a
k
e
h
o
l
d
e
r
s
 
f
a
v
o
u
r
 
E
U
 
b
a
s
e
d
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
.
 
S
w
e
d
e
n
 
I
S
 
c
o
n
s
i
d
e
r
i
n
g
 
t
o
 
l
a
u
n
c
h
 
h
e
a
l
t
h
 
c
l
a
i
m
 
i
n
i
t
i
a
t
i
v
e
 
d
u
r
i
n
g
 
i
t
s
 
P
r
e
s
i
d
e
n
c
y
 
o
f
 
t
h
e
 
E
U
 
i
n
 
2
0
0
 
I
.
 
S
t
a
k
e
h
o
l
d
e
r
s
 
a
l
l
 
f
a
v
o
u
r
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
(
d
e
f
i
n
e
s
 
a
 
h
e
a
l
t
h
 
c
l
a
i
m
)
 
a
n
d
 
n
o
w
 
b
e
i
n
g
 
a
m
e
n
d
e
d
 
t
o
 
i
n
c
l
u
d
e
 
p
r
o
d
u
c
t
-
s
p
e
c
i
f
i
c
 
p
h
y
s
i
o
l
o
g
i
c
a
l
 
c
l
a
i
m
s
.
 
A
l
l
 
s
t
a
k
e
h
o
l
d
e
r
s
 
f
a
v
o
u
r
 
t
h
e
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
 
I
n
i
t
i
a
t
i
v
e
,
 
a
l
t
h
o
u
g
h
 
c
o
n
s
u
m
e
r
s
 
a
n
d
 
g
o
v
e
r
n
m
e
n
t
 
e
v
e
n
t
u
a
l
l
y
 
w
a
n
t
 
a
n
 
E
U
 
r
e
g
u
l
a
t
o
r
y
 
f
r
a
m
e
w
o
r
k
 
t
o
 
h
a
r
m
o
n
i
s
e
 
t
h
e
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
C
o
n
s
u
m
e
r
s
 
a
l
s
o
 
s
t
i
l
l
 
p
r
e
f
e
r
 
p
r
e
-
m
a
r
k
e
t
 
c
l
e
a
r
a
n
c
e
.
 
I
n
d
u
s
t
r
y
 
f
a
v
o
u
r
s
 
t
h
e
 
J
H
C
I
,
 
d
o
e
s
 
n
o
t
 
a
c
c
e
p
t
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
b
u
t
 
a
c
c
e
p
t
s
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
a
n
d
 
w
i
s
h
e
s
 
t
o
 
s
e
e
 
a
n
 
a
m
e
n
d
m
e
n
t
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
 
t
o
 
a
l
l
o
w
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
n
d
 
t
o
 
t
a
k
e
 
o
n
b
o
a
r
d
 
t
h
e
 
l
a
t
e
s
t
 
C
o
d
e
x
 
d
r
a
f
t
 
g
u
i
d
e
l
i
n
e
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
T
h
e
 
o
r
g
a
n
i
s
a
t
i
o
n
s
 
t
h
a
t
 
r
e
g
u
l
a
t
e
 
t
h
e
 
m
e
a
n
s
 
o
f
 
c
o
m
m
u
n
i
c
a
t
i
o
n
 
a
r
e
 
f
i
r
m
l
y
 
o
p
p
o
s
e
d
 
t
o
 
E
U
 
l
e
g
i
s
l
a
t
i
o
n
,
 
a
s
 
t
h
e
 
s
y
s
t
e
m
 
a
p
p
e
a
r
s
 
t
o
 
w
o
r
k
 
c
o
r
r
e
c
t
l
y
.
 
C
u
r
r
e
n
t
 
r
e
g
u
l
a
t
o
r
y
 
s
y
s
t
e
m
 
w
o
r
k
i
n
g
 
w
e
l
l
.
 
T
h
e
r
e
 
i
s
,
 
h
o
w
e
v
e
r
,
 
t
h
e
 
c
o
n
c
e
r
n
 
t
h
a
t
 
a
l
l
o
w
i
n
g
 
i
n
d
u
s
t
r
y
 
g
r
e
a
t
e
r
 
f
l
e
x
i
b
i
l
i
t
y
 
t
o
 
m
a
k
e
 
c
l
a
i
m
s
 
w
i
t
h
 
n
o
 
p
r
i
o
r
 
a
p
p
r
o
v
a
l
,
 
w
i
l
l
 
r
e
s
u
l
t
 
i
n
 
a
n
 
i
n
c
r
e
a
s
e
 
o
f
 
q
u
e
s
t
i
o
n
a
b
l
e
 
c
l
a
i
m
s
.
 
T
h
i
s
 
a
n
d
 
t
h
e
 
I
n
t
e
r
n
e
t
 
m
a
y
 
p
u
t
 
q
u
e
s
t
i
o
n
a
b
l
e
 
c
l
a
i
m
s
 
b
e
y
o
n
d
 
t
h
e
 
e
f
f
e
c
t
i
v
e
 
r
e
a
c
h
 
o
f
 
t
h
e
 
r
e
g
u
l
a
t
o
r
y
 
a
u
t
h
o
r
i
t
i
e
s
.
 
T
h
e
 
l
e
g
i
s
l
a
t
i
v
e
 
f
r
a
m
e
w
o
r
k
 
i
s
 
b
e
i
n
g
 
m
o
d
i
f
i
e
d
 
t
o
 
i
n
t
r
o
d
u
c
e
 
t
h
e
 
U
S
 
I
 
0
 
g
e
n
e
r
i
c
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
a
s
 
w
e
l
l
,
 
a
s
 
i
n
 
t
h
e
 
f
u
t
u
r
e
,
 
t
o
 
a
d
o
p
t
 
s
t
a
n
d
a
r
d
s
 
o
f
 
e
v
i
d
e
n
c
e
 
a
n
d
 
a
 
g
u
i
d
a
n
c
e
 
d
o
c
u
m
e
n
t
 
f
o
r
 
t
h
e
 
s
u
b
m
i
s
s
i
o
n
 
o
f
 
i
n
n
o
v
a
t
i
v
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
,
 
a
s
 
f
a
v
o
u
r
e
d
 
b
y
 
i
n
d
u
s
t
r
y
.
 
C
o
n
s
u
m
e
r
s
,
 
t
o
 
a
 
l
a
r
g
e
 
e
x
t
e
n
t
,
 
a
g
r
e
e
 
w
i
t
h
 
t
h
e
 
d
e
v
e
l
o
p
m
e
n
t
s
,
 
a
s
 
i
t
 
w
i
l
l
 
i
m
p
r
o
v
e
 
t
h
e
 
i
n
f
o
r
m
a
t
i
o
n
 
t
o
 
t
h
e
 
c
o
n
s
u
m
e
r
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
R
e
c
e
n
t
 
g
o
v
e
r
n
m
e
n
t
 
s
t
u
d
y
 
r
a
i
s
e
d
 
i
s
s
u
e
 
o
f
 
e
t
h
i
c
a
l
 
l
a
b
e
l
l
i
n
g
,
 
r
e
c
o
m
m
e
n
d
i
n
g
 
E
U
 
l
e
v
e
l
 
c
o
-
o
p
e
r
a
t
i
o
n
 
t
o
 
e
n
s
u
r
e
 
t
h
a
t
 
c
o
n
s
u
m
e
r
s
 
a
v
o
i
d
 
p
r
o
d
u
c
t
s
,
 
w
h
i
c
h
 
a
r
e
 
m
a
n
u
f
a
c
t
u
r
e
d
 
b
y
 
c
o
m
p
a
n
i
e
s
,
 
w
h
i
c
h
 
b
e
h
a
v
e
 
u
n
e
t
h
i
c
a
l
l
y
.
 
X
 
N
o
 
r
e
a
l
 
p
o
s
i
t
i
o
n
 
a
n
d
 
n
o
 
c
o
m
p
r
e
h
e
n
s
i
v
e
 
a
p
p
r
o
a
c
h
 
b
y
 
e
i
t
h
e
r
 
s
t
a
k
e
h
o
l
d
e
r
s
.
 
X
 
N
o
 
d
e
v
e
l
o
p
m
e
n
t
s
.
 
X
 
F
e
d
e
r
a
l
 
a
u
t
h
o
r
i
t
i
e
s
 
h
a
v
e
 
n
o
 
p
o
s
i
t
i
o
n
,
 
t
h
e
y
 
a
r
e
 
n
o
t
 
p
a
r
t
 
o
f
 
t
h
e
 
c
u
r
r
e
n
t
 
r
e
v
i
e
w
.
 
C
o
n
s
u
m
e
r
s
 
a
n
d
 
i
n
d
u
s
t
r
y
 
a
r
e
 
n
o
t
 
f
o
c
u
s
e
d
 
o
n
 
t
h
e
m
.
 
4
3
 I
 
3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
•
 
F
r
o
m
 
t
h
e
 
a
b
o
v
e
 
a
n
a
l
y
s
i
s
,
 
i
t
 
s
h
o
u
l
d
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
w
h
e
t
h
e
r
 
o
r
 
n
o
t
 
a
 
d
e
f
i
n
i
t
i
o
n
 
n
e
e
d
s
 
t
o
 
b
e
 
a
d
o
p
t
e
d
 
f
o
r
:
 
•
 
a
 
f
o
o
d
s
t
u
f
f
;
 
•
 
a
 
c
l
a
i
m
;
 
•
 
a
 
h
e
a
l
t
h
 
c
l
a
i
m
;
 
a
n
d
 
•
 
e
v
e
n
t
u
a
l
l
y
,
 
i
n
 
t
h
e
 
m
e
d
i
u
m
 
t
e
r
m
 
f
o
r
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
o
n
c
e
 
t
h
e
s
e
 
a
r
e
 
b
e
i
n
g
 
m
o
r
e
 
u
s
e
d
.
 
•
 
W
e
 
w
o
u
l
d
 
r
e
c
o
m
m
e
n
d
 
t
h
a
t
 
a
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
a
 
c
l
a
i
m
 
b
e
 
m
a
d
e
 
a
n
d
 
i
n
c
l
u
d
e
d
 
i
n
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
,
 
b
a
s
e
d
 
o
n
 
v
a
r
i
o
u
s
 
d
e
f
i
n
i
t
i
o
n
s
 
c
u
r
r
e
n
t
l
y
 
m
 
e
x
i
s
t
e
n
c
e
 
r
e
l
a
t
i
n
g
 
t
o
 
c
l
a
i
m
s
.
 
W
e
 
w
o
u
l
d
 
p
r
o
p
o
s
e
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
d
e
f
i
n
i
t
i
o
n
:
 
"
A
 
c
l
a
i
m
 
i
s
 
a
n
y
 
d
i
r
e
c
t
 
o
r
 
i
n
d
i
r
e
c
t
 
s
t
a
t
e
m
e
n
t
,
 
s
y
m
b
o
l
,
 
s
u
g
g
e
s
t
i
o
n
,
 
i
m
p
l
i
c
a
t
i
o
n
 
o
r
 
a
n
y
 
o
t
h
e
r
 
f
o
r
m
 
o
f
 
c
o
m
m
u
n
i
c
a
t
i
o
n
 
(
i
n
c
l
u
d
i
n
g
 
t
h
e
 
b
r
a
n
d
 
n
a
m
e
)
 
t
h
a
t
 
a
 
g
o
o
d
 
h
a
s
 
p
a
r
t
i
c
u
l
a
r
 
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
 
r
e
l
a
t
i
n
g
 
t
o
 
i
t
s
 
o
r
i
g
i
n
,
 
p
r
o
p
e
r
t
i
e
s
,
 
n
a
t
u
r
e
,
 
m
e
t
h
o
d
 
o
f
 
p
r
o
d
u
c
t
i
o
n
,
 
p
r
o
c
e
s
s
i
n
g
,
 
c
o
m
p
o
s
i
t
i
o
n
 
o
r
 
a
n
y
 
o
t
h
e
r
 
q
u
a
l
i
t
y
"
.
 
•
 
A
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
i
n
 
o
u
r
 
v
i
e
w
 
b
e
 
a
d
d
r
e
s
s
e
d
 
v
i
a
 
t
h
e
 
F
o
o
d
 
L
a
b
e
l
l
i
n
g
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
E
q
u
a
l
l
y
,
 
a
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
a
d
d
r
e
s
s
e
d
 
i
n
 
a
n
y
 
f
u
t
u
r
e
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
e
t
h
i
c
a
l
 
l
a
b
e
l
l
i
n
g
,
 
i
f
 
t
h
i
s
 
i
s
 
t
o
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
n
e
c
e
s
s
a
r
y
.
 
•
 
I
n
 
t
e
r
m
s
 
o
f
 
l
e
g
i
s
l
a
t
i
o
n
,
 
w
e
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
a
 
n
u
m
b
e
r
 
o
f
 
h
o
r
i
z
o
n
t
a
l
 
i
s
s
u
e
s
 
(
s
u
c
h
 
a
s
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
;
 
p
r
e
-
c
l
e
a
r
a
n
c
e
/
p
o
s
t
-
c
l
e
a
r
a
n
c
e
)
 
s
h
o
u
l
d
 
b
e
 
a
d
d
r
e
s
s
e
d
 
v
i
a
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
t
h
e
r
e
 
a
r
e
 
a
 
n
u
m
b
e
r
 
o
f
 
m
o
r
e
 
v
e
r
t
i
c
a
l
 
i
s
s
u
e
s
 
(
e
.
 
g
.
 
d
e
t
a
i
l
e
d
 
c
r
i
t
e
r
i
a
 
f
o
r
 
s
c
i
e
n
t
i
f
i
c
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
)
,
 
w
h
e
r
e
 
s
o
l
u
t
i
o
n
s
 
h
a
v
e
 
t
o
 
c
o
m
e
 
v
i
a
 
t
h
e
 
"
v
e
r
t
i
c
a
l
"
 
D
i
r
e
c
t
i
v
e
s
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
 
l
a
b
e
l
l
i
n
g
 
(
9
0
/
4
9
6
)
 
a
n
d
 
o
n
 
f
o
o
d
 
l
a
b
e
l
l
i
n
g
 
(
7
9
/
1
1
2
)
.
 
•
 
W
e
 
c
o
n
s
i
d
e
r
 
n
o
t
a
b
l
y
,
 
t
h
a
t
 
t
h
e
 
u
s
e
 
o
f
 
e
n
h
a
n
c
e
d
 
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
,
 
a
s
 
w
e
l
l
 
a
s
 
d
i
s
e
a
s
e
 
r
i
s
k
 
r
e
d
u
c
t
i
o
n
 
c
l
a
i
m
s
 
n
e
e
d
s
 
t
o
 
b
e
 
a
d
d
r
e
s
s
e
d
 
i
n
 
t
h
e
 
c
o
m
i
n
g
 
y
e
a
r
s
 
v
i
a
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
 
o
n
 
f
o
o
d
 
l
a
b
e
l
l
i
n
g
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
4
4
 B
.
 
C
O
N
S
U
M
E
R
 
P
R
O
T
E
C
T
I
O
N
 
1
.
 
C
o
m
m
e
n
t
 
I
n
 
a
 
m
a
j
o
r
i
t
y
 
o
f
 
E
u
r
o
p
e
a
n
 
c
o
u
n
t
r
i
e
s
,
 
p
r
o
t
e
c
t
i
o
n
 
o
f
 
t
h
e
 
c
o
n
s
u
m
e
r
 
a
p
p
e
a
r
s
 
a
s
 
a
 
m
a
j
o
r
 
c
o
n
c
e
r
n
 
w
h
e
n
 
i
t
 
c
o
m
e
s
 
t
o
 
s
e
t
t
i
n
g
 
r
u
l
e
s
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
c
l
a
i
m
s
.
 
M
o
s
t
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
s
p
e
c
i
f
i
c
a
l
l
y
 
d
e
s
i
g
n
e
d
 
t
o
 
p
r
o
t
e
c
t
 
h
e
a
l
t
h
 
a
n
d
 
s
a
f
e
t
y
 
o
f
 
t
h
e
 
c
o
n
s
u
m
e
r
 
a
n
d
 
t
o
 
a
v
o
i
d
 
t
h
e
 
u
s
e
 
o
f
 
f
a
l
s
e
,
 
e
x
a
g
g
e
r
a
t
e
d
 
o
r
 
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
.
 
H
o
w
e
v
e
r
,
 
i
t
 
s
e
e
m
s
 
t
h
a
t
 
s
o
m
e
 
n
a
t
i
o
n
a
l
 
l
e
g
i
s
l
a
t
i
o
n
 
d
o
e
s
 
n
o
t
 
a
l
w
a
y
s
 
p
r
o
v
i
d
e
 
a
 
s
u
f
f
i
c
i
e
n
t
 
d
e
g
r
e
e
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
A
 
p
o
t
e
n
t
i
a
l
 
o
r
 
a
c
t
u
a
l
 
l
a
c
k
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
w
a
s
 
i
n
d
e
e
d
 
r
e
p
o
r
t
e
d
 
i
n
 
a
 
n
u
m
b
e
r
 
o
f
 
E
u
r
o
p
e
a
n
 
c
o
u
n
t
r
i
e
s
.
 
N
o
t
 
a
l
l
 
t
y
p
e
s
 
o
f
 
c
l
a
i
m
s
 
a
r
e
 
e
q
u
a
l
l
y
 
c
o
n
c
e
r
n
e
d
,
 
h
o
w
e
v
e
r
,
 
a
n
d
 
a
 
d
i
f
f
e
r
e
n
t
i
a
t
i
o
n
 
n
e
e
d
s
 
t
o
 
b
e
 
m
a
d
e
 
b
e
t
w
e
e
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
W
h
e
r
e
a
s
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
p
o
s
e
 
n
o
 
m
a
j
o
r
 
p
r
o
b
l
e
m
 
i
n
 
t
e
r
m
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
,
 
t
h
e
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
p
p
e
a
r
s
 
p
r
o
b
l
e
m
a
t
i
c
.
 
I
t
 
w
a
s
 
r
e
p
o
r
t
e
d
 
t
h
a
t
,
 
i
n
 
c
o
u
n
t
r
i
e
s
 
s
u
c
h
 
a
s
 
A
u
s
t
r
i
a
,
 
B
e
l
g
i
u
m
,
 
F
r
a
n
c
e
,
 
G
r
e
e
c
e
,
 
P
o
r
t
u
g
a
l
,
 
U
K
,
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
s
t
i
l
l
 
m
a
d
e
 
w
h
i
c
h
 
m
i
g
h
t
 
m
i
s
l
e
a
d
 
t
h
e
 
c
o
n
s
u
m
e
r
.
 
T
h
i
s
 
p
r
o
b
l
e
m
 
i
s
 
d
u
e
 
t
o
 
v
a
r
i
o
u
s
 
f
a
c
t
o
r
s
:
 
•
 
i
n
s
u
f
f
i
c
i
e
n
t
 
l
e
g
a
l
 
p
r
o
t
e
c
t
i
o
n
;
 
•
 
a
b
s
e
n
c
e
 
o
f
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
c
r
i
t
e
r
i
a
 
o
r
 
d
i
f
f
i
c
u
l
t
y
 
i
n
 
d
e
f
i
n
i
n
g
 
s
u
c
h
 
c
r
i
t
e
r
i
a
;
 
•
 
d
i
f
f
i
c
u
l
t
y
 
i
n
 
t
h
e
 
i
m
p
l
e
m
e
n
t
a
t
i
o
n
 
o
f
 
e
x
i
s
t
i
n
g
 
r
u
l
e
s
 
(
b
e
c
a
u
s
e
 
o
f
 
a
 
l
a
c
k
 
o
f
 
r
e
s
o
u
r
c
e
s
 
o
r
 
t
h
e
 
o
v
e
r
a
l
l
 
w
e
a
k
n
e
s
s
 
o
f
 
t
h
e
 
s
u
r
v
e
i
l
l
a
n
c
e
 
a
u
t
h
o
r
i
t
y
,
 
f
o
r
 
i
n
s
t
a
n
c
e
)
;
 
•
 
g
r
o
w
i
n
g
 
n
u
m
b
e
r
 
o
f
 
b
o
r
d
e
r
l
i
n
e
 
p
r
o
d
u
c
t
s
,
 
w
h
i
c
h
 
a
r
e
 
d
i
f
f
i
c
u
l
t
 
t
o
 
c
l
a
s
s
i
f
y
 
a
s
 
e
i
t
h
e
r
 
f
o
o
d
s
t
u
f
f
s
 
o
r
 
d
r
u
g
s
;
 
•
 
c
l
a
i
m
s
 
a
r
e
 
m
a
d
e
 
i
n
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
a
 
g
e
n
e
r
a
l
 
d
i
e
t
a
r
y
 
c
o
n
t
e
x
t
;
 
•
 
d
i
f
f
i
c
u
l
t
y
 
i
n
 
d
i
f
f
e
r
e
n
t
i
a
t
i
n
g
 
b
e
t
w
e
e
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
m
e
d
i
c
i
n
a
l
 
c
l
a
i
m
s
;
 
a
n
d
 
•
 
i
n
c
r
e
a
s
i
n
g
 
v
a
r
i
e
t
y
 
o
f
 
c
o
m
p
l
e
x
 
c
l
a
i
m
s
.
 
I
t
 
s
h
o
u
l
d
 
b
e
 
n
o
t
e
d
 
t
h
a
t
 
t
h
e
 
i
s
s
u
e
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
i
s
 
u
n
d
e
r
s
t
o
o
d
 
d
i
f
f
e
r
e
n
t
l
y
 
b
y
 
t
h
e
 
v
a
r
i
o
u
s
 
i
n
t
e
r
e
s
t
e
d
 
p
a
r
t
i
e
s
.
 
C
o
n
s
u
m
e
r
s
 
u
s
u
a
l
l
y
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
i
f
 
t
h
e
r
e
 
i
s
 
r
o
o
m
 
f
o
r
 
a
 
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
 
t
o
 
b
e
 
m
a
d
e
,
 
a
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
p
r
o
b
l
e
m
 
e
x
i
s
t
s
.
 
N
a
t
i
o
n
a
l
 
a
u
t
h
o
r
i
t
i
e
s
 
t
e
n
d
 
t
o
 
b
e
l
i
e
v
e
 
t
h
a
t
 
t
h
e
r
e
 
i
s
 
n
o
 
s
u
c
h
 
p
r
o
b
l
e
m
 
i
f
 
t
h
e
 
c
l
a
i
m
 
c
a
n
 
b
e
 
w
i
t
h
d
r
a
w
n
,
 
b
e
c
a
u
s
e
 
t
h
e
n
 
t
h
e
 
d
a
m
a
g
e
 
i
s
 
l
i
m
i
t
e
d
.
 
A
 
m
a
j
o
r
i
t
y
 
o
f
 
s
t
a
k
e
h
o
l
d
e
r
s
 
i
n
 
t
h
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
i
n
c
l
u
d
i
n
g
 
s
t
a
k
e
h
o
l
d
e
r
s
 
i
n
 
F
r
a
n
c
e
,
 
t
h
e
 
U
n
i
t
e
d
 
K
i
n
g
d
o
m
,
 
I
r
e
l
a
n
d
,
 
G
r
e
e
c
e
,
 
S
p
a
i
n
,
 
L
u
x
e
m
b
o
u
r
g
,
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
 
a
n
d
 
I
t
a
l
y
 
a
d
v
o
c
a
t
e
 
t
h
e
 
r
e
g
u
l
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
b
y
 
t
h
e
 
E
u
r
o
p
e
a
n
 
U
n
i
o
n
 
i
n
 
o
r
d
e
r
 
t
o
 
e
n
s
u
r
e
 
a
 
h
i
g
h
e
r
 
l
e
v
e
l
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
I
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
 
w
e
 
p
r
o
v
i
d
e
 
a
 
c
o
m
p
a
r
a
t
i
v
e
 
o
v
e
r
v
i
e
w
 
o
f
 
t
h
e
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
i
s
s
u
e
s
 
t
h
a
t
 
h
a
v
e
 
b
e
e
n
 
p
e
r
c
e
i
v
e
d
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
4
5
 S
e
e
 
T
A
B
L
E
 
o
n
 
p
a
g
e
 
4
 
7
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
4
6
 2
.
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
C
o
n
s
u
m
e
r
 
P
r
o
t
e
c
t
i
o
n
 
C
o
u
n
t
r
v
 
E
U
 
A
u
s
t
r
i
a
 
B
e
l
g
i
u
m
 
D
e
n
m
a
r
k
 
F
i
n
l
a
n
d
 
F
r
a
n
c
e
 
G
e
r
m
a
n
y
 
n
o
 
p
a
r
t
i
c
u
l
a
r
 
p
r
o
b
l
e
m
 
p
r
o
b
l
e
m
 
i
m
p
o
r
t
a
n
t
 
p
r
o
b
l
e
m
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
X
 
X
 
X
 
X
 
X
 
X
 
X
 
X
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
X
 
X
 
X
 
X
 
X
 
X
 
X
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
C
o
m
m
e
n
t
s
 
A
l
l
 
E
u
r
o
p
e
a
n
 
c
o
n
s
u
m
e
r
 
g
r
o
u
p
s
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
s
 
n
e
e
d
e
d
 
b
e
c
a
u
s
e
 
o
f
 
t
h
e
 
i
n
c
r
e
a
s
i
n
g
 
n
u
m
b
e
r
 
o
f
 
c
l
a
i
m
s
 
m
a
d
e
 
a
n
d
 
t
h
e
 
g
r
o
w
i
n
g
 
r
i
s
k
 
o
f
 
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
.
 
A
u
s
t
r
i
a
n
 
a
u
t
h
o
r
i
t
i
e
s
 
c
o
n
s
i
d
e
r
 
t
h
e
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
s
y
s
t
e
m
 
w
h
i
c
h
 
a
p
p
l
i
e
s
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
s
 
a
n
 
e
f
f
e
c
t
i
v
e
 
m
e
a
n
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
T
h
e
 
A
u
s
t
r
i
a
n
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
 
s
t
r
e
s
s
e
s
 
t
h
a
t
,
 
d
e
s
p
i
t
e
 
t
h
e
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
p
r
o
c
e
d
u
r
e
,
 
t
h
e
r
e
 
a
r
e
 
s
t
i
l
l
 
c
a
s
e
s
 
i
n
 
w
h
i
c
h
 
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
 
a
r
e
 
m
a
d
e
.
 
T
h
e
 
F
e
d
e
r
a
l
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
 
p
o
i
n
t
s
 
o
u
t
 
t
h
e
 
d
i
f
f
i
c
u
l
t
y
 
f
o
r
 
c
o
n
s
u
m
e
r
s
 
t
o
 
i
n
t
e
r
p
r
e
t
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
A
s
 
a
 
c
o
n
s
e
q
u
e
n
c
e
,
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
o
f
t
e
n
 
a
p
p
e
a
r
 
m
i
s
l
e
a
d
i
n
g
 
i
n
 
B
e
l
g
i
u
m
.
 
T
h
e
r
e
 
a
r
e
 
n
o
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
p
r
o
b
l
e
m
s
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
b
e
c
a
u
s
e
 
o
f
 
t
h
e
 
r
e
s
t
r
i
c
t
i
v
e
 
n
a
t
u
r
e
 
o
f
D
a
n
i
s
h
 
l
e
g
i
s
l
a
t
i
o
n
.
 
N
o
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
p
r
o
b
l
e
m
s
 
w
e
r
e
 
r
e
p
o
r
t
e
d
 
b
y
 
t
h
e
 
F
i
n
n
i
s
h
 
s
t
a
k
e
h
o
l
d
e
r
s
.
 
F
o
l
l
o
w
i
n
g
 
c
o
n
s
u
l
t
a
t
i
o
n
s
 
w
i
t
h
 
a
l
l
 
i
n
t
e
r
e
s
t
e
d
 
p
a
r
t
i
e
s
,
 
t
h
e
 
C
o
n
s
e
i
l
 
N
a
t
i
o
n
a
l
 
d
e
 
/
'
A
l
i
m
e
n
t
a
t
i
o
n
 
(
C
N
A
)
 
d
r
e
w
 
u
p
 
a
 
l
i
s
t
 
o
f
 
s
t
r
i
c
t
 
c
o
n
d
i
t
i
o
n
s
 
f
o
r
 
t
h
e
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
N
o
 
a
c
t
i
o
n
 
·
w
a
s
 
t
a
k
e
n
 
s
i
n
c
e
 
F
r
a
n
c
e
 
s
e
e
k
s
 
a
 
b
r
o
a
d
e
r
 
E
u
r
o
p
e
a
n
 
a
p
p
r
o
a
c
h
 
t
o
 
t
h
e
 
p
r
o
b
l
e
m
.
 
C
o
n
s
u
m
e
r
 
o
r
g
a
n
i
s
a
t
i
o
n
s
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
t
h
e
 
p
r
o
t
e
c
t
i
o
n
s
 
p
r
o
v
i
d
e
d
 
b
y
 
l
a
w
 
a
g
a
i
n
s
t
 
m
i
s
l
e
a
d
i
n
g
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
s
 
i
n
s
u
f
f
i
c
i
e
n
t
.
 
T
h
e
 
i
n
d
u
s
t
r
y
 
c
o
n
s
i
d
e
r
s
 
t
h
a
t
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
a
d
v
e
r
t
i
s
i
n
g
 
a
n
d
 
t
h
e
 
p
r
o
h
i
b
i
t
i
o
n
 
o
f
 
c
l
a
i
m
s
 
r
e
l
a
t
i
n
g
 
t
o
 
s
p
e
c
i
f
i
c
 
d
i
s
e
a
s
e
s
 
a
r
e
 
s
u
f
f
i
c
i
e
n
t
 
t
o
 
p
r
o
t
e
c
t
 
t
h
e
 
c
o
n
s
u
m
e
r
s
 
T
h
e
 
m
a
i
n
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
 
r
e
p
o
r
t
s
 
p
r
o
b
l
e
m
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
,
 
p
a
r
t
i
c
u
l
a
r
l
y
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
f
u
n
c
t
i
o
n
a
l
 
f
o
o
d
s
,
 
f
o
o
d
 
s
u
p
p
l
e
m
e
n
t
s
 
a
n
d
 
p
r
o
b
i
o
t
i
c
 
f
o
o
d
s
.
 
T
h
i
s
 
s
i
t
u
a
t
i
o
n
 
i
s
 
a
l
l
 
t
h
e
 
m
o
r
e
 
p
r
e
o
c
c
u
p
y
i
n
g
 
t
h
a
t
 
t
h
e
s
e
 
t
y
p
e
s
 
o
f
 
p
r
o
d
u
c
t
s
 
v
e
r
y
 
o
f
t
e
n
 
b
e
a
r
 
c
l
a
i
m
s
.
 
T
h
e
 
G
e
r
m
a
n
 
M
i
n
i
s
t
r
y
 
o
f
 
H
e
a
l
t
h
 
c
o
n
s
i
d
e
r
s
 
t
h
a
t
 
G
e
r
m
a
n
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
s
u
f
f
i
c
i
e
n
t
 
i
n
 
t
e
r
m
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
H
o
w
e
v
e
r
,
 
i
t
 
r
e
p
o
r
t
s
 
p
r
o
b
l
e
m
s
 
w
i
t
h
 
s
e
l
e
c
t
i
v
e
 
c
l
a
i
m
s
 
(
m
a
d
e
 
o
u
t
 
o
f
 
c
o
n
t
e
x
t
)
 
a
n
d
 
m
o
r
e
 
s
u
b
t
l
e
 
f
o
r
m
s
 
o
f
 
c
l
a
i
m
s
 
s
u
c
h
 
a
s
 
s
p
o
n
s
o
r
i
n
g
 
o
f
h
e
a
l
t
h
-
r
e
l
a
t
e
d
 
t
e
l
e
v
i
s
i
o
n
 
p
r
o
g
r
a
m
m
e
s
.
 
T
h
e
 
C
e
n
t
r
e
 
f
o
r
 
F
i
g
h
t
 
a
g
a
i
n
s
t
 
U
n
l
a
w
f
u
l
 
C
o
m
p
e
t
i
t
i
o
n
 
b
e
l
i
e
v
e
s
 
t
h
a
t
 
G
e
r
m
a
n
 
l
e
g
i
s
l
a
t
i
o
n
 
p
r
o
v
i
d
e
s
 
f
o
r
 
a
d
e
q
u
a
t
e
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
b
u
t
 
a
d
m
i
t
s
 
t
h
a
t
 
t
h
e
 
c
a
t
e
g
o
r
y
 
o
f
 
f
o
o
d
 
s
u
p
p
l
e
m
e
n
t
s
 
i
s
 
p
r
o
b
l
e
m
a
t
i
c
.
 
4
7
 -
C
o
u
n
t
r
v
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
C
o
m
m
e
n
t
s
 
G
r
e
e
c
e
 
J
C
 
J
C
 
P
u
b
l
i
c
 
a
u
t
h
o
r
i
t
i
e
s
 
a
n
d
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
r
e
p
o
r
t
 
a
 
g
e
n
e
r
a
l
 
l
a
c
k
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
i
n
 
G
r
e
e
c
e
,
 
m
a
i
n
l
y
 
d
u
e
 
t
o
 
t
h
e
 
w
e
a
k
n
e
s
s
 
o
f
 
t
h
e
 
s
u
r
v
e
i
l
l
a
n
c
e
 
s
y
s
t
e
m
.
 
C
o
n
s
e
q
u
e
n
t
l
y
,
 
p
u
b
l
i
c
 
a
u
t
h
o
r
i
t
i
e
s
 
w
o
u
l
d
 
l
i
k
e
 
t
o
 
s
e
e
 
a
l
l
 
i
s
s
u
e
s
 
r
e
l
a
t
i
n
g
 
t
o
 
c
l
a
i
m
s
 
r
e
g
u
l
a
t
e
d
 
a
t
 
t
h
e
 
E
U
 
l
e
v
e
l
.
 
I
r
e
l
a
n
d
 
J
C
 
J
C
 
B
o
t
h
 
t
h
e
 
I
r
i
s
h
 
g
o
v
e
r
n
m
e
n
t
 
a
n
d
 
t
h
e
 
C
o
n
s
u
m
e
r
 
A
s
s
o
c
i
a
t
i
o
n
 
o
f
 
I
r
e
l
a
n
d
 
i
n
d
i
c
a
t
e
 
t
h
a
t
 
t
h
e
r
e
 
i
s
 
a
 
d
e
f
i
n
i
t
e
 
l
a
c
k
 
o
f
 
c
o
n
s
u
m
e
r
 
a
w
a
r
e
n
e
s
s
 
a
b
o
u
t
 
c
l
a
i
m
s
.
 
I
n
 
s
p
i
t
e
 
o
f
 
t
h
e
 
p
r
o
h
i
b
i
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
s
o
m
e
 
o
f
 
t
h
e
 
c
l
a
i
m
s
 
m
a
d
e
 
m
a
y
 
c
o
n
s
t
i
t
u
t
e
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
e
v
e
n
 
b
e
 
m
i
s
l
e
a
d
i
n
g
.
 
B
o
r
d
e
r
l
i
n
e
 
p
r
o
d
u
c
t
s
 
a
r
e
 
p
a
r
t
i
c
u
l
a
r
l
y
 
p
r
o
b
l
e
m
a
t
i
c
.
 
A
c
c
o
r
d
i
n
g
 
t
o
 
t
h
e
 
n
a
t
i
o
n
a
l
 
a
u
t
h
o
r
i
t
i
e
s
,
 
t
h
e
 
A
d
v
e
r
t
i
s
i
n
g
 
S
t
a
n
d
a
r
d
 
A
u
t
h
o
r
i
t
y
 
o
f
 
I
r
e
l
a
n
d
 
(
c
l
e
a
r
a
n
c
e
 
b
o
d
y
)
 
s
o
m
e
t
i
m
e
s
 
a
l
l
o
w
s
 
c
l
a
i
m
s
 
t
h
a
t
 
a
r
e
 
p
r
o
h
i
b
i
t
e
d
.
 
I
t
a
l
y
 
J
C
 
J
C
 
J
C
 
N
o
 
m
a
j
o
r
 
p
r
o
b
l
e
m
 
r
e
g
a
r
d
i
n
g
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
b
e
c
a
u
s
e
 
o
f
t
h
e
 
r
e
s
t
r
i
c
t
i
v
e
 
n
a
t
u
r
e
 
o
f
 
I
t
a
l
i
a
n
 
l
e
g
i
s
l
a
t
i
o
n
.
 
L
u
x
e
m
b
o
u
r
g
 
J
C
 
J
C
 
T
h
e
 
L
u
x
e
m
b
o
u
r
g
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
 
d
o
e
s
 
n
o
t
 
h
a
v
e
 
t
h
e
 
r
e
s
o
u
r
c
e
s
 
t
o
 
c
o
n
t
r
o
l
 
e
v
e
r
y
 
p
r
o
d
u
c
t
 
e
n
t
e
r
i
n
g
 
i
t
s
 
m
a
r
k
e
t
 
a
n
d
 
h
e
n
c
e
 
f
e
a
r
 
t
h
a
t
 
t
h
e
 
p
r
o
t
e
c
t
i
o
n
 
o
f
 
c
o
n
s
u
m
e
r
s
 
m
i
g
h
t
 
n
o
t
 
a
l
w
a
y
s
 
b
e
 
g
u
a
r
a
n
t
e
e
d
.
 
S
i
m
i
l
a
r
l
y
,
 
j
u
d
i
c
i
a
l
 
r
e
d
r
e
s
s
 
p
r
o
c
e
d
u
r
e
s
 
a
r
e
 
d
i
f
f
i
c
u
l
t
 
t
o
 
u
s
e
 
i
n
 
L
u
x
e
m
b
o
u
r
g
,
 
s
i
n
c
e
 
i
n
 
m
o
s
t
 
c
a
s
e
s
 
t
h
e
 
p
r
o
d
u
c
e
r
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
 
d
o
e
s
 
n
o
t
 
o
p
e
r
a
t
e
 
o
n
 
t
h
e
 
t
e
r
r
i
t
o
r
y
 
o
f
 
L
u
x
e
m
b
o
u
r
g
 
N
e
t
h
e
r
l
a
n
d
s
 
J
C
 
J
C
 
J
C
 
T
h
e
r
e
 
i
s
 
n
o
 
s
i
g
n
i
f
i
c
a
n
t
 
p
r
o
b
l
e
m
 
r
e
g
a
r
d
i
n
g
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
i
n
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
.
 
H
o
w
e
v
e
r
,
 
s
t
a
k
e
h
o
l
d
e
r
s
 
p
o
i
n
t
 
t
o
 
p
o
t
e
n
t
i
a
l
 
p
r
o
b
l
e
m
s
 
b
e
c
a
u
s
e
 
o
f
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
 
b
e
t
w
e
e
n
 
p
o
s
i
t
i
v
e
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
m
e
d
i
c
a
l
 
c
l
a
i
m
s
.
 
D
i
f
f
i
c
u
l
t
y
 
i
n
 
p
r
o
v
i
n
g
 
w
h
e
t
h
e
r
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
m
i
s
l
e
a
d
i
n
g
 
o
r
 
n
o
t
.
 
A
g
r
e
e
m
e
n
t
 
o
f
 
m
o
s
t
 
i
n
t
e
r
e
s
t
e
d
 
p
a
r
t
i
e
s
 
t
h
a
t
 
p
r
o
b
l
e
m
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
c
o
o
r
d
i
n
a
t
e
d
 
a
t
 
E
U
 
l
e
v
e
l
.
 
P
o
r
t
u
g
a
l
 
J
C
 
J
C
 
P
o
r
t
u
g
u
e
s
e
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
s
t
r
e
s
s
 
t
h
a
t
 
e
x
i
s
t
i
n
g
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
d
o
e
s
 
n
o
t
 
o
f
f
e
r
 
s
u
f
f
i
c
i
e
n
t
 
p
r
o
t
e
c
t
i
o
n
 
t
o
 
t
h
e
 
c
o
n
s
u
m
e
r
s
,
 
m
a
i
n
l
y
 
d
u
e
 
t
o
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
c
l
e
a
r
l
y
 
d
e
f
i
n
e
d
 
r
u
l
e
s
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
t
h
e
m
.
 
S
p
a
i
n
 
J
C
 
J
C
 
S
p
a
n
i
s
h
 
a
u
t
h
o
r
i
t
i
e
s
 
c
o
n
s
i
d
e
r
 
b
o
r
d
e
r
l
i
n
e
 
p
r
o
d
u
c
t
s
 
a
s
 
p
r
o
b
l
e
m
a
t
i
c
 
f
o
r
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
S
w
e
d
e
n
 
J
C
 
J
C
 
J
C
 
N
o
 
s
i
g
n
i
f
i
c
a
n
t
 
p
r
o
b
l
e
m
s
 
r
e
g
a
r
d
i
n
g
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
w
e
r
e
 
r
e
p
o
r
t
e
d
,
 
a
s
 
p
o
l
i
c
y
 
t
h
i
n
k
i
n
g
 
i
s
 
p
r
i
m
a
r
i
l
y
 
b
a
s
e
d
 
o
n
 
t
h
e
 
n
e
e
d
 
t
o
 
p
r
o
t
e
c
t
 
t
h
e
 
c
o
n
s
u
m
e
r
.
 
U
K
 
J
C
 
C
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
p
r
o
v
i
d
e
 
e
x
a
m
p
l
e
s
 
o
f
 
l
a
c
k
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
f
r
o
m
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
.
 
B
o
t
h
 
t
h
e
 
B
r
i
t
i
s
h
 
g
o
v
e
r
n
m
e
n
t
 
a
n
d
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
r
e
p
o
r
t
 
a
 
l
a
c
k
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
U
n
i
t
e
d
 
S
t
a
t
e
s
 
J
C
 
C
o
n
s
u
m
e
r
 
g
r
o
u
p
s
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
t
h
e
 
a
b
o
l
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
i
o
r
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
s
y
s
t
e
m
 
f
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
 
1
9
9
4
 
h
a
s
 
l
e
d
 
t
o
 
a
 
d
e
c
r
e
a
s
e
 
i
n
 
t
h
e
 
l
e
v
e
l
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
C
a
n
a
d
a
 
J
C
 
J
C
 
J
C
 
N
o
 
m
a
j
o
r
 
p
r
o
b
l
e
m
s
 
r
e
g
a
r
d
i
n
g
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
w
e
r
e
 
r
e
p
o
r
t
e
d
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
4
8
 3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
W
h
i
l
s
t
 
t
h
e
r
e
 
i
s
 
a
 
p
e
r
c
e
i
v
e
d
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
p
r
o
b
l
e
m
,
 
n
o
t
 
a
l
l
 
t
y
p
e
s
 
o
f
 
c
l
a
i
m
s
 
a
r
e
 
e
q
u
a
l
l
y
 
c
o
n
c
e
r
n
e
d
.
 
T
h
e
 
m
a
i
n
 
p
r
o
b
l
e
m
s
 
a
r
e
 
p
e
r
c
e
i
v
e
d
 
i
n
 
t
h
e
 
c
a
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
t
h
e
 
p
r
o
b
l
e
m
s
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
t
h
e
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
o
f
t
e
n
 
o
f
 
a
 
h
o
r
i
z
o
n
t
a
l
 
n
a
t
u
r
e
,
 
i
.
e
.
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
,
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
v
s
.
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
 
e
t
c
.
 
T
h
e
s
e
 
h
o
r
i
z
o
n
t
a
l
 
p
r
o
b
l
e
m
s
 
c
a
n
 
i
d
e
a
l
l
y
 
b
e
 
a
d
d
r
e
s
s
e
d
 
v
i
a
 
a
d
e
q
u
a
t
e
 
a
m
e
n
d
m
e
n
t
s
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
A
l
s
o
,
 
a
s
 
i
n
c
r
e
a
s
e
d
 
u
s
e
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
m
a
y
 
b
e
 
e
x
p
e
c
t
e
d
 
i
n
 
t
h
e
 
f
u
t
u
r
e
,
 
t
h
i
s
 
w
o
u
l
d
 
a
l
l
o
w
 
t
h
e
 
d
e
v
e
l
o
p
m
e
n
t
 
o
f
 
a
 
l
e
g
a
l
 
f
r
a
m
e
w
o
r
k
,
 
w
h
i
c
h
 
a
l
r
e
a
d
y
 
t
a
k
e
s
 
f
u
t
u
r
e
 
d
e
v
e
l
o
p
m
e
n
t
s
 
i
n
t
o
 
a
c
c
o
u
n
t
,
 
i
n
s
t
e
a
d
 
o
f
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
a
 
r
e
a
c
t
i
v
e
 
b
a
s
i
s
.
 
C
l
e
a
r
l
y
,
 
t
h
e
r
e
 
a
r
e
 
a
 
n
u
m
b
e
r
 
o
f
 
v
e
r
t
i
c
a
l
 
i
s
s
u
e
s
,
 
w
h
i
c
h
 
w
e
 
c
o
n
s
i
d
e
r
 
c
a
n
n
o
t
 
b
e
 
a
d
d
r
e
s
s
e
d
 
v
i
a
 
a
n
 
a
m
e
n
d
m
e
n
t
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
T
h
e
s
e
 
i
s
s
u
e
s
 
w
i
l
l
 
b
e
 
d
e
v
e
l
o
p
e
d
 
f
u
r
t
h
e
r
 
i
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
s
e
c
t
i
o
n
s
 
o
f
 
t
h
e
 
c
o
m
p
a
r
a
t
i
v
e
 
a
n
a
l
y
s
i
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
-
2
0
0
0
 
4
9
 C
.
 
B
A
R
R
I
E
R
S
 
T
O
 
T
R
A
D
E
 
1
.
 
C
o
m
m
e
n
t
 
B
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
h
a
v
e
 
e
s
s
e
n
t
i
a
l
l
y
 
b
e
e
n
 
r
e
p
o
r
t
e
d
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
N
o
n
e
 
o
f
 
t
h
e
 
s
t
a
k
e
h
o
l
d
e
r
s
 
m
e
n
t
i
o
n
e
d
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
A
s
 
t
o
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
s
o
m
e
 
v
e
r
y
 
s
m
a
l
l
 
p
r
o
b
l
e
m
s
 
w
e
r
e
 
r
e
p
o
r
t
e
d
,
 
a
s
 
s
o
m
e
t
i
m
e
s
 
t
h
e
 
r
e
f
e
r
e
n
c
e
 
v
a
l
u
e
s
 
f
o
r
 
m
a
k
i
n
g
 
a
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
 
d
i
f
f
e
r
 
b
e
t
w
e
e
n
 
M
e
m
b
e
r
 
S
t
a
t
e
s
.
 
A
s
 
t
o
 
t
h
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
i
n
 
t
h
e
 
a
r
e
a
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
t
h
e
s
e
 
w
e
r
e
 
m
a
i
n
l
y
 
r
e
p
o
r
t
e
d
 
b
y
 
i
n
d
u
s
t
r
y
.
 
I
t
 
i
s
 
i
n
t
e
r
e
s
t
i
n
g
 
t
o
 
n
o
t
e
 
t
h
a
t
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
e
r
e
 
m
e
n
t
i
o
n
e
d
 
i
n
 
e
i
t
h
e
r
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
t
h
a
t
 
h
a
v
e
 
a
 
v
e
r
y
 
s
t
r
i
c
t
 
i
n
t
e
r
p
r
e
t
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
(
e
.
g
.
 
A
u
s
t
r
i
a
,
 
I
t
a
l
y
,
 
e
t
c
.
)
 
a
n
d
/
o
r
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
t
h
a
t
 
h
a
v
e
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
i
n
 
p
l
a
c
e
 
(
e
.
g
.
 
A
u
s
t
r
i
a
,
 
B
e
l
g
i
u
m
,
 
F
r
a
n
c
e
)
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
s
o
m
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
e
r
e
 
r
e
p
o
r
t
e
d
 
b
y
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
,
 
w
h
e
r
e
 
f
o
o
d
 
s
u
p
p
l
e
m
e
n
t
s
 
b
e
i
n
g
 
i
m
p
o
r
t
e
d
 
f
r
o
m
 
o
t
h
e
r
 
c
o
u
n
t
r
i
e
s
 
a
r
e
 
o
f
t
e
n
 
c
a
t
e
g
o
r
i
s
e
d
 
a
s
 
m
e
d
i
c
i
n
a
l
 
p
r
o
d
u
c
t
s
 
(
e
.
g
.
 
G
e
r
m
a
n
y
,
 
U
K
)
.
 
P
o
t
e
n
t
i
a
l
 
f
u
t
u
r
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
h
a
v
e
 
a
l
s
o
 
b
e
e
n
 
r
e
p
o
r
t
e
d
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
,
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
t
h
e
 
U
K
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
.
 
A
s
 
t
h
i
s
 
i
n
i
t
i
a
t
i
v
e
 
i
s
 
l
i
k
e
l
y
 
t
o
 
a
l
l
o
w
 
l
i
b
e
r
a
l
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
i
t
 
m
a
y
 
l
e
a
d
 
t
o
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
i
t
h
 
I
r
e
l
a
n
d
.
 
I
n
 
g
e
n
e
r
a
l
,
 
a
n
d
 
q
u
i
t
e
 
l
o
g
i
c
a
l
l
y
,
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
s
e
e
m
 
t
o
 
a
p
p
e
a
r
 
b
e
t
w
e
e
n
 
c
o
u
n
t
r
i
e
s
 
t
h
a
t
 
s
h
a
r
e
 
t
h
e
 
s
a
m
e
 
l
a
n
g
u
a
g
e
,
 
s
u
c
h
 
a
s
 
A
u
s
t
r
i
a
 
a
n
d
 
G
e
r
m
a
n
y
,
 
o
r
 
t
h
e
 
F
l
e
m
i
s
h
 
p
a
r
t
 
o
f
 
B
e
l
g
i
u
m
 
a
n
d
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
.
 
I
n
d
u
s
t
r
y
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
o
f
t
e
n
 
t
h
e
s
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
o
u
l
d
 
n
o
t
 
b
e
 
v
i
s
i
b
l
e
,
 
a
s
 
i
n
d
u
s
t
r
y
 
t
e
n
d
e
d
 
t
o
 
m
o
d
i
f
y
 
i
t
s
 
l
a
b
e
l
l
i
n
g
 
f
r
o
m
 
o
n
e
 
c
o
u
n
t
r
y
 
t
o
 
a
n
o
t
h
e
r
,
 
i
n
s
t
e
a
d
 
o
f
 
g
o
i
n
g
 
t
o
 
t
h
e
 
c
o
u
r
t
s
.
 
I
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
 
w
e
 
p
r
o
v
i
d
e
 
a
n
 
o
v
e
r
v
i
e
w
 
o
f
 
t
h
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
t
h
a
t
 
h
a
v
e
 
b
e
e
n
 
r
e
p
o
r
t
e
d
 
b
y
 
s
t
a
k
e
h
o
l
d
e
r
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
0
 2
.
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
B
a
r
r
i
e
r
s
 
t
o
 
T
r
a
d
e
 
n
o
 
p
a
r
t
i
c
u
l
a
r
 
p
r
o
b
l
e
m
 
p
r
o
b
l
e
m
 
i
m
p
o
r
t
a
n
t
 
p
r
o
b
l
e
m
 
C
o
u
n
t
r
y
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
C
o
m
m
e
n
t
s
 
E
U
 
X
 
X
 
C
I
A
A
 
c
o
n
s
i
d
e
r
e
d
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
o
n
e
 
c
o
u
l
d
 
n
o
t
 
u
s
e
 
t
h
e
 
s
a
m
e
 
h
e
a
l
t
h
 
c
l
a
i
m
 
a
c
r
o
s
s
 
E
u
r
o
p
e
 
a
 
c
l
e
a
r
 
b
a
r
r
i
e
r
 
t
o
 
t
r
a
d
e
.
 
A
u
s
t
r
i
a
 
X
 
X
 
I
n
d
u
s
t
r
y
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
e
x
i
s
t
e
d
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
,
 
b
e
t
w
e
e
n
 
A
u
s
t
r
i
a
 
a
n
d
 
G
e
r
m
a
n
y
 
(
s
a
m
e
 
l
a
n
g
u
a
g
e
 
u
s
e
d
 
o
n
 
l
a
b
e
l
s
)
 
b
e
c
a
u
s
e
 
o
f
 
t
h
e
 
s
t
r
i
c
t
e
r
 
A
u
s
t
r
i
a
n
 
l
e
g
i
s
l
a
t
i
o
n
.
 
A
l
s
o
,
 
t
h
e
 
A
u
s
t
r
i
a
n
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
w
a
s
 
c
o
n
s
i
d
e
r
e
d
 
a
 
b
a
r
r
i
e
r
 
t
o
 
t
r
a
d
e
.
 
B
e
l
g
i
u
m
 
X
 
X
 
I
n
d
u
s
t
r
y
 
i
n
d
i
c
a
t
e
d
 
t
r
a
d
e
 
b
a
r
r
i
e
r
s
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
 
b
e
t
w
e
e
n
 
B
e
l
g
i
u
m
 
a
n
d
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
 
(
s
a
m
e
 
l
a
n
g
u
a
g
e
 
u
s
e
d
 
o
n
 
l
a
b
e
l
s
)
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
t
h
e
 
B
e
l
g
i
u
m
 
n
o
t
i
f
i
c
a
t
i
o
n
 
a
n
d
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
s
y
s
t
e
m
 
i
s
 
c
o
n
s
i
d
e
r
e
d
 
a
 
b
a
r
r
i
e
r
 
t
o
 
t
r
a
d
e
.
 
D
e
n
m
a
r
k
 
X
 
X
 
X
 
F
i
n
l
a
n
d
 
X
 
X
 
X
 
F
r
a
n
c
e
 
X
 
X
 
I
n
d
u
s
t
r
y
 
c
o
n
s
i
d
e
r
s
 
t
h
e
 
c
u
r
r
e
n
t
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
f
o
r
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
 
b
a
r
r
i
e
r
 
t
o
 
t
r
a
d
e
.
 
G
e
r
m
a
n
y
 
X
 
X
 
A
u
t
h
o
r
i
t
i
e
s
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
s
o
m
e
t
i
m
e
s
 
p
r
o
b
l
e
m
s
 
a
r
i
s
e
 
w
i
t
h
 
f
o
o
d
 
s
u
p
p
l
e
m
e
n
t
s
,
 
w
h
i
c
h
 
a
r
e
 
o
f
t
e
n
 
c
l
a
s
s
i
f
i
e
d
 
a
s
 
m
e
d
i
c
i
n
a
l
 
p
r
o
d
u
c
t
s
 
i
n
 
G
e
r
m
a
n
y
 
b
e
c
a
u
s
e
 
o
f
 
t
h
e
 
c
l
a
i
m
s
 
m
a
d
e
.
 
G
r
e
e
c
e
 
X
 
X
 
X
 
I
r
e
l
a
n
d
 
X
 
X
 
X
 
T
h
e
r
e
 
a
r
e
 
f
e
a
r
s
 
t
h
a
t
 
t
h
e
 
U
K
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
 
m
a
y
 
l
e
a
d
 
t
o
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
.
 
I
t
a
l
y
 
X
 
X
 
I
n
d
u
s
t
r
y
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
i
m
p
o
r
t
s
 
f
r
o
m
 
o
t
h
e
r
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
m
a
y
 
s
o
m
e
t
i
m
e
s
 
c
a
u
s
e
 
p
r
o
b
l
e
m
s
,
 
b
e
c
a
u
s
e
 
o
f
 
t
h
e
 
s
t
r
i
c
t
 
a
p
p
l
i
c
a
t
i
o
n
 
o
f
t
h
e
 
b
a
n
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
 
I
t
a
l
y
.
 
L
u
x
e
m
b
o
u
r
g
 
X
 
X
 
X
 
D
u
e
 
t
o
 
L
u
x
e
m
b
o
u
r
g
'
s
 
p
r
o
x
i
m
i
t
y
 
t
o
 
t
h
e
 
m
a
r
k
e
t
s
 
o
f
 
i
t
s
 
n
e
i
g
h
b
o
u
r
i
n
g
 
c
o
u
n
t
r
i
e
s
 
i
t
 
i
s
 
b
a
s
i
c
a
l
l
y
 
f
o
r
c
e
d
 
t
o
 
a
c
c
e
p
t
 
t
h
e
i
r
 
p
r
o
d
u
c
t
s
 
o
n
 
i
t
s
 
m
a
r
k
e
t
.
 
N
e
t
h
e
r
l
a
n
d
s
 
X
 
X
 
X
 
P
o
r
t
u
g
a
l
 
X
 
X
 
I
n
d
u
s
t
r
y
 
c
o
n
s
i
d
e
r
s
 
i
t
s
e
l
f
 
d
i
s
a
d
v
a
n
t
a
g
e
d
,
 
a
s
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
h
a
v
e
,
 
o
n
 
t
h
e
 
o
n
e
 
h
a
n
d
,
 
a
 
r
e
s
t
r
i
c
t
i
v
e
 
p
r
a
c
t
i
c
e
 
v
i
s
-
a
-
v
i
s
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
b
u
t
 
a
l
l
o
w
,
 
o
n
 
t
h
e
 
o
t
h
e
r
,
 
t
h
e
 
i
m
p
o
r
t
 
o
f
 
f
a
r
-
r
e
a
c
h
i
n
g
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
f
r
o
m
 
o
t
h
e
r
 
M
e
m
b
e
r
 
S
t
a
t
e
s
.
 
S
p
a
i
n
 
X
 
X
 
X
 
S
w
e
d
e
n
 
X
 
X
 
X
 
T
h
e
 
S
w
e
d
i
s
h
 
B
o
a
r
d
 
o
f
 
T
r
a
d
e
 
f
e
a
r
s
 
t
h
a
t
 
t
h
e
 
i
n
c
r
e
a
s
i
n
g
l
y
 
u
s
e
d
 
v
o
l
u
n
t
a
r
y
 
l
a
b
e
l
l
i
n
g
 
s
y
s
t
e
m
s
 
(
a
l
s
o
 
i
n
 
t
h
e
 
a
r
e
a
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
)
 
m
a
y
 
p
o
t
e
n
t
i
a
l
l
y
 
c
a
u
s
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
.
 
U
K
 
X
 
X
 
T
h
e
r
e
 
s
e
e
m
 
t
o
 
e
x
i
s
t
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
b
o
r
d
e
r
l
i
n
e
 
c
a
s
e
s
 
b
e
t
w
e
e
n
 
f
o
o
d
 
a
n
d
 
m
e
d
i
c
i
n
a
l
 
p
r
o
d
u
c
t
s
.
 
P
o
t
e
n
t
i
a
l
l
y
,
 
c
l
a
i
m
s
 
a
l
l
o
w
e
d
 
u
n
d
e
r
 
t
h
e
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
 
m
a
y
 
n
o
t
 
b
e
 
a
l
l
o
w
e
d
 
e
l
s
e
w
h
e
r
e
 
i
n
 
E
u
r
o
p
e
 
a
n
d
 
t
h
u
s
 
c
r
e
a
t
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
.
 
U
n
i
t
e
d
 
S
t
a
t
e
s
 
X
 
X
 
X
 
T
h
e
 
s
a
t
u
r
a
t
i
o
n
 
o
f
 
t
h
e
 
U
S
 
m
a
r
k
e
t
,
 
s
p
e
c
i
f
i
c
a
l
l
y
 
f
o
r
 
d
i
e
t
a
r
y
 
s
u
p
p
l
e
m
e
n
t
s
 
m
a
y
 
l
e
a
d
 
t
o
 
a
n
 
i
n
c
r
e
a
s
e
 
o
f
 
t
h
e
 
e
x
p
o
r
t
 
o
f
 
s
u
c
h
 
p
r
o
d
u
c
t
s
 
t
o
 
E
u
r
o
p
e
,
 
p
o
t
e
n
t
i
a
l
l
y
 
c
r
e
a
t
i
n
g
 
t
r
a
d
e
 
p
r
o
b
l
e
m
s
,
 
a
s
 
a
 
r
e
s
u
l
t
 
o
f
 
t
h
e
 
f
a
r
-
r
e
a
c
h
i
n
g
 
c
l
a
i
m
s
 
a
l
l
o
w
e
d
 
i
n
 
t
h
e
 
U
S
.
 
C
a
n
a
d
a
 
X
 
X
 
X
 
B
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
s
e
e
m
,
 
a
t
 
t
h
e
 
m
o
m
e
n
t
,
 
m
o
r
e
 
l
i
k
e
l
y
 
t
o
 
a
p
p
e
a
r
 
b
e
t
w
e
e
n
 
C
a
n
a
d
a
 
a
n
d
 
t
h
e
 
U
S
,
 
t
h
a
n
 
b
e
t
w
e
e
n
 
C
a
n
a
d
a
 
a
n
d
 
E
u
r
o
p
e
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
1
 
-3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
B
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
s
e
e
m
 
t
o
 
b
e
 
g
e
n
e
r
a
t
e
d
 
m
a
i
n
l
y
 
b
y
 
t
h
e
 
d
i
f
f
e
r
e
n
t
 
i
n
t
e
r
p
r
e
t
a
t
i
o
n
 
t
h
a
t
 
M
e
m
b
e
r
 
S
t
a
t
e
 
a
u
t
h
o
r
i
t
i
e
s
 
g
i
v
e
 
t
o
 
t
h
e
 
b
a
n
 
s
p
e
l
l
e
d
 
o
u
t
 
i
n
 
a
r
t
i
c
l
e
 
2
 
o
f
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
,
 
i
.
e
.
 
t
o
 
t
h
e
 
b
a
n
 
o
n
 
c
l
a
i
m
s
 
a
s
 
t
o
 
t
h
e
 
p
r
e
v
e
n
t
i
o
n
,
 
t
r
e
a
t
m
e
n
t
 
a
n
d
 
c
u
r
i
n
g
 
o
f
 
d
i
s
e
a
s
e
,
 
a
s
 
w
e
l
l
 
a
s
 
t
o
 
t
h
e
 
d
e
v
e
l
o
p
m
e
n
t
 
o
f
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
I
t
 
s
e
e
m
s
 
t
h
a
t
 
a
n
 
a
m
e
n
d
m
e
n
t
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
w
i
l
l
 
n
o
t
 
r
e
s
o
l
v
e
 
t
h
e
s
e
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
.
 
I
n
 
o
u
r
 
v
i
e
w
,
 
t
h
e
s
e
 
p
r
o
b
l
e
m
s
 
c
o
u
l
d
 
e
s
s
e
n
t
i
a
l
l
y
 
b
e
 
r
e
s
o
l
v
e
d
 
t
h
o
u
g
h
 
a
n
 
a
m
e
n
d
m
e
n
t
 
o
f
 
t
h
e
 
L
a
b
e
l
l
i
n
g
 
D
i
r
e
c
t
i
v
e
 
7
9
1
1
1
2
.
 
I
t
 
w
o
u
l
d
 
b
e
 
n
e
c
e
s
s
a
r
y
 
t
o
 
c
l
a
r
i
f
y
 
t
h
e
 
s
c
o
p
e
 
o
f
 
i
t
s
 
a
r
t
i
c
l
e
 
2
 
a
n
d
 
t
o
 
p
u
t
 
i
t
 
i
n
 
l
i
n
e
 
w
i
t
h
 
d
e
v
e
l
o
p
m
e
n
t
s
 
a
t
 
C
o
d
e
x
 
A
l
i
m
e
n
t
a
r
i
u
s
,
 
a
s
 
w
e
l
l
 
a
s
 
n
a
t
i
o
n
a
l
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
2
 I
 
D
.
 
S
U
B
S
T
A
N
T
I
A
T
I
O
N
 
N
E
E
D
E
D
 
F
O
R
 
C
L
A
I
M
S
 
1
.
 
C
o
m
m
e
n
t
 
W
i
t
h
 
r
e
g
a
r
d
 
t
o
 
t
h
e
 
c
r
i
t
e
r
i
a
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
c
l
a
i
m
s
,
 
o
n
e
 
h
a
s
 
t
o
 
d
i
s
t
i
n
g
u
i
s
h
 
b
e
t
w
e
e
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
a
n
d
 
a
s
 
t
o
 
w
h
e
t
h
e
r
 
t
h
e
s
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
c
r
i
t
e
r
i
a
 
a
r
e
 
l
i
s
t
e
d
 
i
n
 
v
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
o
r
 
i
n
 
l
a
w
s
.
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
:
 
n
a
t
i
o
n
a
l
 
l
e
g
i
s
l
a
t
i
o
n
 
m
o
s
t
 
o
f
t
e
n
 
o
n
l
y
 
a
p
p
l
i
e
s
 
t
h
e
 
c
r
i
t
e
r
i
a
 
s
e
t
 
o
u
t
 
i
n
 
t
h
e
 
D
i
r
e
c
t
i
v
e
 
9
0
/
4
9
6
 
o
n
 
N
u
t
r
i
t
i
o
n
a
l
 
L
a
b
e
l
l
i
n
g
,
 
i
.
e
.
 
w
h
e
n
e
v
e
r
 
a
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
 
i
s
 
m
a
d
e
 
n
u
t
r
i
t
i
o
n
a
l
 
l
a
b
e
l
l
i
n
g
 
b
e
c
o
m
e
s
 
c
o
m
p
u
l
s
o
r
y
.
 
I
n
 
s
o
m
e
 
c
o
u
n
t
r
i
e
s
,
 
a
d
d
i
t
i
o
n
a
l
 
g
u
i
d
e
l
i
n
e
s
 
(
e
.
g
.
 
F
i
n
l
a
n
d
)
 
a
n
d
/
o
r
 
l
e
g
a
l
 
r
e
q
u
i
r
e
m
e
n
t
s
 
e
x
i
s
t
 
a
s
 
t
o
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
,
 
t
h
a
t
 
h
a
v
e
 
t
o
 
b
e
 
r
e
s
p
e
c
t
e
d
 
i
n
 
o
r
d
e
r
 
t
o
 
b
e
 
a
b
l
e
 
t
o
 
m
a
k
e
 
c
e
r
t
a
i
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
(
e
.
g
.
 
U
K
,
 
G
e
r
m
a
n
y
)
.
 
H
e
a
l
t
h
 
C
l
a
i
m
s
:
 
i
n
 
m
a
n
y
 
c
a
s
e
s
 
c
r
i
t
e
r
i
a
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
t
h
e
s
e
 
c
l
a
i
m
s
 
d
o
 
n
o
t
 
e
x
i
s
t
 
b
y
 
l
a
w
,
 
a
s
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
s
i
m
p
l
y
 
n
o
t
 
a
l
l
o
w
e
d
,
 
o
r
 
c
r
i
t
e
r
i
a
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
t
h
e
s
e
 
c
l
a
i
m
s
 
o
n
l
y
 
a
p
p
l
y
 
f
o
r
 
s
o
m
e
 
e
x
c
e
p
t
i
o
n
s
 
w
h
i
c
h
 
a
r
e
 
a
l
l
o
w
e
d
 
f
o
r
 
f
o
o
d
s
t
u
f
f
s
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
 
(
P
 
A
R
N
U
T
S
)
.
 
I
n
 
t
h
e
s
e
 
c
a
s
e
s
,
 
a
 
m
a
n
u
f
a
c
t
u
r
e
r
 
h
a
s
,
 
m
o
s
t
 
o
f
t
e
n
,
 
t
o
 
s
u
b
m
i
t
 
t
h
e
 
l
a
b
e
l
 
a
n
d
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
.
 
I
n
 
s
o
m
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
a
n
d
 
i
n
 
p
a
r
t
i
c
u
l
a
r
 
i
n
 
t
h
o
s
e
 
w
h
e
r
e
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
f
o
r
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
e
x
i
s
t
s
 
(
A
u
s
t
r
i
a
,
 
F
r
a
n
c
e
)
,
 
c
r
i
t
e
r
i
a
 
h
a
v
e
 
b
e
e
n
 
s
e
t
 
o
u
t
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
c
l
a
i
m
s
.
 
H
e
r
e
 
a
g
a
i
n
,
 
i
n
 
g
e
n
e
r
a
l
 
t
h
e
 
l
a
b
e
l
 
a
n
d
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
 
h
a
s
 
t
o
 
b
e
 
s
u
b
m
i
t
t
e
d
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
s
o
m
e
 
c
o
u
n
t
r
i
e
s
 
a
l
s
o
 
r
e
q
u
i
r
e
 
s
c
i
e
n
t
i
f
i
c
 
d
a
t
a
 
t
o
 
b
e
 
s
u
b
m
i
t
t
e
d
 
(
e
.
g
.
 
F
r
a
n
c
e
)
.
 
V
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
:
 
A
l
l
 
o
f
 
t
h
e
m
 
r
e
q
u
i
r
e
,
 
i
n
 
g
e
n
e
r
a
l
,
 
t
h
e
 
s
u
b
m
i
s
s
i
o
n
 
o
f
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
T
h
e
 
v
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
v
e
r
y
 
o
f
t
e
n
 
d
e
f
i
n
e
 
i
n
 
m
o
r
e
 
d
e
t
a
i
l
 
t
h
e
 
c
r
i
t
e
r
i
a
 
t
h
a
t
 
t
h
e
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
 
m
u
s
t
 
f
u
l
f
i
l
l
.
 
M
o
s
t
 
i
n
t
e
r
e
s
t
i
n
g
 
i
n
 
t
h
i
s
 
r
e
s
p
e
c
t
 
i
s
 
t
h
e
 
C
I
A
A
 
d
r
a
f
t
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
w
h
i
c
h
 
l
i
s
t
s
 
a
 
l
a
r
g
e
 
n
u
m
b
e
r
 
o
f
 
c
r
i
t
e
r
i
a
 
t
h
a
t
 
m
u
s
t
 
b
e
 
f
u
l
f
i
l
l
e
d
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
n
g
 
a
 
c
l
a
i
m
.
 
E
t
h
i
c
a
l
 
c
l
a
i
m
s
:
 
t
h
e
r
e
 
e
x
i
s
t
s
,
 
s
o
 
f
a
r
,
 
n
o
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
T
h
e
 
o
n
l
y
 
t
w
o
 
c
o
u
n
t
r
i
e
s
 
w
o
r
k
i
n
g
 
o
n
 
l
e
g
i
s
l
a
t
i
o
n
 
a
r
e
 
B
e
l
g
i
u
m
 
a
n
d
 
I
t
a
l
y
.
 
I
n
 
B
e
l
g
i
u
m
,
 
o
n
c
e
 
t
h
e
 
b
a
s
i
c
 
l
a
w
 
o
n
 
t
h
e
 
"
p
r
o
m
o
t
i
o
n
 
o
f
 
s
o
c
i
a
l
l
y
 
r
e
s
p
o
n
s
i
b
l
e
 
p
r
o
d
u
c
t
i
o
n
"
 
h
a
s
 
b
e
e
n
 
a
d
o
p
t
e
d
,
 
t
h
e
 
c
r
i
t
e
r
i
a
 
f
o
r
 
o
b
t
a
i
n
i
n
g
 
t
h
e
 
r
e
l
e
v
a
n
t
 
l
a
b
e
l
 
s
t
i
l
l
 
n
e
e
d
 
t
o
 
b
e
 
d
e
t
e
r
m
i
n
e
d
 
i
n
 
t
h
e
 
f
o
r
m
 
o
f
 
a
 
R
o
y
a
l
 
D
e
c
r
e
e
.
 
V
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
o
n
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
:
 
i
n
 
g
e
n
e
r
a
l
,
 
w
h
e
r
e
 
s
u
c
h
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
e
x
i
s
t
,
 
t
h
e
s
e
 
c
o
n
t
a
i
n
 
c
r
i
t
e
r
i
a
 
f
o
r
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
.
 
F
a
i
r
 
t
r
a
d
e
 
l
a
b
e
l
l
i
n
g
 
s
c
h
e
m
e
s
 
a
p
p
l
y
,
 
g
e
n
e
r
a
l
l
y
,
 
t
h
e
 
c
r
i
t
e
r
i
a
 
s
e
t
 
o
u
t
 
b
y
 
t
h
e
 
F
a
i
r
 
T
r
a
d
e
 
L
a
b
e
l
l
i
n
g
 
O
r
g
a
n
i
s
a
t
i
o
n
 
(
F
L
O
)
.
 
T
h
e
s
e
 
c
r
i
t
e
r
i
a
 
a
r
e
 
n
o
r
m
a
l
l
y
:
 
p
u
r
c
h
a
s
e
 
o
n
l
y
 
f
r
o
m
 
a
c
c
e
p
t
e
d
 
s
o
u
r
c
e
s
;
 
p
a
y
m
e
n
t
 
o
f
 
a
 
p
r
e
m
i
u
m
 
i
n
 
a
d
d
i
t
i
o
n
 
t
o
 
t
h
e
 
m
a
r
k
e
t
 
p
r
i
c
e
;
 
r
e
s
p
e
c
t
 
o
f
 
m
i
n
i
m
u
m
 
l
a
b
o
u
r
 
s
t
a
n
d
a
r
d
s
;
 
e
t
c
.
 
T
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
 
p
r
o
v
i
d
e
s
 
a
n
 
o
v
e
r
v
i
e
w
 
a
s
 
t
o
 
w
h
e
t
h
e
r
 
p
r
o
v
i
s
i
o
n
s
 
o
n
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
a
r
e
 
s
e
t
 
o
u
t
 
b
y
 
l
a
w
 
o
r
 
i
n
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
-
2
0
0
0
 
5
3
 2
.
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
S
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
C
l
a
i
m
s
 
C
o
u
n
t
r
y
 
N
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
N
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
H
e
a
l
t
h
 
c
l
a
i
m
s
 
H
e
a
l
t
h
 
c
l
a
i
m
s
 
E
t
h
i
c
a
l
 
c
l
a
i
m
s
 
E
t
h
i
c
a
l
 
c
l
a
i
m
s
 
r
e
g
u
l
a
t
e
d
 
b
y
 
l
a
w
 
r
e
g
u
l
a
t
e
d
 
b
y
 
r
e
g
u
l
a
t
e
d
 
b
y
 
l
a
w
 
r
e
g
u
l
a
t
e
d
 
b
y
 
r
e
g
u
l
a
t
e
d
 
b
y
 
l
a
w
 
r
e
g
u
l
a
t
e
d
 
b
y
 
v
o
l
u
n
t
a
r
y
 
v
o
l
u
n
t
a
r
y
 
v
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
i
n
s
t
r
u
m
e
n
t
s
 
i
n
s
t
r
u
m
e
n
t
s
 
E
U
 
X
 
(
f
o
r
 
P
A
R
N
U
T
S
 
X
 
o
n
l
y
)
 
A
u
s
t
r
i
a
 
X
 
X
 
X
 
X
 
B
e
l
g
i
u
m
 
X
 
(
f
o
r
 
P
 
A
R
N
U
T
S
 
X
 
(
s
t
i
l
l
 
t
o
 
b
e
 
a
n
d
 
f
o
r
t
i
f
i
e
d
 
f
o
o
d
s
 
d
e
t
e
r
m
i
n
e
d
 
b
y
 
o
n
l
y
)
 
R
o
y
a
l
 
D
e
c
r
e
e
)
 
D
e
n
m
a
r
k
 
X
 
X
 
(
h
.
c
.
 
n
o
t
 
a
l
l
o
w
e
d
)
 
X
 
X
 
F
i
n
l
a
n
d
 
(
G
o
v
e
r
n
m
e
n
t
 
X
 
X
 
g
u
i
d
e
l
i
n
e
s
)
 
F
r
a
n
c
e
 
X
 
X
 
X
 
G
e
r
m
a
n
y
 
X
 
(
f
o
r
 
P
 
A
R
N
U
T
S
 
X
 
X
 
o
n
l
y
)
 
G
r
e
e
c
e
 
X
 
X
 
X
 
X
 
X
 
I
r
e
l
a
n
d
 
X
 
x
 
(
h
.
c
.
 
n
o
t
 
a
l
l
o
w
e
d
)
 
X
 
X
 
I
t
a
l
y
 
X
 
x
 
(
h
.
c
.
 
n
o
t
 
a
l
l
o
w
e
d
)
 
X
 
X
 
X
 
L
u
x
e
m
b
o
u
r
g
 
X
 
x
 
(
h
.
c
.
 
n
o
t
 
a
l
l
o
w
e
d
)
 
X
 
X
 
N
e
t
h
e
r
l
a
n
d
s
 
X
 
X
 
X
 
P
o
r
t
u
g
a
l
 
X
 
X
 
(
h
.
c
.
 
n
o
t
 
a
l
l
o
w
e
d
)
 
X
 
X
 
X
 
S
p
a
i
n
 
X
 
X
 
X
 
S
w
e
d
e
n
 
X
 
X
 
X
 
U
K
 
(
F
A
C
 
X
 
X
 
g
u
i
d
e
l
i
n
e
s
)
 
T
o
t
a
l
 
1
5
/
1
5
 
2
/
1
5
 
7
/
1
5
 
5
/
1
5
 
0
/
1
5
 
1
0
/
1
5
 
U
S
A
 
X
 
X
 
X
 
X
 
C
a
n
a
d
a
 
X
 
X
 
(
o
n
l
y
 
X
 
X
 
X
 
s
t
r
u
c
t
u
r
e
/
f
u
n
c
t
i
o
n
 
c
l
a
i
m
s
 
a
l
l
o
w
e
d
)
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
5
 3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
:
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
i
s
 
m
a
i
n
l
y
 
b
a
s
e
d
 
o
n
 
t
h
e
 
r
e
s
p
e
c
t
 
o
f
 
c
e
r
t
a
i
n
 
c
o
m
p
o
s
i
t
i
o
n
a
l
 
c
r
i
t
e
r
i
a
.
 
I
t
 
m
a
y
 
b
e
 
a
d
v
i
s
a
b
l
e
 
t
o
 
i
n
t
r
o
d
u
c
e
 
i
n
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
a
 
g
e
n
e
r
a
l
 
p
r
o
v
i
s
i
o
n
 
t
h
a
t
 
a
n
y
 
c
l
a
i
m
 
m
a
d
e
 
h
a
s
 
t
o
 
b
e
 
s
u
b
s
t
a
n
t
i
a
t
e
d
 
t
h
r
o
u
g
h
 
v
e
r
i
f
i
e
d
 
f
a
c
t
s
 
a
n
d
 
d
a
t
a
 
(
s
e
e
 
a
l
s
o
 
b
e
l
o
w
 
r
e
c
o
m
m
e
n
d
a
t
i
o
n
 
r
e
g
a
r
d
i
n
g
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
)
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
i
t
 
w
o
u
l
d
 
s
e
e
m
 
u
s
e
f
u
l
 
t
o
 
i
n
t
r
o
d
u
c
e
 
a
 
s
p
e
c
i
f
i
c
 
o
b
l
i
g
a
t
i
o
n
 
t
h
a
t
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
n
e
e
d
 
t
o
 
b
e
 
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
 
(
f
o
r
 
f
u
r
t
h
e
r
 
d
e
t
a
i
l
s
 
s
e
e
 
b
e
l
o
w
 
r
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
)
.
 
H
e
a
l
t
h
 
C
l
a
i
m
s
:
 
i
n
 
v
i
e
w
 
o
f
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
a
n
 
i
n
c
r
e
a
s
e
d
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
c
a
n
 
b
e
 
e
x
p
e
c
t
e
d
 
o
v
e
r
 
t
h
e
 
c
o
m
i
n
g
 
y
e
a
r
s
,
 
a
n
d
 
i
n
 
v
i
e
w
 
o
f
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
c
r
i
t
e
r
i
a
 
o
n
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
m
o
s
t
l
y
 
l
i
s
t
e
d
 
i
n
 
v
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
,
 
i
t
 
m
a
y
 
p
r
o
v
e
 
u
s
e
f
u
l
 
t
o
 
i
n
t
r
o
d
u
c
e
 
a
 
p
r
o
v
i
s
i
o
n
 
i
n
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
t
h
a
t
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
m
u
s
t
 
b
e
 
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
A
l
l
 
p
a
r
t
i
e
s
 
s
e
e
m
 
t
o
 
a
g
r
e
e
 
t
h
a
t
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
F
u
r
t
h
e
r
 
d
e
t
a
i
l
s
 
a
s
 
t
o
 
t
h
e
 
s
p
e
c
i
f
i
c
 
c
r
i
t
e
r
i
a
 
t
h
a
t
 
s
h
o
u
l
d
 
a
p
p
l
y
 
t
o
 
t
h
e
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
,
 
s
h
o
u
l
d
 
b
e
 
i
n
t
r
o
d
u
c
e
d
 
v
i
a
 
v
e
r
t
i
c
a
l
 
l
e
g
i
s
l
a
t
i
o
n
,
 
i
.
e
.
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
T
h
i
s
 
w
o
u
l
d
,
 
h
o
w
e
v
e
r
,
 
r
e
q
u
i
r
e
 
a
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
'
h
e
a
l
t
h
 
c
l
a
i
m
s
'
 
t
o
 
b
e
 
i
n
t
r
o
d
u
c
e
d
 
i
n
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
W
h
i
l
e
 
i
t
 
s
e
e
m
s
 
u
s
e
f
u
l
 
t
o
 
i
n
t
r
o
d
u
c
e
 
a
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
'
c
l
a
i
m
s
'
 
i
n
t
o
 
t
h
e
 
D
i
r
e
c
t
i
v
e
 
(
s
e
e
 
c
h
a
p
t
e
r
 
o
n
 
D
e
f
i
n
i
t
i
o
n
s
,
 
L
e
g
i
s
l
a
t
i
o
n
,
 
P
o
l
i
c
y
 
D
e
v
e
l
o
p
m
e
n
t
s
 
a
n
d
 
S
t
a
k
e
h
o
l
d
e
r
s
'
 
P
o
s
i
t
i
o
n
s
)
,
 
i
t
 
c
a
n
 
b
e
 
q
u
e
s
t
i
o
n
e
d
 
a
s
 
t
o
 
h
o
w
 
f
a
r
 
a
 
d
e
f
i
n
i
t
i
o
n
 
o
f
'
h
e
a
l
t
h
 
c
l
a
i
m
s
'
 
s
h
o
u
l
d
 
n
o
t
 
b
e
 
l
e
f
t
 
t
o
 
v
e
r
t
i
c
a
l
 
l
e
g
i
s
l
a
t
i
o
n
,
 
i
.
e
.
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
T
h
e
 
p
r
o
b
l
e
m
 
c
o
u
l
d
 
b
e
 
o
v
e
r
c
o
m
e
,
 
i
f
 
t
h
e
 
p
r
o
v
i
s
i
o
n
 
w
a
s
 
d
r
a
f
t
e
d
 
i
n
 
s
u
c
h
 
a
 
w
a
y
 
t
h
a
t
 
i
t
 
i
s
 
c
l
e
a
r
 
t
h
a
t
 
o
n
l
y
 
t
h
o
s
e
 
c
l
a
i
m
s
 
m
u
s
t
 
b
e
 
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
,
 
w
h
i
c
h
 
a
r
e
 
b
a
s
e
d
 
o
n
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
a
n
d
/
o
r
 
q
u
a
l
i
t
y
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
.
 
T
h
i
s
 
w
o
u
l
d
 
e
n
c
o
m
p
a
s
s
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
a
s
 
w
e
l
l
 
a
s
 
g
r
e
e
n
 
c
l
a
i
m
s
,
 
w
h
i
l
s
t
 
i
t
 
w
o
u
l
d
 
e
x
c
l
u
d
e
 
c
e
r
t
a
i
n
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
f
r
o
m
 
t
h
e
 
o
b
l
i
g
a
t
i
o
n
 
t
o
 
b
e
 
b
a
s
e
d
 
o
n
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
I
t
 
i
s
 
c
l
e
a
r
 
t
h
a
t
 
c
e
r
t
a
i
n
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
s
u
c
h
 
a
s
 
'
p
r
o
d
u
c
e
d
 
w
i
t
h
o
u
t
 
c
h
i
l
d
 
l
a
b
o
u
r
'
 
c
a
n
n
o
t
 
b
e
 
b
a
s
e
d
 
o
n
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
,
 
a
s
 
t
h
e
y
 
a
r
e
 
n
o
t
 
b
a
s
e
d
 
o
n
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
 
o
r
 
q
u
a
l
i
t
y
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
.
 
W
h
i
l
s
t
 
s
o
m
e
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
a
n
d
 
n
o
t
a
b
l
y
 
t
h
e
 
f
a
i
r
 
t
r
a
d
e
 
c
l
a
i
m
s
,
 
f
o
r
 
w
h
i
c
h
 
s
o
m
e
 
f
a
i
r
 
t
r
a
d
e
 
l
a
b
e
l
l
i
n
g
 
s
c
h
e
m
e
s
 
r
e
q
u
i
r
e
 
a
l
s
o
 
t
h
e
 
r
e
s
p
e
c
t
 
o
f
 
c
e
r
t
a
i
n
 
e
n
v
i
r
o
n
m
e
n
t
a
l
 
r
e
q
u
i
r
e
m
e
n
t
s
,
 
w
o
u
l
d
,
 
w
i
t
h
 
t
h
i
s
 
a
p
p
r
o
a
c
h
,
 
f
a
l
l
 
u
n
d
e
r
 
t
h
e
 
o
b
l
i
g
a
t
i
o
n
 
o
f
 
s
o
u
n
d
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
T
h
i
s
 
s
o
l
u
t
i
o
n
 
w
o
u
l
d
 
a
l
s
o
 
a
u
t
o
m
a
t
i
c
a
l
l
y
 
e
l
i
m
i
n
a
t
e
 
a
n
y
 
d
i
s
p
u
t
e
s
 
a
s
 
t
o
 
w
h
e
t
h
e
r
 
s
p
e
c
i
f
i
c
 
c
l
a
i
m
s
 
f
a
l
l
 
u
n
d
e
r
 
t
h
e
 
c
h
o
s
e
n
 
d
e
f
i
n
i
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
w
h
e
t
h
e
r
,
 
f
o
r
 
t
h
e
s
e
 
s
p
e
c
i
f
i
c
 
c
l
a
i
m
s
,
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
 
w
a
s
,
 
t
h
e
r
e
f
o
r
e
,
 
n
e
e
d
e
d
.
 
E
t
h
i
c
a
l
 
c
l
a
i
m
s
:
 
i
t
 
a
p
p
e
a
r
s
 
t
h
a
t
 
t
h
e
r
e
 
e
x
i
s
t
 
a
 
n
u
m
b
e
r
 
o
f
 
c
r
i
t
e
r
i
a
 
u
s
e
d
 
i
n
 
f
a
i
r
 
t
r
a
d
e
 
l
a
b
e
l
l
i
n
g
 
s
c
h
e
m
e
s
.
 
B
u
t
 
n
o
 
c
r
i
t
e
r
i
a
 
a
r
e
 
f
i
x
e
d
 
i
n
 
l
e
g
i
s
l
a
t
i
o
n
.
 
I
n
 
v
i
e
w
 
o
f
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
a
 
m
o
r
e
 
w
i
d
e
s
p
r
e
a
d
 
u
s
e
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
c
a
n
 
b
e
 
e
x
p
e
c
t
e
d
 
o
v
e
r
 
t
h
e
 
c
o
m
i
n
g
 
y
e
a
r
s
,
 
i
t
 
m
a
y
 
b
e
 
w
o
r
t
h
 
c
o
n
s
i
d
e
r
i
n
g
 
t
o
 
t
h
e
 
i
n
t
r
o
d
u
c
t
i
o
n
 
i
n
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
o
f
 
a
 
g
e
n
e
r
a
l
 
p
r
o
v
i
s
i
o
n
 
t
h
a
t
 
a
n
y
 
c
l
a
i
m
 
m
a
d
e
 
h
a
s
 
t
o
 
b
e
 
s
u
b
s
t
a
n
t
i
a
t
e
d
 
t
h
r
o
u
g
h
 
v
e
r
i
f
i
a
b
l
e
d
 
f
a
c
t
s
 
a
n
d
 
d
a
t
a
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
6
 M
o
r
e
 
s
p
e
c
i
f
i
c
 
c
r
i
t
e
r
i
a
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
a
d
d
r
e
s
s
e
d
 
v
i
a
 
(
n
e
w
)
 
v
e
r
t
i
c
a
l
 
l
e
g
i
s
l
a
t
i
o
n
.
 
S
o
 
f
a
r
,
 
d
u
e
 
t
o
 
t
h
e
 
l
i
m
i
t
e
d
 
u
s
e
 
o
f
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
s
p
e
c
i
f
i
c
 
v
e
r
t
i
c
a
l
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
d
o
e
s
 
n
o
t
 
y
e
t
 
s
e
e
m
 
t
o
 
b
e
 
a
 
n
e
c
e
s
s
i
t
y
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
7
 E
.
 
E
X
I
S
T
E
N
C
E
 
O
F
 
P
R
E
-
C
L
E
A
R
A
N
C
E
 
A
N
D
 
P
O
S
T
-
C
L
E
A
R
A
N
C
E
 
1
.
 
C
o
m
m
e
n
t
 
P
r
e
-
C
l
e
a
r
a
n
c
e
:
 
W
h
i
l
e
 
i
n
 
m
o
s
t
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
n
o
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
r
u
l
e
s
 
a
p
p
l
y
 
b
y
 
l
a
w
,
 
t
h
e
r
e
 
e
x
i
s
t
 
i
n
 
a
 
l
a
r
g
e
 
n
u
m
b
e
r
 
o
f
 
i
n
f
o
r
m
a
l
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
r
u
l
e
s
,
 
w
h
e
r
e
b
y
 
c
o
m
p
a
n
i
e
s
 
c
a
n
 
a
s
k
 
t
h
e
i
r
 
l
o
c
a
l
 
e
n
f
o
r
c
e
m
e
n
t
 
a
u
t
h
o
r
i
t
i
e
s
 
t
o
 
v
e
r
i
f
y
 
t
o
 
w
h
a
t
 
e
x
t
e
n
t
 
t
h
e
 
c
l
a
i
m
s
 
t
h
a
t
 
t
h
e
 
p
r
o
d
u
c
e
r
 
w
a
n
t
s
 
t
o
 
u
s
e
 
m
a
y
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
l
a
w
f
u
l
.
 
I
n
 
s
o
m
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
m
o
r
e
 
f
o
r
m
a
l
i
s
e
d
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
r
u
l
e
s
 
e
x
i
s
t
,
 
b
u
t
 
w
h
i
c
h
 
a
r
e
 
e
q
u
a
l
l
y
 
n
o
t
 
s
e
t
 
o
u
t
 
b
y
 
l
a
w
.
 
T
h
i
s
 
i
s
 
n
o
t
a
b
l
y
 
t
h
e
 
c
a
s
e
 
i
n
 
c
o
u
n
t
r
i
e
s
 
w
h
i
c
h
 
r
e
l
y
 
o
n
 
s
e
l
f
-
r
e
g
u
l
a
t
o
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
s
u
c
h
 
a
s
 
t
h
e
 
U
K
,
 
I
r
e
l
a
n
d
 
a
n
d
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
.
 
M
o
s
t
 
i
n
t
e
r
e
s
t
i
n
g
 
i
n
 
t
h
i
s
 
r
e
s
p
e
c
t
 
i
s
 
t
h
e
 
U
K
'
s
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
.
 
T
h
e
 
c
o
d
e
 
i
n
t
r
o
d
u
c
e
s
 
t
h
e
 
p
o
s
s
i
b
i
l
i
t
y
 
f
o
r
 
c
o
m
p
a
n
i
e
s
 
t
o
 
a
s
k
 
f
o
r
 
p
r
e
-
m
a
r
k
e
t
 
a
d
v
i
c
e
 
f
o
r
 
i
n
n
o
v
a
t
i
v
e
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
A
c
t
i
n
g
 
u
p
o
n
 
p
r
e
-
m
a
r
k
e
t
 
a
d
v
i
c
e
 
s
u
g
g
e
s
t
s
 
t
h
e
 
e
x
e
r
c
i
s
e
 
o
f
 
d
u
e
 
d
i
l
i
g
e
n
c
e
.
 
T
h
e
 
c
o
u
r
t
s
 
m
a
y
 
t
a
k
e
 
t
h
i
s
 
i
n
t
o
 
a
c
c
o
u
n
t
 
i
n
 
t
h
e
 
e
v
e
n
t
 
o
f
 
a
n
y
 
l
e
g
a
l
 
c
h
a
l
l
e
n
g
e
 
t
o
 
t
h
e
 
h
e
a
l
t
h
 
c
l
a
i
m
 
u
n
d
e
r
 
t
h
e
 
F
o
o
d
 
S
a
f
e
t
y
 
A
c
t
.
 
S
y
s
t
e
m
s
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
h
a
v
e
 
b
e
e
n
 
s
e
t
 
u
p
 
i
n
 
F
r
a
n
c
e
 
a
n
d
 
A
u
s
t
r
i
a
,
 
w
h
e
r
e
b
y
 
a
u
t
h
o
r
i
s
a
t
i
o
n
s
 
f
r
o
m
 
t
h
e
 
r
e
l
e
v
a
n
t
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
s
 
a
r
e
 
n
e
e
d
e
d
 
i
n
 
o
r
d
e
r
 
t
o
 
b
e
 
a
b
l
e
 
t
o
 
m
a
k
e
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
T
h
e
s
e
 
s
y
s
t
e
m
s
 
d
o
 
n
o
t
 
a
p
p
l
y
 
t
o
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
I
n
 
t
h
e
 
U
S
A
,
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
t
h
a
t
 
i
s
 
a
d
m
i
n
i
s
t
e
r
e
d
 
b
y
 
t
h
e
 
F
D
A
 
a
p
p
l
i
e
s
 
f
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
B
e
l
g
i
u
m
 
a
p
p
l
i
e
s
 
a
 
s
o
m
e
w
h
a
t
 
d
i
f
f
e
r
e
n
t
 
s
y
s
t
e
m
,
 
w
h
i
c
h
 
i
s
 
n
o
t
 
d
e
a
l
i
n
g
 
s
p
e
c
i
f
i
c
a
l
l
y
 
w
i
t
h
 
t
h
e
 
c
l
a
i
m
s
 
t
h
a
t
 
a
r
e
 
b
e
i
n
g
 
m
a
d
e
,
 
b
u
t
 
w
h
i
c
h
 
a
l
l
o
w
s
 
a
l
s
o
 
f
o
r
 
c
l
a
i
m
s
 
t
o
 
b
e
 
c
h
e
c
k
e
d
 
a
s
 
p
a
r
t
 
o
f
 
t
h
e
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
s
y
s
t
e
m
.
 
T
h
u
s
,
 
a
n
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
i
s
 
n
e
e
d
e
d
 
f
o
r
 
f
o
o
d
s
t
u
f
f
s
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
.
 
I
n
 
o
r
d
e
r
 
t
o
 
o
b
t
a
i
n
 
a
n
 
a
u
t
h
o
r
i
s
a
t
i
o
n
,
 
t
h
e
 
p
r
o
p
o
s
e
d
 
l
a
b
e
l
 
a
n
d
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
c
o
m
p
o
s
i
t
i
o
n
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
 
h
a
s
 
t
o
 
b
e
 
s
e
n
t
 
t
o
 
t
h
e
 
F
o
o
d
 
I
n
s
p
e
c
t
o
r
a
t
e
 
o
f
 
t
h
e
 
M
i
n
i
s
t
r
y
 
o
f
 
H
e
a
l
t
h
.
 
E
q
u
a
l
l
y
,
 
f
o
r
 
n
u
t
r
i
e
n
t
s
 
a
n
d
 
f
o
o
d
s
t
u
f
f
s
 
t
o
 
w
h
i
c
h
 
n
u
t
r
i
e
n
t
s
 
h
a
v
e
 
b
e
e
n
 
a
d
d
e
d
,
 
a
n
 
a
 
p
r
i
o
r
i
 
n
o
t
i
f
i
c
a
t
i
o
n
 
p
r
o
c
e
d
u
r
e
 
a
p
p
l
i
e
s
.
 
A
l
s
o
 
i
n
 
t
h
i
s
 
c
a
s
e
 
t
h
e
 
l
a
b
e
l
l
i
n
g
 
h
a
s
,
 
i
n
t
e
r
 
a
l
i
a
,
 
t
o
 
b
e
 
s
e
n
t
 
t
o
 
t
h
e
 
F
o
o
d
 
I
n
s
p
e
c
t
o
r
a
t
e
.
 
I
t
 
i
s
 
i
n
t
e
r
e
s
t
i
n
g
 
t
o
 
n
o
t
e
 
t
h
a
t
,
 
i
n
 
T
h
e
 
N
e
t
h
e
r
l
a
n
d
s
 
a
n
d
 
G
e
r
m
a
n
y
,
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
c
o
n
s
i
d
e
r
e
d
 
c
e
n
s
o
r
s
h
i
p
 
a
n
d
 
i
s
,
 
t
h
e
r
e
f
o
r
e
,
 
n
o
t
 
a
p
p
l
i
e
d
.
 
P
o
s
t
-
C
l
e
a
r
a
n
c
e
:
 
A
s
 
t
o
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
s
,
 
t
h
e
s
e
 
a
r
e
 
i
n
 
g
e
n
e
r
a
l
 
u
n
d
e
r
t
a
k
e
n
 
b
y
 
t
h
e
 
r
e
l
e
v
a
n
t
 
h
e
a
l
t
h
 
o
r
 
f
o
o
d
 
i
n
s
p
e
c
t
i
o
n
 
s
e
r
v
i
c
e
s
.
 
I
n
 
s
o
m
e
 
c
o
u
n
t
r
i
e
s
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
d
e
a
l
i
n
g
 
w
i
t
h
 
t
r
a
d
i
n
g
 
s
t
a
n
d
a
r
d
s
 
a
r
e
 
a
l
s
o
 
r
e
s
p
o
n
s
i
b
l
e
 
f
o
r
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
 
(
e
.
g
.
 
U
K
,
 
P
o
r
t
u
g
a
l
)
.
 
I
n
 
n
e
a
r
l
y
 
a
l
l
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
f
o
r
 
f
o
o
d
s
t
u
f
f
s
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
 
a
s
 
d
e
f
i
n
e
d
 
u
n
d
e
r
 
E
U
 
D
i
r
e
c
t
i
v
e
 
8
9
/
3
9
8
,
 
t
h
e
 
s
y
s
t
e
m
 
o
f
 
n
o
t
i
f
i
c
a
t
i
o
n
 
i
s
 
u
s
e
d
 
a
s
 
a
 
m
e
a
n
s
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
I
t
 
i
s
 
i
n
t
e
r
e
s
t
i
n
g
 
t
o
 
n
o
t
e
 
t
h
a
t
,
 
i
n
 
I
t
a
l
y
,
 
f
o
r
t
i
f
i
e
d
 
f
o
o
d
s
 
a
n
d
 
d
i
e
t
 
i
n
t
e
g
r
a
t
o
r
s
 
a
l
s
o
 
f
a
l
l
 
u
n
d
e
r
 
t
h
e
 
n
o
t
i
f
i
c
a
t
i
o
n
 
p
r
o
c
e
d
u
r
e
 
f
o
r
 
f
o
o
d
s
t
u
f
f
s
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
8
 I
n
 
a
 
n
u
m
b
e
r
 
o
f
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
f
o
r
m
a
l
i
s
e
d
 
o
u
t
-
o
f
-
c
o
u
r
t
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
s
 
a
p
p
l
y
,
 
m
o
s
t
l
y
 
i
n
 
t
h
e
 
f
r
a
m
e
w
o
r
k
 
o
f
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
s
 
o
n
 
a
d
v
e
r
t
i
s
i
n
g
 
(
e
.
g
.
 
G
e
r
m
a
n
y
,
 
G
r
e
e
c
e
,
 
I
t
a
l
y
,
 
I
r
e
l
a
n
d
,
 
e
t
c
.
)
.
 
I
t
 
s
e
e
m
s
 
t
h
a
t
 
c
o
m
p
e
t
i
t
o
r
s
 
q
u
i
t
e
 
o
f
t
e
n
 
m
a
k
e
 
u
s
e
 
o
f
 
t
h
e
s
e
 
s
y
s
t
e
m
s
.
 
I
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
s
,
 
w
e
 
p
r
o
v
i
d
e
 
a
n
 
o
v
e
r
v
i
e
w
 
o
f
 
t
h
e
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
a
n
d
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
s
 
w
h
i
c
h
 
a
p
p
l
y
 
b
y
 
l
a
w
.
 
T
h
i
s
 
i
s
 
s
u
b
d
i
v
i
d
e
d
 
i
n
t
o
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
a
p
p
l
y
i
n
g
 
b
y
 
l
a
w
 
t
o
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
o
n
 
t
h
e
 
o
n
e
 
h
a
n
d
 
a
n
d
 
t
o
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
o
n
 
t
h
e
 
o
t
h
e
r
 
h
a
n
d
.
 
T
h
e
 
s
e
c
o
n
d
 
t
a
b
l
e
 
g
i
v
e
s
 
a
n
 
o
v
e
r
v
i
e
w
 
o
f
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
w
h
i
c
h
 
f
o
r
e
s
e
e
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
5
9
 2
.
a
)
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
P
r
e
-
C
l
e
a
r
a
n
c
e
/
 
P
o
s
t
-
C
l
e
a
r
a
n
c
e
-
B
Y
L
A
W
 
C
o
u
n
t
r
y
 
P
r
e
-
P
r
e
-
P
o
s
t
-
C
o
m
m
e
n
t
s
 
C
l
e
a
r
a
n
c
e
 
C
l
e
a
r
a
n
c
e
 
C
l
e
a
r
a
n
c
e
 
(
b
y
 
l
a
w
)
 
(
b
y
 
l
a
w
)
 
(
b
y
 
l
a
w
)
 
N
u
t
r
i
t
i
o
n
a
l
 
+
 
E
t
h
i
c
a
l
 
A
l
l
 
t
y
p
e
s
 
o
f
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
c
l
a
i
m
s
 
C
l
a
i
m
s
 
E
U
 
X
 
X
 
A
u
s
t
r
i
a
 
X
 
A
u
s
t
r
i
a
 
a
p
p
l
i
e
s
 
a
 
s
y
s
t
e
m
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
f
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
B
e
l
g
i
u
m
 
(
s
t
i
l
l
 
t
o
 
b
e
 
B
e
l
g
i
u
m
 
a
p
p
l
i
e
s
 
a
 
s
y
s
t
e
m
 
o
f
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
f
o
r
 
f
o
o
d
s
t
u
f
f
s
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
 
d
e
f
i
n
e
d
 
b
y
 
f
o
r
 
w
h
i
c
h
 
n
o
 
E
U
 
r
u
l
e
s
 
a
r
e
 
i
n
 
p
l
a
c
e
 
a
n
d
 
a
 
s
y
s
t
e
m
 
o
f
 
p
r
i
o
r
 
n
o
t
i
f
i
c
a
t
i
o
n
 
f
o
r
 
n
u
t
r
i
e
n
t
s
 
a
n
d
 
R
o
y
a
l
 
D
e
c
r
e
e
)
 
f
o
o
d
s
t
u
f
f
s
 
t
o
 
w
h
i
c
h
 
n
u
t
r
i
e
n
t
s
 
h
a
v
e
 
b
e
e
n
 
a
d
d
e
d
 
i
f
 
n
o
 
E
U
 
r
u
l
e
s
 
a
r
e
 
i
n
 
p
l
a
c
e
.
 
I
n
 
b
o
t
h
 
c
a
s
e
s
 
l
a
b
e
l
s
 
a
r
e
 
c
h
e
c
k
e
d
.
 
D
e
n
m
a
r
k
 
X
 
X
 
F
i
n
l
a
n
d
 
X
 
X
 
F
r
a
n
c
e
 
X
 
A
 
'
v
i
s
a
'
 
i
s
 
r
e
q
u
i
r
e
d
 
f
o
r
 
a
d
v
e
r
t
i
s
i
n
g
 
o
f
 
p
r
o
d
u
c
t
s
 
p
r
e
s
e
n
t
e
d
 
a
s
 
b
e
n
e
f
i
c
i
a
l
 
f
o
r
 
h
e
a
l
t
h
.
 
G
e
r
m
a
n
y
 
X
 
X
 
P
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
c
o
n
s
i
d
e
r
e
d
 
c
e
n
s
o
r
s
h
i
p
 
a
n
d
 
i
s
,
 
t
h
e
r
e
f
o
r
e
,
 
n
o
t
 
a
p
p
l
i
e
d
.
 
G
r
e
e
c
e
 
X
 
X
 
I
r
e
l
a
n
d
 
X
 
X
 
I
t
a
l
y
 
X
 
X
 
T
h
e
 
I
t
a
l
i
a
n
 
d
r
a
f
t
 
l
a
w
 
o
n
 
t
h
e
 
c
e
r
t
i
f
i
c
a
t
i
o
n
 
o
f
 
p
r
o
d
u
c
t
s
 
p
r
o
d
u
c
e
d
 
w
i
t
h
o
u
t
 
c
h
i
l
d
 
l
a
b
o
u
r
 
d
o
e
s
 
n
o
t
 
f
o
r
e
s
e
e
 
a
n
 
a
 
p
r
i
o
r
i
 
c
o
n
t
r
o
l
.
 
L
u
x
e
m
b
o
u
r
g
 
X
 
X
 
N
e
t
h
e
r
l
a
n
d
s
 
X
 
X
 
P
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
c
o
n
s
i
d
e
r
e
d
 
c
e
n
s
o
r
s
h
i
p
 
a
n
d
 
i
s
,
 
t
h
e
r
e
f
o
r
e
,
 
n
o
t
 
a
p
p
l
i
e
d
.
 
P
o
r
t
u
g
a
l
 
X
 
X
 
S
p
a
i
n
 
X
 
X
 
S
w
e
d
e
n
 
X
 
X
 
U
K
 
X
 
X
 
T
o
t
a
l
 
3
/
1
5
 
1
/
1
5
 
1
5
/
1
5
 
U
S
A
 
X
 
F
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
 
p
r
i
o
r
i
 
a
p
p
r
o
v
a
l
 
s
y
s
t
e
m
 
a
p
p
l
i
e
s
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
i
n
 
1
9
9
7
,
 
a
n
 
a
l
t
e
r
n
a
t
i
v
e
 
a
p
p
r
o
a
c
h
 
b
a
s
e
d
 
o
n
 
a
u
t
h
o
r
i
t
a
t
i
v
e
 
s
t
a
t
e
m
e
n
t
s
 
o
f
f
e
d
e
r
a
l
 
s
c
i
e
n
t
i
f
i
c
 
b
o
d
i
e
s
 
v
i
a
 
a
 
p
r
e
-
n
o
t
i
f
i
c
a
t
i
o
n
 
s
y
s
t
e
m
 
w
a
s
 
i
n
t
r
o
d
u
c
e
d
.
 
C
a
n
a
d
a
 
X
 
X
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
0
 2
.
b
)
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
P
r
e
-
C
l
e
a
r
a
n
c
e
/
P
o
s
t
-
C
l
e
a
r
a
n
c
e
-
I
N
 
V
O
L
U
N
T
A
R
Y
 
C
O
D
E
S
 
O
N
 
H
E
A
L
T
H
 
C
L
A
I
M
S
 
C
o
u
n
t
r
y
 
E
x
i
s
t
e
n
c
e
 
o
f
 
P
r
e
-
C
l
e
a
r
a
n
c
e
 
C
o
m
m
e
n
t
s
 
E
U
 
X
 
C
I
A
A
 
C
o
d
e
 
h
a
s
 
d
i
f
f
e
r
e
n
t
 
o
b
j
e
c
t
i
v
e
:
 
d
e
a
l
s
 
m
a
i
n
l
y
 
w
i
t
h
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
A
u
s
t
r
i
a
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
B
e
l
g
i
u
m
 
X
 
T
h
e
 
d
r
a
f
t
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
d
o
e
s
 
n
o
t
 
f
o
r
e
s
e
e
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
D
e
n
m
a
r
k
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
F
i
n
l
a
n
d
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
F
r
a
n
c
e
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
G
e
r
m
a
n
v
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
G
r
e
e
c
e
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
P
o
s
s
i
b
l
e
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
h
o
w
 
s
t
r
i
c
t
l
y
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
i
m
p
l
e
m
e
n
t
e
d
 
d
e
p
e
n
d
i
n
g
 
o
n
 
t
h
e
 
m
e
a
n
s
 
o
f
 
c
o
m
m
u
n
i
c
a
t
i
o
n
 
u
s
e
d
 
(
a
b
s
e
n
c
e
 
o
f
 
a
 
r
e
l
e
v
a
n
t
 
b
o
d
y
 
f
o
r
 
t
h
e
 
c
o
n
t
r
o
l
 
o
f
 
c
l
a
i
m
s
)
.
 
I
r
e
l
a
n
d
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
I
t
a
l
y
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
L
u
x
e
m
b
o
u
r
g
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
N
e
t
h
e
r
l
a
n
d
s
 
T
h
e
 
D
u
t
c
h
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
r
e
q
u
i
r
e
s
 
e
v
i
d
e
n
c
e
 
f
o
r
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
o
n
 
f
o
o
d
s
t
u
f
f
s
 
t
o
 
b
e
 
s
c
i
e
n
t
i
f
i
c
a
l
l
y
 
f
o
u
n
d
e
d
 
a
n
d
 
r
e
p
o
r
t
e
d
.
 
I
t
 
c
a
n
,
 
t
h
e
r
e
f
o
r
e
,
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
a
 
s
y
s
t
e
m
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
P
o
r
t
u
g
a
l
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
S
p
a
i
n
 
X
 
T
h
e
 
S
p
a
n
i
s
h
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
f
o
r
e
s
e
e
s
 
o
n
l
y
 
a
 
s
y
s
t
e
m
 
o
f
 
p
o
s
t
-
c
l
e
a
r
a
n
c
e
.
 
S
w
e
d
e
n
 
X
 
I
t
 
i
s
 
b
e
i
n
g
 
d
i
s
c
u
s
s
e
d
 
t
o
 
e
x
t
e
n
d
 
t
h
e
 
S
w
e
d
i
s
h
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
t
o
 
p
r
o
d
u
c
t
-
s
p
e
c
i
f
i
c
 
p
h
y
s
i
o
l
o
g
i
c
a
l
 
c
l
a
i
m
s
,
 
f
o
r
 
w
h
i
c
h
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
w
o
u
l
d
 
a
p
p
l
y
.
 
U
K
 
T
h
e
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
 
e
n
c
o
u
r
a
g
e
s
 
m
a
n
u
f
a
c
t
u
r
e
r
s
 
t
o
 
s
e
e
k
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
A
c
t
i
n
g
 
u
p
o
n
 
p
r
e
-
m
a
r
k
e
t
 
a
d
v
i
c
e
 
s
u
g
g
e
s
t
s
 
t
h
e
 
e
x
e
r
c
i
s
e
 
o
f
 
d
u
e
 
d
i
l
i
g
e
n
c
e
.
 
T
h
e
 
c
o
u
r
t
s
 
m
a
y
 
t
a
k
e
 
t
h
i
s
 
i
n
t
o
 
a
c
c
o
u
n
t
 
i
n
 
t
h
e
 
e
v
e
n
t
 
o
f
 
a
n
y
 
l
e
g
a
l
 
c
h
a
l
l
e
n
g
e
 
t
o
 
t
h
e
 
h
e
a
l
t
h
 
c
l
a
i
m
 
u
n
d
e
r
 
t
h
e
 
F
o
o
d
 
S
a
f
e
t
y
 
A
c
t
.
 
T
o
t
a
l
 
2
/
6
 
U
n
i
t
e
d
 
S
t
a
t
e
s
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
C
a
n
a
d
a
 
N
o
t
 
a
p
p
l
i
c
a
b
l
e
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
1
 3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
C
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
a
r
e
 
w
i
d
e
l
y
 
i
n
 
f
a
v
o
u
r
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
 
o
r
d
e
r
 
t
o
 
e
n
s
u
r
e
 
t
h
a
t
 
o
n
l
y
 
t
r
u
t
h
f
u
l
 
a
n
d
 
n
o
n
-
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
 
a
r
e
 
b
e
i
n
g
 
u
s
e
d
.
 
F
o
r
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
f
o
u
r
 
r
e
a
s
o
n
s
 
i
n
d
u
s
t
r
y
,
 
b
y
 
c
o
n
t
r
a
s
t
,
 
h
a
s
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
i
t
 
w
a
s
,
 
i
n
 
g
e
n
e
r
a
l
:
 
o
p
p
o
s
e
d
 
t
o
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
p
r
o
c
e
d
u
r
e
s
,
 
a
s
:
 
•
 
t
h
e
s
e
 
w
o
u
l
d
 
d
e
l
a
y
 
t
h
e
 
p
l
a
c
i
n
g
 
o
n
 
t
h
e
 
m
a
r
k
e
t
 
o
f
 
a
 
p
r
o
d
u
c
t
,
 
w
h
i
c
h
 
i
s
 
c
r
u
c
i
a
l
 
f
o
r
 
t
h
e
 
f
o
o
d
 
i
n
d
u
s
t
r
y
 
s
i
n
c
e
 
i
t
 
i
s
 
a
 
f
a
s
t
 
m
o
v
i
n
g
 
m
a
r
k
e
t
;
 
•
 
i
t
 
m
a
k
e
s
 
i
t
 
i
m
p
o
s
s
i
b
l
e
 
t
o
 
c
o
p
y
r
i
g
h
t
 
f
i
n
a
l
 
f
o
o
d
 
p
r
o
d
u
c
t
s
 
a
n
d
/
o
r
 
t
h
e
 
c
l
a
i
m
 
m
a
d
e
;
 
•
 
i
n
d
u
s
t
r
y
 
w
a
s
 
w
o
r
r
i
e
d
 
t
h
a
t
 
c
o
n
f
i
d
e
n
t
i
a
l
i
t
y
 
w
a
s
 
n
o
t
 
e
n
s
u
r
e
d
 
d
u
r
i
n
g
 
a
n
 
a
 
p
r
i
o
r
i
 
a
p
p
r
o
v
a
l
 
p
r
o
c
e
d
u
r
e
;
 
a
n
d
 
•
 
i
t
 
w
a
s
 
u
n
p
r
o
p
o
r
t
i
o
n
a
l
 
t
o
 
i
n
t
r
o
d
u
c
e
 
a
 
s
t
r
i
c
t
 
s
y
s
t
e
m
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
I
n
 
t
h
e
 
l
i
g
h
t
 
o
f
 
d
i
v
e
r
g
i
n
g
 
t
h
e
s
e
 
p
o
s
i
t
i
o
n
s
,
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
o
p
t
i
o
n
s
 
c
o
u
l
d
 
b
e
 
c
o
n
s
i
d
e
r
e
d
:
 
a
)
 
P
r
e
-
C
l
e
a
r
a
n
c
e
 
f
o
r
 
a
l
l
 
C
l
a
i
m
s
 
I
n
t
r
o
d
u
c
t
i
o
n
 
o
f
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
t
h
a
t
 
w
o
u
l
d
 
a
l
l
o
w
 
f
o
r
 
f
a
s
t
 
p
r
e
-
c
l
e
a
r
a
n
c
e
,
 
i
.
e
.
 
w
i
t
h
i
n
 
1
 
t
o
 
2
 
m
o
n
t
h
s
.
 
T
h
e
 
a
d
v
a
n
t
a
g
e
 
o
f
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
f
o
r
 
a
l
l
 
c
l
a
i
m
s
 
i
s
 
t
h
a
t
 
i
t
 
w
o
u
l
d
 
e
n
s
u
r
e
 
t
h
a
t
,
 
i
n
 
m
o
s
t
 
c
a
s
e
s
,
 
o
n
l
y
 
t
r
u
t
h
f
u
l
 
a
n
d
 
n
o
n
-
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
 
a
r
e
 
m
a
d
e
.
 
T
h
e
 
d
i
s
a
d
v
a
n
t
a
g
e
s
 
o
f
 
s
u
c
h
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
i
s
 
t
h
a
t
 
i
t
 
i
s
,
 
f
r
o
m
 
a
n
 
a
d
m
i
n
i
s
t
r
a
t
i
v
e
 
p
o
i
n
t
 
o
f
 
v
i
e
w
,
 
v
e
r
y
 
b
u
r
d
e
n
s
o
m
e
 
(
a
n
d
 
r
a
i
s
e
s
 
t
h
e
 
q
u
e
s
t
i
o
n
 
o
f
 
w
h
e
t
h
e
r
 
a
n
 
E
U
 
l
e
v
e
l
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
a
u
t
h
o
r
i
t
y
 
w
o
u
l
d
 
n
e
e
d
 
t
o
 
b
e
 
e
s
t
a
b
l
i
s
h
e
d
,
 
i
n
 
o
r
d
e
r
 
t
o
 
a
v
o
i
d
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
 
d
u
e
 
t
o
 
d
i
f
f
e
r
i
n
g
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
a
d
v
i
c
e
 
i
n
 
t
h
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
)
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
e
v
e
n
 
u
n
d
e
r
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
,
 
i
t
 
c
a
n
n
o
t
 
b
e
 
e
x
c
l
u
d
e
d
 
t
h
a
t
 
s
o
m
e
 
e
c
o
n
o
m
i
c
 
o
p
e
r
a
t
o
r
s
 
m
a
y
 
m
a
k
e
 
m
i
s
l
e
a
d
i
n
g
 
c
l
a
i
m
s
.
 
F
i
n
a
l
l
y
,
 
e
v
e
n
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
f
r
o
m
 
a
 
g
o
v
e
r
n
m
e
n
t
 
a
u
t
h
o
r
i
t
y
,
 
d
o
e
s
 
n
o
t
 
g
i
v
e
 
1
0
0
%
 
i
n
s
u
r
a
n
c
e
 
t
o
 
a
n
 
e
c
o
n
o
m
i
c
 
o
p
e
r
a
t
o
r
 
t
h
a
t
 
a
 
c
o
u
r
t
 
m
a
y
 
n
o
t
 
f
i
n
d
 
t
h
e
 
c
l
a
i
m
 
u
n
l
a
w
f
u
l
.
 
b
)
 
P
r
e
-
C
l
e
a
r
a
n
c
e
 
o
n
l
y
 
f
o
r
 
I
n
n
o
v
a
t
i
v
e
 
C
l
a
i
m
s
 
A
 
s
e
c
o
n
d
 
o
p
t
i
o
n
 
i
s
 
t
o
 
e
s
t
a
b
l
i
s
h
 
a
n
 
E
U
 
l
i
s
t
 
o
f
 
g
e
n
e
r
i
c
 
c
l
a
i
m
s
 
f
o
r
 
w
h
i
c
h
 
n
o
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
n
e
e
d
e
d
,
 
w
h
i
l
s
t
 
f
o
r
 
a
l
l
 
o
t
h
e
r
 
c
l
a
i
m
s
 
(
n
e
w
/
i
n
n
o
v
a
t
i
v
e
)
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
n
e
e
d
e
d
.
 
T
h
i
s
 
i
s
 
t
h
e
 
a
p
p
r
o
a
c
h
 
c
h
o
s
e
n
 
i
n
 
t
h
e
 
U
S
A
.
 
C
a
n
a
d
a
 
i
s
 
c
u
r
r
e
n
t
l
y
 
c
o
n
s
i
d
e
r
i
n
g
 
f
o
l
l
o
w
i
n
g
 
t
h
i
s
 
a
p
p
r
o
a
c
h
.
 
T
h
e
 
e
s
t
a
b
l
i
s
h
m
e
n
t
 
o
f
 
s
u
c
h
 
a
 
g
e
n
e
r
i
c
 
l
i
s
t
 
c
o
u
l
d
,
 
i
n
 
o
u
r
 
v
i
e
w
,
 
o
n
l
y
 
b
e
 
d
o
n
e
 
v
i
a
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
 
o
n
 
t
h
e
 
L
a
b
e
l
l
i
n
g
 
o
f
 
F
o
o
d
s
t
u
f
f
s
.
 
I
t
 
a
l
s
o
 
r
a
i
s
e
s
 
t
h
e
 
q
u
e
s
t
i
o
n
 
o
f
 
h
o
w
 
a
 
l
i
s
t
 
o
f
 
g
e
n
e
r
i
c
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
c
o
u
l
d
 
b
e
 
e
s
t
a
b
l
i
s
h
e
d
 
a
n
d
 
i
n
 
h
o
w
 
f
a
r
 
t
h
i
s
 
c
o
u
l
d
 
b
e
 
a
d
d
e
d
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
.
 
c
)
 
N
o
t
i
f
i
c
a
t
i
o
n
 
P
r
o
c
e
d
u
r
e
 
A
 
t
h
i
r
d
 
o
p
t
i
o
n
 
w
o
u
l
d
 
b
e
 
t
o
 
i
n
t
r
o
d
u
c
e
 
a
 
n
o
t
i
f
i
c
a
t
i
o
n
 
p
r
o
c
e
d
u
r
e
,
 
s
u
c
h
 
a
s
 
t
h
e
 
o
n
e
 
u
n
d
e
r
 
D
i
r
e
c
t
i
v
e
 
8
9
/
3
9
8
 
o
n
 
F
o
o
d
s
t
u
f
f
s
 
f
o
r
 
P
a
r
t
i
c
u
l
a
r
 
N
u
t
r
i
t
i
o
n
a
l
 
U
s
e
s
,
 
w
h
e
r
e
b
y
 
a
n
 
o
p
e
r
a
t
o
r
 
h
a
s
 
t
o
 
n
o
t
i
f
y
 
t
o
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
t
h
e
 
p
l
a
c
i
n
g
 
o
n
 
t
h
e
 
m
a
r
k
e
t
 
o
f
 
a
 
f
o
o
d
s
t
u
f
f
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
n
u
t
r
i
t
i
o
n
a
l
 
u
s
e
s
.
 
T
h
e
 
p
r
o
d
u
c
e
r
 
h
a
s
 
t
o
 
s
u
b
m
i
t
 
t
h
e
 
l
a
b
e
l
 
a
n
d
,
 
w
h
e
r
e
 
c
o
n
s
i
d
e
r
e
d
 
n
e
c
e
s
s
a
r
y
,
 
t
h
e
 
m
a
n
u
f
a
c
t
u
r
e
r
 
m
a
y
 
a
l
s
o
 
b
e
 
r
e
q
u
i
r
e
d
 
t
o
 
p
r
o
d
u
c
e
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
 
a
n
d
 
d
a
t
a
.
 
U
n
d
e
r
 
s
u
c
h
 
a
 
n
o
t
i
f
i
c
a
t
i
o
n
 
p
r
o
c
e
d
u
r
e
 
f
o
r
 
c
l
a
i
m
s
,
 
w
i
t
h
i
n
 
a
 
c
e
r
t
a
i
n
 
p
e
r
i
o
d
 
o
f
 
t
i
m
e
,
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
/
o
r
 
r
e
s
p
o
n
s
i
b
l
e
 
b
o
d
y
 
u
n
d
e
r
 
a
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
 
(
a
s
 
o
n
e
 
m
a
y
 
c
o
n
s
i
d
e
r
 
a
l
s
o
 
a
l
l
o
w
i
n
g
 
n
o
t
i
f
i
c
a
t
i
o
n
 
i
n
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
2
 I
 
t
h
e
 
f
r
a
m
e
w
o
r
k
 
o
f
 
a
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
)
,
 
m
a
y
 
b
e
 
a
l
l
o
w
e
d
 
t
o
 
m
a
k
e
 
c
o
m
m
e
n
t
s
 
o
n
 
t
h
e
 
l
a
b
e
l
/
c
l
a
i
m
 
u
s
e
d
 
o
r
 
i
n
 
j
u
s
t
i
f
i
e
d
 
c
a
s
e
s
,
 
r
e
q
u
i
r
e
 
t
h
a
t
 
t
h
e
 
p
r
o
d
u
c
t
 
b
e
 
w
i
t
h
d
r
a
w
n
 
f
r
o
m
 
t
h
e
 
m
a
r
k
e
t
.
 
T
h
e
 
a
d
v
a
n
t
a
g
e
 
f
o
r
 
c
o
m
p
a
n
i
e
s
 
w
o
u
l
d
 
b
e
 
t
h
a
t
 
t
h
e
y
 
c
o
u
l
d
 
p
u
t
 
t
h
e
i
r
 
p
r
o
d
u
c
t
 
o
n
 
t
h
e
 
m
a
r
k
e
t
 
i
m
m
e
d
i
a
t
e
l
y
 
w
i
t
h
o
u
t
 
h
a
v
i
n
g
 
t
o
 
a
w
a
i
t
 
a
p
p
r
o
v
a
l
 
a
s
 
i
n
 
o
p
t
i
o
n
 
a
)
.
 
T
h
e
 
d
i
s
a
d
v
a
n
t
a
g
e
 
o
f
 
t
h
i
s
 
s
y
s
t
e
m
 
s
e
e
m
s
 
t
o
 
b
e
 
t
h
a
t
 
i
t
 
m
a
y
 
p
r
o
v
e
 
d
i
f
f
i
c
u
l
t
 
f
o
r
 
n
a
t
i
o
n
a
l
 
a
u
t
h
o
r
i
t
i
e
s
,
 
f
r
o
m
 
a
n
 
a
d
m
i
n
i
s
t
r
a
t
i
v
e
 
p
o
i
n
t
 
o
f
 
v
i
e
w
,
 
t
o
 
c
h
e
c
k
 
a
l
l
 
l
a
b
e
l
s
/
c
l
a
i
m
s
 
u
s
e
d
.
 
T
h
i
s
 
c
o
u
l
d
 
p
a
r
t
l
y
 
b
e
 
o
v
e
r
c
o
m
e
 
i
f
,
 
a
t
 
t
h
e
 
s
a
m
e
 
t
i
m
e
,
 
a
 
g
e
n
e
r
i
c
 
l
i
s
t
 
o
f
 
c
l
a
i
m
s
 
w
a
s
 
e
s
t
a
b
l
i
s
h
e
d
 
a
n
d
,
 
i
n
 
w
h
i
c
h
 
c
a
s
e
,
 
f
o
r
 
s
u
c
h
 
g
e
n
e
r
i
c
 
c
l
a
i
m
s
 
n
o
 
n
o
t
i
f
i
c
a
t
i
o
n
 
w
a
s
 
n
e
e
d
e
d
.
 
d
)
 
D
u
e
 
D
i
l
i
g
e
n
c
e
 
f
o
r
 
V
o
l
u
n
t
a
r
y
 
P
r
e
-
C
l
e
a
r
a
n
c
e
 
A
 
f
o
u
r
t
h
 
o
p
t
i
o
n
,
 
w
h
i
c
h
 
h
a
s
 
b
e
e
n
 
p
u
r
s
u
e
d
 
b
y
 
t
h
e
 
U
K
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
I
n
i
t
i
a
t
i
v
e
,
 
w
o
u
l
d
 
b
e
 
t
o
 
e
n
c
o
u
r
a
g
e
 
o
p
e
r
a
t
o
r
s
 
t
o
 
s
u
b
m
i
t
,
 
e
i
t
h
e
r
 
i
n
 
t
h
e
 
f
r
a
m
e
w
o
r
k
 
o
f
 
a
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
 
o
r
 
i
n
 
t
h
e
 
f
r
a
m
e
w
o
r
k
 
o
f
 
a
n
 
a
d
m
i
n
i
s
t
r
a
t
i
v
e
 
b
o
d
y
,
 
t
h
e
 
c
l
a
i
m
 
t
h
a
t
 
h
e
/
s
h
e
 
w
a
n
t
s
 
t
o
 
m
a
k
e
 
f
o
r
 
p
r
e
-
c
l
e
a
r
a
n
c
e
.
 
C
o
m
p
a
n
i
e
s
 
t
h
a
t
 
f
o
l
l
o
w
 
t
h
i
s
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
p
r
o
c
e
d
u
r
e
 
c
o
u
l
d
 
t
h
e
n
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
t
o
 
h
a
v
e
 
e
x
e
r
c
i
s
e
d
 
d
u
e
 
d
i
l
i
g
e
n
c
e
.
 
T
h
e
 
c
o
u
r
t
s
 
m
a
y
 
t
a
k
e
 
t
h
i
s
 
i
n
t
o
 
a
c
c
o
u
n
t
 
i
n
 
t
h
e
 
e
v
e
n
t
 
o
f
 
a
n
y
 
l
e
g
a
l
 
c
h
a
l
l
e
n
g
e
 
t
o
 
t
h
e
 
c
l
a
i
m
s
 
m
a
d
e
.
 
T
h
e
 
d
i
s
a
d
v
a
n
t
a
g
e
 
o
f
 
t
h
i
s
 
s
o
l
u
t
i
o
n
 
i
s
 
t
h
a
t
,
 
i
n
 
s
o
m
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
(
G
e
r
m
a
n
y
,
 
I
t
a
l
y
,
 
A
u
s
t
r
i
a
)
,
 
d
u
e
 
t
o
 
t
h
e
 
l
e
g
a
l
 
s
y
s
t
e
m
s
,
 
c
o
u
r
t
s
 
m
a
y
 
b
e
 
t
e
m
p
t
e
d
 
n
o
t
 
t
o
 
t
a
k
e
 
s
u
c
h
 
v
o
l
u
n
t
a
r
y
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
i
n
t
o
 
a
c
c
o
u
n
t
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
 
w
h
e
r
e
 
s
u
c
h
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
i
s
 
d
o
n
e
 
i
n
 
t
h
e
 
f
r
a
m
e
w
o
r
k
 
o
f
 
a
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
 
t
o
 
w
h
i
c
h
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
a
r
e
 
n
o
t
 
a
 
p
a
r
t
y
.
 
e
)
 
B
u
r
d
e
n
 
o
f
 
P
r
o
o
f
 
w
i
t
h
 
t
h
e
 
M
a
k
e
r
 
o
f
 
t
h
e
 
C
l
a
i
m
 
A
 
f
i
f
t
h
 
p
o
s
s
i
b
l
e
 
w
a
y
 
f
o
r
w
a
r
d
 
w
o
u
l
d
 
b
e
 
t
o
 
c
o
u
n
t
e
r
b
a
l
a
n
c
e
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
a
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
s
y
s
t
e
m
 
b
y
 
r
e
v
e
r
s
i
n
g
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
s
o
 
t
h
a
t
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
 
w
o
u
l
d
 
h
a
v
e
 
t
o
 
p
r
o
v
e
 
t
h
e
 
n
o
n
-
m
i
s
l
e
a
d
i
n
g
 
c
h
a
r
a
c
t
e
r
 
a
n
d
 
t
r
u
t
h
f
u
l
n
e
s
s
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
T
h
i
s
 
s
e
e
m
s
 
t
o
 
b
e
 
a
 
p
o
s
s
i
b
l
e
 
w
a
y
 
f
o
r
w
a
r
d
,
 
a
l
t
h
o
u
g
h
 
t
h
e
 
d
i
s
s
u
a
s
i
v
e
 
e
f
f
e
c
t
 
o
f
 
r
e
v
e
r
s
i
n
g
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
w
o
u
l
d
 
n
e
e
d
 
t
o
 
b
e
 
e
x
a
m
i
n
e
d
 
i
n
 
m
o
r
e
 
d
e
t
a
i
l
.
 
I
t
 
h
a
s
,
 
n
e
v
e
r
t
h
e
l
e
s
s
,
 
t
h
e
 
a
d
v
a
n
t
a
g
e
 
t
h
a
t
 
i
t
 
w
o
u
l
d
 
n
o
t
 
i
m
p
o
s
e
 
a
n
y
 
n
e
w
 
b
u
r
d
e
n
s
 
f
r
o
m
 
a
n
 
a
d
m
i
n
i
s
t
r
a
t
i
v
e
 
p
o
i
n
t
 
o
f
 
v
i
e
w
 
(
t
h
e
 
q
u
e
s
t
i
o
n
 
o
f
 
r
e
v
e
r
s
a
l
 
o
f
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
f
u
r
t
h
e
r
 
d
i
s
c
u
s
s
e
d
 
i
n
 
t
h
e
 
s
e
c
t
i
o
n
 
·
B
u
r
d
e
n
 
o
f
 
P
r
o
o
f
'
)
.
 
e
)
 
S
t
a
t
u
s
 
Q
u
o
 
A
 
f
i
n
a
l
 
o
p
t
i
o
n
 
i
s
 
s
i
m
p
l
y
 
t
o
 
k
e
e
p
 
t
h
e
 
s
t
a
t
u
s
 
q
u
o
,
 
i
.
e
.
 
d
i
f
f
e
r
e
n
t
 
s
y
s
t
e
m
s
 
i
n
 
d
i
f
f
e
r
e
n
t
 
M
e
m
b
e
r
 
S
t
a
t
e
s
.
 
T
h
i
s
 
o
p
t
i
o
n
 
d
o
e
s
 
n
o
t
 
s
e
e
m
 
t
o
 
u
s
 
t
o
 
b
e
 
v
i
a
b
l
e
,
 
i
n
 
v
i
e
w
 
o
f
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
m
o
r
e
 
a
n
d
 
m
o
r
e
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
r
e
 
l
i
k
e
l
y
 
t
o
 
b
e
 
m
a
d
e
 
o
v
e
r
 
t
h
e
 
c
o
m
i
n
g
 
y
e
a
r
s
,
 
t
h
u
s
 
p
o
t
e
n
t
i
a
l
l
y
 
l
e
a
d
i
n
g
 
a
n
 
i
n
c
r
e
a
s
i
n
g
 
n
u
m
b
e
r
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
 
p
r
o
b
l
e
m
s
 
a
n
d
 
b
a
r
r
i
e
r
s
 
t
o
 
t
r
a
d
e
.
 
T
h
e
 
m
o
s
t
 
v
i
a
b
l
e
 
s
o
l
u
t
i
o
n
s
 
a
r
e
 
i
n
 
o
u
r
 
v
i
e
w
:
 
•
 
a
 
s
y
s
t
e
m
 
o
f
 
n
o
t
i
f
i
c
a
t
i
o
n
;
 
a
n
d
/
o
r
 
•
 
t
h
e
 
m
o
d
e
l
 
o
f
 
a
s
s
u
m
p
t
i
o
n
 
o
f
 
d
u
e
 
d
i
l
i
g
e
n
c
e
 
i
n
 
c
a
s
e
 
o
f
 
v
o
l
u
n
t
a
r
y
 
p
r
e
-
c
l
e
a
r
a
n
c
e
;
 
a
n
d
/
 
o
r
 
•
 
t
h
e
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
-
2
0
0
0
 
6
3
 A
l
l
 
t
h
r
e
e
 
o
p
t
i
o
n
s
 
a
l
l
o
w
 
f
o
r
 
i
n
c
r
e
a
s
e
d
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
,
 
w
h
i
l
s
t
 
a
t
 
t
h
e
 
s
a
m
e
 
t
i
m
e
 
k
e
e
p
i
n
g
 
t
h
e
 
a
d
m
i
n
i
s
t
r
a
t
i
v
e
 
b
u
r
d
e
n
 
w
i
t
h
i
n
 
r
e
a
s
o
n
a
b
l
e
 
l
i
m
i
t
s
.
 
F
u
r
t
h
e
r
m
o
r
e
,
 
a
l
l
 
t
h
r
e
e
 
o
p
t
i
o
n
s
 
s
e
e
m
 
t
o
 
b
e
 
c
o
m
p
a
t
i
b
l
e
 
w
i
t
h
 
v
o
l
u
n
t
a
r
y
 
i
n
s
t
r
u
m
e
n
t
s
 
o
n
 
c
l
a
i
m
s
.
 
I
n
 
p
a
r
t
i
c
u
l
a
r
 
t
h
e
 
m
o
d
e
l
 
o
f
 
v
o
l
u
n
t
a
r
y
 
p
r
e
-
c
l
e
a
r
a
n
c
e
,
 
a
s
 
w
e
l
l
 
a
s
 
t
h
e
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
c
o
n
c
e
p
t
 
s
e
e
m
 
t
o
 
b
e
 
s
y
s
t
e
m
s
 
w
h
i
c
h
 
c
o
u
l
d
 
a
p
p
l
y
 
t
o
 
a
l
l
 
t
y
p
e
s
 
o
f
 
c
l
a
i
m
s
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
4
 F
.
 
L
E
G
A
L
 
P
E
R
S
O
N
S
 
E
N
T
I
T
L
E
D
 
T
O
 
T
A
K
E
 
L
E
G
A
L
 
A
C
T
I
O
N
 
1
.
 
C
o
m
m
e
n
t
 
I
n
 
a
l
l
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
,
 
c
o
m
p
a
n
i
e
s
,
 
t
r
a
d
e
 
a
n
d
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
a
r
e
 
e
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
T
h
e
 
o
n
l
y
 
e
x
c
e
p
t
i
o
n
 
i
s
 
A
u
s
t
r
i
a
 
w
h
e
r
e
 
s
o
 
f
a
r
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
a
r
e
 
n
o
t
 
a
l
l
o
w
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
t
h
e
 
A
u
s
t
r
i
a
n
 
L
a
w
 
a
g
a
i
n
s
t
 
U
n
f
a
i
r
 
C
o
m
p
e
t
i
t
i
o
n
 
I
S
 
c
u
r
r
e
n
t
l
y
 
b
e
i
n
g
 
r
e
v
i
s
e
d
,
 
i
n
 
o
r
d
e
r
 
t
o
 
g
i
v
e
 
c
o
n
s
u
m
e
r
s
 
t
h
e
 
r
i
g
h
t
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
T
h
e
r
e
 
a
r
e
 
a
 
f
e
w
 
c
o
u
n
t
r
i
e
s
,
 
w
h
i
c
h
 
d
o
 
n
o
t
 
a
l
l
o
w
 
t
h
e
 
i
n
d
i
v
i
d
u
a
l
 
c
o
n
s
u
m
e
r
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
T
h
i
s
 
i
s
 
n
o
t
a
b
l
y
 
t
h
e
 
c
a
s
e
 
f
o
r
 
A
u
s
t
r
i
a
 
a
n
d
 
G
e
r
m
a
n
y
.
 
I
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
,
 
w
e
 
p
r
o
v
i
d
e
 
a
n
 
o
v
e
r
v
i
e
w
 
o
f
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
w
h
e
r
e
 
a
u
t
h
o
r
i
t
i
e
s
,
 
c
o
m
p
a
n
i
e
s
,
 
t
r
a
d
e
 
a
n
d
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
a
r
e
 
e
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
,
 
a
s
 
w
e
l
l
 
a
s
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
w
h
e
r
e
 
t
h
e
 
i
n
d
i
v
i
d
u
a
l
 
c
o
n
s
u
m
e
r
 
c
a
n
 
a
l
s
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
5
 2
.
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
L
e
g
a
l
 
P
e
r
s
o
n
s
 
E
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
L
e
g
a
l
 
A
c
t
i
o
n
 
C
o
u
n
t
r
y
 
A
u
t
h
o
r
i
t
i
e
s
/
 
C
o
m
p
a
n
i
e
s
/
 
I
n
d
i
v
i
d
u
a
l
 
C
o
m
m
e
n
t
s
 
T
r
a
d
e
 
A
s
s
o
c
i
a
t
i
o
n
s
/
 
C
o
n
s
u
m
e
r
s
 
C
o
n
s
u
m
e
r
 
A
s
s
o
c
i
a
t
i
o
n
s
 
E
U
 
X
 
X
 
T
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
l
e
a
v
e
s
 
i
t
 
i
n
 
p
r
i
n
c
i
p
l
e
 
t
o
 
t
h
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
t
o
 
d
e
f
i
n
e
 
t
h
o
s
e
 
e
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
I
t
 
s
t
a
t
e
s
,
 
n
e
v
e
r
t
h
e
l
e
s
s
,
 
t
h
a
t
 
p
r
o
v
i
s
i
o
n
s
 
s
h
a
l
l
 
b
e
 
i
m
p
l
e
m
e
n
t
e
d
 
u
n
d
e
r
 
w
h
i
c
h
 
p
e
r
s
o
n
s
 
o
r
 
o
r
g
a
n
i
z
a
t
i
o
n
s
 
r
e
g
a
r
d
e
d
 
u
n
d
e
r
 
n
a
t
i
o
n
a
l
 
l
a
w
 
a
s
 
h
a
v
i
n
g
 
a
 
l
e
g
i
t
i
m
a
t
e
 
i
n
t
e
r
e
s
t
 
i
n
 
p
r
o
h
i
b
i
t
i
n
g
 
m
i
s
l
e
a
d
i
n
g
 
a
d
v
e
r
t
i
s
i
n
g
 
m
a
y
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
A
u
s
t
r
i
a
 
X
 
C
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
c
a
n
n
o
t
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
,
 
b
u
t
 
t
h
e
 
l
a
w
 
i
s
 
c
u
r
r
e
n
t
l
y
 
b
e
i
n
g
 
r
e
v
i
s
e
d
.
 
B
e
l
g
i
u
m
 
D
e
n
m
a
r
k
 
F
i
n
l
a
n
d
 
F
r
a
n
c
e
 
G
e
r
m
a
n
y
 
X
 
G
r
e
e
c
e
 
I
r
e
l
a
n
d
 
I
t
a
l
y
 
L
u
x
e
m
b
o
u
r
g
 
N
e
t
h
e
r
l
a
n
d
s
 
P
o
r
t
u
g
a
l
 
S
p
a
i
n
 
S
w
e
d
e
n
 
U
K
 
T
o
t
a
l
 
1
5
/
1
5
 
1
3
/
1
5
 
U
S
A
 
C
a
n
a
d
a
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
6
 3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
N
o
 
p
r
o
b
l
e
m
s
 
h
a
v
e
 
b
e
e
n
 
r
e
p
o
r
t
e
d
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
t
h
e
 
p
e
r
s
o
n
s
 
e
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
,
 
a
p
a
r
t
 
f
r
o
m
 
A
u
s
t
r
i
a
,
 
b
u
t
 
h
e
r
e
 
t
h
e
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
c
u
r
r
e
n
t
l
y
 
b
e
i
n
g
 
m
o
d
i
f
i
e
d
 
i
n
 
t
h
i
s
 
r
e
s
p
e
c
t
.
 
T
h
a
t
 
i
n
d
i
v
i
d
u
a
l
 
c
o
n
s
u
m
e
r
s
 
a
r
e
 
n
o
t
 
a
l
l
o
w
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
c
l
a
i
m
s
 
i
n
 
a
 
f
e
w
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
d
o
e
s
 
n
o
t
 
s
e
e
m
 
t
o
 
h
a
v
e
 
l
e
d
 
t
o
 
a
n
y
 
p
r
o
b
l
e
m
s
 
i
n
 
t
e
r
m
s
 
o
f
 
c
o
n
s
u
m
e
r
 
p
r
o
t
e
c
t
i
o
n
.
 
W
e
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
n
o
 
c
l
a
r
i
f
i
c
a
t
i
o
n
s
/
c
h
a
n
g
e
s
 
n
e
e
d
 
t
o
 
b
e
 
m
a
d
e
 
t
o
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
t
h
e
 
l
e
g
a
l
 
p
e
r
s
o
n
s
 
e
n
t
i
t
l
e
d
 
t
o
 
t
a
k
e
 
l
e
g
a
l
 
a
c
t
i
o
n
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
7
 G
.
 
B
U
R
D
E
N
 
O
F
 
P
R
O
O
F
 
1
.
 
C
o
m
m
e
n
t
 
T
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
i
n
 
a
 
m
a
j
o
r
i
t
y
 
o
f
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
s
o
m
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
h
a
v
e
 
e
s
t
a
b
l
i
s
h
e
d
 
a
 
s
y
s
t
e
m
 
w
h
e
r
e
b
y
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
,
 
i
n
 
t
h
e
 
c
a
s
e
 
t
h
a
t
 
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
s
t
a
r
t
 
a
n
 
i
n
v
e
s
t
i
g
a
t
i
o
n
.
 
T
h
e
 
l
a
t
t
e
r
 
i
s
 
r
e
f
l
e
c
t
e
d
 
i
n
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
,
 
w
h
i
c
h
 
u
n
d
e
r
 
c
e
r
t
a
i
n
 
c
i
r
c
u
m
s
t
a
n
c
e
s
 
e
m
p
o
w
e
r
s
 
n
a
t
i
o
n
a
l
 
c
o
u
r
t
s
 
a
n
d
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
s
 
t
o
 
r
e
q
u
i
r
e
 
a
d
v
e
r
t
i
s
e
r
s
 
t
o
 
f
u
r
n
i
s
h
 
e
v
i
d
e
n
c
e
 
a
s
 
t
o
 
t
h
e
 
a
c
c
u
r
a
c
y
 
o
f
 
f
a
c
t
u
a
l
 
c
l
a
i
m
s
 
i
n
 
a
d
v
e
r
t
i
s
i
n
g
.
 
I
t
 
i
s
 
o
n
l
y
 
t
h
e
 
N
o
r
d
i
c
 
c
o
u
n
t
r
i
e
s
,
 
w
h
e
r
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
c
l
e
a
r
l
y
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
O
n
 
s
e
v
e
r
a
l
 
o
c
c
a
s
i
o
n
s
,
 
i
n
d
u
s
t
r
y
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
m
a
n
u
f
a
c
t
u
r
e
r
s
 
w
e
r
e
 
i
n
 
p
r
a
c
t
i
c
e
 
i
n
 
a
n
y
 
c
a
s
e
 
t
r
y
i
n
g
 
t
o
 
j
u
s
t
i
f
y
 
t
h
e
i
r
 
c
l
a
i
m
s
 
v
i
a
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
I
n
 
G
e
r
m
a
n
y
,
 
i
t
 
w
a
s
 
r
e
p
o
r
t
e
d
 
t
h
a
t
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
c
r
e
a
t
i
n
g
 
p
r
o
b
l
e
m
s
 
f
o
r
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
t
o
 
p
u
r
s
u
e
 
c
a
s
e
s
 
i
n
 
f
r
o
n
t
 
o
f
 
t
h
e
 
c
o
u
r
t
s
,
 
a
s
 
t
h
e
y
 
d
o
 
n
o
t
 
h
a
v
e
 
t
h
e
 
m
e
a
n
s
 
o
f
 
p
a
y
i
n
g
 
a
n
 
e
x
p
e
r
t
 
w
h
o
 
c
a
n
 
p
r
o
v
i
d
e
 
a
n
 
o
p
i
n
i
o
n
 
d
e
m
o
n
s
t
r
a
t
i
n
g
 
t
h
a
t
 
a
 
c
e
r
t
a
i
n
 
c
l
a
i
m
 
c
a
n
n
o
t
 
b
e
 
s
c
i
e
n
t
i
f
i
c
a
l
l
y
 
p
r
o
v
e
n
.
 
A
l
s
o
,
 
t
h
e
 
e
n
f
o
r
c
e
m
e
n
t
 
a
u
t
h
o
r
i
t
i
e
s
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
 
i
n
 
t
h
e
 
U
K
,
 
h
a
v
e
 
h
i
g
h
l
i
g
h
t
e
d
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
t
a
k
i
n
g
 
a
 
m
a
n
u
f
a
c
t
u
r
e
r
 
t
o
 
c
o
u
r
t
 
r
e
q
u
i
r
e
s
 
e
n
o
r
m
o
u
s
 
r
e
s
o
u
r
c
e
s
,
 
w
h
i
c
h
 
t
h
e
y
 
d
o
 
n
o
t
 
h
a
v
e
.
 
H
e
n
c
e
,
 
u
n
l
e
s
s
 
t
h
e
y
 
a
r
e
 
1
 
0
0
%
 
c
o
n
f
i
d
e
n
t
 
o
f
 
t
h
e
i
r
 
c
a
s
e
,
 
t
h
e
y
 
w
i
l
l
 
n
o
t
 
g
o
 
t
o
 
c
o
u
r
t
.
 
I
n
s
t
e
a
d
,
 
t
h
e
y
 
w
i
l
l
 
e
n
t
e
r
 
i
n
t
o
 
n
e
g
o
t
i
a
t
i
o
n
s
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
 
t
o
 
t
r
y
 
a
n
d
 
r
e
s
o
l
v
e
 
t
h
e
 
i
s
s
u
e
 
o
u
t
 
o
f
 
c
o
u
r
t
.
 
I
t
 
i
s
 
d
i
f
f
i
c
u
l
t
 
t
o
 
i
n
d
i
c
a
t
e
 
w
h
a
t
 
t
h
e
 
e
x
t
e
n
t
 
o
f
 
o
u
t
 
o
f
 
c
o
u
r
t
 
s
e
t
t
l
e
m
e
n
t
s
 
i
s
,
 
b
u
t
 
w
e
 
a
r
e
 
o
f
 
t
h
e
 
o
p
i
n
i
o
n
 
t
h
a
t
 
t
h
e
y
 
a
r
e
 
n
u
m
e
r
o
u
s
.
 
T
h
e
 
f
o
l
l
o
w
i
n
g
 
t
a
b
l
e
 
p
r
o
v
i
d
e
s
 
a
n
d
 
o
v
e
r
v
i
e
w
 
o
f
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
w
h
e
r
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
,
 
c
o
m
p
a
r
e
d
 
t
o
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
w
h
e
r
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
8
 
I
 2
.
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
B
u
r
d
e
n
 
o
f
 
P
r
o
o
f
 
C
o
u
n
t
r
y
 
W
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
 
W
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
C
o
m
m
e
n
t
s
 
c
l
a
i
m
 
E
U
 
X
 
X
 
T
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
 
e
m
p
o
w
e
r
s
 
u
n
d
e
r
 
c
e
r
t
a
i
n
 
c
i
r
c
u
m
s
t
a
n
c
e
s
 
n
a
t
i
o
n
a
l
 
c
o
u
r
t
s
 
a
n
d
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
s
 
t
o
 
r
e
q
u
i
r
e
 
a
d
v
e
r
t
i
s
e
r
s
 
t
o
 
f
u
r
n
i
s
h
 
e
v
i
d
e
n
c
e
 
a
s
 
t
o
 
t
h
e
 
a
c
c
u
r
a
c
y
 
o
f
 
f
a
c
t
u
a
l
 
c
l
a
i
m
s
 
i
n
 
a
d
v
e
r
t
i
s
i
n
g
,
 
b
u
t
 
i
t
 
d
o
e
s
 
n
o
t
 
a
s
 
a
 
p
r
i
n
c
i
p
l
e
 
p
u
t
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
o
n
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
A
u
s
t
r
i
a
 
T
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
n
o
r
m
a
l
l
y
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
,
 
b
u
t
 
i
f
t
h
e
 
a
u
t
h
o
r
i
t
i
e
s
 
s
t
a
r
t
 
a
n
 
i
n
v
e
s
t
i
g
a
t
i
o
n
,
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
.
 
B
e
l
g
i
u
m
 
X
 
D
e
n
m
a
r
k
 
X
 
F
i
n
l
a
n
d
 
X
 
F
r
a
n
c
e
 
T
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
n
o
r
m
a
l
l
y
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
.
 
B
u
t
 
w
h
e
r
e
 
a
 
c
o
m
p
a
n
y
 
h
a
s
 
n
o
t
 
r
e
s
p
e
c
t
e
d
 
t
h
e
 
p
r
o
c
e
d
u
r
e
s
 
o
f
 
t
h
e
 
'
v
i
s
a
 
p
p
'
 
t
o
 
o
b
t
a
i
n
 
a
n
 
a
u
t
h
o
r
i
s
a
t
i
o
n
 
f
o
r
 
t
h
e
 
u
s
e
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
i
t
 
h
a
s
 
t
o
 
s
u
b
s
t
a
n
t
i
a
t
e
 
t
h
e
 
c
l
a
i
m
.
 
G
e
r
m
a
n
y
 
X
 
T
h
e
 
F
e
d
e
r
a
l
 
C
o
u
r
t
 
c
o
n
c
l
u
d
e
d
 
i
n
 
s
e
v
e
r
a
l
 
j
u
d
g
e
m
e
n
t
s
 
t
h
a
t
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
w
i
t
h
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
 
w
h
e
r
e
 
h
e
/
s
h
e
 
i
s
 
u
s
i
n
g
 
a
n
 
o
p
i
n
i
o
n
 
t
o
 
j
u
s
t
i
f
y
 
h
i
s
/
h
e
r
 
c
l
a
i
m
 
w
h
i
c
h
 
i
s
 
c
o
n
t
r
o
v
e
r
s
i
a
l
 
a
m
o
n
g
s
t
 
e
x
p
e
r
t
s
 
a
n
d
 
w
i
t
h
o
u
t
 
a
l
s
o
 
m
e
n
t
i
o
n
i
n
g
 
t
h
e
 
d
i
s
s
e
n
t
i
n
g
 
s
c
i
e
n
t
i
f
i
c
 
v
i
e
w
.
 
G
r
e
e
c
e
 
G
r
e
e
k
 
l
e
g
i
s
l
a
t
i
o
n
 
i
s
 
u
n
c
l
e
a
r
 
a
s
 
t
o
 
w
i
t
h
 
w
h
o
m
 
l
i
e
s
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
.
 
P
u
b
l
i
c
 
s
e
c
t
o
r
 
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
 
a
n
d
 
N
G
O
s
 
i
n
d
i
c
a
t
e
d
 
t
h
a
t
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
i
n
 
p
r
a
c
t
i
c
e
 
w
i
t
h
 
b
o
t
h
 
p
a
r
t
i
e
s
.
 
I
r
e
l
a
n
d
 
X
 
I
t
a
l
y
 
T
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
n
o
r
m
a
l
l
y
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
.
 
T
h
e
 
A
n
t
i
t
r
u
s
t
 
A
u
t
h
o
r
i
t
y
 
c
a
n
,
 
n
e
v
e
r
t
h
e
l
e
s
s
 
u
n
d
e
r
 
c
e
r
t
a
i
n
 
c
i
r
c
u
m
s
t
a
n
c
e
s
 
a
s
k
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
s
 
t
o
 
s
u
b
m
i
t
 
p
r
o
o
f
s
 
o
f
 
t
h
e
 
m
a
t
e
r
i
a
l
 
a
c
c
u
r
a
c
y
 
o
f
 
t
h
e
 
d
a
t
a
 
c
o
n
t
a
i
n
e
d
 
i
n
 
t
h
e
 
a
d
v
e
r
t
i
s
i
n
g
.
 
L
u
x
e
m
b
o
u
r
g
 
X
 
N
e
t
h
e
r
 
l
a
n
d
s
 
X
 
U
n
d
e
r
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
D
u
t
c
h
 
A
d
v
e
r
t
i
s
i
n
g
 
C
o
d
e
,
 
t
h
e
 
A
d
v
e
r
t
i
s
i
n
g
 
S
t
a
n
d
a
r
d
 
C
o
m
m
i
t
t
e
e
 
c
a
n
 
a
s
k
 
a
n
y
o
n
e
 
u
s
i
n
g
 
a
 
c
l
a
i
m
 
t
o
 
p
r
o
v
e
 
t
h
a
t
 
t
h
e
 
c
l
a
i
m
 
u
s
e
d
 
i
s
 
t
r
u
e
.
 
P
o
r
t
u
g
a
l
 
T
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
s
 
n
o
r
m
a
l
l
y
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
u
n
d
e
r
 
t
h
e
 
A
d
v
e
r
t
i
s
i
n
g
 
C
o
d
e
 
a
 
c
o
m
p
a
n
y
 
m
u
s
t
 
b
e
 
a
b
l
e
 
t
o
 
p
r
o
v
e
 
t
h
e
 
a
f
f
i
r
m
a
t
i
o
n
s
 
o
n
 
t
h
e
 
n
a
t
u
r
e
,
 
c
o
m
p
o
s
i
t
i
o
n
 
a
n
d
 
p
r
o
p
e
r
t
i
e
s
 
o
f
 
a
 
g
o
o
d
 
a
t
 
a
l
l
 
t
i
m
e
s
 
b
e
f
o
r
e
 
t
h
e
 
c
o
m
p
e
t
e
n
t
 
a
u
t
h
o
r
i
t
i
e
s
.
 
S
p
a
i
n
 
X
 
S
w
e
d
e
n
 
X
 
U
K
 
X
 
T
o
t
a
l
 
1
2
/
1
5
 
8
/
1
5
 
U
S
A
 
X
 
C
a
n
a
d
a
 
X
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
6
9
 3
.
 
R
e
c
o
m
m
e
n
d
a
t
i
o
n
s
 
I
n
 
t
h
o
s
e
 
c
o
u
n
t
r
i
e
s
 
w
h
e
r
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
l
i
e
s
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
,
 
t
h
e
r
e
 
s
e
e
m
 
t
o
 
e
x
i
s
t
 
p
r
o
b
l
e
m
s
 
i
n
 
t
e
r
m
s
 
o
f
 
b
r
i
n
g
i
n
g
 
c
a
s
e
s
 
t
o
 
t
h
e
 
c
o
u
r
t
s
.
 
W
h
i
l
s
t
 
c
o
n
s
u
m
e
r
 
a
s
s
o
c
i
a
t
i
o
n
s
 
a
r
e
 
u
n
a
n
i
m
o
u
s
l
y
 
i
n
 
f
a
v
o
u
r
 
o
f
 
a
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
,
 
i
n
d
u
s
t
r
y
 
s
e
e
m
s
 
i
n
 
g
e
n
e
r
a
l
 
t
o
 
a
g
r
e
e
 
t
h
a
t
 
a
 
m
a
n
u
f
a
c
t
u
r
e
r
 
n
e
e
d
s
 
t
o
 
b
e
 
a
b
l
e
 
t
o
 
j
u
s
t
i
f
y
 
n
u
t
r
i
t
i
o
n
a
l
/
h
e
a
l
t
h
 
c
l
a
i
m
s
 
w
i
t
h
 
s
c
i
e
n
t
i
f
i
c
 
e
v
i
d
e
n
c
e
.
 
T
h
e
r
e
f
o
r
e
,
 
w
e
 
b
e
l
i
e
v
e
 
t
h
a
t
 
a
 
m
o
d
i
f
i
c
a
t
i
o
n
 
o
f
 
t
h
e
 
r
u
l
e
s
 
o
n
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
,
 
a
s
 
s
e
t
 
o
u
t
 
i
n
 
t
h
e
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
 
D
i
r
e
c
t
i
v
e
,
 
s
h
o
u
l
d
 
t
a
k
e
 
p
l
a
c
e
.
 
D
i
f
f
e
r
e
n
t
 
o
p
t
i
o
n
s
 
s
e
e
m
 
t
o
 
b
e
 
p
o
s
s
i
b
l
e
,
 
w
h
i
c
h
 
h
a
v
e
 
a
l
s
o
 
b
e
e
n
 
d
i
s
c
u
s
s
e
d
 
b
y
 
t
h
e
 
E
u
r
o
p
e
a
n
 
C
o
m
m
i
s
s
i
o
n
 
i
n
 
t
h
e
 
c
o
n
t
e
x
t
 
o
f
 
t
h
e
 
G
r
e
e
n
 
P
a
p
e
r
 
o
n
 
L
i
a
b
i
l
i
t
y
 
f
o
r
 
D
e
f
e
c
t
i
v
e
 
P
r
o
d
u
c
t
s
 
(
C
O
M
 
(
1
9
9
9
)
 
3
9
6
 
f
i
n
a
l
 
o
f
 
2
8
.
7
.
1
9
9
9
,
 
p
.
 
2
1
-
2
3
)
.
 
T
h
e
 
f
o
l
l
o
w
i
n
g
 
o
p
t
i
o
n
s
 
s
e
e
m
 
t
o
 
b
e
 
p
o
s
s
i
b
l
e
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
c
l
a
i
m
s
:
 
•
 
T
o
 
i
m
p
o
s
e
 
o
n
 
t
h
e
 
p
r
o
d
u
c
e
r
 
t
h
e
 
o
b
l
i
g
a
t
i
o
n
 
t
o
 
p
r
o
v
i
d
e
 
a
l
l
 
u
s
e
f
u
l
 
d
o
c
u
m
e
n
t
a
t
i
o
n
 
a
n
d
 
i
n
f
o
r
m
a
t
i
o
n
 
s
o
 
t
h
a
t
 
t
h
e
 
p
l
a
i
n
t
i
f
f
 
c
a
n
 
a
v
a
i
l
 
h
i
m
s
e
l
f
 
o
f
 
c
o
n
c
r
e
t
e
 
f
a
c
t
s
 
t
o
 
p
r
o
v
e
 
h
i
s
 
c
a
s
e
.
 
•
 
T
o
 
m
a
k
e
 
t
h
e
 
p
r
o
d
u
c
e
r
 
b
e
a
r
 
t
h
e
 
c
o
s
t
s
 
o
f
 
a
n
 
e
x
p
e
r
t
 
o
p
m
1
o
n
 
u
n
d
e
r
 
c
e
r
t
a
i
n
 
c
i
r
c
u
m
s
t
a
n
c
e
s
,
 
e
.
g
.
 
o
n
 
c
o
n
d
i
t
i
o
n
 
t
h
a
t
 
t
h
e
 
v
i
c
t
i
m
 
r
e
i
m
b
u
r
s
e
s
 
t
h
e
 
c
o
s
t
s
 
i
n
 
t
h
e
 
e
v
e
n
t
 
o
f
 
f
a
i
l
u
r
e
.
 
•
 
T
o
 
m
a
k
e
 
t
h
e
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
d
e
p
e
n
d
a
n
t
 
a
s
 
t
o
 
w
h
e
t
h
e
r
 
t
h
e
 
p
r
o
d
u
c
e
r
 
h
a
s
 
f
u
l
f
i
l
l
e
d
 
c
e
r
t
a
i
n
 
c
r
i
t
e
r
i
a
 
s
e
t
 
o
u
t
 
i
n
 
a
n
 
a
m
e
n
d
e
d
 
D
i
r
e
c
t
i
v
e
 
o
n
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
.
 
T
h
e
 
D
i
r
e
c
t
i
v
e
 
c
o
u
l
d
,
 
f
o
r
 
e
x
a
m
p
l
e
,
 
s
e
t
 
o
u
t
 
c
e
r
t
a
i
n
 
c
r
i
t
e
r
i
a
 
a
p
p
l
y
i
n
g
 
t
o
 
c
l
a
i
m
s
,
 
i
n
 
o
r
d
e
r
 
t
o
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
n
o
n
-
m
i
s
l
e
a
d
i
n
g
 
(
f
o
r
 
f
u
r
t
h
e
r
 
d
e
t
a
i
l
s
 
o
n
 
t
h
i
s
 
p
o
i
n
t
 
s
e
e
 
b
e
l
o
w
 
s
e
c
t
i
o
n
 
o
n
 
V
o
l
u
n
t
a
r
y
 
A
g
r
e
e
m
e
n
t
s
)
.
 
I
f
 
a
 
m
a
n
u
f
a
c
t
u
r
e
r
 
h
a
s
 
f
u
l
f
i
l
l
e
d
 
t
h
e
s
e
 
c
r
i
t
e
r
i
a
,
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
w
o
u
l
d
 
r
e
m
a
i
n
 
w
i
t
h
 
t
h
e
 
p
l
a
i
n
t
i
f
f
.
 
•
 
T
o
 
r
e
v
e
r
s
e
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
.
 
A
l
l
 
a
r
g
u
m
e
n
t
s
 
t
a
k
e
n
 
i
n
t
o
 
a
c
c
o
u
n
t
 
a
n
d
,
 
i
n
 
p
a
r
t
i
c
u
l
a
r
,
 
i
f
 
l
i
n
k
i
n
g
 
t
h
e
 
q
u
e
s
t
i
o
n
 
o
f
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
w
i
t
h
 
t
h
e
 
q
u
e
s
t
i
o
n
 
o
f
 
p
r
e
-
c
l
e
a
r
a
n
c
e
 
(
s
e
e
 
a
b
o
v
e
 
u
n
d
e
r
 
t
h
e
 
c
h
a
p
t
e
r
 
P
r
e
-
C
l
e
a
r
a
n
c
e
/
P
o
s
t
-
C
l
e
a
r
a
n
c
e
)
,
 
t
h
e
 
o
p
t
i
m
a
l
 
s
o
l
u
t
i
o
n
 
i
s
 
a
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
i
.
e
.
,
 
i
t
 
w
o
u
l
d
 
b
e
 
u
p
 
t
o
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
 
t
o
 
p
r
o
v
e
 
t
h
a
t
 
t
h
e
 
c
l
a
i
m
 
i
s
 
n
o
t
 
m
i
s
l
e
a
d
i
n
g
.
 
N
e
v
e
r
t
h
e
l
e
s
s
,
 
a
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
m
a
y
 
b
e
 
c
o
n
s
i
d
e
r
e
d
 
b
y
 
s
o
m
e
 
M
e
m
b
e
r
 
S
t
a
t
e
s
 
a
s
 
a
 
p
r
o
f
o
u
n
d
 
i
n
t
e
r
v
e
n
t
i
o
n
 
b
y
 
t
h
e
 
E
U
 
i
n
t
o
 
i
t
s
 
b
a
s
i
c
 
l
e
g
a
l
 
p
r
i
n
c
i
p
l
e
s
.
 
I
n
 
t
h
i
s
 
c
a
s
e
,
 
w
e
 
c
o
n
s
i
d
e
r
 
a
s
 
t
h
e
 
s
e
c
o
n
d
 
b
e
s
t
 
o
p
t
i
o
n
 
t
o
 
m
a
k
e
 
t
h
e
 
r
e
v
e
r
s
a
l
 
o
f
 
t
h
e
 
b
u
r
d
e
n
 
o
f
 
p
r
o
o
f
 
d
e
p
e
n
d
a
n
t
 
a
s
 
t
o
 
w
h
e
t
h
e
r
 
t
h
e
 
p
r
o
d
u
c
e
r
 
h
a
s
 
f
u
l
f
i
l
l
e
d
 
c
e
r
t
a
i
n
 
c
r
i
t
e
r
i
a
 
s
e
t
 
o
u
t
 
i
n
 
a
n
 
a
m
e
n
d
e
d
 
D
i
r
e
c
t
i
v
e
 
o
n
 
M
i
s
l
e
a
d
i
n
g
 
A
d
v
e
r
t
i
s
i
n
g
,
 
w
h
i
l
s
t
 
a
t
 
t
h
e
 
s
a
m
e
 
t
i
m
e
 
r
e
q
u
i
r
i
n
g
 
t
h
e
 
m
a
k
e
r
 
o
f
 
t
h
e
 
c
l
a
i
m
 
t
o
 
p
r
o
v
i
d
e
 
a
l
l
 
u
s
e
f
u
l
 
d
o
c
u
m
e
n
t
a
t
i
o
n
 
a
n
d
 
i
n
f
o
r
m
a
t
i
o
n
 
s
o
 
t
h
a
t
 
t
h
e
 
p
l
a
i
n
t
i
f
f
 
c
a
n
 
a
v
a
i
l
 
h
i
m
s
e
l
f
 
o
f
 
c
o
n
c
r
e
t
e
 
f
a
c
t
s
 
t
o
 
p
r
o
v
e
 
h
i
s
 
c
a
s
e
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
7
0
 H
.
 
V
O
L
U
N
T
A
R
Y
 
A
G
R
E
E
M
E
N
T
S
 
1
.
 
C
o
m
m
e
n
t
s
 
T
h
e
 
e
x
i
s
t
e
n
c
e
 
o
f
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
,
 
s
h
o
w
s
 
t
h
a
t
 
w
h
e
r
e
 
l
e
g
i
s
l
a
t
i
o
n
 
o
n
 
a
 
p
a
r
t
i
c
u
l
a
r
 
t
y
p
e
 
o
f
 
c
l
a
i
m
 
e
x
i
s
t
s
,
 
t
h
e
 
n
u
m
b
e
r
 
o
f
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
i
s
 
l
o
w
.
 
T
h
u
s
,
 
o
n
l
y
 
i
n
 
D
e
n
m
a
r
k
 
a
 
v
o
l
u
n
t
a
r
y
 
t
y
p
e
 
o
f
 
a
g
r
e
e
m
e
n
t
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
 
e
x
i
s
t
s
,
 
w
h
i
l
e
 
i
n
 
F
i
n
l
a
n
d
 
a
n
d
 
t
h
e
 
U
K
 
g
u
i
d
e
l
i
n
e
s
 
h
a
v
e
 
b
e
e
n
 
d
e
v
e
l
o
p
e
d
 
b
y
 
g
o
v
e
r
n
m
e
n
t
 
a
u
t
h
o
r
i
t
i
e
s
.
 
W
i
t
h
 
r
e
g
a
r
d
 
t
o
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
n
u
m
e
r
o
u
s
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
e
x
i
s
t
 
o
r
 
a
r
e
 
b
e
i
n
g
 
p
l
a
n
n
e
d
.
 
S
w
e
d
e
n
 
i
s
 
t
h
e
 
c
o
u
n
t
r
y
 
w
i
t
h
 
t
h
e
 
o
l
d
e
s
t
 
c
o
d
e
 
o
f
 
c
o
n
d
u
c
t
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
,
 
w
h
i
c
h
 
e
n
t
e
r
e
d
 
i
n
t
o
 
f
o
r
c
e
 
i
n
 
1
9
9
0
.
 
D
u
e
 
t
o
 
t
h
e
 
f
a
c
t
 
t
h
a
t
 
m
o
r
e
 
a
n
d
 
m
o
r
e
 
s
t
a
k
e
h
o
l
d
e
r
s
 
c
o
n
s
i
d
e
r
 
t
h
a
t
 
s
o
m
e
 
s
o
r
t
s
 
o
f
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
a
l
l
o
w
e
d
,
 
s
u
c
h
 
c
o
d
e
s
 
h
a
v
e
 
p
r
o
l
i
f
e
r
a
t
e
d
 
a
c
r
o
s
s
 
t
h
e
 
E
U
,
 
t
h
u
s
 
g
i
v
i
n
g
 
a
 
d
i
f
f
e
r
e
n
t
 
i
n
t
e
r
p
r
e
t
a
t
i
o
n
 
t
o
 
D
i
r
e
c
t
i
v
e
 
7
9
/
1
1
2
.
 
A
s
 
t
o
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
,
 
b
e
i
n
g
 
t
h
e
 
m
o
s
t
 
r
e
c
e
n
t
 
t
y
p
e
 
o
f
 
c
l
a
i
m
s
 
m
a
d
e
,
 
n
u
m
e
r
o
u
s
 
c
o
d
e
s
 
e
x
i
s
t
.
 
T
h
e
s
e
 
c
o
d
e
s
 
d
o
 
n
o
t
 
s
p
e
c
i
f
i
c
a
l
l
y
 
d
e
a
l
 
w
i
t
h
 
c
l
a
i
m
s
,
 
b
u
t
 
r
a
t
h
e
r
 
s
e
t
-
u
p
 
l
a
b
e
l
l
i
n
g
 
i
n
i
t
i
a
t
i
v
e
s
 
a
n
d
 
s
e
t
 
o
u
t
 
c
e
r
t
a
i
n
 
c
r
i
t
e
r
i
a
 
t
h
a
t
 
h
a
v
e
 
t
o
 
b
e
 
r
e
s
p
e
c
t
e
d
,
 
i
n
 
o
r
d
e
r
 
t
o
 
b
e
 
a
b
l
e
 
t
o
 
u
s
e
 
t
h
e
 
l
o
g
o
/
s
y
m
b
o
l
 
o
f
 
t
h
e
s
e
 
l
a
b
e
l
l
i
n
g
 
i
n
i
t
i
a
t
i
v
e
s
.
 
T
h
e
s
e
 
a
r
e
 
m
o
s
t
l
y
 
f
a
i
r
 
t
r
a
d
e
 
l
a
b
e
l
l
i
n
g
 
i
n
i
t
i
a
t
i
v
e
s
.
 
T
h
e
r
e
 
e
x
i
s
t
 
a
l
s
o
 
a
 
n
u
m
b
e
r
 
o
f
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
o
n
 
a
d
v
e
r
t
i
s
i
n
g
 
i
n
 
g
e
n
e
r
a
l
 
i
n
 
n
e
a
r
l
y
 
a
l
l
 
M
e
m
b
e
r
 
S
t
a
t
e
s
,
 
w
h
i
c
h
 
a
r
e
 
a
i
m
e
d
 
a
t
 
p
r
o
v
i
d
i
n
g
 
a
 
s
o
r
t
 
o
f
 
v
o
l
u
n
t
a
r
y
 
f
r
a
m
e
w
o
r
k
 
t
o
 
k
e
e
p
 
a
d
v
e
r
t
i
s
i
n
g
 
w
i
t
h
i
n
 
a
c
c
e
p
t
e
d
 
m
o
r
a
l
 
a
n
d
 
e
t
h
i
c
a
l
 
b
o
u
n
d
a
r
i
e
s
.
 
I
n
 
t
h
e
 
f
o
l
l
o
w
i
n
g
 
w
e
 
p
r
o
v
i
d
e
 
f
i
r
s
t
 
a
 
t
a
b
l
e
 
o
f
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
t
h
a
t
 
e
x
i
s
t
 
w
i
t
h
 
r
e
g
a
r
d
 
t
o
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
.
 
I
n
 
t
h
e
 
s
e
c
o
n
d
 
t
a
b
l
e
 
w
e
 
p
r
o
v
i
d
e
 
m
o
r
e
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
v
o
l
u
n
t
a
r
y
 
a
g
r
e
e
m
e
n
t
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
I
n
 
t
h
i
s
 
s
e
c
o
n
d
 
t
a
b
l
e
,
 
w
e
 
h
a
v
e
 
a
l
s
o
 
i
n
c
l
u
d
e
d
 
t
h
e
 
o
p
i
n
i
o
n
 
o
f
 
t
h
e
 
F
r
e
n
c
h
 
C
o
n
s
e
i
l
 
N
a
t
i
o
n
a
l
 
d
e
 
!
'
A
d
m
i
n
i
s
t
r
a
t
i
o
n
,
 
w
h
i
c
h
 
h
a
s
 
s
e
t
 
o
u
t
 
s
o
m
e
 
c
r
i
t
e
r
i
a
 
a
s
 
t
o
 
h
o
w
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
s
h
o
u
l
d
 
b
e
 
a
d
d
r
e
s
s
e
d
 
i
n
 
t
h
e
 
f
u
t
u
r
e
.
 
E
u
r
o
p
e
a
n
 
s
t
u
d
y
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
,
 
h
e
a
l
t
h
 
a
n
d
 
e
t
h
i
c
a
l
 
c
l
a
i
m
s
 
-
2
0
0
0
 
7
1
 -
-
2
.
a
)
 
C
o
m
p
a
r
a
t
i
v
e
 
T
a
b
l
e
:
 
V
o
l
u
n
t
a
r
y
 
A
g
r
e
e
m
e
n
t
s
 
C
o
u
n
t
r
y
 
N
u
t
r
i
t
i
o
n
a
l
 
C
l
a
i
m
s
 
H
e
a
l
t
h
 
C
l
a
i
m
s
 
E
t
h
i
c
a
l
 
C
l
a
i
m
s
 
C
o
m
m
e
n
t
s
 
E
U
 
X
 
T
h
e
 
C
I
A
A
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
w
a
s
 
a
d
o
p
t
e
d
 
i
n
 
S
e
p
t
e
m
b
e
r
 
1
9
9
9
,
 
i
t
 
d
e
a
l
s
 
m
a
i
n
l
y
 
w
i
t
h
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
c
l
a
i
m
s
.
 
F
a
i
r
t
r
a
d
e
 
L
a
b
e
l
l
i
n
g
 
O
r
g
a
n
i
z
a
t
i
o
n
s
 
I
n
t
e
r
n
a
t
i
o
n
a
l
 
(
F
L
O
)
 
h
a
s
 
e
s
t
a
b
l
i
s
h
e
d
 
c
r
i
t
e
r
i
a
 
f
o
r
 
a
 
n
u
m
b
e
r
 
o
f
 
p
r
o
d
u
c
t
s
.
 
A
u
s
t
r
i
a
 
X
 
X
 
X
 
B
e
l
g
i
u
m
 
X
 
C
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
n
o
t
 
y
e
t
 
a
d
o
p
t
e
d
.
 
D
e
n
m
a
r
k
 
X
 
F
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
,
 
t
h
e
 
N
u
t
r
i
t
i
o
n
a
l
 
C
o
u
n
c
i
l
,
 
t
h
e
 
R
e
g
i
o
n
a
l
 
F
o
o
d
 
C
o
n
t
r
o
l
 
A
u
t
h
o
r
i
t
y
 
o
f
 
C
o
p
e
n
h
a
g
e
n
 
a
n
d
 
a
 
s
o
-
c
a
l
l
e
d
 
"
H
e
a
l
t
h
y
 
C
i
t
y
-
P
r
o
j
e
c
t
"
 
h
a
v
e
 
d
e
v
e
l
o
p
e
d
 
t
h
e
 
S
-
O
l
a
b
e
l
 
t
o
 
i
n
d
i
c
a
t
e
 
t
h
a
t
 
p
r
o
d
u
c
t
s
 
a
r
e
 
l
o
w
e
r
 
i
n
 
f
a
t
 
a
n
d
 
i
n
 
s
u
g
a
r
.
 
F
i
n
l
a
n
d
 
X
 
G
o
v
e
r
n
m
e
n
t
 
g
u
i
d
e
l
i
n
e
s
 
e
x
i
s
t
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
.
 
F
r
a
n
c
e
 
X
 
X
 
N
o
 
c
o
d
e
 
e
x
i
s
t
s
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
,
 
b
u
t
 
C
o
n
s
e
i
l
 
N
a
t
i
o
n
a
l
 
d
e
 
!
'
A
l
i
m
e
n
t
a
t
i
o
n
 
h
a
s
 
a
d
o
p
t
e
d
 
a
n
 
o
p
i
n
i
o
n
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
 
1
9
9
8
,
 
w
h
i
c
h
 
m
a
y
 
s
e
r
v
e
 
a
s
 
a
 
b
a
s
i
s
 
f
o
r
 
a
 
f
u
t
u
r
e
 
E
U
 
c
o
d
e
.
 
G
e
r
m
a
n
y
 
X
 
X
 
G
r
e
e
c
e
 
X
 
X
 
X
 
I
r
e
l
a
n
d
 
X
 
X
 
T
h
e
 
I
r
i
s
h
 
B
u
s
i
n
e
s
s
 
E
m
p
l
o
y
e
r
s
 
C
o
n
f
e
d
e
r
a
t
i
o
n
 
h
a
s
 
i
n
i
t
i
a
t
e
d
 
t
h
e
 
i
d
e
a
 
o
f
 
a
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
a
l
o
n
g
 
t
h
e
 
l
i
n
e
s
 
o
f
 
t
h
e
 
U
K
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
 
I
n
i
t
i
a
t
i
v
e
.
 
I
t
a
l
y
 
X
 
X
 
X
 
L
u
x
e
m
b
o
u
r
g
 
X
 
X
 
N
e
t
h
e
r
l
a
n
d
s
 
X
 
C
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
i
n
i
t
i
a
t
e
d
 
b
y
 
t
h
e
 
D
u
t
c
h
 
N
u
t
r
i
t
i
o
n
 
C
e
n
t
e
r
 
i
s
 
i
n
 
f
o
r
c
e
 
s
i
n
c
e
 
A
p
r
i
l
 
1
9
9
8
.
 
I
t
 
m
a
i
n
l
y
 
d
e
a
l
s
 
w
i
t
h
 
t
h
e
 
s
u
b
s
t
a
n
t
i
a
t
i
o
n
 
o
f
 
c
l
a
i
m
s
.
 
P
o
r
t
u
g
a
l
 
X
 
X
 
X
 
T
h
e
 
P
o
r
t
u
g
u
e
s
e
 
f
o
o
d
 
i
n
d
u
s
t
r
y
 
h
a
s
 
h
a
d
 
f
i
r
s
t
 
c
o
n
t
a
c
t
s
 
w
i
t
h
 
t
h
e
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
 
o
n
 
a
 
p
o
s
s
i
b
l
e
 
c
o
d
e
 
o
f
 
c
o
n
d
u
c
t
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
.
 
S
p
a
i
n
 
X
 
X
 
T
h
e
 
S
p
a
n
i
s
h
 
v
o
l
u
n
t
a
r
y
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
w
a
s
 
s
i
g
n
e
d
 
i
n
 
M
a
r
c
h
 
1
9
9
8
.
 
S
w
e
d
e
n
 
X
 
T
h
e
 
S
w
e
d
i
s
h
 
c
o
d
e
 
o
n
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
h
a
s
 
b
e
e
n
 
i
n
 
f
o
r
c
e
 
s
i
n
c
e
 
1
9
9
0
.
 
U
K
 
T
h
e
 
F
o
o
d
 
A
d
v
i
s
o
r
y
 
C
o
m
m
i
t
t
e
e
 
h
a
s
 
s
e
t
 
u
p
 
g
u
i
d
e
l
i
n
e
s
 
o
n
 
n
u
t
r
i
t
i
o
n
a
l
 
c
l
a
i
m
s
.
 
T
h
e
 
c
o
d
e
 
o
f
 
t
h
e
 
J
o
i
n
t
 
H
e
a
l
t
h
 
C
l
a
i
m
 
I
n
i
t
i
a
t
i
v
e
 
h
a
s
 
b
e
e
n
 
f
i
n
a
l
i
s
e
d
,
 
b
u
t
 
t
h
e
 
c
o
d
e
 
a
d
m
i
n
i
s
t
r
a
t
i
o
n
 
b
o
d
y
 
h
a
s
 
s
t
i
l
l
 
t
o
 
b
e
 
s
e
t
 
u
p
.
 
T
h
e
 
C
o
-
o
p
e
r
a
t
i
v
e
 
W
h
o
l
e
s
a
l
e
 
S
o
c
i
e
t
y
 
h
a
s
 
s
e
t
-
u
p
 
i
n
 
1
9
9
7
 
i
t
s
 
g
u
i
d
e
l
i
n
e
s
 
f
o
r
 
n
u
t
r
i
t
i
o
n
a
l
 
a
n
d
 
h
e
a
l
t
h
 
c
l
a
i
m
s
 
f
o
r
 
l
a
b
e
l
l
i
n
g
 
o
f
 
i
t
s
 
o
w
n
 
p
r
o
d
u
c
t
s
.
 
T
o
t
a
l
 
3
/
1
5
 
5
/
1
5
 
1
0
1
1
5
 
U
n
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3.  Recommendations 
Three recommendations can be extracted from  the voluntary agreements  in place. 
Firstly,  there  is  a  need to  define  claims,  as  well  as  health  claims.  All  voluntary 
agreements on health claims include a definition of health claims. The question of 
definitions has already been developed further in the above section on Definitions, 
Legislation, Policy Developments and Stakeholder Positions. 
Secondly,  there  seems  to  be a  need to  introduce  a  provision  into  the  Misleading 
Advertising Directive requiring Member States to introduce effective and dissuasive 
sanctions  against  the  use  of misleading  claims,  as  only  few  of the  voluntary 
agreements set out a sanction instrumentarium. This point is developed further below 
(see section Applicable Penalties). 
Thirdly,  all  voluntary  agreements  set  out  certain  criteria  for  substantiation.  In 
particular, the voluntary agreements on health claims list a long number of criteria. 
Whilst these criteria are evidently focusing very much on food related health claims, 
some general criteria can be extrapolated. As mentioned in the section on Burden of 
Proof, an option for reversing the burden of proof, would be to make the reversal of 
the burden of  proof dependant as to whether the producer has fulfilled certain criteria 
set out in  an amended Directive on Misleading Advertising. These criteria could be 
added to the Misleading Advertising Directive in the form of  an annex. 
In  the  following  we  list a  number of criteria,  which we have  extracted from  the 
voluntary agreements: 
Claims must be: 
•  True and not misleading; 
•  Clear and understandable; 
•  Complete (indicate for  example for health claims on food the dosage required, 
the effect over time etc.); 
•  Precise  and  not  using  extrapolations/generalisations  (eventually  claims  using 
words such as "implies", "suggests'' etc. should be considered misleading); 
•  Objective  (e.g.  not  evoke  fears,  or if testimonials  are  used  must  provide  an 
objective image of  the effects that a product claims to have); 
•  Substantiated, verifiable and documented; 
•  Supported by scientific evidence if the claim is based on the composition/quality 
of  the product (see also chapter on Substantiation Needed for Claims); 
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1.  Comment 
In  all  Member  States  fines  and/or  imprisonment  is  foreseen  for  misleading 
advertising and/or non-respect of  food labelling rules. Nevertheless, in some Member 
States the  penalties/fines seem to  be  less  stringent than in others.  The  Misleading 
Advertising Directive only foresees that Member States set up a system which allows 
for the cessation of  the misleading advertising. 
2.  Recommendations 
As mentioned in  the previous chapter, one option could be to  introduce a provision 
into  the  Misleading  Advertising  Directive,  requiring  Member  States  to  introduce 
effective and dissuasive sanctions against the use of misleading claims. This would 
guarantee the same level of consumer protection in all Member States with regard to 
the sanctioning of  misleading claims. 
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1.  Comment 
In a number of Member States, case law on claims could be identified. Most case law 
relates to health claims. With regard to ethical claims only one case in Germany could 
be identified. 
In general, even in Member States were some case law on health claims exists, this is 
limited to a few cases. The reason for this seems to be threefold: 
1.  There seems to  be in many Member States a tradition of resolving disputes 
outside the courts on an informal basis. In particular, countries which rely heavily on 
self-regulation (e.g. the UK), disputes tend to be resolved outside the legal system. 
2.  In  some  countries  there  seems  to  be  a  problem  for  consumer  associations 
and/or local authorities to  bring cases before the courts.  This is  due to  a number of 
reasons but the most important appears to  be  cost and the difficulties in securing a 
judgement as  a result of the burden of proof being on  the plaintiff to  show that the 
claim is not justified. 
3.  In countries with a strict legislation and interpretation of health claims by the 
authorities, producers tend to  clarify with the  enforcement authorities beforehand in 
an informal way, in how far there may be objections by the authorities on the use of a 
certain claim. 
Although it is difficult to  draw general conclusions from the limited number of case 
law  that  exists,  it  seems  that  courts  tend  in  general  to  adopt  a  rather  strict 
interpretation of health claims. The Member State with the greatest number of case 
law seems  to  be  Germany.  The cases that have been judged by German courts  on 
health claims are for two reasons highly interesting. 
Firstly, with regard to the arguments used by German courts against allowing the use 
of disease  related claims.  The courts argue that disease related claims  in whatever 
form are not allowed, in order: 
•  to avoid the danger of  self-medication; and 
•  to avoid that consumers might believe that foodstuffs could have the same effects 
as medicines. 
Secondly,  the  interpretation of the interdiction to  make reference to  the  prevention, 
treatment or curing of disease.  German courts consider any indirect reference to  the 
prevention  or  curing  of a  disease  a  disease  related  claim,  which  is,  therefore, 
forbidden, i.e. a paraphrase of  an illness or description of symptoms which can clearly 
be associated with a certain disease, are considered unlawful. 
The European Court of Justice (ECJ) has ruled on a number of cases, which concern 
the classification of medicines.  It is  in this context that the Court has  also looked at 
health  claims.  The  n1lings  indicate  that  the  ECJ  gives  a  broad  interpretation  to 
Directive  65/65  on  medicinal  products,  i.e.  a  product  recommended  as  having 
European study on nutritional, health and ethical claims - 2000  77 prophylactic or therapeutic  properties is  a medicinal product, even if it  is  generally 
regarded as a foodstuff. 
The argumentation used for such a wide interpretation of Directive 65/65 is similar to 
the one  used by German courts,  i.e.  in  order to  preserve consumers  from  products 
used instead of  the proper remedies. 
In a more recent case, the ECJ seems to consider that a control system for claims as 
foreseen  under  the  Misleading  Advertising  Directive  (i.e.  that  courts  and 
administrations can ask advertisers to  furnish evidence as  to  the accuracy of factual 
claims, taking into  account the legitimate interest of the parties involved) is  a viable 
way of  controlling claims. 
Although,  due  to  the  limited  amount  of case  law,  it  is  difficult  to  draw  general 
conclusions,  it  seems  that consumer associations  or  competitors  bring cases  to  the 
courts and to a lesser degree to the surveillance authorities. 
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 3.  Recommendations 
As  mentioned above  in  a  number of Member States  disputes  are  often being resolved in an 
informal way outside the courts. In order to  make such a system work in  all Member States, it 
may  be  considered  necessary  to  introduce  a  system  as  foreseen  under  Directive  98/27  on 
Injunctions for the Protection of Consumers' Interests. This Directive foresees that the party that 
intends to seek an injunction can only start this procedure if it has tried to  achieve the cessation 
of the infringement in  consultation with either the defendant or with both the defendant and a 
qualified entity (i.e.  public bodies and  organisations  whose purpose it is  to  protect collective 
interests of  consumers). 
Access of consumers and even of local enforcement authorities to  the courts seems to constitute 
a problem, because of the difficulties in securing a judgement as a result of the burden of proof 
being on the plaintiff. It should, therefore, be considered in how far the burden of  proof could be 
reversed, so that it  is the maker of the claim who has to provide the proof (see for further details 
section on Burden of  Proof). 
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I K.  DIFFERENCES BETWEEN MEANS OF COMMUNICATION 
1.  Comment 
Claims can be made through different means of communication. The most common means are 
the  label  of the  product and  advertising.  The  countries  studied do  not differentiate  between 
legislation applicable to labelling and legislation applicable to advertising. In addition to national 
legislation,  self-regulatory  rules  apply  to  advertising  in  certain  instances,  whereas  no  such 
schemes exist for labelling. This, however, does not reflect a difference between the means of 
communication, since national legislation remains applicable to both labelling and advertising. 
Advertising includes a variety of means of  communication, such as radio, television, print media 
and the Internet. Neither the EU countries, nor the United States and Canada make a difference 
between the standards that apply to the various advertising media. 
On many occasions, the internet has been described as a potential source of problems because of 
the quasi-impossibility to monitor the claims made on the web, as well as the difficulty to control 
electronic commerce of products bearing prohibited claims.  However, policy thinking on  this 
issue is still at a very early stage and no country has taken measures that would apply specifically 
to the Internet. 
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3.  Recommendations 
All national legislations are based on the principle that a uniform set of rules should 
apply, whatever the  means of communication used. We,  therefore, recommend that 
no  difference  be  made  between  labelling  and  advertising,  on  the  one  hand,  and 
between the various advertising media, on the other. 
In this respect, the scope of the Directive on Misleading Advertising (84/450/EEC) 
should  be  clarified,  as  it  is  unclear whether  its  provisions  apply  to  all  means  of 
communication and,  in  particular, claims made on labelling (on-pack claims).  We, 
therefore,  recommend that  the  Directive be amended so  that it  clearly applies not 
only to advertising but also to labelling. 
This could for example be done by introducing a provision, which would state that 
the  non-respect of labelling legislation shall be  considered misleading advertising. 
This would also be in  line with the  fact  that on a national level,  often misleading 
claims  are judged by the  courts  on  the  basis  of the  national  rules  on  misleading 
advertising/unfair competition. 
Pan- European study on nutritional, health and ethical claims- 1999.  83 IV. COUNTRY SECTIONS 
Pan- European study on nutritional, health and ethical claims- 1999.  84 A.  EUROPEAN UNION LEVEL 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
The study was well received by all interested parties at EU level, i.e  .. , Brussels-based 
organisations.  Those  who  participated  were  extremely  interested  in  the  study  and 
asked to receive a summary of  the study. 
B.  POSITION OF KEY PLAYERS 
1.  Nutritional Claims 
The definition of a nutrition claim in EU law is  very similar to  the one used in the 
Codex Guidelines for Use of Nutrition Claims. The European Consumer Association 
(BEUC) felt that nutrient content claims should be regulated by clear definitions. The 
Confederation of the Food and Drink Industries of the EU (CIAA) was  in favour of 
introducing  the  work  that  had  been  undertaken  in  the  Codex  Alimentarius  on 
nutritional claims into the Nutrition Labelling Directive via an annex. 
2.  Health Claims 
A number of EU Directives prohibit claiming that a foodstuff may help  to  prevent, 
treat  or cure  a  human  disease.  The  same  prohibition  is  contained  in  the  Codex 
Alimentarius  General  Guidelines  on  Claims.  Nevertheless,  the  Codex  recently 
proposed draft recommendations for the use of  health claims, which defined enhanced 
function claims and reduction of  disease risk claims. According to this definition, 'risk 
reduction' is considered not to constitute 'prevention' 
The European Parliament stated in its  Resolution on the Commission's Green Paper 
on  the  General  Principles  of Food  Law  of March  1998  that  "claims  regarding 
nutritional value and healthy diet and their importance to health and/or in reducing the 
risk of  disease should be allowed". 
BEUC considered that it was necessary to  work on health claims at EU  level, due to 
the increasing importance of functional foods and due to the fact that several Member 
States already had voluntary codes in place. BEUC is in favour of strict legislation on 
health claims. 
The association of European Consumer Cooperatives (Eurocoop) also indicated that 
legislation on health claims was needed at EU  level, due to  the increasing number of 
health claims used, particularly on functional foods. 
The CIAA considers that there are increasing benefits of highlighting the relationship 
between nutrition and health in order to reverse the increasing rise in diet-related non-
communicable diseases. CIAA considers that the current regulatory framework needs 
to  be  adapted,  in  particular Labelling Directive  79/112,  so  as  to  allow  disease  risk 
reduction claims. 
Pan- European study on nutritional, health and ethical claims- 1999.  85 The  European Health Product Manufacturers'  Association (EHPM)  also  considered 
that  there  was  a  need  to  clarify  Directive  791112.  The  European  Food  Law 
Association  indicated  that  disease  risk  reduction  claims  should  be  allowed  via  an 
amendment of Directive 79/112 and Directive 65/65. 
The European Retailer Association (Eurocommerce) felt  that if new legislation was 
considered on health claims, it should soften the currently rather strict legislation. 
The European Commission Concerted Action on Functional Food Science in Europe 
(co-ordinated  by  the  International  Life  Sciences  Institute  (ILSI))  supports  in  its 
consensus document the development of enhanced function claims and reduction of 
disease-risk claims. 
3.  Ethical Claims 
There  exists  no  EU  legislation on  ethical  claims.  The  European Commission (DG 
VIII) is currently finalising a Communication on Fair Trade, which aims to provide an 
overview of the current activities of the various Commission services in the field of 
fair trade. No legislative proposals are envisaged at this stage. 
Eurocommerce was of the opinion that no  legislation on ethical claims was  needed 
since a large number of manufacturers were not using ethical claims.  Their reluctance 
was, indeed, due to  the very fact that it was often impossible to  ensure the complete 
veracity of  the ethical claims. Furthermore, Eurocommerce felt that since NGOs, trade 
unions and the press were all very active on ethical issues, the market could regulate 
false ethical claims itself. 
BEUC mentioned that, until now, it has not been asked by its members to  look into 
this issue. 
The European Parliament adopted, in January 1999, a Resolution on EU Standards for 
European Enterprises Operating in Developing Countries.  In this Resolution, it calls 
for  the  creation of a  'Social  Label'  together with a Code of Conduct for  European 
businesses that should comprise existing minimum applicable international standards. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional and Health Claims 
There is currently no code of practice at EU level on nutritional claims. In July 1999, 
the CIAA finalised a code of  practice on the use of  health claims. The purpose of this 
code  is  to  help  companies  to  prepare  the  documentation  necessary  for  the 
substantiation of health claims, in order to avoid inequalities between Member States. 
The CIAA aims at getting its code recognised by the European Commission in  one 
form or the other (e.g. via the Standing Committee for Food). 
Eurocoop stressed that it considered voluntary codes problematic in  terms of control 
and sanctions. On the contrary, the European Advertising Standards Alliance (EASA) 
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by governments) was the best way of  regulating claims and other advertising. 
2.  Ethical Claims 
Currently, there exists no  EU  wide voluntary agreement on ethical claims. While in 
the  textile  and  retail  sector  codes  have  been  adopted,  which  condemn  child 
labour/forced labour and ask member companies to  take measures to  eradicate child 
labour, these codes make no reference to labelling/ethical claims. 
The  Fairtrade  Labelling  Organizations  International  (FLO),  founded  to  co-ordinate 
national  fair  trade  labelling  initiatives,  has  established  criteria  for  a  number  of 
commodities, which if fulfilled  allow the  use  of fair  trade marks.  These  fair  trade 
marks do not in general contain any ethical claims as such. Nevertheless, they may be 
associated by consumers with certain ethical standards. FLO is  currently working on 
the development of  a single international fair trade label. 
D.  VERIFICATION SYSTEMS 
With regard to  the substantiation of claims, the Nutrition Labelling Directive makes 
nutrition labelling compulsory whenever a nutritional claim is made. The Directive on 
Foodstuffs  for  Particular  Nutritional  Uses  establishes  a  notification  system.  The 
primary purpose of this  notification system  is  not  to  verify the  claim but rather to 
ensure  that  the  food  in  question  is  distinguishable  from  foodstuffs  for  normal 
consumption  and  is  suitable  for  the  claim  nutritional  purpose.  However,  several 
national  administrations have  indicated that they also  verify the  claim being made. 
Under the  Directive,  companies have to  submit a model of the label  used and may 
also be asked to produce scientific work and data. 
The European Parliament stated in  its Resolution on the Commission's Green Paper 
on  the  General  Principles  of Food  Law  of March  1998  that  claims  relating  the 
importance  of diet  to  health  and  reduction  of disease  risk  should  be  based  on 
sufficient  and  recognized  scientific  findings  and  be  tested  and  confirmed  by  an 
independent body within the EU. 
The CIAA code of practice provides for a number of  criteria for substantiating health 
claims.  Most  importantly,  any  health  claim  has  to  be  based  on  sound  scientific 
evidence  and  the  effect  must  be  quantitatively,  statistically  and  biologically 
significant. The code lists in further detail these criteria. 
As  to  the  burden  of proof,  the  Misleading  Advertising  Directive  addresses  the 
question of burden of proof at the level of courts and administrations.  At this level, 
advertisers have to furnish evidence as to the accuracy of  factual claims. Nevertheless, 
this is  conditioned by the fact that courts or administrative authorities shall take into 
account the legitimate interests of the parties involved. Whilst the CIAA felt that the 
burden of proof was not something that should be regulated by the EU, it  indicated 
that producers would in any case always have to have all materials available to justify 
the  claim made.  Eurocommerce  and  the  European  Food  Law  Association  were  in 
favour of putting the burden of proof on the  maker of the claim.  EHPM considered 
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medium sized enterprises. 
E.  MEANS OF COMMUNICATION 
In  terms  of means of communication,  the wording used in the  Nutrition Labelling 
Directive,  the  Foodstuff  Labelling  Directive,  the  Directive  on  Foodstuffs  for 
Particular Nutritional Uses and the Misleading Advertising Directive suggest that they 
apply to all means of  communication. 
F.  CONSUMER PROTECTION 
As far as nutritional claims and consumer protection are concerned, BEUC mentioned 
that  in  order to  avoid  confusion  amongst  consumers,  clear definitions  for  nutrient 
content  claims  should  be  introduced.  Overall,  it  seems  that  there  are  no  major 
consumer protection problems regarding nutritional claims. 
With regard to health claims, BEUC felt that a particular problem with health claims 
was its  substantiation. Eurocoop considered it particularly problematic where health 
claims were used on foods,  which from a nutritional point of view, were not highly 
recommended.  (This  is  sometimes  also  referred  to  as  food  products  with  a 
disqualifying composition.) Eurocommerce acknowledged that some claims that were 
currently used might be misleading.  However, this could not be tackled by drafting 
new  legislation,  but  rather  by  ensuring  that  products  conformed  to  the  existing 
legislation. 
As to the question of consumer protection and pre-clearance, Eurocoop indicated that 
it was in favour of  pre-clearance. BEUC has not yet finalised its position on this point, 
but felt at this stage that a pre-clearance procedure may be desirable in order to avoid 
misleading claims. 
The CIAA indicated that it was against pre-clearance systems, as: 
•  these would delay the placing on the market of a product, which was crucial 
for the food industry since it was a fast moving market; 
•  it was not possible to copyright final food product and/or the claim made; and 
•  industry was worried that confidentiality was not ensured during an a priori 
approval procedure. 
G.  BARRIERS TO TRADE 
The CIAA indicated that there existed clear barriers to trade since it was not possible 
to use the same claim in all EU Member States. The CIAA acknowledged that only a 
few cases had been considered by the European Court of Justice.  This was because 
industry preferred to adapt their label and then to go to court. The CIAA stressed that 
since the right for information was not the same in all Member States, this was against 
the  Single Market principle.  EHPM also  felt  that there  were major impediments to 
enter different markets in terms of how to  get a message across and which claims are 
actually acceptable. 
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trade or lack of  consumer protection with regard to ethical claims. 
H.  CASELAW 
There exist only a few  cases at the European Court of  Justice (ECJ) level that directly 
deal with health claims. The few that have come to the Court indicate that the ECJ  is 
in favour of a wide interpretation of Directive 65/65 on Medicinal Products, in order 
to  protect the consumer against products used instead of adequate remedies.  On the 
other hand, the ECJ cases seem to  indicate that the Court considers a control system 
for claims as foreseen under the Misleading Advertising Directive (i.e. that courts and 
administrations can ask advertisers to  furnish evidence as  to  the accuracy of factual 
claims, taking into account the legitimate interest of the parties involved) as  a viable 
way of  controlling claims. The ECJ cases do not provide much information regarding 
barriers to trade. 
I.  STAKEHOLDER ANALYSIS 
In  general,  all  interested parties  seem to  agree that there  is  a need to  look into  the 
issue of health claims. Many consider that an amendment to Directive 79/112 was the 
way forward. Ethical claims are not considered to be a problem so far. 
In conclusion, the positions of  the main stakeholders are: 
1.  The European Parliament/Scientific Community 
•  The recent Resolution of the  European Parliament on the Green Paper on  Food 
Law indicates that it is in favour of allowing disease risk reduction claims.  These 
should be based on sufficient and recognized scientific findings and be tested and 
confirmed by an independent body within the EU. 
•  The  European  Commission  Concerted  Action  on  Functional  Food  Science  in 
Europe supports in its consensus document the development of enhanced function 
claims and reduction of disease-risk claims. 
•  Both the Concerted Action on Functional Food Science, as well as the Forum on 
Functional Food of the Council of Europe concluded that claims had to be based 
on sound scientific evidence. 
2.  Consumers 
•  Consumers consider it necessary for the EU to work on the issue of health claims. 
Consumers are of  the opinion that strict conditions should apply for health claims. 
Eurocoop is  clearly in favour of pre-clearance. BEUC has not yet established its 
position on this point. Consumers want the burden of proof to be with the maker 
of the claim. 
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•  With regard to  health claims, Industry considers it necessary to  amend Directive 
791112.  Industry is  strongly against pre-clearance.  With regard to  the  burden of 
proof, there is no unanimous view. 
•  On ethical claims, overall opinion is  that no legislation is  needed. The European 
Parliament  argued  in  its  recent  Resolution  on  EU  Standards  for  European 
Enterprises Operating in Developing Countries for the creation of a 'Social Label' 
together with a Code of Conduct for European businesses. This should comprise 
existing minimum applicable international standards. 
* * * 
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II.  POLICY 
A.  DEFINITION OF CLAIMS 
1.  Nutritional Claims 
Directive 90/496 on the  Nutrition Labelling for Foodstuffs (see Annex  1)  defines a 
nutritional claim in article 1, para. 4 (b) as: 
"any representation and  any advertising messages which states,  suggests or implies 
that a foodstuff has particular nutrition properties due to the energy (calorific value) it 
provides 
provides at a reduced or increased rate or 
does not provide, 
and/or due to the nutrients it 
contains 
contains in reduced or increased proportions or 
does not contain. 
A reference to qualities or quantities of a nutrient does not constitute a nutrition claim 
in so far as it is required by legislation". 
The Codex Guidelines for Use of Nutrition Claims contain a similar definition to the 
one used under EU law. It states: 
"Nutrition claim means  any representation which states,  suggests  or implies  that  a 
food has particular nutritional properties including but not limited to the energy value 
and to the content of  protein, fat and carbohydrates, as well as the content of vitamins 
and minerals" (article 2.1, CAC/GL 23-1997, see Annex 13). 
The Codex Guidelines further distinguish between nutrient content claims (a nutrition 
claim that describes the level of a nutrient contained in a food), comparative claims (a 
claim that compares the nutrient levels and/or energy value of two  or more foods), 
nutrient function claims (a nutrition claim that describes the physiological role of the 
nutrient in growth, development and normal functions of  the body). and claims related 
to dietary guidelines or healthy diets (articles 2.1.1 following, CAC/GL 23/1997). 
2.  Health Claims 
Directive 791112  on  Labelling, Presentation and Advertising of Foodstuffs does not 
contain a definition of health claims, but establishes a prohibition for certain types of 
health-related  claims.  The definition  given  in  article  2 para.  1 (b)  is  the  following 
(please note we are using here the codified version as published in COM ( 1999)  113 
final, see Annex 3): 
"1. The labelling and methods used must not: 
[ ...  ] 
(b)  subject  to  Community  provisions  applicable  to  natural  mineral  waters  and 
foodstuffs  for  particular nutritional  uses,  attribute  to  any  foodstuff the  property of 
preventing, treating or curing a human disease, or refer to such properties." 
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intended for Particular Nutritional Uses (see Annex 7): 
"The labelling and the labelling methods used, the presentation and advertising of the 
products  referred  to  in  Article  1 must not  attribute  properties  for  the  prevention, 
treatment or cure of  human disease to such products or imply such properties". 
Directive 80/777 on the Exploitation and Marketing of Natural Mineral Waters (see 
Annex 8) also contains a similar provision in article 9 para. 2 (a): 
"All  indications  attributing  to  a  natural  mineral  water  properties  relating  to  the 
prevention, treatment or cure of  a human illness shall be prohibited". 
Directive 65/65 on Proprietary Medicinal Products (Annex 6) uses a similar wording, 
to define medicinal products. It states (article 1 (2)): 
"Medicinal  product:  Any  substance  or  combination  of substances  presented  for 
treating or preventing disease in human beings or animals". 
The fact that this is used as one of  the criteria to define a medicinal product has led to 
a number of court cases regarding the classification of  a product as a foodstuff or as a 
medicine (see section V.A)). 
The  Misleading  Advertising  Directive  84/450  (Annex  4)  does  not  contain  any 
definition of claims.  Nevertheless,  the question  remains whether the  definition  for 
advertising as used in the Misleading Advertising Directive also covers 'claims'. The 
definition used is  "the making of a representation in any form in  connection with a 
trade, business, craft or profession in order to promote the supply of goods or services 
[ ...  ]"  (article  2  (1)).  We  shall  discuss  this  point  further  in  the  section  on 
Recommendations. 
The General Guidelines on Claims of the Codex Alimentarius define claims as  "any 
representation  which  states,  suggests  or  implies  that  a  food  has  particular 
characteristics  relating  to  its  origin,  nutritional  properties,  nature,  production, 
processing, composition or any other quality"  (article 2.,  CAC/GL  1-1979 (Rev.  1-
1991 ), see Annex 12). 
The same Guidelines prohibit claims "as to the suitability of a food  for use  in the 
prevention,  alleviation,  treatment  or  cure  of  a  disease,  disorder  or  particular 
physiological condition[  ...  ]" (article 3.4.). 
The latest proposed draft recommendations for the use of health claims of the Codex 
Alimentarius (Alinorm 99/22A Appendix VII, see Annex 14) establish the following 
definition for health claims: 
"Health claim means any claim establishing a relation between a food or a constituent 
of that food and health, [whether it is good health or a condition related to  health [or 
disease]]. 
or 
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has an impact on health." 
The Codex draft recommendations further defines two types of  health claims: 
•  Enhanced function claims 
•  Reduction of  disease risk claims 
Enhanced function claims are defined in the following way: 
"These claims concern specific  beneficial effects of the  consumption of foods  and 
their  constituents  on  physiological,  [or  psychological]  functions  or  biological 
activities but do not include nutrient function claims. Such claims relate to a positive 
contribution to  health or to  a condition linked to  health or to  the improvement of a 
function or to modifying or preserving health." 
Reduction of disease risk claims are defined in the following way: 
"Claims for  reduction of disease  risk  related to  the  consumption of a  food  or food 
constituent in the context of the total daily diet that might help reduce the risk of a 
specific disease or condition". 
It  is  interesting to  note  that  the  recommendations  clearly state  that  risk  reduction 
"means significantly altering a major risk factor or factors recognized to  be involved 
in the development of a chronic disease or adverse health-related condition" but does 
not constitute "prevention". 
Enhanced  function  claims  as  defined  by the  Codex  recommendations  seem  to  be 
possible under Labelling Directive 79/112. However, disease risk reduction claims as 
defined  by  the  Codex  recommendations  seem  to  go  further  than  the  relevant 
provisions in Labelling Directive 79/112 (Annex 2). 
3.  Ethical Claims 
EU legislation does not provide for any definition of  ethical claims. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Nutritional  claims  are  regulated  by  Directive  90/496  on  Nutrition  Labelling  for 
Foodstuffs (Annex 1  ). 
2.  Health Claims 
Health  claims  are  regulated  by  Directive  79/112  on  Labelling,  Presentation  and 
Advertising of Foodstuffs (Annex 2), whereby the relevant article 2 was last amended 
by Directive 89/395 (Annex 3). 
Health  claims  are  also  regulated  by Directive  89/398  on  Foodstuffs  intended  for 
Particular Nutritional Uses (Annex 7). 
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on Television Broadcasting Activities (Annex 9). 
In addition, health claims on mineral waters are regulated by Directive 801777 on the 
Exploitation and Marketing of  Natural Mineral Waters (Annex 8). 
Finally,  misleading  advertising  is  covered  by  Directive  84/450  on  Misleading 
Advertising (Annex 4). 
3.  Ethical Claims 
There exists no specific EU legislation on ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
a.  Prohibitions/ Restrictions 
Under the Nutrition Labelling Directive 90/496 (Annex  1  ), only nutrition claims are 
permitted, which relate to energy and/or to protein, carbohydrate, fat,  fibre,  sodium, 
vitamins and minerals (article 3).  Vitamin and mineral  claims are  limited to  those 
defined in the Annex of  that Directive and if  these are present in a significant amount. 
A  significant  amount  is  defined  as  15°/o  of the  RDA  (see  Annex  to  Directive  in 
conjunction with article 1, para 4. (a)). 
A  number of conditions have been set out under the Codex Guidelines for  Use of 
Nutrition  Claims  (Annex  13)  for  the  use  of nutrient  content  claims,  comparative 
claims, nutrient function claims and claims related to dietary guidelines. In general, 
only nutrition claims relating to energy, protein, carbohydrate, fat, fibre, sodium and 
vitamins and minerals for which nutrient reference values have been established are 
permitted.  In particular,  for nutrient content claims, with regard to  fat,  cholesterol, 
sugars  and  sodium  certain  limit  values  have  been  established  (see  article  4.-8., 
CAC/GL 23-1997). 
Furthermore, the General Guidelines  on Claims (Annex  12)  establish a  number of 
further restrictions, e.g.  claims stating that any given food will provide an adequate 
source of all essential nutrients are forbidden (see in particular article 3., CAC/GL 1-
1979 (Rev. 1-1991). 
b.  Exemptions 
The Nutrition Labelling Directive (Annex  1) foresees that within the meaning of its 
article 3, provisions restricting or prohibiting nutrition claims may be adopted by the 
Standing Committee for Foodstuffs. Such restrictions or prohibitions have so far not 
been proposed. 
Directive 801777 on Natural Mineral Waters (see Annex 8) establishes in Annex III a 
number of criteria for  the  use of claims such as  "low mineral  content",  "very low 
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mineral content", "suitable for a low-sodium diet" etc. The criteria used are based on 
certain threshold limits for these minerals. 
Similarly, such nutritional claims may be allowed if they are  based on criteria laid 
down in  national provisions. These national provisions have  been drawn up  on the 
basis  of  physico-chemical  analysis  and,  where  necessary,  pharmacological, 
physiological and clinical examinations (Article 9 para. 2 (b)). 
2.  Health Claims 
a.  Prohibitions/Restrictions 
Apart from the prohibition on certain health-related claims (see ll.A.2.), the Labelling 
Directive  provides  for  a  prohibition of misleading  claims.  This  is  defined  in  the 
following way in article 2 para 1: 
"1. The labelling and methods used must not: 
a)  be such as could mislead the purchaser to a material degree, particularly: 
(i)  as  to  the  characteristics of the  foodstuff and,  in  particular,  as  to  its  nature, 
identity,  properties,  composition,  quantity,  durability,  origin  or provenance, 
method of  manufacture or production, 
(ii)  by attributing to the foodstuff effects or properties which it does not possess, 
(iii)  by suggesting that the foodstuff possesses special characteristics when in fact 
all similar foodstuffs possess such characteristics;" 
The Labelling Directive also foresees in article 2 para. 2 that the Council (under co-
decision procedure) shall draw up a non-exhaustive list of the misleading claims that 
must be prohibited or restricted. Such a list has not been drawn up to date. 
Directive 76/768 on Cosmetic Products (as amended by Council Directive 88/667 and 
93/35, see Annex 31) uses a slightly different wording for misleading claims. Article 
6(3) states: 
"Member States  shall  take  all  measures  necessary to  ensure  that,  in  the  labelling, 
putting up  for  sale  and  advertising of cosmetic products,  text,  names,  trade marks, 
pictures and figurative or other signs are not used to  imply that these products have 
characteristics which they do not have". 
Directive 84/450 on Misleading Advertising (Annex 4) contains a number of criteria 
for determining misleading advertising.  It is  interesting to  compare these to  the ban 
on misleading claims  as  set  out under the  Labelling  Directive.  In  article  3(a),  the 
following criteria for determining misleading advertising are listed in the Misleading 
Advertising Directive: 
"the characteristics of goods or services, such as their availability, nature, execution, 
composition, method and date of manufacture or provision, fitness for purpose, uses, 
quantity,  specification,  geographical  or  commercial  origin  or  the  results  to  be 
expected from  their use, or the results and material features of tests or checks carried 
out on the goods or services;" 
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Television Broadcasting Activities (Annex 9).  In  article  15, restrictions on television 
advertising  and  teleshopping  (  teleshopping  has  been  added  through  article  1  7  of 
Directive 97/36 amending Directive 89/552, see Annex 1  0) of  alcoholic beverages are 
laid down: 
(b) it shall not link the consumption of alcohol to  enhanced physical performance or 
to driving; 
(c)  it  shall  not  create  the  impression  that  the  consumption  of alcohol  contributes 
towards social or sexual success; 
(d) it shall not claim that alcohol has therapeutic qualities or that it is  a stimulant, a 
sedative or a means of resolving personal conflict 
(e) it shall not encourage immoderate consumption of  alcohol or present abstinence or 
moderation in a negative light;" 
The Codex General Guidelines on Claims (Annex 12) are based on the principle that 
no  "food should be described or presented in  a manner that is  false,  misleading or 
deceptive or is  likely to create an erroneous impression regarding its character in any 
respect"  (article  1.2.,  CAC/GL  1-1979  (Rev.  1-1991)).  Furthermore,  the  same 
guidelines  prohibit  the  use  of claims,  which  cannot  be  substantiated,  as  well  as 
potentially misleading claims. The guidelines give examples of meaningless claims. 
These  include  incomplete  comparatives  and  superlatives  and  claims  as  to  good 
hygienic practice, such as wholesome, healthful, sound (article 3.3.  and 4., CAC/GL 
1-1979 (Rev. 1-1991)). 
b.  Exemptions 
The  Directive on  Foodstuffs  for  Particular Nutritional  Uses  (Annex  7)  provides  in 
article  6  for  an  exception  to  the  general  ban  on  claims  making  reference  to  the 
prevention,  treatment  or  cure  of human  diseases.  It  is  stated  that  the  Standing 
Committee for Foodstuffs may adopt derogations in  "exceptional and clearly defined 
cases". Such derogations have so far not been adopted by the Standing Committee for 
Foodstuffs. 
The  Directive  on  Natural  Mineral  Waters  (Annex  8)  provides  for  a  number  of 
exemptions to  the general interdiction of claims making reference to  the prevention, 
treatment or cure of human diseases. 
Member  States  may  thus  authorize:  "the  indications  'stimulates  digestion',  'may 
facilitate the hepato-biliary functions' or similar indications." (Article 9 para. 2 (c)) 
Under the  same Directive, Member States may also authorize the inclusion of other 
indications, provided that these do a) not conflict with the principle that attributions to 
the prevention, treatment or cure of  a human illness is forbidden and b) are compatible 
with the criteria listed in Annex III of  the Directive or national criteria. 
The  Codex Alimentarius General  Guidelines on Claims (Annex  12)  provide for  an 
exception with regard to claims on the prevention and treatment or cure of diseases in 
two  cases.  Firstly,  the  Codex  Committee on Foods  for  Special  Dietary  Uses  may 
approve guidelines for claims made on foodstuffs for special dietary uses.  Secondly, 
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under the laws of  a country (article 3.4 CAC/GL 1-1979 (Rev. 1-1991). 
3.  Ethical Claims 
There exists no specific EU legislation on ethical claims. Nevertheless, the Misleading 
Advertising Directive 84/450  can be  seen  as  providing for  certain  restrictions  and 
prohibitions,  as  it  defines  misleading advertising as  "any advertising which  in  any 
way, including its presentation, deceives or is likely to deceive the persons to whom it 
is addressed or whom it reaches and which, by reason of its deceptive nature, is likely 
to affect their economic behaviour or which, for those reasons, injures or is likely to 
injure a competitor" (article 2 (2)). 
D.  POLICY THINKING AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The Confederation of the Food and Drink Industries of the EU (CIAA) was in favour 
of introducing the Codex work on nutritional claims into the EU via an annex to the 
Nutrition Labelling Directive. 
The European Consumer Association (BEUC) felt that nutrient content claims should 
be regulated by clear definitions. 
2.  Health Claims 
BEUC  felt  that it  was  necessary to  work on health claims  at  EU  level,  due to  the 
increasing importance of functional  foods  and due to  the  fact  that  several Member 
States had already voluntary codes in place. 
BEUC is  currently working on finalising its  position on health claims.  It  hoped to 
have done this during 1999. The following information does, therefore, not represent 
the final BEUC position, which is still in the process of  being elaborated. 
BEUC indicated that it was in favour of strict legislation on health claims. BEUC also 
mentioned that  it  was  probably not  possible to  establish a  positive/negative  list of 
claims.  Instead criteria would be needed, in  order to  ensure that only true and non-
misleading claims were being made. 
In its submission to the Green Paper on Food, BEUC supported the following policy: 
"Health  claims  should  not  convey  the  unjustified  message  to  consumers  that  an 
appropriate diet could be replaced by eating particular products. If health claims are 
permitted at  all,  they should preferably be  generic  claims  which reflect significant 
agreement  among  qualified  experts,  supported by the  totality of publicly available 
evidence and which contribute to  inform consumers about the relationship between 
diet and health." (see Annex 20). 
The association of European Consumer Cooperatives (Eurocoop) indicated that due to 
the  increasing  number  of health  claims  used,  particularly  on  functional  foods, 
legislation on health claims was needed at EU level. While Eurocoop is rather critical 
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should establish criteria under which conditions a claim could be allowed. It felt that 
for some claims a positive list could be established, where the link between a certain 
ingredient/nutrient and a health condition has been scientifically proven.  They also 
raised the particular problem that health claims are used on foods, which were, from a 
nutritional point of  view, not highly recommended (e.g. vitamin C in foodstuffs with a 
high fat content). 
The  European Advertising  Standards Alliance  (EASA)  felt  that in  general  industry 
self-regulation, rather than heavy-handed enforcement by governments, was  the best 
approach to regulating claims and other advertising. 
The CIAA argues that there are increasing benefits to be made from highlighting the 
relationship between nutrition and health, in order to  reverse the increasing trends in 
diet-related  non-communicable  diseases.  "CIAA  [therefore]  believes  that  it  is 
desirable  to  optimise  the  communication  on  diet-health  information  to  consumers 
through  coordinated  and  complementary  programmes  involving  food  labelling, 
commercial  communications  and  consumer  education"  (CIAA  Position  Paper  on 
Claims on Nutrition and Health, February 1999). 
Furthennore,  the  CIAA  stresses  that  improving  health-promoting  properties  of 
foodstuffs is expensive. "Manufacturers will be reluctant to continue to invest in this 
type of research if claims concerning these health benefits are  not allowed"  (CIAA 
Position Paper on Claims on Nutrition and Health, February 1999, see Annex 23). 
CIAA  considers  that  the  current  regulatory  framework  needs  to  be  adapted,  in 
particular Labelling Directive  79/112, so  as  to  allow disease  risk reduction claims. 
Claims that a food can treat or cure a disease should continue to be forbidden. 
The CIAA indicated that since it  was  not possible to  use the same claim in  all  EU 
Member States, there clearly existed some barriers to  trade.  CIAA gave the example 
of a functional  yoghurt,  for which a different claim had to  be used in  nearly every 
Member State (e.g.  in Germany "for your well-being", in  Spain "protects the body" 
etc.).  The  CIAA  acknowledged  that  only a  few  cases  had  been  looked  at  by the 
European Court of Justice. Industry prefers to adapt its label instead of going to court. 
The CIAA stressed that it was against the  Single Market principle that the right for 
information was not the same in all Member States. 
The  European  Retailer Association (Eurocommerce)  felt  that no  further  legislation 
was needed at EU level on health claims. If new legislation was considered, it should 
be a way to soften the currently rather strict legislation, e.g. enhanced function claims 
should be clearly allowed. They added that the European Commission should ensure 
that sufficient food  controls were done at  Member State  level.  Eurocommerce also 
indicated that as retailers, they were not experiencing any particular barriers to trade. 
The  European  Health  Product  Manufacturers'  Association  (EHPM),  which  is  an 
association  of federations  dealing  with  health  products  such  as  food  supplements, 
herbals and health foods, considered that there was a need to clarify Directive 791112, 
as they felt that the current legal framework was not appropriate, given the wording of 
article 2 of that Directive and the need for broader interpretation. EHPM mentioned 
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the same example of  a functional yoghurt. EHPM felt that this case demonstrated that 
there  are  major impediments  to  enter different  markets  in  terms  of how  to  get  a 
message across and which claims are actually acceptable. 
The  European  Food  Law  Association,  an  international  scientific  association  that 
mainly aims to  study food law and to  contribute to  its international harmonisation, is 
currently finalising  a position paper on health claims.  EFLA is  of the opinion that 
disease  risk  reduction  claims  should  be  allowed  via  an  amendment  of Directive 
79/112 and Directive 65/65. 
The European Commission Concerted Action on Functional Food Science in Europe 
(FUFUOSE), which is co-ordinated by the International Life Sciences Institute (ILSI), 
supports in  its  consensus document on "Scientific Concepts of Functional Foods in 
Europe" the development of two types of health claims: enhanced function claims and 
reduction of  disease-risk claims (see Annex 14). 
The  Concerted  Action  definitions  are  very  similar  to  the  ones  that  have  been 
introduced  in  the  latest  Codex  draft  recommendations  on  health  claims.  The 
definitions are the following: 
Enhanced  function  claims:  "These  claims  concern  specific  beneficial  effects  of 
nutrients  and non-nutrients  on  physiological,  psychological  functions  or biological 
activities  beyond their  established role  in  growth,  development  and  other  normal 
functions of  the body". 
Reduction of disease-risk claims:  "Claims for reduction of disease risk relate to  the 
consumption of  a food or food component that might help reduce the risk of a specific 
disease or condition because of specific nutrients or non-nutrients contained within 
it."  (Scientific  Concepts  of Functional  Foods  in  Europe:  Consensus  Document,  in: 
British  Journal  of Nutrition,  Volume  81  Supplement  Number  1  1999,  page  S24, 
Annex 15) 
The European Parliament stated in  its  Resolution on the Commission's Green Paper 
on  the  General  Principles  of Food  Law  of March  1998  that  "claims  regarding 
nutritional value and healthy diet and their importance to health and/or in reducing the 
risk of  disease should be allowed" (point 66, see Annex 16). 
3.  Ethical Claims 
Eurocommerce  felt  that  no  legislation  on  ethical  claims  was  needed.  This  was 
because many manufacturers were abstaining from using ethical claims since it  was 
often impossible to ensure the 100% veracity of an ethical statement such as 'no child 
labour'. This was also the case for companies that had very strict control mechanisms 
in place with regard to child labour. 
Furthermore, Eurocommerce indicated that legislation on ethical claims would not be 
useful,  as  it  was  virtually impossible to  enforce  and control.  Finally,  NGOs,  trade 
unions  and  the  press  were  all  very  active  on  ethical  issues.  The  market  could, 
therefore, regulate false ethical claims itself. 
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by its members to look into the issue. 
The European Parliament adopted on 15  January 1999 a Resolution on EU Standards 
for  European  Enterprises  Operating  in  Developing  Countries  (Annex  17).  In  this 
Resolution the European Parliament reaffirms its support for the creation of a 'Social 
Label' together with a Code of  Conduct for European businesses that should comprise 
existing minimum applicable international standards.  Parliament also calls upon the 
Commission to study the  possibility of setting up  a European Monitoring Platform. 
The Resolution does not contain any further details regarding social labels. 
The European Commission (DG VIII) is currently finalising a Communication on Fair 
Trade, which is due to be adopted by the college of Commissioners before the end of 
the year.  The Communication aims at giving an overview of the current activities of 
the various Commission services in the field of fair trade. The Communication does at 
this stage not propose any legislation in this area. 
III.  VOLUNTARY INSTRUMENTS AND OTHER PRACTICES 
A.  VOLUNTARY INSTRUMENTS IN PLACE/PLANNED 
1.  Nutritional 
Currently, there exist no  voluntary instruments on nutritional claims at the EU level. 
CEEREAL, the European Breakfast Cereal Association has, nevertheless, developed 
some guidelines for quantitative nutrition claims for breakfast cereals. 
2.  Health Claims 
The Confederation of the Food and Drink Industries of the  EU (CIAA) finalised in 
July  1999  a  code of practice  on the  use  of health claims  (Annex  21 ).  The  CIAA 
indicates  that  the  purpose  of  the  code  is  to  help  companies  to  prepare  the 
documentation  necessary for  the  substantiation of health  claims,  in  order to  avoid 
inequalities between Member States. 
Eurocoop indicated with regard to  voluntary codes of conduct that whilst these may 
work in some Member States, they would not in other Member States, such as  Italy. 
Voluntary codes were problematic, as  it was difficult to ensure control and sanctions. 
Eurocoop, therefore, favoured legislation. 
BEUC stressed that it was still working on its position on health claims. At this stage 
it  could only indicate that if there were to  be a code of conduct at EU level,  it was 
crucial that such a code was also enforceable. 
The CIAA saw its own work on a European Code of Conduct on health claims as an 
intermediate step prior to changes to Directive 791112.  The CIAA acknowledged that 
in some Member States, such as Italy, a code may not work. 
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3.  Ethical Claims 
Currently, there are no EU wide voluntary agreements on ethical claims. 
In the textile and retail sector, codes have been adopted which condemn child labour/ 
forced labour and ask member companies to  take measures to  eradicate child labour. 
However,  these  codes  make  no  reference  to  labelling/ethical  claims  (see  notably 
Charter by European Social Partners in the Footwear Sector on Child Labour, March 
1995  (updated  1997);  Charter by the  Social  Partners  in  the  European  Textile  and 
Clothing Sector, September  1997; Eurocommerce and Euro-Fiet Joint Statement on 
Combating Child Labour, March 1996, see Annex 30). 
With  regard  to  fair  trade  products,  in  1997,  Fairtrade  Labelling  Organizations 
International  (FLO)  was  founded.  This  aims  to  co-ordinate  national  fair  trade 
labelling initiatives. FLO members include the Max Havelaar Foundations, as well as 
the  TransFair  fair  trade  labelling  organisation  and  the  European  Fair  Trade 
Association. A central responsibility for FLO is to collect data and ensure the audit of 
all  fair  trade  labelled products.  FLO is  currently working on the  development of a 
single international fair trade label. 
To  date,  FLO  has  established  criteria  for  a  number  of products  (coffee,  cocoa, 
bananas, orange juice, sugar, tea and honey), which if fulfilled allow the use of fair 
trade marks. These fair trade marks do not, in  general, contain any ethical claims as 
such.  Nevertheless,  they  may  be  associated  by  consumers  with  certain  ethical 
standards. 
The  FLO  criteria  are  generally  divided  into  two  parts:  criteria  applying  for  the 
importer and criteria applying for the producer. The main criteria for the importer are 
that he has to  buy the product only from accepted sources which are declared in an 
International Producer Register (there are registers for each product) administered by 
the FLO. Furthermore, he has to pay a premium in addition to the market price. The 
premium will be re-channeled to the producers. Producers, in order to be inscribed in 
an International Producer Register have to  respect minimum labour standards, a ban 
on  child  labour,  equal  treatment  etc.  Furthermore,  several  of the  International 
Producer Registers also  contain certain environmental minimum standards that have 
to be fulfilled (see attached the FLO Criteria for coffee, cocoa, bananas, orange juice, 
sugar, tea and honey, Annex 29). 
The European Fair Trade Association (EFTA) is an association of twelve importers in 
nine European countries. EFT  A sees as its core business to make fair trade importing 
more  efficient  and  effective.  EFT  A  provides  services  to  its  members,  such  as 
information exchange on products and producers, encouraging bilateral cooperation 
and  the  development  of a  common  database.  EFT  A  has  developed  Fair  Trade 
Guidelines  (see  Annex  28).  These  guidelines  are  divided  into  Register  Guidelines 
(applying to producers) and Trading Guidelines (applying to EFTA members). 
These  guidelines  state  that  EFT  A  will  work  with  companies  of  marginalized 
producers, employees, and Southern organisations, which seek to support sustainable 
development  through  providing  regular  income,  protect  human  rights,  protect  the 
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provide continuity of relationships through the provision of regular orders, fair prices 
which provide a reasonable  return  to  the prqducer, pre-financing, and assistance in 
product development, etc. The guidelines do not address the issue of  ethical claims. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The  CIAA code of practice  (Annex  21)  distinguishes between two  types  of health 
claims. Firstly, function claims, which are defined in the following way (IV. 2.1.): 
"These claims concern specific beneficial effects of nutrients and non-nutrients on a 
physiological, psychological functions or biological activities beyond their established 
role in growth, development and other normal functions of  the body." 
Secondly, reduction of  diseases risk claims, which are defined as (IV. 2.2): 
"Clailns for  reduction of disease risk related to  the  consumption of a food  or food 
component that might help reduce the risk of a specific disease or condition because 
of  specific nutrients or non-nutrients contained within it". 
3.  Ethical Claims 
The FLO criteria lists (Annex 29) and EFTA guidelines (Annex 28) do not make any 
reference  to  ethical  claims.  The  same  holds  for  the  child  labour  codes  mentioned 
above. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The CIAA code of practice makes  it  clear that it  does not apply to  pharmaceutical 
products and that it only applies to the two types of  health claims described above. 
3.  Ethical Claims 
No restrictions, prohibitions or exemptions are mentioned in the FLO criteria list and 
EFT A guidelines with regard to  ethical claims. The same applies to  the child labour 
codes mentioned above. 
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AUTHORITIES 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The  CIAA  aims  to  have  its  Code  of Conduct  in  some  form  recognised  by  the 
European Commission (e.g. via the Standing Committee for Food). 
3.  Ethical Claims 
The FLO criteria lists and the EFT  A guidelines are not recognised by the European 
institutions. 
The  charter  on  child  labour of the  European  footwear  sector  and  the  textile  and 
clothing  sector (see  Annex  30)  have  been  drafted  in  the  framework  of the  social 
dialogue, in which the European Commission is a participant. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The Nutrition  Labelling  Directive (Annex  1)  makes  nutrition  labelling compulsory 
whenever a nutritional claim is  made (article 2 (2)).  No  further criteria are listed for 
substantiating a claim. 
2.  Health Claims 
Under EU legislation only the Directive on Foodstuffs for Particular Nutritional Uses 
(Annex 7) establishes a notification system. The primary purpose of this notification 
system  is  not to  verify the  claim,  but rather to  ensure  that the  food  in  question  is 
distinguishable  from  foodstuffs  for  normal  consumption  and  is  suitable  for  the 
claimed nutritional purpose (see article 1 of the Directive).  However, several national 
administrations indicated that they also verify the claim made (see country section). 
Under the  Directive, companies are  required to  send as  notification material  to  the 
competent national authority "a model of  the label used for the product" (article 9 (1)). 
Where necessary, the manufacturer may also be required to  produce scientific work 
and data establishing the product's compliance with the claimed particular nutritional 
purpose (article 9 (3)). 
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substantiating health claims. The CIAA code lists a number of  general principles: 
•  "The company responsible for placing a product on the market is  responsible 
that any health claim is based on sound scientific evidence". 
•  Supporting evidence shall be: 
"Consistent in itself. 
Be able  to  meet  accepted  scientific  standards of statistical  and biological 
significance. 
Be plausible in terms of  the relationship between intervention and results." 
•  "Any health  claim  should  be  supported  by appropriate  scientific  evidence 
concerning the specific physiological effects which are claimed." 
•  "Substantiation  should  demonstrate  efficacy with  an  appropriate  amount of 
intake." 
•  "Health claims should be justified in the context of  the whole diet and must be 
applicable to the amount of  food normally consumed" (point V. of  the code). 
Furthermore, the code indicates that in order to justify a claim:  "The effect must be 
quantitatively,  statistically  and  biologically  significant.  The  size  of  the  effect 
measured must be shown to be sufficiently important to justify the claim." (point IV. 8 
of code) 
The code then  lists  a  number of more specific  guidelines  for  the  substantiation of 
health claims (point VI. 1-5 of  code). These are: 
•  Validation of health claims shall have been carried out alongside all the other 
checks  necessary when examining the  suitability of a  food  product for  the 
purpose for which it is marketed. 
•  If the  composition or manufacturing changes substantially, or new scientific 
developments occur, additional checks shall be carried out to ensure that the 
claim is still valid. 
•  It has to  be shown that the specific functional  substances are present in the 
quantity and form needed to justify the claim through shelf life. 
•  Normal  serving  size,  conditions of use  and  consumption pattern  should  be 
taken into account in the assessment of the relevance of  the concerned food. 
•  The evidence collected must show that consumption of the food can result in 
the  health effects  claim.  A  difference  is,  nevertheless,  being made between 
'generic claims' and 'new' claims. For generic claims bibliographic evidence is 
considered to  be normally sufficient.  For new claims the scientific evidence 
required has  to  be determined on  a  case by case basis  and  should  include 
human studies where appropriate. 
Regarding this evidence, the code indicates that it could be expected to  come from 
(point VI. 6 of  code): 
•  scientific literature 
•  in vitro studies 
•  animal models 
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•  epidemiological studies 
•  any other relevant studies 
With regard to human studies, a number of criteria are listed in the code (point VI.  7. 
of the code): 
•  "They must be carried out in a representative sample of  the population. 
•  The use of internationally accepted and validated methods and of biological 
markers is recommended when they exist. 
•  They should demonstrate  efficacy with  respect to  the  specific  physiological 
effect(s).  An  effective  level  and  frequency  of  consumption  should  be 
suggested for a food claiming to have a positive effect on health. 
•  The effect must be studied over sufficient time to  allow adaptation to  occur 
and should consider confounding factors  such as  health status at the time of 
the study, use of  medication, smoking." 
The  code  also  provides  for  the  possibility  for  companies  to  have  their  scientific 
evidence  evaluated by an  independent  scientific  body.  The code  indicates  that  the 
CIAA  is  in  the  process of establishing a  list of such independent scientific bodies 
(point VI. 9 of  code). 
3.  Ethical Claims 
The FLO  criteria lists  do  not go  into further detail with regard to  the  material that 
needs to be submitted for substantiating the use of  fair trade labels. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
No EU system of  pre-clearance exists for claims. 
The  FLO  allows  importers/ producer organizations  to  use  the  fair  trade  label only 
once they have fulfilled criteria set out in  the criteria lists  for the different products 
covered by FLO. 
2.  Post-Clearance Rules/ Guidelines 
Under  EU  legislation  the  Directive  on  Foodstuffs  for  Particular  Nutritional  Uses 
(Annex  7)  establishes  a  notification  system.  This  notification  procedure  can  be 
regarded as a post-clearance system (see also IV. A.). 
With  regard  to  the  FLO,  it  sends  monitoring  experts  to  monitor  the  producers. 
Furthermore, the FLO together with its national members monitors the flow of  goods. 
The  Charter on  Child  Labour of the  European  Footwear  Sector  recommends  that 
companies include the Charter in the terms of purchase with their subcontractors and 
suppliers. No  further statement on post-clearance is  being made.  The Charter of the 
European Textile and Clothing Sector states that the  European Apparel and Textile 
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Clothing and Leather (ETUF:TCL) will conduct a yearly evaluation of the Charter's 
implementation. The results of  this evaluation are due to be reported in the framework 
of  the Social Sectoral Dialogue (see Annex 30). 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Under the Misleading Advertising Directive (see Annex 4), it is in principle left to the 
Member States to define, which persons are entitled to take legal action on misleading 
advertising. Nevertheless, it is stipulated that legal provisions shall exist "under which 
persons or organizations regarded under national law as having a legitimate interest in 
prohibiting misleading advertising"  (Article 4)  may take  legal action or bring such 
advertising before a competent administrative authority. 
D.  BURDEN OF PROOF 
Article 6 of the  Misleading Advertising Directive (as  amended by 97/55) addresses 
the question of  burden of  proof at the level of  courts and administrations. It states that 
the Member States shall empower courts or administrative authorities "to require the 
advertiser to  furnish evidence as  to the accuracy of factual  claims in advertising if, 
taking into account the legitimate interests of the advertiser and any other party to the 
proceedings, such a requirement appears appropriate on the basis of  the circumstances 
of the  particular  case  and,  in  the  case,  of comparative  advertising  to  require  the 
advertiser to furnish such evidence in a short period of time". 
The Directive does not address the burden of  proof at the level of  the complainant. 
It is  interesting to  note  that the  Codex General  Guidelines  on Claims  (Annex  12) 
states that "The person marketing the food should be able to justify the claims made" 
(article 1.3., CAC/GL 1-1979 (Rev. 1-1991) ). 
E.  COMMENTS 
The European Parliament stated in its Resolution on the Commission Green Paper on 
the General Principles of Food Law (see EP Minutes of 10 March 1998, in Annex 16) 
that  food-product  health  claims  should  only be  authorized  "if they are  tested  and 
confirmed  by an  independent  body  within  the  European  Union  and  calls  on  the 
Commission also to continue in future to ban advertising claims that a particular food 
is  suitable  for  treating,  curing  or  preventing  disease,  though  claims  regarding 
nutritional value and health diet and their importance to health and/or in reducing the 
risk  of disease  should  be  allowed  if they  are  based  on  sufficient  and  recognized 
scientific findings and if  they are tested and confirmed by an independent body within 
the European Union" (point 66 of  Resolution). 
While the European Parliament did not make it clear whether it was in favour of pre-
or  post-clearance,  it  is  clear  that  Parliament  is  in  favour  of clearance  via  an 
independent  body.  Furthermore,  in  the  Parliament's  view,  claims  should  be 
substantiated via sufficient and  recognized scientific  findings.  Again these  findings 
have to be confirmed by an independent body. 
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claims should be established.  In terms of substantiation of health claims, Eurocoop 
indicated that health claims need to be supported by scientific evidence, controlled by 
an independent body of  experts. 
Other criteria mentioned by Eurocoop for making a claim were: 
"- ensure that the product making the claims is of a composition, which, overall will 
positively contribute to a nutritionally adequate diet; 
ensure  that  health  claims  are  consistent  with  official  dietary  and  nutrition 
recommendations; 
ensure that health claims are clear, understandable and not misleading; 
health claims are formulated to take into account the need for a balanced diet; 
health claims should be sufficiently detailed to enable the consumer to evaluate 
the claim him/herself; 
health claims must give an overall picture  of  the cause and effect described in the 
marketing material, with particular reference to the food product in question; and 
appropriate  additional  information  on  the  ingredients  of  the  product,  the 
percentage  of  the  'functional'  ingredient,  maximum  limits,  serving  size, 
recommended amounts, etc." (Eurocoop presentation at Nutraceutical Technology 
Europe, 4 March 1999, see Annex 24). 
As to the burden of  proof, it was clear that Eurocoop believes that this should be with 
the maker of  the claim. 
BEUC stressed that it had not yet finalised its position on health claims. At this stage 
it felt that a pre-clearance procedure may be desirable, in order to  avoid misleading 
claims. This should not stop a producer from bringing the new product immediately 
onto the market but without the claim. 
The CIAA indicated that it was against a priori approval procedures, as: 
•  these would delay the putting on the market of a product, which was crucial 
for the food industry since it was a fast moving market; 
•  it was not possible to copyright final food product and/or the claim made; and 
•  industry was worried that confidentiality was not ensured during an a priori 
approval procedure. 
In addition, as additives could only be used if  they fulfilled the safety criteria set up in 
the  EU  additives  legislation,  and as  any new ingredients had to  follow  the  Novel 
Foods regulation procedure, there was no need for a prior verification. Furthermore, 
the CIAA felt that for the limited amount of false claims, it would be unproportional 
to introduce such a strict system as pre-clearance. 
With regard to the burden of proof, the CIAA felt that this was not something that 
should be regulated by the EU. In any case, the producer would always have to have 
all materials available to justify the claim made. 
On this issue, Eurocommerce stated that whoever uses a claim had to be able to prove 
it. 
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should be with the maker of  the claim. 
On the issue of pre-clearance, EHPM argued that if a mandatory system was set up, it 
would  establish  yet  another  competence  for  an  authority,  which  would  become 
inflexible, potentially expensive,  subjective  and where probably there  would be no 
appeal and no clear deadlines as to when an approval would be given. A notification 
type system, such as  for foodstuffs  for particular nutritional uses, was seen as  a far 
better system. 
EHPM  also  felt  that  in  terms  of pre-clearance  it  should  be  left  to  industry  self-
regulation.  This would ensure that  it  was  flexible  and would help  industry to  get 
products  onto  the  market  as  quickly  as  possible,  whilst  obviously  providing  the 
required checks. 
With  regard  to  scientific  substantiation  of  claims,  EHPM  considered  this  an 
acceptable approach. However, they raised the issue that the scientific evidence could 
easily be subjective,  lead to  disagreements,  as  well  as  the necessity of undertaking 
clinical trials.  Whilst they agreed that trials needed to be done,  they could become 
expensive and very costly for small and medium sized enterprises. 
In a similar way, EHPM felt that if  there were to be a shift of  the burden of proof, this 
would be very costly for small and medium sized enterprises. 
On  the  issue  of substantiation,  the  European  Commission  Concerted  Action  on 
Functional  Foods  in  Europe,  states  in  its  consensus  document  that  any  claim  or 
statement  "must be based  on sound  scientific  evidence  that  is  both  objective  and 
appropriate".  It continues to  state  that  "it  is  important that the  required supporting 
evidence should: 
•  be consistent in itself; 
•  be able to  meet accepted scientific  standards of statistical and biological 
significance 
•  be plausible in terms of  the relationship between intervention and results; 
•  be  provided  from  a  number  of  sources,  including  human  studies." 
(Scientific Concepts of  Functional Foods in Europe: Consensus Document, 
in:  British Journal of Nutrition, Volume 81  Supplement Number 1 1999, 
page S.24-S25, Annex 15). 
On  the  issue  of substantiation,  it  is  also  interesting  to  note  that  the  Forum  on 
Functional  Food  of the  Council  of Europe,  which  was  held  in  December  1998, 
concluded  in  its  recommendations  that  claims  "needed  to  be  supported  by sound 
science in  order to  demonstrate their relevance and validity.  It was underlined that 
messages  should  not  mislead  the  consumer."  (Forum  on  Functional  Food, 
Proceedings,  Strasbourg, Council of Europe  1-2  December 1998,  p.  29,  see Annex 
26). 
As  mentioned  above,  Eurocommerce  indicated  that  many  manufacturers  were 
abstaining from  using ethical  claims,  as  it  was  often impossible  to  ensure  the  full 
veracity of an ethical statement such as  'no child labour'. This was also the case for 
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labour. 
A European Workshop on Monitoring of Codex of Conduct and Social Labels was 
organised in  November  1998  by DG  V.  The aim of the  workshop was to  have  an 
exchange of experience gained with codes and labels, as well as an exchange of  views 
on  monitoring  of codes  and  labels.  The  workshop,  in  which  a  large  number  of 
interested parties from  industry and NGOs participated, concluded that monitoring, 
"in the  view of most participants  - has  to  be  independent and should be organised 
externally. It must be carried out meeting professional standards. For this reason, the 
accreditation  of auditors  and  the  development of methods  of certification  are  two 
priority issues.  The ILO could play a major role in the accreditation of certification 
agencies  and  the  training of auditors.  Nevertheless  the  input  from  local,  national, 
European, and international levels must not be  neglected."  (European Workshop on 
Monitoring of Codes of Conduct and  Social  labels,  European Commission DG  V, 
January 1999, p. 20, see Annex 27). 
V.  CASELAW 
1.  Nutritional Claims 
We did not come across any Court cases on nutritional claims. 
2.  Health Claims 
There exist only a few cases from the European Court of  Justice that directly deal with 
health claims.  A number of cases deal with the definition of medicinal products, in 
which context the issue of  health claims is addressed. 
A prominent example is  the Ter Voort case (Case C-219/91,  Ter  Voort,  28  October 
1992).  Mr.  Ter  Voort  marketed  herbal  teas  in  The  Netherlands,  which  had  been 
imported from South America. These herbal teas were sold without any indication of 
any  therapeutic  properties.  Nevertheless,  a  foundation  called  "Stichting  Nieuwe 
Horizon",  which  is  also  based  in  The  Netherlands  sent  to  consumers  on  request 
brochures describing the therapeutic or prophylactic properties of  these herbal teas. 
In a preliminary ruling, the ECJ  was asked by the national court inter alia whether a 
product  which  has  - based  on  current  scientific  knowledge  - no  pharmacological 
properties, but which is presented as having curative or preventive properties can be 
considered a medicine under Directive 65/65.  The national court furthermore  asked 
whether  for  answering  this  question  it  was  determinant  that  the  pharmacological 
properties  were  not  mentioned  on  the  product,  but  were  sent  separately  m  a 
publication either in conjunction with the sale or independently from the sale. 
The  ECJ  based  its judgement on  Directive  65/65  on medicinal  products.  The  ECJ 
stated  that  Directive  65/65  establishes  two  definitions  of medicinal  products:  a 
definition by virtue of the presentation of  the product and one by virtue of  its function. 
The ECJ  indicated that a product was a medicinal product if it falls within either of 
those definitions. 
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or therapeutic properties is  a medicinal product within the meaning of the provisions 
of the  first  subparagraph of Article  1 (2)  of Directive 65/65, even if it  is  generally 
regarded as  a foodstuff and even if in the current state of scientific knowledge it has 
no known therapeutic effect". 
The  ECJ  argued  that  Directive  65/65  was  designed  to  "catch  not  only  medicinal 
products having a genuine therapeutic or medical effect but also those which are not 
sufficiently effective or do not have the effect which their presentation might lead to 
expect,  in  order to  preserve  consumers  not  only from  harmful  or  toxic  medicinal 
products  as  such  but  also  from  a  variety  of products  used  instead  of the  proper 
remedies". 
The  ECJ  also  concluded that a product "whose therapeutic properties are  indicated 
solely  in  a  publication,  such  as  a  brochure,  which  is  sent,  at  his  request,  to  the 
purchaser after sale by the manufacturer or the seller of the product or by a third party 
- in the latter case, where the third party does not act completely independently of the 
manufacturer or the seller - may be categorized as a medicinal product [  ...  ] ". 
The ECJ stated that the exercise of  freedom of expression as laid down in article 10 of 
the  European  Human Rights  Convention has  to  be measured with the  objective of 
health protection, which is the objective of  Directive 65/65. The ECJ drew attention to 
the fact that article 10 (2) of the European Human Rights Convention provides for the 
possibility to restrict the freedom of  expression on public health grounds. 
This ruling indicates that the ECJ considers a strict interpretation of 65/65  as  a mean 
to  protect consumers not only against toxic medicinal products, but also from other 
products (e.g.,  foodstuffs  such as  herbal teas)  which are used instead of the proper 
remedies. 
The ECJ came to the same conclusion in a case involving Upjohn against Farzoo Inc. 
(Case C-211189,  The  Up  john Company,  16  April  1991 ).  Upjohn was  selling in  The 
Netherlands a lotion called 'Regaine' aimed at combating alopeica androgenetica. An 
identical  product  of the  company  Farzoo  Inc.  called  'Minoxidil'  was  sold  in  The 
Netherlands  as  a  cosmetic  product.  Upjohn  complained  that  this  was  unfair 
competition. It is interesting to note the part of the preliminary ruling where the ECJ 
analyses the wording 'presentation' used in  Directive 65/65. The ECJ concludes that 
"le  critere  dit  de  'presentation'  retenu  par  le  premier  alinea  du  texte  a  pour  but 
d'apprehender  non  seulement  les  medicaments  qui  ont  un  effet  therapeutique  ou 
medical  veritable,  mais  egalement  les  produits  qui  ne  seraient  pas  suffisamment 
efficaces, ou qui n'auraient pas l'effet que leur presentation permettrait d'en attendre 
afin  de  preserver  les  consommateurs  non  seulement  des  medicaments  nocifs  ou 
toxiques en tant que  tels,  mais aussi  de  divers produits utilises en lieu et place des 
remedes adequates.  II  en resulte que la notion de presentation d'un produit doit etre 
interpretee de fac;on extensive". 
Here again, the ECJ argues for a wide interpretation of Directive 65/65, in particular 
with regard to the term 'presentation'. 
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preparations can be found in the Glob-Sped AG case (Case C-328/97, Glob-Sped AG, 
10  December 1998). The company Glob-Sped AG wanted to import two vitamin C 
preparations as medicinal products under the Common Customs Tariff. The German 
customs held that the product should be classified as a food preparation. The customs 
authorities also held that the properties of  the product (in particular the strong dose of 
vitamin C) were not sufficient for the product to be classified as a medicament under 
the  Common  Customs  Tariff,  in  particular  as  the  packaging  did  not  contain  an 
indication on the specific effectiveness in combating certain illnesses. 
The national court asked the ECJ in a preliminary ruling inter alia whether vitamin 
preparations  with  1  OOOmg  and 500mg of vitamin C  per pill  respectively and with 
product information stating "to build up resistance: for colds and influenza infections, 
[ ...  ]  and  allergic  processes"  and  "as  a  prophylactic  at  times  of increased  risk  of 
infection"  should be  considered a  medicinal  product under the  Common Customs 
Tariff. 
The ECJ concluded that it was "undisputed that the vitamin C content of  the products 
in  question  is  much  greater  than  what  is  necessary  or recommended  for  general 
dietary purposes.  Furthermore,  besides  assisting  the  immune  system of the  human 
organism to  resists infections in cases of,  inter alia,  asthenia or severe strain,  such 
doses of vitamin C, which the human body is incapable of making for itself, are also 
recommended as  treatment for allergic reactions and severe traumatisms, of the kind 
which may result form  an  injury or a  surgical  operation,  or to  combat deficiency-
related illnesses [ ...  ]". 
The ECJ, therefore, concluded that the two vitamin preparations had to be considered 
as medicinal products under the Common Customs Tariff. 
While the Court did not directly indicate whether the claims made would be sufficient 
to qualify the vitamin preparations as a medicinal product, some more indications can 
be found in the opinion of  the Advocate General, who concluded that the packaging of 
the  products  concentrates  on  "the  products'  more  general  effects  on  the  body's 
immune system.  It also  refers to  their traditional use as  a  strengthener,  which use, 
taken on its  own, would not be sufficient to  qualify the products as  a  medicament 
[ ... ]". 
Nevertheless,  it  1s  difficult  to  apply  directly  cases  on  the  interpretation  of the 
Common  Customs  Tariff for  our  research,  as  the  ECJ  concluded  itself that  the 
objectives  of Directive  65/65  (public  health  protection  and  elimination  of trade 
obstacles)  are  different  from  those  of the  Common  Customs  Tariff and  that  the 
classification of a product as a medicinal product for the purpose of Directive 65/65 
was wide and could vary between Member States. The Common Customs Tariff on 
the other hand had to be applied in a uniform manner by all Member States (see recent 
Case 270/96,  Laboratoires Sarget SA,  12  March  1998,  as  well  as  Case C-201/96, 
Lahoratoires de Therapeutique Moderne, 6 November 1997). 
A  more  recent case that came before the ECJ  is  of direct  interest to  our study  as 
regards  substantiation of claims  (Case  77/97,  Osterreichische  Unilever  GmbH,  28 
January  1999).  The  preliminary  ruling  concerned  a  dispute  between  Unilever  and 
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Austria. 
Smithkline sold the toothpaste with on-pack and television advertising stating that it 
helps to prevent parodontosis, provides triple protection against dental caries, plaque 
and parodontosis and removes  or prevents the  formation of tartar.  Unilever argued 
that  these  claims  were  contrary  to  the  Austrian  cosmetic  decree  and  the  relevant 
article  on  health  claims  of the  Austrian  Food  Law,  as  the  toothpaste  in  question 
contained only one of the decay-inhibiting pharmacologically active substances listed 
in an annex to the Austrian cosmetic decree and none of the substances listed therein 
which prevent the formation of tartar or parodontosis. Unilever, therefore, considered 
these statements to be incorrect and misleading. 
Unilever objected to Smithkline's reasoning that article 30 of the EU Treaty could be 
invoked, as the issue here concerned the health of consumers which was covered by 
the exceptions listed in article 36 of the EU treaty. Furthermore, as there existed no 
Community rules on the composition and content of cosmetic products, the Austrian 
cosmetic  decree  could  not  be  regarded  as  being  contrary  to  Community  law. 
Smithkline on the other hand argued that EU Directive 76/768 on Cosmetic Products 
fully harmonises legislation in this area. Where a product fulfills the requirements of 
Directive 76/768, a Member State may not restrict its sale or marketing. 
The ECJ was asked by the Handelsgericht Wien whether article 30 of the Treaty in 
conjunction  with  the  Cosmetic  Products  Directive  preclude  a  national  provision 
"which, as regards advertising in connection with the marketing of  cosmetic products, 
contains prohibitions going beyond the restrictions contained in the directive?". 
The ECJ  stated that  Directive  76/768  completely harmonised national  rules  on the 
packaging  and  labelling  of cosmetic  products.  Article  6(3)  of Directive  76/768 
notably  forbids  attributing  characteristics  to  those  products  in  the  labelling  and 
advertising of cosmetic products, which they do not have. The ECJ indicated that this 
was also aimed at "protecting human health, within the meaning of article 36 of the 
Treaty,  in  so  far  as  misleading  information  regarding  the  characteristics  of such 
products could affect public health". Nevertheless, measures applied under article 36 
have to be proportional to the aim researched. 
The  ECJ  then  analysed  in  more  detail  the  question  of proportionality.  Smithkline 
pointed out to the ECJ that the Austrian cosmetic decree would be compatible with 
article 6(3) of Directive 76/768, if its  annex comprised all  active substances which 
may prevent  the  formation  of tartar  of parodontosis.  The  ECJ  stated  that  it  was 
apparent from the hearing it held in the context of this legal dispute, that this was not 
the case. 
While Austrian law foresees that manufacturers of cosmetic products which contain 
active substances not listed in the annex to the Austrian cosmetic decree may apply 
for special authorisation for the use of  such substances, the ECJ argued: 
"It is possible to ensure the protection of consumers, public health and fair trading by 
adopting measures which are less restrictive of the free movement of goods than the 
automatic  exclusion  of advertising  by  a  system  that  prohibits  the  advertising  of 
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substances  not  expressly  listed  m  the  Kosmetikverordnung  [Austrian  cosmetic 
decree]". 
The ECJ concluded:  "Thus, the controls exercised by the national authorities could 
take the form, inter alia, of an obligation requiring the manufacturer or distributor of 
the product in  question, in  the  event of any uncertainty, to  furnish  evidence of the 
accuracy of the advertisements concerned, in the manner provided for by Article 6 of 
Council Directive 84/450/EEC [ ...  ]". 
While this case solely concerned a claim made on the basis of an ingredient not listed 
in the Austrian cosmetic decree, it seems to  indicate that the ECJ considers a control 
system for claims as foreseen under article 6 of the Misleading Advertising Directive 
as a viable way of  controlling claims. 
The ECJ did not further define claims in this ruling, but used the wording 'statement' 
and 'advertising'. 
There are only a few ECJ cases dealing directly with health claims. The few that have 
come to  the  Court  indicate  with  regard  to  consumer protection that  the  ECJ  is  in 
favour of a wide interpretation of Directive 65/65 (see Annex 6),  in  order to  protect 
the consumer against products used instead of adequate remedies. On the other hand, 
the ECJ cases seem to indicate that the Court considers a control system for claims as 
foreseen under article 6 of the Misleading Advertising Directive as  a viable way of 
controlling claims. The ECJ cases do not provide much information regarding barriers 
to trade. 
3.  Ethical Claims 
We have not come across any Court cases involving ethical claims. 
VI.  MEANS OF COMMUNICATION 
Under  Directive  90/496  on  Nutrition  Labelling  (Annex  1  ),  it  is  stipulated  that  a 
nutritional claim means "any representation and any advertising message"  (article  1 
(  4) (b) ). This wording suggests that it applies to all means of  communication. 
Under  Directive  79/112  on  the  Labelling  of Foodstuffs  (Annex  2),  the  ban  on 
misleading claims and the restriction of certain health-related claims shall under the 
Directive apply to  the  labelling,  presentation of foodstuffs,  their shape,  packaging, 
display and  advertising (see  article 2  (1)  and  2 (3)).  This wording suggests  that  it 
applies to all means of  communication. 
Equally,  the  interdiction of certain health-related claims under Directive  89/398  on 
Foodstuffs  for  Particular Nutritional  Uses  (Annex  7)  applies  to  labelling,  labelling 
methods used, presentation and advertising (see article 6 ( 1  )). 
Directive  84/450  on  Misleading  Advertising  Directive  (Annex  5)  applies  to 
advertising. The definition of  advertising used is the following: 
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trade, business, craft or profession in order to promote the supply of  goods or services, 
including immovable property, rights and obligations" (article 2 (1)  ).  The wording 
"the  making  of a  representation  in  any  form"  would  suggest  that  all  means  of 
communication are covered. 
The  specific  provisions  on  claims  made  on  alcoholic  beverages  as  set  out  under 
Directive  89/552  on  Television  Broadcasting  Activities  (Annex  9)  only  apply  to 
television  advertising,  as  the  scope  of  the  Directive  is  confined  to  television 
broadcasting (see article 15). 
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I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study on nutritional, health and ethical claims was generally well received by all 
interested parties in Austria. Those who participated in the study were pleased to  see 
that DG XXIV was looking at this issue. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of a nutritional claim is a direct transposition of EU law.  Legislators, 
industry  and  consumers  are  generally  satisfied  with  the  current  legislation  on 
nutritional  claims.  However,  it  was  pointed out that  a revision would be  useful  to 
include some substances (e.g. potassium), which are not listed in the EU Directive on 
Nutrition Labelling. 
2.  Health Claims 
With  regard to  health claims,  these  are  forbidden  under the  national  implementing 
legislation of Directive  79/112.  Nevertheless,  Austrian  legislation  is  much  stricter 
than Directive 79/112, as  it  also forbids  references relating to  physiological effects, 
especially with  regards  to  the  preservation of youth,  the  prevention of the  ageing 
process, and the preservation of  health. 
Since the Foodstuffs Inspection Service is  increasingly notified of borderline cases, 
(where it is not clear whether these health claims are forbidden or not) the Federal 
Chancellery published in June 1999 an Enactment, which provides a list of examples 
of claims which are allowed and not allowed. The Enactment is  aimed at  providing 
clearer guidelines to food inspectors. 
3.  Ethical Claims 
The issue of ethical claims has received little attention to date in Austria. There exist 
no  legislation  or  voluntary  agreements  on  ethical  claims.  Nor  are  the  authorities 
envisaging  any  legislation  on  ethical  claims.  Consumer associations  indicated  that 
ethical labels do not so far have a great influence on the shopping habits of Austrian 
consumers. 
C.  VOLUNTARY CODES OF PRACTICE 
Although  there  exists  no  voluntary  agreement  on  nutritional  or health  claims,  an 
industry voluntary agreement  was  set up  in  September  1995  which was  geared  at 
protecting  Austrian  consumers  from  misleading  advertising.  As  such,  it  indirectly 
impacts on claims. This voluntary agreement also contains a section on health, which 
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This voluntary agreement is a self-restraining agreement, i.e. whereby industry agrees 
not  to  make  certain  claims  in  advertising.  The  authorities  consider  this  voluntary 
agreement  to  be an  element  of consumer protection  and  an  additional  support  to 
existing legal provisions. 
D.  VERIFICATION SYSTEMS 
With  regard  to  the  substantiation  of claims,  in  the  case  of nutritional  and  health 
claims,  Austrian  authorities  require  manufacturers  to  send  in  information  on  the 
composition of the  product and  a copy of the  label.  In  addition,  for  health claims, 
(which are complex or could be controversial) an explanation must be included. There 
are no  suggested or mandatory formats  or guidelines for supplying the information. 
However, the Federal Chancellery indicated that if more qualitative support material 
is  provided for  substantiating a claim,  the  authorisation process  will  be easier and 
faster. 
There is  no  legal  timeframe  for  the  approval  procedure of claims.  In practice,  the 
duration  varies  considerably according  to  the  type  of claim and the  quality of the 
information  provided.  It can  take  between  6  months  and  2  years.  On  average  a 
decision is  made within 3 to  6 months. On average  1000 to  2000 authorisations are 
requested per year. Claims for which an authorisation is requested most frequently are 
claims in line with current trends (i.e.,  staying fit,  losing weight), such as  "reduces 
weight" or "encourages digestion". 
The Federal Chancellery can withdraw a manufacturer's authorisation for the use of a 
certain claim, if it considers that the grounds on which the claim was originally based 
is no longer valid. 
As to post-clearance, the supervision of the products on the market is exercised at the 
level  of the  regions.  There  are  nine  regional  bodies  in  charge  of supervision  and 
analysis of foodstuffs. 
If the authorities start an  investigation or lodge a complaint, the  burden of proof is 
with the manufacturer.  If a party starts a legal procedure on the basis of the law on 
unfair competition, the burden of proof is  with the plaintiff. The penalties can range 
between 100,000 shillings (approx EUR 7 267) and 200,000 shillings (approx. EUR 
14 534) for fines imposed by the authorities on the basis of the food law. Following a 
procedure  under  the  law  on  unfair  competition,  products  can  be  confiscated  and 
compensation as  well  as  the publication of the judgement can be asked for  by the 
court. 
E.  MEANS OF COMMUNICATION 
Austrian legislation does not differentiate between means of  communication as it does 
not  differentiate  between  labelling  and  advertising.  Legislation  on  nutritional  and 
health claims applies to all forms of  communication. It has, however, been pointed out 
on several occasions and by all  parties (in particular the  consumer association) that 
direct mail and the Internet are very problematic. 
Pan- European study on nutritional, health and ethical claims- 1999.  117 F.  CONSUMER PROTECTION 
The  Federal  Chancellery acknowledges  that whilst certain health  claims  should be 
allowed, there was a need to protect consumers from exaggerated or inexact claims. 
Despite the fact that the authorisation procedure for health claims is  time consuming, 
the authorities consider it to be an effective means of  consumer protection. 
The Austrian consumer association felt  that, in  spite of the authorisation procedure, 
there  were  still  cases  where  the  authorities  were  allowing  misleading  claims.  An 
example provided concerned "Schonkaffee" ('light coffee' or 'soothing coffee') where 
the 'soothing' element was difficult to  see and may lead to  the assumption that this 
type of coffee "is good for you". 
G.  BARRIERS TO TRADE 
Industry indicated that,  as  Austrian legislation on health claims is  very restrictive to 
the point that some industry representatives claim that Austrian rules do not conform 
to  EU  law and,  therefore, create barriers to  trade.  They argue that companies cannot 
sell their products across the EU in a similar manner. Such barriers seem to  exist in 
particular between Austria and Germany, due to the use of the same language. 
Industry  felt  that  Austria's  authorisation procedure  for  health claims  had  created  a 
complex system with long delays for the approval of products (up to two years).  This 
created further barriers to trade. 
H.  CASELAW 
There  are  a  number  of Austrian  court  cases  with  regard  to  health  claims.  These 
indicate  that  Austrian  courts  generally  follow  a  very  strict  interpretation of health 
claims. 
I.  STAKEHOLDER ANALYSIS 
Austria is  one of the  few  countries  in  the  EU  that has established an  authorisation 
system for the use of nutritional and health claims.  While this  system is  considered 
too 'heavy' by industry, the authorities and consumer associations seem to favour such 
a system.  They believe  it  constitutes a rather good mechanism to  ensure consumer 
protection. How far such a system complies with the principle of the free movement 
of  goods is yet to be seen. A complaint has been submitted in 1998 with DG XV. 
In conclusion, the positions of the main stakeholders are: 
1.  Government Authorities 
•  On  nutritional  claims,  authorities  are  m  general  satisfied  with  the  current 
legislation. 
•  On  health  claims,  the  authorities  concede  that  certain  health  claims  should be 
allowed.  However,  in  order to  protect  consumers,  the  Austrian  system  of pre-
clearance should be applied. 
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•  Consumers  support the  system of pre-clearance for  claims  and  are,  in  general, 
against allowing health claims. 
3.  Industry 
•  With  regard  to  nutritional  claims,  industry does  in  general  not  see  a  need  for 
review  (except for  adding  some  ingredients  currently not  covered  by nutrition 
labelling). 
•  Industry  considers  Austrian  legislation  to  be  too  strict.  Physiological  claims 
should in its view be allowed. 
•  On ethical claims, there is no position. But in general, all interested parties do not 
see a need for legislation. 
* * * 
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A.  DEFINITION OF CLAIMS 
1.  Nutritional Claims 
According  to  §3(2)  of  the  Austrian  law  on  nutritional  labelling 
(Nahrwertkennzeichnung von Lebensmitteln, NMKV, 29 December 1995, BGBI. No. 
89611995, see Annex I) nutritional claims are defined as: 
"Statements, depictions or messages which, at the time of marketing of a foodstuff, 
suggest  or  directly  state  that the  foodstuff has  particular nutritional  characteristics 
because it delivers I does not deliver energy (in higher or reduced doses) or because it 
includes I does  not include nutrients  (in higher or reduced measure).  Statements or 
claims about the alcohol content of a foodstuff are not considered to  be nutritional 
claims according to this law." 
The law does not refer to drinking water, water from natural springs or natural mineral 
water as well as claims regulated by other legal acts (§ 1  (2.1 ), NMKV 1995). 
The  NMKV  is  a  direct transposition  of the  EU  Directive  90/496/EC  on  Nutrition 
Labelling of  Foodstuffs. 
2.  Health Claims 
According to  §9(1) of the  Austrian foodstuff legislation (Lebensmittelgesetz,  LMG, 
23 January 1975, BGBI. No. 86/1975, last adaptation BGBI No. 37211998, see Annex 
II)  all  health  claims  are  forbidden  on  foodstuffs  if they  fall  under  the  following 
definition: 
"Claims referring to the prevention, relief or cure of diseases or symptoms, or relating 
to physiological or pharmacological effects or the impression of causing such effects, 
especially with regards to  the preservation of youth or the prevention of the  ageing 
process as well as  the loss of weight or the preservation of health. Health claims are 
also  regarded  as  recommendations  from  doctors,  medical  reports  and  tails  about 
sickness. Furthermore, health-related, pictorial or stylised representations of organs of 
the human body, portrayals of members of the medical professions or health resorts/ 
spas  as  well  as  other  depictions  relating  to  health  are  considered  as  unacceptable 
health claims." 
The Enactment No.1  of the Federal Chancellery of2 June 1999 (GZ AV 31.901/31-
Vl/B/12/99,  see  Annex  VI)  gives  a  more  detailed  definition  of health  claims  and 
distinguishes between claims that are directly health related and may not be used on 
foodstuffs under any circumstances and claims that refer to  the well-being of people 
and may be used with or in some cases without going though the approval procedure. 
The Federal Chancellery established this  Enactment as  a point of reference for  the 
foodstuffs inspection in Austria on the request of  interested parties. 
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•  misleading for consumers 
The Enactment states  that in  order to  determine whether a claim on the  label of a 
foodstuff  is  misleading,  the  national  court  has  to  consider  how  an  alert  and 
understanding average  consumer with  an  average knowledge would understand the 
claim in question (ECJ case law, C-210/96). Examples are given (see section II.D). 
•  "disease-related"  (krankheitsbezogen)  or  give  the  impression  of having  an 
effect  in  this  direction.  (Natural  mineral  water  and  dietetic  foodstuffs  are 
excluded from this definition). Examples are given (see section II.D). 
•  The  Enactment  defines  health  claims  as  admissible  following  approval 
according  to  §9(3)  LMG  1975  if they  are  claims,  which  are  generally, 
considered to  be true and refer to the function or effect of substances in the 
human body. Examples are given (see section II.D). 
•  The  Enactment  also  gives  examples  for  claims  that  may  be  used  without 
approval as they should not be considered to be health related according to the 
definition given in §9 LMG 1975. Examples are given (see section ll.D). 
The  LMG  follows  article  2§2  of the  EU  Directive  791112/EC  on  labelling  of 
foodstuffs as well as  the Codex Alimentarius (which both states that disease related 
claims  are  not  allowed  on  foodstuffs).  Compared  with  the  proposed  Codex  draft 
recommendations for the  use  of health-claims, Austrian legislation clearly does not 
allow  disease  risk  reduction  claims  and  even  the  use  of enhanced  function  claims 
seems to be very limited. 
3.  Ethical Claims 
There are no definitions/explanations for ethical claims in Austria. 
B.  LEGISLATION IN PLACE 
t.  Nutritional Claims 
The EU Directive 90/496/EEC on Nutrition Labelling for Foodstuffs of 24 September 
1990 was transposed into Austrian law by NMKV 1995. NMKV 1995 implements the 
requirements of 90/496/EEC in  all  essential respects (i.e.  definitions,  information to 
be supplied, form  of declaration, etc.).  However,  it  does  not include a definition of 
' dietary fibre. 
Nutritional labelling is  voluntary under NMKV  1995  but it  must comply with legal 
provisions if it  is  used.  Furthermore,  as  explained above, the law does not apply to 
drinking water, water from natural springs or natural mineral water as  well as claims 
regulated by other legal acts(§ 1(2.1), NMKV 1995). 
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The  making of claims  on  product  labels  is  regulated by the  Austrian  law  on  the 
labelling of foodstuffs (Lebensmittelkennzeichnungsverordnung, LMKV, 30 January 
1993, BGBI No.  72/1993, see Annex III). For the definition of health claims and the 
implementation of the relevant provisions of Directive 79/ 112/EEC of 18  December 
1978 on the approximation of the laws of the Member States relating to the labelling, 
presentation and advertising of foodstuffs for sale to the ultimate consumer, Austrian 
legislation is regulated by LMG 1975. 
Furthermore,  the  Directive  89/398/EEC  on  the  approximation  of the  laws  of the 
Member  States  relating  to  foodstuffs  intended  for  particular  nutritional  uses 
(PARNUTS) has been transposed into Austrian legislation by LMG 1975. 
Health  claims  are  defined by §9  LMG  1975  in  a  broad  sense  as  comprising any 
information,  in  writing  or  in  pictorial  form,  which  refers  to  health  related  or 
physiological effects (see also detailed definition in Section II.A.2). Health claims are 
forbidden unless the Federal Chancellery has granted authorisation. 
Derogations apply for 'traditional health claims' if they do  not mislead the consumer. 
In  practice,  a  'traditional  health  claim'  must  have  been  in  use  for  at  least  one 
generation before  1975.  A further derogation is  given to  'truthful'  claims about the 
dietetic purpose of a dietetic foodstuff(§ 17( 1.b) LMG 1975). 
3.  Ethical Claims 
There is no legislation on ethical claims at either EU or Austrian national level. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
The NMKV 1995 sets out very clearly, which claims may be made and which claims 
cannot be made for those ingredients covered by legislation. The existing restrictions 
and exemptions relate to ingredients not covered by the NMKV 1995. It is unclear to 
all  interested parties why these  ingredients  were  left out.  However,  the  fact  of the 
matter is  that they do  lead to  restrictions.  An example, which was put forward,  are 
nutritional claims about the Potassium-content of  a foodstuff. 
2.  Health Claims 
Existing prohibitions, restrictions and exemptions for health claims are detailed in the 
Enactment No.I of the Federal Chancellery of2 June 1999. 
For health claims that are generally inadmissible because they are misleading, 
the Enactment gives the following examples: 
•  "Gesundheitstrunk" (health drink) 
•  "Ein taglicher Beitrag zur Gesundheit. .. " (A daily contribution to your health) 
•  "  ...  fur gesunde Fingemagel und Haare ...  " (for healthy finger nails and hair) 
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•  "  .. .ist  hervorragend  zum  Masseaufbau  geeignet. .. "  (is  very  well  suited  for 
building up your muscular volume) 
•  "  ...  unterstiitzt  Betacarotin  die  natiirliche  Hautbraunung, ...  "  (Beta-carotene 
supports the body's natural tanning process) 
•  "regt den Stoffwechsel an,  unterstiitzt die  Verdauung"  (encourages the  digestive 
system, supports digestion) 
•  "entwassemd" (dehydrating) 
•  "  ...  enthalt  natiirliche  Flavonoide.  Diese  konnen  bei  friihzeitigen 
Alterserscheinungen  helfen,  geistige  Erfrischung zu  schaffen"  (contains  natural 
flavonoides.  In case of signs of early ageing, these can help in creating spiritual 
freshness) 
•  " ...  kann es sinnvoll  sein,  die  Uigliche  Nahrung mit Q  10  zu erganzen,  damit sie 
ihre  volle  Lei stung erbringen konnen."  (it can make  sense to  add Q  10  to  your 
daily food in order to be able to deliver your full potential) 
For  health  claims  that  are  generally  inadmissible  because  they  are  disease-
related, the Enactment gives the following examples: 
•  "  ...  heilt Magenkrebs" (cures cancer of  the stomach) 
•  "  ...  beugt dem Herzinfarkt vor" (prevents heart attacks) 
•  "  ...  gegen Schlaganfall" (against strokes) 
•  "  ...  schiitzt vor Osteoporose" (protects against osteoporosis) 
•  "Zur  Starkung  der  Blasenfunktion"  (for  strengthening  the  functioning  of the 
bladder) 
•  "XY senkt den Cholesterinspiegel" (XY reduces the cholesterol level) 
•  "Nahrstoffe  fur. .. "iVm  Herz,  Kreislauf,  Gedachtnis, ...  "  (Nutrient  for. .. heart, 
circulation, memory) 
•  "unterstiitzt Nerven, Kreislauf, Verdauungs- und Immunsystem" (supports nerves, 
circulation, digestive and immune system) 
•  "Hilfe bei Durchfallerkrankungen" (helps relieve constipation) 
For  health  claims  considered  as  admissible  following  approval,  the  following 
examples are given in the Enactment: 
•  "Die Inhaltsstoffe der Kiirbiskerne wirken positiv auf Blase und Prostata" (The 
components of pumpkin seeds have a positive effect on the bladder and the 
prostate). 
•  "Levithin ist ein wichtiger Baustein der Zellen,  besonders der Zellmembran und 
des Nervengewebes. AuBerdem enthalt es  die  ... Linolsaure, die beim Transport 
des  Cholesterins  benotigt  wird"  (Lecithin  is  an  important  element  of cells, 
specially of the cell-membrane and of the nerve-texture. It also contains Linolacid 
which is needed for the transport of  cholesterol) 
•  "Zink  niitzt  Haut,  Haaren  und  Nageln,  es  ist  ein  wichtiges  Spurenelement  im 
Insulinstoffwechsel" (Zinc is good for skin, hair and nails, it is an important trace 
element for the insulin-metabolism) 
•  "Die  Polyphenole wirken  als  Antioxidantien  und unterstiitzen  die  korpereigene 
Abwehrkrafte" (Polyphenols act as antioxidants and support the body's resistance 
ability) 
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•  "Omega-3-Fettsauren  sind  mehrfach  ungesattigt  und  haben  einen  posttlven 
Einflu13 auf den Stoffwechsel" (Omega-3-fatty acids are polyunsaturated and have 
a positive influence on fatty-metabolism) . 
•  "Vitamin E ist wichtig flir die Funktionsfahigkeit von Muskulatur, Nervensystem 
und Fortpflanzungsorganen" (Vitamin E is important for the muscles functioning, 
nerve-system and reproductive organs) 
•  "Calcium  gehort zu den  Mineralstoffen,  die  der Korper zur  Hartung  und  zum 
Aufbau  von  Knochen,  N  ageln  und  Zahnen  benotigt"  (Calcium  is  one  of the 
minerals which the body needs for strengthening and  for growth of bones, nails 
and teeth) 
•  "Betacarotin hat die  ... Fahigkeit durch UV -Strahlung aktivierte, zellschadigende 
Substanzen, sogenannte "Freie Radikale",  abzufangen und zu neutralisieren"  (13-
Carotene has  the  ability to  catch and to  neutralise the  so-called "Free-Radicals" 
which contain through UV -rays activated cell-damaging substances) 
•  "Die ausreichende Versorgung mit Kieselerde erhalt das Bindegewebe, die Nagel, 
Haut und Haare elastisch und widerstandsfahig"  (Connective  tissue,  nails,  skin 
and hair remain elastic  and resistant if there  is  an  adequate supply of siliceous 
earth) 
•  "Bioflavonoide konnen doe negativen Einflusse von  Oxidantien auf die  Gefa13e 
vermeiden" (Bioflavonoids can avoid the negative influences of oxidants on the 
vessels) 
•  "Die  probiotischen  Kulturen  untersllitzen  bei  regelma13igem  Genu13  das 
Gleichgewicht der Darmflora, beinflussen den Stoffwechsel poitiv und starken die 
nallirlichen  Abwehrkrafte  des  Korpers"  (The  pro-biotic  cultures  support,  if 
regularly consumed,  the  balance  of intestinal  bacteria,  positively  influence  the 
metabolism and strengthen the body's natural resistance) 
For claims that may be used without approval procedure, the following examples 
are given in the Enactment: 
•  "Fur Diabetiker geeignet" (suitable for diabetics) 
•  "(apetit)anregend" (stimulates (the appetite)) 
•  "schmackhaft" (tasty) 
•  "leicht verdaulich" (easily digestible/easy to digest) 
•  "belebend" (invigorating) 
•  "bekommlich" (digestible) 
•  "cholesterinfrei" (free of  cholesterol) 
•  "kalorienarm" (low in calories) 
•  "wohltuend" (agreeable/does good) 
•  "vitalisierend" (vitalizing) 
•  "fur Wohlbefinden" (for well-being) 
•  "zur Unterstutzung bei geistiger Beanspruchung" (for support during demanding 
mental exercises) 
•  "zur Kraftigung" (for fortification) 
•  "fur Energie" (for energy) 
•  "fur Raucher" (for smokers) 
In  addition  "harmless"  and  non-deceptive  advertising  such  as  "power  drink"  or 
"stimulate the senses" are given as examples of  what is allowed. 
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There are no  existing prohibitions, restrictions and exemptions for ethical claims in 
Austria. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
Policy thinking in Austria is currently focussed on health claims. 
Legislators,  industry and  consumers  are  generally satisfied  with  nutritional  claims 
legislation  as  it  currently  exists  since  it  is  well  defined  by the  Austrian  law  on 
nutritional labelling (NMKV 1995). 
The NMKV  1995  does  have some small deficiencies because the  value of allowed 
content is  sometimes  not given and  certain nutritional  ingredients are  not included 
(e.g., potassium). This can lead to  minor problems of interpretation with regards to 
ingredients not directly covered by nutritional labelling legislation (i.e., Austrian and 
EU  legislation,  as  the  EU  directive  90/496  has  been  transposed  1: 1 into  Austrian 
legislation,  NMKV  1995).  When  such  difficulties  arise,  e.g.  "mit  rechtsdrehender 
Milchsaure" (in this case it was unsure whether such a claim could be used or should 
be  prohibited  as  it  was  not  covered  by nutritional  labelling  legislation),  Austrian 
authorities have very often taken the issue to  the EU level.  They have done this via 
their Permanent Representation in the  EU  and  through discussions with colleagues 
from other Member States (in the case of the given example it was decided, following 
an exchange of  views, that the claim should be forbidden). 
Furthermore, foodstuffs destined for human consumption but without any nutritional 
value  (e.g.  chewing  gum  or  gelatine  products)  referred  to  as  "Verzehrprodukte" 
(definition  in  §3  LMG  1975)  are  legally  excluded  from  the  NMKV  1995,  but 
nevertheless follow the nutritional labelling law. 
2.  Health Claims 
According to the Federal Chancellery, the LMG  1975 as well as the LMKV 1993  are 
a good basis on which the use of health claims in Austria can rest. The ministry is of 
the opinion that the use of certain health claims should be allowed but that there is  a 
real  need  to  protect  consumers  from  exaggerated  or  inexact  claims  made  by 
manufacturers. 
According to  industry, the LMG  1975 is too broad as it includes under health claims 
both physiological and disease related claims.  It believes that there should be some 
differentiation. 
a.  Ministries 
Despite the pre-clearance system, legislation on health claims does  leave some grey 
area as it is not always necessarily clear from the LMG 1975, which claims should be 
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allowed  and  which  claims  should  not.  The  Foodstuffs  Inspection  has  to  be 
increasingly notified of  borderline cases. At present there are about 100 of  these cases 
a year.  The Federal Chancellery,  therefore,  recently decided to  issue an Enactment 
(Enactment No.  1,  2 June  1999)  in  order to  provide clearer guidelines  to  the  food 
inspectors and inspections when evaluating claims.  The Enactment is  considered to 
add to  the  LMG  1975  and to  help establish more uniform procedures between the 
Austrian Lander for the use of  claims. 
Barriers to  trade exist in  cases where a claim made on a product marketed in both 
Germany and Austria (which use the same packaging as  the same language is being 
used in both countries) contains a health claim which is allowed in Germany, but not 
allowed in Austria, e.g.  "gesund" (healthy). A typical product where this is the case is 
"Jodsaltz"  (iodine  containing  salt)  which  is  marketed  in  Germany  with  the  claim 
"gesiinder durch Jodsaltz"  (healthier because of iodine-containing salt).  This  is  not 
allowed in  Austria as  - unlike Germany - enough iodine is  contained in the natural 
environment and the claim is, therefore, unsubstantiated. 
As the NMKV 1995 does not take account of certain nutritional ingredients, Austrian 
authorities did mention that  it  would be useful  to  revise  the  legislation in  the  near 
future to take account of these missing elements. 
b.  Industry 
Industry stressed that Austrian legislation for health claims is  very restrictive to  the 
point where some industry protagonists claim that Austrian rules do  not conform to 
EU  law (see in particular Christian Hauer,  "Osterreichisches Lebensmittelrecht und 
EU",  pp.  79-81,  Annex  IX;  and  Christian  Hauer,  "Verbot  gesundheitsbezogener 
Angaben  (§9  LMG  1975)  und  Gemeinschaftsrecht",  Emahrung!Nutrition,  Vol.  23, 
No.3 1999, Annex X). 
This situation creates barriers to trade, as companies cannot sell their products across 
the whole EU in a similar manner because Austria is much more restrictive than other 
EU  Member States in the use of health claims.  This causes a restriction in  the free 
movement of  goods). 
c.  Consumers 
According to  the  consumers,  one  of the  main problems  of Austrian  legislation on 
health claims is that it is not restrictive enough and that there are still cases in which 
claims are being allowed by the authorities which are misleading. An example given 
was  "cholesterol  free  rape-seed  oil".  Here  it  was  difficult  to  prove  whether  the 
product is really free of  the ingredient and what this means for the consumer. Another 
example was  "Schonkaffee"  ('light  coffee'  or 'soothing coffee')  where  the  'light'  or 
'soothing' element is  difficult to  see and may lead to the assumption that this type of 
coffee "is good for you". 
3.  Ethical Claims 
Ethical  claims  are  not  considered to  be a  high priority.  There  is  no  legislation  in 
Austria on ethical claims and there are no attempts by the government to propose such 
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this field to date. 
Consumer associations have informed us that ethical labels do so far not have a great 
influence on the shopping habits of Austrian consumers. 
III.  VOLUNTARY INSTRUMENTS 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
There  are  no  voluntary instruments  in  place  in  Austria,  which  regulate  the  use of 
nutritional claims. The use of  nutritional claims is solely regulated by NMKV 1995. 
2.  Health Claims 
There are no  voluntary instruments in  place in Austria regulating the  use of health 
claims on product labels as this is regulated by LMG 1975 and LMKV 1993. 
There  is,  however,  an  industry  voluntary  agreement  ("Der  Osterreichische 
Selbstbeschrankungskodex")  of 28  September  1995  geared  at  protecting  Austrian 
consumers from misleading advertising (see Annex VIII), which indirectly impacts on 
claims. It is  a self-restraining agreement,  i.e.  whereby industry agrees  not to  make 
certain claims in advertising. It was established by the Austrian Advertising Council 
(Osterreichischer Werberat) located within the Austrian Association for  Advertising 
and  Marketing Communications (Fachverband Werbung und Marktkommunikation) 
and includes a section on "health" (Gesundheit). 
The  Austrian  Voluntary  Agreement  is  divided  into  two  parts.  The  first  part 
"grundsatzliche  Verhaltensregeln"  (fundamental  rules  of  conduct)  deals  with 
guidelines for sensitive areas (ethics, violence, health, security and environment) and 
is  considered  to  be  the  centrepiece  of the  agreement.  The  second  part  "spezielle 
Verhaltensregeln"  (specific  rules  of conduct)  deals  with  areas  that  have  received 
particular attention over time at national and international level and,  therefore, need 
specific rules. 
3.  Ethical Claims 
There are no voluntary agreements in Austria on the use of  ethical claims. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
Not applicable. 
Pan-European study on nutritional, health and ethical claims- 1999.  127 I 
2.  Health Claims 
The definition used in the voluntary agreement is very similar to the definition used in 
§9 LMG 1975. Section 1.4, point 5.1  ofthe Austrian voluntary agreement refers to the 
use of  health claims. It says: 
"Claims  which  refer  to  physiological  or  pharmacological  effects  and  give  the 
impression to the consumer that the product which is  being advertised preserves the 
health, reduces or reverses the ageing process, reduces body weight without a change 
in the way of life, has a dietetic effect or a similar effect should not be made" (literal 
translation, see annex VIII for original text). 
Otherwise,  the  agreement mainly refers  to  the  prevention of misleading claims  or 
pictorial representations. In particular, section 1.4, point 5 generally states that: 
"Advertising of  health should not be misleading" 
Regarding  pictorial  representations,  there  is  no  direct  relation  in  the  text  between 
health claims and pictorial representations, but the use of such representations should 
generally be avoided according to  the agreement in general and according to  section 
1.4 in relation to health. 
3.  Ethical Claims 
Not applicable 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
Not applicable. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
The  Austrian Voluntary Agreement states in  its  introduction that  it  is  an  important 
element  for  consumer protection  against  misleading  advertising.  Furthermore,  'the 
self-regulatory  mechanisms  of the  advertising  sector  should  oversee  and  correct 
erroneous developments around the legal provisions'. Austria is described as a country 
with  a  rather  well  developed  system  for  consumer  protection  and  the  voluntary 
agreement should add to that, in particular with regards to more sensitive areas. 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The voluntary agreement is  accepted by the  authorities as  an  element of consumer 
protection and an addition to existing legal provisions. 
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Not applicable. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
Approval for the use of nutritional claims needs to be given by the Austrian Federal 
Chancellery prior to  marketing a product. In order to  assess the accuracy of claims 
companies must submit, according to LMG 1975, information to the authorities on the 
substances used when manufacturing the product and a copy of the label to  be used. 
Manufacturers and importers may also be requested to supply additional information 
on the composition of the product and the way it  is prepared if this is  necessary for 
reasons of  public health protection, and protection against fraud. 
There are no suggested or mandatory formats or guidelines as to how the information 
should be supplied. 
2.  Health Claims 
Approval for the use of health claims on foodstuffs needs to  be given according to 
§9(3)  LMG  1975  by the Federal Chancellery.  In  order to  assess  the  accuracy of a 
claim the manufacturer must send in information on the composition of the product 
and a copy of the label to be used. The Federal Chancellery also pointed out that if the 
claim is complex or could be controversial, an explanation must be included. 
As for nutritional claims, there are no suggested or mandatory formats or guidelines 
for supplying the information. However, the Federal Chancellery pointed out that if 
more qualitative support material is  given for substantiating a claim, the process will 
be easier and faster.  Companies usually recognise this and send in the right type of 
information. 
The Federal Chancellery takes all information supplied into account when it makes its 
decision, including references to websites. 
3.  Ethical Claims 
Not applicable. 
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B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/Guidelines 
See Section IV.A (above). 
There is no legal timeframe. In practice, the duration of the approval procedure varies 
considerably  according  to  the  type  of claim  and  the  quality  of the  information 
provided. It can take between 6 months and 2 years.  On average a decision is made 
within 3-6 months. 
The Federal Chancellery can also withdraw a manufacturer's authorisation for the use 
of a certain claim if it considers that the grounds on which the claim was originally 
based are no longer valid (see point 2 below). 
2.  Post-Clearance Rules/Guidelines 
The supervision of the products on the market is  exercised at the level of the regions 
(Lander).  There  are nine  regional  bodies  in  charge of supervision  and  analysis  of 
foodstuffs  (Lebensmittelaufsichten)  with  a  total  of 260  staff.  Each  region has  one 
Executive Officer (Landeshauptmann) who is  in charge of the supervisory body. The 
Executive Officers report to the Federal Chancellery's Food Surveillance Authority. 
The Landeshauptmiinner take samples of products and their advertising and these are 
transferred  to  the  regional  supervisory  body  for  analysis  on  their  composition, 
labelling and advertising claims. All information supplied with or in  vicinity of the 
product is  also  analysed.  About  150,000  samples are  taken each year and  of these 
about 41 ,000 are analysed. 
If a product is not in line with the relevant provisions for claims a negative report is 
sent  to  the  Food  Surveillance  Authority  which  lodges  a  complaint  with  the  High 
Administrative Court (Verwaltungsgericht), which is  an obligatory process according 
to §44 LMG 1975. In principle, any person working for the surveillance of foodstuffs 
in Austria can lodge this type of complaint. 
Competitors and social partners (but, at present, not consumer associations) can also 
start  court proceedings  on  the  basis of misleading advertising in  order to  take  the 
product off the market or to claim compensation under the law on unfair competition 
(Bundesgesetz gegen den unlauteren Wettbewerb, UWG, 1984, BGBI No.  44811988, 
last modified by BGBI 42211994, see Annex IV). The UWG 1984 transposes the EU 
Directive  84/450/EEC  on  the  approximation  of  the  laws,  regulations  and 
administrative provisions of  the Member States concerning misleading advertising. 
The  UWG  is  being  modified  at  the  moment  to  also  offer  the  Austrian  consumer 
association,  the  VKI  (Verein fiir  Konsumenteninformation),  the  possibility  to  start 
court proceedings on the basis of the misleading advertising provisions (modification 
of §14(1),  see  annex  IV).  The  UWG  is  being modified  in  order to  implement the 
Directives 9717 /EEC and 98/27 /EEC on consumer protection. 
Pan- European study on nutritional, health and ethical claims- 1999.  130 The proposed modification of UWG 1984 has been approved by the Austrian Council 
of  Ministers. However, it still needs to be passed through Parliament, which could still 
be done in this legislature, according to the V_KI.  The VKI also mentioned that there 
are not very many cases started under UWG 1984.  This is because only a few dare to 
do so and the proceedings can take between 2 and 3 years. 
Each of the most recent judgements of the High Administrative Court (March 1999) 
cost the losing party 4,565 shillings (approx. EUR 331 ). 
According to the authorities, the pre-clearance procedure for claims (§9 LMG 1975) is 
somewhat inconvenient. This is because it is very time consuming since every claim 
has  to  be examined on  its  own merits  (see  section  IV).  Nevertheless, the  Austrian 
authorities consider it very useful and necessary as it guarantees to a very large extent 
that claims made by manufacturers are as close to the truth as possible. 
In  industry's  view,  the  pre-clearance  system of §9  LMG  1975  does  too  much  for 
consumer protection and leaves industry behind with a complex system of long delays 
for  the  approval  of products  (up  to  two  years).  In  industry's  opinion,  a  delay  of 
maximum 6 months should be allowed. 
Furthermore, there is no overview of what type of claims has been allowed and what 
type  of claims  has  not  been allowed,  which  makes  the  current system  unclear.  It 
would be beneficial to have a system, which is more transparent as to the reasons why 
certain claims were allowed on particular products.  This would make it possible to 
find  a  way of speeding-up  the  approval  of claims  that  already  exist  for  similar 
products. 
An issue,  which is  very important for  the  consumer association is  that they do  not 
have any means of  taking legal action at present where they would consider that legal 
action is required because of a misleading claim. This leads, in their opinion, to a lack 
of consumer protection and a lack of input from an important actor in society. It was, 
however,  also  pointed out that  the  law  against unfair competition (UWG  1984)  is 
currently being revised to give consumers the right to take legal action. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Currently, the authorities dealing with the supervision of foodstuffs, competitors and 
social  partners  (except  consumer associations)  may  take  legal  action  according  to 
UWG 1984. 
D.  BURDEN OF PROOF 
The burden of proof is  always with the manufacturer or importer when the claim is 
sent to  the Federal Chancellery. Decisions are based on the information supplied by 
the manufacturer or importer in question. 
If the authorities start an  investigation or lodge a complaint, the burden of proof is 
with  the  manufacturer.  If a  party  starts  a  legal  procedure  on  the  basis  of unfair 
competition (UWG 1984), the burden of  proof is with the plaintiff. 
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E.  APPLICABLE PENAL  TIES 
The LMG  1975  foresees  administrative and judicial penalties. Penalties can be of a 
maximum amount of 100,000 shillings (aprox. EUR 7 267), and a repetition can entail 
a fine of  up to 200,000 shillings (EUR 14 534). 
Following  a  procedure  under  the  UWG,  products  can  be  confiscated  and 
compensation as well as the publication of  the judgement can be asked by the court 
V.  CASELAW 
1.  Nutritional Claims 
No case law on nutritional claims has been brought o our attention. 
2.  Health Claims 
We have been informed about the following cases by industry: 
•  Decision ofthe Verwaltungsgerichtshof, 30 January 1979 
The  product  in  this  case  was  coffee  labelled  with  the  claim  "Schonkaffee", 
meaning that it  is  free  from  unwelcome stimulating/bitter characteristics and  is, 
therefore,  a pleasure  for  many sensitive stomachs  ("mit  schonender Wirkung"). 
The administration had considered that such a claim was  misleading.  However, 
the highest administrative court overruled this decision. 
•  Decision of  the Verwaltungsgerichtshof, 12 May 1980 
The product, fruit candy tablets, was considered by the administration not to be a 
foodstuff but a medical product that should be notified as a pharmaceutical (under 
the  medical  products  law,  Arzneimittelgesetz,  AMG,  2  March  1983,  BGBI 
No.185/1983,  last  amended  by  BGBI  No.  78/1998,  see  Annex  V).  The 
administration based its  decision on  the  Vitamin C content of the product.  The 
highest administrative court overruled this decision, confirming that upon request 
the administration should allow health claims that are  not consumer misleading. 
Therefore,  foodstuffs  can  also  carry  claims  stating  that  they  can  have  healing 
benefits without them being defined as pharmaceutical products. 
•  Decision ofthe Verwaltungsgerichtshof, 14 January 1985 
The product, mint-hops syrup, was not allowed to be labelled with the claim that it 
was 'relaxing the nerves and stimulating the readiness to sleep'.  It considered the 
product under those circumstances to  be a medical product and  not a foodstuff. 
The highest administrative court confirmed this decision. 
•  Decisions (3) ofthe Verwaltungsgerichtshof, 22 March 1999 (see annex VII) 
Three cases were decided on 22 March 1999 where the administration had decided 
that  certain  products,  to  be  registered  as  foodstuffs  (more  precisely  as 
'Verzehrprodukte'),  could  not  be  allowed  onto  the  Austrian  market  - although 
already marketed in Germany - because of health claims which are inadmissible 
Pan- European study on nutritional, health and ethical claims- 1999.  132 according to  §9  LMG  1975.  In  all  three  cases  the  highest administrative court 
confirmed the decision. 
In all of  these cases, it was also claimed that the Austrian procedure for registering 
products  was  too  long  and  not  easily  accessible  and,  therefore,  constituted  a 
barrier to trade (free movement of goods) within the EU as  these products were 
already being sold in Germany with the  same label.  The highest administrative 
court rejected these arguments, saying that the delay was reasonable for the claims 
being made and,  more  importantly,  that the  refusal  by the  Austrian  authorities 
does  not constitute a barrier to  intra-EU  trade.  Rather the  court argued  that  it 
guarantees  the  protection  of consumers  and  public  health  from  misleading 
claims/advertising. 
•  Procedure  about  Free  Movement of Goods  with  the  European  Commission 
DGXV 
A procedure was initiated with the European Commission's DGXV (No. 98/4739) 
regarding difficulties for marketing foodstuffs in Austria because of §9 LMG 1975 
and these difficulties constituting a barrier to  intra-EU trade and therefore going 
against the principle of  free movement of  goods. 
3.  Ethical Claims 
There is no case law in Austria on the use of ethical claims. 
VI.  MEANS OF COMMUNICATION 
Austrian legislation does not differentiate between means of  communication as it does 
not  ditierentiate  between  labelling  and  advertising.  Legislation  on  nutritional  and 
health claims applies to all forms of  communication. 
It has, however, been pointed out on several occasions and by all parties (in particular 
the consumer association) that direct mail and the Internet are very problematic. It is 
almost  impossible  to  track  the  sort  of claims  made  on  the  Internet.  Furthermore, 
products sold in other markets where health claims are allowed which are prohibited 
in Austria can enter the country via direct mail order services (although not in large 
quantities). 
VII.  STATISTICS ON CLAIMS 
There are no statistics available in Austria with regards to  the frequency of use  and 
types of  nutritional, health or ethical claims. 
However,  the  Federal  Chancellery  informed  us  that  the  claims  for  which  an 
authorisation is requested most frequently are claims in  line with current trends (i.e. 
staying fit, losing weight) such as "reduces weight" or "encourages digestion". 
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two-thirds are granted after modification (which is often substantial). 
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C.  BELGIUM 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
The  study  was  well  received  by  all  interested  parties,  except  for  the  Belgium 
consumer association 'Test Achats/Testaankoop', which was not willing to participate 
in  the  study.  Due to  the  dioxin  crisis,  it was  difficult to  get  into  contact with  the 
Belgium administration. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of a nutritional claim is  the  same as  defined in  EU  law.  There  are 
currently no policy initiatives envisaged with regard to nutritional claims. 
2.  Health Claims 
With regard to  health claims, Belgian legislation does not use the same wording as 
Directive  79/112,  which  forbids  making  reference  to  the  prevention,  curing  or 
treatment of diseases.  Instead,  the  word  'illness'  and any synonyms  of it,  certain 
health-related words, pictures and/or references are forbidden.  It is clear that disease 
risk reduction claims, as  defined under the  latest Codex recommendations on health 
claims are not allowed under Belgian law. 
Due to the elaboration of the voluntary code of conduct on health claims (see below), 
the Belgian authorities have indicated that there will be a need to revise the working 
of the legislation on food advertising, in order to allow disease risk reduction claims. 
The  Belgian  food  industry  considers  current  legislation  far  too  restrictive.  In 
particular, the  authorisation system for  foodstuffs  for  particular nutritional uses and 
the pre-clearance system for foodstuffs to which nutrients have been added. 
3.  Ethical Claims 
NGOs, such as Max Havelaar and Oxfam, as well as consumer associations have been 
the  driving force behind social  labelling.  Public authorities and industry have also 
become more  and more interested in  the  issue.  There are  currently two  legislative 
proposals on the  table.  On the one hand, a draft law for the  promotion of socially 
responsible production.  In order to promote a socially responsible product, the draft 
law foresees  a certificate for companies and a label for their products if they fulfil 
certain ILO standards.  The exact modalities for obtaining both the certificate and the 
label  are  still  to  be  determined in  the  form  of a Royal  Decree.  Under the  law,  a 
Council of Appeal will be set up  to handle complaints on the abuse or misuse of the 
label. 
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provisions  with  an  ethical  notion  to  the  Belgian  law  on  unfair  competition  and 
consumer  information.  The  amendment  foresees  that  ethical  claims  may  be 
considered as  misleading advertising and proposes to  establish fines  for companies, 
which make ethical claims in their advertising without substantiating them. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional and Health Claims 
While no  voluntary codes on nutritional  claims  are  planned,  the  food  industry  has 
been the driving force for the elaboration of a voluntary code on health claims.  It has 
been  elaborated  together  with  manufacturers,  distributors,  scientists,  consumer 
associations and the government.  The distributors and the Health Council have so far 
approved it, but consumers are still hesitant and do not see it as  a priority.  The code 
distinguishes  between four  types  of health  claims  (nutrient function  claims,  health 
effect claims,  healthy eating patterns claims  and  disease risk reduction claims).  It 
establishes a number of criteria for substantiating health claims and rules for  using 
them on packaging or in advertising. 
Its final adoption is planned for the end of 1999/beginning of 2000 and will - if all 
goes well -be starting a two-year test period thereafter. 
The food industry is in favour of extending such a voluntary code to the whole of the 
EU.  In  order  to  achieve  this  it  considers  it  necessary  to  have  mutual  recognition 
between the  competent national  authorities,  and  to  move  away  from  the  idea  that 
different national systems are necessary because the issue affects "public health". 
2.  Ethical Claims 
There  is  a  voluntary  'fair trade  label'  in  Belgium,  which  is  issued  by  the  Max 
Havelaar group for coffee and bananas.  The labels do not carry any claims, only the 
logo of  the organisation. 
D.  VERIFICATION SYSTEMS 
Under Belgian legislation, for foodstuffs for particular nutritional uses, as well as  for 
nutrients and foodstuffs to which nutrients have been added, the proposed label and 
information on the composition of  the product must be sent to the Ministry of Health. 
For foodstuffs for particular nutritional uses, an authorisation has to be obtained from 
the  Food  Inspection  Unit  of the  Ministry  of Health  prior  to  its  marketing.  A 
somewhat different pre-clearance system is  in place  for  nutrients and foodstuffs  to 
which nutrients have been added.  A  prior notification procedure applies  for  these 
products,  whereby  the  Food  Inspection  can  make  comments  within  one  month, 
notably asking the manufacturer to modify the labelling. 
Post-clearance is undertaken by the Food Inspection Unit.  The Food Inspection Unit 
receives  annually  approximately  500  notifications  for  nutrients  and  foodstuffs  to 
which nutrients are added and conducts about ten a posteriori investigations per year. 
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manufacturer.  All third parties can take legal action.  The fines imposed by the Food 
Inspection usually range between 250 and  I ,250 Euro.  According to the authorities 
and the food industry, there exists no case law on nutritional, health or ethical claims. 
E.  MEANS OF COMMUNICATION 
There exist no differences between means of communication, except for the Belgian 
nutritional  labelling  decree,  which  does  not  apply  to  audio-visual  means  of 
communication. 
F.  CONSUMER PROTECTION 
In  general,  the  consumer  association  (Centre  de  Recherche  et  d'Information  des 
Organisations de Consommateurs) pointed to  the difficult of interpretation of health 
claims and that these were often misleading, as most people do  not have a profound 
understanding  of foodstuffs  and  the  effect  of particular  ingredients.  In  order  to 
increase  the  awareness of consumers  and  to  bridge the  knowledge  gap,  they have 
issued several publications on understanding nutrition and health claims. 
G.  TRADE BARRIERS 
Overall, no  problems were reported with regard to  nutritional claims.  The  Belgian 
food industry indicated that there was sometimes a problem as  a claim on a certain 
nutrient was allowed in one Member State but not in another. 
Food  industry  considered  Belgian  legislation  too  restrictive,  in  particular  the 
authorisation  system  for  foodstuffs  for  particular  nutritional  uses  and  the  pre-
clearance  system for  foodstuffs  to  which nutrients have  been added.  The  Belgian 
food industry pointed out that there are trade barriers between all EU  Member States, 
but they are not always visible mainly because of the different languages used.  They 
were, however, visible between countries that use the same language (e.g.  Belgium-
The Netherlands).  The food  industry refers to  these barriers as  ""language  induced 
trade barriers". 
There have been no problems reported with regard to ethical claims. 
H.  CASELAW 
According  to  the  Food  Inspection  Unit,  there  is  no  known  case  law  on  nutrition, 
health or ethical claims.  The Belgian Food Industry Association (FEVIA) conducted 
research a short while ago and did not find any records of  case law. 
I.  STAKEHOLDER ANALYSIS 
Belgium has introduced a system, which allows for the verification of many claims. 
As for foodstuffs for particular nutritional uses, an authorisation system applies.  For 
nutrients and foodstuffs to which nutrients have been added, a pre-notification system 
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very much on top of the agenda and in which legislation is being prepared in this area. 
1.  Government Authorities 
•  On nutritional claims, no need for review is seen. 
•  On health claims, authorities acknowledge that legislation has to  be modified in 
one form or the other, in order to  allow disease risk reduction claims, following 
the adoption of the Belgium voluntary code on health claims. 
2.  Consumers 
•  Consumers underlined that health claims are often misleading, as most consumers 
do  not  have  a  deep  knowledge  about  foodstuffs  and  the  effect  of particular 
ingredients. 
3.  Industry 
•  On health claims, industry considers the voluntary code currently being elaborated 
in Belgium a step in the right direction.  Industry is in favour of extending such a 
code to the whole of  the EU. 
•  On ethical claims, the overall opinion seems to be that these are useful to promote 
products  that  have  been  ethically manufactured.  However,  a  clear  regulatory 
framework should apply for such claims. 
* * * 
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II.  MEMBER STATE POLICY 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The definition  of nutritional  claims  in  Belgium  is  given  in  the  Royal  Decree  on 
nutritional  labelling  of foodstuffs  of 8  January  1992  (published  in  the  Belgisch 
Staatsblad/Moniteur Beige of  21  February 1992, see annex I). Art.1, §2 states that: 
Nutritional  claims  are  considered  to  be  all  indications,  representations  and 
advertising messages which  state,  suggest or imp(v that a foodstuff has particular 
nutritional characteristics or qualities with regard to energy content, i.e.  it: 
supplies, 
supplies to a higher or lower level, or 
does not supp(v, 
and/or with regards to nutritional substances/content, i.e.  it: 
contains, 
contains to a higher or lower level, or 
does not contain. 
Furthermore, the qualitative or quantitative indication of a nutritional substance does 
not constitute a nutritional claim as these are described by the decree and the Minister 
responsible may decide in certain cases whether the conditions foreseen in this section 
are being met. 
The definition is a literal translation from the EU Directive on Nutrition Labelling. 
Art.  11  of the law on nutritional labelling also amends Art.3, §3 of  the royal decree on 
advertising  of  foodstuffs  of  1  7  April  1980  (published  in  the  Belgisch 
Staatsblad/Moniteur Beige of 6 May 1980, amended by the royal decree of 4 August 
1983,  see  annex  II).  It  now  states  that  nutritional  claims  used  in  advertising  of 
foodstuffs  must contain the  same  information given on  the  label of the  product as 
defined  by  the  law  on  nutritional  labelling.  This  does,  however,  not  apply  to 
advertising via audio-visual means. 
2.  Health Claims 
There  is  no  direct  definition  of what a  "health claim"  is  in  Belgium.  There  are, 
however, restrictions with regards to  the use of health-related words, pictures and/or 
references on labels and in  advertising. These are defined by the Royal Decree of 1  7 
April  1980  on  Advertising  of Foodstuffs  (article  2  and  3).  They  state  that  the 
following is forbidden: 
•  the use of the words "hygiene", "medical", "ill" or "illness" and any variations, 
translations or synonyms of  these words; 
•  the  name  of illnesses,  depicting  symptoms  of illnesses  and  depicting  people 
suffering from an illness; 
•  references to reducing weight/thinning down; 
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effect the foodstuff could have on them; 
•  pictures of people,  clothes  or equipment which make  reference to  the  medical, 
paramedical or pharmaceutical profession; 
•  references to  recommendations, certificates, declarations or medical  opinions as 
well as endorsements, except of  the statement that a foodstuff may not be taken in 
against a medical opinion; 
•  references  to  the  Minister,  the  Ministry of Public  Health  or the  services,  civil 
servants or regulations of  the Ministry of Public Health or any other bodies active 
in the area of  public health; 
•  the  use  of the  words  "biological",  "organic",  "reform"  and  any  variations, 
translations or synonyms of  these words; 
•  the  use  of the  words  '"natural",  "pure"  and  any  variations,  translations  or 
synonyms of  these words; and 
•  the use of  the words "nutritious", "high-energy", "low-calorie", '"high-calorie" and 
any variations, translations or synonyms of  these words. 
Advertising as defined in this royal decree also includes labelling. 
It  is  interesting  to  note  that  the  Belgium  decree  is  not using the  wording used  in 
Directive 79/112 that reference to  the prevention, curing or treatment of diseases are 
not allowed.  Nevertheless, as the word 'illness' and any synonyms of  it are forbidden, 
it  is  clear  that  disease  risk  reduction  claims,  as  defined  under  the  latest  Codex 
recommendations on health claims are not allowed under Belgian law. 
3.  Ethical Claims 
There is  no definition of ethical claims in Belgian legislation yet, but legislation has 
been proposed and the proposed modification of the  law on unfair competition (see 
section B.2.b) includes the following wording on ethical claims in §  1: 
"  ... ethical claims of  a philanthropic or humanitarian nature or claims which evoke 
the generosity of  consumers". 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
The EU Directive on Nutritional Labelling for Foodstuffs of 24 September 1990 was 
transposed  into  Belgian  Law  by  the  Royal  Decree  on  Nutritional  Labelling  of 
Foodstuffs of 8 January 1992 and the Royal Decree on the Marketing of Nutrients and 
Foodstuffs  to  which  Nutrients  have  been  added  of  3  March  1992  (Moniteur 
Belge/Belgisch Staatsblad, 15 April 1992, see annex Ill). 
The EU  Directive on PARNUTS 89/395/EEC of 3 May  1989  was  transposed  into 
Belgian legislation by the Royal Decree of 18  February 1991  relating to  Foodstuffs 
for Particular Nutritional Uses (Moniteur Belge/Belgisch Staatsblad, 30 August 1991, 
annex XI). 
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2.  Health Claims 
Health  claims  are  mainly  regulated  by  the  Royal  Decree  of  17  April  1980  on 
Advertising of Foodstuffs. This decree regulates the use of health claims and defines 
what types of  claims may be used and what types of  restrictions apply. 
The relevant provisions of the  EU Directive on Misleading Advertising have been 
transposed into Belgian law by the Law on Unfair Competition of 14 November 1983, 
modifying the law of 14 July 1971  (Moniteur Belge/Belgisch Staatsblad, 8 December 
1983, see annex IV) and the Law on Unfair Competition and Consumer Information 
and Protection of 14 July 1991  (Moniteur Belge/Belgisch Staatsblad 29 August 1991, 
see annex XII). 
3.  Ethical Claims 
Not applicable. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Nutritional claims that may be used are restricted to  the ingredients referred to in the 
relevant legislation.  We have not come across any particular ingredients that have 
been described as particularly problematic or that have been left out. 
2.  Health Claims 
For the restrictions on health claims, see chapter II. A. 2. 
3.  Ethical Claims 
Not applicable. 
D  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Health and Nutritional Claims 
There are no new legislative  initiatives  on  nutritional  claims or health claims.  The 
government has, however, indicated that there will be a need to revise the working of 
the  legislation on advertising of food with regard to  health claims once the code of 
conduct (see section III. A).  1.) has been approved. 
According to the food industry, the voluntary code of conduct (see section III.  A.  1.) 
that is  currently being drawn up is a step in the right direction and will allow for a 
system in which industry takes responsibility. There is  a necessity to  extend such a 
code to  the whole EU  on the basis of the nutritional labelling directive.  In order to 
achieve this, it will be necessary to have mutual recognition between the competent 
national authorities and to move away from the idea that different national systems are 
necessary because the issue affects "public health". 
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restrictive than in other EU Member States). In particular, the authorisation system for 
foodstuffs for particular nutritional uses and the pre-clearance system for foodstuffs to 
which nutrients have been added is considered cumbersome (see chapter V). 
In Belgium, the use of the word "disease" is prohibited. In The Netherlands, its use is 
possible. Industry indicated that manufacturers have adapted themselves and the claim 
does,  therefore,  not  figure  on  the  label.  The  same  applies  for  claims  on  certain 
nutrients.  Sometimes  they are  allowed in  one  country but forbidden  in another.  In 
order not to  have to  produce different packaging, manufacturers need to  go  for the 
minimum instead of  the most applicable claims. 
The  Belgian food  industry pointed out that there  are trade barriers between all  EU 
Member  States,  but  they  are  not  always  visible  mainly  because  of the  different 
languages  used.  They  are,  however,  visible  between  countries  that  use  the  same 
language as, for example, Belgium and The Netherlands (or Austria and Germany, see 
report on Austria).  The Belgian food  industry refers  to  these barriers  as  '"language 
induced trade barriers". 
The  centre  de  Recherche  et  d 'Information  des  Organisations  de  Consommateurs 
(CRIOC/OIVO) was particularly helpful.  In  general, CRIOC/OIVO have pointed to 
the difficulty of interpretation of health claims and to the fact that they are very often 
misleading as most people do not have a profound understanding of foodstuffs and the 
effect of  particular ingredients. In order to increase the awareness of consumers and to 
bridge  the  knowledge  gap  they  have  issued  several  publications  on  understanding 
nutrition and health claims (see CRIOC/OVIO publication in annex X). 
2.  Ethical Claims 
Industry indicated that they believe ethical and social claims to be an interesting and 
new field that is rapidly developing, in which consumer associations and NGOs have 
so far taken the lead. 
No mention was made of  the lack of  consumer protection or barriers to trade. 
Consumer associations are particularly interested in ethical and social claims as it has 
been a relatively unexplored area thus  far.  Social and  ethical claims were also  the 
subject  of  a  conference  on  responsible  consumption  in  December  1998  (see 
conclusions  and  recommendations  attached,  annex  IX).  Consumer  associations 
declared that their aim is to establish a clear regulatory framework for social labelling. 
Social  labels  should  inform  consumers  about  the  way  in  which  goods  are  being 
produced and should make them confident that products with such labels have been 
produced under fair and socially responsible circumstances. 
According to consumer associations, NGOs have been the driving force behind social 
labelling, e.g.  Max Havelaar, Oxfam, etc., and a regulatory framework needs to  take 
account of their experiences.  From the consumer's point of view, social labelling is a 
necessity and should go in parallel with adequate and independent control. 
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Furthermore, social and ecological labels should be combined - while taking account 
of the  different  criteria used - as  there  is  some  competition  among them  already 
today. Combining them should be done in the interest of clarity and transparency vis-
a-vis the consumer.  No further explanations were given as to how this could be done. 
Public  authorities  have  also  actively  started  to  undertake  measures  to  create  a 
framework for social labelling.  Like industry, they are interested in the topic and see 
it as one of the emerging issues on labelling.  Several initiatives have been launched 
and both the Ministry of Economic Affairs and the Department of Development Co-
operation are taking the lead.  In addition, many members of parliament have a keen 
interest in the topic. 
There are two legislative proposals aimed at creating a legislative framework for the 
use of social claims in Belgium. 
a.  Draft law for the promotion of socially responsible production 
The idea behind socially responsible production was first spelled out by Ms Lisette 
Croes MP  in  a proposition  de  loi  (law drafted by a  Member of Parliament) on  10 
November 1998. Both the government's own projet de loi on the same issue and Ms 
Croes' proposition  de  loi  were discussed and adopted by the  Belgian Chamber of 
Representatives on 28 April 1999 and transferred to the Belgian Senate (see annex V) 
on that day.  The procedure was definitively cancelled, however, due to the fact that 
national elections were held six weeks later. 
The draft law aims in the first place at promoting socially responsible production by 
looking at  the  production  process.  To  achieve  this  goal,  the  draft  law  foresees  a 
certificate for companies and a label for their products. The criteria for obtaining such 
a certificate and social label are  the implementation of the five  basic criteria of the 
International Labour Organisation (ILO): 
prohibition of  forced labour (no. 29 &  1  05); 
right to form trade unions (no. 87); 
right of  gathering and collective bargaining (no. 98); 
prohibition of discrimination in terms of employment and salary (no.  I 00 & Ill); 
and 
minimum age for child labour (no. 138). 
The certificate and label is voluntary and is granted for a period no longer than three 
years  to  companies (including their subcontractors  and  suppliers),  which  fulfil  the 
criteria as  set out in the draft law.  The exact modalities and procedure for obtaining 
both the certificate and the label are to be determined in the form of a Royal Decree, 
which will be prepared by the Council of Ministers.  The control will be assumed by 
institutions accredited according to  the  law of 20 July  1990 on the accreditation of 
certificates and control-organisations, as well as laboratories. 
If  the label is used counter to the provisions of the law, the permission to use it will be 
withdrawn (Art 11,  §I).  In  case of abuse of the  law (in particular use of the label 
without approval and rnisleading advertising) fines can be imposed from eight days to 
five years imprisonment and/or €120 to €120,000 (Art 12).  A Council of Appeal is, 
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complaints by (all)  third parties about the  abuse or misuse of the  label  as  well  as 
appeals regarding the refusal or withdrawal of  the label. 
The  draft  law  also  establishes  a  Committee  on  Socially  Responsible  Production, 
which will issue opinions on all laws, amendments and decrees on the implementation 
of  this draft law. 
The government has the right to take up the thread and take new initiatives. 
b.  Addition of labelling and advertising provisions with an ethical notion to the 
law on  unfair competition  and the information of the consumer of 14  July 
1991 
This amendment ofthe law on unfair competition of 14 July 1991  (see annex VI) goes 
hand in hand with the proposal by Ms Croes.  The amendment foresees  that ethical 
claims may be considered as  misleading advertising and proposes to  establish fines 
for companies, which make ethical claims in their advertising without substantiating 
them. The aim is  to encourage companies to provide the consumer with information 
about  their  production  methods  by giving  them  a  comparative  advantage  in  their 
advertising. 
The amendments propose to  enlarge the competencies of the Committee on Green 
Advertising (which is a subgroup of  the Consumer Council, which itself is attached to 
the  Economic  Ministry)  to  include  social/ethical  criteria  and  to  take  legal  action 
against companies misusing such claims.  The proposal includes the participation of 
NGOs in the Committee and gives them the possibility to start legal action. 
III.  VOLUNTARY INSTRUMENTS 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutrition and Health Claims 
On the basis of an opinion from the Belgian Health Council of 1996 (see annex VIII) 
discussions about nutrition and health claims were started in Belgium. 
In  its  opinion,  the  Health Council proposed the  establishment of a  positive  list of 
claims that may be used on the basis of  generally accessible scientific knowledge.  For 
claims on the positive list, verification would be a posteriori and for claims that are 
cleared on the basis of a dossier it would be a priori. The list would be established by 
a multi-disciplinary committee of experts appointed by the Minister responsible for 
public health. The Food Inspection Unit of the Ministry of Social Affairs, Health and 
Environment would have a  final  say on how to  deal  with  infractions.  The Health 
Council  also proposed the establishment of a  short list of claims that  could not be 
accepted at any time, as they would not be able to have scientific backing. 
Industry reacted negatively to the proposals put forward by this opinion saying that a 
list prevents industry from assuming its own responsibility and that a voluntary code 
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would be much more useful and effective. Industry was particularly opposed to a list, 
which  in  its  opinion has  many disadvantages.  Consequently,  a  voluntary code for 
health claims has,  since then,  been drawn up between government,  manufacturers, 
distributors,  scientists and consumer associations (see draft of January  1999, annex 
VII). The distributors and the Health Council have approved it, but consumers are still 
hesitant and do not see it as a priority. 
The code has not been discussed for some time due to the dioxin crisis. However, it is 
expected to be fully finalised by the end of  this year, or the beginning of next year. If 
all goes well, it will be starting a two-year test period at that moment. 
The code is not fully compatible with the Royal Decree on Food Advertising (Annex 
II)  because legislation forbids  all  health claims;  and when the code will enter into 
force a modus vivendi will have to be established for them to exist in parallel.  The 
government  has  stated  that  it  is  prepared  to  make  and/or  endorse  the  necessary 
adaptations. 
2.  Ethical Claims 
There  is  a  so-called  (voluntary)  'fair trade  label'  in  Belgium  issued  by the  Max 
Havelaar  group  for  coffee  and  bananas.  Max  Havelaar  works  together  with 
manufacturers/producers via the FLO (international fair trade labelling organisation). 
Labels only apply to  food products not textiles. The labels do not carry any claims, 
just the logo of  the organisation. 
The Max Havelaar label  stands for  ethical business practice,  in the  sense that the 
company in question does give farmers in third world countries the possibility to earn 
a fair amount of  money. 
The  Max  Havelaar  group  does  not  have  any  active  support  from  the  Belgian 
government but does co-operate with the Department for development co-operation 
which set up the "Internationaal Huis/Maison internationale" (international house). 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The  voluntary  code  distinguishes  between  four  types  of health  claims:  "Nutrient 
Function  Claims",  "Health  Effect  Claims",  "Healthy Eating  Pattern  Claims"  and 
"Disease Reduction Claims'' (see annex VII, pp. 4-5). 
"Nutrient Function Claims" describe the role of  a nutrient on the normal physiological 
functions of  the body. They are based on generally accepted scientific knowledge. 
E.g.: 
•  "Calcium is necessmyfor a solid bone structure"; and 
•  "Vitamin B2 is necessary for the metabolism of  proteins". 
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health.  They are also  applicable to  non-nutritional  substances,  which offer positive 
health effects.  · 
E.g.: 
•  "A good intake of  calcium reinforces the bones"; and 
•  "Product X reduces the cholesterol/eve!" 
"Healthy Eating  Pattern  Claims" refer  to  official  recommendations  by national  or 
international organisations about healthy eating patterns, nutritional recommendations 
or similar recommendations. 
E.g.: 
•  "The National Nutrition Council recommends a daily intake of  800mg of  calcium. 
The product X contains 120mg/dl of  calcium." 
'"Disease  Reduction  Claims"  refer  to  the  effect  the  consumption  of a  particular 
foodstuff can have on reducing the risk of getting a certain disease.  The claim may, 
however, not refer to  the prevention of a disease but merely indicate the benefits of 
healthy eating habits as a guarantee for a better health. 
E.g.: 
•  "An adequate intake of  calcium may help to reduce the risk of  osteoporosis "; and 
•  "Product X can contribute to reducing the risk of  cardiovascular diseases'' 
The  code  indicates  that a number of criteria apply in  the  communication of these 
claims: 
•  Health claims have to be clear and cannot be misleading. 
•  Health claims have to be as  precise as  possible with regard to the description 
of the effect. 
•  Health claims cannot imply any extrapolation or generalisation of the proven 
scientific findings. 
•  Health claims have to be complete (i.e. indication of  nature, form, dosage etc.). 
•  A claim has to be considered in the framework of  a normal diet. 
•  Health  claims  shall  not  incite  the  adoption  unbalanced  eating  habits  or 
overconsumption of foodstuffs. 
•  The advantages shall not be presented in an exaggerated manner. 
•  Health claims, which propose or suggest a solution for problems, which do not 
exist in the national context, are forbidden. 
•  Health claims shall not suggest that normal health is affected if the foodstuff in 
question is not used. 
•  Health  claims  shall  not  imply  or suggest  that  the  use  of the  foodstuff  in 
question guarantees normal health. 
•  Health claims shall not use detailed descriptions or representations of organs 
or  physiological  functions,  which  could  lead  persons  to  make  wrong 
judgements about their own status of  health. 
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3.  Ethical Claims 
Not applicable. 
C.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
l.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The voluntary code will be recognised by the authorities as soon as  it  has formally 
been approved by them. 
The  voluntary  code  is  not  yet  in  force.  It is,  therefore,  too  early to  comment  on 
barriers to trade or consumer protection. Nevertheless, consumer associations seem to 
be rather hesitant about this voluntary code. 
3.  Ethical Claims 
Not applicable. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Health and Nutritional Claims 
Concerning foodstuffs destined for particular nutritional uses, as well as for nutrients 
and foodstuffs to which nutrients have been added, the proposed label and information 
on the composition of the product must be sent to the Ministry of Health (see below 
point B). 
There  is  no  format  or guidelines  to  be  observed  in  the  dossier but  the  better the 
scientific information and backup provided the easier it is for a case to be accepted by 
the authorities. 
The  voluntary  code  on  health  claims  provides  for  a  number  of  criteria  for 
substantiating health claims: 
•  The company responsible for placing a product on the market has to be able to 
proof the claim scientifically. 
•  The scientific dossier has to  refer to the whole foodstuffs and not only to  the 
substance with the health effect 
Regarding this evidence, the code indicates that it could be expected to come from: 
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•  in vitro studies 
•  animal models 
•  clinical studies 
•  epidemiological studies 
•  any other relevant studies 
A distinction is, nevertheless, being made between 'generic claims' and 'new' claims. 
For generic claims bibliographic evidence may be considered to  be sufficient.  For 
new claims the scientific evidence required has to be "complete and significant". 
For generic claims and new claims: 
•  The studies used have to have been supported by objective scientific tests (e.g. 
peer reviewed, consensus position, judgement of  independent experts etc.). 
•  The  studies used have  to  be undertaken with a representative  and pertinent 
segment of  the population. 
•  The  studies  used  have  to  be  based on  the  consumption  of foodstuffs  in  a 
reasonable quantity and frequency, i.e. a normal food consumption. 
•  The studies used have to have been carried out over a sufficiently long period. 
•  The studies must be quantitatively and statistically pertinent. 
•  The measured result of the study must be sufficiently important,  in  order to 
proof the health claim. 
2.  Ethical Claims 
There is  no verification system for ethical claims at present but proposed legislation 
may  include  a  verification  system  for  a  company's  production  practices  but it  is 
unclear what form of  verification will be proposed. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
Before  marketing  a  foodstuff for  particular  nutritional  use,  a  manufacturer has  to 
obtain an authorisation from the competent national authority, i.e. the Food Inspection 
of the  Ministry of Health  (see  §  7  of Royal  Decree  on  Foodstuffs  for  Particular 
Nutritional Uses, see Annex XI).  To this end the proposed label and information on 
composition  of the  product  must  be  sent  m.  The  authorities  can  ask  for  further 
information, if they consider it necessary. 
The  Supreme  Health  Council,  which  consists  of about  100  scientists,  doctors, 
professors etc. has to  give an opinion on the application for marketing. The Supreme 
Health Council also examines the claim made.  The Ministry of Health takes the final 
decision. 
The  Supreme  Health  Council  has  to  give  an  opinion  within  four  months,  but  the 
Ministry  can  extend this  period to  8  months,  if requested  by the  Supreme  Health 
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Council. Furthermore, where the authorities ask for additional information from  the 
manufacturer, the deadline is further extended. 
For nutrients and foodstuffs  to  which nutrients (i.e.  vitamins, minerals, amino acids) 
have  been added,  an  a  priori  notification procedure  applies  (see  Royal  Decree  on 
Marketing of  Nutrients, see Annex III). 
A dossier has to  be sent to  the Food Inspection Unit.  A dossier has to be submitted 
indicating  the  nature  of the  product,  the  ingredient  list,  a  nutritional  analysis,  the 
labelling and the necessary documentation enabling the Food Inspection to  evaluate 
the nutritional value of the product.  Within one month, the Food Inspection Unit can 
make  comments,  notably  asking  the  manufacturer  to  modify  the  labelling. 
Furthermore,  it  can  ask  for  further  information  on  the  bio-disposability  of the 
nutrients. 
The manufacturer is then given a number, which needs to be placed on the label of the 
product. The number indicates that the product has been cleared by the administration. 
Industry  indicated  that  the  pre-clearance  system  for  claims  is  cumbersome.  The 
system  (application  and  verification)  is,  however,  rather  weak (mainly  because  of 
under-staffing) and many exceptions are being made. The system is, therefore, not at 
all transparent. 
The Food Inspection believes that the current a priori clearance system for nutrients 
and foods to which nutrients have been added is quite performing - 500 applications a 
year,  5,000  since  1980.  However,  the  intensity of ex  post controls  depends  on the 
financial  means  at  its  disposal.  It  goes  without  saying  that  Food  Inspection 
concentrates on the most  'serious'  cases,  the  worst breaches of the  law.  The Food 
Inspection Unit investigates about 10 cases a year. 
2.  Post-Clearance Rules/ Guidelines 
The Food Inspection Unit is  responsible for verifying claims.  Once products are  on 
the  market which bear claims  that  have  not  been  cleared  (see  above)  or could be 
considered  to  be  misleading,  the  Food  Inspection  Unit  can  ask  the  company  in 
question to take the product off the market (procedure verb ale).  It can also decide to 
take legal action against the company in question on the basis of the  Law on Unfair 
Competition of 14  November  1983  (modifying the  law of 14  July  1971,  Moniteur 
Belge/Belgisch Staatsblad, 8 December 1983, see annex IV). 
Also other manufacturers and social partners (including consumers) may draw to  the 
attention  of the  Food  Inspection  Unit  in  a  formal  or  informal  way  a  possible 
infraction, or take legal action themselves (see below). 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
All  third  parties  can  take  legal  action  and  table  a  complaint  with  the  Court  of 
Commerce.  If it agrees with the complaint, the Court may ask a manufacturer to stop 
selling and marketing the product in question.  According to  the gravity of the case, 
the Court may impose a fine. 
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Health Ministry, which is  allowed to  impose an administrative fine.  If that fine is not 
being paid- which rarely occurs - the case is referred to the Court of Justice. 
D.  BURDEN OF PROOF 
The burden of proof is always with the third party that tables a complaint against the 
manufacturer.  · 
E.  APPLICABLE PENAL  TIES 
The Food Inspection Unit's usual fine ranges from  10,000 to 50,000 BEF (Euro 250 
to  Euro  1  ,250).  A judicial fine  is  usually much higher and varies according to  the 
gravity, scope and scale of  the case. 
V.  CASELAW 
According  to  the  Food  Inspection  Unit,  there  is  no  known  case  law  on  nutrition, 
health or ethical claims.  The Belgian Food Industry Association (FEVIA) conducted 
research a short while ago and did not find any records of  case law. 
VI.  MEANS OF COMMUNICATION 
Legislation  as  well  as  voluntary  agreements  on  health  claims  do  not  make  any 
distinction  between  types  of media  (print,  radio  and  television).  Labelling  and 
advertising regulations  apply for all  types  of communication except for  nutritional 
labelling, where legislation excludes advertising via audio-visual means (see section 
II.A)l). 
It is unclear what the status of the Internet is, i.e. who regulates the use of claims via 
websites.  This will pose difficulties as products can be bought or advertised via the 
Internet, including products with claims or advertising containing claims not allowed 
in Belgium. 
VII.  STATISTICS ON CLAIMS 
We  could not  find  any statistics  on claims  in  Belgium.  We  have,  however,  been 
informed  by  the  Food  Inspection  Unit  that  it  deals  with  approximately  500 
notifications for nutrients and foodstuffs to  which nutrients are  added and conducts 
about  ten  a posteriori  investigations  every year.  Until  now a  total  of some  5,000 
notifications have been made. 
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I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study has,  in  general, been well received by all  interested parties/stakeholders 
who  together  have  been  very  co-operative  in  arranging  to  meet  and  provide 
information. 
Whereas  traditional  nutritional  claims  are  fairly  well  regulated  and  not  subject  to 
much  controversy,  more  attention  has  been  paid  to  health  claims  in  the  present 
discussion on a different and more liberalised practice for food related claims.  The 
Danish authorities clearly recognises that the present regulatory situation for health 
claims  is  very  restnchve  and  perhaps  not  in  line  with  mainstream 
European/international policy developments.  Ethical claims are a fairly new subject 
in  Danish debate  and  have  for  the  first  time  been discussed more  thoroughly in  a 
recent report published by the Consumer Agency. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of a nutritional claim is  the  same as  defined in EU  law and,  having 
adopted the nutrient content claim and comparative claim definition, is in accordance 
with the Codex guidelines.  However, Codex's nutrient function claim has not been 
accepted.  Government policy is directed towards consumer and health protection and 
ensuring the overall promotion of healthy eating habits. The Danish Food Directorate 
has  prepared  a  note  suggesting  that  Danish  policy  should  be  amended  to  accept 
nutrient function  claims in  accordance with Codex.  However,  there  is  no political 
commitment on this as yet. 
2.  Health Claims 
The definition of health claims is,  in  essence, the same as  that of the EU  Directive, 
791112.  However, in comparison to Codex they are more medicinal in their focus.  As 
in  the case above, consumer protection is at the heart of Danish policy and to  date, 
they  have  taken  a  restrictive  approach  regarding  the  use  of health  claims.  The 
fundamental view is that it is the composition of  the overall diet rather than any single 
food  product that  is  important to  the  health of consumers.  Consequently,  it  is  not 
relevant to  consider using health claims, as  they are likely to  mislead the consumer. 
However,  the  Danish  Government  is  also  changing  its  policy  thinking  towards  a 
potentially wider application of health claims (i.e.,  to  accept generic  as  opposed to 
product related reduction of disease risk claims, along the lines of  the US and Swedish 
model) and tends to favour the EU initiative. 
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No official definition exists for ethical claims, or any specific legislation, although the 
general clauses regarding correctness, honesty and non-misleading information in the 
Marketing Act would cover such claims. However, the Danish Government and the 
Consumer Agency are examining the issue and are effectively calling for a dynamic 
definition which, in their understanding would cover human rights, employees' rights, 
child labour, working environment, fair-trade, animal welfare and social engagement. 
They tend to favour the development of a new labelling system rather than trying to 
integrate the  ethical dimension into other types of labelling.  Furthermore,  any  new 
labelling initiative should not limit Third World countries to  their current economic 
level.  Rather it should improve it and not limit access to the Danish market, i.e. new 
ethical labelling initiatives must not act as  a barrier to  trade.  An  EU  initiative was 
also favoured. 
C.  VOLUNTARY CODES OF PRACTICE 
On  nutritional  claims,  interestingly,  the  Nutritional  Council,  the  Regional  Food 
Control  Authority  of Copenhagen  and  a  so-called  '"Healthy  City-Project"  have 
developed the S-label to indicate that products are lower in fat and in sugar. Some 15-
20 companies and retailers have started to the use the S-label, which is in line with the 
existing legislation. 
No voluntary codes or practices exist for health claims. By contract, ethical claims are 
being used more and more through such initiatives as  the international Max Havelaar 
organisation, which has the elephant logo for tea and coffee products and there is also 
the Rugmark and Clean Clothes campaign.  Voluntary systems for organic/ecological 
and quality labelling, recognised by the authorities, are also in place. 
D.  VERIFICATION SYSTEMS 
As  a framework, the Danish Marketing Practices Act provides an  umbrella function 
covering all types of  claims requiring that such activities are carried out in accordance 
with good marketing practice and makes it  an offence to  make use of any false  or 
misleading  information  likely  to  affect  the  demand  for  goods  and  services.  With 
regard to food products, it is the Food Directorate and the regional food control units 
which are responsible. 
There  is  in  essence  no  pre-clearance,  although  inquiries  can  be  made  to  both 
organisations.  The Food Directorate would not provide a legal opinion,  as  they are 
responsible  for  handling  complaints  and  act  as  the  final  controlling authority.  The 
only exemption is the pre-clearance system under the P  ARNUTS Directive. As to post 
clearance, it is the responsibility of  the regional food control units to supervise the law 
and they can change the labelling or marketing, prohibit sales and  impose fines.  If 
there were no  compliance, they would take the case up to the Food Directorate who 
could then take them to the civil court. Anyone can complain to the local or regional 
food control unit or to  the Consumer Agency. The burden of proof lies with the legal 
person responsible for the claim. 
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No  differences  exist  in  the  applicability  of  the  relevant  legislation/guidelines 
regarding the means of communication used such as television, internet, press, labels, 
etc.  concerning the interpretation seen from  the authorities' point of view.  There is, 
however, an interesting case concerning a product whose benefits were advertised in 
press material.  An examination is now taking place to decide whether press materials 
are covered by the Food Act. 
F.  CASELAW 
No  examples  of relevant  case  law  exist  in  this  area.  However,  on  a  number  of 
occasions  the  authorities  have  administratively  issued  orders  to  change  existing 
marketing practices with reference to  both misleading advertisement and the use of 
health claims. 
G.  CONSUMER PROTECTION 
The  question  of consumer protection  is  regarded  as  very  important  in  the  Danish 
political context and this question is  also central to  the authorities when considering 
any  new  regulations  or  any  changes  in  administrative  practices.  Consumer 
(protection) issues are regarded as being more important today than ever before. 
H.  BARRIERS TO TRADE 
It is generally accepted that Danish laws and practices on nutritional claims do not act 
as  a  barrier  to  trade  as  the  policy  is  the  same  for  both  Danish  and  non-Danish 
products. However, the Danish policy regarding health claims can in some cases be 
seen as  a barrier to  trade since a food product with a scientifically well documented 
health effect will not be permitted to use such a claim in the marketing of  the product. 
I.  STAKEHOLDERS POSITIONS 
1.  Government and enforcement authorities 
•  On  both  nutritional  and  health  claims,  government  policy  is  directed  toward 
consumer  and  health  protection.  Overall  they  have  been  restrictive  in  their 
approach.  Nevertheless,  there  is  now  a  shift  in  policy  to  allow  both  nutrient 
function claims and possibly generic reduction of disease risk claims. On ethical 
claims, there is a call to define exactly what they are and to develop an appropriate 
labelling scheme. 
2.  Consumer Organisations 
•  The  Danish  Consumer  Association  is  clearly  in  favour  of  legislation  and 
government endorsement of claims in labelling and advertising.  An  independent 
body should control any claims and the association supports real sanctions. More 
specifically, the association has supported the restrictive Danish practice regarding 
health  claims.  The  Consumer  Association  strictly  opposes  health  claims  of a 
specific food product. 
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•  The food  industry wants a liberalisation of current restrictive practice and would 
like to  introduce health claims in the marketing of food products.  Interestingly, 
the Danish industry would support a system involving government endorsement as 
industry believes that this will add to the credibility of  claims. 
In  conclusion,  Denmark would welcome new  initiatives from  the  EU Commission 
regarding health claims. 
* * * 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
Nutritional claims are defined in the Nutritional Declaration Act No. 198 of  20 March 
1992. (Bekendtg0relsen om nreringsdeklaration m. v.) Article 1, section 5 (1) contains 
the following definition: 
"A nutritional claim means any presentation on packaging, in the presentation 
or in advertising, which is suited to give consumers the impression that a food 
product has particular nutritional properties due to energy or nutrients." 
The Danish definition of a nutritional claim is  basically in accordance with the EU 
definition. 
Furthermore,  the  Danish  definition  is  in  accordance  with the  Codex Alimentarius 
(herein referred as Codex) definition of nutritional claims. As will be described later 
on, the Danish Authorities have adopted the Codex "nutrient content claim" and the 
"comparative claim", whereas the Codex "nutrient function claim" is not accepted as 
a nutritional claim. 
2.  Health Claims 
Health claims are defined in the Danish Food Act (Levnedsmiddelloven) No.  310 of 
June 6,  1973 with amendments: In Article 4, section 28 (2} it is stated: 
"It is forbidden in advertisements, etc.  or on packaging to cite: 
•  information that may cause or exploit fear in the consumers, and 
•  Information that may cause doubt as to the propriety of  using other similar food 
products. " 
Section 28 (3), which is the most central one in relation to the question of  definition, 
states: 
"It is forbidden in advertisements. etc.  or on packaging to cite: 
•  that a food product is recommended by doctors,  or that consumption of  the food 
product may prevent, relieve or have a beneficial effect on diseases or symptoms 
ofdisease." 
Thus, the Danish definition is  fairly similar to  the EU definition in Article 2 of the 
1979/112 Labelling Directive. 
In  the latest Codex definitions of health claims from April  1999 (still at discussion 
stage}, two different definitions are used.  It is interesting and important to  note that 
neither of  these definitions includes words like "preventing, treating or curing." 
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a-vis the Codex definitions suggests that these are not really in accordance with each 
other,  i.e.  the  Danish  and  EU  definitions  are  more  '~medicinal" than  the  Codex 
definitions. 
3.  Ethical Claims 
No  official  definition exists  for  ethical  claims.  The  subject of ethical  labelling  is, 
however,  becoming  an  item  on  the  agenda  of the  Danish  Government/Consumer 
Agency.  The  Consumer  Agency  will  publish  a  report  (Labelling:  The  Labelling 
Committee's Review, The Consumer Agency, Ministry of Business and Industry) on 
labelling of consumer goods  in July  1999.  This report also  looks  into  the  area of 
ethical labelling. 
As far as definition is  concerned, the report refers to  the definition used in the New 
Economics Foundation's report: Social Labels: Tools for Ethical Trade: 
"Social labels are words and symbols associated with products or 
organisations which seek to influence the economic decisions of  one set of 
stakeholders by describing the impact of  a business process on another group 
of  stakeholders. " 
Further on, the Danish report emphasises the need for a "dynamic definition", as new 
ethical themes will surface over time. Presently, the Consumer Agency thinks that 
some of  the relevant issues for potential ethical labelling would be: human rights, 
employee's rights, child labour, working environment, fair-trade, animal welfare and 
social engagement. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Nutritional claims are regulated by 
•  The Food Act, Article 4,  section 23 regarding non-misleading ofthe consumer and 
Section 29 regarding nutritional value information. 
•  The  Nutritional Declaration  Act,  Article  1,  section  5  regarding definition  and 
Article 3,  section 11 regarding applicable nutrients. 
Furthermore,  the  Danish Veterinary- and Food Directorate,  which will  be  renamed 
The Danish Food Directorate as of 1st August 1999, has issued guidelines relating to 
the Nutritional Declaration Act and specific guidelines for the use of  "light" claims. 
The  Council  Directive  90/496/EEC  on  nutritional  labelling  for  food  products  IS 
implemented in the Food Act and in The Nutritional Declaration Act. 
2.  Health Claims 
Health claims for foods including dietary supplements are regulated by: 
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•  Section 28 (2) and (3)  regarding prohibition and definition of  health claims. 
The Danish Food Directorate has published guidelines regarding the administration of 
section 28 (2) and (3) of  the Food Act. 
The Council Directive 791112  on Labelling of food products is  implemented in the 
Food Act. 
Health claims for natural remedies are regulated by The Medicinal Products Act. 
3.  Ethical Claims 
There is no specific legislation in place regarding ethical claims. However, any claim 
- including ethical  claims  - is  subject to  the  general  clauses regarding  correctness, 
honesty and non-misleading in The Marketing Act. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
There is nothing special to report. 
D.  POLICY THINKING AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The essence of policy thinking regarding claims is  related to  consumer protection, in 
particular,  not  misleading  the  consumer.  In  relation  to  food  products,  the  policy 
thinking also includes consumer safety, consumer health and the overall promotion of 
healthy  eating habits.  With  regard  to  nutritional  claims,  the  Danish  policy has  m 
general been coherent with Codex guidelines and EU policies/directives. 
The  nutrient  content  claims  and  the  comparative  claims  are  administered  in 
accordance with the Codex Guidelines on Nutrition Labelling and Nutrition Claims. 
The declaration of nutrient content is voluntary but if a nutritional claim is made, the 
food product must be  labelled with a nutrient declaration in  accordance with the EU 
Directive on nutrition labelling and the Codex Guidelines. 
The adoption of the Codex Guidelines for Use of Nutritional Claims in 1997 includes 
nutrient function claims. From now on, the Danish Government regards these claims 
as  health  claims.  Consequently,  nutrient  function  claims  have  been  forbidden 
according to the general prohibition regarding health claims in the Danish Food Act. 
Concerning nutritional claims relating to "low", "free", ''"high" etc., the Danish policy 
is in line with Codex recommendations and criteria.  With regard to the claim "light" 
the  Danish  Authorities  have  introduced  rules  somewhat  stricter  than  the  Codex 
Guidelines. 
The Danish Food Directorate, which is part of the Ministry of Food, Agriculture and 
Fisheries,  and which acts  in  matters  relating  to  nutrition and health policies  of the 
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ought to  be changed. It is  generally recommended that the administrative practice is 
adapted  to  include  the  nutrient function  claims  according to  the  Codex  guidelines 
adopted in  1997. Up until now, no firm political commitment has been made on this 
recommendation from the Food Directorate. 
The Danish policy regarding nutritional claims can hardly be said to act as a barrier to 
trade.  The  policy  is  administered  similarly  towards  both  Danish  and  foreign 
companies. A restrictive policy regarding claims does not exclude an otherwise fully 
legal and acceptable food product from being marketed on the Danish market. 
The  question  of consumer  protection  is  regarded  as  being  very  important  in  the 
Danish  political  context  and  this  question  is  also  central  to  the  authorities  when 
considering any new regulations or any changes in administrative practices. Consumer 
(protection) issues are regarded as being more important today than ever before. 
2.  Health Claims 
The overall policy thinking regarding health claims is similar to the policy mentioned 
under nutritional claims. 
Furthermore, it is relevant to add that the Danish Authorities have traditionally taken a 
very restrictive attitude regarding the use of health claims. The fundamental view is 
that it is the composition of the overall diet rather than any single food product that is 
important  to  the  health of consumers.  Consequently,  it  is  not  relevant  to  consider 
using health claims, as they are likely to mislead the consumer. 
The Danish policy thinking regarding health claims has been summarized in  1998 as 
follows: 
"All types of  claims related to diseases or symptoms of  diseases are 
prohibited. Physiological claims like "calcium is important for the formation 
and maintenance of  bones and teeth " are classified as health claims and are, 
thus, prohibited. The same applies to all references to cholesterol. Health 
claims to food products are prohibited, whether documented or not.  The 
authorities, interpretation of  the Food Act and its provision is restrictive." 
However, as discussed below, policy thinking is currently changing towards a 
potentially wider application of  health claims. 
The Danish Government is in favour of  an EU initiative regarding harmonised 
terminology and regulations for health claims. 
The Food Directorate is also undertaking a discussion regarding health claims. 
The following has been concluded: 
•  Physiological claims  (earlier  Codex  terminology)  or enhanced function  claims 
(latest  Codex terminology).  are not considered a suitable vvay  to  convey health 
messages to  the consumers.  It is argued that the consumers will misunderstand 
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Physiological claims will therefore often be considered misleading. 
•  Health claims relating to  a specific food product and the total diet (in  the latest 
Codex documents referred to  as  "Reduction of  Disease Risk Claims") should be 
considered and fitrther  explored.  The  Food Directorate has some sympathy for 
both the US and Swedish models which are based on a two-step principle i.e.  that 
any claim relating to  a specific food product is placed in  the context of  the total 
diet. 
There has to be a political response from the Ministry and the Parliament regarding 
these proposed policy changes. 
The Danish policy regarding health claims can in some cases be seen as a barrier to 
trade in as far as a food product with a scientifically well documented health effect 
will not be permitted to use such a claim in the marketing of  the product 
3.  Ethical Claims 
The policy thinking concerning ethical claims/labelling, according to  the mentioned 
labelling report, favours the development of a new labelling system rather than trying 
to integrate the ethical dimension into other types of  labelling.  Furthermore, any new 
labelling initiative should not limit Third World countries to  their current economic 
level.  Rather it should improve this level. It should also not limit access to the Danish 
market, i.e. new ethical labelling initiatives must not act as a barrier to trade. 
The same report also stresses the need for a clearly defined purpose/foundation for a 
new ethical label and the need for EU co-ordination is also mentioned. 
From now on, according to the report, very little experience has been gained regarding 
ethical  claims/labelling  and  a  concrete  proposal  for  political  action  has  been 
suggested: 
"To gain practical experience with ethical labelling it is recommended that 
opportunities are created  for companies, organisations (including NGO 's) and 
public authorities to jointly seek public financial support to carry out pilot 
experiments with ethical labelling in selected areas. " 
Such experiments should be evaluated after a three-year period. It is necessary to 
underline that this recommendation has not yet entered into the political phase of 
approval. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
The following voluntary instrument is in operation: 
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so-called ""Healthy City-Project" has developed an "'S-label" indicating that products 
labelled in this way has a lower fat content and, in some cases, a lower sugar content 
than  other food  products  in  the  same  category.  In  reality,  this  S-label becomes  a 
nutritional claim and as such it is regulated by existing legislation. Consequently, the 
use of  the S-label requires a complete nutritional declaration. 
The Copenhagen Food Control  Authority assists  in  developing the  S-label  system. 
Some  15-20 food companies and some of the major retail chains have started to  use 
this label. 
A private company, Dansk Varefakta N  £evn  (DVN) has issued guidelines concerning 
nutritional claims and the company advises producers and importers in this area.  The 
DVN guidelines fully reflect the legislation and guidelines of  the national authorities. 
2.  Health Claims 
No voluntary instruments  -e.g. a self-regulating code of  conduct  -are in place. 
3.  Ethical Claims 
The international Max Havelaar organisation has been active in Denmark since 1994. 
The Max Havelaar elephant-logo is  used on coffee and  tea and the  intention is  to 
expand the  use  of the  logo  to  other product categories such  as  cocoa,  cane-sugar, 
orange juice concentrate, etc. 
The Max Havelaar organisation operates a licensing system including a set of criteria 
to  which participating companies must adhere. Although market share remains fairly 
limited, the use of the elephant logo - measured by the volume of products sold - has 
increased steadily since 1995. In general, consumer awareness is also limited. 
Other ethically based labelling systems e.g.  the  Rugmark, Clean Clothes Campaign 
and others are not really used to any extent. 
The National Authorities have voluntary systems in place for organic/ecological and 
quality labelling. Both of  these labels contain ethical elements, i.e. animal welfare. 
Max  Havclaar co-operates  internationally with  Transfair International  and  the  Fair 
Trade Foundation and the different logos used are all about "'fair trade and sustainable 
development/trade". Since 1997, all Fair Trade labelling is  co-ordinated by FLO, the 
International Fair Trade Labelling Organisation. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
No remarks. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
No remarks. 
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THE AUTHORITIES 
The  S-labelling  system,  the  guidelines  from  DVN  and  the  orgamc  and  quality 
labelling systems are all accepted/recognised by the authorities. 
The authorities also accept the Max Havelaar licensing system and logo but limited 
attention has been paid to the matter. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The  criteria  for  using  nutritional  claims  are  based  on  the  relevant  legislation  and 
guidelines mentioned under Section II C  1,  reflecting the 90/496/EEC Directive and 
Codex. 
As mentioned earlier, any claim appearing on labelling, etc. makes nutrition labelling 
compulsory. As  far  as  the allowed nutritional claims are  concerned, i.e.  content and 
comparative  claims,  these  are  based  on  quantitative  criteria  thereby  making  it 
relatively easy to verify if  such claims are justified. 
2.  Health Claims 
As  all  health  claims  are  prohibited  the  discussion  of criteria  for  substantiation 
becomes irrelevant. 
3.  Ethical Claims 
The Max  Havelaar licensing system is  based on  a  set of principles  and  criteria  to 
which  all  actors  in  the  food  value  chain  will  have  to  adhere  in  order to  use  the 
elephant logo in their marketing. 
The main criteria for  the  use of the  Max  Havelaar label/logo  are:  direct purchase, 
surcharge,  guaranteed  minimum  price,  credit  allowances,  long-term  relations  and 
production criteria for plantations. 
The so-called Register Committees organisationally associated with the International 
Fair Trade Labelling Organisation (FLO) monitor compliance with these criteria. 
The  national  authorities  are  not  involved  in  any verification  of the  Max  Havelaar 
label. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
The Danish Marketing Practices Act (Act No.  428  June  1,  1994)  applies to  private 
business  activities  and  to  similar activities  undertaken by public  bodies.  Section  1 
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practices and Section 2 makes it  an offence to  make use of any false  or misleading 
information  likely  to  affect  the  demand  for  goods  or  services.  The  Consumer 
Ombudsman and the National Consumer Agericy under the Ministry of Business and 
Industry in  general administer the Marketing Act.  However, as far as food products 
are  concerned  the  authority  and  competence  has  been  passed  on  to  the  Food 
Directorate under the Ministry of Food, Agriculture and Fisheries following the  lex 
specialis  principle.  Furthermore,  the  Food  Act  referred  to  under  II  A  includes 
regulation similar to the Marketing Act. 
1.  Pre-Clearance Rules/ Guidelines 
Companies  can  take  their  marketing  activities,  including  claims,  to  the  Food 
Directorate. In reality, however,  such inquiries will be directed to  the regional food 
control unit and they will give an opinion on the legality of the initiative. The Food 
Directorate does not give any explicit statements on the legality of a specific claim, as 
they  are  the  ones,  which  not  only  handle  complaints  but  also  act  as  the  final 
controlling authority. 
Therefore, in essence, no system is in place for pre-clearance. As an exemption to this 
general system, the Danish Authorities practice a kind of pre-clearance model as  far 
as Products for Particular Nutritional Uses ("PARNUTS'') products are concerned cf. 
Article 9 of  the EU 90/496 Directive. 
2.  Post-Clearance Rules/ Guidelines 
As  mentioned  above,  the  regional  food  control  units  supervise  that  laws  and 
regulations  are  observed.  These  units  can  order  companies  to  undertake  concrete 
actions;  for example, changing the  labelling and marketing or prohibiting sales and 
imposing a fine. 
If actions taken by the regional control units are not accepted by the companies, they 
can  lodge  a  complaint  with  the  Food  Directorate,  which  will  then  take  the  final 
decision  at  the  administrative  level.  These  decisions,  if not  accepted,  can  then  be 
taken to the civil courts. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Any  legal  person,  including  consumers  or  competitors,  can  complain  to  the 
local/regional  food  control unit or the  Consumer Agency as  far  as  food  marketing 
including claims is concerned. 
D.  BURDEN OF PROOF 
The burden of proof always rests with the legal person responsible for the marketing 
of  the product and no specific kind of  proof is adduced. 
Pan-- European study on nutritional, health and ethical claims- 1999.  163 I  E.  APPLICABLE PENALTIES 
The applicable penalties when violating claims regulations are usually of  limited size, 
i.e.  below  EUR  3-5.000.  However,  fines  are  rarely  used,  as  the  authorities  will 
endeavour to settle any breach of  the regulations/guidelines through negotiation. 
V.  CASELAW 
No  examples  of relevant  case  law  exist  in  this  area.  However,  on  a  number  of 
occasions  the  authorities  have  administratively  issued  orders  to  change  existing 
marketing practices with reference to both misleading advertisements and the use of 
health claims. 
Recently, the Danish Authorities rejected the marketing of the drink Red Bull on the 
Danish  market.  The  rejection,  however,  was  based  on  the  Danish  regulations 
regarding the addition of nutrients rather than on claims. 
Also very recently,  the  authorities  (a  regional  food  control unit)  have  submitted  a 
notification to the police regarding health claims made in press material in relation to 
the  marketing of the  Swedish product Pro  Viva with reference to  section 28  of the 
Food Act. 
VI.  MEANS OF COMMUNICATION 
There  are  no  differences  in  the  applicability  of the  relevant  legislation/guidelines 
regarding the means of communication used such as television, internet, press, labels, 
etc.  concerning  the  interpretation  seen  from  the  authorities'  point  of view.  The 
Pro  Viva case is putting this interpretation to the test as mentioned under Section V on 
Case Law.  This investigates whether press material is also included under section 28 
of  the Food Act. 
VII.  STATISTICS ON CLAIMS 
No data is available. 
VIII.  ANNEXES 
I)  Nutritional Declaration Act No. 198 of  March 20, 1992 (Bekendtg0relse om 
meringsdeklaration m.v. affrerdigpakkede levnedsmidler) 
2)  Danish Food Act No. 310 of  June 6, 1973 (Lov om levnedsmidler m.m.) 
3)  Guidelines for nutritional declaration of prepared foodstuffs, (Vejledning om 
nreringsdeklaration af frerdigpakkede levnedsmidler), September 1993 
4)  Guidelines for health claims, (Vejledning om sundhedsanprisninger), The 
Veterinary- and Food Directorate, June 1993 
5)  The Danish Marketing Practices Act, Act No. 428 of  June 1
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E.  FINLAND 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study on nutritional, health and ethical claims was well received by all interested 
parties/stakeholders and together have been very co-operative regarding meetings and 
information. 
At the time of this  study,  the National Food Administration (NFA) is  reviewing its 
guidelines from 1996 to industry regarding nutritional labelling and nutritional claims 
to  reflect  Codex  and  scientific  developments.  Given  a  recent  proposal  from  the 
Finnish  Food  and  Drinks  Industry,  the  National  Food  Administration  is  also 
reconsidering its current practice regarding health claims.  There are  indications that 
Finland will adopt a more liberalized attitude.  The process is  ongoing and the final 
outcome remains to  be determined.  The authorities  are concerned that  they do  not 
infringe current legislation including the EU labelling directive. 
B.  MEMBER STATE POLICY 
Policy thinking  in  Finland  on  nutritional  and health  claims  is  based  on  consumer 
protection (not misleading the  consumer),  combined with consumer safety and  the 
promotion of healthy eating habits. 
1.  Nutritional Claims 
Nutritional claims are defined in Finnish law and are in complete accordance with EU 
legislation as well as the Codex guidelines. 
2.  Health Claims 
Whilst not explicitly defined in legislation, the Food Act states that presenting health 
claims or medical information concerning foodstuffs or referring to such information 
is forbidden- effectively in line with EU  Directive 79/112. However, Finnish rules do 
permit  in  certain  conditions  that  nutritional  education  may  be  supported  by 
explanations of the  positive effects of foodstuffs  on vital  functions  when there is  a 
clear connection between these.  Thus, claims regarding the  effects  of foodstuffs  or 
other substances on  vital  functions  do  not always fall  under the  ban.  This  type  of 
'"vital function" claim has to relate to the positive effect of the active ingredient rather 
than the foodstuff itself. 
Health claims, which are permitted in Finland, are similar to enhanced function claims 
as  defined in the draft Codex documents on health claims.  Policy makers in Finland 
tend  to  favour  an  EU  based  regulatory  framework  with  a  list  of acceptable  and 
prohibited health claims. 
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Drink Industry Federation to  introduce product specific physiological health claims. 
However it  is  not  prepared to  consider  so-called disease  reduction  claims  without 
changing the Food Act or the Council Directive 791112/EEC. 
3.  Ethical Claims 
There is no specific legislation and/or definition regarding ethical claims, although the 
Consumer Protection Act applies. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Ethical Claims 
The Finnish Association for promoting Fair Trade (Reilun Kaupan Edistamisyhdistys 
Ry)  was  established  in  1998  and  is  associated  with  the  International  Fair  Trade 
Labelling Organisation (FLO). The organisation uses the "elephant" logo as its ethical 
trademark,  which  was  used  on  the  market  for  the  first  time  in  August  1999.  The 
Finnish International Development Agency has agreed to give financial support to the 
organi  sa  ti on. 
D.  VERIFICATION SYSTEMS 
No pre-clearance system exists for claims (apart from the PARNUTS), although the 
NFA publishes  guidelines  concerning the  interpretation of the  Food Act and other 
relevant legislation. In terms of post-clearance, it is  the Consumer Agency/Consumer 
Ombudsman  and  the  NFA,  which  are  responsible,  together  with  the 
municipal/regional authorities. Cases are virtually never taken to  court.  Instead they 
are  settled  out  of court  by  issuing  prohibitions  or  information  orders,  combined 
sometimes with fines.  The burden of proof lies with the legal person responsible for 
the marketing of  the product. 
E.  MEANS OF COMMUNICATIONS 
No  differences  exist  in  the  applicability  of  the  relevant  legislation/guidelines 
regarding the means of  communication used. 
F.  CONSUMER PROTECTION 
Consumer protection is at the forefront of Finnish policy when it comes to  labelling. 
There  is  generally a  good  working  relationship  between  authorities  and  consumer 
organisations. 
G.  BARRIERS TO TRADE 
It is fair to say that this is not an issue. 
H.  CASELAW 
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According  to  the  NF  A,  there  has  not  been  any  decisions  or  court  cases  on  an 
inappropriate  use  of health  claims  in  foodstuffs  since  1995  (before  1995  the 
Consumer Ombudsman had the responsibility for the market control of claims). Since 
1995, the NF  A has passed comment on unsuitable claims in ten instances. 
I.  STAKEHOLDERANALYSIS 
1.  Government Authorities 
•  Whilst the authorities acknowledge that they have no defined position on ethical 
claims, the Consumer Agency has indicated that this will become a priority in the 
year 2000. 
•  On nutritional and, in particular, health claims, the Finnish Government is clearly 
in  favour of a more liberal regime, possibly accepting enhanced function claims 
and specific physiological claims, although they are still sceptical about allowing 
disease reduction claims. They are in favour of  Codex developments and support a 
clear EU regulatory framework with a positive and negative list of  claims. 
2.  Consumer Organisations 
•  The two  Finnish consumer organisations are generally in favour of the cautious 
approach  by the  National  Food Administration.  They are  concerned  about  the 
possible  introduction of health  claims  for  individual  products as  they consider 
these potentially misleading. Therefore,  they have a  preference for  the  Swedish 
system with health claims in two-steps. 
•  The  consumer organisations are equally concerned about the  lack of what they 
perceive as inadequate resources for the supervision and control of  health claims. 
•  The major consumer organisation, The Finnish Consumers' Association, has taken 
a  proactive  role  in  raising  the  awareness  of  ethical  issues  regarding  the 
consumption of normal consumer goods. 
3.  Industry 
•  There  is  no  indication  from  industry that  modifications  are  needed concerning 
nutritional  claims.  As  to  health  claims,  the  Finnish  Food  and  Drink  Industry 
Federation has proposed the  introduction of product specific  claims,  along  the 
lines  of the  Swedish  proposal.  The  federation  has  also  proposed  disease  risk-
reduction claims in line with the European Union. 
* * * 
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A.  DEFINITION OF CLAIMS 
1.  Nutritional Claims 
Nutritional  claims  are  defined in  a  Decision  issued by the  Ministry of Trade  and 
Industry concerning the nutritional labelling of foodstuffs  ( 1496/1993: Handels- och 
industriministeriets beslut om naringsvardesdeklaration for livsmedel). 
In §  1, section 2 (2), it is cited: 
"A nutritional claim is a claim made on packaging, in a brochure or any other 
information in  relation to marketing which is meant to state,  imply or suggest 
that a foodstuff  has special nutritional properties. , 
It is  also  stated that  such  claims  may concern  energy,  protein,  carbohydrates,  fat, 
fibre,  sodium  or parts  of these  nutritional  groups  as  well  as  certain  vitamins  and 
minerals. Any compulsory information on the quality or quantity of  nutrients does not 
constitute a nutritional claim. Nutritional declaration is, in general, voluntary. 
The Finnish definition of a nutritional claim is  in complete accordance with the EU 
definition and with the Codex Alimentarius definition. The Codex "nutrient content 
claim", "comparative claim" and "nutrient function claim" are all accepted in Finland. 
2.  Health Claims 
Health claims are not explicitly defined in the Finnish Food Act. However, according 
to  §6  of the  Food Act, presenting health claims or medical information concerning 
foodstuffs or referring to such information is forbidden. 
In Control  11/97 Medicinal and Health claims in the marketing of foodstuffs (Tilsyn 
1111997  Handbok for  tillsynen  over pastaenden  som  galler medicinska  egenskaper 
och halsan)  issued by the  National  Food Administration (NFA),  it  is  said that  this 
prohibition  to  a  large  degree  is  based  on  Directive  79/112/EEC,  which  prohibits 
marketing claims to the effect that foodstuffs prevent, treat or cure human diseases. 
The ban in §6 of the Food Act concerns all marketing of all types of foods including 
dietary supplements. 
The Finnish "definition" of  health claims thus reflects the EU definition. 
In  the  latest  Codex  definitions  of health  claims  from  April  1999,  two  different 
definitions  are  used.  It  is  interesting  and  important  to  note  that  neither  of these 
definitions includes words such as ""preventing, treating or curing." 
Consequently, a comparative analysis regarding the Finnish and the EU definition vis-
a-vis the Codex definitions suggests that these are not really in  accordance with each 
other,  i.e.  the  Finnish  and  EU  definitions  are  more  '"medicinal"  than  the  Codex 
definitions. 
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No definition exists. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
The regulatory framework for nutritional claims includes: 
•  The Food Act 
•  The Decision concerning the nutritional labelling o.f  foodstuffs 
•  The Consumer Protection Act 
The  Council  Directive  90/496/EEC  on  nutritional  labelling  is  implemented  in  the 
Decision concerning nutritional labelling of  foodstuffs. 
2.  Health Claims 
The  regulatory  framework  for  health  claims  regarding  foodstuffs  and  dietary 
supplements consists of: 
•  The Food Act 
•  The Ordinance concerning labelling ojfoodstuffs 
•  The Consumer Protection Act 
Health  claims/medicinal  claims  regarding  natural  remedies  1s  covered  by  the 
Medicinal Act. 
The Council Directive 79/112 on the  labelling of Foodstuffs is  implemented in  the 
Food Act and the Ordinance concerning labelling of  foodstuffs. 
3.  Ethical Claims 
There is no specific legislation in place regarding ethical claims. However, any claim 
- including ethical  claims  - is  subject to  the  general  clauses  regarding  correctness, 
honesty and non-misleading information in the Consumer Protection Act. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
Nothing special to report. 
D.  POLICY THINKING AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
Policy thinking on claims  is  guided by an  overarching desire  to  protect and not to 
mislead  the  consumer.  In  relation  to  food  products,  consideration  is  also  given  to 
consumer safety, consumer health and the overall promotion of healthy eating habits. 
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Codex guidelines and EU policies/directives. 
All kinds of claims used either in labelling or marketing must be in accordance with 
the totality of relevant legislation: the main laws being the Food Act, The Consumer 
Protection Act and the Decision concerning the nutritional labelling of  foodstuffs. 
Nutritional claims are, in general, administered according to the Codex guidelines on 
Nutrition Labelling and Nutrition Claims. 
The NFA has issued guidelines for the use of nutritional declarations and nutritional 
claims (Valvonta 5/96) and is currently working on updating these guidelines. A new 
set of guidelines is expected to be produced in the Autumn of 1999. 
2.  Health Claims 
Policy thinking is, to  a large extent, reflected in the above-mentioned Control 11/97. 
According  to  the  manual,  the  Food  Act particularly  prohibits  claims  according  to 
which a person can prevent, treat or cure a disease or its symptoms by eating a given 
foodstuff.  When evaluating the  effect of a  particular marketing practice,  attention 
should  be  paid  to  the  impression  which  it,  as  a  whole,  tends  to  create  in  the 
consumer's mind. 
A claim may fall under the ban in  Section 6 even if marketing does not mention the 
name of a specific disease.  General claims referring to  symptoms, discomfort, pain 
etc.  may fall  under that ban even if a specific disease is not mentioned. The manual 
also  states that the  name of a foodstuff may not make reference to  a disease or be 
designed to create an association with a disease in consumer's mind. 
Examples of forbidden claims in the manual include claims that a foodstuff or any of 
its  ingredients  prevent  osteoporosis,  relieve  indigestion/upset  stomach,  prevent 
cavities or relieve symptoms associated with the menopause.  Appended to the manual 
is a list of  claims, which are seen to conflict with §6 of  the Food Act. 
However, according to the manual, in certain conditions nutritional education may be 
supported by explaining the  positive  effects of foodstuffs  on  vital  functions  when 
there  is  a clear connection. Thus claims regarding the  effects of foodstuffs  or other 
substances on vital functions do not always fall under the ban in Section 6 of  the Food 
Act. 
This type of "vital function  claim'' describes  the  effect of nutrients,  compounds or 
microbes on normal vital functions. The manual says that acceptable claims are those 
which refer to vital functions with which nutrients have a clear connection. The term 
nutrient refers to substances in foodstuffs, which provide energy for growth, support 
the  maintenance  and  development  of  life  and  whose  absence  causes  certain 
biochemical and physiological changes. 
Permissible claims  include  those  referring to  vital  functions  with which  foodstuffs 
have a clear connection. In presenting claims, attention should also be focused on the 
general principles, which are mentioned below. 
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Permissible claims, under certain conditions, include the following examples, which 
refer to strengthening of  bones, digestion, fat balance and blood cholesterol: 
•  calcium strengthens bones 
•  xylitol is good  for teeth 
•  fibre promotes digestion 
•  soft fats help keep the blood cholesterol under control 
•  a low-salt diet has a positive effect on the control of  blood pressure: product X is 
low in salt and contains x grams of  salt. 
In  using claims referring  to  vital  functions,  the  positive effect  should apply to  the 
active  ingredients  rather  than  the  foodstuff  itself.  In  marketing,  therefore,  it  is 
permissible to state that calcium strengthens bones but it  is  not permissible to  state 
that product X strengthens bones. 
According  to  the  manual,  in  evaluating  marketing  claims  and  especially  claims 
referring  to  vital  functions,  attention  should  also  be  paid  to  the  following 
matters/principles: 
Y  The decisive thing for human nutrition and welfare is  total diet and not any 
single food.  In presenting marketing claims, which refer to vital functions, the 
significance of  total diet should therefore be emphasized. 
Y  The portion of an  active  ingredient in a  food  should be such that the  effect 
presented in marketing is accomplished by regularly using normal amounts of 
the food as part of  a normal diet. 
';;- Permissible  claims  must  be  provable.  If a  claim  regards  anything  but  a 
generally  known  effect  on  vital  functions,  it  must  be  based  on  sufficient 
scientific proof. 
Finnish permissible health claims are similar to those referred to as enhanced function 
claims in  the  latest Codex documents on health claims.  The current Finnish policy 
thinking is clearly in favour of an EU based regulatory framework for health claims. 
This  has  been  stated  in  the  Finnish  comments  in  the  Green  Book  on  EU  food 
policy/legislation. More precisely, Finland is  in favour of explicit lists of acceptable 
and prohibited health claims. 
The  NFA  has  received  a  proposal  from  the  Finnish  Food  and  Drink  Industry 
Federation  regarding  the  possibility  of introducing  product  specific  physiological 
health  claims  (similar  to  the  proposal  made  in  Sweden)  and  so-called  disease 
reduction claims. 
After meeting with the NF A, we have personally been informed that the authorities 
will  take  a positive  attitude  towards  physiological health claims,  i.e.  the  NF A  will 
require that a positive list be worked out between the authorities and nutrition experts. 
These approved claims will then eventually be integrated into the mentioned Control 
11/97 guidelines. 
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conclusion that at present this  is  not possible without changing the Food Act or the 
Council Directive 791112/EEC. 
3.  Ethical Claims 
The  Finnish  Government  has  not  really  considered/addressed  the  issue  of ethical 
claims. In  a personal communication, the Consumer Agency has said that this  issue 
will be one of  three major consumer related subjects to be looked at in the year 2000. 
III.  VOLUNTARY INSTRUMENTS 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
No additional comments. 
2.  Health Claims 
No additional comments. 
3.  Ethical Claims 
The Finnish Association for promoting Fair Trade (Reilun Kaupan EdisHimisyhdistys 
Ry)  was  established  in  1998  and  is  associated  with  the  International  Fair  Trade 
Labelling Organisation (FLO). The organisation uses the "'elephant" logo as its ethical 
trademark. 
As with all member organisations of the FLO, the Reilun Kaupan EdisHimisyhdistys 
Ry  organisation  has  identical  principles  and  criteria  for  its  work  and  licensing 
schemes, i.e.  for small farmers:  democratic forms of organisation, no  discrimination, 
political independence, good product quality, and for employee; fair salaries, the right 
to organize itself, no child labour, etc. 
The first products with the elephant logo will appear on the market in August 1999. 
Four  companies  have  signed  licensing  contracts  with  the  Finnish  Fair  Trade 
organisation and some of the major retail chains have agreed to  stock the products -
initially coffee and tea. 
The Finnish Association for promoting Fair Trade has been founded by various NGO 
organisations, including the trade unions for  food  and textile products.  Initially,  the 
Finnish  International  Development Agency has  agreed  to  support  the  organisation 
with a total of approximately 640 000 EUR for its first three years of operation. 
Other ethically based labelling systems, e.g. the Rugmark Clean Clothes Campaign is 
not widely used. 
Pan- European study on nutritional, health and ethical claims- 1999.  173 I 
I 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
No comments. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
No comments. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
The  authorities  recognize  the  work  of the  Finnish  Fair  Trade  Organisation  and 
financial support is  given by the Finnish government.  Eventually, any ethical claims 
made will  obviously have  to  be  in  accordance  with  the  provisions  regarding non-
misleading information, etc. in the Consumer Protection Act. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The  criteria  for  using nutritional  claims  are  based  on  the  relevant  legislation  and 
guidelines  discussed  in  Section  II  C  1,  reflecting  the  90/496/EEC  Directive  and 
Codex. 
As  mentioned  earlier,  any  claim  appearing  on  labelling,  etc.  makes  nutritional 
labelling compulsory.  As  far  as  the  allowed  nutritional  claims  are  concerned,  i.e. 
content and comparative claims, these are based on quantitative criteria.  In this way, 
it is made relatively easy to verify if  such claims are justified. 
As far  as the mentioned nutrient function claims are concerned (in  Finland:  claims 
referring  to  vital  functions),  guidelines  are  included in  Control  11/99  as  discussed 
earlier. Apart from these guidelines, no particular verification system exists. 
2.  Health Claims 
Acceptable health claims are claims referring to  vital functions  (based on  nutrients, 
compounds or microbes). Guidelines for permissible claims are included in  Control 
11/97.  Control 11197 states that permissible claims must be provable. Furthermore, it 
is  quoted  that  if a  claim  regards  anything  but  a  generally  known  effect  on  vital 
functions, it must be based on sufficient scientific proof. The proof will be evaluated 
on a case-by-case basis. 
3.  Ethical Claims 
The voluntary system operated by the Finnish Fair Trade Organisation has its own set 
of principles and criteria corresponding to  those of the FLO organisation.  The FLO 
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engaged in any supervision of  this system. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
The regulatory framework/administrative system concerning labelling and marketing 
(including  claims)  consists  of the  Consumer  Protection  Act,  administered  by the 
Consumer Agency/Consumer Ombudsman  and  the  Food  Act,  administered by the 
NF A.  Both of these  administrative agencies  are  part of the  Ministry of Trade  and 
Industry. 
The Consumer Protection Act is  relevant for  all  types  of claims including all  food 
related claims whereas the NF  A only deals with claims for products regulated by the 
Food Act. Similarly, claims regarding products under the Medical Act is administered 
by the  Medicinal  Agency.  In  reality,  the  NF A  handles  questions  relating  to  both 
labelling  and  marketing  of food  products  in  accordance  with  the  so-called  lex 
specialis principle. 
The  municipal/regional  authorities  handle  the  concrete  labelling  of the  product 
whereas marketing in a wider sense (including advertising, etc.) is mainly supervised 
at a national level, i.e. by the NF A. 
The  Consumer  Agency  only  gets  involved  in  the  marketing  of foodstuff cf.  the 
Consumer Protection Act when the Food Act for one reason or another cannot take 
measures against specific marketing. 
1.  Pre-Clearance Rules/Guidelines 
Questions  from  companies  about  food  legislation  including  claims  should  be 
addressed  to  the  company's  supervisory authority,  which  is  usually the  municipal 
health protection administration. 
The NF A publishes guidelines concerning the interpretation of the Food Act and other 
legislation  and  is  available  for  advice  regarding  special  cases.  However,  no  pre-
clearance mechanism exists in general. When the National Authorities are notified of 
products regulated by the Directive 89/389  on  Foodstuffs  for  Particular Nutritional 
Uses, the label (including claims), nutrients, instructions for use, etc. are checked. 
2.  Post-Clearance Rules/ Guidelines 
In  most cases, where the regulations are not complied with, the cases are settled in 
out-of-court procedures.  Otherwise,  cases  may be  taken  to  the  civil  court and  the 
Market Court. Criminal responsibility will be invoked only in exceptional cases. 
Most cases are settled by issuing prohibitions or information orders. These orders can 
be combined with a fine. 
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C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Any legal person including consumers or competitors can complain to the Consumer 
Agency or the municipal/regional authority regarding labelling or marketing which is 
not in accordance with the regulations. 
However, as mentioned above the municipal/regional authorities can only take action 
as far as the labelling is concerned whereas the NF  A will take action against any other 
marketing activities. 
D.  BURDEN OF PROOF 
The burden of proof always rests with the legal person responsible for the marketing 
of  the product and no specific kind of proof is adduced. However, as mentioned under 
Section  IV  A  2,  so-called  claims  referring  to  vital  functions  should  be  based  on 
"sufficient scientific proof.'' 
E.  APPLICABLE PENAL  TIES 
The applicable penalties when violating claims regulations are usually of limited size, 
i.e.  below  EUR  2-4.000.  However,  fines  are  rarely  used,  as  the  authorities  will 
endeavour to settle any breach of  the regulations/guidelines by negotiation. 
v.  CASE LAW 
The NF A directs the  market control of all  foodstuffs  in  Finland.  According to  the 
N  FA, there has not been any decisions or court cases on an inappropriate use of  health 
claims  in  foodstuffs  since  1995  (before  1995  the  Consumer Ombudsman  had the 
responsibility  for  the  market  control  of claims).  Since  1995,  the  NF A  has  passed 
comment on unsuitable claims in ten instances.  However, in all these cases the claims 
have been corrected without further action and,  therefore, the NFA is  not willing to 
list them. 
Before the year 1995 there is one court case (Market Court, MT:  1993:023, 9.11.1993, 
Ombudsman  vs.  Valio  Oy),  where  Valio  (Finland's  biggest  dairy  company)  was 
prohibited from using the claim that milk cures/relieves/prevents osteoporosis. 
There  has  also  been  a  few  cases  where  health  claims  have  been  used  in  an 
inappropriate  way  in  the  marketing  of dietary  supplements  (for  example  MT: 
1993:008 PSK-Javidox Ab vs.  Vitabalans, ""High  Potency Garlic").  Maybe the most 
flagrant case was last November when the NF A prohibited the selling and importing 
of Noni  Juice:  the  seller  claimed  that  the  product  cures  cancer,  HIV,  diabetes, 
rheumatism, etc. Press release 21/26.11.1998 is appended. 
VI.  MEANS OF COMMUNICATION 
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regarding the means of communication used such as television, Internet, press, labels, 
etc. 
VII.  STATISTICS ON CLAIMS 
Besides  information  given  in  Section  V  Relevant  Case  Law,  no  further  statistical 
information is available. 
VIII.  ANNEXES 
1.  The Finnish Food Act (Livsmedelslag 361/95) March 17, 1995 
2.  The Ordinance concerning labelling of foodstuffs  (Forordning om paskrifter pa 
livsmedelsforpackninger 794/91) May I 0, 1991 
3.  Decision  of The  Ministry  of Trade- and  Industry  concerning  declaration  of 
nutritional  value  for  foodstuffs  (Handels- och  Industriministeriets  beslut  om 
naringsvardesdeklaration for livsmedel 1496/93) May 10,  1991 
4.  Control  1111997  Medicinal  and  Health  claims  in  the  marketing of foodstuffs 
(Tilsyn  11/1997  Handbok  for  tilsynen  over pastaenden  som  galler medicinska 
egenskaper och halsan) 
5.  The Consumer Protection Act (20 January 1978/38). 
6.  National Food Administration, Press release 21126.11.1998. 
IX.  DATABASE OF CONTACTS 
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F.  FRANCE 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study on nutritional, health and ethical claims was well received by all interested 
parties in France. Every person consulted expressed a great interest in the study and 
collaborated fully in our research. 
B.  MEMBER STATE POLICY 
Whilst a nutritional claim is given a definition in legislation, health claims and ethical 
claims are not legally defined 
1.  Nutritional Claims 
These are clearly defined in French law, based on relevant EU legislation. 
2.  Health Claims 
Health claims are in  line with the current Codex Alimentarius definition guidelines 
and  a  Decree  provides  a  specific  definition  for  therapeutic  claims,  which  are 
forbidden, as per EU legislation 791112, Article 2.  Interestingly, there is an exemption 
to  the  general  rule banning therapeutic  claims, under the  Public  Health Code.  This 
states  that  advertisements  for  products  other  than  medicines  that  are  presented  as 
favouring  the  diagnostic,  treatment or the  prevention of a human disease require a 
"visa de  publicite" from  the  Agence Franc;:aise  de securite sanitaire des produits de 
sante. 
The most interesting development to date in France concerns the June 1998 opinion of 
the  Conseil  National  de  1' Alimentation on the  use of health claims.  This followed 
extensive  consultation  with  interested  parties.  The  position  of the  major  actors  is 
worth noting since they set the scene for the CNA's recommendations: 
•  There  is  a  general  agreement,  shared  by  consumers,  that  a  foodstuff  has  an 
important impact on health. Consequently they wish to learn more about nutrition. 
However, they are concerned that the current protection provided by law against 
misleading  claims  are  insufficient and  request  that  the  Misleading  Advertising 
Directive should be extended to distance selling and electronic commerce. 
•  Industry is heavily investing in Research and Development (R&D) to understand 
the  contribution of its  products on the  improvement of consumers'  health and, 
hence, wishes to  advertise the effects through the use of health claims.  Industry 
accepts that, at present, health claims should be limited to  claims describing the 
effects of  their products on organic functions (e.g., help the intestinal transit), on a 
physiologic condition or on  the reduction of certain pathologic risks (reduce the 
risk  of cardiovascular  diseases).  Claims  focusing  on  the  treatment  or  cure  of 
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advertising legislation and the ban on claims relating to  a disease are sufficient to 
protect the consumer. However, they are dissatisfied with the current system of 
authorising health claims  through  the  Visa  PP  procedure because  it  is  seen  as 
cumbersome and expensive. 
•  The scientific community believes that a health claim does not provide sufficient 
consumer information.  Therefore,  further  information on  nutrition  is  needed  in 
order to put health claims in a more informed context. 
The final  CNA recommendations  include twelve conditions, which need to  be met 
before they will fully accept the development of  health claims: 
1.  The  ban of therapeutic  claims.  It  should  be noted  that  the  CNA believes  that 
claims focusing on the diagnostic,  treatment or cure of a disease should still be 
forbidden. However, it is ready to accept the following type of  claims: 
•  A claim suggesting a real contribution of a foodstuff to  the  prevention of a 
pathology and presented as "help reduce the risk"; 
•  A  claim  suggesting  a  contribution  to  the  general  health  condition,  and 
recognised by the scientific community; and 
•  Nutritional and functional  claims describing the positive role of a nutrient in 
the normal functioning of  the body. 
2.  The need to apply the same principles to all foodstuff using claims; 
3.  The use of a trial period, during which an analysis of the impact of the  claims 
would be conducted; 
4.  The adoption of a comprehensive regulatory framework; 
5.  A precise system of  substantiation of  claims; 
6.  The  recognition  and  the  valorisation  of  the  expertise  necessary  to  the 
substantiation of  claims; 
7.  The adoption of a code of conduct for the communication of claims in the context 
of  the Laws on advertising; 
8.  The necessity to be rigorous in the application of sanctions for illegal claims; 
9.  The improvement of the analysis capabilities of  consumers, with the collaboration 
of consumer organisations; 
10. The responsible involvement of  all actors of  the food process; 
11. The education of  the general public; and 
12. The adoption of  a real nutrition policy. 
Whilst these recommendations have not been followed  up,  most stakeholders agree 
that this a sensible way forward and should be used as the basis of a broader European 
approach to the problem. 
3.  Ethical Claims 
Ethical  claims,  which  are  generally  understood  to  be  associated  with  guaranteed 
human rights in the production phase, are not legally defined and there is no specific 
legislation in place. Nevertheless, the issue is gaining recognition in France through a 
major campaign called "de l'ethique sur !'etiquette'', which groups together 51  NGOs 
and  consumer associations. The authorities (Ministry of Trade) are of the view that 
they are not competent to regulate on ethical claims due to WTO requirements. Thus, 
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either the EU or international level. 
C.  VOLUNTARY CODES OF PRACTICE 
Whilst  the  CNA  Recommendations  are  helpful,  there  are  still  no  voluntary 
instruments, similar to  those found  in other EU  Member States, in place in France. 
Industry,  for  its  part,  is  putting considerable emphasis on the role  that the  CIAA's 
future voluntary code on health claims may have in better regulating health claims. 
The "de 1' ethique sur 1  'etiquette" campaign is  a clear signal that whilst on the  one 
hand,  consumers  are  aware  of world issues  relating to  human rights,  on  the  other 
hand, they are looking not only to government but also to the business community to 
do something responsible. 
The Bureau de verification de Ia publicite, (the Office for Advertising Verification) is 
a  self-regulatory  body  whose  purpose  is  to  eliminate  excessive  claims  in  a  pre-
clearance system. It provides copy advice, monitors and handles complaints and can 
issue sanctions. It is deemed to work well and provide flexibility. 
D.  VERIFICATION SYSTEMS 
The  '"Direction  Generale  de  la  Concurrence  et  de  Ia  Repression  des  Fraudes" 
(DGCCRF) is responsible for the implementation and the control of the relevant legal 
instruments, pertaining to nutritional claims, whilst the '"Agence Franc;aise de Securite 
Sanitaire des Produits de Sante" (AFSSAPS) is responsible for the Visa PP procedure, 
used for health claims. 
In  case  of nutritional  claims,  the  verification  is  a  posteriori  once  the  product  is 
commercialised  as  per the  requirements  of the  relevant  legislation.  In  the  case  of 
health claims, the Visa PP procedure is a priori, despite the fact that the AFSSAPS is 
aware of health claims not having sought the Visa PP.  If a manufacturer is found not 
to have requested a Visa PP, the authorities can suspend the product/claim. 
The burden of proof, in the case of nutritional claims, lies with the administration to 
demonstrate that a claim is  misleading.  In  the case of a manufacturer not respecting 
the visa pp procedure, the burden is  on the shoulders of the company to  substantiate 
the  claims.  In  the case of misleading advertising  or labelling,  infringements  to  the 
legislation can led to both fines and/or penal sanctions. 
E.  MEANS OF COMMUNICATION 
There exist any difference between the means of  communications. 
F.  CONSUMER PROTECTION 
According  to  consumer  organisations,  the  protection  provided  by  law  against 
misleading  health  claims  is  insufficient.  Consumers  also  believe  that  Misleading 
Advertising  Directive  should  extend  to  new  forms  of commerce,  such  as  distance 
selling and electronic commerce. 
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The Visa PP is sometimes considered to be a heavy procedure and can be perceived as 
a barrier to trade. This has an impact only on products using health claims. 
H.  CASELAW 
There  is  little  case  law  in  France  on  claims  as  most  infringements  are 
examined/negotiated between the  manufacturer and the  authorities  and never reach 
the court. 
I.  STAKEHOLDER ANALYSIS 
1.  Government Authorities 
•  The conclusion of the  debate held by the  CNA  is  the  backbone of the  current 
French thinking on health claims. However, no concrete follow-up measures have 
been taken at national level but the optimal solution seems to  lie at the European 
level. 
2.  Consumers 
•  The position of the consumers is best reflected in the consultation process, which 
took place within the CNA. They agree that a foodstuff has an important impact 
on health and hence, they wish to  learn more about nutrition.  However, they are 
concerned that the current protection provided by law against misleading claims 
are insufficient and request that the Misleading Advertising Directive should be 
extended to distance selling and electronic commerce. 
3.  Industry 
•  Once again the position of Industry as  it relates to health claims is  that it invests 
heavily in R&D to understand the contribution of its products on the improvement 
of  consumers' health and, hence, wishes to advertise the effects through the use of 
health claims. Industry accepts that, at present, health claims should be limited to 
claims  describing  the  effects  of their  products  on  organic  functions,  on  a 
physiologic condition or on the reduction of certain pathologic risks  (reduce the 
risk  of cardiovascular  diseases).  Claims  focusing  on  the  treatment  or  cure  of 
diseases are not under discussion at present. 
•  Industry considers that the advertising legislation and the ban on claims relating to 
a disease  are  sufficient to  protect the  consumer.  However,  they are dissatisfied 
with  the  current  system  of authorising  health  claims  through  the  Visa  PP 
procedure because it is seen as cumbersome and expensive. 
* * * 
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II.  MEMBER STATE POLICY 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The  definition  of nutritional  claims  in  France  is  based  on  article  1  of Directive 
90/496/CEE of 24 September 1990 on nutrition labelling of foodstuff, transposed by 
Decree N°93-1130 in French law. 
Article 4 of  the Decree states that a nutritional claim is a representation or any form of 
advertising message  that states,  suggests  or  implies  that  a  foodstuff has  particular 
nutritional properties. 
A nutritional claim is a claim focusing on the presence, the absence, or the presence at 
a low or high level of energy or nutriments that a foodstuff may contain. 
Claims such as "rich in vitamins" or "low in cholesterol" are considered as nutritional 
claims in France. 
2.  Health Claims 
For the French administration, health claims indicate, suggest or imply that a relation 
exists between a foodstuff or a nutrient or a substance contained in a foodstuff and a 
health condition or a modification of a biological parameter, without any reference to 
a disease. This is in line with the Codex Alimentarius definition 
3.  Ethical Claims 
There is no legal definition of an ethical claim. Ethical claims are usually associated 
with a guarantee that human rights have been respected in the production phase of the 
product. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
The  provisions  of Directive  90/496  on  nutntlon  labelling  of foodstuff have  been 
transposed in French law under Decree N° 93-1130 of 27 September 1993 concerning 
nutrition  labelling  of foods  (Decret  N°93-1130  du  27  septembre  1993  concernant 
1  'etiquetage relatif aux qualites nutritionelles des denrees alimentaires  ). 
The Decree provides for: 
•  The following definition of a nutritional claim: any representation or advertising 
message that states,  suggests or implies  that a foodstuff has  specific nutritional 
properties:  1)  because  of the  energy  (caloric  value)  it  provides  or it  does  not 
provide, or it provides in a high or low level; 2) because of the nutrients it contains 
or it does not contain, or that it contains in a high or low proportion. 
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following nutrients 1) proteins 2) glucides 3) lipids 4) fibres 5) sodium 6) vitamins 
and minerals. 
•  The type of information that should be provided to the consumers: quantity of the 
different nutrients and energy value. 
2.  Health Claims 
Health claims are not precisely defined by French law. 
Decree 84-114  7 provides for a definition of "therapeutic claims". Article 3 forbids the 
use  of therapeutic  claims:  "Sous  reserve  des  dispositions  applicables  aux  denrees 
destinees  a une  alimentation  particuliere  ainsi  qu'aux  eaux  minerales  naturelles, 
1' etiquetage  d 'une  denree  alimentaire  ne  do it  pas  faire  etat  de  proprietes  de 
prevention, de traitement et de guerison d 'une maladie humaine". 
3.  Ethical Claims 
There is no specific legislation on ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
The regime applicable to  nutritional claims is  detailed in  Decree N°  93-1130 of 27 
September 1993 concerning nutrition labelling of  foods. 
The main exemptions to  this Decree are mineral water and foodstuffs  for particular 
nutritional uses (as defined by Directive 89/398). 
2.  Health Claims 
•  Article 3 of Decree N°  84-114  7 of 7 December 1984, implementing the law of 1 
August 1905 on frauds and falsifications on products and services relating to  the 
labelling and presentation of foodstuffs, provides that the labelling of a foodstuff 
cannot claim  to  prevent,  treat  or cure  a human disease.  This  type of claims  is 
defined as a therapeutic claim (allegation therapeutique  ). 
•  Article L551-1 0 of the Public Health Code states that advertisements for products 
other than medicines that are presented as  favouring the diagnostic, treatment or 
the prevention of a human disease requires a ""visa de publicite" from the Agence 
Fran<;aise de securite sanitaire des produits de sante. 
The Visa PP in this context could be seen as an exemption to the general rule that 
forbids the use of  therapeutic claims. 
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3.  Ethical Claims 
There  are  no  specific  legal  rules  prohibiting,  restricting  or  exempting  the  use  of 
ethical claims. 
D.  POLICY THINKING AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims and Health Claims 
On 30 June 1998, the "Conseil Superieur de  1' Alimentation" published its advice on 
the  use  of health  claims 
1  following  a  long  debate  between  representatives  from 
industry, consumers, the advertising board and the scientific community which came 
together in the context of  the CNA. 
The report is divided into two parts.  In the first part, there is an analysis of  the current 
situation and in the second part, concrete recommendations are made. 
•  Current situation: 
The CNA noted that most consumers aspire to a healthier way of life. Consumers are 
increasingly  aware  of the  role  that  foodstuffs  may play in  improving  their  health 
condition. This trend has led to the development of  health claims. The CNA felt it was 
necessary  to  open  a  debate  between  the_  different  interested  parties  in  order  to 
recommend new policies to the government. 
Position of  the different parties: 
•  Consumers: 
Consumers expressed their desire to  learn more about nutrition and to  extend their 
knowledge on the role that foodstuffs have on their health. According to the consumer 
organisations,  the  protection  provided  by  law  against  misleading  health  claims  is 
insufficient.  Consumers  also  believe  that  Misleading  Advertising  Directive  should 
extend to new forms of commerce, such as distance selling and electronic commerce. 
•  Industry: 
Industry  invests  more  and  more  in  research  and  development  to  understand  the 
contribution of its  products in the improvement of consumers' health.  The industry 
wishes  to  advertise  the  effects  of its  products  through  the  use  of health  claims. 
Representatives  from  industry  consider  that,  at  present,  health  claims  should  be 
limited to  claims describing the effects of their products on organic  functions  (e.g. 
help the intestinal transit), on a physiologic condition or on the reduction of certain 
pathologic  risks  (reduce  the  risk  of  cardiovascular  diseases).  However,  claims 
focusing  on  the  treatment  or cure  of diseases  are  not  currently  under discussion. 
Industrialists  consider that the  advertising legislation and  the  interdiction of claims 
relating to a disease are sufficient to protect the consumers. The industry believes that 
1  Conseil  National  de  !'Alimentation;  Seance Pleniere  du 30 juin  1998;  avis  adopte a 1  'unanimite; 
Allegations faisant un lien entre alimentation et sante. Covers nutritional, functional and health claims. 
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• 
•  Scientific experts: 
They believe that a health claim does not provide enough information to the consumer 
and that more general information on nutrition is needed in order to put health claims 
in a more informed context. 
•  The CNA proposals: 
The  recommendation of the  CNA covers  functional,  nutritional  and  health  claims. 
From a general perspective, all parties believe that health claims could be developed if 
there was a greater level of  information on nutrition amongst the population. 
The  CNA believes  that  claims  focusing  on  the  diagnostic,  treatment  or cure  of a 
disease should still be forbidden. 
The CNA is ready to accept the following type of  claims: 
A claim suggesting a real  contribution of a foodstuff to  the  prevention of a 
pathology and presented as ""help reduce the risk"; 
A  claim  suggesting  a  contribution  to  the  general  health  condition,  and 
recognised by the scientific community; and 
Nutritional and functional claims describing the positive role of a nutriment in 
the normal functions of  the body. 
The  CNA  considers  that  there  is  a  need  to  adapt  the  regulatory  system  and  to 
distinguish  between  the  scientific  substantiation  of claims  and  the  communication 
means. 
The CNA agreed on the following: 
Therapeutic claims are forbidden; 
Health claims referring to the reduction of a risk should require pre-clearance, 
except if  there are on a positive list established by the authorities; 
Functional claims should be subject to  laws on misleading advertising, with a 
list of authorised claims being verified by a reference organisation external to 
the company making using the claim. 
Generally, all claims subject to a clearance by an external organisation or included on 
a positive list would be subject to "'a posteriori" control. 
The CNA believes that a code of conduct should be adopted by the professionals in 
order to self regulate the form of  the claims. 
The final  recommendation of the CNA contains twelve points that are the necessary 
conditions to accept the development of  health claims: 
2 See V.B.l: Visa PP procedure 
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•  Ban of  therapeutic claims; 
•  The need to apply the same principles to all foodstuff using claims; 
•  The use of a trial period,  during which an  analysis of the  impact of the  claims 
would be conducted; 
•  The adoption of  a comprehensive regulatory framework; 
•  A precise system of  substantiation of  claims; 
•  The  recognition  and  the  valorisation  of  the  expertise  necessary  to  the 
substantiation of claims; 
•  The adoption of a code of conduct for the communication of  claims in the context 
of  the laws on advertising; 
•  A requirement to be rigorous in the application of  sanctions for illegal claims; 
•  The improvement of the analysis capabilities of consumers, with the collaboration 
of  consumer organisations; 
•  The responsible involvement of all actors in the food process; 
•  The education of  the general public; and 
•  The adoption of a real nutrition policy. 
The recommendation has not been followed up until now. Most actors expect that this 
work will be put into practice in  the context of a broader approach at the European 
level. 
The French administration and French consumer organisations do not believe that the 
current regulatory framework leads to barriers to trade. However, there seems to be a 
consensus that the Visa PP could be seen as a form of barrier. Nevertheless, most of 
the  people  with  whom  we  talked  (besides  industry)  believe  that  such  a  procedure 
might be  needed  to  protect  consumers'safety.  This  question was  discussed  by the 
CNA, which concluded that a less stringent "a priori" control could be a solution to 
the current situation. 
2.  Ethical Claims 
As opposed to "Nordic countries", the issue of ethical claims has not reached the same 
level of debate in France. However, campaigns from NGO's have managed to obtain 
results from private companies and public authorities have begun to get involved. 
The French Government has recently started to  work on the issue of ethical claims. 
The  Minister  for  trade  and  the  "Direction  des  relations  economiques  exterieures" 
(DREE) are the main actors. 
The authorities still consider that they are not competent to regulate on ethical claims. 
Their view is  that due to WTO requirements, the French government cannot regulate 
on  ethical  claims  as  this  could be perceived  as  being  a  trade  barrier.  Thus,  they 
consider that any regulatory action should be taken at the level of the WTO or in the 
context  of the  International  Labour  Organisation.  The  government  is  now  in  a 
preliminary period during which an analysis of the different options at  international 
level  is  being  carried  out.  The  objective  of the  government  would  be  to  build  a 
consensus on the issue at European and International level. 
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NGO's.  The  main  campaign  in  France  is  entitled  "'de  l'ethique sur !'etiquette".  It 
brings together 51  NGOs and consumer associations, representing most of actors from 
a consumer perspective. The objective of the campaign is  to  create a '"label  social" 
(social  label)  guaranteeing  consumers  that  fundamental  human  rights  have  been 
respected in the production chain. 
III.  VOLUNTARY INSTRUMENTS OR OTHER PRACTICES 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  The "Bureau de Verification de Ia  Publicitt~" (BVP) 
The "bureau de  verification de  la  publicite" (BVP) is  a self-regulatory body, which 
has  self-regulated  advertising  for  the  past  60  years.  It is  not  recognised  by  the 
authorities. However, it is a form of  "'pre-clearance" that eliminates excessive claims. 
The BVP's responsibilities are as follows: 
•  Drawing-up  and  implementing  self-regulatory codes  of practice  in  conjunction 
with the advertisement industry; 
•  Advice  on  and  control  of advertisements  in  all  media on the  basis  of relevant 
legislation and codes of  practice; and 
•  Handling complaints from consumers. 
The main activities of  the BVP are as follows: 
•  Copy advice/Pre-clearance: Copy advice plays an increasingly important role in 
the BVP's activities. For television advertising, advertisers are required to submit 
finished television commercials to  the BVP for pre-clearance. The advice of the 
BVP is  binding on the advertiser. For non-television advertising, advertisers and 
media can voluntarily seek copy advice at the pre-publication stage. 
•  Monitoring:  The  BVP  carries  out  monitoring  of published  advertising  in  all 
media  except  television.  Monitoring  may,  in  some  cases  lead  to  a  formal 
complaint. 
•  Complaints handling: One of the BVP's main tasks is to investigate complaints. 
These  complaints  are  handled  free  of charge by a  permanent staff of lawyers. 
Complaints should be addressed to BVP in writing, if possible with a copy of the 
offending advertisement.  If,  upon examination,  an infringement is  apparent,  the 
advertiser  is  requested  either  to  substantiate  his  claims  or to  modify  them  to 
comply with  the  ntles.  In  case  of non-compliance  with  this  request,  and  after 
notice  has  been given to  the  advertiser,  the  BVP asks  the  media concerned to 
cease  publication  of the  advertisement.  The  BVP  publishes  its  decision  in  its 
newsletter, BVP Echos. 
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•  Sanctions: The BVP can expel, after a hearing,  any member who has  failed  to 
comply with its decisions. The BVP can also be party. to  any court case against 
those  it has found  guilty of misleading or otherwise  abusing advertising.  Other 
sanctions, which the BVP applies, are formal warnings and adverse publicity. 
2.  Nutritional claims 
There is no voluntary instrument in place. 
3.  Health Claims 
There  is  no  voluntary  instrument  in  place.  The  industry,  with  the  support  of the 
French administration is involved in the development of a European code of conduct 
in the context of  the CIAA. 
4.  Ethical Claims 
There are several voluntary instruments in place. We have chosen to use the campaign 
"de 1' ethique sur 1  'etiquette" as our main example considering its importance and the 
significant number of  participating parties (see Section II, B, 3). 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
There is no voluntary instrument in place. 
2.  Health Claims 
There is no voluntary instrument in place. 
3.  Ethical Claims 
Companies  using  the  social  label  as  defined  by  the  campaign  "de  1  'ethique  sur 
I' etiquette" respect a code of conduct. To adopt the code of  conduct and use the social 
label companies must respect the following ILO conventions: 
•  Convention N°87 on the freedom of  trade unions; 
•  Convention N°98 on the right of association and collective conventions; 
•  Convention N° 105 on the abolition of forced labour; 
•  Convention N° 111  on non-discrimination of  workers; 
•  Convention N° 138 on the minimum required age for employment; 
•  Conventions N°26 and N° 131 on minimum wages; 
•  Convention N°  1 on maximum working time and overtime; 
•  Convention N°  155 on health and safety at the workplace. 
The companies n1ust also: 
•  Promote the code of conduct with their sub-contractors and providers; 
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•  Participate in an independent control system; and 
•  Guarantee to consumers that all fundamental human rights have been respected in 
the processing chain. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
Not applicable. 
3.  Ethical Claims 
Considering the system is  based on voluntary agreements there are no prohibitions, 
restrictions or exemptions. To benefit from a "'social label" a company needs to fulfil 
all obligations laid down in the voluntary agreements. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
There is a posteriori verification system to substantiate claims. A company wishing to 
use nutritional claims should forward to the DGCCRF a dossier, which includes (see 
annex and note from Conseil Superieur d'Hygiene Publique de France): 
•  A presentation of  the company; 
•  A  general  presentation  of  the  product  (definition,  description,  process, 
qualitative and quantitative production, labelling). 
2.  Health Claims 
Theoretically, a company wishing to use a health claim should obtain a Visa PP from 
the Agence Franc;aise de Securite Sanitaire des Produits de Sante (AFSSAPS) before 
it can use a claim in the labelling or advertising of the product. The visa is  delivered 
by the Director of AFSSAPS  after a  recommendation from  the  Committee  on  the 
control of  advertising
3
. 
However, it appears that a number of  products using health claims have recently been 
put on the market without any Visa PP. 
3  Sec annex on the "recommendations pour Ia  constitution des dossiers" - Direction des etudes et de 
!'information pharmaco-economiques- Agence Fran9aise de Sccurite Sanitaire des Produits de Sante. 
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3.  Ethical Claims 
The  criteria  are  defined  by  the  obligation of the  code of conduct,  which refers  to 
several ILO conventions (see above). The objective of the campaign "de l'ethique sur 
1' etiquette"  is  not  to  certify  a  product  and  the  claim  attached  but  to  certify  the 
production plants of  the manufacturer, which could then claim a social label. 
Until now, the campaign has approached the French authorities (Minister of  consumer 
affairs) to see whether they could participate in the definition of a certification system 
(type ISO). 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
The  "Direction  Generale  de  la  Concurrence  et  de  la  Repression  des  Fraudes" 
(DGCCRF) is responsible for the implementation and the control of the relevant legal 
instruments.  The  "Agence  Fran9aise  de  Securite  Sanitaire  des  Produits  de  Sante" 
(AFSSAPS) is responsible for the visa pp procedure. 
1.  Pre-Clearance Rules/ Guidelines 
a.  Visa PP procedure
4 
According to the French health code (articles L.  551-10, L.  556, R.5052 to R.5052-3), 
advertisements for products presented as beneficial for health have to be approved by 
the Director of  the AFSSAPS before the product is put on the market. 
According to AFSSAPS, the following products have to follow this procedure: 
•  Products  favouring  the  diagnosis,  the  prevention or the  treatment of human 
diseases; 
•  Products  favouring  the  diagnosis  or  the  modification  of the  physical  or 
physiological state. 
The manufacturer or the distributor of the product must request a visa for every form 
of advertising:  packaging,  labelling, brochure,  TV or radio  advertisement etc ...  The 
AFSSAPS collects a tax of3000 FF (approx. EUR 457) on every Visa PP. 
The dossier must include: 
•  A covering letter indicating the type of advertisement; 
•  A completed form (see annex); 
•  A photocopy of  the advertisement; 
•  An example of  packaging; 
•  A dossier on the substantiation of the claim including the composition of the 
product, and a scientific dossier substantiating the claims. 
-t  Demandes de  "Visas PP"- Recommandations pour la constitution des dossiers- Agcncc Franc;aise 
de Securite Sanitaire des Produits de Sante-April 1999 
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A dossier has to be submitted to the DGCCRF and must include: 
•  Information on the producer; 
•  Definition of  the product; 
•  Description of  the production process; 
•  Qualitative and quantitative composition 
•  Labelling. 
2.  Post-Clearance Rules/ Guidelines 
Although the Visa PP is normally a pre-clearance procedure, a lot of products 
are put on the market without the approval of AFSSAPS. If a product using 
claims  without  a  Visa  PP  is  identified  by AFSSAPS,  the  producer  or  the 
distributor is requested to fill  up an  application for the visa.  In certain cases, 
the marketing of  the product might be suspended. 
3.  What are the administrative/legal costs? 
A tax of3000 FF (approx. EUR 457) is collected for each Visa PP 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
•  Any legal or natural person considering that a nutritional or health claim is illegal 
is entitled to take legal action. The person can directly address the complaint to the 
judiciary system or to the administration, which can address the complaints to the 
relevant judiciary institutions after a preliminary inquiry. 
•  On the basis of local enquiries the DGCCRF can start redress procedures on the 
basis of  misleading advertising. 
•  On the basis of  local enquiries the AFSSAPS can start redress procedures. 
•  If a health claim is being used without a Visa PP, the AFSSAPS can suspend the 
marketing of the product until the producing company can substantiate the claim 
being made. 
D.  BURDEN OF PROOF 
1.  Burden of proof 
•  In  the  case  of nutritional  claims,  the  burden  of the  proof  belongs  to  the 
administration.  It has to  demonstrate the misleading aspect of the advertisement 
ofthelabel. 
5  Conseil  Superieur d'Hygiene  Publiquc  de  France -- Section de  l'alimentation et  de  la  nutrition -
Groupe de travail "Valeur Nutritionnelle"- proposition sur les elements a  fournir par un petitionnairc 
pour l'analyse des docciers par le groupe de travail. 
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•  If a company has not respected the procedures of the Visa PP, it must substantiate 
its claim. 
2.  Proof to be adduced 
See Vis a PP procedures. 
E.  APPLICABLE PENAL  TIES 
In  the  case of misleading advertising or labelling, infringement to  the  legislation in 
place may lead to fines or to  penal sanctions (up to  two  years imprisonment and/or 
250 000 FF (approx EUR 38  112) fine and the publication of  the judgement). 
The Visa PP is sometimes considered to be a heavy procedure and can be perceived as 
a barrier to trade. However, the administration believes that a pre-clearance procedure 
(although it  could be  lighter than  the  one  in place at  the moment)  is  necessary to 
guarantee consumer protection. 
V.  CASELAW 
1.  Nutritional Claims 
No relevant case law. 
2.  Health Claims 
There  are  only a  few  cases  in  France.  The  best  example  is  provided  by C.  Paris 
(13eme Ch. Sect. A) 5 February 1997: Teillard d'Evry vs. Ms Petit. 
During  a  control  carried  out by the  DGCCRF,  the  authorities  established  that  the 
labelling of certain foodstuff was using health claims as defined by article L551  of the 
Health  Code.  The claims were "convient a  toute personne souhaitant renforcer son 
dispositif cerebral",  "accelere  la  perte  des  surcharges  graisseuses",  "'cffets  laxatifs 
incontestables" etc ... 
The companies never requested a Visa PP as provided in article L 551. 
The  judge considered  that  these  claims  were  more  than  a  precision  to  the  list  of 
ingredients  and,  therefore,  considered  that  they  should  be  subject  to  the  Visa  PP 
procedure. 
3.  Ethical Claims 
There is no specific case law. 
VI.  MEANS OF COMMUNICATION 
There are no real differences between means of  communication. 
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We could not find any relevant statistics. 
VIII.  ANNEXES 
•  Loi N°86-1 067 du 30 septembre 1986 relative a  la liberte de communication. 
•  Decret  N°93-1130  du  27  septembre  1993  concernant  l'etiquetage  relatif aux 
qualites nutritionnelles des denrees alimentaires; 
•  Arrete  du  3  decembre  1993  portant  application  du  decret  N°93-1130  du  27 
septembre  1993  concernant  1  'etiquetage  relatif aux  qualites  nutritionnelles  des 
denrees alimentaires. 
•  Decret  N°92-280  du  27  mars  1992  pris  pour !'application du  paragraphe  1 de 
!'article 27 de la loi du 30 septembre 1986 relative a  la liberte de communication 
et fixant les principes generaux concernant le regime applicable a  la publicite et au 
parramage; 
•  Decret N°84-1147 du 7 decembre 1984, portant application de  la loi du 1er Aout 
1905  sur les fraudes et falsifications en matiere de  produits ou de services en ce 
qui concerne 1  'etiquetage et la presentation des denrees alimentaires. 
•  Decret N°96-531  du  I4 juin 1996 relatif a la  publicite pour les  medicaments et 
certains  produits  a usage  humain  et  modifiant  le  code  de  la  sante  publique 
(deuxieme partie: Decrets en Conseil d'Etat). 
•  Decret N° 99-I44 du 4 mars  1999 portant transfert de competences au  profit de 
l'agence fran9aise de securite sanitaire des produits de sante et modifiant le livre 
V du code de la sante publique (deuxieme partie: Decrets en Conseil d'Etat). 
•  Code de la Consommation (Partie Legislative) - Section  I:  Publicite - Articles L 
121-I to L I2 I-15; 
•  ode de la Consommation (Partie Legislative) - Section  1:  Tromperie - Articles L 
213-1  to L 213-2; 
•  Code  de  la  Consommation  (Partie  Reglementaire) - Livre  I:  Informations  des 
consommateurs et formation des contrats - Article R 112-7. 
•  Code de la Sante Publique (Partie Legislative)- Chapitre 4: Reglementation de la 
publicite- Articles L55I to L556. 
•  Code de la Sante Publique - Article R.5046-1 
•  Avis du Conseil National de  I' Alimentation adopte lors de sa seance pleniere du 
30 juin 1998 concernant les allegations faisant un lien entre alimentation et sante. 
•  Proposition  sur  les  elements  a fournir  par un  petitionnaire  pour !'analyse  des 
dossiers  de  demande  d'autorisation  d'allegations  nutritionnelles  - Conseil 
Superieur d'Hygiene Publique de France. 
•  Dossier from the campaign "de 1  'ethique sur l 'etiquette"; 
•  Receuil de fiches  de  recommandations pour les publicites en faveur des produits 
presentes  comme  benefique  pour  la  sante.  Ministere  du travail  et  des  affaires 
sociales. Commission de contr6le de la publicite. 
•  A  vant-projet de recommandations concernant les allegations relatives a  la sante -
observations de la France a  l'etape 3. 
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caractere non trompeur des allegations nutritionnelles fonctionnelles. 
IX.  DATABASE OF CONTACTS 
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I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study on nutritional, health and ethical claims was generally well received by all 
interested parties in Germany.  All contacted parties were willing to provide an input 
to the study.  There was a general opinion that something needed to be done on health 
claims. 
The following Executive Analysis outlines the key points of  interest for the purpose of 
the study. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The  definition  of a  nutritional  claim  is  very  similar to  the  one  used  in  EU  law. 
Nevertheless,  German law  does  not foresee  the possibility to  make  a claim on  the 
energy or nutrient value that the foodstuff does not provide or contain. 
From  the  authorities  point  of view,  current  legislation  on  nutritional  claims  is 
satisfactory  and  no  new  initiatives  are  currently  planned.  The  Food  Industry 
Association felt that in some cases the 15% RDA rule for vitamin and mineral claims 
was too restrictive. 
2.  Health Claims 
With regard to health claims, Germany implemented word by word Directive 791112. 
But  in  addition  further  provisions  are  made  under  German  law,  which  somewhat 
extend the prohibitions of  Directive 79/112. 
The Ministry of Health felt that in principle it was not harmful to allow manufacturers 
to  make  statements,  which  were  scientifically proven.  This  could  eventually also 
include  disease  risk  reduction  claims.  Nevertheless,  if such  claims  were  to  be 
permitted, one would quickly reach the borderline with pharmaceutical products.  In 
Germany, the authorities were, therefore, giving a wide definition to pharmaceuticals 
in  order to reduce the danger of self-medication and to  avoid the situation where the 
consumers might believe that foodstuffs have the same effects as medicines. 
The main German Consumer Association felt that EU legislation may be necessary, as 
more  and  more  functional  foods,  food  supplements  and  probiotic  foodstuffs  were 
coming on the market, which were primarily using claims. 
The Food Industry Association is in favour of an amendment to  Directive 79/112, in 
order to  allow disease risk reduction claims. Industry and authorities considered that 
before legislating on health claims, it was  necessary to  define at  EU  level  the term 
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product was a foodstuff or not. 
3.  Ethical Claims 
The issue of ethical claims has  received only limited attention by the authorities in 
Germany.  There  is  no  legal definition of an ethical claim and no  directly relevant 
legislation. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional and Health Claims 
No voluntary instruments exist in Germany on health or nutritional claims.  While the 
Food Industry had reflected on a code of conduct with consumer groups, it felt that a 
code  of conduct  would  not  resolve  barriers  to  trade,  as  German  courts  would 
eventually continue their strict application of Directive 79/112.  The main Consumer 
Association  considered that  a code of conduct might  be  used  as  an  excuse  not  to 
legislate. 
Having said that, the German Advertising Council, which is  the self-regulatory body 
of the  German advertising industry has  developed guidelines  on  the  advertising of 
alcoholic  beverages,  which  re-inforce  prohibitions  on  health  claims  contained  m 
Directive 79/112 and in particular in Directive 89/552 on TV without Frontiers. 
2.  Ethical Claims 
There exist a number of labelling schemes with regard to  ethical claims.  The most 
well-known  is  the  one  administered  by  TransFair,  which  acts  as  an  independent 
organisation  selling  licences  for  the  use  of its  TransFair-Seal.  In  the  licensing 
agreements  that  TransFair  concludes  with  companies,  it  sets  out  the  text  that 
companies have to  use  on the  backside of their label.  This text usually contains a 
number of  ethical claims. 
D.  VERIFICATION SYSTEMS 
With regard to the criteria for substantiating claims, the only ones that apply are those 
set out in  the  law on nutritional  labelling and  for  dietary foods  the  ones  as  set out 
under the  notification  procedure  of dietary  foods  apply.  In  addition,  the  Federal 
Health  Office  has  drafted  a  position  paper  on  sports  foods,  which  is  used  as  an 
internal guideline and which states that claims made have to be factually correct and 
scientifically sound. 
Pre-clearance  is  considered  censorship  and  is,  therefore,  not  applied  in  Germany. 
Nevertheless,  there  exist  some  informal  arrangements,  which  allow  companies  to 
verify their claims with the relevant surveillance authorities. 
As  to  post-clearance, this  is  in  general done by the  food  and medicine surveillance 
authorities in the German regions.  They routinely carry out checks. In addition, there 
exist a number of out-of-court procedures.  The  Centre for  Fight against  Unlawful 
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Competition serves  as  a  contact point  for  consumers.  The  Centre  can bring such 
complaints - if necessary - to  settlement points  established within the  chambers of 
commerce.  Another out-of-court procedure dealing more specifically with immoral, 
unethical, sexist etc. advertising is run by the Advertising Council. 
As  to  the  burden  of proof,  it  lies  with  the  complainant under the  Law  on  Unfair 
Competition, as well as the Food Law.  Nevertheless, the Federal Court concluded in 
several judgements that the  burden of proof was with the  defendant where he  was 
using an opinion, which is controversial amongst experts.  This is without mentioning 
the  dissenting  scientific  view.  Nevertheless,  consumer  associations  seem  to 
experience  problems  with  claims  that  cannot  be  scientifically  proven.  It  appears 
difficult for consumer associations to find and finance an expert who could provide an 
opinion proving that the claim cannot be scientifically proven.  Therefore, many cases 
are not brought to court. 
Penalties  can  range  from  small  fines  to  imprisonment.  Misleading  advertising  IS 
punished under law more severely than forbidden health claims. 
E.  MEANS OF COMMUNICATION 
There is no difference between means of  communication, although the Internet, whilst 
not proving to be an actual problem yet, is seen as a potential problem. 
F.  CONSUMER PROTECTION 
The  Ministry  of Health  felt  that  German  legislation  was  sufficient  in  terms  of 
consumer protection.  It indicated,  nevertheless,  that  the  law  did  not  address  the 
problem that food companies were sometimes using selective statements, which were 
true in themselves, but without putting them into context.  In its answer of October 
1996  to  a  Commission  request  for  information  on  miracle  products,  the  German 
Government indicated that the surveillance instruments available may be less efficient 
with regard to door to door and mail-order selling. 
The  main  Consumer  Association  indicated  that  there  were  problems  of consumer 
protection.  In  particular,  there  seemed  to  be  problems  with  regard  to  probiotic 
foodstuffs,  functional  foods  and  food  supplements,  as  food  manufacturers  were  in 
these cases trying to check out the limits of the prohibition of disease related claims. 
In  the consumer association's view,  it was necessary to  regulate as  to  which claims 
may be used under which conditions.  The association also indicated that there were 
some more subtle forms of claims, which were either not regulated by law, or which 
the  surveillance authorities  did  not pursue,  e.g.  food  companies  sponsoring certain 
health related TV series. 
The Centre for Fight against Unlawful Competition (which is  a  private  association 
acting  against  unlawful  competition,  including  claims)  considered  that  German 
legislation provided for adequate consumer protection.  Nevertheless, a problem area 
was food supplements, as the current legislation did  not seem to  be fitted  for these 
products, which seemed to be neither a foodstuff nor a medicine. 
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Fight  against  Unlawful  Competition  receives  with  regard  to  food-related  claims 
around  100  complaints per year.  The Consumer Protection Association's  database 
that goes back to  1992, indicates that it has sent around 150 complaints to companies 
with regard to  health  related advertising.  Out of these,  80  concern advertising for 
slimming products. 
The authorities, industry and consumer associations indicated that there had not been 
any problems in terms of  consumer protection regarding fair trade labelling schemes. 
G.  BARRIERS TO TRADE 
In the Ministry of Health's view, there exist no significant barriers to trade with regard 
to  health claims.  It acknowledges that sometimes problems arose with regard to  the 
import of food  supplements,  as  these were often defined as  a medicinal product in 
Germany simply because of  the claims made. 
The  Food  Industry  Association  indicated  that  in  practice  it  was  difficult  to  find 
barriers to trade, as  German legislation on health claims was already one of the most 
restrictive  in the EU  and also  because companies would in  general  try to  adapt to 
national labelling rules instead of  bringing such issues to the courts. 
The authorities, industry and consumer associations indicated that there had not been 
any problems in terms of  barriers to trade regarding fair trade labelling schemes. 
H.  COURT CASES 
There  exist  a  considerable  number of court  cases  in  Germany,  in  particular  with 
regard to  health claims.  German courts interpret health claims restrictively, i.e.  even 
if a reference is not explicitly made clear to a certain illness it was sufficient to use a 
clear  paraphrase  of an  illness,  or  where  the  symptoms  described  made  a  clear 
reference to a specific sickness.  The court cases also  indicate the reasoning for the 
courts' strict interpretation of  health claims.  This is mainly done for two reasons: - to 
avoid the danger of self-medication and to avoid consumers believing that foodstuffs 
have the same effects as medicines. 
I.  STAKEHOLDER ANALYSIS 
There is  a general view that with the development of new products, such as  dietary 
supplements and probiotic foods,  authorities need to  look into  the  issue of claims. 
There seems to be a general agreement that voluntary codes are not a viable way in 
Germany to address the issue. 
In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  On nutritional claims, the authorities see no need for review. 
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•  On health claims,  although the  authorities  consider that the  current situation is 
satisfactory, they indicated that because of the borderline with medicines an  EU 
definition  of the  term  foodstuffs  was  necessary,  before  legislating  on  health 
claims. If the EU saw a need to address health claims, this should be done via an 
amendment to Directive 791112. 
•  On ethical claims, there is no real position. 
2.  Consumers 
•  Consumers  consider  legislation  on  claims  necessary,  in  particular  due  to  the 
increasing sale  of functional  foods,  food  supplements  and  probiotic  foodstuffs. 
The burden of proof should in their view be shifted to the manufacturer.  There is 
not yet a  clear view on pre-clearance vs.  post-clearance amongst the  consumer 
associations. 
3.  Industry 
•  The food industry is of the opinion that EU rules on health claims needed to  be 
adapted  via  an  amendment to  Directive  79/112.  Disease  risk reduction claims 
should be allowed, while claims on the  treatment and curing of diseases should 
remain prohibited.  Food industry also  considers it  necessary to  define  the  term 
foodstuff at EU level. 
•  With regard to nutritional claims, it is considered that the 15% RDA value in order 
to be able to make a claim should be reviewed. 
•  On  ethical  claims,  the  overall  view  of all  parties  IS  that  there  Is  no  need  for 
legislation. 
*** 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The definition of  nutritional claims is provided in article 1, paragraph 2 of  the German 
nutrition  labelling  decree  (Verordnung  zur  Neuordnung  der 
Nahrwertkennzeichungsvorschriften fur Lebensmittel, BGBL  I  1994 S.  3256, Annex 
1)  implementing the EU Nutrition Labelling Directive 90/496.  The definition is  the 
same as the one used in the EU Directive 90/496. 
It reads:  "1.  Nutritional claims: any representation or message used in advertising or 
marketing  of foodstuffs,  which  states,  suggests  or  implies  that  a  foodstuffs  has 
particular nutrition properties due to the energy or nutrient value it possesses". 
It is interesting to note that 'nutritional claim' has been translated into German literally 
as a 'nutrition property related indication'.  From this has to be distinguished nutrition 
labelling, which literally has been translated in German as  'nutrition property related 
labelling'. 
The  definition  of a  nutritional  claim  is  very  similar to  the  one used  in  EU  law. 
Nevertheless,  German law does  not foresee  the possibility to  make  a claim  on  the 
energy or nutrient value that the foodstuff does not provide or contain. 
2.  Health Claims 
German  law  does  not  contain  any  definition  of health  claims.  Nevertheless,  by 
default, the  law  forbids  medical claims and  provides for a narrow interpretation of 
health  claims.  Under  the  German  Food  Law  (Lebensmittel- und 
Bedarfsgegenstandegesetz, BGBI. I 1997 S. 2296, Annex 2), paragraph 18 states that: 
"[ ...  ] it is prohibited when marketing foods or when advertising foods in general or in 
individual instances: 
1.  to use statements referring to the elimination, alleviation or prevention of sickness 
[same as Article 2 of  791112], 
2.  to make reference to medical recommendations or medical expertise, 
3.  to feature or refer to case histories', 
4.  to  feature  or refer  to  statements by third  parties,  particularly letters  of thanks, 
recognition  or  recommendation  insofar  as  they  refer  to  the  elimination  or 
alleviation of  illnesses, 
5.  to show pictures of people wearing a uniform of the medical profession or in the 
process of carrying out an activity reserved for members of the medical, nursing 
or pharmacological professions, 
6.  to use statements capable of  arousing or exploiting people's fears, 
7.  to  feature  documents or written information instructing people to  treat illnesses 
with foodstuffs." 
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The  German  Food  Law  is,  therefore,  similar  to  Article  2  of the  EU  Labelling 
Directive 791112,  in that it does not allow the claim that a foodstuff has the property 
of preventing,  treating,  or curing a human disease.  However,  a number of further 
provisions are made, which extend the prohibitions of Directive 791112  (see points 2. 
to  7.  in  paragraph  18  of the German Food Law listed above), thereby establishing a 
more restrictive interpretation of79/112. 
As for nutritional claims, the term claim seems to be linked to the 'marketing' and/or 
'advertising'  of  a  foodstuff,  while  for  labelling  terms  such  as  'denomination', 
'indication' and 'presentation' are used (see paragraph 18 point 5). 
In  addition,  the  German Food Law provides for  a general prohibition to  market or 
advertise foodstuffs in a misleading manner (paragraph 17  alinea 5).  The Food Law 
gives three examples, which can be considered as misleading: 
•  if a foodstuff claims to  have certain effects, which are  either not proven by 
science or are not proven by sufficient scientific evidence; 
•  if a foodstuff is given the appearance of a medicinal product; and 
•  if expressions,  indications,  presentations,  or  other  statements  are  used  to 
mislead about the origin, the quantity, the weight, the date of production, the 
date of best before or any other circumstance, which are determinant for the 
judgement of the product. 
Under German  Food  Law,  certain enhanced function  claims,  as  defined  under the 
latest Codex draft recommendations for the use of health claims, could be permitted 
(see IV.  A) 2.  ).  However, diseases risk reduction claims as  defined under the same 
Codex draft are clearly not permitted under German law. 
3.  Ethical Claims 
German legislation does not contain any definition of  ethical claims. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
EU  Directive 90/496 on Nutrition Labelling of Foodstuffs has been implemented in 
Germany  via  the  nutrition  labelling  decree  (Verordnung  zur  Neuordnung  der 
Nahrwertkennzeichnungsvorschriften fur  Lebensmittel,  Annex  1  ).  This decree  also 
contains provisions for a number of nutritional claims, which are not foreseen in the 
EU Directive (see II.  D)  1) b)). 
The  EU  Directive  89/398  on  Foodstuffs  for  Particular  Nutritional  Uses  was 
implemented  via  the  decree  for  dietary  foods  (V erordnung  tiber  ditatetische 
Lebensmittel, Annex 7). 
Specific  legislation  exists  for  claims  made  on  milk  products  (Verordnung  tiber 
Milcherzeugnisse, Annex 6) (see II) D) 1) b)). 
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mineral and table waters (Annex 5), which contains a list of  nutritional claims that can 
be made (see II) D) 1) b)). 
2.  Health Claims 
The relevant parts of EU Directive 79/112 on Labelling of Foodstuffs dealing with 
health  claims  have  been  implemented  via  the  Food  Law  (Lebensmittel- und 
Bedarfsgegenstandegesetz, Annex 2). 
The  German  decree  for  dietary  foods  (Annex  1)  also  contains  some  provisiOns 
regarding specific health claims (see II) D) 2) c)). 
The EU Directive 84/450 on Misleading Advertising was implemented in Germany 
via the law on unfair competition (Gesetz gegen den unlauteren Wettbewerb, Annex 
8). 
EU Directive 89/552 on Television Broadcasting was implemented via the  Federal 
Broadcasting Agreement (Rundfunkstaatsvertrag, Annex 16), as well as guidelines of 
the  German  Advertising  Council  on  alcohol  advertising  (Verhaltensregeln  des 
Deutschen  Werberates  tiber  die  Werbung  und  das  Teleshopping  fur  alkoholische 
Getranke, Annex 1  0). 
3.  Ethical Claims 
There exists no specific legislation in Germany on ethical claims.  For ethical claims 
used on foodstuffs the Food Law therefore applies, and in a more general manner the 
law on unfair competition applies. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
a.  Prohibitions 
Under article 1 paragraph 6 point 1 of the German nutrition labelling decree (BGBL 
1994  I  S.  3526,  Annex  1  ),  it  is  forbidden  "in  the  marketing or advertisement of 
foodstuffs  to  use  designations,  indications  or presentations,  which  suggest  that  a 
foodstuff has slimming properties or acts as an aid to slimming or weight reduction". 
This provision does not apply to  foodstuffs that are intended to be used as  a  daily 
ration for overweight people (see below under c)). 
b.  Restrictions 
Under article 1 paragraph 2 of  the German nutrition labelling decree (BGBI. 1994 I S. 
3526,  Annex  1  ),  nutritional  claims  may only refer to  the  energy value  and/or the 
content of protein, carbohydrates, fats  and saturates, as well as substances which are 
part of these groups of nutrients (including cholesterol).  Furthermore claims relating 
to salt can be made. 
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Claims  regarding  the  vitamin  and  mineral  content  are  restricted  to  the  following 
nutrients: vitamin A, B 1, B2, B6, folic acid, pantothenic acid, niacin, vitamin B 12, C, 
D,  E,  biotin, calcium, phosphor, iron, magnesium, zinc and iodine.  Such claims can 
only be made if the vitamins are contained to a significant amount in the foodstuff, i.e. 
15o/o of  the RDA (nutrition labelling decree, article 1, para 4., point (2), alinea 6.) 
There  are  also  a  number of restrictions  in  the  German  nutrition  labelling  decree 
regarding  low-energy and reduced-energy claims  (article  1,  paragraph  6,  point  (2) 
alinea 1 and 2).  No reference may be made in marketing or advertising of foodstuffs 
to the low energy value of  a food if: 
in the case of foods other than drinks, soups or broths, the energy value amounts 
to more than 210 kJ or 50kcal per 1  OOg of the ready-to-consume product; or 
in the case of drinks, soups and broths, the energy value amounts to more than 84 
kJ or 20kcal per 1  OOml of  the ready-to-consume product. 
No reference may be made in marketing or advertising of foodstuffs  to  the reduced 
energy value of a food if the energy values per 1  OOg  listed in Annex II for a number 
of foodstuffs (bread, cake, meat products etc.) are exceeded.  For the  foodstuffs  not 
listed  in  Annex  the energy value has  to  be  at  least 40o/o  below the  average energy 
value of comparable foodstuffs, in order to be able to  make a reduced-energy claim. 
The Ministry indicated that this applied to 'light' claims. 
Furthermore,  restrictions  apply  with  regard  to  reduced-nutrient  content  claims. 
Reduced nutrient content claims are  only allowed if the  nutrient content is  at  least 
40o/o less than the average nutrient content of comparable foodstuffs.  An exception is 
made with regard to reduced carbohydrate claims for bread and bakery products.  The 
reference value here is 30o/o (paragraph 6, point 3a of  the nutrition labelling decree). 
Finally, restrictions apply with regard to sodium claims.  It is permissible to refer to a 
reduced sodium content only for a number of  foods (listed in Annex III of the decree: 
bread, bakery products, soups, sauces, products from  fish,  cheese etc.) and only if a 
limit value of 250mg per 1  OOg is not exceeded (article 1, paragraph 6, point (2) a  linea 
3b). 
Reference should not be made to  a low salt or sodium content, if in the case of food 
products other than beverages, the sodium content is more than 120mg per 1  OOg of the 
ready-to-eat product.  In the case of  beverages, the sodium content should not be more 
than 2mg per 1  OOml  of the ready-to-drink product (article  1,  paragraph 6,  point (2) 
alinea 4). 
There exists specific legislation with regard to  the composition and labelling of two 
products: mineral waters and milk based products. 
With regard to mineral waters, the decree on mineral and table waters (BGBl I 1984, 
S.  1036,  Annex  5)  establishes  in  Annex  4  the  allowed  nutritional  claims.  Thus, 
specific limits have been set for low mineral content, extra low mineral content and 
high mineral content claims (500mg/l, 50mg/l and 1500mg/l respectively). 
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these  minerals  certain  threshold  values  have  been  established.  Thus  only  claims 
regarding  bicarbonate,  sulfate,  chloride,  calcium,  magnesium,  fluoride,  iron  and 
sodium are allowed. 
Finally, the decree fixes that the claim 'suitable for a diet poor in sodium' can only be 
made for mineral and table waters with a sodium content that is below 20mg/l. 
With  regard  to  milk  based  products,  a  decree  from  1970  covering  these  products 
(BGBI.  1970 I, S.  1150 as last amended in 1990, Annex 6) establishes in its Annex the 
sales names for milk based products (ranging from  sour milk products over mixed 
milk drinks to cheese products) and the criteria that have to be fulfilled for being able 
to  use  these  sales  names.  The  term  'low-fat'  forms  part of the  sales  name  and  a 
maximum fat content is established for each low fat product, e.g. low-fat yoghurts can 
only have a fat content between 1.5 and 2.0% per I 00% of  its weight. 
c.  Exemptions 
Two  exemptions  exist  regarding  slimming  claims  (nutrition  labelling  decree 
paragraph 6 point (3)).  Firstly, under the nutrition labelling decree (Annex  1  ),  it  is 
possible to refer in restaurants for the main meal that has an energy value below 2100 
kJ or 500 kcal as "for a weight control diet". 
Secondly, for the marketing and advertising of  foodstuffs that are intended to be used 
as  a daily ration,  reference to  a low or reduced energy value may only be made if 
these products fulfill the composition criteria listed in  the German decree on dietary 
foods (Verordnung iiber diatetische Lebensmittel, BGBl. 1988 I S.  1713, last amended 
in 1996, Annex 7), where a number of energy values and vitamin and mineral content 
criteria are listed (paragraph 14a) 
2.  Health Claims 
a.  Prohibitions 
As indicated under the definition of health claims, these are defined very narrowly in 
Germany (see II.A) 2) ).  Apart from this narrow definition, no further prohibitions are 
mentioned under German law. 
b.  Restrictions 
See again the definition of  health claims mentioned above (under II. A) 2) ). 
c.  Exemptions 
Although  medical  claims  are  in  general  forbidden,  the  German decree  on  dietary 
foods (Verordnung iiber diatetische Lebensmittel, Annex 7) allows the use of certain 
medical claims for dietetic foodstuffs  (which are defined as under the EU Directive 
89/398 on Foodstuffs for Particular Nutritional Uses). Paragraph 3 of  the dietary foods 
decree  indicates  that  as  an  exception to  the  German Food  Law,  certain  statements 
referring to the elimination, alleviation or prevention of  sickness are allowed. 
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These statements are the following: 
'dietetic foodstuff suitable for the treatment of infant dyspepsie, only in the framework 
of  the medical decree" 
'dietetic foodstuff suitable for the treatment of  congenital metabolic disorders' 
liver insufficiencies" 
kidney insufficiencies' 
Furthermore,  statements can be  made regarding foodstuffs  that may be used in  the 
special diet in case of: 
maldigestion or malabsorption; 
food intake troubles; 
mellitus; 
chronically inflamed intestines,  or pre- or post operative  treatment of intestinal 
operations; 
chronic pancreatitis; and 
gout. 
In these cases, the statement has to be used:  'for the special diet in case of . . . in the 
framework of  a diet plan'. 
Furthermore, the restrictions applying to  health claims as  defined in paragraph  18 of 
the German Food Law do not apply to  advertising which is addressed to members of 
the medical or nursing professions (paragraph 18, point 2). 
3.  Ethical Claims 
a.  Prohibitions 
As  no  specific  legislation  exists  for  ethical  claims,  the  general  law  against  unfair 
competition applies (RGBI.  1909, S.  499, last amended in  1998, Annex 8).  Notably 
paragraph 3 of  the law states that: 
"Who in commercial activities makes for competitive purposes misleading statements 
over the  commercial conditions,  in particular the  nature,  the  origin,  the  production 
method  or  the  price  determination of individual  products  [ ...  ]  can  be  claimed  for 
injunction of  statements." 
Furthermore, the  general  interdiction of misleading claims under the  German Food 
Law applies (see paragraph 17, alinea 5). 
b.  Exemptions 
As no specific legislation exists for ethical claims, no exemptions are foreseen under 
German law. 
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As  no  specific legislation exists for ethical claims, the  general restriction of the law 
against  unfair  competition  (see  point  a)  above)  apply.  Furthermore,  the  general 
interdiction of misleading claims under the German Food Law applies (see point a) 
above). 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The  German  authorities  consider  current  legislation  on  nutritional  claims  to  be 
satisfactory and there are no new initiatives in the pipeline. 
The Ministry of Health indicated that there sometimes existed problems in terms of 
whether a nutritional statement on the label could be considered a nutritional claim or 
was part of the ingredient list.  But this seems neither to  have lead to  any barriers to 
trade or consumer protection problems. 
The German Food Industry Association indicated that in  general there were neither 
barriers to trade nor consumer protection problems with regard to nutritional claims. 
The association gave, nevertheless, two  examples where German nutrition labelling 
legislation was working against the consumer: 
•  Under the nutrition labelling decree vitamin and mineral claims can only be 
made if the  amounts were above a level of 15o/o  of the  RDA.  But for  some 
drinks it  was not possible reach such high mineral values, without leading to 
taste problems of the product. 
•  For several milk products it was impossible to  make a calcium claim for the 
same reason, i.e.  15o/o of the RDA of calcium would sometimes significantly 
change the taste of the product. Not being able to  make a calcium claim on 
milk products was in the association's view rather absurd, as milk was one of 
the most significant providers of  calcium. 
In these cases, the  15% value should, therefore, be reduced, in order to being able to 
make a claim. 
2.  Health Claims 
The current policy thinking of the Ministry of Health is  that in principle it  was not 
harmful to allow manufacturers to make statements, which were scientifically proven. 
This could eventually also include disease risk reduction related claims. Nevertheless, 
if such claims  were  to  be  permitted,  one would quickly reach  the  borderline  with 
pharmaceutical products.  In Germany, the authorities are giving a wide definition to 
pharmaceuticals  in  order to  reduce the  danger of self-medication and to  avoid  that 
consumers might believe that foodstuffs have the same effects as medicines. 
Because  of the  borderline  with  medicines,  the  Ministry  of Health  feels  that  It  Is 
necessary first to define at EU level the term foodstuffs, before legislating on health 
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specific product was a foodstuff or not. 
As to  defining a health claim, the Ministry is not entirely convinced as to  whether a 
definition is  needed,  as  a  claim  was  in  essence  advertising (consequently,  the  EU 
Directive  on  Misleading  Advertising  would  cover  claims).  They  suggested  that 
eventually  a  claim  could  be defined  negatively  (i.e.,  not  the  sales  name  nor  the 
ingredients listing). 
If the  Commission felt  that health claims needed to  be  regulated,  in  the  Ministry's 
view this should be regulated via an amendment to Directive 791112. 
The  main  German  consumer  associatiOn  (Arbeitsgemeinschaft  der 
Verbraucherverbande) felt  that EU legislation may be  necessary, as  more and more 
functional  foods,  food  supplements  and  probiotic  foodstuffs  were  coming  on  the 
market (see Annex 3),  which were primarily using claims.  In  its view, a regulation 
such as in the US or the Swedish code of conduct may be a way forward. 
The  German  Food  Industry  Association  (Bund  fur  Lebensmittelrecht  und 
Lebensmittelkunde)  is  of the  opinion that EU  rules  on  health claims  needed to  be 
adapted via an amendment to  Directive 79/112.  In the association's view claims on 
disease risk reduction should be allowed, while claims on the treatment and curing of 
diseases should remain prohibited (see materials from press conference of BLL of 6 
May 1999, Annex 4). 
The association indicated that in this  context there was  a need to  define what  is  a 
foodstuff at  the  EU  level.  This  was  in  particular necessary as  the  differentiation 
between a foodstuff and a medicine was often made based on the claim used.  Basing 
the  differentiation  on  the  claim  made  should  only apply  when  it  was  clear  that  a 
certain  product  could  eventually  fall  in  one  or the  other  category.  But  where  a 
product  was  in  its  substance  clearly  a  foodstuff,  then  even  a  strong health  claim 
should in the association's view not make it a medicinal product. 
In addition,  a definition of the term health claim was  in  the association's view also 
needed, as discussions in the Codex Alimentarius had shown that the understanding of 
the term health claims differed sometimes (some seemed to  understand health claims 
in the sense of  disease related claims, others purely as health related claims and others 
seemed to consider under the same term both). 
The  Centre  for  Fight  against  Unlawful  Competition  (Zentrale  zur  Bekampfung 
unlauteren  W  ettbewerbs  ),  which  is  a  private  association  acting  against  unlawful 
competition, including claims (for further details see V) B.  2) c) ), was of the opinion 
that  EU  legislation  may  be  needed  in  the  area  of food  supplements,  as  current 
legislation was not adequate for these products.  Nevertheless, it  felt that a specific 
definition  of claims  was  not  necessary,  as  at  least  in  Germany  advertising  was 
interpreted quite widely, thus covering claims. 
The  Ministry of Health  is  currently working  on  legislation  for  food  supplements, 
which  will  also  include  some  labelling  rules.  The  Ministry  indicated  that  these 
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claims would not be allowed. 
In  the  Ministry of Health's view,  there existed no  significant barriers to  trade  with 
regard to health claims.  Germany was following Directive 79/112.  If other Member 
States were to  allow illness-related claims, they would be in  contradiction with EU 
law.  The import of such products could, therefore, be blocked under EU law. 
Furthermore,  the Ministry felt  that barriers  to  trade had most often to  do  with the 
composition  of a  product.  While  a  manufacturer had  in  any  case  to  change  the 
language of his  label  when crossing the border,  it  was  felt  that  it was  not a major 
problem to eventually change the claim accordingly.  It was on the other hand much 
more difficult to change the composition of  a product.  Nevertheless, the Ministry also 
indicated that some uniform rules as to how article 2 of 791112  should be interpreted 
would bring some legal certainty. 
The  Ministry,  nevertheless,  acknowledged  that  there  were  sometimes  problems  in 
terms of free movement of goods with regard to food supplements.  This was due to 
the fact that food supplements were often defined as a medicinal product in Germany, 
simply because of  the claims made. 
In  terms  of consumer  protection,  the  Ministry  felt  that  German  legislation  was 
sufficient (for more remarks on consumer protection see following chapters). 
The German Food Industry Association mentioned that it was in practice difficult to 
find barriers to  trade with regard to  Germany, because German legislation on health 
claims  was  already  one  of the  most  restrictive  ones  in  the  E U  and  also  because 
companies would in general try to adapt to national labelling rules instead of bringing 
such issues to the courts. 
The  Centre  for  Fight  against  Unlawful  Competition  (Zentrale  zur  Bekampfung 
unlauteren  W  ettbewerbs  ),  which  is  a  private  association  acting  against  unlawful 
competition,  including  claims  (for  further  details  see  V)  B.  2)  c)  )  believes  that 
German legislation provides for adequate consumer protection.  Nevertheless, it felt 
that a problem area was food supplements, as  the current legislation did not fit these 
products, which seemed to be neither a foodstuff nor a medicine. 
In  terms of legislation, the main German consumer association (Arbeitsgemeinschaft 
der Verbraucherverbande) considers that there are especially problems with regard to 
probiotic foodstuffs,  functional  foods  and food  supplements, as  food  manufacturers 
were in these cases trying to  check out the  limits of paragraph 18  of the Food Law, 
which  defines  in  more  detail  the  prohibition  of disease  related  claims.  In  the 
consumer association's view,  it is  necessary to  regulate as  to  which claims may be 
used under which conditions (i.e. scientific proofs to be submitted etc.). 
3.  Ethical Claims 
The Ministry for  Development Co-operation indicated that no  legislative initiatives 
with regard to ethical claims were envisaged for the time being.  The Ministry has, 
therefore,  so  far  not  thought  about  how  ethical  claims  could  be  defined.  As 
Pan - European study on nutritional, health and ethical claims -- 1999.  208 I 
mentioned above, the Ministry focuses  at  the  moment on pushing the  issue of fair 
trade up the agenda during the next WTO round. 
The absence of legislation on ethical claims does not seem to have been the catalyst 
for any problems in terms of  barriers to trade or consumer protection.  The authorities, 
trade associations and consumer associations contacted were unanimous that they had 
not heard of any problems in this area. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
No voluntary instruments exist in Germany for nutritional claims. 
2.  Health Claims 
No voluntary instruments exist in Germany for health claims.  Nevertheless, for sports 
foods there exists a position paper from  1993 of the working group on sports foods, 
which was set up  by the Federal Health Office (Bundesgesundheitsamt), and which 
was composed by eminent scientists from different disciplines. 
This  position paper has  no  legal  value,  but may be used by companies  producing 
sports foods as a reference point.  The paper defines sports foods and lays down some 
compositional standards for  sports foods.  The paper also contains some indications 
regarding  health  claims  (Anforderungen  an  Sportlemahrungen  aus  der  Sicht  des 
Bundesgesundheitsamtes,  Stellungnahme  der  Arbeitsgruppe  "Sportlemahrung"  im 
Bundesgesundheitsamt, 8.12.1993, Annex 9). 
The paper states that only sportsfoods may use the following three claims: 
•  "the  ingredients  of  the  product  equilibrate  the  loss  of  energy  and/or 
carbohydrates  and/or  protein  and/or  liquid  and/or  minerals  during  or after 
intensive body activity. 
•  they support an optimum nutritional balance and make the relevant nutrients 
available, during or after intensive body activity. 
•  they  delay  performance  decrease  during  intensive  muscular  activity." 
(Anforderungen an Sportlemahrung, point IV. 3)) 
Furthermore, the German Advertising Council, which is  the  self-regulatory body of 
the  German  advertising  industry,  has  developed  guidelines  on  the  advertising  of 
alcoholic  beverages.  These  establish  a  number  of prohibitions  in  terms  of the 
advertising of alcohol (see below in section C) of this chapter).  The functioning of 
the Advertising Council is explained in more detail further on (see V) B. 2) c)) 
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a.  TransFair 
There exist a number of labelling schemes in Germany regarding ethical claims.  The 
German non-profit organisation TransFair is the most well-known actor in this field. 
TransFair is supported by 39 organisations from the catholic and protestant churches, 
third world associations to environment associations. 
TransFair  acts  as  an  independent  organisation  selling  licences  for  the  use  of its 
TransFair-Seal.  Over  100  companies  have  already  a  licence  agreement  with 
TransFair (see TransFair Annual Report 1997, Annex 11). 
The seal guarantees that certain social standards are met in third countries (such as 
minimum  salary  paid,  no  child  labour,  guaranteed  workers  employment  rights 
according to  national  and international law).  Furthermore,  the seal  guarantees that 
certain environmental standards are being respected.  The products currently covered 
by  the  TransFair-Seal  are  coffee,  chocolate,  tea,  bananas,  honey,  orange  juice, 
bonbons. 
In terms of labelling, normally the seal is accompanied by a text which states that the 
product has been fair traded and that fair trade means 'increasing the  independence 
and equality of the disadvantaged partners in the third world', or that fair trade means 
'improving the living conditions through guaranteed minimum prices and direct trade 
relations' (for examples of  product labels see Annex No. 12). 
b.  Fair Traded Flowers 
Another labelling scheme which was started at the beginning of 1999 concerns fair 
traded  flowers.  An  agreement was  reached  between the  trade  union  'Bauen-Agra-
Umwelt', the aid association 'Brot fiir die Welt', Terre des Hommes, the human rights 
organisation FIAN, as  well as  the flower importing industry 'Verband des deutschen 
Blumen-, Grof3- und Importhandel' and producers in the export countries. 
The  label  guarantees  minimum  wages,  no  child  labour,  equal  treatment  for  all 
employees, as well as the respect of certain environmental standards.  The label states 
'from human and environmentally preserving production'. 
c.  Rugmark 
TransFair has since January 1999 also the secretariat of the German Rugmark office. 
Rugmark  is  a  Foundation  based  in  India  and  Pakistan,  which  licences  a  seal  for 
handknotted rugs, certifying that these rugs have been produced without child labour. 
Rugmark has created a trademark, which is registered in  14 European countries.  So 
far the Rugmark seal does not make any ethical claim or other ethical statement.  But 
the Rugmark office indicated that they were currently considering eventually adding 
some  information  on  what  the  Rugmark  seal  stands  for,  which  then  would  also 
include ethical claims. 
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B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
No voluntary instruments for nutritional claims exist. 
2.  Health Claims 
No specific definition of claims is  used in the position paper on sports foods of the 
Federal Health Office nor in the  guidelines on alcoholic  advertising of the German 
Advertising Council. 
3.  Ethical Claims 
TransFair  does  not  use  any  definition  for  ethical  claims  in  its  labelling  scheme. 
Nevertheless, in some of the licensing agreements reference is made as to what could 
constitute a misleading ethical claim.  For example, in the licensing agreements for 
coffee that TransFair concludes with importers,  it  is  made  clear that  the use of the 
term  "fair  traded  coffee"  may be  violating  competition  laws,  if a  price  is  paid  to 
producers which is below the minimum prices set out in the licensing agreement (see 
TransFair Licensing Agreement for Coffee, Annex 13). 
The fair flowers initiative does not use any definition for ethical claims in its labelling 
scheme. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
No voluntary instruments for nutritional claims exist. 
2.  Health Claims 
The  position  paper  of  the  Health  Office  states  that  claims  must  be  easily 
understandable, factually correct and scientifically founded.  Furthermore, they shall 
not mislead the  consumer or create exaggerated expectations.  Finally,  claims shall 
not give the impression that only by eating these products a performance increase is 
possible (Anforderungen an Sportlemahrung, point IV. 3), Annex 9). 
As  mentioned  above,  the  guidelines  of  the  German  Advertising  Council  on 
advertising  of  alcoholic  products,  establishes  the  following  prohibitions  that 
(Verhaltensregeln des Deutsch  en W  erberates fur die W  erbung und das Teleshopping 
fiir alkoholische Getranke, article 8/9/10, see Annex 1  0): 
•  no statements shall be made which refer to the curing, treatment or prevention 
of  diseases; 
•  no  statements shall be made which attach alcoholic beverages the effect of a 
medicament; 
•  no  reference shall be  made to  a medical recommendation or expert opinion; 
and 
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profession or in the process of carrying out an activity of the medical, nursing 
or pharmacological professions 
3.  Ethical Claims 
In the licensing agreements that TransFair concludes with companies, TransFair sets 
out the text that companies have to use on the backside of  their label (see example of  a 
TransFair Licensing Agreement for Coffee, Annex 13).  This text usually contains a 
number of  ethical claims, such as 'improving the living conditions through guaranteed 
minimum prices and direct trade relations' (see also III. A) 3) ). 
TransFair indicated that the problems they sometimes encounter with companies arise 
not  so  much  from  the  text  imposed,  but  from  the  length  of the  text,  which  is 
sometimes difficult to put on a package. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
1.  Nutritional 
No voluntary instrument on health claims exists. 
2.  Health Claims 
The position paper on sports foods of the Federal Health Office is in general used by 
the authorities as a guideline. 
The guidelines on alcoholic advertising of the Advertising Council are recognised by 
the authorities, since they implement the relevant provisions on alcoholic advertising 
of EU Directive 89/552 on TV without Frontiers. 
The  German  Food  Industry  Association  indicated  that  it  had  reflected  about 
eventually discussing a code of conduct with consumer groups, but it felt that a code 
of conduct would not resolve barriers to  trade,  as  German courts would eventually 
continue their strict application of Directive 79/112. 
The  main  German  consumer  association  (Arbeitsgemeinschaft  der 
V  erbraucherverbande) indicated that a code of  conduct might be used as an excuse not 
to legislate. 
3.  Ethical Claims 
The  different  fair  trade  labelling  schemes  mentioned  above  (see  III.  A)  3)  )  are 
supported  by  the  German  Ministry  for  Development.  Most  often  the  ministry 
provides funding for the local certification structures in the producing countries (see 
press release of BMZ from 6 May 1999 on the fair traded flower initiative, Annex 14). 
Neither the consumer associations, nor industry, nor the authorities felt that there had 
been any problems in terms of  consumer protection or barriers to trade regarding these 
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fair  trade  labelling  schemes.  It  was  indicated  that  if there  were  any  consumer 
protection  problems,  these  could  be  easily  be  resolved  via  the  law  on  unfair 
competition  or  via  paragraph  17  of the  Food  Law,  which  forbids  misleading 
advertising for foodstuffs. 
One consumer association, the Consumer Initiative (Die Verbraucherinitiative e.V.), 
which is  also a member of TransFair, indicated that due  to  the  fact  that TransFair, 
Rugmark and other fair trade associations were extremely active, it would be difficult 
for economic operators to use either misleading or false ethical claims without these 
coming  to  the  attention  of these  associations,  which  would  normally  immediately 
become active. 
E.  OTHER PRACTICES 
1.  Nutritional Claims 
No other practices on nutritional claims have been mentioned to us. 
2.  Health Claims 
The  main  German  consumer  association  (Arbeitsgemeinschaft  der 
Verbraucherverbande) indicated that there were some more subtle forms  of claims, 
which  were either not  regulated by law  or voluntary instruments and/or which the 
surveillance  authorities  did  not  pursue,  as  it  was  not  clear  whether  the  legal 
instruments  were  sufficient.  The  consumer association  mentioned  the  case  where 
food companies were apparently sponsoring certain health-related TV series. 
The  same  association  also  mentioned  that  there  were  some  claims,  which  the 
surveillance  authorities  seemed  to  tolerate,  but which  consumer associations  were 
opposed to.  These claims were: "improves the efficiency" and "improves the immune 
system" (although the later one had been subject to a Court case, see below VI. A) 2)). 
The Ministry of Health mentioned that the perception of the surveillance authorities, 
as to the claims that were making a link to a disease were evolving over time.  While 
several years  ago,  it would have been impossible to  make claims on the cholesterol 
lowering properties of a product,  this  seemed now to  be generally tolerated by the 
surveillance authorities. 
The Ministry also indicated that one problem, which the law did not address, was the 
fact that food companies were often using selective statements.  The Ministry gave as 
an example the claim "calcium helps against osteoporosis".  While this may be true in 
itself, it felt that a manufacturer should be obliged to indicate as well that one needed 
to have an intake of  calcium at an early age, in order to help against osteoporosis. 
It  seems that more subtle forms  of health claims, i.e.  via sponsoring are not clearly 
addressed by the law (although it seems possible to  act - if necessary - via the Food 
Law or the law against unfair competition ) nor seem to have attracted the attention of 
the surveillance authorities. 
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mentioned above.  Such selective statements did in the Ministry's view mask that a 
balanced diet was necessary. 
3.  Ethical Claims 
TransFair undertook in  1995 a campaign against a TV advertisement by Tchibo, one 
of the biggest coffee retailers in Germany.  The advertisement was for a new coffee 
called "Privat-Kaffee" and showed happy coffee farmers.  TransFair felt that this was 
romantisicing the real situation of  coffee farmers and started a gathering signatures for 
a petition.  In total, 4000 signatures were collected and send to  Tchibo (see extract 
from  TransFair Annual Report  1995, Annex  15).  Subsequently, Tchibo apparently 
stopped this TV advertisement. 
The example mentioned above by the Consumer Initiative raises the bigger question, 
in  how far  images/pictures  can constitute a  claim.  At least  in  the  field  of ethical 
claims,  there  does  not  really seem to  exist a  consumer protection problem  in  this 
respect. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The German nutrition labelling decree and the German Food Law do not provide for 
any  criteria  for  substantiating  nutritional  claims.  Having  said  that,  the  nutrition 
labelling decree establishes the criteria that have to be  fulfilled  (in terms of energy 
value of  the product etc.) for using certain nutrition claims (see above II. D) 1) ). 
But the decree does not provide for any documents that a manufacturer would need to 
submit or keep  in  his file  to  proof that he is  respecting the composition criteria for 
being able to make certain nutritional claims.  Nevertheless, it is clear that in the case 
of a lawsuit, a manufacturer should for his own defense keep relevant documentation 
concerning the production process of  the product in question, so as to be able to proof 
the respect of  the composition criteria. 
2.  Health Claims 
Health claims are in general not allowed (see II.  D)  2)  a)  ).  For the limited list of 
health  claims  allowed  under the  decree  on  dietary  foods,  the  normal  notification 
procedure  for  dietary  foods  as  set  out  under  EU  Directive  89/398  on  foods  for 
particular nutritional uses applies.  Under paragraph 4a of the decree on dietary foods 
(Annex  7)  a  manufacturer has  to  notify such a product to  the  Federal Institute  for 
Consumer  Health  Protection  and  Veterinary  Medicine  (Bundesinstitut  fur 
gesundheitlichen V  erbraucherschutz und Veterinarmedizin  ). 
For the  notification, a manufacturer has to  submit a model of the  label he wants to 
use.  The Federal Institute then examines whether the product conforms to the criteria 
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criteria of EU Directive 89/398), i.e. whether it is aimed at the consumer group which 
the manufacturer claims it is  destined for,  and whether it  serves the dietetic purpose 
claimed by the manufacturer. 
Under  the  decree  on  dietary  foods,  the  Federal  Institute  can  additionally  ask  the 
manufacturer to  provide all  scientific  work and  data,  which  show that the  product 
corresponds to the criteria for a dietary food. 
While under this procedure, the Federal Institute examines only whether the product 
has the dietetic purpose for which it is  supposed to  be destined, it was clear that the 
dietetic  purpose  was  often  defined  by  the  claim  made.  The  Federal  Institute, 
therefore, also examines the claim made on the label. 
The position paper on sports foods of the Federal Health Office states with regard to 
the criteria for substantiating the specific nutritional claims that may be made on such 
products:  "Each  claim  has  to  be  [ ...  ]  factually  correct  and  must  be  scientifically 
sound"  (Anforderungen an Sportlemahrungen, IV.  3,  Annex 9).  No  further criteria 
are mentioned. 
3.  Ethical Claims 
To  be able to  use the TransFair seal together with the relevant claims set out in the 
licensing agreement, an importer has to respect certain criteria.  These are in general: 
•  Buying of products (coffee, bananas,  etc.) only from  small producers (often 
contracts list the small producers from which an importer is allowed to buy); 
•  Providing  TransFair  access  to  the  invoices,  certificates  of origin  etc.  for 
verification purposes; 
•  Payment  of certain  minimum  prices  (sometimes  this  provision  is  in  the 
licensing agreements non-binding); and 
•  Payment of  a certain amount into a social fund. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
No  pre-clearance rules exist in  Germany. Pre-clearance is considered censorship and 
is, therefore, not applied. 
Nevertheless,  there  exist  some  informal  arrangements,  which  allow  companies  to 
verify their claims.  It is  almost normal practice for  big companies, and companies 
that have been on the market for  a long time,  to  have informal  contacts with  their 
respective surveillance authorities asking them to check the label they want to use.  It 
was clear that this informal verification is not legally binding. 
Furthermore, companies often ask independent food chemists, who in Germany give 
advice as to the lawfulness of a product (in terms of composition and labelling of the 
product). 
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the Regional Media Authorities (Arbeitsgemeinschaft Landesmedienanstalten), which 
is  responsible  for  the  uniform  application  of the  rules  concerning  advertising  and 
sponsoring on television and radio,  indicated that it  has  from time to  time  informal 
contacts with companies who want to  get the Office's view on a planned advertising 
campaign, in order to make sure that their advertising is in line with these rules. 
2.  Post-Clearance Rules/ Guidelines 
a.  Civil or criminal law redress procedures 
Companies, trade associations, consumer associations and chambers of commerce can 
start civil redress procedures based on paragraph 1 and paragraph 3 of the law against 
unfair competition (Annex 8). 
Paragraph  1 is  a  catch-all  clause,  which  states:  "Who  undertakes  actions,  which 
violate  good  practices,  in  the  framework  of  commercial  activities  aimed  at 
competition,  can  be  claimed  for  injunction  and  damages".  Paragraph  3  is  more 
specific making reference to misleading statements over the commercial conditions, in 
particular the nature, the origin, the production method or the price determination of 
products. 
For any claims used in private broadcast advertising, the Regional Media Authorities 
are, in general, responsible.  Thus, the Federal Broadcasting Agreement states that for 
infringements  of  the  agreement  the  Regional  Media  Authorities 
(Landesmedienanstalten) are responsible (Rundfunkstaatsvertrag, paragraph 49 alinea 
3,  Annex  16).  Nevertheless,  a  special procedure has  been set up  by the  Working 
Group  of  the  Regional  Media  Authorities  (Arbeitsgemeinschaft  der 
Landesmedienanstalten),  which  acts  as  a  co-ordinating  body  of  these  regional 
authorities.  The  Joint  Advertising  Office  (Gemeinsame  Stelle  Werbung)  of the 
Working  Group  is  charged  to  look  after  a  uniform  application  of the  relevant 
advertising rules of the guidelines implementing the Federal Broadcasting Agreement. 
Members of the Joint Advertising Office are all the Regional Media Authorities, one 
Authority  has  the  chairmanship  (see  Verfahrensordnung  der  Gemeinsamen  Stelle 
Werbung der Landesmedienanstalten, 13. December 1994, Annex 17). 
If a Regional  Media Authority indicates a violation against the  relevant advertising 
rules, it has to inform the Joint Advertising Office.  The Joint Advertising Office then 
adopts a recommendation by simple majority.  The recommendation can be to start an 
administrative infringement procedure.  However, a Regional Media Authority is not 
obliged to follow the recommendation.  In this case, the conference of directors of the 
Regional Media Authorities is informed of this fact.  But the rules do not foresee any 
possibility to stop a Regional Media Authority for not following a recommendation of 
the Joint Advertising Office. 
The  Consumer  Protection  Association  (Verbraucherschutzverein  e.V.),  based  in 
Berlin,  has  in  its  statutes  the  specific  mandate  to  stop  unlawful  competition  (see 
Annex  18).  Its  members are all regional consumer associations, as  well as  the main 
federal  consumer association (Arbeitsgemeinschaft der Verbraucherverbande  ).  It is, 
therefore, extremely active in asking companies under the law on unfair competition 
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association  that  it  will  no  longer  make  the  admonished  claim/advertising.  If the 
company does  not  make  such  a  declaration,  the  Consumer  Protection  Association 
brings the complaint to court. 
b.  Specific procedures for claims 
The authorities  have the possibility to  follow  a specific procedure for nutrition and 
health claims under the German Food Law.  As set out in paragraph 41  of the Food 
Law (Annex 2), the food and medicine surveillance authorities in the German regions 
are  responsible  for  supervising  compliance  with  the  Food  Law.  The  food  and 
medicine surveillance authorities have around 5000 employees (figure indicated by 
the Ministry of  Health). 
The food and medicine surveillance authorities are notably allowed to  take samples 
(paragraph 42 of  the Food Law). 
Based on the Law on Disciplinary Fines (Gesetz tiber Ordnungswidkrigkeiten, BGBI. 
I  1968,  S.  481) the  surveillance authorities can impose certain civil charges against 
companies not respecting labelling rules (for the fines  applicable see V.  E) ).  Based 
on  the  Food  Law  the  surveillance  authorities  can  in  some  cases  bring  a  criminal 
charge against companies (for these cases see V. E)). 
No specific procedures exist for ethical claims. 
c.  Out-of-court procedures 
The  German  law against unfair competition allows the  establishment of settlement 
points (Eingigungsstellen) within the chambers of commerce (RGBI.  1909, S.499, last 
amended in  1998, paragraph 27 following, Annex 8).  Such settlement points exist in 
all German regions. 
Under the law against unfair competition, consumer associations, trade associations, 
and companies are allowed to bring complaints to these settlement points.  The Centre 
for  Fight  against  Unlawful  Competition  (Zentrale  zur  Bekampfung  unlauteren 
W  ettbewerbs) has a special role: it is a private association with around 1600 members, 
mostly companies, trade associations and chambers of commerce.  It acts mainly on 
the basis of the  law against unfair competition and brings  every year thousands of 
cases in front of  these centres (see Annex 19). 
The procedure that the Centre follows is the following: 
•  Complaints are sent to the Centre, mostly by its members, but complaints also 
come sometimes from consumers. 
•  If after examination the Centre comes to  the conclusion that a company is  in 
violation of the law on unfair competition (and notably with regard to  claims 
and  advertising),  it  asks  the  company to  make a declaration of forbearance, 
whereby the company declares vis-a-vis the Centre that it will no longer make 
the admonished claim/advertising and will pay a small financial penalty. 
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competition, there are two possibilities.  If the company agrees, it is possible to 
refer the matter to the settlements points at the chambers of commerce.  If the 
company opposes to  go  to  the  settlement point,  the  issue is  brought by the 
Centre to the courts. 
•  If the company agrees to go to a settlement point, the settlement point makes a 
proposal  as  to  how  to  settle  the  issue.  The  settlement points  cannot  take 
legally binding decisions.  If the proposal of the settlement point is  accepted 
by the Centre and the company in question, the procedure ends there.  If not, it 
is referred to court. 
The  settlement  points  are  usually  composed of a  chairman,  who  has  to  have  the 
qualification  of a judge,  and  two  businessmen.  These  settlement  points  work  in 
general  quite well,  but suffer sometimes from  time  delays,  as  the  members  of the 
settlement points are working on a voluntary basis. 
Another  out-of-court  complaint  procedure  is  provided  by the  German  Advertising 
Council  (Deutscher  Werberat),  which  is  the  self-regulatory  body  of the  German 
advertising  industry.  The  Advertising  Council  is  composed  of  12  members 
regrouping  those  that  advertise,  those  that  produce  advertising,  and  advertising 
agencies  (for more  details  see  Arbeitsgrundsatze  des  deutschen Werberates).  The 
Advertising Council accepts only complaints from consumers.  If companies complain 
against a competitor, the Advertising Council asks the company to exercise its rights 
himself (see Verfahrensordnung des Deutschen Werberates, article 2, Annex 20), i.e. 
to  enter into contact with the competitor and eventually bring the competitor to  the 
courts. 
The Advertising Council is  responsible for  advertising,  which  is  questioned by the 
consumers  to  be  immoral,  unethical,  sexist  etc.  When  the  Advertising  Council 
considers that a certain advertising violates German law and notably the law on unfair 
competition, it refers the matter to the Centre for Fight against Unlawful Competition 
(see  Verfahrensordnung  des  Deutschen  Werberates,  article  2,  Annex  20).  The 
Advertising Council  indicated that consumers  often  do  not know about  the  Centre 
and,  therefore, a number of consumer complaints are first  addressed to  the Council, 
although they are a matter for the Centre. 
Complaints which address a violation of the medicine advertising law are referred to 
the  Association  for  Fair  Medicament  Advertising  (Verein  fur  lautere 
Heilmittelwerbung). 
Sometimes,  the  Centre refers  complaints back to  the  Advertising Council, where it 
considers  that  the  advertising  does  not  violate  German  law.  In  this  case,  the 
Advertising Council considers the matter further to see if it shall become active. 
In some few cases, the procedure of  the Advertising Council may overlap with the one 
of  the Centre.  Due to the fact that the Advertising Council has a specific guideline on 
alcohol advertising, which makes reference to  health claims with regard to  alcoholic 
products, we explain hereunder the procedure of a complaint under the procedure of 
the  Advertising  Council  (Arbeitsgrundsatze  des  Deutschen  Werberates,  article  3 
following, Annex 21 ): 
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•  Complaints  have  in  general  to  be  submitted  in  written  form.  The 
confidentiality of  the complainant is ensured. 
•  If the Advertising Council considers itself to  be competent, and it  considers 
the complaint not to be evidently ungrounded, it will ask the advertiser or the 
advertising agency to comment on the complaint within a certain deadline. 
•  The advertiser or the advertising agency can indicate that it  will change the 
advertisement or no longer run the advertisement. 
•  In  case  that  the  advertiser  or  the  advertising  agency  do  not  comment  or 
indicate that they consider the complaint to  be ungrounded,  the  Advertising 
Council takes a decision.  Decisions are taken by simple majority. 
•  The Advertising Council may decide that the complaint is indeed ungrounded. 
•  The  Advertising  Council  may  also  decide  to  ask  the  advertiser  or  the 
advertising  agency  to  modify or stop  the  advertisement  and  to  inform  the 
Advertising Council within a certain deadline if it has done so. 
•  If the advertiser or the advertising agency decides not to  change or stop its 
advertising or does not inform the Advertising Council whether it has done so, 
the Advertising Council can make his decision public. 
The system works in general quite well and efficiently.  A recent example of  a health 
claim  that  the  Advertising  Council  admonished  concerned  an  alcoholic  beverage, 
which  was  sold with  the  following  claim:  "Did  you know that  beer increases  the 
performance?"  To  this  statement  was  added  that  a  certain  doctor  from  a  medical 
institute in Rome had done tests, which had shown that the performance of sportsmen 
drinking one liter of beer per day was higher than the performance of sportsmen who 
drank less  beer.  The  Advertising Council admonished the  advertisement,  as  it  was 
against its guideline on the advertising of alcoholic products, which forbids making 
reference to  medical recommendation (see Spruchpraxis Deutscher Werberat, Bonn 
1997, page 17, Annex 22). 
No out-of-court procedures exist for ethical claims. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Under  the  unfair  competition  act,  only  companies,  trade  associations,  consumer 
associations and chambers of commerce can start civil redress procedures (paragraph 
13). 
For  individual  consumers,  It  IS  not  possible  to  bring  a  complaint  to  the  courts 
regarding misleading/unlawful claims.  But consumers can complain to the Centre for 
Fight against Unlawful Competition, as well as the German Advertising Council and 
any consumer association.  These will then verify in how far the claim is valid and can 
then undertake action (see above point B). 
D.  BURDEN OF PROOF 
The burden of proof lies with the complainant under the law on unfair competition, as 
well  as  the Food Law.  Nevertheless, the German Food Law Association (Bund fur 
Lebensmittelrecht und Lebensmittelkunde) indicated that in its view it was in practice 
the  companies  who  would be  trying to  justify that  their  claims  were  scientifically 
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making claims. 
Furthermore, the Federal Court (Bundesgerichtshof) concluded in several judgements 
that the burden of proof was with the defendant where he was using an opinion which 
is controversial amongst experts and without also mentioning the dissenting scientific 
view (see also below VI. A) 2.). 
Nevertheless,  consumer  associations  seem  to  experience  particular  problems  with 
regard to the burden of  proof in case of  misleading claims (see below F) 2) ). 
E.  APPLICABLE PENALTIES 
Under  the  German  Food  Law,  the  penalties  vary  depending  on  whether  it  is  an 
infringement  against  paragraph  17  on  misleading  marketing  and  advertising  or 
paragraph 18 on health related marketing and advertising (see above II. A) 2) ). 
An infringement against paragraph 17  is  considered a criminal offence (Straftat) and 
can  be  punished  with  imprisonment  of up  to  one  year  or a  fine  (see  Food  Law 
paragraph 52 alinea 1 point 10, Annex 2). 
An  infringement  against  paragraph  18  is  considered  an  infringement 
(Ordnungswidrigkeit) and can be punished with a fine of up to 50,000 Deutschmarks 
(= 25,000 Euro) (see Food Law paragraph 53 alinea 2 point 1. 3), Annex 2 ). 
It  is  interesting  to  note  that  while  the  dietary  order  lists  a  number  of penalties 
applying, no reference is made to the penalties applying for those who do not respect 
the allowed health claims listed in the dietary order (paragraph 3  ).  The Ministry of 
Health explained that in  this  case the  penalties as  defined under the Food Law for 
misleading  and  forbidden  claims  would  apply  (for  these  penalties  see  paragraphs 
above in this chapter). 
Under the  unfair competition act  the  penalties applying are  listed in  the civil court 
order (Zivilprozef3ordnung,  BGBI.  I  1950,  S.  535,  last  amended  in  1997).  Under 
paragraph 890 of the order,  a Court can ask the  party responsible not to  undertake 
certain actions again (e.g.  using a certain claim).  In case the party responsible does 
not  respect  the  Court's  ruling,  a  financial  penalty of up  to  500.000  Deutschmarks 
(250.000 Euro) can be  imposed.  Where it  is  not possible to  obtain from  the  party 
responsible, this amount of  money, imprisonment up to 6 months can be imposed. 
F.  COMMENTS APPLICABLE TO HEALTH CLAIMS 
The Ministry of Health indicated that as the surveillance of food and pharmaceutical 
products was organised on  a regional  basis  in  Germany,  this  sometimes led  to  the 
situation whereby one surveillance authority in one region may allow a claim, while 
an authority in another region, may forbid the same claim. 
In order to  avoid barriers to  trade within Germany, the surveillance authorities have 
established a number of bodies to deal with such problems.  Thus, there is every year 
several  meetings  of  the  Working  Group  of  Food  Chemists  (Arbeitskreis 
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Lebensmittelchemischer  Sachverstandiger)  and  the  Working  Group  of the  Chief 
Medical  Officials  of  the  Regional  Surveillance  Authorities  (Arbeitskreis  der 
Leitenden Medizinalbeamten der Oberwachungsbehorden der Lander).  The latter has 
a working group on labelling. 
Barriers to trade within Germany may, therefore, sometimes come up, but only during 
a limited period of time, until the surveillance authorities have found an agreement. 
The German Food Industry Association indicated that in practice these problems were 
minimal.  The Food Industry Association felt that a far bigger problem in terms of 
barriers to  trade was the very narrow interpretation of the Food Law with regard to 
health claims by the surveillance authorities. 
In  terms  of  consumer  protection,  the  main  German  consumer  associatiOn 
(Arbeitsgemeinschaft der Verbraucherverbande) and the Ministry of Health concurred 
that  the  internet was posing a problem, as  it  was difficult to  undertake procedures 
against claims used on internet sites, specifically where the advertising was provided 
through servers outside of the EU.  The consumer association was in favour of the 
country of  destination principle with regard to Internet advertising. 
In  its answer of October 1996 to  a Commission request for information on miracle 
products,  the  German  Government  indicated  that  the  surveillance  instruments 
available, may be less efficient with regard to door to door selling and sale by mail. 
Similar,  the  Consumer Protection  Association  (Verbraucherschutzverein)  indicated 
that there existed sometimes problems in enforcing declarations of forebearance and 
court rulings in the case of  foreign companies selling products in Germany.  It felt that 
possibilities for consumer associations to become active in other EU countries should 
be improved. 
As  to  the  burden  of proof,  the  main  German  consumer  assoctahon  stated  that  it 
favoured a change of the burden of  proof.  Consumer associations had often problems 
with  claims that  could not be  scientifically proven.  It was  difficult  for  consumer 
associations to find and finance an expert who could provide an opinion proving that 
the claim could not be scientifically proven.  Therefore, many cases were not brought 
to  court.  The Consumer Protection Association indicated that this was in particular 
the case for misleading health claims.  Courts often dismissed a complaint, where the 
association  was  not able  to  have  sufficient scientific  material  that  showed that  the 
claim made was misleading. 
On the question of  pre-clearance or post-clearance of  claims, the Consumer Protection 
Association indicated that it had not yet established a position.  But the representative 
of the Consumer Protection Association who we interviewed felt, on a personal basis, 
that  pre-clearance  via  an  administrative  body  or  agency  would  only  create 
unnecessary  bureaucracy.  Such  pre-clearance  could  eventually  be  considered 
censorship.  He  felt  that  the  law  against  unfair  competition  was  a  strong  enough 
instrument,  which  would  make  the  introduction  of  a  pre-clearance  system 
unnecessary. 
The  German food  industry association felt  that  pre-clearance was  not  necessary if 
rules  were  in  place  that would  allow  an  easy a  posteriori  verification.  Therefore, 
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The association indicated that such a pre-clearance would slow down the putting on 
the market of a product, which meant reducing competitiveness.  Furthermore, such a 
pre-clearance system would eventually need a large bureaucracy function. 
V.  CASELAW 
1.  Nutritional Claims 
Little case law in Germany on nutritional claims exists.  The High Court of Cologne 
(Oberlandesgericht Koln) rules in  1994 on  the use of the term "poor in natrium" on 
mineral water (6 U 32/94, OLG Koln, 30/9/94, Annex 23). 
A complaint was put forward by a consumer protection association against a producer 
who  was  using  the  term  "poor  in  natrium"  on  his  natural  mineral  water,  which 
contained  112mg/l of natrium.  The Court found  that  this  was  a misleading claim 
based on  paragraph  3 of the  law  against  unfair competition and  an Annex  to  the 
decree on mineral water. 
The Court stated that using the  term  "poor in  natrium"  was a  similar indication as 
"suitable for a diet poor in natrium", which under the decree on mineral water has to 
contain less than 20mg/l of  natrium. 
The  Court  also  concluded that this  statement  was  not  only misleading but  it  also 
constituted unfair competition, as  it would influence consumers - who follow a diet 
poor  in  natrium  - to  tum  towards  this  product.  Competitors  selling  an  identical 
product  but  without  such  an  indication  would  therefore  suffer  from  unfair 
competition. 
The Court ruled that the company could no longer use the term "poor in natrium" for 
its natural mineral water and was asked to cover the costs of the consumer protection 
agency for bringing the complaint to the Court (costs of  267,50 DM). 
The  Court  does  not  give  any  definition  for  nutritional  claims,  but  uses  without 
prejudice  a  number of terms  to  describe  the  claim  "poor in  natrium".  These  are: 
reference (Hinweis), designation (Bezeichung), term (Begriff), label (Kennzeichung). 
2.  Health Claims 
There are a significant number of cases in  Germany on health claims.  One of the 
most  recent  cases  that  were  considered  by the  Federal  Court  (Bundesgerichtshot) 
concerned  a  complaint brought  forward  by a  trade  association  against  a  company 
distributing a food supplement which used the following claim (I ZR 125/95, BGH, 
4112/97, Annex 23): 
"If sometimes the joints crack and creak, it could be that you are missing 'lubricating 
oil for joints' and that wear and tear is  coming to  the forefront .. .In many such cases 
gelatine-hydrolysat has proved successful". 
Pan-European study on nutritional, health and ethical claims- 1999.  222 I 
I 
The Federal Court agreed with the lower courts that this was against paragraph 18 of 
the  Food Law,  which in a  linea  1  (1)  forbids  the  use of statements referring to  the 
elimination,  alleviation  or  prevention  of sickness.  Furthermore,  it  was  against 
paragraph 1 of  the law on unfair competition and constituted unfair competition. 
The Federal Court elaborated that even if a reference is not explicitly made clear to a 
certain illness, it was sufficient to use a clear paraphrase of an illness, or where the 
symptoms described made a clear reference to a specific sickness.  In this case, the 
Court held that the claim used clearly made reference to arthritis. 
The Court also  gave  an explanation why under German Food Law disease related 
claims are forbidden.  This is mainly for two reasons: - to  avoid the danger of self-
medication and to  avoid that consumers might believe that foodstuffs have the same 
effects as medicines. 
The problem of indirect references to a disease has also been considered in a number 
of  other cases.  The High Court Hamburg (Oberlandesgericht Hamburg) ruled in 1994 
against a company selling food supplements using the claim "improves the immune 
system"  (3  U  23/94,  OLG  Hamburg,  5/5/94,  Annex  23).  The  Court  stated  that 
paragraph 18, alinea 1 ( 1) forbids statements on the prevention, curing or treatment of 
diseases.  But  this  also  covered  indirect  statements  on  the  prevention,  curing  or 
treatment of diseases.  The Court concluded that the  consumer would interpret the 
claim  "improves  the  immune  system"  not  as  improving  health,  which  the  Court 
indicated was  allowed under the Food Law.  Instead the  Court concluded that this 
claim would be  interpreted by the  consumer as  making reference to  prevention of 
infections,  notably  flues.  The  Court ruled  that  the  claim  "improves  the  immune 
system"  was  unlawful  under  paragraph  18,  alinea  1  (1)  of the  Food  Law  and 
confirmed the ruling of  a lower court for the continuation of  the injunction. 
The word 'claim' has not been further  defined by the  Court, which uses the terms 
'advertising' and 'claims' without distinction to describe it. 
Similarly,  the  State  Court  of Hamburg  (Landesgericht  Hamburg)  ruled  against  a 
producer of  cough-drops using the claims: "In particular in case of weather provoking 
colds you should protect your respiratory ducts in a prophylactic manner";  "Thyme 
helps in particular in the case of spasmodic cough"; "Fennel loosens and alleviates in 
case of cough".  The Court concluded that this was against paragraph 18, a linea 1 (1) 
of  the Food Law and paragraph 1 of the law on unfair competition (15 0  643/77, LG 
Hamburg, 25/1/78, Annex 23). 
The  Court  concluded  that  while  a  simple  throat  irritation,  or  a  throat  that  is 
overstrained during a short period of time cannot be considered a disease or a disease 
symptom, which in the Court's view also falls under the prohibition of paragraph 18, 
alinea 1 (1) of the Food Law. Nevertheless, the claims used suggest that these cough-
drops help curing or at least alleviate strong forms of coughs, i.e. spasmodic coughs, 
which have to be considered a disease, as they "impair in an intensive and enduring 
way the general condition". 
These claims  are  not  further defined by the Court,  which simply call  them  'effect 
statements'  (Wirkungsaussagen).  The Court  also  gave  an  explanation  why under 
Pan - European study on nutritional, health and ethical claims  1999.  223 German Food Law disease related claims are forbidden: -to avoid the danger of self-
medication and to  avoid that consumers might believe that foodstuffs have the same 
effects as medicines. 
Another example of indirect references to diseases has been considered by the State 
Court of  Oldenbourg (Landgericht Oldenburg).  It ruled against an egg producer, who 
was  selling  his  eggs  with  the  claims:  "The  egg  for  all  who  follow  a  cholesterol 
conscious nutrition"; "The first cholesterol-neutral egg: Naturally rich in unsaturated 
fatty  acids,  which  counteract  an  increase  of the  cholesterol  level".  The  Court 
concluded that the average consumer would make a link between the cholesterol level 
and heart and circulation diseases ( 11  0  138/96, LG Oldenburg, 22/8/96, Annex 23). 
This was against paragraph 18,  alinea 1 (1) of the Food Law and paragraph 1 of the 
law against unfair competition. The egg producer was asked not to use these claims 
any more. 
These claims are not further defined by the Court, which simply calls them "diseases 
related advertising". 
An interesting case, which describes in further detail the difference between a health 
related  claim  that  is  allowed under German  food  law  and  a  disease  related  claim 
which  is  forbidden,  was  decided  in  1992  by  the  Chamber  Court  of  Berlin 
(Kammergericht Berlin). 
The Court had to rule on the sale of a vitamin supplement, which was using the claim 
" ...  protects against fat soluble antioxidants ...  the so called free radicals, which attack 
the cells", "it stabilizes the walls of the cell ... and can therefore reduce the damaging 
effects of the free radicals". The Court concluded that this was a disease related claim, 
as  stabilizing the  walls of the  cell  meant  preventing a  disease,  i.e.  preventing the 
damaging of  the cells (27 U 6020/92, KG Berlin, 14/12/92, Annex 23). 
The  Court  gave  a  number of examples of the  difference  between a  health-related 
claim and a disease-related claim.  A health-related claim was in the Court's view a 
claim that made reference to  the maintenance or improvement of the  health via  a 
foodstuff,  e.g.  "eat more  apples  and you keep  healthy",  or "bread X  for  a  healthy 
nutrition".  On the other hand, whenever reference was made to a disease, it was a 
disease-related claim and was, therefore, forbidden.  The Court gave the  following 
example: "disease is serious - bread X for a healthy nutrition". 
Another interesting case concerns the sale of bed-linen under the name 'Rheumalind', 
which  in  English could be  best  translated  as  'Rheumatism  Relief.  A  competitor 
complained  that  using  this  term  was  unfair  competition  under  the  law  on  unfair 
competition,  as  bed-linen  containing  pure  lamb  wool  did  not  have  the  effect  of 
alleviating rheumatism (I ZR 127/89, BGH, 7/3/91, Annex 23).  The main point of the 
complaint concerned the burden of proof.  In its ruling, the Federal Court concluded 
that in general the burden of proof was with the plaintiff.  But - as the Court held in 
several cases - the burden of  proof is on the shoulders of the defendant where he uses 
an opinion which is  controversial amongst experts, and without also mentioning the 
dissenting scientific view. 
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was  needed in  order to  clarify whether bed-linen containing pure lamb wool  could 
alleviate rheumatism or not.  As the product in question is neither a foodstuff, nor a 
medicine, the only legislation that applies is the law on unfair competition. 
3.  Ethical Claims 
There basically exists no  case law on ethical claims.  The only case we came across 
concerns  a  ruling  on  a  cosmetic  product  using  the  claim  "product  not  tested  on 
animals".  The  complaint  was  brought  forward  by  the  Centre  for  Fight  against 
Unlawful  Competition against  a  producer of cosmetic products  (KfH  0  39/96,  LG 
Mosbach, 1110/96, Annex 23). 
The  Regional  Court  of Mosbach  (Landgericht Mosbach)  concluded  that  the  claim 
"product not tested on animals" was a breach of the law against unlawful competition. 
The Court concluded that as all similar cosmetic products of the competitors had not 
been tested on animals, this claim was clearly unlawful competition.  The Court stated 
that the average consumer could consider the product in question had been produced 
in "a way respecting humanitarian and ecological requirements", which those of the 
competition did not.  Also, consumers may be prepared to pay more money for such a 
product,  although all  similar products of the  competitors  fulfilled  the  same  quality 
requirements. 
B.  REMARKS ABOUT BARRIERS TO TRADE AND LACK OF 
CONSUMER PROTECTION 
1.  Nutritional Claims 
With  regard  to  nutritional  claims,  German case law  does  not  indicate any relevant 
consumer protection problems and/or barriers to trade. 
2.  Health Claims 
The German food industry indicated that it was problematic that German courts were 
interpreting the ban on disease related claims in such a restrictive way.  It felt that if 
one was pursuing the courts' logic far enough even claims that were referring clearly 
to health and not to a disease may be forbidden.  It considered that forbidding a claim 
such as  "improves the immune system" was already reaching this borderline.  It was, 
therefore,  difficult  for  the  industry  to  make  claims,  which  could  contribute  to 
consumers' health. 
The  Advertising  Council  felt  that  it  was  problematic  that  German  courts  were 
following a different consumer concept than the European Court of  Justice.  While the 
European  Court of Justice  was  basing  its  rulings  on  the  concept  of the  informed 
consumer,  German courts  were basing their rulings  on  the  concept of the  average 
consumer, who may not be well informed.  This could potentially lead to  barriers to 
trade. 
On the other hand, the main German consumer association (Arbeitsgemeinschaft der 
Verbraucherverbande  ),  as  well  as  the  Consumer  Protection  Association 
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find  an expert (and pay an  expert) who  could provide an  opinion proving that  the 
claim could not be scientifically proven.  Courts often dismissed a complaint, where 
the  consumer associations  were  not  able  to  have  sufficient  scientific  material  that 
showed that the claim made was misleading. 
3.  Ethical Claims 
Apart from  the  case  cited above,  no problems  seem to  exist in  terms of consumer 
protection and/or barriers to trade. 
VI.  MEANS OF COMMUNICATION 
With regard to  nutritional and health claims,  the  German Food Law applies in  the 
interpretation  of the  Ministry  of Health  to  all  means  of communication.  Thus 
paragraph  17  and  18  of the  Food  Law  make  reference  to  the  marketing  and 
advertising of food products. 
The  law  on  unfair competition (Annex  8),  which  applies  to  any misleading  claim 
covers  equally all  means  of communication.  It  states  in  paragraph  1 and  3  that  it 
applies to 'commercial activities' (geschaftlichen Verkehr).  The Ministry of  Health, as 
well as the Centre for Fight against Unlawful Competition confirmed that in its view 
the unfair competition act applies to all means of  communication. 
The  Federal  Broadcasting  Agreement  (Rundfunkstaatsvertrag,  Annex  16)  which 
regulates television and radio broadcasting makes clear that misleading advertising is 
forbidden (Rundfunkstaatsvertrag, paragraph 7 alinea  1  ).  The guidelines developed 
by  the  Regional  Media  Authorities  (Arbeitsgemeinschaft  Landesmedienanstalten), 
which  is  responsible  for  administering  the  Agreement  state  in  reference  to  this 
provision that the  specific  legislation applying for  advertising,  consumer protection 
and unfair competition apply.  The guidelines make particular reference to  the Food 
Law  (Gemeinsame  Richtlinien  der  Landesmedienanstalten  fur  die  Werbung,  zur 
Durchfiihrung der Trennung von W erbung und Programm und fur das Sponsoring im 
Fernsehen,  16.  Dezember  1997, paragraph 3 alinea 2;  and  Gemeinsame Richtlinien 
der Landesmedienanstalten  fur  die  Werbung,  zur Durchfiihrung  der Trennung  von 
W  erbung und Programm und fur das  Sponsoring im  H6rfunk,  16.  Dezember 1997, 
paragraph 3 alinea 2, Annex 24). 
VII.  STATISTICS ON CLAIMS 
It has proven extremely difficult to  obtain statistical information on  claims.  One of 
the best sources proved to be the Centre for Fight against Unlawful Competition.  The 
Centre received in 1998 a total of 21.190 complaints relating to unlawful competition 
(see  Zentrale  zur  Bekampfung  Unlauteren  Wettbewerbs  e.V.  Frankfurt  am  Main, 
Riickblick auf die Arbeit im Jahre  1998, p.  1,  Annex 25).  Out of these, the Centre 
estimates  that  around  1300  complaints  concerned  health  and  disease  related 
advertising.  More specifically concerning food-related claims, the Centre estimates 
that  around  l 00  complaints  are  received  each  year,  of which  only  3  concern 
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complaints were settled out-of-court. 
Another very useful  source proved to  be the Consumer Protection Association  in 
Berlin.  It has a data base that goes back to 1992 and tracks all the letters it has sent to 
companies  asking  for  declarations  for  forbearance.  The  Consumer  Protection 
Association  indicated  that  its  database  contains  around  150  such  admonitions 
covering health related  advertising, of which 80  concern advertising  for  slimming 
product. 
The German Consumer Association (Arbeitsgemeinschaft der Verbraucherverbande) 
reckons that each year several hundred complaints are received by all the consumer 
associations in Germany regarding health/medical claims. 
The German Advertising Council also has some statistics regarding complaints that 
are  being  submitted.  In  1997,  the  number  of complaints  received  concerning 
foodstuff advertising was 23.  But this number went down to 8 in 1998.  The statistics, 
unfortunately, do not reveal how far these claims concerned health claims or other 
sorts of food  advertising related complaints.  The number of complaints regarding 
alcoholic advertisements numbered at 19  in 1998 (see Jahrbuch Deutscher Werberat 
1999, 25-26, Annex 26). 
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H.  GREECE 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
Overall, the issue of claims, be it  nutritional, health or ethical,  is  not a priority issue for 
stakeholders, nor is it particularly recognised as a problem.  However, following the recent 
"Belgium dioxin crisis", the Greek authorities have realised the urgent need to  establish a 
uniform control body to tackle all issues pertaining to the food & drink industry. 
The Consumer General Secretariat of the Ministry of Development is responsible for setting-
up  the  first  Uniform Foodstuffs Control Board in Greece.  The  Board, soon to  come into 
effect, will only deal with packaged foodstuffs and will be assisted by a number of  consumer 
organisations, industry representatives, as well as the National Pharmaceutical Organisation 
and the State Laboratory for General Chemistry. The Control Board will serve as a starting 
point so  that the issue of claims is  more closely monitored by the State and consequently 
dealt with via clearly defined administrative channels. 
B.  MEMBER STATES POLICY 
1.  Nutritional Claims 
The definition provided by the Greek legislation on 'Nutritional Claims' cc:>nforms  to the EU 
definition in all respects. According to Ministerial Decision no. 843/91 FEK 80, Article 11 a, 
par.  2b a  nutritional  claim  is  defined as  "Any representation  and  any advertising  which 
states,  implies  or leads to  the  conclusion that a  food  has  particular nutritional  properties 
according to the energy (calorific value)". 
2.  Health Claims 
A  definition  for  'Health  Claims'  is  not provided as  such by Greek legislation.  However, 
health claims are considered as anything making reference to health in general. It should be 
mentioned that the National Food & Drink Code of Conduct provides the notion of health 
claims in terms of prohibitions. Article  11  refers to Article 2 of 709/112: labelling and the 
way it is presented should not "attribute to a foodstuff properties ofprevention, treatment or 
cure of diseases or insinuate such properties, with the reservation of the special provisions 
provided for natural mineral waters and foodstuffs for particular nutritional uses. 
3.  Ethical Claims 
No definition of an 'Ethical Claim' is provided in Greek legislation. The assumption is that 
they would fall under the misleading advertising Directive implementing rules. 
C.  VOLUNTARY CODES OF PRACTICE 
The  Hellenic  Advertising Agencies  Association  has  issued a  Code of Conduct,  which  is 
binding  for  all  its  members  as  well  as  the  media.  It  makes  reference  to  misleading 
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advertising  and  indirectly to  claims.  The  Federation of Hellenic  Food Industries  (SEVT) 
conforms to  all  rules and regulations.  The Code is  accepted and recognised by the  Greek 
authorities  as  the  official  self-regulatory  document  dealing  with  the  control  of 
advertisements. 
D.  VERIFICATION SYSTEMS 
The National Food & Drink Code of Conduct and other relevant legislative documents do 
not provide any criteria for substantiating claims in particular. Specifically, there is no list of 
documents  mentioned in  relevant  Greek  legislation (except baby foods)  to  determine  the 
necessary  proof that  needs  to  be  adduced  in  order  to  substantiate  a  claim  made  on  a 
foodstuff. On the other hand, it is  considered inherent that the manufacturer who wishes to 
use a certain claim is in a position to defend this with scientific documentation. 
A formal  system and/or organisation responsible  for  the  control  of foodstuffs  and  claims 
does  not  exist  in  Greece.  Relevant controls  fall  under the  competence of various  public 
organisations such as  the  Ministry of Development (State Market Inspection Service), the 
State Laboratory of General Chemistry and the National Pharmaceutical Organisation. There 
is  an  evident  overlap  of responsibility  between  all  the  above  mentioned  organisations, 
especially  between  the  State  Laboratory  for  General  Chemistry  and  the  National 
Pharmaceutical  Organisation,  which  in  the  view  of consumers  leads  to  a  lack  of clear 
control. 
No pre-clearance rules exist in Greece officially. As to post clearance, a consumer wishing to 
sue for a misleading claim is  obliged to do  so through a consumer organisation. Such cases 
are  submitted  to  the  civil  courts  and  are  most  often  handled  through  the  procedure  of 
provisional measures. 
According to  Unfair Competition Law and Consumer Protection Law,  it is  not clear with 
whom  lies  the  burden of proof.  Evidently,  Greek legislation does  not define  whether the 
producer/manufacturer or the consumer organisation has the ultimate responsibility to prove 
that a claim is misleading or not. However, the authorities indicated that the burden of  proof 
lies in practice with both parties. 
E.  MEANS OF COMMUNICATIONS 
On a theoretical basis, all legislative documents - related to nutritional or health claims - are 
applicable to all means of communication. However, there is a possible discrepancy between 
law and practice based on two facts. First, the absence of a relevant body for the control of 
claims (both nutritional and health) and second, the very wide spectrum of activities - apart 
from the verification of  claims - of  the organisations currently responsible for this issue, such 
as  the  State  Laboratory  for  General  Chemistry  and  the  National  Pharmaceutical 
Organisation. Consequently, there could be differences as to the strictness and intensity with 
which the law is applied among the various means of  communication. 
F.  CONSUMER PROTECTION 
From the viewpoint of consumer organisations, the issue of  claims is inefficiently approached 
by the  State.  At the same time, lack of knowledge on their behalf has prevented them from 
thoroughly informing consumers on the possible issues.  The limited resources of the Greek 
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State as  well  as  the  fact  that they admit that the control systems  in place for  claims need 
improvement and that certain sections of  the Greek legislation relating to Food & Drink issues 
are outdated clearly demonstrates an apparent lack of consumer protection. According to the 
consumer  organisations'  viewpoint,  consumer rights  are  not  effectively  protected  and  the 
action taken by the former is  becoming somewhat restricted. This occurs due to the fact that 
the control system is complicated and there are many overlaps of responsibility between the 
various competent bodies. 
G.  BARRIERS TO TRADE 
There are no apparent problems. 
H.  CASELAW 
There is  no  body of case law, although there are two cases, which found both claims to be 
misleading, resulting in the closure of one company and the withdrawing of the claim on the 
packaging in the other. 
I.  STAKEHOLDER ANALYSIS 
1.  Government Authorities 
•  Public sector representatives expressed the wish to see all issues relating to claims being 
regulated  at  EU  level.  It is  their belief that  detailed  EU  rules  that  could  serve  as  a 
sanction  would  help  Member  States  define  the  relevant  boundaries  on  claims  and 
harmonise their legislation in an appropriate way, which does not leave any grey areas 
unresolved. 
•  However, it was also suggested that further regulation should avoid being 'suffocating'. 
This should occur in a way so as to literally protect consumers instead of confusing them 
with  the  variety  of claims  that  may  appear  on  the  market.  On  the  other  hand,  the 
industry's concerns should also be accounted for,  as  additional limitations imposed on 
foodstuff may in practice constitute a barrier to trade. 
2.  Consumer Organisations 
•  They wish to see further protection through updated national and ideally EU level rules as 
well  as  clear  responsibilities  as  to  who  in  Greece  verifies  claims.  Their  relative 
inexperience  on  the  issue  of claims  prevented  them  from  having  a  more  detailed 
viewpoint, although they were of  the opinion that a lack of  consumer protection existed. 
3.  Industry 
•  The industry in general is in favour of  EU action, supporting the CIAA Code as the way 
forward. 
•  The Hellenic Advertising Agencies Association, are against further regulation of claims 
and their incorporation in the EU  Directive on Misleading Advertising. It is  their belief 
that this would be highly dysfunctional and would ultimately lead to  barriers to  trade. 
Therefore, their suggestion is that self-regulation would be the best solution. If the law 
Pan- European study on nutritional, health and ethical claims- 1999.  231 becomes more specific and strict on claims, it may restrict the food and drink industry 
that use more technologically advanced methods than others for the improvement of  their 
products. 
* * * 
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A.  DEFINITION OF CLAIMS 
1.  Nutritional Claims 
According to Ministerial Decision no. 843/91 FEK 80 of 1911111991 Article 11a, par. 2b (see 
Annex 1) a nutritional claim is defined as: 
"Any  representation  and  any  advertising  which  states,  implies  or  leads  to  the 
conclusion that a food has particular nutritional properties according to  the  energy 
(calorific value): 
*Provides, 
* Provides at a reduced or increased rate or does not provide 
Or also according to the nutritional substances it: 
*Contains, 
* Contains at a reduced or increased rate, or 
* Does not contain". 
Nevertheless, a quantitative or qualitative statement for particular nutritional substances does 
not constitute a 'nutritional' claim, if such a statement is requested by the Code. 
Article 10, par. 3 of the National Food &  Drink Code of Conduct (see Annex 2) provides for 
a definition  of what  is  a misleading claim:  it  is  "forbidden  as  it  aims  at  misleading  the 
consumers, and is persecuted as  misleading any statement or advertising, in any way, of a 
foodstuff,  with  which  it  is  directly  or  indirectly  implied  that  the  food  offered  for 
consumption by a particular producer, is  particularly rich (or in some cases poor) in one or 
more of its basic nutrient ingredients, or that it contains these (ingredients) in higher, or in 
some cases lower, ratios than usual, even if  this is real, if these ingredients are included in a 
percentage that lies within the agreed limits, determined by the Code, for the corresponding 
type of food." 
As  such, a misleading claim is also considered as any writing on the packaging regarding a 
foodstuff's content of a certain ingredient, at a spot clear and distant from the one, where the 
food's composition is provided. 
The definition provided by the Greek legislation on 'Nutritional Claims' conforms to  the EU 
definition in all respects. 
However, the Greek definition and the definition given by the Codex Alimentarius differ in 
terms of specificity. For example, the distinction between the four categories of nutritional 
claims  (nutrient  content  claims,  comparative  claims,  nutrient function  claims  and  claims 
related  to  dietary  guidelines  or healthy  diets),  given  by the  Codex  Alimentarius,  is  not 
included in the definition provided by the Greek legislation. 
2.  Health Claims 
A  definition  for  'Health  Claims'  is  not  provided  as  such  by Greek  legislation.  However, 
health claims in Greece are considered as anything making reference to health in general. It 
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health  claims  in  terms  of prohibitions  (Article  11,  par.  2.a.ii  &  Article  10,  par.2).  The 
definition of what is a misleading claim as stated in Article 11, par. 2.a.ii (see Annex 3) of 
the National Food &  Drink Code of Conduct, could be interpreted as  a negatively defined 
health claim, i.e. in terms of  prohibitions. 
According to Article 11, par. 2a.ii: 
The labelling and the way it is presented should not "attribute to a foodstuff properties of 
prevention, treatment or cure of diseases or insinuate such properties, with the reservation of 
the  special  provisions  provided  for  natural  mineral  waters  and  foodstuffs  for  particular 
nutritional uses". 
Article 10, par.2. ofthe National Food & Drink Code of  Conduct specifically states that: 
It is "forbidden as it aims at misleading the consumers, and is persecuted as misleading. Any 
statement or advertising, in any way, of a foodstuff with which it is  directly or indirectly 
implied  that  the  food  in  question  possess  properties,  not  actually  present  in  it  during 
consumption. 
Or 
That this (food) is appropriate for the prevention and/or cure of: 
Alcoholism,  hair loss,  appendicitis,  arteriosclerosis,  collapse,  prostate  disease,  dysentery, 
cancer,  spasms,  diabetes,  menstruation  disorder,  epilepsy,  gangrene,  glaucoma,  arthritis, 
heart disease, high pressure, hernia, low pressure, flue, neuropathy, leukaemia, liver disease, 
nausea and other pregnancy related conditions, obesity, pleurisy, pneumonia, poliomyelitis, 
rheumatic  fever,  rheumatic  arthritis,  psoriasis,  septicaemia,  sexual  dysfunction,  tetanus, 
thyroid disease,  tuberculosis,  tumours  and  oedema, digestive ulcer and  in  general  colitis, 
aphrodisiac diseases as well as relevant diseases and conditions. 
3.  Ethical Claims 
No definition of  an 'Ethical Claim' is provided in Greek legislation. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
a.  Directive 79/112 on Labelling of Foodstuffs
6 
Article 2 of the  EU directive  79/112  is  included identical  in  the  Greek legislation under 
Article 11  ofthe National Food & Drink Code of  Conduce (see Annex 3). 
6 Reference only to the consolidated version of  this directive (including all amendments). 
7 Article 11  is amended with decisions of  the Supreme Chemical Council No. 2206/85 <I>EK 49/B/86 
and No. 804/90 <l>EK  I 04/891. 
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as  could mislead the purchaser to a material degree, particularly as  to  the characteristics of 
the  foodstuff and, in particular, as to  its nature, identity, properties, composition, quantity, 
durability, origin or provenance, method of manufacture or consumption, by attributing to 
the foodstuff effects or properties which it does not possess,  by suggesting that the foodstuff 
possesses  special  characteristics  when  in  fact  all  similar  foodstuffs  possess  such 
characteristics". 
Article 5, par. 3 of  the Directive has also been adopted as such by the Greek legislation under 
Article 11, par. 4c of  the National Food & Drink Code of Conduct. 
Specifically, par. 4c of  the Article states that: 
"The name under which the product is sold shall include or be accompanied by particulars as 
to  the physical condition of the foodstuff or the specific treatment which it has undergone 
(e.g. powdered, freeze-dried, deep-frozen, concentrated, smoked) in all cases where omission 
of such  information could create  confusion  in the  mind of the  purchaser.  Any  foodstuff 
which has been treated with ionising radiation, if and when this is allowed, must bear the 
indication ("epexergasmeno me ionizousa aktinovolia" or "epexergasmeno")
8
• 
Additional provisions regarding nutritional claims are given by the Greek legislation under 
Article 10 of the National Food &  Drink Code of Conduct
9
.  These provisions are present in 
par. 4-16 of  Article 10 (see Annex 2) and  include a number of measures covering claims 
on proteins (i.e.  claims as  "exceptional protein quality"), on dietary products (i.e. claims as 
"thin, slim,  light, low calorie, carbohydrate free") 
b.  Directive 90/496 on Nutrition Labelling of Foodstuffs 
Article  lla of the  National  Food  &  Drink  Code of Conduct  (on  Nutrition  Labelling)
10 
includes additional provisions to  Article  11  of the same Code aiming to  harmonise Greek 
legislation  on  the  issue  of nutrition  labelling  for  foodstuffs  to  Directive  90/496  of the 
Community. 
All  provisions  of the  Directive  90/496  are,  therefore,  included  identical  in  the  Greek 
legislation under Article  11 a  and  no  additional  provisions (either more  or less  strict)  are 
present. Provisions included in Articles l.4.b, 2 and 3 of  the Directive (mentioned above) are 
presented as such in Article 11 a, par. 2b, par.3 and par. 4 of  the National Food & Drink Code 
of  Conduct respectively (see Annex 1). 
Specifically,  par.  4  of the  Article  is  of major interest  as  it  states  that  nutritional  claims 
allowed are only those referring to the calorific value and the nutritional substances, as these 
are presented in paragraph 2.a.ii of the same article and, to the substances belonging in one 
of  the categories of  these nutritional substances or constitute their components. 
8 In English: "treated with ionising radiation" or "irradiated". 
9 Article 10: Statement and Advertising of  Foodstuffs. 
10  Decision no. 843/91, <DEK, 80/B/12.2.92  page 84 of the Supreme Chemical Council 
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c.  Directive 89/398 on Foodstuffs for Particular Nutritional Uses 
Ministerial Decision no. A2E/54  78 FEK 189/99 was introduced earlier this year with the aim 
to harmonising Greek legislation with EU Directive 89/398. All provisions of the Directive 
are  included identical in the Greek legislation under Articles  1-12 
11  page 2663-2665  (see 
Annex 4). 
Article 4.1  of the Directive provides for the issuance, by the Member States or the EU, of 
specific  legislative  documents  for  each  different  category  of individuals  (e.g.,  infants, 
athletes, etc.) as stated and analysed in par. 1.2.b of the same directive. 
There is  also an additional legislative document regarding baby foods - FEK 585/B/9.8.93, 
no.  Y3d 1510 page 6399 (see Annex 5)- following the provisions included in Article 4.1  of 
Directive 89/398 and the succeeding Directive 91/321 on baby foods. Of  interest: 
1.  Article 5, par 3. states that "the use of  terms such as humanised, matemalised or other 
similar terms is forbidden" 
2.  Article 5, par 5. suggests that "the labelling of  baby-foods should not include pictures 
of  babies or other pictures or texts that idea  lise the use of  the particular product". 
3.  Article 5, par 6. states that "the labelling (of baby foods) may include claims relating 
to  special composition of a baby-food as regards the cases mentioned in Annex IV 
and according to the terms determined therein". 
Specifically  Annex  IV  (see  Annex  5)  provides  for  6  categories  of claims  (e.g.  adapted 
protein, enriched iron, etc.) on baby foods as  well as  the relevant criteria for substantiating 
them. 
d.  Directive 84/450 on Misleading Advertising 
The  Directive  aims  at  providing  the  grounds  for  the  effective  control  of misleading 
advertising by the Member States and is  introduced in its entirety in the Greek legislation. 
The latter is more detailed, but does not make any direct references to claims (see Annex 7). 
2.  Health Claims 
a.  Directive 65/65 on Medicinal Products 
Article 1 of the directive on medicinal products seems to be of particular interest to the issue 
of claims. This is mainly due to the definition given for what is a medicinal product, leading 
to the conclusion that the "dividing line between a medicinal product and a foodstuff is very 
thin". 
Directive 65/65 is included in Greek legislation under Ministerial Decision no.  A6 9392/91, 
FEK B number 233  of 07/04/1992 page 2258 (see Annex 6).  This particular law calls for 
"the harmonisation of Greek legislation to the corresponding Community legislation in  the 
fields of  production, importing and circulation of  medicinal products". 
11  Which replaced ministerial decision no.  1552/90 of29.ll.1990 FEK 8 number 7R6 of 13.12.1990 
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Article 1 of Directive 65/65 is identical to  Article 2 of Law A6a/9392/91. According to the 
latter: 
1.  Medicinal Product: Any medicine already produced that goes in circulation under a 
specific name and specific packaging. 
2.  Medicine: Any substance or combination of  substances presented for treating or 
preventing disease in human beings or animals. 
As a medicine is also considered any substance or combination of substances that could be 
supplied to  a human being or animal,  with the aim  to  perform a medical diagnosis  or to 
restore, improve or modify organic functions of  the human being or animal. 
3.Substance: Any substance regardless of  origin that might be: 
Human (i.e. human blood, human blood derivatives etc), 
Animal (i.e. toxins, animal excretions), 
Vegetable (i.e. vegetable parts, vegetable excretions etc.). 
Note:  It is  also worth mentioning here that those articles of the Directive 65/65  related to 
labelling (i.e. Articles 13- 20) are also included identical in the Greek legislation (see Annex 
6). 
b.  Directive 79/112 on Labelling for Foodstuffs 
Article  2,  par.  b  of the  EU  Directive  is  included  identical  (word-by-word)  in  the  Greek 
legislation under Article  11,  par 2, ii of the National Food &  Drink Code of Conduct (see 
Annex 3). 
c.  Directive 89/398 on Foodstuffs for Particular Nutritional Uses 
Article 6 of the EU directive is  included as  such (it states that in the labelling, presentation 
and advertising of these products it is forbidden to  "attribute properties for the prevention, 
treatment or cure of human disease to such products or imply such properties") under Article 
7, par. 1 of  Ministerial Decision no. A2E/5478 FEK 189/99 page 2664 (see Annex 4), and no 
additional provisions, whatsoever, are present. 
d.  Directive 84/450 (+amendment 97/55) on Misleading Advertising 
In  an  attempt  to  harmonise  Greek  legislation  with  the  corresponding  EU  directive  on 
Misleading Advertising, Ministerial Decision no. 5206/89 has been introduced. 
Greek  legislation  does  not  include  any  provisions  related  to  Article  6  regarding  the 
verification procedure for misleading advertising and the relevant proof adduced. 
Greek  legislation  includes  some  provisions,  under  Article  4  (Ministerial  Decision  no. 
5206/89) on Misleading Advertising, relevant to our study but in a more general framework 
(see  Annex  7).  These  set  up  in  general  the  procedure  to  be  followed  in  each  case  of a 
misleading  advertising  (i.e.  court  procedures,  administrative  bodies,  independent 
organisations).  It should be  noted that  the  above  article conforms to  Article 4 of the  EU 
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Directive,  which  leaves  at  the  discretion  of each  Member  State  to  determine  the  exact 
procedure to be followed (i.e. judicial procedure or resolution via an administrative body). 
Greek  legislation,  under Article  3,  par.2  of Law 5206/1989  (and  also  under Article  9 of 
2251/1994 on Consumer Protection), provides for additional criteria under which an advert 
can be considered misleading (see Annex 8). 
e.  Directive 89/552 on Television Broadcasting 
The above-mentioned Community directive is adopted in Greek legislation under Ministerial 
Decision (no.  236/1992  and amendment 231  of 19/20.6.1995) on 'Television broadcasting 
rights in Greece' (see Annex 9). No additional provisions were revealed. 
Article 6 par. 1 of  the Greek law states clearly that "surreptitious advertising" is forbidden. 
Article  7,  par.2  of the  same  law  states  that  "television  advertisements  of alcohol  drinks 
should conform with the following criteria: 
(a)  Neither address specifically to  minors, nor -particularly- show minors consuming such 
drinks, 
(b) Not relate the  consumption of alcohol drinks to  improved physical performance or the 
driving of  vehicles, 
(c)  Not give  the  impression  that  consumption of alcohol  drinks  favours  social  or sexual 
success, 
(d)  Not  insinuate  that  alcohol  drinks  have  therapeutic  properties  or  that  they  act  as 
stimulants, tranquillisers or appeasers, 
(e) Not encourage the unlimited consumption of alcohol drinks and not provide a negative 
picture of  those not consuming such drinks or consuming them within certain limits, 
(f) Not emphasise as an advantage of  such drinks, their increased capacity in alcohol". 
3.  Ethical Claims 
We could not find any direct legislation referring to  ethical claims.  The assumption is  that 
they would fall under the misleading advertising Directive implementing rules. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
The analysis was based on nutritional or health claims that are allowed to be made or not and 
relevant restrictions, prohibitions and exemptions relating to this general rule are presented. 
a.  Statement- Advertising of Foodstuffs. (Article 10, National Food &  Drink Code 
of Conduct) - (see Annex 2) 
i.  Prohibitions-Restrictions 
Paragraph 3 of the article states that it is  "forbidden as  it aims at misleading the consumers, 
and is persecuted as misleading any statement or advertising, in any way, of  a foodstuff, with 
which it is directly or indirectly implied that the food offered for consumption by a particular 
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ingredients, or that it contains these (ingredients) in higher,  or in some cases lower,  ratios 
than  usual,  even if this  is  real,  if these  ingredients are  included in  a percentage that lies 
within the agreed limits, determined by the Code, for the corresponding type of  food. 
As such, a misleading claim, is  also  considered any writing on the packaging regarding a 
foodstuffs content of a certain ingredient, at a spot clear and distant from the one, where the 
food's composition is provided". 
Par. 6 of  Article 10 forbids the use of  the word 'protein' as part of  the name of  any foodstuff. 
Additional restrictions are included in par.  7- 16  of the article. These include a number of 
provisions for issues like: 
•  The  statement  - advertising  of a  foodstuff  that  makes  a  claim  on  the  nutritional 
value/quality of a protein is  permitted only following approval of NPO according to  a 
number of  nutritional criteria. 
•  The circumstances under which it is  possible to  claim that a  foodstuff is  low/poor in 
carbohydrates. E.g. special dietary foods claiming to be appropriate for low-carbohydrate 
diets  must  not  include  more  than  0.25% of assimilated carbohydrates  as  a maximum 
limit. 
•  Food categories involving claim such as slim, light, line etc. 
•  Products that claim 'low/poor calorific values' 
•  Products  originating  from  a  particular  geographical  location  while  circulating  m  the 
market under the name of  another, etc.(see Annex 2). 
ii.  Exemptions 
Paragraph 5 of  the article exempts from the provisions included in par. 3 of the same article 
(mentioned above), cases  where such a claim has  prevailed or is  included  in  the  code of 
conduct for the distinction of  the product (i.e., Salted Butter, Skimmed Milk, etc.). 
b.  Labelling-Presentation of Foodstuffs (Article 11, National Food & Drink Code 
of Conduct)- (see Annex 3). 
i.  Prohibitions-Restrictions 
Par. 2 (I) of the article forbids the labelling of a foodstuff in a way that is  likely to mislead 
the consumer particularly: 
•  As  regards  the  foodstuffs  characteristics,  especially  its  nature,  identity,  properties, 
composition, quantity, place of  production or origin, method of  production. 
•  By attributing to the foodstuff effect or properties which it does not possess. 
•  By  stating  that  a  foodstuff has  special  characteristics when  these  (characteristics)  are 
present in all similar foodstuffs. 
Par. 6a defines the terms 'no colours', 'no preservatives' or equivalent claims can be included 
on the packaging of a foodstuff,  if and only if,  the  foodstuff in  question does not include 
such substances wherever these may come from. 
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the same article (see Annex 3). 
c.  Nutrition Labelling of Foodstuffs (Article lla, National Food &  Drink Code of 
Conduct) - (see Annex 1). 
i.  Exemptions 
Par.  1  b of the article exempts natural mineral waters (destined for human consumption) as 
well as  dietary supplements and fortified foods from the provisions related to  the nutrition 
labelling of  foodstuffs and consequently nutritional claims. 
d.  Foodstuffs for Particular Nutritional Uses  (Ministerial Decision  no.  A2E/5478 
FEK 189/99) - (see Annex 4). 
i.  Prohibitions-Restrictions 
Article  2,  par.  4  states  that it  is  forbidden  for  foodstuffs  of ordinary consumption to  be 
labelled, presented or advertised as: 
•  dietary' or 'for diet' and the use of these words on their own or together with others for 
their distinction. 
•  with any other labelling methods, likely to  give the impression that these are products 
that fit the description of products for particular nutritional uses; as defined in par.  1 and 
2 of  the same article. 
Moreover, there is an additional legislative document
12  that includes a prohibition regarding 
foodstuffs for particular nutritional uses 
13
. 
Thus, according to Article 5 (on presentation - advertising), "the labelling, advertising and, 
generally, presentation of  such products shall not include any statements regarding the speed 
and extension of weight  loss,  likely to  occur after consumption of these products,  or the 
reduction of the feeling of  hunger or the increase of  the feeling of  satisfaction". 
ii.  Exemptions 
In  Article 2, par.  5 of Ministerial Decision no.  A2E/5478 FEK 189/99, it is  stated that "for 
foodstuffs for ordinary consumption, in case these are considered appropriate for particular 
nutritional  purposes,  it  is  allowed  to  carry  relevant  claims  according  to  the  procedure 
outlined in Article 5 of  this Min. Decision". 
e.  Baby Foods (Ministerial Decision no. 2039736/4719/0022)
14
- (see Annex 5). 
i.  Prohibitions-Restrictions 
12  no. YEA Y3E/5497 15.10.97/13.3.98)- (sec Annex 17). 
13  This particular law aims to harmonise Greek legislation with the corresponding Community directive 
96/8/EC regarding "foodstuffs intended to be used in 'reduced-calories' diets for the loss of  weight" 
14  Sc\: annex for full text. 
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Article 2 (on circulation - disposal), par.  1 states that "no other products, except from those 
that fulfil the requirements for baby foods- should be allowed to circulate in the market or be 
presented  in  any other way  as  appropriate  for  satisfying  the  nutritional  needs  of babies 
during the first 4-6 months of  their lives ... ". 
Article 5 (on labelling), par.  3 states that "the labelling of foodstuffs  for babies should be 
carried out in such a way so as to provide all the necessary information for the right use of 
the product and should not discourage breast feeding". 
Moreover the same paragraph forbids the use of the terms "humanised" and "maternalised". 
The term "adapted" can only be used in accordance with the provisions of  paragraph 6 of the 
same article. 
Par. 5 of the same article states that "the labelling of baby foods should not contain pictures 
of  babies or any other pictures or objects that will idealise the use of  the product". 
ii.  Exemptions 
Article 5, par. 5 of the above Ministerial Decision (that forbids the use of  pictures of babies) 
exempts the use of shapes, which will assist in the identification of the product and which 
present the guidelines for consuming it. 
f.  Food Supplements (Ministerial Decision no. Y8/10170 FEK 935/95 page 12218) -
(see Annex 1  0) 
i.  Prohibitions-Restrictions 
Article  6,  par.  2  (on  presentation  - advertising)  of this  law  prohibits  any  "misleading 
presentation, advertising and labelling as far as composition, names, terms, words, phrases or 
pictures are concerned". 
g.  Misleading Advertising (Ministerial Decision no. FEK. 5206/89) - (see Annex 7). 
i.  Prohibitions-Restrictions 
Article 4 of  the law forbids misleading advertising. 
h.  Television Broadcasting (Ministerial Decision no. 236 10/16.7.92) 
-(see Annex 9) 
i.  Prohibitions-Restrictions 
Article 6, par. 1 of  the Greek law forbids "surreptitious advertising". 
i.  Mineral Waters (Ministerial Decision no. 433 FEK 163/83 of9.11.83.) 
-(see Annex 11). 
i.  Prohibitions-Restrictions 
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under many different brand names. 
Article 9, par.  1 states that it is "forbidden, either on the packaging or label, or in any form of 
advertising, the use of brand indications, industrial or commercial labels, pictures or other 
symbolic parts, or not, which: 
a)  for  a  natural  mineral  water,  insinuate  a  characteristic,  which  it  does  not  possess, 
particularly as regards the origin, license date for sale, the analysis results and also any 
relevant statements regarding guarantees of authenticity; 
b)  for a packaged drinking water, not conforming to  the terms of paragraph}  of section I, 
likely to create confusion with a natural mineral water and mostly the indication "mineral 
water". 
ii.  Exemptions 
Article  9,  par.  2b  exempts  the  use  of indications  that  conform  to  a  number  of criteria 
presented in section 3 of  Ministerial Decision no. 433 FEK 163/83 of 9.11.83. 
2.  Health Claims 
a.  Statement- Advertising of Foodstuffs (Article 10, National Food &  Drink Code 
of Conduct) - (see Annex 2) 
i.  Prohibitions-Restrictions 
Article  10,  par. 2 states that it is  "forbidden as it aims at misleading the consumers, and is 
persecuted as  misleading.  Any statement or advertising,  in any way,  of a  foodstuff with 
which it  is  directly or indirectly implied that the food  in  question possess properties, not 
actually present in it during consumption or that this (food) is appropriate for the prevention 
and/or cure of: 
Alcoholism,  hair loss,  appendicitis,  arteriosclerosis,  collapse,  prostate  disease,  dysentery, 
cancer,  spasms,  diabetes,  menstruation  disorder,  epilepsy,  gangrene,  glaucoma,  arthritis, 
heart disease, high pressure, hernia, low pressure, flue, neuropathy, leukaemia, liver disease, 
nausea and other pregnancy related conditions, obesity, pleurisy, pneumonia, poliomyelitis, 
rheumatic  fever,  rheumatic  arthritis,  psoriasis,  septicaemia,  sexual  dysfunction,  tetanus, 
thyroid disease, tuberculosis, tumours and oedema, digestive ulcer  and in  general,  colitis, 
aphrodisiac diseases as well as relevant diseases and conditions. 
b.  Labelling- Presentation of Foodstuffs (Article 11, National Food & Drink Code 
of Conduct) - (see Annex 3). 
i.  Prohibitions-Restrictions 
Par.  2a.ii of the article states that labelling should not "attribute to  the foodstuff properties 
for the prevention, treatment or cure of  diseases, or insinuate such properties'. 
ii.  Exemptions 
Pan-- European study on nutritional, health and ethical claims-- 1999.  242 Par.  2a.ii  exempts  mineral  waters  and  foodstuffs  for  particular nutritional  uses  from  the 
above mentioned prohibitions - restrictions. 
c.  Food Supplements (Ministerial Decision no. Y8/10170 FEK 935/95 page 12218) 
-(see Annex 10). 
i.  Prohibitions-Restrictions 
Article  6,  par.  3  (on  presentation  - advertising)  states  that  "the  wntmg  of claims  or 
indications that insinuate directly or indirectly the prevention - cure of diseases, preservation 
or  change  of physical  functions,  in  the  labelling,  advertising  or  presentation  of food 
supplements is forbidden". 
d.  Television Broadcasting (Ministerial Decision, no. 236 of 10/16.7.92) 
- (see Annex 9). 
i.  Prohibitions-Restrictions 
Article 7,  par.2 of this ministerial decision states that "television advertisements of alcohol 
drinks should : 
(a) Neither address specifically to minors, nor - particularly- show minors consuming such 
drinks, 
(b) Not relate the consumption of alcohol drinks to  improved physical performance or the 
driving of  vehicles, 
(c)  Not give the  impression  that consumption of alcohol  drinks  favours  social  or sexual 
success, 
(d)  Not  insinuate  that  alcohol  drinks  have  therapeutic  properties  or  that  they  act  as 
stimulants, tranquillisers or appeasers, 
(e) Not encourage the unlimited consumption of alcohol drinks and not provide a negative 
picture of  those not consuming such drinks or consuming them within certain limits, 
(f) Not emphasise as an advantage of  such drinks, their increased capacity in alcohol". 
e.  Mineral Waters (Ministerial Decision  no.  433  FEK 163/83  of 9.11.83.)  - (see 
Annex 11). 
i.  Prohibitions-Restrictions 
Article 9, par. 2a forbids all indications that attribute to a natural mineral water, properties of 
preventing  medical treatment  or of curing  a  human disease.  Par.  2c  of the  same  article 
forbids indications such as  "enhances digestion" or other similar indications related to the 
effects of water on the functions of the human organism, even if these are not inconsistent 
with the requirements of par.2a of the same article or cover the presumptions determined in 
par. 2b. 
Examples: 
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in some cases the National Pharmaceutical Organisation- have prohibited the use of specific 
claims (nutritional and/or health) on foodstuffs. 
Following is a representative list of examples, which may further assist us in identifying the 
viewpoint of  the Greek State on this issue: 
1. "Strong milk". 
2.  "The only fresh milk which contains iron and vitamins Bl2 and C".  The word only was 
prohibited. 
3. "Fresh product", referring to a yoghurt. 
4. "Rich in proteins", referring to instant soups. 
5. "High quality and healthy ingredients". 
6. Prohibition of  the use of  word "protein" as part of  a spaghetti brand name. 
7.  "For a healthy nutrition", referring to a cereal product for general use. 
8. "For diabetics", referring to candies. 
9. "Low calorific value", referring to sweet. 
10.  "Soothing, relieving digestive ... ./upset stomach for  babies", referring to  foodstuff for 
general uses (beverage). 
11. "Replenishes lost energy", referring to a beverage Uuice  ). 
12. "Stress relieving, increases physical endurance", referring to a drink. 
13. "  ... offers all ingredients necessary to the human body", referring to a common milk. 
14.  "It is the first fresh milk, enriched with vitamins A, D and E which give beauty, vitality, 
glow and health". 
15.  "Gives vitality and strength to  your body, beauty and glow to  your skin", referring to 
milk. 
16.  "  ... reinforces the immune system", referring to a milk enriched with vitamins A, D and 
E. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
Overall, the Greek authorities have not realised the importance of the issue of claims per se 
and in the general context of consumer protection and free trade in the EU Member States. 
Consequently, Greece's policy regarding claims has not been developed so as  to  efficiently 
regulate related issues and provide for tailored measures to handle the current situation in the 
country and confront problems that may arise. 
A contributing factor to this Greek State's policy is  the absence of an official and uniform 
organisation/body to  tackle  all  issues  relevant  to  the  control of foodstuffs  and  therefore, 
claims.  At  this  stage,  given  the  lack of ability  and  promptness  to  provide  solutions  on 
consumer protection (particularly for the Food & Drink Industry), the State is in the process 
of  establishing a relevant body. A process that is expected to proceed rather rapidly after the 
considerable public unease that followed the  Belgium dioxin crisis  on foodstuffs.  So  far, 
however, the only action initiated by the State on the issue of  claims is that it conforms to the 
applicable Directives of  the EU. 
The Consumer General Secretariat of the Ministry of Development is the authority that has 
initiated the efforts to set up the first Uniform Foodstuffs Control Board in Greece.  This is a 
project,  which  was  conceptually  formulated  in  the  last  decade.  The  delay  for  its 
implementation lies in the difficulty to orchestrate the variety of organisations involved and 
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the  disparity  of their  responsibilities.  The  Board,  which  will  probably  come  into  effect 
possibly by the end of this  Summer (the legislative document still needs to  be  concluded) 
will consist of a Board of Directors, a National Council for Foodstuff Policy and a Scientific 
Committee. It will function under the authority of the Ministry of  Development and will only 
deal with packaged foodstuffs.  Furthermore, a number of consumer organisations, industry 
representatives,  as  well  as  the  National  Pharmaceutical  Organisation  and  the  State 
Laboratory for General Chemistry will participate in the workings of  the Control Board. 
This Control Board will serve as  a starting point so that the issue of claims is  more closely 
monitored  by  the  State  and  consequently  dealt  with  via  clearly  defined  administrative 
channels. This will be a co-ordinated effort, as consumer organisations and NGO's will play 
an active role in order to serve its objective in a comprehensive and efficient way. 
From  the  viewpoint  of  consumer  organisations,  the  issue  of  claims  is  inefficiently 
approached by the State. At the same time, lack of knowledge on their behalf has prevented 
them from thoroughly informing consumers on the possible issues that may arise due to the 
gaps  in  the  relevant  regulatory  documents.  Following  our  contacts  with  consumer 
organisations,  some of them were sensitised and decided to  take action  by informing and 
educating Greek consumers. They are also in favour of the establishment of such a Control 
Board, as this will further enhance consumer protection. 
The limited resources of the Greek State to deal with the issues arising in the Food &  Drink 
Industry  in  general,  and  in  regards  to  claims  on foodstuffs,  shows  an  apparent  lack  of 
consumer  protection.  The  public  sector  authorities  responsible  for  consumer  protection 
further reinforced our conclusion, by clearly admitting that the control systems in place for 
claims needs improvement and that certain sections of the Greek legislation relating to Food 
& Drink issues are outdated. Their comment was that Greek legislation has to conform to the 
current market reality in order to  practically assist the relevant authorities to  perform their 
duties effectively and consistently. 
Interestingly, there is a specific case relating to  a type of honey claiming to have fortifying 
properties, which was approved by the  State  Laboratory for  General Chemistry but at the 
same time rejected by the NPO.  Interesting to  note that this claim was approved, although 
the  Greek  law  does  not permit  health  claims  per se.  This  probably constitutes  the  most 
supportive evidence that the State does not provide for a complete and reliable verification 
system and cannot, therefore, take impartial and fair decisions. 
Public  sector representatives  expressed the  wish to  see  all  issues relating to  claims being 
regulated at  EU level.  It is  their belief that a detailed EU document that could serve as  a 
sanction would help Member States define the relevant boundaries on claims and harmonise 
their  legislation  in  an  appropriate  way,  which  does  not  leave  any  grey  areas unresolved. 
However, it was also suggested that further regulation should avoid being 'suffocating'. This 
should occur in a way so as to literally protect consumers instead of  confusing them with the 
variety of claims that may appear on the market. On the other hand, the industry's concerns 
should also be accounted for,  as additional limitations imposed on foodstuff may in practice 
constitute a barrier to trade. 
According  to  the  consumer organisations'  viewpoint,  consumer rights  are  not  effectively 
protected and the action taken by the former is  becoming somewhat restricted. This occurs 
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responsibility between the various competent bodies. 
Other NGOs,  such as  the  Hellenic  Advertising Agencies  Association,  are  against further 
regulation of claims and their incorporation in the EU Directive on Misleading Advertising. 
It is their belief that this would be highly dysfunctional and would ultimately lead to barriers 
to trade. Therefore, their suggestion is that self-regulation would be the best solution. If the 
law becomes more specific and strict on claims, it  may restrict to  a  great extent Food & 
Drink manufacturers that use more technologically advanced methods than others for  the 
improvement of their products. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
The  Hellenic  Advertising Agencies  Association has  issued a  Code of Conduct,  which  is 
binding  for  all  its  members  as  well  as  the  media.  This  document  outlines  the  general 
principles  to  be  followed  by all  parties  concerned  regarding  advertising.  It also  makes 
reference to misleading advertising and indirectly to the claims issue (Article 4) by stating 
that  "adverts should not include  statements or visual presentations, that either directly or 
indirectly  ... may mislead the consumer.  .. " (see Annex 12). 
The Federation of Hellenic Food Industries (SEVT) as  a member of CIAA conforms to all 
rules and regulations as these are adopted by all other members. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
There is no definition of  a claim in the above-mentioned code. 
C.  VOLUNTARY  INSTRUMENTS  ACCEPTED/RECOGNISED  BY  THE 
AUTHORITIES 
The Hellenic Advertising Agencies Association Code of  Conduct is accepted and recognised 
by the Greek authorities as the official self-regulatory document dealing with the control of 
advertisements (following the guidelines provided by the relevant Greek legislation 
15
). 
The same applies to all rules and regulations adopted by SEVT as a member of  CIAA. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
Overall,  the  National  Food  &  Drink  Code  of Conduct  and  other  relevant  legislative 
documents do not provide any criteria for substantiating claims in particular.  Specifically, 
there  is  no  list  of documents  mentioned  in  relevant  Greek  legislation  to  determine  the 
necessary  proof that  needs  to  be  adduced  in  order  to  substantiate  a  claim  made  on  a 
15  See Annex 12. 
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use a certain claim is in a position to defend this with scientific documentation. 
The only legislative document clearly providing for specific criteria for substantiating certain 
claims is  the  one referring to  baby foods.  In  particular,  Annex  IV  included in  Ministerial 
Decision no.Y3E/3452, <I>EK  1040/B, 25.11.97, provides for characteristics which justify the 
following claims: 
1. Adjusted protein 
2. Low sodium capacity 
3. Saccharine free 
4. Only lactose included 
5. Lactose free 
6. Enriched iron 
7. Reduces the risk of allergies in milk proteins  (see Annex 13 for Annex IV) 
Moreover, a number of  criteria are established in Article 1la, par. 3b, 4 and 5 of  the National 
Food &  Drink Code of Conduct, relevant to  nutrition labelling.  These refer to  the energy 
value of the product, the quantity of proteins, carbohydrates, fat,  saturated fat acids, sodium 
etc., depending on the claim made (see Annex 1  ). 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
A  formal  system and/or organisation responsible  for  the  control of foodstuffs  and  claims 
does  not  exist  in  Greece.  Relevant  controls  fall  under the  competence  of various  public 
organisations  such  as  the  Ministry  of Development,  the  State  Laboratory  of General 
Chemistry and the National Pharmaceutical Organisation (NPO). There is an evident overlap 
of  responsibility between all the above mentioned organisations, especially between the State 
Laboratory  for  General  Chemistry  and  the  National  Pharmaceutical  Organisation.  The 
majority of relevant controls is  actually conducted by the  State Market Inspection Service 
(Ministry  of Development,  Directorate  General  for  Commerce)  through  the  procedures 
provided for in the State Market Inspection Code  (see Annex 14 ). 
A  State Laboratory for General Chemistry 
SLGC is  responsible for  the control of ordinary foodstuffs  and  subsequently of nutritional 
claims.  The  authority  responsible  to  conduct  controls  (in  most  cases,  the  State  Market 
Inspection  Service  in  collaboration  with  the  responsible  Chemist  Service  of the  SLGC) 
forwards its final report to the relevant authorities of  the SLGC. 
All products, which contain ingredients that are not addressed by the law, are characterised 
as  not normal and the relevant results are submitted to the District Attorney responsible. In 
this case, the producer/manufacturer is entitled to appeal against the decision and ask for the 
revision of all relevant controls, within 48 hours.  The revised control test may be conducted 
in  presence  of a  private  chemist  appointed  by  the  producer/manufacturer.  In  case  of 
conflicting  opinions  between  the  two  chemists,  the  issue  is  forwarded  to  the  Supreme 
Chemical Council, which studies the two conflicting reports and submits them to the District 
Attorney. 
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In general, product samples collected by the State Market Inspection Service for inspection, 
are  submitted to  the  SLGC  for  control  regarding the  quantity and quality of ingredients, 
relevant labelling and claims. 
B.  National Pharmaceutical Organisation (NPO) 
The National Pharmaceutical Organisation (NPO) is  the competent body for the control of 
foodstuffs for particular nutritional uses, including relevant claims. According to ministerial 
decision  A2E/5478,  FEK  I89/B,  5.3.99,  Article  6,  setting  the  general  guidelines  for  the 
control  of all  foodstuffs  for  particular  nutritional  uses  (additional  and  more  specific 
provisions  have  been  envisa~ed for  foodstuff categories  included  in  Article  II  of the 
document  - see  Annex  4)
1 
,  such  products  are  subject  to  control  by  the  National 
Pharmaceutical Organisation. Companies that wish to sell similar products have to notify the 
product to the relevant authority.  Specifically, companies have to submit: 
a)  A sample of  the product 
b)  Evidence regarding the producer,  the  composition and the  labelling,  in  order to  check 
whether production and disposal conform with the relevant legislative provisions; and 
c)  Scientific  studies  and relevant documents,  in  case it  is  considered necessary to  prove 
whether the product has the purpose for which it is supposed to serve. 
No reference is made to the control of claims, in particular. However, claims are considered 
part of  the labelling and are also related to the particular nutritional purpose of  the product in 
question.  Consequently,  claims  are  examined  in  conjunction  with  the  relevant  control 
procedure applicable to products for particular nutritional uses. 
Health claims are not officially allowed by the Greek law. However, in case a health claim is 
made on a product or a company asks for a certain health claim to be approved, the decision 
making procedure lies within the jurisdiction of the National Pharmaceutical Organisation. 
In practice the NPO has issued in the past licences regarding health claims. 
Two recent examples of  health claims approved so far by the NPO are: I) Kellogg's All Bran; 
claim  regarding  fibres  and  their  beneficial  effect  on  the  physiological  function  of the 
intestines and 2) A specific chewing gum that has a claim on its packaging about helping 
avoid teeth's decay. 
Overall, it should be mentioned that there is a fine line between the responsibilities of these 
two competent bodies, which are very often intermingled, thus creating a grey area for this 
research. 
1.  Pre-Clearance Rules I Guidelines 
No pre-clearance rules exist in Greece officially. 
2.  Post-Clearance Rules I Guidelines 
16  For further details, refer to Ministerial Decision Y611 0170 on the circulation of food supplements, 
<l>EK 935/B, 13.11.95, article 4 and Ministerial Decision Y3E/3452 on baby foods, <DEK  1  040/B, 
25.11. 97, article 2. 
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The  legal  procedure  for  the  verification  as  to  whether  a  claim  made  by  a 
producer/manufacturer is  misleading or not  is  as  follows.  Following the Greek Consumer 
Protection Legislation (Law 2251/1994) a consumer wishing to sue for a misleading claim is 
obliged to  do  so through a consumer organisation. This is  because the ultimate goal of the 
State is to protect the interest of the general public/consumers. Such cases are submitted to 
the civil courts and are most often handled through the procedure of provisional measures. 
Following the  application of these  provisional  measures,  a  product may be banned from 
circulation and compensation is given to the consumer. 
Apart from  the civil courts, such cases are often submitted to the criminal courts for fraud. 
According to  Article  57  of the  Greek civil code on  "Protection of One's Personality",  an 
individual consumer can also stand before a criminal court and request compensation from 
the producer/manufacturer of  a product for a misleading claim. 
b.  Specific procedures for claims 
There is no specific procedure applicable to claims only. The procedure followed is the one 
applied to all consumer protection cases. 
c.  Out-of-court procedures 
i.  Consumer Protection Law 2251/1994 
According to law 2251/1994 on Consumer Protection, every Prefecture is responsible to set-
up  a  Committee  of Out-of-Court  Settlement,  which  would  resolve  differences  between 
vendors and consumers or consumer organisations (Article 11, par. 1  ). 
ii.  Procedure defined by administrative bodies 
The  Hellenic  Advertising Agencies Association has  set-up  two  committees that  deal  with 
complaints  and  are  responsible  for  the  resolution  of  issues  that  concern  misleading 
advertising  and  misleading  claims.  According  to  the  Association's  internal  regulation 
procedures, all complaints are directed and handled by the First Degree Committee for the 
control of advertisements and in the case that an appeal is  filed for a decision, this case is 
submitted to the Second Degree Committee. 
The primary function of the  two  Advertising Standard Control Committees is  to  examine 
alleged breaches of the Greek Advertising Code.  In the occasion that either the advertising 
company  or  the  company  being  advertised  refuse  to  implement  the  decision  of the 
Committees, the latter can request the discontinuation of the advertisement directly from the 
media broadcasting it. 
iii.  Internal settlement 
In practice, there exists a number of cases, which are resolved via out-of-court procedures. 
These  involve  the  internal  settlement of a  dispute between  two  competing companies  or 
between a company and a consumer organisation. 
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There is no fixed cost for going to  court in Greece. This depends on the case handled, the 
time required and actually spent in order to  reach a resolution.  There are,  however, some 
fixed costs that apply to  all  cases.  These include the court filing costs (deposition of case 
files  and  documents,  stamps)  and the  court hearing  costs  (for  the  legal  representation to 
court), which amount to a maximum of 100.000 DRS. 
In case the plaintiff asks for compensation there is also a fixed cost for going to court, which 
amounts  to  7,5/1.000  of the  compensation  amount.  As  a  general  statement,  a  lawyer in 
Greece should charge a minimum of 20.000 DRS. per hour in defending a case. The Greek 
Lawyers Association has set this amount as a benchmark. Since there are no cases available 
on claims, no further information can be provided as to the fixed amount such a case would 
actually cost. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
According to Law 2251/1994 on Consumer Protection, consumer organisation are entitled to 
take legal action against misleading claims and represent consumers both in court and in out-
of-court procedures (Article 9, par. 1  ). 
However,  according  to  Article  57  of the  Greek  civil  code  on  "Protection  of One's 
Personality", a consumer can sue individually the producer/manufacturer of a product for a 
misleading  claim  with  the  accusation  of fraud  (before  criminal  courts)  and  also  request 
compensation. 
According to information gathered from our interviews with voluntary instruments, it seems 
that part of the legal action was taken by a consumer organisation through the procedure of  a 
collective lawsuit,  while in  other cases legal  action was  taken from  one company against 
another competitor company. 
D.  BURDEN OF PROOF 
a.  Burden of proof 
According to  the  legislative documents dealing with  Unfair Competition (Law  14611914) 
and Consumer Protection  (Law 2251/1994)  it is  not clear with  whom  lies  the  burden of 
proof.  Evidently, Greek legislation does not define whether the producer/manufacturer or 
the consumer/consumer organisation have the ultimate responsibility to prove that a claim is 
misleading or not. 
However, public sector representatives and NGOs indicated that the burden of proof lies in 
practice with both parties. 
b.  Proof to be adduced 
Greek legislation does not provide for  a list of documents that have to  be  submitted by a 
producer/manufacturer and/or consumer/consumer organisation to court as proof against/for 
a misleading claim. However, it is evident that a producer/manufacturer has to  keep record 
of all  documents relevant to  the  production methods and composition,  labelling standards 
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and  requirements  and,  therefore,  claims.  On  the  other  hand,  the  consumer/consumer 
organisation  needs  to  defend  its  case  by submitting all  relevant  evidence  in  the  form  of 
documents to prove the alleged damage or loss. 
E.  APPLICABLE PENALTIES 
1.  General Rule 
As a general principle, according to Law 225111994 on Consumer Protection, the penalties 
that are inflicted on the producer/manufacturer by the Ministry of Development (Directorate 
General for Commerce) for any violation of the current law range between 500.000 DRS to 
20 million DRS. In the case of repetition of an offence, the maximum penalty limit doubles, 
while in  the  case of further  repetition of an  offence,  the  Deputy Minister of Commerce, 
following the recommendations of the National Consumers' Council, may order the shutting 
down of a company (or part of its operations) for up  to  one year (Law 2251/1998, Article 
14., par. 3). 
2.  Penalties imposed by NPO (National Pharmaceutical Organisation) 
According to the Law  1316/11.11.83, article 33, paragraph 3, the penalties that are inflicted 
on a producer/manufacturer who breaks the law in regards to  the mandatory indications of 
the  labelling of medicinal  and  other products  (such  as  dietary  foods,  infant  milk)  reach 
500.000 DRS. In the case of  repetition of  the offence, the penalty rises to  1 million DRS and 
the company may be shut down. 
V.  CASELAW 
Given that the claims issue in Greece is  still in its embryonic stage of development and all 
cases so far have been reported on an ad-hoc basis, there is  an  evident lack of information. 
The fact that Greek courts of Justice are not yet fully accustomed with modern information 
technology systems is  in itself another contributing factor to this inefficiency and, therefore, 
a limitation to our study. 
There  is  no  pertinent case  law  available  in  Greece for  all  the  above  mentioned  reasons. 
Additionally,  representatives  from  consumer  organisations  could  not  recall  of any  cases 
relating to  claims, although they referred to  a limited number of cases on food  and drink 
issues in general, that reached the courts. 
Case 1  : A well known slimming pill called SLIM was banned from circulation following a 
collective lawsuit that was filled against the company by the General Consumers' Federation 
of Greece (G.C.F.G.).  This was done on behalf of 2.400 consumers that had called in with 
complaints about misleading claims  (this was the case of the 'miracle' pill that one could 
take and lose weight). The case was resolved through legal action (civil and criminal courts) 
and the company was shut down and had to also pay a large fine. 
Case  2:  One  of the  largest  Greek  dairy  companies  was  taken  to  court  by  its  biggest 
competitor  for  a  misleading  claim.  Specifically,  the  company  claimed  that  its  highly 
pasteurised  milk  must  be  preserved  only  in  the  refrigerator.  Such  a  claim  carries  the 
connotation of a fresh  product.  This was proved to  be  a misrepresentation of the  specific 
Pan-- European study on nutritional, health and ethical claims- 1999.  251 I 
product, because when milk is  highly pasteurised it is  considered as  UHT and,  therefore, 
does  not need  to be preserved in  the  refrigerator.  Following the  legal  decision  that  was 
incriminating, the company withdrew the specific claim from the packaging. 
VI.  MEANS OF COMMUNICATION 
On a theoretical basis, all legislative documents - related to nutritional or health claims - are 
applicable to all means of  communication. 
Specifically,  Article  10  of  the  National  Food  &  Drink  Code  of  Conduct,  on 
statement/advertising of  foodstuffs states that: 
"The provisions included in this article concern the statement or advertising of a foodstuff 
including any references on or inside the packaging as well as any written or oral statement 
in the press, radio, television, cinema". 
The article goes on to forbid:  "Any statement or advertising, in any way, of  a foodstuff with 
which it is directly or indirectly implied that the food in question": "Possess properties, not 
actually  present  in  it  during  consumption  or  "That  this  (food)  is  appropriate  for  the 
prevention  and/or  cure  of:  alcoholism,  hair  loss,  appendicitis,  arteriosclerosis,  collapse, 
prostate disease, dysentery, cancer, spasms, diabetes." (see section Il.A.2 ofthis report)". 
Article  9  of Law  2251/1994  on  Consumer  Protection  clearly  states  that  misleading 
advertising is forbidden - and defines the term advertising as "any statement made in terms 
of  commercial, industrial or professional activities". 
At this point, however, it  is  necessary to  comment on a possible discrepancy between law 
and practice based on two facts.  First,  the  absence of a  relevant body for the control of 
claims (both nutritional and health) and second, the very wide spectrum of activities - apart 
from checking on claims - of the organisations currently responsible for this issue, such as 
the State Laboratory for General Chemistry and the National Pharmaceutical Organisation. 
Consequently, there could be differences as to the strictness and intensity with which the law 
is applied among the various means of communication. 
In television adverts, for example, seen by a much larger percentage of potential consumers 
than, say, a press release, existing legislation on labelling, advertising and therefore claims is 
more accurately applied. This, on the other hand, may not be the case with other means of 
communication, such as information or promotional material, targeting specific segments of 
the market being therefore "less regulated". 
For example, our research revealed the existence of  a specific advertising booklet for the Red 
Bull Energy Drink in which both the nutritional and health claims present are clearly illegal, 
according to the national legislation on claims. Examples of claims within this promotional 
leaflet include (a)"enhances the ability to concentrate" (nutritional) and (b) "revitalises brain 
cells" (health). 
As  a general comment,  it could be stated that there  is  an excessive number of legislative 
documents on advertising (including misleading advertising) in all means of  communication, 
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which  are  also  obviously  overlapping.  More  specifically,  the  provisions  on  misleading 
advertising  are  spread  in  a  wide  variety  of Greek  legislative  documents,  thus  creating 
confusion as regards the purpose behind their existing differences. This is most probably due 
to the fact that these legislative documents have an underlying difference in their approach. 
VII.  STATISTICS ON CLAIMS 
Neither the  official  state  authorities  nor consumer organisations  or industry  groups  have 
statistical information on claims. 
VIII.  ANNEXES 
I)  Ministerial decision no.843/9I FEK 80 of I9/11/199I, p 846, article 11a of the National 
Food and Drink Code of Conduct, harmonising Greek legislation with the corresponding 
EU Directive 90/496 on Nutrition labelling of  Foodstuffs. 
2)  National Food and Drink Code of  Conduct, article 10, par 3 (advertising of  foodstuffs) 
3)  National Food and Drink Code of Conduct, article II par.2.a.ii (labelling-presentation of 
foodstuffs) 
4)  Min. Decision A2E/5478 pages 2663-2665 
5)  Decision no. 843/91,- FEK 585/B/9.8.93, no. Y3L\ 1510 page 6399 
6)  Ministerial Decision No.A6 9392/9I, fek B NUMBER 2330F 07/04/1992  PAGE 2258, 
Which replaced Ministerial Decision no.  1552/90 of 29.11.1990 FEK B number 786 of 
13. 12.1 990. 
7)  Ministerial Decision no.5206/89 on Misleading Advertising. This particular law aims at 
harmonising  Greek  legislation  with  the  corresponding  Community  directive  96/8/EC 
regarding  "foodstuffs  intended  to  be  used  in  'reduced-calories'  diets  for  the  loss  of 
weight". 
8)  Law 5206/1989, article3, par.2 and article 9 of  2251/1994 on Consumer and Protection. 
9)  Ministerial Decision  no.236/1992  on Television Broadcasting rights in Greece" 
1  0) Food supplements \Ministerial Decision no.YB/1 0170 FEK 935/95 
11)Mineral Waters Ministerial decision no. 433 FEK 163/83 of9.11.83 
12) Greek Advertising Code 
13) Baby Food (amendments) Ministerial Decision no. Y3E/3452 FEK 1040/ 
14) The State Market Inspection Code 
15) Unfair Competition Law no. 46/1914. 
16) National Pharmaceutical Organisation. Penalties imposed. 
17) Ministerial Decision no. Y3E/5497. 
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FOOTNOTES 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
Reference  only  to  the  consolidated  versiOn  of  this  directive  (including  all 
amendments). 
Article 11  is amended with decisions of  the Supreme Chemical Council No. 2206/85 
FEK 49/B/86 and No. 804/90 FEK 104/891. 
In English: "treated with ionising radiation" or "irradiated". 
Article 10: Statement and Advertising of  Foodstuffs. 
Decision no. 843/91, FEK, 80/B/12.2.92 page 84 of  the Supreme Chemical Council 
This replaced ministerial decision no.  1552/90 of 29.11.1990 FEK B number 786 of 
13.12.1990. 
This  particular  law  aims  to  harmonise  Greek  legislation  with  the  corresponding 
Community directive 96/8/EC regarding "foodstuffs intended to be used in 'reduced-
calories' diets for the loss of  weight" 
See annex for full text. 
For further details, refer to Ministerial Decision Y  6110170 on the circulation of food 
supplements, FEK 935/B, 13.11.95, article 4 and Ministerial Decision Y3E/3452 on 
baby foods, FEK 1040/B, 25.11.97, article 2. 
IX.  DATABASE OF CONTACTS 
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I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
The  study  was  well  received  by  all  interested  parties  in  Ireland.  Those  who 
participated were by and  large  pleased  to  see  that  the  European  Commission/DG 
XXIV is taking an interest in these issues, especially as many, particularly in the Irish 
government,  are  often under-resourced and welcome  EU-level support.  There was 
some concern expressed, however, that this may be simply another in a long line of 
studies which lead to the setting up of new consultative committees, but which do not 
bring concrete results.  There was a widespread desire that this study should result in 
real action to address the claims issue. 
The following Executive Analysis outlines the key points of  interest for the purpose of 
the study. 
B.  MEMBER STATE POLICY 
1.  Nutritional claims 
The definition of  a nutritional claim is the same as defined in EU law, although claims 
related to  dietary guidelines or healthy diets are not allowed under Irish law, making 
them somewhat stricter to  that of the  latest Codex guidelines on nutritional claims. 
From the  authorities'  standpoint,  the  government departments  and the Food Safety 
Authority of Ireland (FSAI), the legislation in  place is  working well and there is  no 
need  for  any  review.  However,  this  position  is  not  shared by the  Irish  Business 
Employers Confederation.  They believe that the current legislation is not sufficiently 
clear, leading to confusion as to what type of  nutritional claim can be made. 
2.  Health Claims 
With  regard  to  health  claims,  these  are  banned  under  the  national  implementing 
legislation of 79/112, word for word.  Nevertheless, the authorities recognise the fact 
that  health  claims  are  being  used,  but  they  have  neither  the  human  or  financial 
resources to verify and/or bring manufacturers to court. 
The  Irish  Medicines  Board (1MB),  aware  of the  growing  problem  of '"borderline" 
products, has tried to rectify the situation by issuing guidelines on the definition of a 
medicinal product.  In  effect, these guidelines, together with a list of non-exhaustive 
words, which could imply a claim, reinforce the notion that any product, which claims 
to  cure, alleviate or prevent disease, should be considered a medicinal product.  The 
1MB takes into account ofECJ ruling of 1991  (OJ 1991  C219/91), which states that a 
product  which  is  recommended  or  described  as  having  preventive  or  curative 
properties is a medicinal product, even if it is generally considered as a foodstuff and 
even if  it has no known therapeutic effect in the present state of  scientific knowledge. 
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reference to Directive 65/65 on medicinal products.  At the same, they should issue a 
positive list of health claims, based on sound science as developed by the FDA in the 
US, instead of relying merely on guidelines or definitions.  They also commented that 
the burden of proof should lie with the manufacturer, who wanted to  add a claim to 
the  list,  and  a  Scientific  Committee  would  consider  the  evidence  put  forward. 
National authorities, or European, could then prosecute on the basis of  this list without 
having to mount a huge scientific case.  Furthermore, a pre-vetting system should be 
set-up, such as is the case of  the Novel Foods pre-market authorisation. 
There was no apparent support for using the Misleading Advertising Directive as this 
was deemed to be a too broad based Directive, which would not be suited to such a 
complex issue. 
3.  Ethical claims 
The issue of ethical claims has received little attention to date in Ireland.  There is no 
legal definition of  an ethical claim and no directly relevant legislation. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional and Health Claims 
Whilst there are no  voluntary codes of practice on health or nutritional claims,  the 
Irish Business Employers Confederation (IBEC) did initiate the  idea of a voluntary 
code for health claims, along the lines of the UK Joint Health Claim Initiative.  The 
IBEC hopes that the FSAI will support such self-regulation as the best way forward. 
However, the authorities feel that any self-regulation would have to be supplemented 
by legislative regulation.  IBEC's standpoint is  that the  situation is  not sufficiently 
clear for manufacturers and sees the US  positive list of claims as a viable option.  A 
Code Committee made-up  of food  nutritionists  as  well  as  industry and  consumer-
nominated representatives could add new claims subject to  review.  The burden of 
proof would be on the manufacturers to substantiate claims they wanted to add to the 
list. 
2.  Code of Advertising Standard for Ireland 
Of interest is  also  the Code of Advertising Standard for  Ireland, established by the 
independent self-regulatory body of the Advertising Standards Authority for Ireland 
(ASAI).  The Code covers all means of communication equally and there are specific 
rules  to  cover  health,  beauty,  slimming  and  environmental  claims.  The  code 
comprises  a  well-defined  complaint  procedure;  sanctions;  and  a  pre-publication 
vetting  service,  which  according to  the  ASAI,  was  an  invaluable  system  as  many 
possibly misleading claims were pre-vetted and dropped before ever being aired. 
Interestingly,  the  authorities  expressed  reservations  about  self-regulation  and 
voluntary instruments in the case of health claims.  They believe that the regulators 
should  be  involved,  as,  for  example,  the  ASAI  code  does  not  offer  sufficient 
consumer protection as it functions in a passive way, not going out of its way to verify 
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consumer awareness of the  complaint procedure, to  the  extent that it was  generally 
acknowledged that there is a lack of any real tradition of  making formal complaints in 
Ireland.  This is,  however, changing as  awareness of general food safety and health 
issues is  growing and,  hence, consumer demands for  controls will  be  made sooner 
rather than later. 
3.  Ethical Claims 
With  regard  to  ethical  claims,  there  are  two  types  of initiatives:  the  campaign by 
companies  and retailers  to  promote  good  commercial  practice/guaranteeing  certain 
minimum conditions for  workers and the  introduction of products trading under an 
ethical label. 
These company campaigns, which focus primarily on the banana, toy and supermarket 
sectors,  are highly commendable but there is  always  the  fear  that  the  members of 
these  codes  might use  them  as  a basis  of ethical  claims  in  promotional  activities. 
While the codes of  conduct issue is implicitly linked to the issue of  ethical claims, it is 
important  to  note  that  no  supermarket  or  company  in  Ireland  is  using  a  code  of 
conduct as  a basis to  make ethical claims about its products.  In fact,  there has been 
widespread reticence about using codes of conduct as  a marketing tool.  This  is  in 
contrast  to  fairtrade  labels,  which  have  been  used  as  the  basis  for  marketing 
campaigns and the use of  ethical claims. 
Products trading under a fair trade label have begun to gain a hold on the Irish market. 
The label is awarded by the Irish Fair Trade Network (IFTN), which is a member of a 
pan-European organisation, the Fairtrade Labelling Organisations International, which 
operates a comprehensive and thorough verification system of all  its  members.  The 
initiative is  still  in  the  early days  and,  thus,  there  is  no  widespread use  of ethical 
claims used by the manufacturers subscribed to the Fair Trade scheme.  To date, there 
have been no verification systems set up by the Irish authorities to check the claims in 
relation  to  products  bearing  the  fairtrade  label.  Nevertheless,  as  these  labels 
proliferate,  the  authorities  and  or  consumer  organisations  might  wish  for  an 
independent check as these products might be perceived as "better" by the consumer 
and,  therefore, provide unfair competition. For now,  Irish authorities seem satisfied 
with the control systems set up by the Fair trade Labelling organisations. 
D.  VERIFICATION SYSTEMS 
With  regard  to  the  issue of verification of claims,  the only criteria which exist are 
those set out in the  law on nutritional  claims and by the  Fair Trade organisations. 
However,  the  Irish  Medicines  Board  has  developed  criteria  for  medicinal  (health) 
claims, which require that a medical product should have a demonstrable therapeutic 
benefit.  However,  the  IMB  does  not  provide  further  information  on  how  a 
manufacturer would demonstrate a therapeutic benefit in order to substantiate a health 
claim. 
The practice of pre-vetting a claim is  hardly used,  although it is  starting in  a very 
informal way.  It  is  also  generally believed that with the proliferation of borderline 
products, pre-vetting will take place more often and would most probably be carried 
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voluntary,  non-binding  system,  offering no  guarantees,  is  being used  a  lot  by  the 
media and even some manufacturers. 
As to post-clearance, it is the eight regional Health Boards, which are responsible for 
the enforcement of  the nutritional claims.  They routinely carry out checks.  Also, the 
FSAI,  which  will  take  over  responsibility  for  many  areas  of labelling,  including 
nutritional claims plans to issue Guidance Notes to the eight Health Boards as part of 
their new service contracts.  These Guidance Notes should include one on nutritional 
labelling and might cover verification guidelines for nutritional claims.  The IMB  is 
responsible  for  medicinal  claims  and  would,  therefore,  in  theory  have  some 
responsibility for health claims. 
It is the regional health boards and the Director of  Consumer Affairs whose job it is to 
take legal action against manufacturers.  The burden of proof also lies with them to 
prove that on the balance of probability a claim is  false.  Penalties can range  from 
small fines  to  imprisonment.  In the past five  years, there have been no  legal cases 
relating to claims. 
E.  MEANS OF COMMUNICATION 
There is  no differences between the means of communication, although the Internet, 
whilst  not  proving to  be  an  actual  problem  yet,  was  nevertheless  earmarked  as  a 
potentially huge problem, with no apparent solution to combat misleading claims. 
F.  CONSUMER PROTECTION 
As  regards  the  issue  of whether the  situation  on  claims  was  leading  to  a  lack  of 
consumer protection, both the FSAI and the Consumers Association of Ireland (CAl), 
agreed that there was a definite lack of consumer awareness  about claims.  It was 
found that consumers bought products based on the claims made, rather than on the 
factual  ingredients  labelling.  Whilst  neither  could  provide  concrete  examples  of 
consumer complaints  against  claims  (in  fact  there  have  been none  brought  to  the 
Office  of the  Director of Consumer Affairs  in the  last 20  years)  both  agreed that 
something  needed  to  be  done.  The  former  recommended  that  the  European 
Commission  launch an  information campaign,  providing assistance  to  the  Member 
States.  The latter confirmed their wish to see further regulation on health claims, e.g., 
a positive or negative list and that the authorities, whether local, national or European, 
should be more active in prosecuting on misleading claims. 
G.  BARRIERS TO TRADE 
As to barriers to trade within the EU, this seems almost a non-issue in Ireland, save 
for the fact that there are concerns with regard to the UK Joint Health Claim Initiative, 
which  could  establish  different  norms  and/or  criteria  to  that  of EO/national  Irish 
implementing  legislation  and  in  effect,  establish  some  sort  of barrier  to  trade. 
Nevertheless, the  Irish appear to  support the  UK initiative.  There was  mention of 
trade problems with the US, where clearly their labelling/claims rules were far more 
liberal  and  could/will cause  problems with  foodstuffs  entering the market,  and  via 
Internet shopping. 
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H.  CASELAW 
No examples of  cases in public law have been found over the past five years, although 
in  the Self-Regulatory Code of the Advertising Standards Authority of Ireland 
(ASAI) have examined several cases. 
I.  STAKEHOLDER ANALYSIS 
In general, the Irish authorities tend to look to the UK for the lead on the regulation of 
many  issues,  such  as  nutritional,  health  and  ethical  claims,  for  instance.  Irish 
authorities, including industry and consumers, are closely following developments in 
the UK with the Joint Health Claims Initiative.  As this initiative develops, it is likely 
that  Irish  authorities  will  be  under  increasing  pressure  from  manufacturers  and 
consumers to regulate on the claims issue and perhaps to  follow the same path as the 
UK:_ 
In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  On nutritional claims, govemment/FSAI see no need for review. 
•  On health claims, they wish to  see clarification on borderline products (the Irish 
Medicines Board has already tried to  address the issue) and would welcome E U 
initiative regarding a positive list of health claims, based on sound science, and 
shifting  the  burden  of proof on  the  manufacturer.  However,  amending  the 
Misleading Advertising Directive was not seen as the feasible way forward. 
•  On ethical claims, there is no real position, although independent checks might be 
considered in due course. 
•  The  Irish  authorities  and  the  vanous  enforcement  bodies  admitted  a  lack  of 
resources  and,  therefore  would  welcome  increased  EU  involvement.  The 
proliferation of borderline products is a cause of concern, which led them to state 
that increased pre-vetting would be required. 
2.  Consumers 
•  Consumer  perception  of the  issue  is  only  starting  to  raise  questions.  The 
Consumers  Association of Ireland indicates  the  lack of consumer awareness  to 
labelling and claims and,  therefore,  calls upon the EU to  launch an information 
campaign to assist Member States. 
3.  Industry 
•  On  nutritional  claims,  the  Irish  Business  Employers  Confederation  believes 
legislation to be unclear and, therefore, request amending clarifications. 
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regulation, as  in the case of the UK JHCI, with a positive/generic list of allowed 
health claims, together with a Code Committee to regulate new innovative claims 
•  On  ethical  claims,  there  is  no  position,  except  for  those  organisations  which 
promote ethical trading and who are naturally in favour of  voluntary systems. 
In conclusion, we would surmise that the Irish situation could require EU action.  In 
particular with regard to health claims and the borderline cases as well as  additional 
clarification for manufacturers on nutritional  claims,  and  finally further  checks  and 
balances on the use of ethical codes and  claims to ensure that consumer safety and 
awareness is guaranteed. 
*** 
Pan  European study on nutritional, health and ethical claims- 1999.  260 II.  MEMBER STATE POLICY 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
a.  Irish definition 
In  Ireland,  the  Nutritional  Labelling  Directive  90/496  is  transposed  by the  Health 
(Nutritional Labelling for  Foodstuffs) Regulations,  Statutory Instrument No.  388  of 
1993  (Annex  1  ).  These Regulations provide the definition of a nutritional claim as 
"any representation and advertising message which states, suggests or implies that a 
foodstuff has particular nutrition properties due to the energy (calorific) value it 
provides, 
provides at a reduced or increased rate, or 
does not provide, 
and/or due to the nutrients it 
contains, 
contains in reduced or increased proportions, or 
does not contain." 
b.  EC definition 
The Irish definition is word for word the same definition as the Directive 90/496. 
c.  Codex Alimentarius definition 
The Irish definition is stricter in terms than the Codex definition. While both the Irish 
definition  and  the  Codex  allow  nutrient  content  claims,  comparative  claims,  and 
nutrient function claims, claims related to  dietary guidelines or healthy diets are not 
allowed by the Irish definition. 
2.  Health Claims 
a.  Irish definition 
Directive  791112  on  the  Labelling,  Presentation  and  Advertising  of Foodstuffs  is 
transposed  in  Ireland  by  the  S/I  82/205  European  Communities  (Labelling, 
Presentation & Advertising ofF  oodstuffs) Regulations, 1982 (attached in annex 2  ).
17 
17  Explanatory Note:  A number of different methods are used to  implement EU  directives in Ireland. 
Primary legislation is occasionally used but more generally secondary legislation (statutory instruments 
or S.I.s) is used. Secondary legislation can, in turn, take a number of  forms, including restating the text 
of the  Directive  in  the  S.l.  (as  is  the  case  with  SI  388/93  implementing  Directive  90/496)  or 
implementation of the directive "by reference" (as is  the case with SI  205/82). That is  to  say, the S.I. 
simply states (as does  Regulation  5(1)  of S.I.  205  of 1982)  that  "A  person  shall  not sell  foodstuffs 
unless they comply with the provisions of  the Council Directive [79/112/EEC] and these Regulations". 
The rest of the  S.I. consists of exemptions, derogations and ancillary provisions such as  the power to 
prosecute. 
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foodstuff are defined as 'attributing to that food the property of preventing, treating or 
curing a human disease'. The reference to a disease in a claim would put that claim in 
the health/medicinal category and  it  would thus  be  examined by the  Irish  Medical 
Board (IMB) (see further on the  IMB below). Claims should not mislead consumers 
and it prohibits such claims (in labelling, presentation or advertising) relating to  the 
prevention, treatment of cure of  disease. 
In Ireland, products containing vitamins and/or mineral ingredients, herbal ingredients 
and/or  amino  acids  and  whose  labelling  or  accompanying  or associated  literature 
make  any  preventative,  curative  or remedial  claim  or  whose  recommended  daily 
intake  exceeds  the  maximum  recommended  allowance  for  such  constituent  are 
regarded as  medical preparations and must receive approval as such to be placed on 
the market. 
b.  EC definition 
The Irish definition follows the EC definition word for word. 
3.  Ethical Claims 
There is no definition of an ethical claim in Irish legislation. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
In  Ireland,  the  Nutritional  Labelling  Directive  90/496  is  transposed  by the  Health 
(Nutritional Labelling for Foodstuffs) Regulations,  Statutory Instrument No.  388  of 
1993 (Annex I). 
The Health Regulation follows the wording of each article of the Directive, with the 
exception that Article 2 of the Directive is  not included i.e. "Subject to  paragraph 2, 
nutrition labelling shall be optional.  Where a nutrition claim appears on labelling, in 
presentation  or in  advertising,  with  the  exclusion  of generic  advertising,  nutrition 
labelling shall be compulsory". 
2.  Health Claims 
Directive  79/112  on  the  Labelling,  Presentation  and  Advertising  of Foodstuffs  is 
transposed  in  Ireland  by  the  S/I  82/205  European  Communities  (Labelling, 
Presentation &  Advertising of Foodstuffs) Regulations,  1982.  The wording of the 
Directive  is  followed  exactly  by  the  Irish  legislation,  with  a  health  claim  for  a 
foodstuff defined as  'attributing to  that food  the  property of preventing,  treating or 
curing a human disease'. 
3.  Ethical Claims 
There is no legislation in place dealing with ethical claims. 
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1.  Nutritional Claims 
As per Directive 90/496, SI  388 of 1993  states in Article 2 that ''these Regulations 
shall not apply to: 
(i)  natural  mineral  waters  or  other  waters  intended  for  human 
consumption, 
(ii)  diet integrators, or 
(iii)  food supplements." 
2.  Health Claims 
All health claims are banned in Ireland without exemptio11:, 
3.  Ethical Claims 
Not applicable as there is no Irish legislation on ethical claims. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
No  major policy changes  are  envisaged by the  Irish  government  on  the  Issue  of 
claims, although some minor developments will take place with: 
(a)  the transposition into Irish law of: 
•  Directive 97 /36/EC  amending  Directive  89/552/EEC on the  coordination of 
certain  provisions  laid  down  by law,  regulation  or administrative  action  in 
Member States concerning the pursuit of  television broadcasting activities, and 
•  Directive 97/4/EC amendment Directive 79/112/EEC on the approximation of 
the  laws  of  Member  States  relating  to  the  labelling,  presentation  and 
advertising of  foodstuffs; and 
(b) The FSAI, which is still in the process of  being formally set-up, will issue service 
contracts  to  the  eight regional  Health Boards in  Ireland.  As  part of these service 
contracts, the FSAI plans to issue Guidance Notes on a number of  issues, among them 
nutritional  labelling.  The  FSAI  official  mentioned  that  they  intended  to  use  the 
Swedish guidance note as a model. 
1.  Nutritional Claims 
It is  generally felt by Irish administrators that the legislation on nutritional claims is 
quite clear and they have found no problems in relation to nutritional claims. 
Officials we spoke to expressed their concern that this study would lead to the setting 
up of another working group, this time on the issue of health claims, as had happened 
following the study on environmental claims.  These working groups,  involving all 
interested  parties  such  as  Member  States,  consumers,  NGOs,  industry,  were 
ineffective talking shops and concern was expressed about their proliferation.  Groups 
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balanced by inter-service consultations within the European Commission. 
However,  the  industry  representatives  from  the  Irish  Business  Employers 
Confederation felt that the regulation of nutritional claims was far from clear.  While 
nutritional  claims  are  allowed,  there  are  no  guidelines  for  Irish  industry  on  what 
exactly could be used.  As a result, a lot of misinformation was being given out by 
many  manufacturers  on  the  subject  of nutrients,  such  as  'reduced  fat'  or  'lower 
cholesterol' comparisons. IBEC was aware that the European Breakfast Association 
had produced some guidelines for nutritional claims on cereal products. 
As stated above, government officials feel that legislation on nutritional claims is well 
defined and well implemented, with sufficient protection of  the consumer. The official 
from the Food Safety Authority of  Ireland (FSAI) agreed with this. 
As  Ireland follows  strictly EC  legislation on nutritional claims,  there was no  trade 
barriers created with respect to other EU countries. There may, however, be problems 
in relation to the US. So far,  the Irish government has not seen any serious complaint 
made on this issue. There has, however, been some limited lobbying from a number of 
US  and EU cereal companies to  allow a generic list of health claims to  be used in 
Ireland. 
2.  Health Claims 
Health claims, as defined above, are banned in  Ireland.  Nevertheless, Irish officials 
recognised that  there  may be claims being used on  labelling and  in  advertising in 
Ireland that may constitute health claims.  However, they have neither the human nor 
financial resources to bring manufacturers to court. 
The Irish Medicines Board (IMB) 
18
,  on the other hand, has looked at how to address 
health claims and the many so-called 'borderline' products on the market in Ireland. 
To clarify the situation regarding these products, the IMB issued a set of guidelines on 
the definition of  a medicinal product (attached in annex 3).
19 
These  guidelines  describe  IMB  policy  in  categorisation of medicinal  products  for 
human  use.  They  address  those  products,  which  occupy  the  'borderline'  position 
between  medicines  and  nutritional  products,  between  medicines  and  cosmetic 
substances between medicines and medical devices and between medicines and so-
called 'lifestyle' products. 
18  The Irish Medicines Board was established by the Irish Medicines Board Act in  1995. The IMB is 
the competent authority for the licensing and supervision of human and veterinary medicines in Ireland. 
The  mission  of the  1MB  is  to  protect  and  enhance  public  health  and  animal  health  through  the 
regulation  of  human  and  veterinary  medicinal  products.  The  1MB  regulates  the  manufacture, 
importation, distribution and supply of  medicinal products for human use in Ireland. Under the terms of 
the Irish Medicines Board Act 1995, anyone who contravenes a regulation made by the Minister under 
the Act, is liable to fines or to a prison term, as appropriate. The 1MB regulates the licensing and sale of 
medicinal products for human use in Ireland by means of the medicinal Products (Licensing and Sale) 
Regulations (S.I. 142 of 1998) (Regulations) and relevant EC Directives. 
19 The IMB stresses that these guidelines should not be assumed to be a definition of  the law in this 
area and that they should be read in conjunction wit the various relevant Directives and Regulations. 
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The IMB states that the interests of  medicine users should be protected in a number of 
areas,  in  particular  regarding  claims.  The  guidelines  state  that  'there  should  be 
demonstrable  therapeutic  benefit."  If a medicinal  claim  is  made,  the  consumer is 
entitled, within reason, to  expect a benefit and the review process should protect the 
consumer, as far as  possible, from  products which do  not offer a potential for  such 
benefit. (Page 4) 
With this  in mind, the  IMB  goes  on to  define a medicinal product.  As  part of the 
presentation,  the  IMB  examines  the  totality of the  product  including  products  for 
which  (explicitly or implicitly)  claim to  cure,  alleviate  or prevent disease.  These 
products will be considered by the IMB as medicinal products.  Any particular words 
or phrases, which imply such a claim, will be taken into account (page 5). 
The  IMB  then provides a  list,  not intending to be exhaustive, of words  or phrases 
which  could  imply  a  claim:  cures,  heals,  treats,  restores,  prevents,  clears,  stops, 
protects,  helps  with,  traditionally  used  for,  strengthens  the  immune  system,  calm, 
helps maintain normal water balance. 
The  IMB  takes  into  account  the  ECJ  judgement  from  1991  (OJ  1991  C219,  91 
attached in annex 4) which states that a product which is recommended or described 
as  having preventive or curative properties  is  a medicinal  product  ... even if it is 
generally considered as  a foodstuff and even if it has no known therapeutic effect in 
the present state of  scientific knowledge. 
The  IMB  in  its  guidelines  addresses  'borderline'  products  in  four particular areas, 
namely cosmetic products, foods, herbals and slimming products.  In relation to foods,· 
the  IMB  states  that  clearly  most  foods  are  not  medicinal  products.  There  are, 
however,  certain  products  that  may  be  classified  as  medicinal  products  even  in 
circumstances where they may be described by the manufacturers as  'foods' or 'food 
supplements'.  In  this  regard,  the  IMB  clearly  has  in  mind  products  which  are 
presented in  a form usually associated with medicinal products, i.e.  capsules, tablets 
or certain liquids, rather than more regular foodstuffs.  The 1MB's position on those 
products  is  nonetheless  relevant.  For the  subcategories  of foods  which  the  IMB 
examines,  products  containing  vitamins  and/or  minerals,  and  products  containing 
selected amino acids, it states that these preparations are considered to  be medicinal 
products when their labelling or associated literature makes any preventative, curative 
or remedial claim (page I 0). 
Having thus defined a medicinal product, the IMB states clearly that unless a specific 
exemption  has  been  granted,  medicinal  products  may not  be  marketed  without  a 
current  product  authorisation  in  accordance  with  the  1998  regulations.  It is  the 
responsibility of the person or organisation marketing such a product to  ensure that 
the relevant legislation is complied with.  Failure to comply with this legislation may 
result in prosecution, with liability for fines or prison terms (page 16). 
After discussions with the Food Safety Authority of Ireland (FSAI)
20
,  we gather that 
such guidelines on borderline products should be issued at EU level under Directive 
20 The Food Safety Authority of Ireland came into being in January 1999. It is a statutory, independent 
and science-based body, overseeing all functions relating to  the regulation of the food industry. In July 
1998, the Food Safety Authority of Ireland Act was passed, providing for the FSAl to take over all the 
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be  developed at EU level.  A positive list of claims should be made, rather than a 
nebulous set of guidelines or definitions.  That way the burden of proof would be on 
any manufacturer who wanted to  add a claim: to  the list and a Scientific Committee 
would  consider  the  evidence  put  forward. .  National  Authorities  (or  European 
authorities) could then prosecute on the basis of this list without having to  mount a 
huge scientific case. 
It was suggested that the Novel Foods Directive, which for the first time provided for 
a pre-market assessment for products not significantly used in the EU, might be a way 
forward to pre-vet claims. 
The Department of Enterprise, Trade and Employment suggested that the Misleading 
Advertising Directive would not be the best way forward on the health claims issue. 
He felt that the issue was too  complex for a broad-based Directive such as  this and 
that it would be better dealt with sectorally. 
The  Food  Safety  Authority  of Ireland  (FSAI)  felt  that  manufacturers  should  be 
allowed to  give information about certain properties of their product, specifically on 
the issue of trans-fatty acids. Manufactures, the FSAI felt,  should be allowed to  give 
information to  consumer about their benefits.  There also seemed to be strong views 
about the need to be clearer rules on health claims, such as providing a positive list of 
claims firmly based on sound science, as developed by the FDA in the US.  The real 
benefit of such a list would be to place the burden of  proof with the manufacturer who 
wanted to  add a claim to  the list.  It was suggested that an EU Scientific Committee 
could be responsible for adjudicating on claims. 
The DETE and the Department of Health did not feel that there was any real lack of 
consumer protection in relation to  health claims.  They pointed to  the  lack of any 
consumer complaints against claims.  There have been no  complaints  on  the  issue 
over the 20  years of the existence of the Office of the Director of Consumer Affairs 
(ODCA) 
21
.  In  any case,  Irish government officials  felt  that Irish consumers were 
regulatory functions of existing authorities (relevant government Departments, Health Boards,  Local 
Authorities etc.) The principle function  of the  FSAI  is  take all  reasonable steps  to  ensure that food 
produced,  distributed  or marketed  in  the  Republic  meets  the  highest  standards  of food  safety  and 
hygiene reasonably available. The FSAI  also  ensures that food  complies with legal requirements,  or 
where appropriate,  with recognised codes of good practice. The FSAI  comes under the aegis  of the 
Minister for Health and Children and currently has a board of  five. It also have a 15  member Scientific 
Committee that assists and advises the Board. 
In  August  1999  the  new  Food  Safety  Law  came  into  force  and  the  FSAI  formally  took  over 
responsibility for 48  food  law enforcement agencies, including the  regional Health Boards.  The new 
Authority  will  operate  on  the  national  food  safety  compliance  programme  by  means  of service 
contracts  with  these  agencies.  In  future,  these  agencies  will  act  as  agents  of the  Authority  in  the 
performance of their contracts and the Authority will publish details of these contracts. The contracts 
will come into effect by the end of 1999 and will apply for 3  V:!  years with reviews at the end of each 
year.  The  FSAI  also  acts  as  an  information  resource,  operating a  Food Safety helpline  and  a  Food 
Safety  Information  Centre.  More  information  about  the  FSAI,  as  well  as  some  of the  information 
brochures it has produced, is attached in annex 14. 
21  The current Director of Consumer Affairs is  Carmel Foley, appointed in  November 1998. The post 
was created in  1978 to make criminal law prosecutions against offences of making false or misleading 
statements  about  goods  or services,  a  remit  which  has  now  been  extended  to  cover  many  other 
consumer rights.  The DCA now has  responsibilities for over 60  regulatory measures. The  Director's 
office also takes care of  small consumer claims (where the consumer docs not necessarily have to usc a 
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Standards Authority (see below) also shared this view. 
The Food Safety Authority of Ireland (FSAI), however, felt that there was a lack of 
protection.  This was due to the lack of  consumer information about claims.  This is in 
fact one of  the jobs of  the new FSAI to increase consumer awareness about claims and 
to  launch an information campaign on the issue.  It  was suggested that this was an 
area where the European Commission could be of great assistance to  Member State 
governments, by providing materials to help create awareness about claims. 
The Consumers Association of  Ireland (CAl) also feel that there is a lack of consumer 
protection on health claims, as they pointed out that most consumers base their buying 
decisions on the claims made by producers rather than the factual information on the 
product label. 
The CAl feels that a positive and negative list of health claims would be a good way 
to  address the lack of consumer protection.  According to  the  CAl, the positive list 
must  have  strict  definitions  and  criteria  for  making  these  claims.  An  expert 
committee should have responsibility for advising on,  and monitoring,  the issue of 
these claims. 
It  was  suggested  that  the  burden  of  proof  should  not  be  left  solely  up  to 
manufacturers,  as  substantiating information they put forward  is  often not reliable. 
The CAl believes that the  authorities, Irish or European, should take a more active 
rule in prosecuting on misleading health claims.  Overall, the CAl called for a new 
Directive, specifically dealing with both nutrition and health. 
Again,  as  Irish  legislation  follows  EC  legislation  on  health  claims,  there  are  no 
barriers  to  trade  created  by  the  fact  that  Ireland  does  not  allow  health  claims. 
Government  officials  had  no  examples  from  industry  about  barriers  to  trade. 
However,  officials pointed out that should,  for  instance,  the  UK set up  guidelines, 
referring to the Joint Health Claims Initiative (see UK Country Section), there is  no 
doubt that this might cause a legal barrier to  trade.  In  such a case, Irish legislation 
would most likely be adapted to follow UK rules. 
3.  Ethical Claims 
The issue of ethical claims is  not a very important one for the Irish authorities we 
spoke to.  There has been little response from the Irish government to NGO and Trade 
Union activity on  the  issue of codes of conduct for multinational  companies or to 
initiatives such as the Fairtrade label. 
The  Irish  government  does,  however,  provide  indirectly  some  funding  for  NGO 
campaigns through the National Committee for Development Education. This funding 
is  given  on  the  basis  of an  annual  application  round  for  grants  to  be  used  for 
development education (i.e. education about "Third World" issues).  The total amount 
allocated is  about IEP  1 million.  The  total  amount allocated to  work on codes  of 
solicitor  or  other  legal  advisor  to  seck  redress)  and  runs  a  Consumer  Helpline.  The  Director  of 
Consumer Affairs (DCA) is  independent from the government but her office is staffed by government 
officials. The DCA  's Annual Report for 1998 is attached in annex 15. 
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amounted to about IEP 3,000 in 1998. An additional IEP 40,000-50,000 was allocated 
to three of  four organisations working on 'fair trade'. 
At  a  recent  conference  entitled  ('Ethical  Trading  Initiative - Ireland'  on  23  April 
1999)  the  Minister  for  Labour,  Mr.  Tom  Kitt,  welcomed  initiatives  to  increase 
awareness about the problem of working conditions and expressed the hope that Irish 
companies would adopt codes of conduct.  However, he did not mention any role for 
the Irish government in this process (speech in annex 5). 
III.  VOLUNTARY INSTRUMENTS AND OTHER PRACTICES 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Code of Advertising Standards for Ireland 
The main voluntary instrument in place in Ireland dealing with any type of claims is 
the  Code of Advertising Standards for  Ireland  of the Advertising  Standards 
Authority for Ireland (ASAI).  It is the independent self-regulatory body set up and 
financed by the advertising industry.  The rules are set out in the Code of Advertising 
Standards and the Code of Sales Promotion Practice, drawn up by the Board of ASAI 
following consultation with relevant interests including consumer representatives and 
Government Departments (a copy of  the ASAI is attached in annex 6). 
The Code of Advertising Standards applies to  commercial advertisements, i.e.  those 
which promote the sale of  a product or service.  The Code defines an advertisement as 
a paid-for communication addressed to the public or a section of  it.  It is characteristic 
of an advertisement that the advertiser engages media to  communicate a commercial 
message.  In effect the ASAI code covers all means of  communication equally. 
The Code contains a set of General Rules and these are supplemented by additional 
requirements  for  particular  products  or  sectors.  These  sectors  include  health  and 
beauty, slimming and environmental claims. 
The complaints procedure against any advertisement is  as  follows:  The complaint is 
evaluated initially by the  Secretariat to  determine whether it  is  within the terms of 
reference of  ASAI and whether there is a case for investigation.  Where there is a case 
to  answer,  the  advertiser or promoter (or the  agency  involved)  is  informed of the 
complaint  and  invited  to  comment.  In  the  light  of the  response,  the  Secretariat 
prepares  a recommendation to  the  Complaints Committee and  sends  a  copy to  the 
complainant and the advertiser who have an opportunity to express further views in 
the matter before adjudication. 
The  ASAI  Complaints  Committee  decides  whether  or  not  Code  rules  have  been 
contravened.  Details  of the  case,  including  the  names  of the  advertiser  and  the 
advertising agency involved, together with the Committee's adjudication, are set out 
in a Case Report which is issued to the parties involved and released for publication. 
An  advertisement  or  promotion  which  breaks  the  rules  must  be  withdrawn  or 
promptly amended. 
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in  the advertising business and eight independent members including four nominees 
of  the Director of  Consumer Affairs. 
Publication of Case Reports, including names of advertisers and agencies involved, is 
an  important  element  of the  self-regulatory  system.  An  advertisement  or  sales 
promotion which breaks  the  rules  must be withdrawn or amended  and media will 
refuse to publish an advertisement which fails to conform to Code requirements. 
A member who does not accept ASAI decisions may be disciplined by the Board and 
may be subject to penalties including fines and/or suspension of membership.  These 
penalties  are  rarely  invoked;  there  is  a  strong  commitment  to  the  self-regulatory 
system  throughout  the  advertising  business  and  ASAI  adjudications  are  invariably 
accepted and implemented. 
There also exists a pre-publication vetting service, which is available free of charge. 
The advice given is  not binding and there is no  guarantee that there will not be any 
problems with the advertisement or campaign when run. 
2.  Irish Business Employers Confederation 
In Ireland there has been some attempt by industry to start up an initiative along the 
lines of  the Joint Health Claims Initiative in the UK.  In June 1998, the Irish Business 
Employers Confederation (IBEC) held a meeting of  interested parties on the issue of 
claims.  It  included  representatives  from  Goldenvale  (an  Irish  manufacturer  of 
margarine  spread),  Kellogg's,  Nestle,  as  well  as  nutritionists  from  the  FSAI, 
government officials,  and  a  representative  from  the  Director of Consumer Affairs. 
Since that  meeting little was done,  due  to  a  lack of time  and  resources,  but IBEC 
mentioned that it hoped to take the issue up again over the coming months.  IBEC is 
hoping that the government authorities, such as the FSAI, will support them in their 
moves towards self-regulation. 
IBEC's approach to health claims is that they have found that consumers want to be 
given the type of information that claims provide.  That is to say, consumers want a 
link to be made between a product and the health effects it can have.  Simply listing 
the ingredients of a product means very little to most consumers.  In that context, Irish 
industry feels that it should be allowed to make health claims. 
IBEC's position is  that companies need clear guidelines on what claims are and on 
what is not allowed.  IBEC also suggests a list of positive claims, as used in the US. 
Any new claims to  be added to  that list would then be subject to  peer review,  for 
example, by a Code Committee.  This Committee should be science-based, made up 
of food  nutritionists,  as  well  as  industry  and  consumer-nominated representatives. 
The  burden  of proof would  be  on  the  manufacturers  to  substantiate  claims  they 
wanted to add to the list. 
IBEC  is  closely watching developments in  the Joint Health Claims Initiative in  the 
UK and is  very positive about that approach.  IBEC seemed more in  favour of the 
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CIAA on claims. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
In  Section 3.10 of the  ASAI Code states  in  relation to  vitamins,  mineral  and food 
supplements that "An advertisement should not suggest or imply that a well balanced 
diets  needs  to  be  augmented  by  vitamins  or  minerals  on  a  regular  basis. 
Advertisements  should  not  imply  that  supplements  will  guard  against  dietary 
deficiency,  elevate mood  or enhance  performance  and  supplements  should  not  be 
promoted as a substitute for a healthy diet".  It goes on" Although there may be some 
depletion of vitamin stores during illness, an advertisement should not suggest that the 
replacement of  such vitamins will influence the speed or extent of  recovery". 
2.  Health Claims 
The  ASAI  Code contains  a  Section  3  on  Health  and  Beauty,  which  refers  to  the 
Medicinal Preparations (Advertising) Regulations,  1993  regarding the advertising of 
medical preparations.  The Code states that '" claims about health and beauty products 
and treatments should be  backed by substantiation including the results of practical 
trials  on  human  subjects  of sufficient  rigour,  design  and  execution  as  to  warrant 
general acceptance of the results".  Furthermore, part 3.5 of the Code states that '"An 
advertisement for a health or beauty product or treatment .... Should not imply words, 
phrases or illustrations that claim or imply the cure of any ailment, disability, illness 
or disease, as distinct from the alleviation or relief of symptoms; .. should not suggest 
that a product or treatment will achieve success in every case or that the outcome can 
be other than dependent on the particular circumstances of  the individual person". 
3.  Ethical Claims 
The ASAI Code makes no special reference to ethical claims, but it is accepted that 
such claims would fall under verification provisions of  the Code. 
C.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
The Office of the Director of Consumer Affairs (ODCA) is responsible for approving 
self-regulatory codes. Besides the ASAI Code on Advertising, other Codes include the 
Code  of Standards  of Advertising  for  Proprietary  Home  Medicines  of the  Irish 
Pharmaceutical Healthcare Association. 
In  general,  it  is  important  to  note  that  government  officials  expressed  some 
reservations about self-regulation and voluntary instrument.  They felt that the AS AI'  s 
code  worked  because  advertising  was  a  very  special  industry.  However,  with 
something as serious as food safety and human health, they felt that public regulators 
should  be  involved.  This  is  not  an  issue  that  could  be  regulated  without  real 
government  involvement.  Officials  had  had  some negative  experiences  with other 
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self-regulatory  codes,  which  they  felt  were  not  being  adhered  to  by  industry. 
Insurance and infant food codes were two examples. 
This view was  shared by the FSAI,  which felt  that the  ASAI did not in  fact  offer 
enough consumer protection as it functions passively, i.e. questions are brought to the 
AS AI'  s attention rather than the ASAI actively monitoring advertising.  Thus, he felt 
that the ASAI may be missing certain misleading advertising. 
The  Consumers  Association  felt  that  while  the  ASAI  Code was  not  ideal,  it  was 
perhaps the best way to regulate the advertising sector. 
E.  OTHER PRACICES 
In  Ireland, there are currently two types of initiatives related to  the  issue of ethical 
claims.  The first is  the campaign for multinational companies and retailers to  adopt 
codes  of conduct and  the  second  is  the  introduction of products  trading  under  an 
ethical label into the Irish retail sector. 
1.  Codes of  Conduct 
Current campaigns for companies to adopt codes of  conduct are relevant to the claims 
issue, as codes of conduct are the first step towards making manufacturers and, in tum 
consumers more aware of ethical questions.  Once codes of  conduct are adopted by a 
manufacturer or a retailer,  they might then be used as  the basis for  advertising and 
promotion, leading to ethical claims. 
The campaign for the adoption of codes of conduct in Ireland is  mainly focussed on 
three sectors: (i) supermarkets, (ii) the banana trade and (iii) the toy sector. 
a.  Supermarkets 
Regarding  supermarkets,  this  initiative  has  mainly  come  about  following  similar 
campaigns in the  UK.  As  UK supermarkets, such as Tesco, which also operates in 
Ireland, have begun to  adopt codes of conduct, it is  expected that Irish supermarkets 
will also follow suit. 
While many initiatives discourage supermarkets from  using their involvement with 
codes of conduct as a promotional issue, as  retailers make a greater commitment to 
ethical  trade  and  codes  of conduct,  they  will  want  to  use  this  as  a  competitive 
advantage.  Supermarkets might then  use  Codes of Conduct as  the  basis of ethical 
claims in promotional activities. 
The campaign in Ireland has been focused on supermarkets' own brands, which have 
a large role in the Irish retail sector, and trying to make supermarkets responsible for 
the conditions under which they are produced. 
However,  in  the  Irish  retail  sector,  there  is  very  little  direct  buying.  Irish 
supermarkets purchase products through the large European wholesale buying groups. 
This situation is unlike the UK, where there is a lot of direct buying (i.e. supermarket 
buys direct from producer/grower).  Thus, it has been argued that this  lack of direct 
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UK  counterparts  (see  'Who  profit?  Who  pays?'  an  analysis  of the  role  of Irish 
supermarket  in  ethical  trade  produced  by  Christian  Aid  Ireland,  Development 
Education for Youth (DEFY) and the Irish Fair Trade Network in  annex 7).  Thus, 
Christian Aid in its report, states that 'consumer concern' must be harnessed so as  'to 
provide the grocery retailers with the ammunition to put pressure upon their suppliers' 
(page  26,  'Who profit? Who  pays?' an  analysis of the role of Irish supermarket in 
ethical trade produced by Christian Aid Ireland).  Thus, there have been a number of 
awareness-building campaigns aimed at the Irish consumer on the  issue of working 
conditions.  One  example  has  been  'The  Great  Supermarket  Challenge'  aimed  at 
raising awareness among school children, run by Christian Aid Ireland and DEFY (in 
annex 8). 
It has  also,  however,  been pointed out  that the  lack of direct  involvement of Irish 
supermarket chains may make it easier for them to adopt codes of  conduct. 
To facilitate the adoption of codes, Christian Aid, along with its international partners 
the Fairtrade Foundations, the International Union of Food and Agricultural Workers, 
as  well  as  Development  Education  for  Youth  (DEFY)  and  the  Irish  Fair  Trade 
Network in  Ireland, have drawn-up a model code of practice based on ILO  Labour 
Conventions, which they want adopted by Irish supermarkets (in annex 9).  This Code 
of  Practice calling on suppliers and retailers to  guarantee certain minimum conditions 
for workers producing the products they supply and sell. 
So  far,  Irish supermarkets have shown a strong interest in the issue, one or two  are 
considering the SA8000 standard, though none have as yet directly adopted a code of 
conduct.  Tesco  and  Marks  and Spencer have  adopted the  British  Ethical  Trading 
Initiative Code, and account for more than 20% of the Irish retail grocery trade. 
As part of  the campaign for the adoption of  codes by supermarkets, an Ethical Trading 
Seminar was organised in the European Parliament Office on 23  April 1999, with the 
involvement  of  Irish  NGOs,  government  officials,  politicians,  supermarket 
representatives,  industry  representatives,  and  Trade  Unions  (see  attendance  list  in 
annex  10).  The aim of the seminar was to  provide information on codes of conduct, 
what  international  standards  and  what  independent  verification  systems  exist, 
international  best practice  in  codes of conduct and  to  exchange  ideas  on  codes  in 
Ireland. 
b.  Banana Trade 
The reasons  for the  Irish interest in  the banana trade  is  that Fyffes is  an Irish fruit 
importing company, with 30 per cent of  their sales in bananas and a strong presence in 
developing countries.  As a result of growing pressure from both the UK and Ireland, 
Fyffes signed up to the UK Banana Industry Code of Best Practice along with other 
banana importing companies, such as  Del Monte and Geest Bananas (see annex  11). 
This Code commits its signatories to the development of a safe, financially viable and 
environmentally sustainable banana industry. It has not, up until now, been used as a 
selling point by the Banana Industry, though may be so used in the future. 
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c.  Toy Industry 
The third sector that has attracted interest is the toy sector.  In the run up to Christmas 
1998,  an  'Ethical  Shopping  Campaign'  was  launched  by Tr6caire,  an  Irish  NGO 
operating  in  the  third  world,  and  the  Irish  Congress  of Trade  Unions  to  urge 
multinationals  to  adopt  and  implement  codes  of conduct  for  their  suppliers  and 
subcontractors. The campaign was targeted at Mattei and Hasbro in particular. 
While the codes of  conduct issue is implicitly linked to the issue of ethical claims, it is 
important  to  note  that  no  supermarket  or company  in  Ireland  is  using  a  code  of 
conduct as  a basis to  make ethical claims about its products. In fact,  there has been 
widespread  reticence  about using  codes of conduct as  a marketing tool.  This  is  in 
contrast  to  fairtrade  labels,  which  have  been  used  as  the  basis  for  marketing 
campaigns and the use of  ethical claims. 
2.  Fair Trade 
Products trading under a fair trade label have begun to gain a hold on the Irish market, 
albeit a small but rising percentage of  the market.  It is expected that total sales of  fair 
trade coffee will amount to about IEP 500,000 (max.) (  634,869 euro) in 1999.  This is 
less than 1  o/o of the market, but comes from a figure of  almost zero in late 1996, when 
the first Irish fair trade labelled product (Bewley's Direct) was launched.  Most of this 
so  far is  in  the catering market, and retail sales are only now beginning to  take off. 
This share compares to an expected average EU market share of about 3o/o in the next 
two to three years, according to the Irish Fair Trade Network (IFTN). 
In Ireland, this label (of the same design as the UK) is awarded by the Irish Fair Trade 
Network  (IFTN),  which  is  made  up  of development  agencies,  research  groups, 
alternative trading organisations and other individuals. 
The  IFTN  is  a  member  of .FLO  - Fairtrade  Labelling Organisations  International, 
based in Bonn, which operates a common verification system for all its members (see 
brochure  in  annex  12).  This  involves a contract for  the  importers,  who  must buy 
either direct from a list of approved coffee farmers or, where quantities are small, as 
in the Irish case, from a list of  approved importers.  This whole arrangement is heavily 
audited and cross-checked to make sure that the amount supplied exactly matches the 
amount ordered, sold,  etc.  Order numbers are  cross-checked, etc.  This  is  seen as 
critical to credibility of  the scheme. 
In Ireland, Bewleys, an Irish coffee company, was the first to be awarded the Fairtrade 
label for  its  fairtrade brand, Bewley's Direct.  Two other coffee companies,  Robert 
Roberts  and  Johnson  Brothers  (in Northern  Ireland)  as  well  as  a  number of Irish 
supermarket chains, such as  Superquinn, Tesco and Dunnes Stores, now also offer a 
brand with the fairtrade label.  Bewley's Direct has in fact taken a strong hold on the 
catering  market  in  Ireland,  supplying  coffee  for  many  universities  and  large 
compames. 
Bewley's Direct has been marketed and advertised to  a certain extent in Ireland.  In 
this advertising, ethical claims have been made.  However, in general, fairtrade brands 
lack the marketing budget of the other larger brands of  coffee and so often find it hard 
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through publicity in Irish newspapers (see article by Mary Russell in the Irish Times, 
19 January 1999 in annex 13).  Thus, there is  no widespread use of ethical claims by 
these brands. 
In Ireland, there have been no verification systems set up by the Irish government or 
any other independent bodies to check the claims made in relation to products bearing 
the fairtrade label. There have been no moves by the Irish government to  intervene in 
the FLO verification system in place. 
F.  REMARKS  ABOUT  BAIDUERS  TO  TRADE  AND  LACK  OF 
CONSUMER PROTECTION 
1.  Barriers to Trade 
In  terms  of barriers  to  trade,  the  ASAI  felt  that  all  advertising  restrictions  were 
barriers  (such  as  commercial  communications  differences  etc).  However,  on 
advertising, officials at the ASAI did not know of any case where an advertisement 
was allowed in one  country but not in  another.  Of course,  there  were  differences 
regarding taste  and  decency,  and  this  is  where  self-regulation adds  value,  but  not 
generally on health claims.  In this respect, Ireland is at the tail-end of  any advertising 
vetting, i.e. an advertisement is run somewhere else before it is used in Ireland. 
2.  Lack of Consumer Protection 
The ASAI  felt  strongly that  its  code offered full  consumer protection.  That  said, 
officials from  the  government and the FSAI expressed some reservations about the 
AS AI' s method of vetting,  which they  suggested may be too  passive  and may  be 
allowing some claims to be used in advertising that should not be. 
It was  also  suggested that  there  is  a  lack of consumer complaints  on  the  issue  of 
claims due  to  the  lack of consumer awareness of complaints processes such as  the 
ASAI.  If consumers  did  have  questions  or  complaints  about claims  they may not 
know where to bring them.  Some advertisers we spoke to put this down to a lack of 
any  real  tradition  of  making  formal  complaints  in  Ireland.  The  Consumers 
Association agreed with this assessment. 
In  general, the ASAI feels that under the current system, both the national legislation 
and the ASAI code work effectively, and thus does not need to be further regulated at 
EU  level.  If there  had  to  be  legislation,  the  ASAI  would  prefer  to  see  general 
principles  or a  general  framework  rather  than  any  kind  of list  of claims.  It was 
strongly  felt  that  the  EU  should  look  more  at  what  could  be  done  through  self-
regulation  before trying to  bring in  legislation.  Self-regulation had  a  lot  to  offer, 
particularly as it was cheaper, and thus more accessible.  It was also more flexible for 
the consumer to change and modify than legislation.  The ASAI suggested that there 
was no better option on advertising than self-regulation. 
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IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
There  is  no  list  of criteria  for  substantiating  nutritional  claims,  other  than  the 
information provided in the Nutritional Labelling Directive 90/496, as transposed by 
the  Health  (Nutritional  Labelling for  Foodstuffs)  Regulations,  Statutory Instrument 
No. 388 of 1993. 
2.  Health Claims 
There is no list of  criteria for substantiating health claims in Irish legislation. 
The Irish Medicines Board states that any product making a health claim would be 
seen as  a medicinal product and would require 1MB authorisation for use in Ireland. 
One  of the  1MB's  requirements  of a  medicinal  product  is  that  there  should  be  a 
demonstrable therapeutic benefit.  If  a medicinal or health claim is made the consumer 
is  entitled,  within  reason,  to  expect a  benefit  and  the  review  process  of the  1MB 
should protect the consumer, so far as possible, from products which do  not offer a 
potential for such benefit. 
The IMB does not give any further detail on how a manufacturer would demonstrate a 
therapeutic benefit in order to substantiate a health claim. 
3.  Ethical Claims 
There is no list of  criteria for substantiating ethical claims in Irish legislation. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
a.  Nutritional Claims 
No  formal  guidelines or rules have been produced for  the pre-vetting of nutritional 
claims on labelling or advertising at government level.  Any pre-vetting that does take 
place at government level is purely informal. 
b.  Health Claims 
As for  nutritional claims, no  formal  guidelines  or rules  exist for  the  pre-vetting of 
health claims.  Again, any vetting that does take place is on an informal basis. 
It was suggested, however, that with the proliferation of borderline products on the 
market,  the  government  would  be  called  upon  more  and  more  often  to  give  an 
opmwn. 
The FSAI felt that this pre-vetting role may fall more and more to the FSAI. 
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however, no  formal  guidelines or rules  set down by the ASAI for the pre-vetting of 
claims.  The pre-vetting is  entirely voluntary and non-binding.  The ASAI offers no 
guarantee that there will be no problems with any advertisement after it passes pre-
vetting.  Most of the ASAI's pre-vetting questions come from the media (newspapers, 
broadcasters etc), though some manufactures do come to the ASAI first. 
The  advertising  industry  uses  the  ASAI  a  lot,  as  the  industry must  be  seen  as  a 
responsible industry as  advertising is  based entirely on consumer trust.  Generally, 
pre-vetting lasts one day,  as  the ASAI was aware that advertisers were under time 
pressure.  The ASAI is currently trying to raise awareness of its activities among the 
media, industry and consumers.  This was beginning to  have an effect, as  the ASAI 
pre-vetting facility is being used more and more by manufacturers.  It was suggested 
that this was due to increased awareness of the ASAI rather than manufacturers trying 
out more controversial advertisements. 
The  Consumers  Association  of Ireland  mentioned  that  some  manufacturers  had 
approached them to give endorsement to certain products, which they refuse to do, as 
it is against their policy. 
c.  Ethical Claims 
There  is  no  experience  in  the  Irish  government  of any  pre-vetting,  formally  or 
informally, of  ethical claims. 
2.  Post-Clearance Rules/ Guidelines 
a.  Nutritional Claims 
The verification of a nutritional claim is the responsibility of the eight regional Health 
Boards of  Ireland, who enforce S.l. 388/93.  No guidelines have been produced by the 
Department of Health or the Health Boards on their system of verifying nutritional 
claims,  other than  the  information  provided  in  the  Nutritional  Labelling  Directive 
90/496,  as  transposed  by  the  Health  (Nutritional  Labelling  for  Foodstuffs) 
Regulations,  Statutory  Instrument  No.  388  of 1993.  The  Health  Boards  use  the 
control systems in  place under the general Health Regulations to  control nutritional 
claims.  These  involve  routine  and  ad  hoc  inspections  by  officers  of the  Health 
Boards. 
As  already mentioned,  however,  the  FSAI,  which will  take  over responsibility for 
many areas of  labelling, including nutritional claims, plans to issue Guidance Notes to 
the eight Health Boards a part of their new service contracts.  These Guidance Notes 
should include one on nutritional labelling and might cover verification guidelines for 
nutritional claims. 
b.  Health Claims 
Given that health claims are not allowed under Irish law, there are  no  guidelines or 
systems in place for the verification of  claims. 
Pan- European study on nutritional, health and ethical claims  1999.  276 Taking the IMB approach, a product making a health claim would be controlled in the 
same way as a medicinal product.  Under existing IMB rules, there is a responsibility 
on the  holders of product authorisations  to~ keep  the  IMB  informed of events with 
potential  safety  consequences  for  their products.  The  Irish  Medicines  Board also 
monitors the quality of medicines by conducting inspections at sites of manufacture 
and distribution of medicines and by random sampling of products both pre and post 
authorisation. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
1.  Nutritional Claims 
The eight regional Health Boards in Ireland enforce legislation on nutritional claims. 
An offence under the Health Regulations may be prosecuted by a health board within 
the functional area of which the offence was committed (Article 13 of S.I. No. 388 of 
1993, the Health (Nutritional Labelling for Foodstuffs) Regulations, 1993). 
2.  Health Claims 
An offence under SI  82/205 which implements Directive 791112  may be prosecuted 
by the Director of  Consumer Affairs or by a Health Board in whose functional area an 
offence was committed. 
D.  BURDEN OF PROOF 
1.  Nutritional Claims 
In any proceedings for an offence under SI 388/93, the burden of proof lies with the 
prosecution, which must prove on the balance of  probability that a claim is false. Such 
proceedings are tried as  civil actions  in the  District Court in the area of which the 
offence was committed. 
2.  Health Claims 
The burden of proof lies with the Director of Consumer Affairs or the Health Board 
bringing  the  case,  who  must prove  that  a  claim being used  by a  manufacturer  is 
actually a health claim and cannot be allowed. 
E.  APPLICABLE PENAL  TIES 
1.  Nutritional Claims 
Persons found guilty of an offence under the Health Regulations are liable to  a fine 
not  exceeding  IR£1,000  (1,270  euro)  at  the  discretion  of  the  Court,  or  to 
imprisonment for a term not exceeding six months, or both. 
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Persons found guilty of an offence under SI  205/82 are liable to  a fine not exceeding 
IEP 800 (1,015 euro) or, at the discretion of the court, to imprisonment for a term not 
exceeding six months or to both such a fine and such imprisonment. 
V.  CASELAW 
No examples of  cases in public law have been found over the past five yearS:, 
In  the Self-Regulatory Code of the Advertising Standards Authority of Ireland 
(ASAI) there have been two cases which may be considered relevant to  the issue of 
claims. 
The  first  relates,  in  fact,  to  an  environmental  claim,  which  is  nevertheless  an 
indication of how that ASAI may view a health,  nutritional  or ethical  claim.  The 
complaints were from Earthwatch/Friends of the Earth Ireland, the Green party and a 
number  of individual  complainants  to  the  Shell  (Pura)  Petrol  campaign.  The 
complainants  considered  the  claim  "Purer  air.  From  Pura  Petrol"  to  be  false  and 
misleading.  Section  11  of the ASAI Code, which deals with environmental claims, 
provides that qualified claims and comparisons may be acceptable if advertisers can 
demonstrate that their product provides for an improvement in environmental terms, 
either against their competitors' or their own products.  The Complaints Committee of 
the ASAI considered that the advertising claim for purer petrol had been substantiated 
in that regard. 
However,  the  Committee  went  on  to  consider  that  in  some  radio  advertisements, 
expressions such as  "it's a breath of fresh  air  .. :"  and  "Shell Pura doesn't just help 
make the air clean .. " were tantamount to being absolute claims, which could not be 
justified and should not be used.  The Committee concluded, however, that consumers 
in general would be well aware that emissions from all petrol engines are harmful to 
the  environment  and  would  not  be  led  to  believe  that  they  would  result  in  the 
environment depicted in the advertisements. 
The second complaint related to  claims made  in  advertising by the  National Dairy 
Council (NDC) to the effect that "milk is good for your bones".  The complainant said 
that the entire scientific community connected with nutrition knows that calcium in 
milk is  passed straight out of the body, doing no  good whatever.  The complainant 
also contended that milk is actually a major contributory factor to osteoporosis, which 
is  caused by excessive protein and not calcium deficiency.  He  asserted that these 
facts  have been proven in  every study carried out on this subject and quoted studies 
and  references  in  support  of the  complaint.  The  complainant  said  that  the  only 
contradictory studies had been funded by the National Dairy Council of Ireland or its 
counterparts in other countries. 
The complaint was not upheld as the Committee felt that it would be more appropriate 
for  the  complainant  to  pursue  the  various  differences  of  opinion  in  a 
scientific/academic forum. 
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All  those  interviewed stressed that there  was no  difference in  the  regulation of the 
means of communication, such as broadcast and print media.  In Ireland, regulation of 
the Internet is still at a very early stage. 
VII.  STATISTICS ON CLAIMS 
No  statistics  on  claims  in  Ireland  are  available  from  any of the  sources  checked, 
including the Consumers Association, Industry Confederation, Government officials, 
Advertising Association, and the Food Safety Association. 
VIII.  ANNEXES 
1.  SI 388/93 on Nutritional Labelling 
2.  S  I 210/82 on Presentation, Label23 ling and Advertising ofF  oodstuffs 
3.  Irish Medicines Board Guidelines on the Definition of  a Medicinal Product May 
1999 
4.  ECJ Case Ter Voort C219/91. 
5.  Speech by Tom Kitt, Ethical Trading Initiative Ireland, 23 April 1999 
6.  ASAI Code of  Conduct 
7.  Irish Supermarkets in Ethical Trade, DEFY and IFTN 
8.  The Great Supermarket Challenge, DEFY and IFTN 
9.  Model Code of  Practice, DEFY and IFTN 
10. Ethical Trading Seminar attendance list 
11. UK Banana Industry Code of Best Practice 
12. FLO information 
13. Article by Mary Russell, Irish Times, 19 1  anuary 1999 
14. FSAI information 
15. Annual Report for 1998 of  the Director of  Consumer Affairs 
IX.  DATABASE OF CONTACTS 
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I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study on nutritional, health and ethical claims was generally well received by all 
interested parties  in  Italy,  although we were unable to  obtain information from  the 
consumer organisations.  Those who participated in  the  study were pleased that  the 
issue of  claims is being taken up by the EU institutions. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
Italian legislation provides for a definition of nutritional claims, which is  identical to 
the definition used in EU law.  The Italian administration is  not particularly satisfied 
with the current working of the system in place for nutritional claims.  The authorities 
would favour  a  system of preventive control,  but nevertheless  acknowledge that  it 
would be probably too  difficult to  administer.  This remark also  applies  for  health 
claims.  Industry, on the other hand, seems to be satisfied with current legislation on 
nutritional claims. 
2.  Health Claims 
With regard to  health claims, Italian legislation implements Directive 79/112 nearly 
word for word.  According to the food industry, the authorities interpret health claims 
very strictly.  The use of claims on disease risk reduction is,  therefore, not possible 
under Italian  legislation and the  use of enhanced function  claims  as  defined under 
Codex guidelines are very limited. 
Due  to  the  growing  problem  of "borderline"  products,  i.e.  where  the  distinction 
between a food product and a medical product is  difficult, the Ministry of health has 
set up  a working group made up of nutritional experts to  look into  this  issue.  The 
working  group  has  already  established  guidelines  to  categorize  these  kinds  of 
products. Another working group of the Ministry is  currently looking into probiotic 
foodstuffs. 
No  legislative  1mtiatives  on  health  claims  are  currently  planned.  The  authorities 
consider that the initiative on health claims has to come from the EU level.  Industry 
also indicated that the EU should regulate health claims.  Nevertheless, industry was 
in favour of  an amendment of  Directive 79/112. 
3.  Ethical Claims 
The Italian Parliament is in the process of adopting a law on the certification of social 
conformity of products produced without the  use of child labour.  Neither the  food 
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Under the  law, a register will be  set up,  in  which companies can certify not to  use 
child labour in the production of  their products.  The law foresees that 60 days after its 
entry into force,  the  Minister for  Industry and Commerce shall  adopt  a Decree,  in 
order to institute a social conformity label, which would allow the consumer to clearly 
and  rapidly  identify  the  product  as  being  manufactured  without  child  labour. 
Subscription  to  the  register  has  to  be  renewed  every  three  years.  A  monitoring 
committee  is  foreseen  under  the  draft  law.  This  will  be  composed  of officials, 
consumers, entrepreneurs, retailers and trade unions. 
The  law  foresees  that  the  Antitrust  Authority  will  have  the  power  to  decide  on 
complaints brought forward with regard to social labelling. 
C.  VOLUNTARY CODES OF PRACTICE 
An  advertising self-regulation  code  was  adopted  in  1966  with  the  creation  of the 
Advertising  Self-Regulation  Institute.  The  code  is  aimed  at  ensuring  correct  and 
lawful communication. Several Chambers of Commerce use the code as a benchmark. 
The  code  contains  notably  rules  for  advertising  of food  integrators  and  dietetic 
products, which state that advertising shall not induce consumers "to make nutritional 
mistakes". 
D.  VERIFICATION SYSTEMS 
As to the substantiation of  claims for foodstuffs for particular nutritional uses, as well 
as  fortified  food  and  diet  integrators,  a  sample  of the  label  and  on  request  also 
scientific  literature  has  to  be sent  to  the  Ministry of Health  when  the  product  is 
marketed.  In  addition,  the  Italian  law on  misleading  advertising  foresees  that  the 
Antitrust Authority can ask the advertising operator to  furnish proofs on the material 
exactness of the facts contained in the advertising. 
No  system of pre-clearance exists.  The food  industry indicated that  such a system 
was far too heavy.  Furthermore, a pre-vetting by the Ministry of Health would in the 
food industry's view not give the producer the certainty of  not facing a complaint, as a 
Ministerial  approval  of a  claim  would  not  limit  the judge's  power to  act  upon  a 
complaint.  Nevertheless,  food  producers,  often  before  putting  a  product  on  the 
market, ask the Ministry of Health on an informal basis to check the conformity of the 
label and the claim made with national legislation. 
As  to  post-clearance,  a special branch of the  police  (Nuclei Anti  Sofisticazione) is 
responsible for food safety and hygiene.  Furthermore, on the basis of the misleading 
advertising law,  consumers,  competitors  and  the  public  administration  can bring a 
case in  front of the  Antitrust Authority.  The burden of proof is  with the  plaintiff. 
Nevertheless the Antitrust Authority can ask the person who has commissioned the 
advertising or its creator to  provide proof of the material's accuracy and of the data 
contained in the advertising. 
The penalties can range from  1.2 million liras to  12 million liras for cases judged on 
the  basis  of relevant  food  legislation.  For  cases  that  have  been  brought  to  the 
Antitrust Authority, these are judged on the basis of the misleading advertising law, 
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advertising in case of  urgency and/or it can order the complete ban of the advertising. 
The Antitrust Authority is  a collegial  organ,  which takes  its  decisions by majority 
voting (it is composed of 5 members).  If an advertising operator does not follow the 
order of the Antitrust Authority, he can be fined with up to  3 months imprisonment in 
conjunction with a fine of up  to  5 million lira.  Decisions of the Antitrust Authority 
can be contested in an administrative court. 
E.  MEANS OF COMMUNICATION 
There are no differences between means of communication. However, in cases where 
the  Antitrust  Authority  is  called  to  decide  on  advertising  broadcast  on  TV  or 
published  in  the  press,  it  has  to  ask  the  advise  of the  authority  responsible  for 
monitoring broadcasting and publishing. 
F.  CONSUMER PROTECTION 
On the issue of consumer protection, we have not been able to obtain any input from 
consumer associations (see  above).  Overall, contacted parties indicated due to  the 
strict interpretation of health claims in  Italy, there existed no  problems in  terms of 
consumer protection. 
Statistics of the Antitrust Authority, which is  the administrative body responsible for 
complaints  on  misleading advertising,  indicate  that  in  the  period  1992-1997  there 
have been a growing number of complaints on misleading advertising.  For the same 
period the statistics indicate that with regard to  food  out of the  42  cases that were 
analysed by the Authority only 14o/o were found misleading.  Nevertheless, in the field 
of cosmetic and health care out of the 100 cases analysed, around 70% were found to 
be misleading. 
As regards ethical claims and consumer protection, the Italian Clean Cloth Campaign 
indicated that it was against the proposed law on the certification of social conformity 
of products produced without the use of child labour, as  it would allow companies to 
put a label on their products without that any a-priori control of the companies takes 
place (under the  law  companies that want to  be put on the register have to  send a 
declaration  testifying that they do  not  use  child  labour).  The  Italian  Clean  Cloth 
Campaign is  also against the possibility of certifying just one single product of one 
company, as consumers may assume that all other products of  the same company have 
also been produced without child labour. 
G.  BARRIERS TO TRADE 
As for barriers to trade, no examples were mentioned where a health claim had been 
at the basis of a controversy on trade barriers.  The food industry indicated that trade 
barriers may come up where in  one EU  Member State a self regulating code exists 
which allows the use of certain health claims.  In  this case,  the  importation of this 
kind of products into the Italian territory could pose problems. 
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The  only case  law  as  such  is  the  decisions  that have  been taken  by the  Antitrust 
Authority.  With regard to health claims, the Antitrust Authority has only dealt with a 
few  cases.  These  seem  to  indicate  that  the  Authority  follows  a  rather  strict 
interpretation of  health claims. 
I.  STAKEHOLDERANALYSIS 
Italy follows  a rather strict interpretation of Directive 791112  with regard to  health 
claims.  Most interestingly, Italy has introduced a notification procedure not only for 
dietetic foodstuffs,  as  foreseen  under EU  law,  but also  for  fortified  foods  and food 
supplements, which are those categories of foods where most often health claims are 
being made.  All interviewees seemed to agree that there was a need to regulate health 
claims  at  EU  level.  Italy  is  also  one of the  very few  EU  Member States  that  is 
drafting legislation on ethical claims. 
In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  On nutritional claims, the authorities see in principle no need for review. 
•  On health claims, the authorities consider the interdiction of  health claims to be an 
acceptable  approach.  Eventually a  system of pre-vetting  should be  introduced, 
although this was considered to be difficult from an administrative point of  view. 
2.  Consumers 
•  We were not able to gather the opinion of  the Italian consumer associations. 
3.  Industry 
•  The  food  industry  seems  to  be  quite  satisfied  with  the  current  legislation  on 
nutritional claims. 
•  Industry is in favour of liberalising the rules on health claims. This should be done 
through an amendment of the EU Directive on labelling of foodstuffs.  Industry is 
clearly against pre-vetting. 
•  On  ethical  claims,  industry  is  against  the  proposed  law.  The  Clean  Cloth 
Campaign, although for other reasons, is against the proposed law, as well. 
*** 
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A.  DEFINITIONS OF CLAIMS 
It may be useful, as a general remark, to point out that the Antitrust Authority, which 
is the administrative entity in Italy responsible for misleading advertising (see section 
VI.  A)  in  particular),  often  uses  the  English word claim  in  its  decisions,  without 
making use of  any Italian translation. 
Also the food industry seems keen to use the English expressions health claims and 
nutritional claims, without making use of  any Italian translation. 
1.  Nutritional Claims 
The Italian legislation provides for a definition of  nutritional claims, which is identical 
to the one provided by the EU Directive 90/496/CEE on the labelling of foodstuff and 
of  alimentary products. 
According to the Decree No. 77 of 16 February 1993 (see annex 1), a nutritional claim 
IS: 
"a  description  or an  advertising message  which  states,  suggests  or implies  that  a 
foodstuff  has particular nutritional features regarding: 
1)  the energetic value which it furnishes or it jitrnishes at a reduced or at a 
majored value or which it does not  furnish; 
2)  the  nutrients  it contains  or that it  contains  in  a  reduced or a  majored 
proportion or which it does not  furnish". 
According to the same Decree, "the quantitative or qualitative indication of  nutrients, 
when it is required by the existing legislation", shall not be considered as nutritional 
claim as defined above. 
2.  Health Claims 
There is  no precise definition of what is  to be considered as  a health claim in  Italy. 
The  only  definition  is  a  negative  one,  as  the  Decree  No.  109/92  (see  annex  2) 
implementing  the  EU  Directive  791112  on  foodstuff  labelling,  presentation  and 
advertising, prohibits any kind of medical claims, and has been used as a benchmark 
to prohibit also any kind of health claims. 
According to Art. 2 of  the Decree 109/92: 
"The labelling, the presentation and the advertising of  foodstuff[. . .} do not have to be 
as such as to  induce to  confer to  the product properties which are aimed to prevent, 
cure or heal human diseases,  or mention features which  it does  not have.  With  the 
exception of  what has been foreseen by the norms on  nutritional labelling,  they [the 
labelling,  the presentation and the advertising offoodstuffl do  not have to point out 
particularfeatures when similar products have the same features". 
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by the  Italian Administration.  Disease  risk  reduction claims,  as  defined under the 
latest draft Codex recommendations, are not allowed in Italy.  The use of enhanced 
function claims as defined under the draft Codex recommendations seem to  be  also 
extremely limited in Italy (see further sections of the report). 
3.  Ethical Claims 
As  specific legislation dealing with ethical claims does not exist in Italy, there is  no 
specific definition of  an ethical claim. 
The draft Act on the certification of social conformity of the goods produced without 
the  use  of child  labour,  which  is  currently  under  discussion  within  the  Italian 
Parliament (see section D.  3.), does not contain definition of what an ethical claim is. 
However, in that law, reference is made to a specific "social conformity label". 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
The  EU  legislation  concerning  food  and  foodstuff has  been  implemented  in  Italy 
through various different laws and decrees. 
Directive No.  90/496 on the nutritional labelling of foodstuff has been implemented 
by the Decree No. 77 of 16 February 1993 (see annex 1). 
The Directive No.  398/89 on foodstuff for  particular uses  was  implemented by the 
Italian Decree 111 of  27 January 1992 (see annex 3). 
Special norms on sport foodstuff are contained in a Ministerial Circular No.  8 of the 
Ministry  of Health  which  was  adopted  on  7  June  1999,  and  is  awaiting  official 
publication (see annex 4  ). 
Furthermore, there are special rules for beer and olive labelling.  The Decree of the 
President of the Republic No. 272 of 30 June 1998 deals with beer (see annex 5) and 
law No.  313 of 3 August 1998 regulates the labelling of olive oils' bottles (see annex 
6). 
Finally,  the  Ministerial  Circular of the  Ministry of Health  No.  5 of 3  April  1998 
regulates  beverages  coming  from  other  EU  member  States  with  high  content  of 
caffeine (see annex 7). 
2.  Health Claims 
Directive 79/112 on the labelling, the presentation and the  advertising of foodstuff, 
was implemented by the Italian Decree No.  109 of  27 January 1992 (see annex 2). 
The Directive on misleading advertising was implemented by the Decree No. 74 of  25 
January 1992 (see annex 8). 
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3.  Ethical Claims 
There is no Italian piece of  legislation, which regulates ethical claims. 
c.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
According to  the Italian Decree No.  109  of 27 January 1992 as  modified by Decree 
No. 77 of 16 February 1993 implementing Directive 90/496 on nutrition labelling (see 
annexes 2 and 1  ): 
"Only the nutritional information which are related to  the energetic value and to  the 
nutrients listed in article 3 point A or that belong or compose one of  the categories of 
said nutrients, are allowed". 
The products listed in Article 3 point A are: 
1.  Proteins; 
2.  Carbohydrates: 
3.  Fats,· 
4.  Foodfibres: 
5.  Sodium,· and 
6.  Vitamins  and mineral salts which  are listed in  the  annex and are present in  a 
significant quantity according to what is foreseen in the annex itself'. 
According to the Annex of  the Decree 77/93, 
''a quantity is significant for each 1  OOg or 1  OOml when it represents at least 15% of 
said portion". 
The main prohibitions, restrictions and exemptions to the use of nutritional claims are 
contained in  the  Italian  Decree No.  Ill of 27  January  1992  (see  annex  3),  which 
implements the Directive 398/89 on foodstuff for particular nutritional uses. 
According to this Decree, it is possible to use the word "dietetic" or "di regime" only 
to indicate two specific kinds of  products: 
a)  foodstuff  which  is  aimed  at  the  nutritional  needs  of  those  people  whose 
assimilation process or whose metabolism is disturbed; 
b)  foodstuff which is  aimed at the  nutritional needs of those people who  are  in  a 
particular physiological condition, and hence can have particular benefit from the 
controlled intake of some substances contained in these foodstuffs. 
The Italian legislation explicitly states that in the labelling, the presentation and the 
advertising of  foodstuff for normal use, it is forbidden: 
a)  to use the word ''dietitic'' or "di regime", both as  single words and together with 
other terms; 
Pan- European study on nutritional, health and ethical claims- 1999.  286 b)  to use any other expression or whatever claim (in Italian it reads ""whatever other 
'presentation' - presentazione, in Italian") which can generate the belief that it is 
one of the foodstuffs for particular use as defined above. 
The Decree No.  111 of 1992 gave the Italian Ministry of Health the task of  adopting a 
Ministerial Decree to indicate the foodstuff for normal use which could however be 
used for particular nutritional use.  In this case, even if it were not a foodstuff for 
particular nutritional use as defined above, it would be possible to mention these 
nutritional properties. 
Apart from  Decree  Ill  /92,  there  are  other pieces of legislation that  provide  other 
specific prohibitions or restrictions applicable only to a specific range of  products. 
According to the Decree No. 272 of  30 June 1998 on beers (see annex 5), 
"The use of  the term  'birra leggera ' or 'birra light '
22 is reserved to  the product with 
PLATO  degree  included  between  5  and 10,5  and with  alcohometric  volume  title 
superior to  1, 2% and not superior to 3, 5% ". 
2.  Health Claims 
With  reference  to  foodstuff for  particular nutritional  uses,  the  Decree  111/92  (see 
annex 3) contains a specific Article entitled ""Prohibitions and Information", Article 6. 
According to this Article, 
""the  labelling and the modalities used for its realization,  as well as the presentation 
and the advertising of  foodstuff [for particular nutritional uses} shall not either imply 
characteristics  aimed  to  prevent,  cure  or  heal  diseases.  or  mention  such 
characteristics". 
However, the Ministry of Health can identify those cases in which derogations to this 
principle are admitted. 
However,  ""the  d(ffusion  of information  and of useful recommendations exclusively 
targeted to qualified personnel in  the sectors of  the medicine. of  the alimentation and 
of  the pharmacology" is admitted. 
As  we  pointed  out  in  the  section  regarding  the  definitions,  health  claims  are  not 
allowed in Italy. 
3.  Ethical Claims 
So far, no legislation on ethical claims has been brought into force. 
22  Light in English in the Italian text. 
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D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The Italian administration is not particularly satisfied with the current working of the 
system in place for nutritional claims.  Particularly, the lack of a preventive control on 
the label and on the claim used by the food producer is perceived as  a shortcoming, 
although the  Administration acknowledges  the  fact  that  the  introduction of such  a 
preventive control would certainly lead to  a huge amount of work.  This remark also 
applies for health claims. 
The  food  industry seems  to  be  quite  satisfied with  how  the  system  on  nutritional 
claims has been working so  far,  and no changes to the current legislation are deemed 
necessary. 
In the case of  foodstuff for particular uses, the Italian administration has come up with 
a number of mandatory labelling indications, i.e. warnings that have to be put on the 
label.  This is the case for sport foodstuffs.  However, an extension of this system to 
all types of foodstuff does not seem to be considered as  a viable option for changing 
the current situation. 
A new Ministerial Circular on sport foodstuff has been signed on 7 June 1999, but is 
still awaiting publication (see annex 4).  This Circular deals with different kinds of 
sport products, fixing not only compositional standards, but also dealing with specific 
claims which have to be put on the label of  each of  these products. 
For example, for those products which aim at protein integration, the following claims 
are to be reported on the label: 
•  The total contribution of  proteins (diet and integrator) shall not be higher than I,5 
g. per day per each kg of  the body 's  weight. 
•  In  case of  prolonged use  (beyond the  6-8 weeks) it is  necessary to  ask for the 
doctor's advice. 
•  The product is counter-indicated in  cases of  renal pathology. hepatic pathology, 
during pregnancy and below I2 years. 
For  those  products  which  aim  at  integrating  ammo  acids  and  derivatives,  the 
following claims are to be put on the label: 
For the ramified amino-acids and for the creatina: 
•  In case of  prolonged use (beyond 6-8 weeks) it is necessary to askfor the doctor's 
advice. 
•  The product is  counter-indicated in  cases of  renal pathology,  during pregnancy 
and below I2 years. 
For essential amino-acids and other kinds of  amino-acids: 
Pan- European study on nutritional, health and ethical claims- 1999.  288 •  In case of  prolonged use (beyond 6-8 weeks) it is necessary to ask  for the doctor's 
advice. 
•  The product is counter-indicated in  cases of  renal pathology, hepatic pathology, 
during pregnancy and below 12 years. 
2.  Health Claims 
The use of health claims in Italy is currently forbidden by Italian legislation, which 
has implemented the Directive on the labelling of foodstuff maintaining the ban on the 
use  of claims,  which  refer  to  the  possibility for  the  product  to  cure  or prevent  a 
disease. 
This prohibition has been interpreted very strictly by the Italian administration, which 
has not allowed any claims to be made in relation to any possible human disease. 
Within the Italian Ministry of Health, there is  currently a working group made up of 
nutritional experts which is looking at those cases in which it can be difficult to draw 
a clear distinction between a food product and a medical product. 
This working group  already came up  with  guidelines, which can be used to  better 
categorize these kinds of products (we have not been able to obtain a copy of these 
guidelines). 
Another working group is looking at pro-biotic foodstuff, and is expected to come up 
with  a  document which  could  be  the  basis  of an  official  Ministerial  document  or 
which could simply be used for internal reference. 
The Ministry of Health considers the interdiction of health claims to be an acceptable 
approach.  On the  contrary, not being able to  use health claims is  one of the major 
points of  concern for the food industry. 
According  to  the  food  industry,  health  claims  should  be  as  clearly  admitted  as 
nutritional  claims,  and  the  areas  should  be  regulated  by  the  EU,  through  an 
amendment to the Directive on the labelling of  foodstuffs. 
No new legislation is expected on health claims.  Legislation regulating this issue has 
to  be adopted first at EU level and the Italian Legislator is  not planning to  take any 
initiative on its own which could then be contradictory to new EU Directive. 
3.  Ethical Claims 
As we have already mentioned, the Italian Parliament is in the process of adopting a 
law on the certification of social  conformity of goods produced without the use of 
child labour.  Per se,  this  demonstrates that at  least the Italian Parliament deems it 
necessary to have a specific piece of  legislation regulating this issue. 
It seems that neither the food industry nor the trade associations believe that such a 
legislative measure is really necessary. 
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The  food  industry,  although  not  fully  aware  of parliamentary  initiative  on  ethical 
claims,  did  not  show  particular  support  for  the  introduction  of this  legislation  on 
ethical labels, while the trade confederation was clearly against it. 
According to the trade confederation, the introduction of this new ethical label would 
probably only further confuse the consumer. 
On 2 June  1999, the Upper House of the Italian Parliament adopted a proposed Act 
which  aims  to  establish  a  "Certification  of social  conformity  of those  products 
realised without making use of  minor age work" (see annex 9). 
Although  this  proposed  piece  of legislation  does  not  specifically  refer  to  ethical 
claims, it can constitute a development, which is worth noting.  As a matter of fact, 
this law will establish an apposite Register for those firms which can certify that they 
do  not use  child labour in  the  production of their products,  and will provide these 
firms with the right to put a specific label on the package of  their products. 
The proposed law makes reference to the international conventions and treaties, which 
protects  the  rights  of minor  age  people.  In  particular,  reference  is  made  to  the 
International Convention of the Rights of  the Child, and to the Convention No. 138 of 
the International Labor Organisation. 
The Law will  institute a specific national Register (Albo  nazionale) of those goods 
manufactured without the use of  child labour and of  the relative producing firms.  The 
aim of the  Register is  to  "spread the knowledge among Italian  consumers of  those 
products commercialised on the national territory for which no child labour is used 
during the manufacturing phases". 
Within  60  days  of the  entry  into  force  of this  law,  the  Minister  responsible  for 
Industry, Commerce and Handcraft will have to adopt a Decree in order to institute "a 
specific social conformity Iaber', as a logo, " which manufacturers will be allowed to 
put on  their production  or on  the packages of their products or on  the products 
themselves". This label will "allow the consumer to  clearly and rapidly identify the 
product which has been manufactured without the use of  child labour". 
Signing up to the national Register is not mandatory but voluntary. 
In  order to  have the possibility of signing up to this  Register, and hence to  use this 
label, the firms  will have to  make a specific request accompanied by a declaration 
which can testify that in no phase of  the production was child labour used. 
It is  important  to  remark that  a  firm  has  three  different  options  when deciding  to 
subscribe to the Register: 
•  It can decide to sign up for a single specific product; 
•  It can decide to sign up for the firm as a whole; 
•  It can decide to sign up for all the products manufactured. 
The subscription to this Register has to be renewed every three years.  In case the firm 
does  not  renew  its  subscription,  the  specific  Monitoring  Committee,  which  IS 
established by the law itself, will delete the product or the firm from the Register. 
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Foreign Trade Minister,  one by the  Industry Minister,  one by the Labour Minister. 
The remaining four would be appointed by the presidency of the Ministers, and one 
would represent the consumers, one the entrepreneurs, one the retailers and one the 
trade unions.  These members will not receive any form of monetary compensation 
for carrying out this function. 
It is  very  interesting  to  note  that  the  proposed  law  explicitly  makes  reference  to 
misleading advertising.  According to Article 4, "it is  forbidden whatever untrue and 
misleading advertising,  together with  the  use of whatever label  or logo  which  can 
generate confusion with the label created" by this law. 
This means that the general rules applying to misleading advertising are also applied 
to  this specific label.  This is  particularly important with regard to  the power of the 
Antitrust Authority, which is the administrative authority responsible for all the cases 
of  misleading advertising.  As a matter of fact, the Authority will also have the power 
to decide cases, which refer to the social labelling provided within this proposed piece 
of  legislation. 
Once  the  law  is  finally  approved  and  has  entered  into  force,  the  Monitoring 
Committee will  prepare a yearly report on the  status of implementation of the law. 
This report will have to be presented to the Parliament and to the Government by 31 
May of  each year. 
It is  important to  note  that the  Italian centre adhering to  the  so-called Clean Cloth 
Campaign  does  not  agree  with  this  proposed  legislation.  Particularly,  the  Italian 
Clean Cloth Campaign is against the possibility provided by the law to certify just one 
single product of one company, as  consumers may assume that all other products of 
the same company have also been produced without child labour. 
Moreover, the fact that signing up to this Register is automatic upon the request of  the 
company,  i.e.  that  there  is  no  a  priori  control,  is  perceived  as  not  giving  enough 
security in terms of  minor workers' protection.  As a matter of  fact, the Clean Clothes 
Campaign has  a different proposal, which would allow companies to  put a label on 
their products only after a specific control had taken place.  They believe that this 
procedure would grant a higher level of certainty that no  child labour is  involved in 
the manufacturing of  a specific product. 
E.  REMARKS  ABOUT  BARRIERS  TO  TRADE  AND  LACK  OF 
CONSUMER PROTECTION 
1.  Nutritional Claims 
From the contacts we had with the Ministry of Health, the representatives of  the food 
industry sector and of the retail sector, we understand that there have not been major 
cases  in  which  a  nutritional  claim  or  a  health  claim  has  been  at  the  centre of a 
controversy over barriers to trade. 
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The only case which could be quoted is one relating to an energy drink (Red Bull), in 
1996, and was cited by an official we spoke to in the Ministry of  Health. 
This energy drink had been prohibited in Italy because its caffeine content was higher 
than the  limits foreseen  in a Presidential Decree of 1958  (No.  719).  The European 
Commission initiated a procedure of infringement against Italy for creating a barrier 
to trade within the European market. 
Facing the possibility of condemnation by the European Court of Justice, the  Italian 
Health  Superior Council  conducted a  study on the  effects  of the  high  contents  of 
caffeine and taurine.  On the basis of  the findings of this study, the Ministry of Health 
adopted a Ministerial Circular (No. 5, 3 April 1998), which allowed the marketing of 
"Beverages corning from another EC  Member which are characterised by high level 
of  caffeine and taurine". 
This document also provides for some indications on what has to appear on the label 
(see annex 7). 
Relying  upon  the  findings  of the  Italian  Health  Superior  Council,  the  Ministerial 
Circular states that beverages containing 320rng per litre of caffeine and 4g/litre of 
taurine do not pose particular danger to public health. 
However,  with specific reference to  the information to  be put on the  label of these 
beverages, the circular states the following: 
"Considering the content of  caffeine,  it is particularly necessary to provide a correct 
and adequate information for the consumer through the wording and the warnings on 
the  label.  It  is  opportune  to  indicate  those  individuals  who  are  exposed  to  risk 
(children,  pregnant women and particularly sensitive individuals),  and to  suggest a 
moderate consumption [of these beverages} in  case of  contemporary consumption of 
caffeine from other sources. 
Allegations on the beneficial effects of  these beverages, which, at the current status of 
knowledge, cannot be adequately documented, cannot be put on the label. 
Among  the  warnings,  it  is  opportune  to  insert  also  the  advise  of avoiding  the 
contemporary exposure to alcohol and tobacco." 
The  Italian  ban on  the  commercialisation  of this  kind  of beverages  was  based  on 
considerations aimed at granting a higher level of  consumer protection. 
2.  Health Claims 
Although we could not find any cases in which a health claim had been at the basis of 
a controversy on trade barriers, the possibility of having one was mentioned by the 
food industry sector. 
According to the food industry, disputes over barriers to trade could arise if a code of 
self regulation exists in one EU Member State which allows the use of certain health 
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could pose some problems. 
As  health  claims  are  currently  not  allowed,  there  IS  no  problem  of consumer 
protection in this field. 
According to the food industry, should health claims be allowed, this would result in a 
higher level of  protection not only for consumers, but also for producers.  As a matter 
of fact, each food producer would check that what a competitor says on a package is 
in conformity with the rules on health claims, and would ask for the intervention of 
the judiciary power in case of  a breach of  the law. 
3.  Ethical Claims 
With regard to  the proposed Act on the "Certification of social conformity of those 
products realised without making use of child labour", Article 4 of the law explicitly 
makes reference to the risk of  distorting competition among different firms. 
Literary, the provision of  the law reads: 
"The President of  the Council [the Prime Minister} will watch at that the Register will 
not  improperly  managed  to  distort  the  freedom  of competition  between  the 
enterprises". 
This is a clear reference to the risk of creating trade barriers based on the new social 
label that will be introduced after the  entry into force of this new law, should it  be 
adopted. 
According to the representative of  the retail industry, the intention to put on packages 
this kind of ethical label will not benefit the consumer.  As a matter of fact, there are 
already too many symbols on the package, and this new one would only add to  the 
customer confusion. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
A  self-regulation  advertising  system  was  set  up  in  Italy  in  1963,  but  the  first 
advertising  Self-Regulation  Code  was  only  adopted  on  21  May  1966,  when  the 
Advertising  Self-Regulation  Institute  (lAP,  which  stands  for  Instituto 
dell'  Autodisciplina  Pubblicitaria)  was  also  created.  The  advertising  industry 
(operators and creators) adhere to this Code. 
Since 1966, the Self-Regulation Code has been updated and amended several times. 
The last amendment to the Code was adopted in May 1999, and now the 29th version 
of the Code is in force (see annex 1  0). 
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I The aim of the rules in the Code is to set-up guidelines about what can be considered 
as correct and lawful communication. 
Although not an official document, this Code has received wide appreciation, and was 
included  in  the  collection of ~·uses in the  field  of advertising" by the  Chambers of 
Commerce in Milan, Turin, and Bari. 
The role of the lAP partially overlaps the role that was given in 1992 to the Antitrust 
Authority in the field of  misleading advertising. 
Moreover,  the  lAP  plays  an  important  role  in  the  advertising  of pharmaceutical 
products.  According to an Italian Decree of 30 December 1992, No. 541, companies 
that produce advertisements for pharmaceutical products to be sold over the counter, 
can submit their advertisements for prior approval to a "self-regulatory institute".  The 
Minister responsible for Health has identified this institute as the lAP. 
On 10 December 1996, a working group within the Ministry of Health elaborated and 
adopted  an  internal  document  which  has  not  been officially published  and  which 
provides rules for diet integrators (see annex 12). 
This document, (please find a copy annexed) specifies the values of  each vitamin and 
mineral,  which can be  contained in  food,  and provides specific definitions of each 
kind of integrators: energy and protein, lipid, biological, fibre integrators. 
It  is  interesting  to  point  out  that,  when  referring  to  integrators  "with  a  health 
component";  the  Ministerial  guidelines  bar the  possibility of those  integrators  that 
have  among  their  ingredients  herbs  which  are  known  for  their  pharmaceutical 
properties. 
What is  equally interesting to note is  that these guidelines also have a specific part 
dedicated to labelling.  In this section, the Ministry also provides some guidelines on 
nutritional labelling.  According to the Ministry: 
~'The reference to a specific physiologic activity of  the various nutritional components 
which  is  clearly documented,  especially in  case this  reference is  useful to favour a 
more aware choice among the products, is admitted. 
Reference  to  a  specific function  is  admitted  when  it  is  clearly  documented  (i.e. 
calcium for the bones, fluorine for teeth enamel and anti-caries action). 
Reference to particular metabolic roles are admitted when they are clearly specified 
and documented. 
For the essential nutrients.  reference to  their use has to  be done in  case of  reduced 
contribution with the common food portion". 
The document of the Ministry also states: 
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23  "with no sugar  Is" or "with no added sugar" are used,  there is the 
obligation of  having a nutritional labelling listing all the information, with a specific 
reference to the "sugars". 
So far the Ministry has accepted only a limited number of nutritional claims that the 
producer can use when referring to  the effects of a specific component of the food 
integrator: 
Chrome: "it also plays a role in the metabolism of  the sugars and of  the lipids". 
Lipotrops factors: "they positively acts on the metabolism of  the lipids". 
Fosfatidilserina: "it plays a role as modulator of  the biochemical-metabolic process 
at brain level". 
Antioxidant and bioflavonoidi vitamins: "among the other effects, also the function 
of  the micro-circulation". 
These  ones  listed  above  are  the  only  claims,  which  can  be  put  on  the  label  by 
producers when referring to  these substances.  There is  currently a working group, 
which meets in the Ministry of Health to analyse labels and the claims on them.  It is 
composed of nutritional and pharmacological experts.  So far,  this working group has 
accepted very few claims. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
In  the  Self-Regulation Code no  definition is  provided for  nutritional  claims, health 
claims or ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
The lAP Self-Regulation Code contains several prohibitions and restrictions regarding 
the  message,  which  can  be  used  to  advertise  certain  particular  products.  Precise 
guidelines are given for the advertising of alcoholic products, but also for cosmetic 
products,  food  integrators  and  dietetic  products,  medical  products  and  healing 
treatments. 
1.  Nutritional claims 
On  food  integrators  and  dietetic  products,  Art.  23  bis  of the  Self-regulating Code 
states that: 
"Advertising  of  food  integrators  and dietetic  products  shall  not  claim  properties 
which  are not in  conformity with  the particular characteristics of the products,  or 
properties which are not really owned by the products. 
23  Claim in English in the Italian text. 
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induce consumers to make nutritional mistakes, and it has to  avoid mahng reference 
to medical recommendations or statements". 
2.  Health claims 
The Code makes reference to the prohibition of using health claims in several of its 
prOVISIOnS. 
With regard to cosmetic products, the Self-Regulating code makes implicit reference 
to health claims in Article 23, by saying that: 
"although  cosmetic  advertising  can  present  these products  [cosmetics}  as  having 
subsidiary features for the prevention of  particular pathologic situations,  provided 
that they have specific ingredients and  formula to that aim,  it does not have to induce 
the consumer to make confusion between cosmetic products and products for personal 
car on one hand and medical products and healing treatments on the other hand". 
In  Article  24,  referring  to  '"Physical  or aesthetic  treatments",  the  Code  states  that 
advertising 
"shall not induce to believe that these treatments have therapeutic effects [. . .} or have 
the  capacities  to  produce  radical  results,  and  shall  avoid  reference  to  medical 
recommendations or statements". 
The  Code  also  contains  a  specific  article  on  the  advertising  of medical  products. 
There  is  also  a  specific  regulation,  which  sets  up  the  rules  for  the  Section  of the 
monitoring body instituted by the Code, which deals specifically with pharmaceutical 
products.  (See annex 11 ). 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY  THE 
AUTHORITIES 
As  we  have  mentioned,  the  Code  published  by the  lAP  has  been  retained  as  a 
benchmark that is used by several Chambers of  Commerce. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
Apart from the criteria for nutritional labelling, as  set out in the nutritional labelling 
Decree (No. 77 of 16 February 1993, see annex  I), the relevant sections of the Decree 
111 of 1992 on foodstuff for particular nutritional uses (see annex 3) applies. For such 
foodstuffs  the  manufacturer or importer has  to  notify the  Ministry of Health of its 
placing on the market by transmitting a model of the label.  The Ministry may require 
the manufacturer or the importer to also provide scientific data to justify the particular 
nutritional use of  the product (article 7). 
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foodstuffs with added vitamins and minerals, as well as diet integrators also fall under 
the  notification procedure of foodstuffs for particular nutritional uses.  The Ministry 
of Health indicated that it felt that as long as there existed no EU legislation for these 
products, a certain control was needed. 
Furthermore, under the Italian Decree on foodstuffs for particular nutritional uses, the 
product categories listed in  Annex  I (which are  the  same as  the  one listed in  EEC 
Directive 89/398) require a marketing authorisation from the Ministry of Health, until 
specific Decrees have been adopted for these products (i.e. once EU Directives have 
been adopted for these products, which are then implemented by Decrees in  Italy). 
For these  products, the manufacturer has  to  send to  the  Ministry a  sample of their 
product within three months of  beginning production. 
2.  Health Claims 
Health claims are not allowed in Italy. 
3.  Ethical Claims 
According to the draft proposal for a law on the social certification on the use of child 
labour, companies which want to sign up to the Register which will give them right to 
make  use  of the  apposite  social  label  for  their  products,  simply have  to  sign.  No 
special requirement or control is needed. 
It is  interesting to  note that Article 4 of the draft law on the social conformity label 
states that the office of the Prime Minister will pay attention to the managing of the 
Register  established  by the  law.  This  will  not  alter  the  free  competition  among 
manufacturers. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
a.  Nutritional claims 
As  mentioned above under the Decree Ill  /92 on foodstuff for  particular nutritional 
uses (see annex 3), for the products not listed in Annex  1 a notification procedure is 
mandatory. 
In the case of  the marketing of  a new product, which is thus not on the list of  Annex 1, 
the manufacturer or the importer has to inform the Ministry of Health, by transmitting 
a model of the  label  used for  such a product.  In  cases where these  products have 
already been sold in another EU Member State, the manufacturer or the importer will 
also have to  notify to the Ministry of Health and the recipient authorities of the first 
notification. 
Whereas the products, which have been notified to  the authorities, do  not fall  in the 
category  of foodstuff  for  particular  nutritional  uses  as  described  in  Article  1, 
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paragraph 2 of the Decree, the Minister for Health can ask the companies concerned 
to withdraw these products from the market.  In a case where the company does not 
withdraw the product, the Minister of Health can sequestrate it. 
Moreover, as  foreseen  in  the  Directive, the Ministry of Health can also  sequestrate 
those products, which present a danger to human health.  Both in this case and in the 
previous one, the Ministry has to  inform the European Commission and the other EU 
Member States of  the measures adopted and of  their reasons. 
If the  Ministry of Health believes that a product falls  within the  category of those 
listed in Annex  1, it can prohibit its sale, and submit it to the authorisation procedure 
provided with by Article 9, which is foreseen for Annex 1 products. 
For all  those  products,  which are  listed  in  Annex  1 of the  decree,  production and 
importation are submitted to an authorisation of the Ministry of Health.  However, as 
mentioned above,  this  procedure applies only until  the  Ministry of Health does  not 
adopt ad hoc ministerial decrees for every and each of the categories of products in 
Annex 1.  So far, decrees have been adopted for infant formulae, baby foods, follow-
up milk and foods, as well as foods intended for weight control. 
As the company applies for an authorisation, the company has the legal obligation to 
keep  at  the  Ministry of Health's disposal  the  samples of the  product for  which  it 
demands the authorisation.  In any case, within three months from  the beginning of 
the production of the product, the company itself has to  send a sample of the product 
to the national Health Superior Institute, which informs the Ministry of Health of the 
results of the analytical controls. 
b.  Health claims 
Health claims are not allowed in Italy. 
The industry sector does not believe that a pre-clearance control for example by the 
Ministry of Health would serve the scope, as  it would be far too heavy.  It considers 
that some general guidelines have to be set-out at EU level, so that they are uniformly 
applied in all the EU Members. 
Moreover,  having  a  preventive  control  by the  Ministry  of Health,  and  maybe  a 
clearance of the label and of the claim on the label, would not - in the interviewee's 
view - give the producer the certainty of not facing a complaint by the consumer in 
front of the Antitrust Authority or in front of a normal judge. As a matter of fact, the 
judicial power in Italy is  completely separated from the Public Administration.  This 
means, for example, that the police could always intervene on a consumer's request, 
and that a Ministerial Circular on a specific product would not hamper the judge to 
act. 
Moreover,  having  pre-clearance  from  the  central  Ministry  would  not  give  any 
certainty about a real  uniform interpretation by all  the  different ASL (Local Health 
Authority),  which are  responsible in  every district, and which, de facto,  have often 
given very different interpretation of the documents and  guidelines provided by the 
central authority. 
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Please refer to the section II.E on ethical claims, where the procedure foreseen by the 
law currently under discussion within the Italian Parliament is explained. 
2.  Post-Clearance Rules/ Guidelines 
a.  Nutritional Claims/ Health Claims 
The  present  control  system  foresees  that  the  so-called  NAS,  Nuclei  Anti 
Sofisticazione, which is a branch of one of the two Italian police forces (carabinieri), 
have the specific task of ensuring that no  crimes are committed in the field  of food 
safety and hygiene.  Once the NAS is called into action, whereas they find something, 
which  could  constitute  a  violation  of the  law  on  foodstuff,  the  judge can  start  a 
procedure against the producer. 
According  to  the  representatives  of the  food  industry,  the  real  control  on  the 
compliance with the interdiction of  health claims is exercised by the industry itself. 
As a matter of fact, when there is a manufacturer who makes use of a health claim on 
the packaging of one of its products, the first to intervene are its competitors, who get 
in  touch  with this  manufacturer to  convince  it  to  stop the  use  of the  claim.  This 
approach is  usually successful, as the threat to bring the issue in front of a court is  a 
useful tool of persuasion. 
b.  Ethical claims 
The subscription to this Register has to be renewed every three years.  In case the firm 
does not renew its  decision to  be included in  the  Register,  the  specific Monitoring 
Committee, which is instituted by the law itself, will take care of deleting the product 
or the firm from the Register. 
The  Monitoring  Committee  will  present  a  yearly  report  on  the  status  of 
implementation of the law.  This report will have to  be  presented to  the Parliament 
and to the Government by 31  May of each year. 
The Monitoring Committee will have the task of checking on a random basis whether 
the companies included in the Register fulfil the obligation not to use child labour.  In 
case the Monitoring Committee finds  out that  there are  violations,  it can decide to 
exclude the products concerned or the company from the Register.  When it deems it 
necessary,  the  Monitoring  Committee  can  also  publish  the  decision  to  exclude  a 
product or a company from the Register. 
c.  Out-of-Court Procedures 
The Self Regulation Code on  advertising of the  Institute  for  the  Advertising  Self-
regulation foresees a precise procedure for verifying claims. 
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There  are  two  separate  organs,  the  Jury  (Giuri)  and  the  Committee  of Control 
(Comitato di Controllo).  The Jury is made of  up ofbetween 9 and 15 members and is 
responsible to analyse cases of  possible violations of the Self Regulating Code which 
are  transmitted  by  the  Committee  of Control,  made  up  of between  10  and  15 
members. 
According to Article 36 of  the Code, 
"Whoever believes to  suffer from prejudices deriving from  advertising activities in 
breach of  the Code of  Self-regulation may ask for the intervention of  the Jury against 
those  who,  having  accepted  the  norms  of the  Code  [. . .]  have  committed  those 
activities which are deemed prejudicial". 
When the Jury decides that a certain piece of advertising is  in violation of the Code, 
then it can  ask  the  economic operator in question to  suspend its  use.  In  case  the 
economic operator does not comply with the decisions of  the Jury, the Jury can decide 
to make public this refusal in the newspapers, in magazines or on television. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Any legal person can demand the intervention of  the NAS. 
Moreover,  on the basis of the  Italian  law  on misleading advertising,  the  following 
persons are entitled to bring a case in front of  the Antitrust Authority: 
•  the competitors; 
•  the single consumer, the consumer associations or organisations; 
•  the Ministry of Industry; 
•  the Ministry of  Trade; and 
•  any other public administration, also on the demand of  the public. 
D.  BURDEN OF PROOF 
The burden to prove that a certain product has not the characteristics, which have been 
put  on  the  claim,  is  on  the  plaintiffs shoulders.  However,  it  is  normal  that  the 
company that is  investigated will tend to  provide all  the information to  demonstrate 
that what was said on the package was real. 
However, the norms on misleading advertising have different provisions.  As a matter 
of fact,  the Antitrust Authority can ask the advertising operator (the person who has 
commissioned the advertising or its creator) 
"to  provide  the  proves  on  the  material  accuracy  of the  data  contained  in  the 
advertising if,  considering  the  rights  or the  legitimate  interests  of the  advertising 
operator and of  whatever other  par~v in  the procedure, this can be justified, taking the 
specific  situation  into  account.  If  such  a proof is  not given  or  is  considered not 
sufficient, the data shall be considered inaccurate "(article 4). 
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1.  Nutritional claims and health claims 
According to the Decree 77 of 1993 implementing Directive 90/496 on the nutritional 
labelling of  foodstuff (see annex 1  ), 
"whoever manufactures, keeps for sale or sales products which are not in conformity 
with  the  rules  of the present Decree  is  punished with  the  administrative sanction 
which consists in paying an  amount of  money included between 1.250.000 liras and 
7.500.000 liras" (646 and 3.874 Euro). 
With  regard  to  foodstuff for  particular  nutritional  uses,  the  Decree  111  of 1992 
implementing the Directive 398/89 (see annex 3)  foresees different sanctions, which 
depend on what articles of  the Decree itself is violated. 
In case of a violation of Articles  1, 2,  3, 4, 5 and 6 (which contain the norms on the 
labelling of the foodstuff), the punishment consists of paying between 2 million and 
12 million liras ( 1. 03 3 and 6.198 Euro  ). 
In  case  of a  violation  of Article  7  (which  contains  the  rules  on  the  sale  of the 
foodstuff),  the  amount of money to  pay is  between  1 and  6 million liras  (516  and 
3.099 Euro). 
In  case someone imports foodstuff,  which should be submitted to  the  authorisation 
procedure foreseen in Article 8,  he will be sanctioned with a fine of between 10 and 
60 million liras (5.160 and 30.990 Euro). 
As health claims are not allowed in Italy, in case a manufacturer makes use of them, 
this  will  constitute  a  violation  either  of Decree  77/93  or of the  Decree  111/92, 
depending on the kind of  product. 
For cases that have been brought to the Antitrust Authority, these are judged on the 
basis of the misleading advertising law, which foresees  that the  Antitrust Authority 
can order a provisional ban of the advertising in case of urgency and/or it can order 
the  complete ban of the  advertising.  The  Antitrust  Authority  is  a  collegial  body, 
which takes  its  decisions by majority voting (it is  composed of 5 members).  If an 
advertising operator does not follow the order of the Antitrust Authority, he can be 
fined with up to 3 months imprisonment in conjunction with a fine of up to 5 million 
lira.  Decisions of  the Antitrust Authority can be appealed to an administrative court. 
2.  Ethical Claims 
Penalties applying to ethical claims fall under the misleading advertising law. 
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A.  PERTINENT CASE LAW 
1.  Nutritional Claims 
It  has  proved  impossible  to  find  a  case  debated  in  an  Italian  Court  which had  a 
controversy on a nutritional or a health claim as its basis. 
According to  the Ministry of Health,  this is  due  to  the  fact  that the  food  producer, 
before putting a product on the market,  asks  the Ministry whether it thinks that the 
label and the claims conform to the national legislation. 
This  sort  of preventive  control,  which  is  not  foreseen  by the  law,  works  well  in 
preventing these cases from reaching court. 
Moreover, according to the representative of the food industry, when there are claims 
that possibly violate the law, by saying something about a product which according to 
the current laws cannot be said,  the competitors themselves  intervene to  block this 
kind of  claim by acting directly against the producer. 
This kind of approach is also used for TV advertising: when there is  a producer who 
makes a TV advertisement which refers to,  for example,  the beneficial effects of a 
given product on human health, the same competitors act to  stop it.  The practice of 
stopping such advertising seems to  warn the company that its competitor may ask a 
judge to look into this issue, or by simply asking a consumer association to intervene. 
There have been two  cases:  one case against an  aspartame producer,  and one case 
against a specific kind of milk whose TV advertising was making reference to  some 
beneficial  effects for  the human heart.  In  both cases,  after the  intervention of the 
competitors, the TV advertising was suspended "voluntarily" by the producer, without 
the issue going to court. 
However,  the  Antitrust  Authority  has  analysed  several  cases  in  which  nutritional 
claims have been called into question. 
The Italian Antitrust Authority, Autorifa' Garante per Ia  Concorrenza ed if Mercato, 
is  an independent administrative authority, not a judicial one.  As mentioned above, 
the Antitrust Authority is a collegial body, which takes its decision by majority voting 
(it is composed of 5 members). 
In  1  992, the Antitrust Authority was also given the competence to rule on the respect 
of  the norms on misleading advertising. 
In  one  of the  cases  decided  on  the  basis  of the  misleading  advertising  rules,  the 
Pharmalife ltalia case of 1997  (see annex 21 ),  the Antitrust Authority analysed the 
claim and the advertising of food integrators, which are regulated in Italy by Decree 
111/92. 
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company had regularly transmitted the labels to the Ministry of Health, as foreseen in 
the Decree  111192,  and the Ministry of Health had authorised most of the claims on 
the labels, asking for some of  the claims to be changed as they were making reference 
to therapeutic properties of the products.  The producer complied with the requests of 
the Ministry of  Health. 
However,  according  to  the  Antitrust  authority,  the  claims  used  by Pharmalife  to 
advertise its products on leaflets and in  brochures constituted a case of misleading 
advertising.  As  a  matter of fact,  the  producer was  describing  its  products  in  the 
leaflets as  sport products or as integrators having particular features,  although these 
claims were not on the actual label of  the products. 
The Antitrust Authority decided that the claim on the advertising materials could have 
made the  consumer think that the products had characteristics that did not actually 
exist,  and  hence  the  advertising  was  declared  misleading,  even  if the  nutritional 
information on the label of the packages was correct. 
Another case on a nutritional claim decided by the Antitrust authority on the basis of 
the misleading advertising is the Cuore Oil case, of 1997 (see annex 22). 
According to a consumer, the claims used in the advertising of  this particular oil were 
misleading.  The  plaintiff focused  on  the  fact  that  many of the  claims  used were 
unfounded, as the actual content of  the oil could not have the effect claimed. 
This oil had been advertised with claims such as: 
•  with Cuore Oil lightness wins; 
•  with Cuore Oil unsaturated acids win; and 
•  health and youth of  our cells win. 
According to  the  consumer who  complained,  the  virtues  claimed by the  Cuore  oil 
were misleading, as the Cuore Oil had exactly the same characteristics as all the other 
oils. 
The  Antitrust  Authority  concluded  that  the  advertising  of this  oil  was  fully  in 
compliance with the existing legislation, and that all the claims used by the company 
producing the Cuore oil were well founded. 
In  particular,  the  Antitrust  Authority recognised  that  the  Cuore  oil  was  a  specific 
dietetic  product,  which  conformed  to  the  requirements  of the  Decree  111/92. 
Moreover, the producer was successful in providing scientific data to demonstrate all 
the properties described in the claims. 
2.  Health Claims 
There  are  no  cases  on  health  claims  that  have  been  judged  by  Italian  courts. 
Nevertheless, one was decided by the Italian Antitrust Authority.  Once again, it was 
focused on the advertising of  Cuore Oil. 
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In  the  case known as  Cuore Oil  II of 1998  (see  annex 23),  the Antitrust Authority 
analysed an  advertisement that appeared in  an  Italian newspaper,  in which various 
claims described the Cuore Oil as  a foodstuff which had "'a  wide range of  positive 
effects on health". 
This claim was supported by means of a series of other claims which tried to explain 
to  what extent the  nutrients  contained in this  particular oil  had  positive  effects  on 
human  health,  in  particular  with  reference  to  heart-vascular  diseases,  diabetes, 
arteriosclerosis and tumours. 
The Antitrust Authority, after a long analysis of the scientific elements, came to  the 
conclusion that none of the nutrients present in Cuore Oil could have a sure beneficial 
effect on the human diseases indicated in the claims. 
Moreover, and more interestingly, the Antitrust Authority made explicit reference to 
Article 6 of the  Decree  111/92, which explicitly says  that the  presentation and the 
advertising  of  foodstuff  for  particular  nutritional  uses  shall  not  either  imply 
characteristics aimed to prevent, cure or heal diseases, or mention such characteristics. 
On the basis of this provision and of the lack of scientific data which supported the 
health  claims  provided  by  the  advertising  of Cuore  Oil,  the  Antitrust  Authority 
declared the advertising misleading, and banned its further diffusion. 
3.  Ethical Claims 
Considering  that  the  law  on "Certification of social  conformity of those  products 
realised without making use of child labour" still has to  be finally approved by the 
Italian Parliament, it is impossible to present case law decided on that basis. 
No cases on ethical claims are known. 
VI.  MEANS OF COMMUNICATION 
There is no difference between the means of  communication. 
However, in cases where the Antitrust Authority is called to decide on the basis of the 
legislation on  misleading  advertising,  it  has  to  ask for  the  advise  of the  Authority 
responsible  for  monitoring  broadcasting  and  publishing  (Garante  per  la 
Radiodiffusione e l'Editoria) when the  advertising was either broadcasted on TV or 
published on the press. 
VII.  STATISTICS ON CLAIMS 
Real  statistics  on  nutritional  and  health  claims  were  not  available.  However,  the 
Antitrust Authority responsible for misleading advertising has published some data, 
which are useful. 
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advertising had been raised by the following plaintiffs: 
•  41% consumers; 
•  27°/o various associations; 
•  20% competitors; 
•  11% public administration; and 
•  1  o/o others. 
In the period 1992-1997, the Antitrust Authority analysed a growing number of cases 
related to  misleading advertising.  The number of cases which have been recognised 
as misleading increased as well: in 1992 only 35°/o of the cases analysed turned to be 
misleading, while in 1996 they were 73°/o, with more than 350 cases examined. 
Regarding the number of misleading messages found per communication tool  used, 
the statistics for the period 1992-1997are as follows: 
•  63% press; 
•  68o/o leaflet and brochure and publications; 
•  67% TV; 
•  79% post; 
•  49% package; 
•  61 °/o posters; 
•  58% radio; 
•  100% telephone (only one case). 
The areas which presented the highest number of misleading advertising per number 
of  cases analysed in the period May 1992-April 1997 are: 
•  Instructions and publishing, with more than  150  cases analysed and around 67o/o 
of  the cases found misleading; 
•  Trade, with more than 130 cases, and around 69% found misleading; 
•  Cosmetic  and  health  care,  with  more  than  100  cases,  and  around  70°/o  found 
misleading; 
•  Tourism and travels, with 60 cases, and 38% found misleading 
•  Food, with 42 cases and only 14% found misleading. 
VIII.  ANNEXES 
Legislation 
1.  Decree  16  Febbraio  1993,  No.  77,  implementing  EEC  Directive  496/90  on 
nutritional labelling of  foodstuff. 
2.  Decree 27 Gennaio  1992, No.  109,  implementing the EEC Directive No.  395/89 
and No. 396/89 on labelling, presentation and advertising of foodstuff. 
3.  Decree 27 Gennaio  1992, No.  111, implementing the EEC Directive No.  398/89 
with regard to foodstuff for particular uses. 
4.  Circular of  the Ministry of Health No. 8 of 7 June 1999 on sport foodstuff. 
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5.  Decree by the President of  Republic No. 272 of 30 June 1998 amending norms on 
production and commercialisation of  the beer. 
6.  Law No.  313 of 3 August 1998 on labelling of oilve oil  'extra vergine', olive oil 
'vergine' and of  olive oil. 
7.  Circular of the Ministry of Health No.  5 of 3 April  1998 on "Beverages coming 
from another EC Member which are characterised by high level of caffeine and 
taurine". 
8.  Decreto  Legislativo  25  Gennaio  1992,  No.  74,  implementing the  EC  Directive 
450/84 on misleading advertising. 
9.  Draft adopted by the  Senate of the Italian Republic, but not yet by the House of 
Representatives,  on  the  "Social  Conformity  Certification  for  products  realised 
without the use of  minors' work". 
10. Self-regulating Advertising Code by the  Institute for  Self-regulating Advertising 
Institute. 
11. Regulation by the Institute for Self-regulating Advertising on the Pharmaceutical 
section of  the monitoring committee. 
12. Internal  guidelines  of the  Ministry of Health  on  food  integrators  (unpublished 
document) 
13. Decree by the Ministry of Health No. 519, of7 October 1998  implementing EU 
Directive  8/96  on  foodstuff  destined  to  ipo-caloric  diets  aimed  at  weight 
reduction. 
14. Circular of the Ministry of Health No. 8 of 16 April 1996 on foodstuff integrated 
with vitamins and/or mineral and integrators. 
15. Decree 30 November 1991, No. 425, implementing Articles 13,  15  and 16 of the 
EEC Directive 552/89 on television advertising of tobacco products and alcoholic 
beverages and on the protection of  minors. 
16. Act of 6 Agosto  1990,  No.  223:  discipline  of the  public  and private television 
system (known as Mammi' Act). 
17. Decree  by the  President  of Republic  27  Marzo  1992,  No.  255  - Regulation 
implementing the Law 223/90 on the discipline of  the public and private television 
system. 
18. Decreto Legislativo 28  Agosto 1995, No. 356 - Urgent provisions on the budgets 
of those enterprises active in the publishing and broadcasting sector, and on  the 
prosecution  of activities  of television  and  radio  broadcasters  which  have  an 
authorization at local level. 
19. Decreto del Presidente della Repubblica No.  627,  10 October 1996 - Regulation 
setting up the rules for the preliminary procedures of the Authority responsible for 
the competition with regard to misleading advertising. 
20. Decree by the Ministry of Health No.  518, of 1 June  1998 implementing the EU 
Directive 4/96/CE on foodstuff for suckling babies. 
Case Law 
Autorita' Garante per la Concorrenza ed il Mercato (Antitrust Authority): 
21. Case No. 4568 of 1997, Olio Cuore; 
22. Case No.  5228 of 1997, Pharmalife ltalia; 
23. Case No. 6124 of 1998, Olio Cuore II. 
IX.  DATABASE OF CONTACTS 
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K.  LUXEMBOURG 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
The study on nutritional, health and ethical claims was generally well received by all 
interested parties  in  Luxembourg.  Overall,  interested parties were pleased that DG 
XXIV was taking an interest in these issues. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of  a nutritional claim is the same as defined in EU law. 
2.  Health Claims 
With  regard  to  health  claims,  these  are  banned  under  the  national  implementing 
legislation of Directive 79/112. Luxembourg legislation on the one hand implements 
Directive 79/112 word by word.  But in  addition, further provisions are  made under 
Luxembourg  legislation,  which  somewhat  extends  the  prohibitions  of Directive 
79/112. 
The use of certain enhanced function claims, as defined under the latest Codex draft 
recommendations  for  the  use  of health  claims,  seems  to  be  rather  limited  under 
Luxembourg legislation. The reduction of the risk of disease claims, as defined under 
the same Codex draft, are clearly not permitted under Luxembourg legislation. 
No  legislative  initiatives  are  foreseen  with  regard  to  nutritional,  health  or ethical 
claims,  nor  is  there  any  ongoing  discussion  on  these  issues  taking  place  in 
Luxembourg. 
3.  Ethical Claims 
Ethical claims seem to be a non-issue in Luxembourg.  Neither any specific labelling 
schemes  have  been developed  in  Luxembourg,  nor are  any political  or regulatory 
initiatives planned. 
C.  VOLUNTARY CODES OF PRACTICE 
No voluntary codes of practice exist in Luxembourg, moreover, no  such codes  are 
planned, with the exception of "Trans  fair Minka Luxembourg." 
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With regard to the criteria for substantiating claims, the only ones applying are those 
set out in the law on nutritional labelling.  As for dietary foods, the ones set out under 
the notification procedure of  dietary foods apply. 
There exists no pre-vetting in  Luxembourg.  A posteriori controls are undertaken by 
the  Laboratoire  National  de  Sante,  the  Inspection  Sanitaire  (Health  Inspection 
Service) of  the Ministry of  Health, and by the police (control of  markets). 
The  burden of proof lies  with the  complainant.  Penalties can range  from  1000  to 
30000 Luxembourg Francs and/or 8 days to one year imprisonment. 
E.  MEANS OF COMMUNICATION 
There are no differences between the means of  communication. 
F.  CONSUMER PROTECTION 
The consumer associations and the government feel that single-market rules and more 
specifically the  obligation to  allow the  marketing of a product on the  Luxembourg 
territory if it is allowed on the territory of another Member States creates difficulties. 
The Luxembourg administration does not have the resources to control every products 
entering its market and hence fear that the protection of consumers might not always 
be  guaranteed.  Hence,  Luxembourg  can  only rely  on  the  controls  made  in  other 
European countries. 
Similarly, judicial redress  procedures  are  difficult  to  use  in  Luxembourg,  since  in 
most  cases  the  producer  of the  product  does  not  operate  on  the  territory  of 
Luxembourg and if its claims are accepted in another Member States, it is difficult to 
challenge them in Luxembourg. 
G.  BARRIERS TO TRADE 
No barriers to  trade have been reported.  This is  due on the one hand to  the fact that 
there  is  only  a  very  small  Luxembourg  food  industry  and,  on  the  other  hand,  to 
Luxembourg's proximity to the markets of its neighbouring countries.  In this way, it 
is basically forced to accept their products on its market. 
H.  CASELAW 
There exists no case law on nutritional, health or ethical claims in Luxembourg. 
I.  STAKEHOLDERANALYSIS 
Luxembourg,  being  the  smallest  EU  market,  is  in  general  forced  to  allow  the 
marketing of all products that are already on the market in other Member States.  In 
particular,  as  Luxembourg does  not  have  the  necessary resources  to  control  every 
product entering its market, the authorities consider the development of a control at a 
European level a potential solution to problems of  consumer protection. 
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In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  The authorities are in favour of  a control of  claims at the European level. 
2.  Consumers 
•  Equally,  consumer  associations  are  m  favour  of a  control  of claims  at  the 
European level. 
•  On  ethical  claims,  the  Luxembourg  fair  trade  associatiOn  considers  that  the 
certification of fair traded products needs, in the medium-term, to be regulated at 
international level. 
3.  Industry 
•  There is no position. 
*** 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The Reglement Grand-Ducal of 22  June 1992  on Nutrition Labelling (see Annex  1) 
defines  a  nutritional  claim  as  "any representation  and  advertising  message  which 
states, suggests or implies that a foodstuff has particular nutrition properties due to the 
energy (calorific value) it 
provides, 
provides at a reduced or increased rate, or 
does not provide, 
and/or due to the nutrients it 
contains, 
contains in reduced or increased proportions, or 
does not contain." 
Luxembourg  legislation,  therefore,  implements  word  by  word  the  EU  Directive 
90/496. 
2.  Health Claims 
There is  no  definition of health claims as  such in Luxembourg legislation. However, 
the  Reglement Grand Ducal of 16  April  1992  on the  labelling and presentation of 
foodstuffs (see Annex 2) provides for a negative definition. It states in article  15  (2) 
that it  is  forbidden to  attribute to  a  foodstuffs  properties "of preventing, treating or 
curing a human disease". In addition article 16 states that: 
..... it is forbidden to use in the labeling of  foodstuffs: 
1.  names of diseases and any allusion to  diseases or to people suffering from  a 
disease; 
2.  names or representation, even in abstract form,  of organs or circulatory and 
nervous systems that may imply that the foodstuff has such effects~ 
3.  representations or people, clothes, or machines relating to  the  medical, para-
medical or pharmaceutical activities; 
4.  references to  recommendations, attestations, declarations or medical advises, 
except if  it is to mention that the foodstuff does not suit certain diets; 
5.  reference to the Ministry of  health; 
6.  references to weight loss diets; 
7.  any  indication  referring  to  health  in  general  such  as  "supporting" 
[reconfortant],  '•fortifying",  "energizing",  "'for  your  health'',  'vitalizing'  of 
foodstuffs or of  products consumed for pleasure that contain alcohol; 
8.  claims that may- exploit or provoke anxiety; 
- discredit similar foodstuffs." 
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Furthermore, article 17 ofthe same law, forbids: 
"claims referring to objective and measurable elements, which cannot be justified", as 
well as  "references to  an effect of the  foodstuff on health or the metabolism, if the 
proof of that claim is  not provided, without prejudice of the provisions of article  16 
above" 
In addition, labelling and methods used in labelling that are misleading are forbidden. 
In particular, those attributing to a foodstuff effects or properties that it does not have, 
and  by suggesting  that  a  foodstuff has  particular  characteristics,  when  all  similar 
foodstuffs have the same characteristics (article 15 (1.2.) and (1.3.) ). 
Luxembourg  legislation  is  thus  implementing  word  by word  article  2  of the  EU 
Labeling Directive 79/112. However, a number of further provisions are made, which 
extend the prohibitions of  Directive 79/112. 
Under  Luxembourg  legislation,  the  use  of certain  enhanced  function  claims,  as 
defined under the latest Codex draft recommendations for the use of health claims, 
seems to  be rather limited.  Disease risk reduction claims as  defined under the same 
Codex draft are clearly not permitted under Luxembourg legislation. 
3.  Ethical Claims 
There is no definition of  ethical claims in national legislation. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Nutritional claims are regulated by the Reglement Grand-Ducal of 22  June  1992 on 
the nutritional labelling of food products (as last amended in 1998) (see Annex 1) and 
implements Directive 90/496. 
The  regulation  provides  that  nutritional  labeling  ts  mandatory  if the  labeling  of 
foodstuffs contains nutritional claims. 
2.  Health Claims 
The Reglement Grand Ducal of 16  April  1992  on  the  labeling and presentation of 
foodstuff (see Annex 2)  regulates the use of health claims and implements Directive 
79/112. 
Foodstuffs for particular nutritional uses are regulated by Reglement Grand Ducal of 
8  April  1991  (as  last  amended  in  1997)  (see  Annex  3)  and  implements  Directive 
89/398. 
Misleading Advertising  is  regulated by the  Law of 27  November  1986  on Certain 
Commercial  Practices  and  Sanctioning  Unlawful  Competition  (as  last  amended  in 
1992) (see Annex 4  ). It implements Directive 84/450. 
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There is no specific legislation on ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Mineral waters and foodstuff for particular nutritional uses are not within the scope of 
the national legislation on nutritional claims. 
2.  Health Claims 
In principle, all health claims are forbidden. 
3.  Ethical Claims 
There is no specific legislation on ethical claims.  Therefore, the general Law of 27 
November  1986  on  Certain  Commercial  Practices  and  Sanctioning  Unlawful 
Competition applies to such claims. 
Under article 17 of this law dealing with "false indications", it is considered unlawful 
competition  inter alia  when  an  economic  operator makes  wrong indications  which 
mislead the consumer, as well as  inexact indications on the nature of the product its 
conditions of  productions and its quality (notably para. a) and i) of  article 17). 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
There is no ongoing discussion on the issue of nutritional, health and ethical claims in 
Luxembourg, nor are any legislative developments foreseen. 
The consumer associations and the government feel that single-market rules and more 
specifically the  obligation to  allow the  marketing of a product on the  Luxembourg 
territory if it is allowed on the territory of another Member States creates difficulties. 
The Luxembourg administration does not have the resources to control every product 
entering its market and hence fear that the protection of consumers might not always 
be  guaranteed.  Hence,  Luxembourg  can  only  rely  on  the  controls  made  in  other 
European countries.  The development of a control  at a European level  is  seen as  a 
potential solution to this problem (see also Annex 5). 
The Luxembourg fair trade NGO (TransFair Minka) indicated that it was under the 
impression that large companies were sometimes using wording that implied that they 
were fair trading, without actually doing so. 
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III.  VOLUNTARY INSTRUMENTS AND OTHER PRACTICES 
1.  Nutritional and Health Claims 
There are no  voluntary agreements or other practices with regard to  nutritional and 
health claims. 
2.  Ethical Claims 
The  Luxembourg fair  trade  organisation,  TransFair Minka,  acts  as  an  independent 
organisation selling licences for the use of  its TransFair-Seal. 
The seal guarantees that certain social standards are  met in  third countries (such as 
minimum  salary  paid,  no  child  labour,  guaranteed  workers  employment  rights 
according to  national  and  international law).  Furthermore, the  seal  guarantees that 
certain  environmental  standards  are  being respected.  TransFair  Luxembourg is  in 
principle using the  same  licensing agreements  as  TransFair Germany (see  German 
report). 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
Article 7 of  the Reglement Grand Ducal of 8 April 1  991  on foodstuffs for a particular 
nutritional use provides that the producer or the importer of the product has to inform 
the Ministry of Health before the product is  put on the market.  The producer or the 
importer must forward an example of the labeling to the Ministry.  The ministry can 
request the producer to provide the scientific evidence to substantiate its claims. 
Furthermore, article  17  of the Reglement Grand Ducal of 16  April  1992 regulating 
food  labelling, provides that references to  the  effect of a foodstuff on health or the 
metabolism may not be made,  if the proof for that claim cannot be submitted.  No 
further  indications  are  made  in  this  law,  as  to  which  kind  of proofs  need  to  be 
submitted. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
A  posteriori,  controls  are  undertaken  by  the  Laboratoire  National  de  Sante,  the 
Inspection Sanitaire (Health Inspection Service) of the Ministry of Health, and by the 
police (control of  markets). 
The  control  of advertising  IS  undertaken  by  the  pharmaceutical  division  of the 
Ministry of  health. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
The administration, consumer organizations and individuals are entitled to  take legal 
action  (see  notably  article  21  of the  Law  on  Certain  Commercial  Practices  and 
Sanctioning Unlawful Competition). 
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In  terms  of advertising,  the  burden of proof belongs  to  the  producer marketing  a 
product with the use of  a claim. 
However, if a product is  already on the market, the complainant bears the burden of 
proof. 
E.  APPLICABLE PENAL  TIES 
In  practice, the  producer is  requested to  modify its  advertising or its  labelling.  In 
theory, infringements of the  food  legislation previously mentioned, are regulated by 
article 9 of the law of 25 September 1953 on the Reorganisation of Food Control (see 
Annex  6).  The  penalties  established under article  9  range  from  1 000  to  30  000 
Luxembourg Francs and/or 8 days to one year imprisonment applies. 
To  violations  of article  17  of the  Law  on  Certain  Commercial  Practices  and 
Sanctioning  Unlawful  Competition,  which  forbids  operators  to  make  wrong 
indications  which mislead  the  consumer (see  II.C)3.  ),  the  following  penalties  are 
applicable:  firstly,  an  order by the  Court  to  stop  any  acts  contrary  to  this  law; 
secondly, if  the defendant does not conform to this order, a fine between 10,000 and 2 
million Luxembourg Francs  can  be  imposed.  If within  a  period of five  years  an 
economic operator is  for the  second time ordered by the  Court to  stop any acts  of 
unlawful competition, automatically a fine between 10,000 and 2 million Luxembourg 
Francs is imposed (article 21  and 22). 
Judicial redress procedures are difficult to use in Luxembourg, since in most cases the 
producer of the  product does not operate on the territory of Luxembourg and if its 
claims  are  accepted in  another Member  States,  it  is  difficult  to  challenge  them  in 
Luxembourg. 
The Luxembourg fair trade association considers that the  certification of fair traded 
products needed in the medium-term to be regulated at international level. 
V.  CASELAW 
There exists no case law on nutritional, health or ethical claims in Luxembourg. 
VII.  MEANS OF COMMUNICATION 
There are  no  differences between means of communication. The Reglement Grand-
Ducal of 16  April  1992  on food  labelling states  in  article  19  that it applies  to  the 
presentation, packaging, packaging material used and advertising of  foodstuffs. 
Furthermore,  the Law of 27  November  1986 on  Certain Commercial Practices and 
Sanctioning Unlawful Competition does not make any difference between means of 
communication. 
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VII.  STATISTICS ON CLAIMS 
We did not come across any statistics. 
VIII.  ANNEXES 
1.  Reglement  Grand-Ducal  du  22  juin  1992  relatif a l'etiquetage nutritionnel  des 
denrees alimentaires 
2.  Reglement  Grand-Ducal  du  16  avril  1992  concernant  l'etiquetage  et  la 
presentation  des  denrees  alimentaires  ainsi  que  Ia  publicite  faite  a leur  egard 
(version du 7 juillet 1998) 
3.  Reglement Grand-Ducal du 8 avril 1991  relatif aux denrees alimentaires destinees 
a  une alimentation particuliere (version du 4 novembre 1997) 
4.  Loi  du  27  novembre  1986  reglementant  certaines  pratiques  commerciales  et 
sanctionnant la concurrence deloyale (version du 29 mai 1992) 
5.  Note du Laboratoire National de Sante 
6.  Loi  du  25  septembre  1953,  ayant  pour objet la  reorganisation  du  controle  des 
denrees alimentaires, boissons et produits usuels. 
IX.  DATABASE OF CONTACTS 
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L.  THE NETHERLANDS 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This  study  on  nutritional,  health  and  ethical  claims  has  been  conducted  with  the 
positive  contribution  of all  parties  concerned  in  The  Netherlands.  Whereas  some 
parties concerned initially thought the idea of the  study was born out of the dioxin 
crisis(!) everyone felt it was a very good initiative to map out the regulatory practice 
regarding  claims  and  to  highlight  the  areas  in  which  DG  XXIV  eventually  could 
intervene. 
B.  MEMBER STATE POLICY 
1.  Nutritional claims 
The  definition  of a  nutritional  claim  is  the  same  as  the  one  used  in  Directive 
90/496/EEC.  Claims  related  to  nutrition  but  which  do  not  concern  the  nutritional 
value,  do  not  fall  under  this  definition.  On  these,  the  rules  with  respect  to  the 
prohibition on the use of  misleading claims and the use of medical claims are applied. 
Policy  thinking  by  the  public  authorities  is  that  current  legislation  on  nutritional 
claims is satisfactory and that restriction or extension of  possibilities should take place 
on  the  basis  of nutritional  goals  that  are  being pursued.  Dutch  regulatory practice 
regarding nutritional claims goes  further than EU law and is  considered satisfactory 
by the parties concerned. Apart from some fine-tuning regarding optional rules, there 
seems to be no need for adaptation. The only policy developments taking place in this 
field concern different types of  fats. 
2.  Health claims 
Dutch law does not contain any definition of  health claims. However, relevant parts of 
Directive  79/112/EEC  dealing  with  health  claims  have  been  implemented  in  The 
Netherlands via the Commodities Act ('Warenwet'). The Dutch policy and regulatory 
practice regarding health claims allows this type of claim for foodstuffs providing that 
they are true and not misleading. It is, however, forbidden to allude to medical claims. 
In general, all parties concerned feel that the current policy regarding health claims is 
satisfactory. The public authorities play a supporting, but modest role,  leaving room 
for self-regulation. There seems to be no immediate need in The Netherlands for new 
legislation regarding health claims at national level and most of the parties concerned 
do see the need for future legislative developments to be arranged at EU level. 
Nevertheless, the Dutch foodstuffs industry feels that a clearer definition could cover 
borderline cases in the subtle field between positive health claims and medical claims. 
The  industry  considers  that,  under  the  conditions  of the  voluntary  instruments  in 
place,  the  Dutch  Commodities  Act  should  not  prohibit  health  claims  aimed  at 
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could be captured under a code of  practice. 
It is worth noting here that over the past years a debate has been taking place in The 
Netherlands  regarding  functional  foods,  novel  foods,  food  supplements  and  the 
verification problem of  claims in this field. 
3.  Ethical claims 
There is  no  legal definition of ethical  claims and no directly relevant legislation in 
The  Netherlands.  Neither  is  there  any  specific  policy.  Nevertheless,  the  relevant 
articles  from  the  Dutch  Civil  Code  and  the  general  guidelines under Part I of the 
Dutch Advertising Code that stipulate that advertisements must not be misleading or 
untrue  are  applicable  to  ethical  claims.  In  particular,  the  rules  in  this  section 
stipulating that advertising must not be gratuitously offensive or contrary to good taste 
and common decency refer to ethical claims. 
In The Netherlands, the Ministry of Economic Affairs and the Ministry of  Agriculture 
are responsible for social claims and animal welfare claims respectively. Currently, a 
project  group  under  the  Ministry  of Economic  Affairs  is  looking  into  consumer 
concerns.  This  might provide  some  information  on  public  opinion  towards  ethical 
claims.  For the Ministry of Agriculture,  ethics,  in  general,  play a role in its  policy 
preparation regarding guaranteeing animal welfare and food safety. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional, Health and Ethical claims 
While  no  specific  voluntary  instruments  exist  in  The  Netherlands  for  nutritional 
claims,  there is  one voluntary code relevant for all  three types of claims and there 
exist some specific instruments for health respectively ethical claims. 
a.  Dutch Advertising Code 
The most important voluntary code of practice regarding claims in The Netherlands, 
however,  is  the  Dutch  Advertising  Code  ('Nederlandse  Reclame  Code'),  which 
contains rules that, in principle, apply to  all three types of claims. It consists of two 
parts. 
The first  part of the Code contains  general  guidelines that stipulate,  inter alia,  that 
advertisements must not be misleading or untrue. This section also contains a number 
of rules based on subjective criteria. One of these stipulates that advertising must not 
be gratuitously offensive or contrary to good taste and common decency. The second 
part contains special guidelines and related rules for specific products and services. 
These  were  drafted  in  co-operation  with  self-regulatory  bodies,  such  as  the 
Foundation  for  the  Responsible  use  of  Alcohol  ('Stichting  Verantwoord 
Alcoholgebruik'), the Advertising Steering group Foundation ('Stichting Stuurgroep 
Reclame'). 
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2.  Health claims 
There exist two voluntary codes regarding health claims in The Netherlands. 
a.  Code of Practice Health Benefits Health Claims 
The  Code  of  Practice  Health  Benefits  Health  Claims  ('Gedragscode 
Gezondheidseffecten Gezondheidsclaims) aims to  find evidence for health claims on 
foodstuffs to  be scientifically founded and reported.  This Code was initiated by the 
Dutch  Nutrition  Centre  ('Voedingscentrum'),  which  is  an  independent  non-profit 
organisation  consisting  of  professionals  in  the  food  sector.  This  organisation 
facilitates the testing procedure, by bringing together a panel of  independent academic 
specialists. The disadvantage of the Code of practice is  that it concerns a heavy and 
expensive procedure, whereby the addressee has to go through prescribed stages. 
The Code has been in force  since April  1998  and,  so far,  three products are  in  the 
pipeline and, in the future, one can expect several margarine producers to make use of 
the  testing  procedure  with  a  view  to  having  their  claims  confirmed.  Although  a 
signatory of  the Conduct Code, industry is still uneasy about the testing procedure and 
the functioning of  the Code will be evaluated in two years time in order that it may be 
attuned to safety assessment methods. 
b.  KOAG/KAG Code for the advertisement of Health products 
The highly regarded  'KOAG/KAG Code for the advertisement of Health products' 
('KOAG/KAG  Code  voor  de  aanprijzing  van  Gezondheidsproducten'),  is  mainly 
aimed  at  preventing the  use  of medical  claims  on  health  products.  The  Code was 
initiated by the Dutch Verification Council ('Keuringsraad'), a self-regulatory body 
for the public advertising of medicinal products (KOAG) and natural remedies and 
other health products (KAG), and has been in place for many years now. KOAG/KAG 
does not handle complaints. 
3.  Ethical claims 
There exist two labelling schemes in The Nether  lands regarding ethical claims, while 
a further two are being developed. 
a.  The Max Havelaar Trademark 
The best known idealist scheme in The Netherlands is the 'Max Havelaar Trademark' 
('Max Havelaar Keurmerk').  This  is  an  instrument  to  help  farmers  in  developing 
countries and thereby improve the country's economic situation. The trademark, with 
32 licensees in the field of coffee, bananas, tea and cacao, was initiated because of a 
need among producers. The idea behind the trademark is to inform consumers. 
b.  Fair Trade Charter for Garments 
Secondly, there is a 'Fair Trade Charter for Garments', which is a code of conduct for 
all  retailers  selling clothes  in  The Netherlands.  This  is  part  of the  'Clean Clothes 
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produced in developing countries. 
c.  Others 
The Dutch organisation Fenecom is working on a trademark for the clothes-sector in 
The  Netherlands  under  the  name  Fair  Trade  Charter  for  Clothes  Foundation 
('Stichting Eerlijke Handels Handvest voor Kleding'). The aim of the trademark is to 
support the International Labour Organisation (ILO) rules. 
D.  VERIFICATION SYSTEMS 
The system for verifying claims in The Netherlands is twofold: on the one hand, there 
is  the Health Protection Inspection/Commodities and Veterinary surgeons ("Inspectie 
Gezondheidsbescherming/Waren  en  Veterinairen"),  a  public  authority  appointed 
(market)  supervisor,  and  on  the  other  hand,  there  is  the  Advertising  Standard 
Committee ("Reclame Code Commissie"), a private body and not a legal court in the 
strict sense of  the word. 
1.  Health Protection Inspection 
The Health Protection Inspection can initiate a post-clearance procedure (notifications 
of  claims are only obligatory under the 'Directives for Special Foods') to prove that a 
particular claim is untrue. However, it usually works on the basis of  complaints about 
non-compliance with the Commodities Act. The possibility for lodging a complaint is 
not  limited  to  certain  groups  or persons  however.  The  number of cases  regarding 
claims  dealt  with  by  the  Health  Protection  Inspection  has  been  relatively  small. 
According to the Inspection, this method has a preventive function. 
As far as the procedure of the Health Protection Inspection is concerned, infringement 
of  the rules on claims is considered an economic offence and is to be submitted to the 
Public Prosecutor who will notify the party concerned by means of a warrant. A first 
infringement will be penalised by a settlement consisting of a relatively little amount 
of money. In case of a second breach of the rules and when a claim is considered to 
endanger  public  health,  the  Public  Prosecutor  can  eventually  decide  on  taking  a 
particular product off  the market. 
2.  Advertising Code Committee 
Real  verification  in  The  Netherlands  is  taking  place  by  an  Advertising  Code 
Committee, set up  by the Advertising Code Foundation ('Stichting Reclame Code'). 
The  Advertising  Standard  Committee  has  the  remit  of assessing  compliance  of 
advertisements with the Dutch Advertising Code ('Nederlandse Reclame Code'). The 
committee does not work with a pre-clearance system - complaints are made to  the 
committee. It is empowered to monitor advertisements on its own initiative. However, 
in practice it rarely does so, because monitoring is considered unacceptably arbitrary. 
In the event of an appeal against the Committee's ruling, the matter is referred to the 
Appeals  Board  ('College  van  Beroep'),  which  issues  a  definite  ruling.  If  an 
advertisement is  found to  infringe the Dutch Advertising Code, the Committee will 
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instruct the  advertiser to  stop using it  in  its  current  form.  In  the  event of a repeat 
offence or a  serious  violation of the  Code,  the  Committee-affiliated media will  be 
instructed to stop publishing the advertisement concerned. 
The  Advertising  Code  Committee  can  ask  anyone  using  a  claim  to  prove  that  a 
particular claim is  true.  Until  now,  only a  limited number of cases  have been put 
before the  Advertising Standard Committee.  Most of the  cases  the  Committee has 
been dealing with health claims and, in particular, borderline cases. This shows that 
there is  a growing tendency in The Netherlands to use forms of medical claims. In its 
judgements,  the  Advertising  Code  Committee  does  not  yet  refer  to  the  Code  of 
practice Health benefits 1998. 
The  twofold  verification  system  of  claims  in  The  Netherlands  has  not  been 
functioning to  the  satisfaction of all  parties  concerned and could cause barriers  to 
trade or lack of consumer protection as  far as  positive health claims are concerned. 
According to  the  Health Protection Inspection, producers of claims are inventive in 
using scientific information and this makes it very difficult to prove whether a claim 
is legally true or not. 
E.  MEANS OF COMMUNICATION 
In general, the Dutch Commodities Act and its relevant Decrees apply to 'dealing' in 
foodstuffs and non-foodstuffs and make no distinction between the use of nutritional 
and health claims in advertising or in labelling. The application of the regulations is 
independent from the medium used, although it has to be said that the 'Commodities 
Act'  does  not  refer  to  the  'Advertising  Code',  which  specifically  deals  with 
misleading advertising. 
The  fact  that  claims  from  other  countries  can  easily  appear  on  the  Internet  is 
considered rather a practical than a legal problem. Claims on the Internet fall, like any 
other nutritional and health claims, under the provisions of  the Commodities Act. And 
also  the  testing  procedure  of the  Code  of Practice  makes  no  difference  between 
communication means. 
F.  CONSUMER PROTECTION 
Borderline cases between positive health claims and medical  claims may lead to  a 
potential lack of consumer protection in The Netherlands since it is difficult to prove 
whether  this  type  of health  claim  is  misleading  or  not.  According  to  the  Dutch 
Consumer association, the EU could play an important role. However, it has to be said 
that steering the issue at EU level would require further information on the way in 
which all the Member States deal with substantiating of  claims. 
G.  BARRIERS TO TRADE 
It is  said that potential trade barriers are  caused by differences in the interpretation 
and substantiating of claims between the Member States of the European Union.  A 
recommendation by the Dutch Nutrition Centre to counterbalance these differences is 
to  initiate and facilitate  a  similar instrument as  the  Dutch  Code of Practice Health 
Benefits 1998 at European Union level.  Panels that are testing claims in accordance 
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Member States. However, this implies that cultural differences would first have to be 
overcome. This could take some time. 
The EU could also play a role in initiating a common sanctioning system in all the 
Member States.  This  solution would have the benefit of overcoming both potential 
trade barriers and potential lack of  consumer protection. 
H.  CASELAW 
There is  no important case law in The Netherlands on nutritional claims, while no 
case law at all exists on ethical claims.  Regarding health claims, there  is  one case 
judged by a civil court in The Netherlands: The Nimm-2 case, on a health claim for 
sweeteners. 
Talks with people from the Inspection Health Protection indicated that a warrant had 
been  given  a  maximum of ten  times  following  infringement of Article  19  of the 
Commodities  Act.  Until  now,  it  has  never  come  to  prosecution.  In  50  cases, 
advertisers have been pointed at a possible infringement of the Articles 19 and 20 of 
the Commodities Act, followed by a discussion with the advertiser. According to the 
Inspection, this method has a preventive function. Criminal verification of advertising 
regulations is in general not very effective, partly because of  difficulties regarding the 
burden of  proof. 
Real  verification  is  taking  place  through  complaints  at  the  Advertising  Code 
Committee. The following 3 cases that have been put before the Advertising Standard 
Committee are  worthwhile mentioning because of the great impact of the verdicts: 
Decision  26.10.1994  (see  Annex  9),  Decision  18.12.1995  (see  Annex  10)  and 
Decision 02.07.1996 (see Annex 11). The above mentioned cases show that it is  not 
the Health Protection Inspection, but the Advertising Code Committee that plays an 
important role in more precisely defining borderline cases concerning health claims. It 
is this Inspection that fills the legal gap wherever there could be a lack of consumer 
protection. 
I.  STAKEHOLDER ANALYSIS 
In general, whilst all parties concerned in The Netherlands are content with the way 
nutritional claims are regulated, they underline the importance of the voluntary codes, 
in  particular regarding health claims.  The  issue of ethical  claims has received  less 
attention  by  the  main  actors  in  The  Netherlands.  Most  parties  agree  that  future 
developments regarding health and ethical claims should be co-ordinated at EU level. 
However, their approach to the issue differs. 
In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  On nutritional claims, the Dutch public authorities see no need for review. 
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voluntary  codes  of practice  and  labelling  schemes.  However,  informally  the 
Ministry of Health and the Health Protection Inspection are  positive about both 
codes. It has to be said that the functioning of  the Code of  practice Health Benefits 
1998 still has to prove itself. The public authorities would like to see a regulatory 
system,  including all  the  codes.  They have already started discussing this  issue 
with the parties concerned. However, it is  clear that it will not be easy to  find a 
solution,  which  meets  the  requirements  of all  parties  concerned.  The  Health 
Protection  Inspection  feels  that  the  verification  system  of  claims  in  The 
Netherlands does not function  satisfactorily as  far  as  positive health claims are 
concerned. According to the Health Protection Inspection, producers of claims are 
inventive  in  using scientific  information.  This  makes  it  very difficult  to  prove 
whether a  claim is  legally  true or not.  They would  welcome  EU  involvement. 
However, they do not know exactly what action the EU should take. 
•  On ethical claims, there is no formal policy. The Ministry of  Economic Affairs has 
just  started  looking  into  consumer  concerns,  which  might  generate  some 
information on public opinion about ethical claims. 
2.  Consumer Organisations 
•  According to  the Dutch Consumer Association, the EU could play a general role 
in the verification of borderline cases between positive health claims and medical 
claims. The Association points out, however, that steering the issue at European 
Union level would require further information on the way all the Member States 
deal with substantiating of  claims. 
3.  Industry 
•  On nutritional claims, the Dutch Foodstuffs Industry has no substantial comments. 
•  On health claims,  industry feels  that a clearer definition could cover borderline 
cases in the subtle field between positive health claims and medical claims. The 
industry considers that, under the conditions of  the voluntary instruments in place, 
the Dutch Commodities Act should not prohibit health claims aimed at preventing 
human diseases.  Industry feels  that this  type of so-called effect claims could be 
captured under a code of  practice, eventually at EU level. 
•  On ethical claims, industry has no particular position apart from a preference for 
self-regulation. 
•  In  conclusion,  we  would surmise  that  future  developments  in  The  Netherlands 
regarding claims could require EU co-ordination. This is particularly the case with 
regard to the borderline cases between positive health claims and medical claims. 
There is  also a need for a better integration of ethical claims and codes into the 
policy field to ensure optimum consumer protection. 
* * * 
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In good Dutch tradition, claims policy in The Netherlands is the result of consultation 
with all the parties concerned. As far as nutritional and health claims are concerned, 
these  consultations  are  expressed  through  the  'Regular Deliberation  Commodities 
Act' forum.  Here both public authorities and consumers and industry are represented. 
Other parties concerned, such as nutritionists and retailers, are closely involved in the 
deliberations of  this forum. 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The definition of  nutritional claims is provided in article I, paragraph I.f of  the Dutch 
Commodities  Act Decree  on  Nutrition  Labelling of Foodstuffs  ("Warenwetbesluit 
V  oedingswaarde-informatie  Levensmiddelen'',  Decree  of 07  September  1993,  Stb. 
1993, 483, as amended by Decree of 15  January 1997, Stb.  1997, 20, (see Annex  I), 
implementing Directive 90/496/EEC concerning Nutrition Labelling. The definition is 
the same as the one used in Directive 90/496/EEC. 
In Article  I, paragraph I.f of the above mentioned Decree it reads:  'Any advertising 
message that is not part of  a collective advertising campaign, and any message which 
states,  suggests  or  implies  that  a  foodstuffs  as  far  as  the  energetic  value  or  the 
presence of  nutrients is concerned, has particular qualitative or quantitative nutritional 
properties, as long as these kind of messages are not prescribed in or in virtue of any 
legal regulation". 
Everything  falling  under  the  definition  of nutritional  claims,  in  conformity  with 
Directive  90/496/EEC,  is  considered  to  be  a  nutritional  claim.  The  explanation of 
'nutrition labelling' and 'nutrition claims' are essentially the same. Claims related to 
nutrition but which do not concern the nutritional value, as such do not fall under this 
definition. On these, the rules, with respect to the prohibition on the use of  misleading 
claims and the use of  medical claims, are applied. 
Definitions  of  protein,  carbohydrate,  sugars,  fats,  saturates,  monounsaturates, 
polyunsaterates  and  'average value'  are  the  same  as  the  Directive  90/496/EEC.  In 
addition,  the  Dutch legislation  includes  'polyols'  (sweeteners),  'salt'  and  'content' 
(quantity).  There is  no  definition of 'fibre'; however,  a method of analysis  for  the 
determination of  the content of  soluble and insoluble fibre is laid down (the enzymic-
gravimetric method according to Asp et al). 
2.  Health Claims 
Dutch  law  does not contain  any definition of health claims.  Before  discussing  the 
generally accepted definition of health claims in The Netherlands, it  is  necessary to 
clarify the legal distinction between foodstuffs, health products and medicines. 
Foodstuffs are considered to be edible items and drinking stuffs in terms of the Dutch 
Commodities  Act ('Warenwet',  Act  of 28  December  1935,  Stb.  1935,  793,  most 
recently amended by Act of06 November 1997, Stb.  1997, 510 (see Annex 2).  This 
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orally).  However,  it  defines  commodities  as  food  products,  including  masticate 
preparations, others than tobacco, and drink products, as well as other stirring stuffs. 
These two notions do not have the same meaning. Not all food and drink products are 
considered to be foodstuffs. 
Health products are not defined as  such in the Commodities Act. They may be partly 
considered  food  and  drink  products  as  meant  in  Article  19,  paragraph  l.a of the 
Commodities Act and partly commodities, not being food and drink products as meant 
in Article 19, paragraph l.b of the Commodities Act. According to Article I.e of the 
Dutch  Health  Products  Code  ('Code  Gezondheidsproducten'),  they  are:  'Products 
either in a pharmaceutical form  and with a pharmaceutical character or for which a 
primary function related to health is being claimed, without making them a medicine. 
Health products are not  supposed to  be used as  medicine  and,  in  principle,  do  fall 
under the Commodities Act. 
The  Dutch  Act  on  Medicine  Provision  ('Wet op  de  Geneesmiddelenvoorziening') 
defines under Article  1,  paragraph  I.e, medicines as  'substance or compositions of 
substances,  which  are  either  meant  to  be  used  or  to  be  marked  somehow  or 
recommended as being appropriate for:  1.  curing, alleviating or preventing a kind of 
affection,  disease,  symptom,  pain,  wound  or  infirmity  of man,  2.  recovering, 
improving or altering of the functioning of human organs, 3.  diagnosing the medical 
case by administration of  or application on man'. 
Bearing this distinction in mind, the Dutch regulatory practice defines health claims 
affecting  human  health  as  "claims  that  state,  suggest  or  make  come  true  that  a 
commodity would possess special qualities with regard to  improving or maintaining 
the health of  the user." 
It should be underlined that medical claims - claims that contain a direct connection or 
a suggestion regarding possible diseases - are forbidden for foodstuffs under Article 
19,  paragraph  l.a (marketing)  and  Article  20,  paragraph  2.a  (advertising)  of the 
Commodities Act. In addition, the Dutch Commodities Act (Article 19, paragraph l.b 
and  Article  20,  paragraph  2.b)  provides  for  a  general  prohibition  to  market  or 
advertise  commodities  in  a  misleading manner and,  therefore,  endangering  human 
safety or health.  Article  19  of the Dutch Commodities Act is  the implementation of 
Article 2, paragraph l.b of  Labelling Directive 79/112/EEC. 
3.  Ethical Claims 
Dutch legislation does not contain any definition of  ethical claims. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Directive 90/496/EEC on Nutrition Labelling of Foodstuffs has been implemented in 
The Netherlands via the Commodities Act Decree on Nutrition Labelling of  Foodstuffs 
(''Warenwetbesluit  Voedingswaarde-informatie  Levensmiddelen'')  (see  Annex  1). 
Rules and safeguards with respect to nutritional claims may be found under Article 8 
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ultimate consumer and also to mass caterers. Natural mineral water and other types of 
water for human consumption are not covered by the Decree.  Neither are food  and 
drink products that are mainly intended to provide certain nutrients. 
Other  relevant  legislation  for  nutritional  claims  is  the  Commodity Act Decree  on 
Products  for  Particular  Nutritional  Uses  ('Warenwetbesluit  Produkten  voor 
bijzondere voeding', Decree of 16 April1992, Stb.  1992,222, most recently amended 
by Decree of 23  January 1998, Stb.  1998, 96) (see Annex 3) and the Commodity Act 
Decree  on  the  Addition  of  Micro-nutrients  to  Foodstuffs  ('Warenwetbesluit 
Toevoeging micro-voedingsstoffen aan levensmiddelen, Decree of 24 June 1996, Stb. 
1996,311, as amended by Decree of23 April1998, Stb. 1998, 255) (see Annex 4). 
The Decree on Products for Particular Nutritional Uses covers the same products as 
are designated in Directive 89/398/EEC on this subject. Such foods are allowed to be 
labelled with the  description  'dietetic'  or 'dietary'  and  if necessary in  conjunction 
with other terms or designations that relate to  their suitability for particular dietary 
needs. Other labelling requirements are as laid down in the EC Directive on this class 
of  products. 
2.  Health Claims 
The relevant parts of Directive 791112/EEC  on the Labelling of Foodstuffs dealing 
with health claims have been implemented in The Netherlands via the Commodities 
Act (Warenwet, see Annex 2). 
The  Commodity  Act  Decree  on  Products  for  Particular  Nutritional  Uses 
('Warenwetbesluit Produkten voor bijzondere voeding', see Annex 3)  also  contains 
some provisions regarding specific health claims. 
Directive  84/450/EEC  on  Misleading  Advertising  and  Directive  89/552/EEC  on 
Television Broadcasting have been implemented in  The Netherlands via  the  Dutch 
Civil  Code  ('Burgelijk Wetboek 6', Article  194-196,  see  Annex  5)  and  the  Dutch 
Media Act ('Mediawet), which provides for the issue to  be dealt with by the  self-
regulatory Dutch Advertising Code ('Nederlandse Reclame Code', See Annex 6). 
3.  Ethical Claims 
There is  no  specific  legislation regarding ethical  claims.  Nevertheless,  the  relevant 
articles  from  the  Dutch Civil  Code and  the  general  guidelines  under Part  I of the 
Dutch Advertising Code that stipulate that advertisements must not be misleading or 
untrue  are  applicable  to  ethical  claims.  In  particular,  the  rules  in  this  section 
stipulating that advertising must not be gratuitously offensive or contrary to good taste 
and common decency, refer to ethical claims. 
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I C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
a.  Prohibitions 
Under Article 2 of the Commodities Act Decree on Nutrition Labelling of  Foodstuffs 
("'Warenwetbesluit Voedingswaarde-informatie levensmiddelen", see Annex  1  ),  it  is 
prohibited to  market any food or drink product without taking into consideration the 
rules  referred  to  in  or  in  virtue  of this  Decree.  This  applies  for  messages  or 
presentations when nutritional labelling or a nutritional claim is being used. 
Goods  not  belonging to  one of the  categories  of foodstuff for  which further  more 
specific rules may be laid down, must be registered with the authorities, with a sample 
label, before they are brought onto the market for the first time. 
b.  Restrictions 
Under  Article  3,  paragraph  1  of the  'Decree  on  the  Nutritional  Labelling  of 
Foodstuffs', detailed requirements are given concerning the only statements that may 
be made in relation to the energy or nutrient content of food. 
In  the  above  mentioned  Decree,  Article  8  provides  for  rules  to  be  taken  into 
consideration  for  other  nutritional  claims  on  foods:  energy  claims,  sugar  claims, 
protein  claims,  fat  claims,  fatty  acid  claims,  dietary  fibre  claims,  sodium  claims,_ 
vitamin claims, mineral claims and micro-nutrients in general. 
Article 5 of the Decree on the Addition of Micro-nutrients to Foodstuffs provides for 
the  addition to  food  of certain named vitamins and minerals.  Food containing such 
additions  is  classified  as  'fortified  food  or  drink  products'.  However,  the  main 
purpose of the product is not the supply of micro-nutrients. Nutrition labelling must 
be  declared  on  fortified  foodstuffs  (Article  7,  Decree  on  the  Addition  of Micro-
nutrients to Foodstuffs). A declaration of the added micro-nutrients must also be made 
for  fortified  foodstuffs  that  are  not  restored  or  substitution  products  (Article  8, 
paragraphs 2 and 3 of the same Decree). Claims concerning the nutritional value of 
"fortified foods or drinks' may be made only in relation to  micro-nutrients naturally 
present (Article 8, paragraph 1 of  the same Decree). 
Statements  relating  to  the  fat  content of certain  foods,  such  as  cheese,  yogurt  or 
spreadable  fats,  are  provided  for  in  Dutch  legislation,  but  these  are  not,  strictly 
speaking, nutrition claims. 
c.  Exemptions 
Nutritional  labelling  is  not  compulsory  under  the  Commodities  Act  Decree  on 
Nutrition  Labelling  of Foodstuffs  ("'Warenwetbesluit  Voedingswaarde-informatie 
Levensmiddelen", see Annex 1  ).  However, once a nutritional claim is  made on the 
label, nutrition labelling as described in the Decree must take place. Information to be 
supplied,  form  of declaration,  basis  for  declared  values  and  calculation  of energy 
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pre-packaged foodstuffs packaged at the point of  sale. 
2.  Health Claims 
a.  Prohibitions 
In  line  with  the  status  of a  generally  accepted  definition  of health  claims  on 
foodstuffs, no further prohibitions are mentioned under Dutch law. 
b.  Restrictions 
See again the definition of  health claims as mentioned before. 
c.  Exemptions 
Article 19, paragraph 3 and 20 and paragraph 4, of the 'Commodities Act' provide for 
the  possibility  to  decide  on  messages  or  presentations  that  are  considered  to  be 
messages or presentations, under Article 19, paragraph I or Article 20, paragraph 2 of 
the Act. This possibility, however, needs to be approved by a Ministerial Decision. 
3.  Ethical Claims 
a.  Prohibitions 
As  no specific legislation exists for ethical claims, Articles  194-196 from the Dutch 
Civil Code Number 6 apply.  This aims  to  protect consumers and competitors from 
misleading advertising.  These rules,  also  described  as  the  'Misleading Advertising 
Act', consist of a specification of  illegal offences (Civil Code Number 6, Article 162). 
Article  194  provides  for  a  non-exhausting  list  of announcements  that  could  be 
considered misleading. This could be the case regarding price, origin or composition 
of  the commodity. 
b.  Exemptions 
As no specific legislation exists for ethical claims, no exemptions are foreseen under 
Dutch  law.  Articles  194-196  of the  Dutch  Civil  Code  Number  6  only  apply  to 
misleading advertising and not, for example, to negative or positive advertising. The 
latter two forms of  unlawful advertising fall under the general unlawful practice rules. 
c.  Restrictions 
Since no  specific  legislation exists for  ethical claims, the  general restriction of the 
above  mentioned  Articles  from  the  Civil  Code  apply.  They  only  apply  to 
announcements made while exercising a profession or business.  General, ideal  and 
political announcements do not fall under these Articles. 
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I D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
The Dutch public authorities favour the process of coming to  common definitions of 
claims at EU level, through the guidelines as given by the Codex Alimentarius. 
1.  Nutritional Claims 
The  nutrition policy as  implemented by the  Dutch authorities  (Ministry of Health, 
Welfare and Sports) is based on two basic assumptions: 
•  Guaranteeing an adequate level of  food safety; and 
•  Encouraging good nutritional behaviour. 
The policy states that a right use of nutritional claims can contribute to  honouring 
these  assumptions.  For  the  authorities,  this  means  ensuring  honest,  transparent 
information  and  correct  implementation  of the  principles  set  out  in  relevant  EU 
Directives,  in  particular 79/112/EEC  on  Labelling  and  90/496/EEC  on  Nutritional 
Labelling. 
The starting point for this is the Dutch 'Balanced Diet Guidelines', which reflect the 
state of science in this field.  These guidelines should be taken as  far as possible into 
consideration  when  applying  the  rules  for  nutritional  claims.  That  is  to  say  that 
nutritional claims regarding a product should relate to  a property that is nutritionally 
relevant.  On  the  basis  of this  approach,  a  number  of claims  groups  have  been 
regulated. 
Policy thinking is that current legislation on nutritional claims is satisfactory and that 
a  restriction  or  extension  of possibilities  should  take  place  on  the  basis  of the 
nutritional goals that are being pursued. 
The Dutch regulatory practice regarding nutritional claims goes further than the EU 
Directives and is  considered satisfactory by the parties concerned. Apart from some 
fine-tuning  regarding optional rules,  there seems to  be no need for  adaptation.  The 
only policy developments taking place in this field concern different types of  fats. 
2.  Health Claims 
Dutch  policy  and  regulatory  practice  regarding  health  claims  allows  this  type  of 
claims for foodstuffs, providing that they are true and not misleading. It is, however, 
forbidden to allude to medical claims. This way of  policy thinking is based on the idea 
that  one  should  not  profit  by  making  consumers  anxious  about  diseases.  It  is 
worthwhile noting that currently there  is  insufficient scientific data  available  to  be 
able  to  determine  whether  the  use  of health  claims,  unlike  the  use  of nutritional 
claims, can be to the advantage of the consumer. 
In  general,  all  parties  concerned feel  that current policy regarding health claims  is 
satisfactory:  the  public  authorities  playing  a  supporting,  but  modest,  role  thereby 
leaving room for self-regulation. There seems to  be no  need in The Netherlands for 
new  legislation  regarding  health  claims  at  national  level  but  most  of the  parties 
concerned do  see the need for  future  legislative developments to  be arranged at the 
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making process to  approve health claims at national level and to have a negative list 
of  health claims at EU level. 
Some policy developments might be expected relating to borderline cases, which exist 
between  positive  health  claims  and  medical  claims  (including  claims  regarding 
cholesterol).  There is  a general view that  there  is  a  'grey area'  between these  two 
types of claims, which is  not covered by legislation. The issue has  already been the 
subject of discussion during a long time and touches upon the reach of prevention, 
which is now limited to vaccines. 
In  particular, the Dutch foodstuffs  industry considers this  issue a priority and  feels 
that, under the conditions of the voluntary instruments in place, the Commodity Act 
should not prohibit health claims aimed at preventing human diseases. Industry feels 
that this type of so-called effect claim could be captured under a code of  practice. The 
problem  is  that  adaptation  of the  law  would  require  further  information  on  the 
substantiating of claims and whilst no academic data is  available, this information is 
only available to  industry.  According to  the  Dutch Consumer Association,  the  EU 
could play a general role here.  However, steering the issue at European Union level 
would require further information on the way in which all  the Member States deal 
with the substantiating of  claims. 
It is worth noting here that over the past years another thorough discussion has been 
taking  place  in  The Netherlands  regarding functional  foods,  novel  foods  and  food 
supplements and the verification problem of claims in this field.  In fact,  it  has been 
voluntarily agreed to  substantiate claims on vitamin supplements to margarine, while 
a similar agreement for claims on herb preparations is in the pipeline, taking the issue 
out of the scope of  the current legislation. 
Furthermore, it should be underlined that the Dutch Parliament is currently discussing 
deregulation of the 'Commodities Act'. However, this is without consequence for the 
regulatory practice regarding health claims in The Netherlands. This practice is under 
permanent  discussion  by  all  parties  concerned  in  the  'Regular  Deliberation 
Commodity Act' platform. 
3.  Ethical Claims 
At the moment, there is no specific Dutch policy in the field of ethical claims. In The 
Netherlands,  the Ministry of Economic Affairs and the Ministry of Agriculture are 
responsible for social and animal welfare claims respectively. 
Currently,  a  project group  under the  Ministry of Economic Affairs  is  looking  into 
consumer concerns. This might provide information on public opinion towards ethical 
claims.  For the  Ministry of Agriculture,  ethics  in  general  play a role  in  its  policy 
preparation regarding guaranteeing animal welfare and food safety. 
The  only  idea  of  the  public  authorities  (Ministries  of  Economic  Affairs  and 
Agriculture) is to  divide this type of claims according to  their specific character and 
deal with them on a separate basis. 
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F.  BARRIERS TO TRADE AND LACK OF CONSUMER PROTECTION 
1.  Nutritional Claims 
It  seems  generally  accepted  that  regarding  nutritional  claims,  there  are  no  real 
problems relating to barriers to trade or lack of  consumer protection. 
2.  Health Claims 
Furthermore, as  regards health claims, it seems generally accepted that there are no 
significant  problems  relating  to  barriers  to  trade  or lack  of consumer  protection. 
Nevertheless, it is worthwhile noting the following: 
•  The Dutch legislation on health claims is considered quite severe; 
•  On 4 June  1999, the Dutch Parliament adopted a law, making it compulsory for 
health clai1ns to be made in the Dutch language; 
•  Barriers to  trade could be caused by the  above mentioned 'grey area'  between 
positive  health  claims  and  medical  claims,  since  it  is  not  fully  covered  by 
legislation. This situation could also affect consumer protection. 
3.  Ethical Claims 
In spite of  the absence of  any specific legislation on ethical claims, none of the parties 
concerned in The Netherlands felt that there were barriers to trade or lack of  consumer 
protection. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
No specific voluntary instruments exist in The Netherlands for nutritional claims. 
2.  Health Claims 
In The Netherlands, there are three important voluntary instruments covering the field 
of  health claims. 
•  The Dutch Advertising Code ('Nederlandse Reclame Code', see Annex 6); 
•  The Code of  practice assessing the scientific evidence for Health benefits stated in 
Health claims on food and drink products 1998 ('Gedragscode wetenschappelijke 
onderbouwing Gezondheidseffecten ten behoeve van Gezondheidsclaims voor eet-
en drinkwaren 1998, see Annex 7); 
•  The KOAG/KAG Code for the advertisement of  Health  products' ('KOAG/KAG 
Code voor de aanprijzing van Gezondheidsproducten, see Annex 8). 
Pan- European study on nutritional, health and ethical claims- 1999.  330 a.  The Dutch Advertising Code 
The  Dutch  Advertising Code  contains  rules  which,  in  principle,  apply to  all  three 
types of claims. It is divided into a General section and a Special Section. In addition 
to  the  General Code, certain specific codes have been added.  These were drafted in 
co-operation with self-regulatory bodies, such as  the Foundation for the Responsible 
use  of Alcohol ('Stichting Verantwoord Alcoholgebruik'), the Advertising Steering 
group Foundation ('Stichting Stuurgroep Reclame'), which are the Dutch advertising 
tripartite, and the industries concerned (e.g. tobacco, direct mail or motor industry). 
Part I of the Dutch Advertising Code contain general guidelines that stipulate, inter 
alia,  that  advertisements  must  not  be  misleading  or  untrue.  This  section  also 
contains a number of rules based on subjective criteria, one of which stipulates that 
advertising  must  not  be  gratuitously  offensive  or  contrary  to  good  taste  and 
common decency. Part II  of the Code contains Special Guidelines and related rules 
for specific products and services. These rules supplement the general provisions of 
the Code and are as follows: 
•  Rules on advertising for medicines and homeopathic products, which require pre-
clearance by the KOAG and the Council for the Advertising of non-prescription 
Medicines); 
•  Rules on advertisements for training courses; 
•  Rules on advertisements for competitions; 
•  Rules on advertisements for loans, investments and property; 
•  Rules on advertisements for home working; 
•  The Code for Alcoholic Beverages; 
•  The  Code  on  Letterbox  Advertising,  House  Sampling  and  Direct  Response 
Advertising; 
•  The Code on the Distribution of  Unaddressed Advertising Leaflets; 
•  The Advertising Code for Casino Games; 
•  The Environmental Advertising Code; 
•  The Code for Passenger Cars; 
•  The Advertising Code for Tobacco Products; 
•  The Sweepstakes Codes; and 
•  The Confectionary Code. 
b.  The  Code of practice assessing the  scientific  evidence for  Health  benefits 
stated in Health claims on food and drink products 1998 
The Code of  practice is aimed at getting evidence for health claims on foodstuffs to be 
scientifically founded and reported.  This Code was initiated by the Dutch Nutrition 
Centre  ('Voedingscentrum'),  which  is  an  independent  non-profit  organisation 
consisting of  professionals in the food sector. The Nutrition Centre is mainly financed 
by the  Ministries of Agriculture  and  Health  and  its  Advisory  Council  consists  of 
representatives  from  science,  trade  and  industry  and  several  independent  groups 
(including the Central Office for Foodstuffs Trade, the Consumer Association and the 
Dutch  Foodstuffs  Industry).  This  organization  facilitates  the  testing  procedure,  by 
bringing together a panel  of independent academic specialists.  The disadvantage of 
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the Code of practice is that it concerns a heavy and expensive procedure, whereby the 
addressee has to go through prescribed stages. 
The  Code has  only been in force  since April  1998  and  so  far  there  have been no 
concrete cases. Although industry is a signatory of  the Conduct Code, it is still uneasy 
about the testing procedure. Nevertheless, three products are in the pipeline and, in the 
future,  one  can  expect  several  margarine  producers  to  make  use  of the  testing 
procedure with a view to having their claims confirmed. The functioning of the Code 
will be evaluated in two years time, with a view to  attuning it to  safety assessment 
methods. 
c.  The KOAG/KAG Code for the advertisement of Health products 
The  highly regarded  KOAG/KAG  Code  is  mainly aimed  at  preventing the  use  of 
medical claims on health products. The Code was initiated by the Dutch Verification 
Council  ('Keuringsraad'),  a  self-regulatory  body  for  the  public  advertising  of 
medicinal products (KOAG), natural  remedies and other health products (KAG).  It 
has now been in place for many years. 
Under the guidelines of its Code, KOAG/KAG pre-vets all public advertising for non-
prescription  products  and  homeopathic  medicines  and  for  health  products. 
KOAG/KAG  is,  therefore,  competent  for  the  public  advertising  of all  medicinal 
products (including foodstuffs) whose use is recommended for treating, alleviating or 
preventing disease, illness, symptoms, pains, injury or deficiency. KOAG/KAG does 
not handle complaints. 
3.  Ethical Claims 
There  currently  exist  two  specific  labelling  schemes  regarding  ethical  claims.  A 
further two are being developed. 
•  The Max Havelaar Trademark ('Max Havelaar Keurmerk'); 
•  The Fair Trade Charter for Garments; 
•  The  Fair  Trade  Treaty  for  Clothes  Foundation  ('Stichting  Eerlijke  Handels 
Handvest voor Kleding')~ and 
•  The Conduct Code for the Coffee-sector. 
a.  The Max Havelaar Trademark ('Max Havelaar Keurmerk') 
The  Max  Havelaar  Trademark  is  an  instrument  to  help  farmers  in  developing 
countries  to  improve  their  economic  situation.  It guarantees  these  farmers  higher 
revenues and, therefore, offers better opportunities. The 'Max Havelaar Foundation' is 
the  certifying  institution  controlling  the  Max  Havelaar  trademark.  The  trademark, 
with 32 licensees  in  the  field  of coffee, bananas, tea and  cacao,  is  one of the  best 
known idealist ones in The Netherlands. It was initiated because of the need among 
producers. The idea behind the trademark is to inform consumers. 
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The  'Fair Trade Charter for Garments'  is  a code of conduct for  all  retailers  selling 
clothes  in  The  Netherlands  and  is  part  of the  'Clean  Clothes  Campaign'.  This 
Campaign in The Netherlands is  an appeal to consumers to be more conscious when 
buying clothes, and to  support demands the campaign is making to retail companies. 
This is done by supplying information, by giving lectures, participating in discussions 
and holding pickets and other street-actions to draw attention to the conditions under 
which garments are produced in developing countries. 
c.  The  Fair  Trade  Charter  for  Clothes  Foundation  ('Stichting  Eerlijke 
Handels Handvest voor Kleding') 
The Dutch organisation Fenecom is working on a trademark for the clothes-sector in 
The  Netherlands  under  the  name  Fair  Trade  Charter  for  Clothes  Foundation 
C  Stichting Eerlijke Handels Handvest voor Kleding'). The aim of the trademark is to 
support  the  International  Labour Organisation  (ILO)  rules.  In  the  current  roll-out 
phase, Dutch companies can apply for membership. 
d.  The Conduct Code for the Coffee-sector 
Currently,  the  Dutch Fair Trade  Organisation  is  initiating a  Conduct  Code  for  the 
coffee-sector in The Netherlands, while at the same time asking the public authorities 
for a more active policy in this field. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
t.  Nutritional Claims 
No voluntary instruments for nutritional claims exist. 
2.  Health Claims 
Both  the  Dutch  Advertising  Code  and  the  Code  of practice,  as  well  as  the 
KOAG/KAG Code use the same generally accepted definition for health claims. The 
Dutch  regulatory practice  defines  health  claims  affecting  human  health  usually  as 
"claims that state, suggest or make come true that a commodity would possess special 
qualities with regard to improving or maintaining the health of the user' (see chapter 
II, paragraph A.2). 
As  far  as  the  Code  of practice  is  concerned,  the  panel  of independent  academic 
specialists is doing its tests on the basis of 3 criteria that cover: 
•  Quality of  the scientific substantiating; 
•  The relevance for the target group; 
•  Whether the health effect is opposed to healthy food. 
The actual application of  these criteria is very precise, since it concerns a case-by-case 
approach. 
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3.  Ethical Claims 
The  two  labelling  schemes  in  place  in  The  Netherlands  do  not  use  any  specific 
definition of ethical claims. However, they implicitly use the notion of ethics in their 
goals. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
The Dutch Advertising Code does not specifically refer to any claims; however, Part 
II  of the Code contains Special Guidelines and the related rules for specific products 
and services. 
•  For beverages,  a  notification  obligation  is  in force  (tobacco,  alcohol)  and  in a 
number  of  cases  an  absolute  prohibition  to  advertise  for  these  products 
(prohibition of radio and television advertising for tobacco, general prohibition of 
advertising for drugs). 
•  Regarding alcohol and sweets a prohibition of  health claims is in force. 
•  As  far  as  pharmaceutical (vitamin preparations, minerals), cosmetic and miracle 
products are concerned, a general prohibition is in force of misleading advertising 
and,  therefore,  endangering the  consumer's health.  It is  absolutely prohibited to 
advertise  for  medicines  and  it  is  also  prohibited  to  use  medical  claims  for 
foodstuffs. 
The main restriction for health claims of the Code of practice is the fact that it cannot 
force  any sanctions. The way of sanctioning is  either positive or negative publicity 
following a decision by the panel of independent academic specialist.  According to 
the  Dutch  Nutrition  Centre,  the  EU  could  play  a  role  in  initiating  a  common 
sanctioning system in all the Member States. 
The limitation of  the KOAG/KAG Code is that it basically applies to health products. 
3.  Ethical Claims 
All the  labelling schemes mentioned before, use ethical claims either in the field of 
worker protection or fair trade. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
1.  Nutritional Claims 
No voluntary instruments for nutritional claims exist. 
Pan- European study on nutritional, health and ethical claims- 1999.  334 2.  Health Claims 
Formally,  the  public  authorities  do  not  support  these  three  instruments.  However, 
informally  the  Ministry  of Health,  as  well  as  the  Health  Protection  Inspection  is 
positive about both codes, although it has to be said that the functioning of the Code 
of  practice still has to prove itself. 
What the public authorities would like to see is a regulatory system, including these 
three  codes.  They  have  already  started  discussing  this  issue  with  the  parties 
concerned. However, it is clear that it will not be easy to find a solution, which meets 
the requirements of  all parties concerned. 
3.  Ethical Claims 
Formally,  the  public  authorities  do  not  support  the  labelling  schemes.  However, 
informally they are positive about them. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The Dutch Decree on Nutritional Labelling of Foodstuffs does not provide for  any 
criteria for substantiating nutritional claims. 
2.  Health Claims 
Whereas  the  Dutch  Commodities  Act  does  not  provide  for  specific  criteria  for 
substantiating  health  claims,  with  the  coming  into  force  of the  Code  of practice 
assessing the scientific evidence for Health benefits stated in  Health claims on food 
and drink products 1998, scientific evidence for a health benefit is assessed using the 
following formula of 3 criteria: 
•  The  quality of the scientific evidence:  The  evidence  must be based on relevant 
scientific data on human subjects; the evidence must apply to a product or product 
group; and the evidence must be reproduced. 
•  Relevance to the target population: The data must concern normal use (consumed 
quantities)  by the  target  population  and  the  product  must  carry  health  benefit 
relevant to that target group. 
•  Must not clash  with  dietary guidelines:  The health benefit must not clash with 
dietary guidelines, as laid down in publications by the former Nutrition Council 
and the Health Council and in similar publications. 
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As  far  as  ethical  claims  are  concerned,  no  specific  criteria  for  substantiating 
nutritional claims exist. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
No  pre-clearance  rules  exist  in  The  Netherlands.  Pre-clearance  is  considered 
censorship and is, therefore, not applied. 
2.  Post-Clearance Rules/ Guidelines 
The system for verifying claims in The Netherlands is twofold: 
•  On  the  one  hand,  there  is  the  Health  Protection  Inspection/Commodities  and 
Veterinary  surgeons  ("Inspectie  Gezondheidsbescherming/W  aren  en 
Veterinairen"), with whom one can lodge a complaint or that can initiate a post-
clearance procedure to prove that a particular claim is untrue. 
•  On the other hand, there is the Advertising Standard Committee ("Reclame Code 
Commissie"), which is following up all types of claims and can ask anyone using 
a claim to prove that a particular claim is true. 
The  twofold  verification  system  of  claims  in  The  Netherlands  has  not  been 
functioning  to  the  satisfaction of all  parties  concerned and  could cause  barriers  to 
trade or lack of consumer protection as  far as  positive health claims are concerned. 
According to  the Health Protection Inspection, producers of claims are inventive in 
using scientific information and this makes it very difficult to prove whether a claim 
is legally untrue or not. 
a.  Legalprocedure 
Unlawful nutritional and health claims are viewed as  infringements of the regulations 
concerned  in  the  "Commodities  Act'.  Complaints  about  non-compliance  can  be 
lodged to the Health Protection Inspection, which is appointed as (market) supervisor. 
The possibility for lodging a complaint is not limited to certain groups or persons. 
Non-compliance with  specific  labelling requirements  and/or specific  limitations  on 
advertising  are  legally  regarded  as  misleading  advertising,  when  it  concerns  non-
compliance of specific labelling regulations and/or specific restrictions with regard to 
advertising under article  19  of the  'Commodities Act' regarding medical claims and 
article 20, first indent of the 'Commodities Act', article 29 of the 'Commodities Act 
Decree on Labelling Foodstuffs' regarding misleading recommendations and article 8 
of the  'Commodities  Act  Decision  Nutritional  Information  Foodstuffs'  regarding 
nutritional claims. 
The number of cases regarding claims dealt with by the Health Protection Inspection 
has been relatively small. It concerns both nutritional and health claims as far as they 
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nothing  to  do  with  the  Health  Protection  Inspection,  these  two  organisations  do 
consult each other informally twice a year. 
b.  Self-regulatory procedure 
Next to this, relevant complaints can also be brought before the Advertising Standard 
Committee, which has been set up by the Advertising Code Foundation ('Stichting 
Reclame Code') that unites consumers,  advertisers  and the  media.  The Advertising 
Standard Committee is an independent private body and not a legal court in the strict 
sense of  the word. It has the remit of  assessing compliance with the Dutch Advertising 
Code ('Nederlandse Reclame Code') of advertisements against which complaints are 
made. In the event of an appeal against the Committee's ruling, the matter is referred 
to the Appeals Board ('College van Beroep'), which issues a definite ruling. 
The  Advertising  Code  Committee  consists  of  four  independently-operating 
committees,  each  composed  of  five  members.  The  appropriate  committee  is 
determined by the  media,  in  which the  advertisement appeared.  Each committee is 
chaired by an independent legal expert. The other four members are appointed by the 
Foundation's member organisations, but act in an independent capacity. The Appeal 
Board  is  organised  on  the  same  media-specific  basis  as  the  Advertising  Code 
Committee. 
The  Advertising Code Committee  does  not  work with  a  pre-clearance system  and 
although it is empowered to monitor advertisements on its own initiative, in practice it 
rarely does  so,  because monitoring is  considered unacceptably arbitrary.  The three 
broadcasting bodies  and individual  commercial broadcasters,  however,  examine  all 
broadcast advertising before transmission for compliance with the Advertising Code. 
Any member of the public can lodge a written complaint with the Secretariat of the 
Committee, clearly outlining to  which advertisement the complaint relates, why the 
complainant considers  the  advertisement to  be  in  breach of the  Dutch Advertising 
Code and, where possible, enclosing a copy of  the advertisement in question. 
Upon receipt of the  complaint, an initial assessment is  carried out by the Chairman 
and the  Secretariat, to  determine whether the complaint should be considered by the 
Committee.  If it  decides  that it should not,  the  Committee's Chairman informs  the 
complainant accordingly, in the form of a rejection - an appeal against which can be 
lodged with the plenary Advertising Code Committee. Complaints which are judged 
suitable for consideration by the Committee are subject to the following procedure: 
•  Firstly, the advertiser is provided with a copy of the complaint for his response, a 
copy of  which is then forwarded to the complainant; 
•  A hearing  is  then  arranged at  the  offices of the Advertising Code Foundation, 
where the parties are invited to elaborate on their respective points of  view; 
•  The Advertising Code Committee issues a written ruling within a few  weeks of 
this hearing. 
•  The  loser  has  the  option  of lodging  an  appeal  with  the  Appeals  Board.  Four 
decisions  are  open  to  the  Appeals  Board:  The  appeal  is  well-founded  and  the 
decision of  the Committee is annulled; the appeal is unfounded and the decision of 
the Committee is confirmed; the appeal is partially founded and the decision of the 
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Committee  is  amended;  and  the  case  Is  referred  back  to  the  Committee  for 
reconsideration. 
Complaints  can  be  submitted  and  handed  free  of charge,  except  in  cases  where  a 
complaint is filed on behalf of  a professional body or company, in which case a fee of 
HFl 500 (approx.  EUR 227) is  charged.  Up  to  now, only a limited number of cases 
have been put before  the  Advertising  Standard Committee.  Most of the  cases  this 
Committee has been dealing with concern health claims and, in particular, borderline 
cases. This shows that there is a growing tendency in The Netherlands to use forms of 
medical claims. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
As far as the Health Protection Inspection is  concerned, the possibility for lodging a 
complaint is not limited to certain groups or persons. 
Any member of the public can lodge a written complaint with the Secretariat of the 
Advertising Code Committee, clearly outlining to which advertisement the complaint 
relates, why the complainant considers the advertisement to be in breach of  the Dutch 
Advertising  Code  and,  where  possible,  enclosing  a  copy  of the  advertisement  in 
question. 
D.  BURDEN OF PROOF 
1.  Burden of proof 
Whereas  the  Health  Protection  Inspection  can  initiate  a  post-clearance  procedure 
(notifications of claims are only obligatory under the  'Directives for Special Foods') 
to  prove that a particular claim is untrue, the Advertising Code Committee can ask 
anyone  using  a  claim  to  prove  themselves  that  a  particular  claim  is  true.  In  its 
judgements,  the  Advertising  Code  Committee  does  not  yet  refer  to  the  Code  of 
practice assessing the scientific evidence for Health benefits stated in Health claims 
on food and drink products 1998. 
E.  APPLICABLE PENAL  TIES 
As far as the procedure of the Health Protection Inspection is concerned, infringement 
of  the rules on claims is considered an economic offence and is to be submitted to the 
Public Prosecutor, who will notify the party concerned by means of a warrant. A first 
infringement will be penalised by a settlement consisting of a relatively little amount 
of money. In case of a second breach of the rules and when a claim is  considered to 
endanger  public  health,  the  Public  Prosecutor  can  eventually  decide  to  take  a 
particular product off the  market.  The  idea  is  to  change the  provisions  for  a  first 
infringement into  a system of public fines,  whereby the whole procedure would be 
dealt  with  by the  Health  Protection  Inspection.  A  second breach  would  then  still 
follow the current legal procedure. 
Regarding the procedure of the Advertising Code Committee sanctions are being dealt 
with as follows:  If an advertisement is found to  infringe the Dutch Advertising Code, 
the Committee will instruct the advertiser to stop using it in  its current form.  In  the 
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media will be instructed to  stop publishing the advertisement concerned. The media, 
who  are  obligatory members  of the  Advertising Code  Foundation,  are  required  to 
refuse advertisements against which such a ban has been issued. 
Only  on  the  basis  of agreements  between  the  Committee  and  certain  sectoral 
organisations  (alcohol,  tobacco,  gambling  and  sweepstakes),  the  Committee  is  in 
certain cases empowered to  impose sanctions on the advertiser.  The Committee can 
oblige  him  to  reimburse  money,  promulgate  its  recommendation  amongst  the 
recipients of the advertisements, or publish a corrective statement. Decisions reached 
by the Advertising Code Committee and the  Appeals  Board are  published every 6 
months in a report. 
V.  CASELAW 
1.  Nutritional Claims 
There is no important case law in The Netherlands on nutritional claims. 
2.  Health Claims 
The only health claim judged by a civil court in The Netherlands concerns a health 
claim for sweeteners, the Nimm-2 case. The implicit claim  'They ask for a sweetie, 
you give them a bit more' combined with  'Nimm-2 the new sweetie with grape-sugar 
and vitamin C' was judged to fall under the prohibition of health claims under Article 
4 of the Code for Sweeteners. It was judged that in reality the sugar containing sweet 
stimulated caries and therefore harmed the health of  the teeth and the well being of  the 
user.  And  by referring  to  a  relatively  low  sugar  content,  one  may  not  give  the 
impression that the chances for developing caries are relatively small. 
Talks with people from the Inspection Health Protection indicated that a warrant had 
been  given  a  maximum  of ten  times  following  infringement of Article  19  of the 
Commodities  Act.  Until  now,  it  has  never  come  to  prosecution.  In  50  cases, 
advertisers have been pointed at a possible infringement of the Articles  19  and 20 of 
the  Commodities Act,  followed  by a discussion with the  advertiser.  The results  of 
these  procedures  may  be  found  in  the  annual  reports  of the  Health  protection 
Inspection (The  1998 Report will be available by September 1999). According to the 
Inspection, this method has a preventive function. Criminal verification of advertising 
regulations is in general not very effective, partly because of difficulties regarding the 
burden of  proof. 
Real  verification  is  taking  place  through  complaints  at  the  Advertising  Code 
Committee. This Committee is  in practice the only institution that regularly assesses 
health claims on the basis of its contents. The following 3 cases that have been put 
before the Advertising Standard Committee are worthwhile mentioning because of  the 
great impact of  the verdicts: 
•  Decision ofthe Advertising Standards Committee. 26.10.1994 (see Annex 9): 
1.  The decision allowed the claim ''"A desert that improves your resistance"; 
2.  Product: 'MONA VIFIT', daily based desert; 
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3.  Conclusion of the  Committee:  The claim  is  not considered as  a medical  claim 
because  it  is  not  plausible  that  the  product  could  be  regarded  as  preventing, 
treating or healing of  illnesses. 
•  Decision of  the Advertising Standards Committee, 18.12.1995 (see Annex 10): 
1.  The decision disapproved the claim "Don't catch a cold custard"; 
2.  Product: 'Vat Geen Kou-VIa', dairy based dessert; 
3.  Conclusion: The claim is considered misleading, because there is no evidence that 
by consuming this custard one would be protected from catching a cold. 
•  Decision of  the Advertising Standards Committee, 02.07.1996 (see Annex 11): 
1.  The decision allowed the claim "Contributes to an appropriate cholesterol level"; 
2.  Product: 'MONA FISIQ', yogurt; 
3.  Conclusion of the Committee: The claim is not misleading, because the producer 
has presented scientific evidence, justifying the claimed contribution to  reducing 
the cholesterol level. 
The above mentioned cases show that it is  not the Health Protection Inspection, but 
the  Advertising  Code  Committee  that  plays  an  important  role  in  more  precisely 
defining borderline cases concerning health claims. It is  this Inspection that fills  the 
legal gap wherever there could be a lack of  consumer protection. 
3.  Ethical Claims 
There exist no case law regarding ethical claims. 
VI.  MEANS OF COMMUNICATION 
In general, the Dutch Commodities Act and its relevant Decrees apply to dealing in 
foodstuffs and non-foodstuffs.  Dealing is defined as  "offering for sale, exposing for 
sale, selling, delivering or having in store/stock of a commodity". This means that no 
distinction is  made between the use of nutritional and health claims in advertising or 
in labelling. The application of the regulations is independent from the medium used, 
although  it  has  to  be  said  that  the  'Commodities  Act'  does  not  refer  to  the 
'Advertising Code', which specifically deals with misleading advertising. 
Since  4  June  1999,  there  is  a  requirement  in  the  Dutch  legislation  for  labeling 
information to be in the Dutch language, as it  must be clearly understandable to  the 
purchaser. 
The  fact  that  claims  from  other  countries  can  easily  appear  on  the  Internet  is 
considered rather a practical than a legal problem. Claims on the Internet fall, like any 
other nutritional and health claims, under the provisions of the Commodities Act. And 
also  the  testing  procedure  of the  Code  of practice  makes  no  difference  between 
communication means. 
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TNO Report V97 .180 concerning project 334304 on consumer acceptance of health 
claims for foodstuffs (see Annex 12). 
In  1996, by order of the  Ministry of Health,  Research Institute  TNO Nutrition  had 
done  a  research  to  consumer  acceptance  of health  claims.  Face-to-face  interviews 
were  held among  1018  households.  The respondents consisted for  82o/o  of women. 
The objective of the research was the  following:  'To get an overview of consumer 
acceptance of  different (types of) nutritional- and health claims for foodstuffs'. 
The conclusion of the research is  that consumers have a considerable critical attitude 
towards food additives and accompanying nutritional and health claims.  Because of 
relatively  poor nutritional  knowledge,  the  information  available  cannot  always  be 
valued properly. These findings confirm the view that for successfully applying health 
claims  on  foodstuffs,  it  is  vital  that these  claims  are  comprehensible  and  reliable, 
while being supported by solid nutritional information. 
VIII.  ANNEXES 
Annex  1:  Commodities  Act  Decree  on  Nutrition  Labelling  of  Foodstuffs 
("Warenwetbesluit  Voedingswaarde-informatie  Levensmiddelen",  Decree  of  07 
September  1993,  Stb.  1993,  483,  as  amended by Decree of 15  January  1997,  Stb. 
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Annex  2:  Article  19  and 20 of the  Commodities  Act ('Artikel  19  en  20  van  de 
Warenwet', Act of 28 December 1935, Stb.  1935, 793, most recently amended by Act 
of  06 November 1997, Stb.  1997, 51 0) 
Annex  3:  Commodity  Act  Decree  on  Products  for  Particular  Nutritional  Uses 
('Warenwetbesluit Produkten voor bijzondere voeding', Decree of 16 April 1992, Stb. 
1992, 222, most recently amended by Decree of  23 January 1998, Stb. 1998, 96) 
Annex  4:  Commodity Act Decree on  the Addition of  Micro-nutrients  to  Foodstuffs 
('Warenwetbesluit Toevoeging micro-voedingsstoffen aan levensmiddelen, Decree of 
24 June  1996,  Stb.  1996, 311,  as  amended by Decree of 23  April  1998,  Stb.  1998, 
255) 
Annex 5: Civil Code -Article 194-196 ('Burgelijk Wetboek 6', Article 194-196) 
Annex 6: Dutch Advertising Code ('Nederlandse Reclame Code') 
Annex 7:  Code of  practice assessing the scientific evidence for Health benefits stated 
in  Health claims on food and drink products 1998 ('Gedragscode wetenschappelijke 
onderbouwing Gezondheidseffecten ten behoeve van Gezondheidsclaims voor eet-en 
drinkwaren 1998) 
Annex 8: KOAGIKAG Code for the advertisement of  Health products' ('KOAG/KAG 
Code voor de aanprijzing van Gezondheidsproducten) 
Annex 9: Decision of  the Advertising Standards Committee, 26.10.1994, allowing the 
claim "A desert that improves your resistance" from product 'MONA VIFIT', a daily 
based desert 
Annex  10:  Decision  of  the  Advertising  Standards  Committee,  18.12.1995, 
disapproved the  claim "Don't catch a cold custard"  from  product  'Vat Geen Kou-
Vla', a dairy based dessert 
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Annex 11:  Decision of the Advertising Standards  Committee,  02.07.1996,  allowing 
the  claim  "Contributes  to  an  appropriate  cholesterol  level"  from  product  'MONA 
FISIQ', a yogurt 
Annex 12:  TNO Report V97.180 concerning project 334304 on consumer acceptance 
ofhealth claims for foodstuffs ('TNO Rapport V97.180 van project 334304 aangaande 
consumentenacceptatie van gezondheidsclaims voor voedingsmiddelen) 
IX.  DATABASE OF CONTACTS 
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M.  PORTUGAL 
I.  EXECUTIVE SUMMARY 
A.  INTRODUCTION 
The study was well received by all interested parties in Portugal. A problem with the 
research undertaken in Portugal was that many respondents were not familiar with the 
issue of  claims and could, therefore, provide only limited information. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The  definition  of a  nutritional  claim  is  the  same  as  defined  in  EU  law.  The 
terminology is  slightly different,  as  the word 'claim' has been literally translated as 
'declaration'.  Portuguese  authorities  consider  the  current  legislation  on  nutritional 
claims to be satisfactory. 
2.  Health Claims 
With regard to health claims, Portugal implemented nearly word by word Directive 
791112.  But in  addition,  further  provisions  are  made under Portuguese  law,  which 
somewhat extends the prohibitions of  Directive 79/112. 
The Portuguese authorities indicated that they had, so far, not reflected on the issue of 
health claims. No policy initiatives are currently planned. 
3.  Ethical Claims 
There is  no  legal definition of an ethical claim and no  directly relevant legislation. 
The  consumer  associations  are  pressing  for  the  introduction  of a  mechanism  to 
supervise  the  use  of ethical  claims.  A  proposal  has  been  put  forward  by  the 
Portuguese Association for Consumer Defence (DEC) for the introduction of a social 
label. No feedback has so far been given by the authorities on this proposal. 
C.  VOLUNTARY CODES OF PRACTICE 
There do not exist any voluntary codes of practice in Portugal for nutrition, health or 
ethical  claims.  Nevertheless,  the  Portuguese  food  industry  association  is  currently 
working on codes of  practice for health claims, but these are still at a very early stage. 
D.  VERIFICATION SYSTEMS 
With regard to the criteria for substantiating claims, the only ones that apply are those 
set out in the law on nutritional labelling and on dietary foods. Those set out under the 
notification procedure of  dietary foods apply. 
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Directorate  General  for  Surveillance  and  Control  Food,  which  is  attached  to  the 
Ministry of Agriculture, and the General Inspectorate of Economic Activities, which 
is  the  central  service  of the  Ministry  of Commerce.  Furthermore,  the  Consumer 
Institute,  which  is  a  public  institution,  is  in  charge  of the  supervision  of the 
application of  the Advertising Code. The competencies of the different administrative 
authorities sometimes overlap. 
The burden of proof lies with the complainant. Nevertheless, the situation is different 
when  the  authorities  start  an  investigation.  The  Advertising  Code  states  that 
affirmations on the origin, nature, composition, properties and conditions of purchase 
of  advertised goods and services have to be true and these affirmations must be able to 
be proven at all times before the competent authorities. 
Penalties range between 1750 euro and 45000 euro.  In  addition, the  authorities can 
confiscate the products in question, as well as suspend the commercialisation and sale 
of  the products. 
E.  MEANS OF COMMUNICATION 
There are no  differences between the different means of communication with regard 
to claims or advertising. 
F.  CONSUMER PROTECTION 
The  consumer associations indicated that there were only a few  identified cases of 
lack of consumer protection, but which were in  their view partly attributable to  the 
lack  of means  available  to  inspect  products  being  marketed  or  crossing  borders. 
Furthermore, the consumer associations felt that existing legislation on health claims 
did  not offer sufficient legal  protection  to  consumers.  In  particular the  absence  of 
clearly defined rules for substantiating claims implies that only if a grave threat to the 
health of consumers is identified can an investigation to determine the veracity of the 
claim be started. 
The only statistics available from  the Portuguese Association of Consumer Defence 
(DECO)  refer to  complaints  on  labelling in  general.  Most of the  cases  seem to  be 
related to the fact that labelling was written in languages other than Portuguese, or in 
the omission or incorrect use of information. These statistics do not provide specific 
information on claims. 
G.  TRADE BARRIERS 
The authorities consider that there are  no significant barriers to  trade with regard to 
health claims, as EU Directive 79/112 is fully applied in Portugal. 
The Portuguese food industry association considers that the Portuguese food industry 
is at a disadvantage, as the Portuguese authorities are, on the one hand, very restrictive 
in  their practice  vis-a-vis  health  claims,  but  on  the  other  they  import  far-reaching 
health claims from other Member States. 
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H.  CASELAW 
No recent court cases exist on either type of  claims. 
I.  STAKEHOLDER ANALYSIS 
In general, there has been very little reflection in Portugal on the issue of nutritional 
and  health claims.  Overall,  nutritional  and  health claims  are considered issues  that 
need to  be tackled by the EU.  With regard to  ethical claims, consumer associations 
have undertaken some reflection on this issue. 
In conclusion, the positions of  the main stakeholders are: 
1.  Government Authorities 
•  On nutritional claims, the authorities consider current legislation satisfactory. 
•  On health claims, no policy thinking has yet taken place. 
2.  Consumers 
•  Consumers are in favour of  clearly defined rules for substantiating claims. 
3.  Industry 
•  Industry considers the practice of the Portuguese authorities with regard to health 
claims too restrictive.  Industry is  looking towards the EU to  create a framework 
for health claims. 
•  On ethical claims, consumer associations are in favour of  some instruments (either 
legal or in the form of  voluntary instruments) to supervise their use. 
*** 
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A.  DEFINITION OF CLAIMS 
1.  Nutritional Claims 
The definition of nutritional claims is provided in article 2, point b) of the Portuguese 
nutrition labelling decree, determining the  conditions that must be  observed by the 
nutrition labelling of  foodstuffs (Decree 7  51/93, see Annex 1): 
"b) Nutritional claim: any representation or message used in advertising which states, 
suggests  or implies  that  a  foodstuffs  has  particular nutrition  properties  due  to  the 
energy or caloric value that it gives or does not give or the nutrients it possesses or 
does not possess; however, it is not considered a nutritional claim the qualitative or 
quantitative indication of  a nutrient, according to the legislation in force;" 
The content of the definition is  in essence the same as the one provided by Directive 
90/496 on Nutrition Labelling. 
We  can  notice  a  difference  in  terms  of terminology between  the  English  and  the 
Portuguese, as the word 'claim' has been literally translated as 'declaration' (declarat;ao 
nutricional) 
2.  Health Claims 
Portuguese  legislation does not  contain  any definition of health  claims.  The only 
definitions  used  are  negative,  i.  e.,  they  forbid  medical  claims  and  provide  for  a 
narrow  interpretation  of  health  claims.  The  Portuguese  foodstuff  labelling, 
presentation and  advertising decree  (Law  Decree  1  70/92,  see Annex  3) establishes 
some prohibitions related to health claims: 
In its article 9, paragraph 1, point c) and d) it is stated that: 
"1- [ ... ]  it  is  prohibited  in  advertisements  to  include  any  statement  that  might 
mislead the consumers, namely: 
[  ... ] 
c)  those that include medical, paramedical and pharmaceutical recommendations, or 
recommendations made by competent authorities or organisms in the nutritional field 
or public health, with the exception of  those authorised by law; 
d) those that make reference to members of medical, paramedical and pharmaceutical 
professions and, as well, to medical instruments or to the human body for illustrating 
physiological functions, even if stylised, with the exception of those that support the 
statements mentioned in the previous number authorised by law;" 
Paragraph 2 of the same article adds the following: 
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mineral  and  table  waters,  it  is  prohibited  in  labelling  to  include  any  statements 
referring to the prevention or elimination of  ~ickness." 
The Portuguese foodstuff labelling, presentation and advertising decree limits itself to 
comply with the EU labelling Directive 791112, in that it does not allow to claim that 
a foodstuff has the property of  preventing, treating, or curing a human disease. 
Compared with the Codex Alimentarius definitions as  mentioned in the  latest draft 
recommendations on health claims, Portuguese legislation does not allow disease risk 
reduction claims.  The use of  enhanced function claims seems to be limited. 
3.  Ethical Claims 
Portuguese legislation does not contain any definition of  ethical claims. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Directive 90/496 on Nutrition Labelling has been implemented by Decree No. 751193 
from 23 August 1993 (see Annex 1  ). 
Directive 89/398 on Foodstuffs for Particular Nutritional Uses has been implemented 
by a number of Law Decrees, which have been codified by Law Decree 227/99 of 22 
June 1999 (see Annex 2). 
2.  Health Claims 
Directive 791112  on Labelling of Foodstuffs has been implemented by different Law 
Decrees, which have been codified by Law Decree 170/92 from 8 August 1992. 
Directive 84/450 on Misleading Advertising has been implemented by Law Decree 
330/90 of 23  October 1990 (there have been made several amendments to  this Law 
Decree, the latest one in  1998 to  include comparative advertising. A codified version 
is annexed to Law Decree No. 275/98 of  9 September 1998, see Annex 4 ). 
3.  Ethical Claims 
There exists no specific legislation on ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
a.  Prohibitions/ Restrictions 
Under  article  2  of the  Portuguese  nutnhon  labelling  decree  (Decree  751/93,  see 
Annex  1  ), nutritional claims may only refer to  the energy value and to  the following 
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are part of  or belong to one of  the categories of  these nutrients. 
Vitamin and mineral claims are restricted to the following  ~nutrients: 
Recommended  Recommended 
Nutrients  Daily Allowances  Nutrients  Daily Allowances 
(mg)  (mg) 
Vitamin A  800  Vitamin B12  1 
Vitamin D  5  Biotin  0,15 
VitaminE  10  Pantothenic acid  6 
VitaminC  60  Calcium  800 
Titamin  1,4  Phosphor  800 
Riboflavina  1,6  Iron  14 
Niacin  18  Magnesium  300 
Vitamin B6  2  Zinc  15 
Folic acid  200  Iodine  150 
Such claims can only be made if these nutrients are contained to a significant amount 
in the foodstuff(l5% ofthe RDA). 
b.  Exemptions 
Article  1,  paragraph 4,  of the Portuguese nutrition labelling decree (Decree 751/93, 
see Annex 1  ),  exempts natural mineral waters, as well as  the other waters for human 
consumption, and diet integrators/ food supplements from its scope. 
2.  Health Claims 
a.  Prohibitions/ Restrictions 
The Portuguese foodstuff labelling, presentation and advertising decree (Law Decree 
170/92, see Annex 3) prohibits the use of  health claims (see chapter A) 2). 
The  Advertising Code forbids  certain advertising for  alcoholic  beverages,  i.e.  such 
advertising shall  not suggest success,  certain therapeutical properties  or stimulating 
effects (article 17 of  Advertising Code, see Annex 4). 
b.  Exemptions 
The Portuguese foodstuff labelling, presentation and advertising decree (Law Decree 
170/92, see Annex 3), also refers an exception concerning dietetic products, mineral 
and table waters (article 9, paragraph 2): 
"Without prejudice of the dispositions applicable to  dietetic products and to  mineral 
and table waters, it is prohibited in labelling to include any statements referring to the 
prevention or elimination of  sickness." 
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Nevertheless, the Portuguese Law Decree on dietetic products (Law Decree 227/99, 
see Annex 2) states that reference to the prevention, cure or treatment of diseases for 
these products is not allowed (Article 9 ( 1) e)). 
3.  Ethical Claims 
There is no specific legislation for ethical claims under Portuguese Law. Nevertheless, 
the Advertising Code's (see Law Decree 275/98, Annex 4) prohibition of misleading 
advertising  (article  11)  applies,  which  is  nearly  a  literal  translation  of the  EU 
Misleading Advertising Directive 84/450 (article 2 and 3). 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
Portuguese  authorities  consider  the  current  legislation  on  nutritional  claims 
satisfactory. Policy thinking is  currently not focusing on nutritional claims.  It is  in 
any case considered to be subject to EU harmonisation policy. 
One  of the  problems  that  was  pointed  out  by  the  main  Portuguese  consumer 
association in  terms of nutritional claims was the fact that nutritional labelling was 
only compulsory when a nutritional claim was made (see Portuguese Decree 751/93 
on nutrition labelling, article 3,  see Annex  1).  In the consumer association's view, 
nutrition labelling should always be compulsory. 
2.  Health Claims 
Portuguese  authorities  indicated that  they had  so  far  not  reflected  on  the  issue  of 
health claims. No policy initiatives are currently planned.  Nevertheless, food industry 
has had first contact with the Ministry of Agriculture and the Ministry of Health on a 
possible industry code of  conduct on health claims (see below III.). 
The  competent  authorities,  and  the  Ministry of Health,  consider that  there  are  no 
significant barriers to trade with regard to health claims.  Directive 79/112 is fully in 
force. 
The consumer associations mentioned that there are relatively few identified cases of 
barriers to  trade or lack of consumer protection but, according to them, this  can be 
partly attributed to the lack of  means on behalf of  the consumer associations to inspect 
products being marketed or crossing borders. 
The Portuguese food industry association considers that the Portuguese food industry 
is  being  disadvantaged,  as  the  Portuguese  authorities  are  on  the  one  hand  very 
restrictive in  their practice vis-a-vis health claims, but on the other hand they allow 
the import of far-reaching health claims from other Member States.  The association 
mentioned  as  an  example  the  Omega  3  cholesterol  claims  made  on  some  milk 
products. 
3.  Ethical Claims 
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Consumers ("Uniao Geral de Consumidores"- UGC), promoted with the support of 
the  Institute  of Consumption  ("Instituto  do  Consumo"),  an  information  campaign 
aiming  to  raise  awareness,  and  increase  the  consumption  of,  goods  produced  in 
conditions that were not socially degrading or in violation of the human rights.  The 
campaign has stressed the need for the creation of a "social labelling" as  a guarantee 
that the goods were produced in countries that respect the working conditions of their 
workers and the human rights. 
There  is  no  specific  legislation  on  ethical  claims  in  Portugal.  Despite  this  legal 
vacuum, the national authorities, food industry and consumer associations contacted 
indicated that they were not aware of  any problems in this area. 
III.  VOLUNTARY INSTRUMENTS AND OTHER PRACTICES 
We found no  voluntary instruments in place or other practices used in  Portugal for 
either type of  claims. 
The Portuguese food industry association is  currently working on a code of practice 
on  health  claims.  This  code  will  be  an  industry  code  and  is  aimed  at  putting 
Portuguese  food  industry  on  an  equal  footing  with  foreign  producers  importing 
products with health claims that Portuguese authorities do  not allow.  The aim is  to 
get such a future code approved by the authorities. 
The food industry association had so far a quite positive response from the Ministry of 
Agriculture.  Discussions are currently on-going with the  Ministry of Health.  The 
food industry association considers that it will be a medium to long term project to get 
such a code of  practice in place. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The Portuguese nutrition labelling decree (Decree 7  51/93,  see Annex  I) establishes 
the criteria that shall be respected in order to substantiate a nutritional claim in terms 
of energy value, vitamins, etc.  It reproduces almost literally the Council  Directive 
90/496 of  24 September on the nutrition labelling of foodstuffs. 
As it is stated in the results from the Commission Food Inspection Team (see Results 
of the Official Foodstuffs Control System in Portugal by the European Commission 
Foodstuffs  Assessment Team,  I 0-14  March  1997),  the  legal  basis  for  the  official 
control  of foodstuffs  is  very  broad  and  complex.  There  is  so  far  no  specific 
transposition of the EU  Food Control Directives 89/397/EEC and 93/99/EEC.  The 
Portuguese  authorities  (Direcr.;iio  Geral da  Fiscalizar;iio  e  Controlo  da  Qualidade 
Alimentar) considered that  the  content of these  Directives was  already included in 
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the transposition of these Directives. 
Under the Portuguese decree on foodstuffs for particular nutritional uses (Law Decree 
227/99, see  Annex 2)  the normal notification procedure for  dietary foods  as  set out 
under Directive 89/398 on foods  for particular nutritional foods  applies. Article 7 of 
the decree defines the criteria for substantiating a claim. 
According to paragraph 2, for the first commercialisation of a product the producer or 
the  importer must submit to  the Directorate General for  Health (Direcc;iio-Geral de 
Saude DGS) an  example of the  respective label.  DGS  decides whether the  product 
conforms with the criteria of  a dietary food (which are set out in paragraph 2 points a) 
and b)  of article  2.  )  If the  product has  already been commercialised in  another 
Member State the producer or the importer must submit to DGS the indication of the 
entity to which the first notification of  the label of the product was sent. 
Whenever judged necessary,  DGS  is  entitled,  within a  delay of 90  days  from  the 
reception  of the  label  of a  product,  to  demand  a  producer  or  importer  for  the 
submission of scientific work and all  the data which shows  the  compliance of the 
product  with  the  criteria  established  by  the  decree  on  foodstuffs  for  particular 
nutritional uses. 
2.  Health Claims 
Health claims are not allowed in Portugal. 
According to the consumer associations, the existing Portuguese legislation on health 
claims (see II)  A)  2)  ) does not offer sufficient legal protection to  consumers.  The 
absence of  clearly defined rules for substantiating claims implies that only if  a striking 
threat to  the health of consumers is  identified by any of the legal persons entitled to 
take legal action there can be an investigation to determine if the claim is in violation 
of the law.  This slow process combined with the lack of means of the  consumers 
associations  constitutes  in  their  view  an  inefficient  system  for  the  protection  of 
consumers rights. 
The food industry association is  against any pre-clearance systems, as  already today 
only foodstuffs  that  are  safe  are  allowed to  be  put on  the  market.  It agrees  that 
manufacturers should have available scientific documentation to prove that the claims 
made are scientifically justified. 
3.  Ethical Claims 
There is no verification system for ethical claims. 
There is no system or mechanism for the control, regulation or supervision of ethical 
claims.  Consumer  associations  (e.g.  Associavao  Portuguesa  para  a  Defesa  do 
Consumidor - DECO)  are  pressing for  the  introduction of mechanisms  that  could 
supervise the introduction of ethical claims.  These mechanisms could have a legal 
nature or assume the form of voluntary instruments or codes of conduct to be agreed 
Pan- European study on nutritional, health and ethical claims- 1999.  351 between  the  consumer  associatiOns  and  the  commercial  associations  or  the 
organisations representing the different branches of  products. 
A proposal has been put forward by DECO which would consist of  the introduction of 
a social label.  No  feedback has been registered from  the  authorities on this subject 
matter. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
In  Portugal  the  verification/inspection of labels  is  undertaken by an  administrative 
system.  The competencies of  the different administrative authorities mentioned below 
sometimes overlap: 
1)  In  accordance  with  Decree  98/97  (see  Annex  6),  the  system  in  place  for 
verifying claims is an ex-post system under the responsibility of the Directorate 
General  for  Surveillance  and  Control  of Food  Quality  (Direcc;ao  Geral  de 
Fiscalizac;ao  e  Controlo  da  Qualidade  Alimentar  - DGFCQA),  which  is 
attached to  the  Ministry of Agriculture.  According to  article 2 of the Decree 
98/97 on the DGFCQA, this official body is  entitled to verify, in co-ordination 
with  the  regional  services  from  the  Ministry  of  Agriculture,  Regional 
Development and Fisheries, and without prejudice of the competencies of other 
authorities, the compliance of  foodstuff labelling with Portuguese law. 
The  DGFCQA  is  also  required  to  prevent  infractions  against  the  quality, 
authenticity,  composition,  labelling  of foodstuffs,  food  additives,  and  other 
substances. 
Furthermore, it  is  competent for the co-ordination and control,  as  well  as  the 
implementation of the regulations,  on the  production,  preparation,  packaging, 
labelling, transportation and sale of foodstuffs,  ingredients and food additives. 
It is  also in charge of the regulations for the packaging and other products that 
come  in contact with  foodstuffs  (see  Law  Decree  No.  98/97,  article  12,  see 
Annex 6). 
2)  The  General  Inspectorate  of  Economic  Activities  (lnspecc;ao  Geral  das 
Actividades Econ6micas  - IGAE)  is  the  central  service  from  the  Ministry of 
Commerce  that  supervises  the  compliance  of laws,  regulations  instructions, 
orders and other norms that regulate the economic activities. IGAE is competent 
for the investigation and instruction of the processes for administrative offences 
in respect of  the law. 
3)  The  Consumer  Institute  (Jnstituto  do  Consumidor)  is  a  public  institution  in 
charge of the promotion of policies for the safeguard of consumers rights.  It is 
responsible as  well for the co-ordination and execution of the measures aiming 
at the protection, information and education of  consumers, and for the support to 
consumer associations (Law No.  24/96 on Consumer Protection, see Annex 5). 
It  is  notably in  charge of supervising the application of the  Advertising Code 
(see Codified Advertising Code, article 38, see Annex 4). 
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Under  Portuguese  Laws  on  Consumer  Protection,  the  individual,  consumer 
associations,  public  prosecution  services  and  the  Consumer  Institute  can  start  a 
judicial proceeding aiming at preventing, correcting or terminating any practice that 
damages the rights of consumers.  This is namely practices that constitute a threat to 
health and physical integrity; practices consisting of generally forbidden clauses and 
commercial practices which are in violation of the law (Law No. 24/96, article 10 and 
article 13, see Annex 5.) 
D.  BURDEN OF PROOF 
The burden of  proof lies with the complainant.  Nevertheless, the situation is different 
when  the  authorities  start  an  investigation.  The  Advertising  Code  states  that 
affirmations on the origin, nature, composition, properties and conditions of purchase 
of  advertised goods and services have to be true and these affirmations must be able to 
be proven at all moment before the competent authorities (Advertising Code, article 
10, see Annex 4). 
E.  APPLICATION OF PENALTIES 
Penalties  for  misleading  advertising  range  between  $350,000  (1750  Euro)  and 
$9000,000 (45000 Euro) under the Advertising Code (article 34, see Annex 4).  The 
exact amount is decided by a Penalty Commission set up under the Advertising Code. 
In  case  of misleading  advertising  or advertising  dangerous  to  health  or consumer. 
safety,  the  Consumer  Institute  can  order  the  cessation  or  suspension  of  the 
advertisement.  This decision is subject to judicial review. 
Infractions of  the law decree on foodstuffs for particular nutritional uses (article 9, see 
annex  2)  can be  fined  with  a  maximum pecuniary penalty of $3.000.000  (15.000 
euro  ).  In addition, the authorities can confiscate the products in question, as well as 
suspend the marketing and sale of the products. 
V.  CASELAW 
1.  Nutritional Claims 
We did not come across any case law on nutritional claims. 
2.  Health Claims 
There exists very little case law in Portugal on health claims.  The case below was not 
decided in  front  of a  civil  court,  but was  analysed by the  Directorate  General  for 
Health.  The fine was determined by the Penalty Commission, established under the 
Advertising Code. 
As  a  result  of an  inspection  by the  General  Inspectorate  of Economic  Activities 
(IGAE), a complaint was put forward against a producer for marketing 41  packages of 
wheat bran cereals with a label containing, apart from indications on the ingredients 
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properties of  wheat bran. 
The statements were the following: 
"For a healthy life. 
It has  been proved that regular fibre consumption  helps to  prevent 
some diseases  that are characteristic of our time,  like colon  (large 
intestine)  cancer,  arteriosclerosis,  obstipation,  obesity  or 
cardiovascular diseases". 
The product clearly claims to contain some properties that can help in the prevention 
of diseases like colon (large intestine) cancer, arteriosclerosis, obstipation, obesity or 
cardiovascular  diseases  which  goes  against  the  Portuguese  foodstuff  labelling, 
presentation and advertising decree (Law Decree 170/92, see Annex 3), in particular it 
violates its article 9, paragraph 2. 
The Portuguese foodstuff labelling, presentation and advertising decree establishes an 
exception for dietetic products, mineral and table waters.  The competent authority to 
analyse  foodstuffs  for  particular nutritional  uses  is  under  Portuguese  Law  Decree 
227/99 on  dietetic  products the  Directorate General for  Health (Direq:iio  Geral de 
Saude- UGS). 
The  DGS  concluded  that  the  advertising  used  on  the  packages  of this  product  is 
prohibited  and  potentially it  could  mislead  the  consumer.  Therefore,  it  has  been 
classified  as  misleading  advertising  according  to  article  11,  paragraph  1,  of the 
Advertising  Code  by  the  Penalty  Commission  established  under  the  Portuguese 
Advertising Code (see Annex 4). 
The  disrespect  of the  above  mentioned  legal  dispositions  is  punishable  by  law 
according to  article 34 of the Portuguese Advertising Code with a financial penalty 
between $350.000 (1750 Euro) and $9.000.000 (45000 Euro). 
It was decided to  apply the penalty of $1.5000.000 (7500 Euro) to the importer and 
distributor of the product and a penalty of $1.000.000 (5000 Euro) to the store where 
the product was for sale. 
(Reference: Comissiio de Aplicar;iio de Coimas em Materia de Publicidade, Proc. No 
81-D, 10 de Julho de 1996) 
3.  Ethical Claims 
We did not come across any case law on ethical claims. 
VI.  MEANS OF COMMUNICATION 
There are no differences between the different means of communication with regard 
to claims or advertising. 
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VIII.  STATISTICS ON CLAIMS 
The  authorities  consulted  and  the  consumer associations  do  not have  any relevant 
statistics on claims.  Only the Associar;iio Portuguesa para a Defesa do  Consumidor 
(DECO)  indicated  the  following  statistic  on  labelling  where  the  association  was 
invited to mediate in 1998 and 1999: 
Complaints 1998  Nr. of  complaints 
Nutritional labelling  90 
Health related labelling  96 
Ethical labelling  14 
Complaints 1999  Nr. of complaints 
Nutritional labelling  92 
Health related labelling  74 
Ethical labelling  27 
For most of the  cases the problem was  related with the  fact  that the  labelling was 
written in other languages than Portuguese.  A smaller number of complaints relate to 
the  omission  or  incorrect  use  of information.  Most  of the  cases  are  still  under 
investigation  by  the  competent  authorities  (Direcr;iio  Geral  de  Fiscalizar;iio  e 
Contra/a da  Qualidade Alimentar, Inspecr;iio  Geral das Actividades Econ6micas and 
Direcr;iio Geral de Sazide ). 
IX.  ANNEXES 
1.  Portaria n°  7  51/93  from  23  August - Estabelece  as  condi<;oes  a que  deve 
obedecer a rotulagem nutricional dos generos alimenticios em natureza, sejam 
ou nao pre-embalados, a partir do momento em que se encontram no  estado 
em que idio ser fomecidos ao consumidor final, bern como as regras relativas a 
sua apresentac;;ao. 
2.  Decreto-Lei n° 227/99 from 22 de June- Regula o regime juridico aplicavel 
aos generos alimenticios destinados a uma alimentac;;ao especial. 
3.  Decreta-Lei no  170/92 from 8 August- Estabelece OS principios e regras 
gerais a que deve obedecer a rotulagem, apresentac;;ao e publicidade dos 
generos alimenticios. 
4.  Decreta-Lei no  275/98 from  9 September- Altera o C6digo da Publicidade 
(with annex containing codified Advertising Code). 
5.  Lei  no  24/96 de  31  de Julho - Estabelece o regime legal aplicavel a defesa 
dos Consumidores. 
6.  Decreto-Lei  n.o  98/97  de  28  de  Abril  - Direc<;ao  Geral  de  Fiscalizac;;ao  e 
Controlo da Qualidade Alimentar. 
X.  DATABASE OF CONTACTS 
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N.  SPAIN 
I.  EXECUTIVE ANALYSIS 
A  INTRODUCTION 
This study aims to analyse the status of  nutritional, health and ethical claims in Spain. 
Whilst much has been written about the first type of claim, both in  legislative and in 
judicial terms, health claims have become more noticeable in the past five years with 
the  increase in "border line products"(medicine or foodstuff).  Ethical claim, on the 
other hand, are not perceived as an issue/problem, although in the last few months the 
public and "civil society' at large have started to pay attention. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of nutritional claim transposes Directive 90/496/CEE: the definition of 
""nutrition  labelling"  and  "nutrition  claim"  are  the  same  and  related  to  energy 
provision,  and  to  the  same  nutrient  components  of the  food  as  in  the  Directive. 
Currently, the Spanish Government does not seem to wish to make any changes in its 
approach to this issue. 
The Spanish Government has no  plans to  modify existing legislation, but is open to 
discussing the possibility of  extending the list of allowable claims in the event of  new 
nutrients. 
2.  Health Claims 
There  is  no  legal  definition of health  claims.  A  Royal  Decree  on  the  labelling  of 
foodstuffs transposes Directive 791112/EEC  prohibiting claims that attribute disease 
prevention, therapeutic or curative properties to a foodstuff. Thus, if a claim includes 
a comparison with a medication, the relevant pharmaceutical legislation will apply. 
However, a voluntary agreement (see below) providing manufacturers with guidelines 
provide a definition as: 
•  any claim, which makes reference to the effects of one or several of the nutrients or 
ingredients of  a foodstuffs on the human body; 
•  any claim, which makes reference to a foodstuffs effect on health; and/or 
•  any claim, which refers to healthy eating habits. 
The Federation of Food and  Drink Industry (FlAB),  together with  the  Ministry of 
Health, initiated a Voluntary Agreement. This agreement provides for certain health 
claims if  they meet some specific requirements. 
The authorities are somewhat skeptical about health claims as  they could mislead the 
consumer and even if  they are presented as a way of increasing consumer information 
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becomes a marketing tool. One solution to the problem of health claims would be to 
draw-up a positive list of claims, providing clear-cut conditions of  use. 
3.  Ethical claims 
There is no specific legislation regulating claims, nor is there any legal definition and 
nor is there any real interest on them from the point of  view of the Public Authorities. 
C.  VOLUNTARYINSTRUMENT 
lm  March  1998,  FlAB (Federation of Beverage  and Agro-Food Industry)  together 
with  the  Ministry  of Health  agreed  a  voluntary  agreement  to  be  applied  to  the 
publicity  of health  related  foodstuff properties,  whilst  still  in  accordance  to  the 
Spanish implementing measures of79.112. 
As well as  a clear definition (see above), a positive list of forbidden claims is given, 
drawn-up on the basis of the claim contents, and also on the grounds of  the way they 
have  been  formulated  (the  text  states:  '"the  value  each  word  has").  A  number of 
conditions to  be  fulfilled by the  claim are given,  for  example:  the  claim should be 
backed by scientific proof; the nutrient has to  be present in "significant quantities"; 
the claim also has to be followed by a statement on the importance of a balanced diet, 
etc. A follow-up Committee has been set-up to respond to complaints. 
The voluntary agreement follows very much the spirit of latest draft Codex guidelines. 
Until now no voluntary agreement has been reached in the field of ethical claims. On 
the industry side, many Codes of conduct exist. They reflect their commitment to the 
respect for different types of norms or requirements.  Consumer organisations try to 
bring the issue to  the  surface and various initiatives have been begun including the 
creation of  list of  "'guilty enterprises" and the stamping of  products with ethical labels. 
D.  VERIFICATION SYSTEMS 
Individual  consumers,  association  of consumers  or  individual  companies  can  take 
legal action against a claim either by following the guidelines of the General Law on 
advertising,  which  transposes  Directive  84/450/CEE,  or by using  the  Law on  the 
protection of  Consumers and Users and the Royal decree on Infractions and Sanctions 
in the areas of  Consumer Protection and the Agro-food industry. 
There are no pre-guidelines for accepting claims. Usually this process takes place at 
the regional level. At a federal level, however, a case can be brought before the 
Intituto Nacional de Consumo (National Institute of  Consumption). This autonomous 
body, dependent on the Health and Consumption Ministry, has received the mission 
of  investigating claims and the powers to ban a claim or even a product. Its decision 
can then be taken before the Supreme Court. 
E.  MEANS OF COMMUNICATION 
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There are no  differences between the different means of communication with regard 
to claims or advertising. 
F.  BARRIERS TO TRADE 
Nothing has been noted as acting as a barrier to trade. 
G.  CASELAW 
There is  no  body of case  law relevant to  claims, except for  one single  court case, 
which ruled in favour of  a health claim. 
I.  STAKEHOLDERS ANALYSIS 
1.  Government Authorities 
•  Government  Authorities  are  satisfied  with  current  national  legislation  and  no 
particular problem has  been highlighted regarding nutritional  claims.  On health 
claims,  the  problems arising with  this  new category of claims are well  known, 
although there is some hesitation to see further European Union intervention. 
2  Consumer Organisations 
•  Consumers would welcome EU action on health claims  and regret the  fact that 
ethical  claims  are  not  in  any way taken  into  account  in  Spanish  or European 
legislation per se. 
3.  Industry 
•  FlAB  is  currently supporting  CIAA's  mttlahves  towards  their being European 
legislation on the  harmonisation of health  claims.  Industry Associations clearly 
and strongly advocate in favour of EU harmonisation on health claims. It has been 
a growing market for several years now, and, in order to avoid barriers to  trade, 
both internally and at the European level, such a measure, in combination with the 
Codex work, would constitute real progress. 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
Nutritional claims are defined as all labels or advertising which, confirm, suggest, or 
imply that  a  foodstuff possesses  specific  nutritional  properties.  The  properties  can 
only refer to: 
•  the foodstuffs energy value (reduced, increased or eliminated); or 
•  the actual nutrients present in the foodstuff (reduced, increased or eliminated). 
The claim cannot make reference to the effect or lack of effect, properties or actions, 
that these nutrients may have. 
Example of  a nutrient claim:  "High in fibre content" 
Vitamin content may be shown in chart format. 
This definition is  included in Royal Decree 930/1992
24
,  which transposes Directive 
90/496/CEE. 
An  agreement  reached  by  the  Inter-ministerial  Committee  on  the  Regulation  of 
Foodstuffs, stipulates that the use of the word "light" is  allowed only if the product 
has undergone treatment reducing its energy content by 30%. 
2.  Health Claims 
A legal definition for health claims does not exist. If a claim includes a comparison 
with a medication, then it is the pharmaceutical product. 
Several  legislative  pieces  do,  however,  list  those  claims  that  are  permitted  or 
prohibited, distinguishing between claims related to  foodstuffs and claims related to 
other products and services. 
Hence, regarding claims related to foodstuffs, Royal Decree 212/92
25  on the labelling 
of foodstuffs  transposes  Directive  79/112/EEC  and  stipulates  that  a  claim  cannot 
attribute  disease  prevention,  therapeutic  or  curative  properties  to  the  foodstuff.  In 
addition, Royal Decree 1907/1996
26  lists which health claims related to foodstuffs are 
prohibited (please see section on prohibitions and restrictions). 
24 See Annex l.Real Decreta 930/1992, 17.07.1992, BOE 187. 
25  See Annex 6. Real Decreta 212/1992,06.03.1992, BOE 72. 
26 Sec Annex 5. Real Decreta 1907/1996, 02.08.1996, BOE 189. 
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developed under the Voluntary Agreement
27 signed between the "Ministerio de Salud 
y  de  Consumo"  (Ministry of Health  and  Consumer Affairs)  and  the  "Federacion 
Espanola  de  Industrias  de  Alimentacion y' Bebidas"  (Federation  of Beverage  and 
Agro-Food  Industries  (FlAB))  on  20  March  1998  (see  section  on  voluntwy 
agreements). 
Health Claims are defined in this Voluntary Agreement as: 
•  any claim, which makes reference to the effects of one or several of  the nutrients or 
ingredients of  a foodstuffs on the human body; 
•  any claim, which makes reference to a foodstuffs effect on health; and/or 
•  any claim, which refers to healthy eating habits. 
Regarding products  and  services other than  foodstuffs,  Royal  Decree  1907  I 1996
28 
regulates  the  advertising  and  commercial  promotion  of health  related  products, 
activities or services, by stipulating which claims are permitted and which are not. A 
list of the claims, which are prohibited under this Directive, is included in section D 
on Prohibitions, Restrictions and Exemptions. 
3.  Ethical Claims 
There is no definition for Ethical Claims. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
Royal Decree 212/1992
29  approves the "General Norm on Claims, presentation and 
publicity of foodstuffs",  which was approved by the Royal Decree  1122/7988, as  a 
consequence of the necessary transposition of Directive 79/112/CEE. The key points 
are: 
•  Area of  Application: all foodstuffs' claims, labelling, presentation and publicity 
•  Prohibitions: of misleading the consumer on the product's characteristics (nature, 
identity,  qualities,  composition,  quantity,  origin,  means  of  fabrication);  of 
attributing effects that the foodstuff does not possess. 
•  The  fifth  chapter  details  the  obligatory  information  to  be  given  (nature, 
ingredients, quantities, date of  expiry, specific storage,) and the way to present the 
obligatory information. 
Royal Decree 93011992
30 on the Nutrition Labelling of Foodstuffs gives a definition 
for  legal  nutritional claims and sets down the information, which nutritional claims 
must contain. 
27  See Annex 9. Ministerio de Sanidad y de Consumo/Federacion de Industriales de la Alimentacion y 
bebidas : Acuerdo interpretativo sabre Ia publicidad de las propiedades d elos alimentos en relacion 
con Ia salud. 
28  See Annex 5.  Op.cit 
29 See Annex 6. Op.cit. 
30 See Annex 1. Op.cit 
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31  and Royal Decree 1945/1983
32 sets down the legal framework 
in the event of  false or misleading claims. 
Law 26/84 for the Consumers and Users defence defines their basic rights: 
•  to be protected against any risk that could affect their Health and Safety; 
•  to be protected in their economic and social rights; 
•  to be compensated; 
•  to be given the correct information on different products or services as well as  to 
be given education on these issues; 
•  to be represented (through associations, associations, groups, confederations); and 
•  to be judicially, administratively and technically protected. 
The  text  is  then  divided  into  different  sections:  Health  protection  and  security, 
economic  and social  interests  protection,  information rights,  right to  education and 
formation,  representation,  consultation  and  participation  rights,  guarantees  and 
responsibilities infractions and sanctions. 
Royal  Decree  1945/1983  lists  the  different types of infractions (sanitary infraction, 
infractions  in  the  field  of consumer protection,  infractions  in  the  area of foodstuff 
quality).  It then lists the different applicable sanctions and deals with the problem of 
investigations (see below). 
Royal  Decree  268511976
33  sets  down  the  legal  framework  for  the  approval  of 
Foodstuffs for Particular Nutritional Uses(  diet or land specific foodstuffs). 
Royal Decree 1809/1991
34 regulates the marketing of these foodstuffs and transposes 
Directive  89/398/CEE  into  national  legislation.  The  labelling of these foodstuffs  is 
regulated by Royal Decree 1809/1991
35
. 
2.  Health Claims 
Spanish  legislation was  strict in  the  way that  it used  to  consider claims  related  to 
health.  Finding itself in  a very difficult situation (with the  number of "middle-way 
products" - between  foodstuff and medicines- increasing every year),  the  Spanish 
food industry asked the Ministry of Health for a more appropriate way of dealing with 
this issue, which led to a Voluntary Agreement. 
Until  1996,  Royal  Decree  212/92
36  was  the  only  legislative  framework,  which 
regulated the use of health claims that do  not fall  under pharmaceutical  legislation. 
(Chapter III, article 4.1.4 states that claims could neither attribute to any foodstuff the 
property  of preventing,  treating,  or  curing  a  human  disease,  nor  mention  these 
properties.). 
31  See Annex 8. Law 26/1984 for the Consumers and Users defence. 
32  Sec Annex 7. Real Decreta 1945/1983,22.06. 1983, BOE 72. 
33  Sec Annex 2. Real Decreta 268511976, 16.  I 0.  1976, BOE 1984. 
34 See Annex 3. Real Decreta 180911991,  13.12.1991, BOE 308. 
35  See Annex 3. Ibid. 
36 Sec Annex 6., ap. cit. 
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more closely as early as  1995, with the proliferation of so-called "miracle products", 
which included non-food goods such as:  weight loss apparatus, wristbands, etc. This 
new kind of product between a foodstuff and a medicine was being developed and 
needed appropriate tools,  which led to  the  adoption of the  Royal Decree  1907/96
37 
"on publicity and commercial promotion of products, activities, or services with an 
alleged sanitary aim". The decree is relevant for the area of foodstuffs in its Article 4 
as  it prohibits in certain listed cases, any kind of publicity or promotion on products, 
materials,  substances,  energies  or  methods ,  if the  products,  materials,  substances, 
energies or methods are said to possesses a sanitary aim. 
This decree has also had an impact on the food industry (see II.  A.2) and the Ministry 
of Health and Consumer Affairs later used it as a vehicle against companies, which 
used such prohibited health claims. 
This evolution prompted the  food  industry,  through FlAB (the Federation of Agro-
Food Industries), to  seek a Voluntary Agreemene
8  with the Ministry of Health and 
Consumption, on the use of health claims on food products (please see section III on 
Voluntary Instruments). 
N.B : Natural mineral waters and special diet foodstuffs fall under their own specific 
legislation. 
3.  Ethical Claims 
There is no legislation regulating the use of  Ethical Claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Nutritional  claims  that  do  not  meet  the  requirements  and  stipulations  of national 
legislation on the use of  such claims are prohibited. 
Strict restrictions of the contents of  the claim and on the composition of the foodstuff, 
are set in the legislation. 
Exemptions  are  allowed  only  after  careful  analysis  by  the  competent  authorities, 
which include: 
•  The Ministry of Health and Consumer Affairs; 
•  Ministry of  Agriculture; 
•  Ministry of Economy; 
•  Regional equivalents of  the three ministries mentioned above. 
37  Sec Annex 5., op.cit 
38  Sec Annex 9., op.cit. 
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39  are  in 
line  with  those  set out  in  Directive  791112/CEE.  As  such they do  not represent  a 
barrier to trade in foodstuffs. 
2.  Health Claims 
The  prohibitions  applied  in  Spain  correspond  to  the  rules  set  out  in  Article  2  of 
Directive  79/112/CEE  and  transposed  by  Royal  Decree  212/1992
40
.  These  rules 
prohibit any claim which "attributes disease prevention or curative properties to  the 
foodstuff'.  In  addition,  Royal  Decree  1907/1996
41  specifically  lists  those  claims, 
which are not allowed under Spanish legislation, namely claims: 
•  which  attribute  prevention,  therapeutic  or  curative  properties  for  transmissible 
diseases, cancers, insomnia, diabetes, and other metabolic illnesses; 
•  which refer to weight loss properties or against obesity; 
•  which  attribute  therapeutic  properties  against  diseases  to  the  product/service, 
without complying with pharmaceutical and medical rules and regulations; 
•  which guarantee the product/service will provide a cure or relief; 
•  which  use  any  type  of  authorisation,  recognition  or  approval  from  health 
authorities from other countries; 
•  which refer to its use in sanitary centres or to its distribution in pharmacies. 
•  which use testimony of health professionals, famous people or of real or supposed 
patients, to increase consumption of  the good; 
•  which  aim  to  replace  standard  and  common  nutritional  habits,  especially when 
related to  maternity, breast-feeding, childhood or old age; 
•  which attribute concrete and specific preventive, therapeutic, or curative properties 
to particular foodstuffs' form, presentation, or brand. 
•  which  attribute  to  diet  foodstuff  preventive,  therapeutic,  curative  or  other 
properties, that are distinct from the usually known properties of  these products; 
•  which  attribute  different  properties  to  cosmetics,  than  those  accepted  under 
legislation regulating the cosmetics industry; 
•  which  suggest  or  indicate that use  or consumption of the  product will  improve 
physical, psychological, athletic or sexual activities; 
•  which use  the  word  "natural''  as  a  characteristic  of the  product  which  gives  it 
therapeutic or preventive properties; 
•  which  give  the  product  a  superfluous  character or which  claim  it  can  replace 
medication or legally recognised health products; 
•  which give the product a superfluous character or which aim to replace the need for 
advice from health professionals; 
•  which,  in  general  give the product prevention, therapeutic or curative properties, 
without the necessary support and verification from the appropriate authorities. 
However, several exemptions to  this rule are listed under the Voluntary Agreement 
signed between FlAB and the Ministry of  Health and Consumer Affairs. 
39  See Annex 6., op.cit 
40 See Annex 6., op.cit. 
41  See Annex 5., op.cit. 
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3.  Ethical Claims 
Given the  lack of legislation on  the use of ethical claims  and the  lack of any such 
claims on the Spanish market, there are currently no rules prohibiting or restricting the 
use of such claims. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The Spanish Government has no  plans to  modify existing legislation, but is  open to 
discussing the possibility of  extending the list of allowable claims in the event of  new 
nutrients. 
2.  Health Claims 
The  Ministry  of Health  has  highlighted  a  number  of "'problems"  related  to  the 
identification and definition of  authorised Health claims: 
•  It is difficult to make a clear distinction between the type of health claim - still to 
be defined - that could be authorised, and the claims that attribute to any foodstuff 
"the  property  of preventing,  treating  or  curing  human  disease",  and  that  are 
prohibited in Royal Decree 21211992 (which transposes the provision set up under 
the article 2 of Directive 79/112/CEE). 
•  Added  to  this  problem  of definition  is  the  problem  of the  criteria  that  could 
constitute  grounds  for  such  a  definition:  it  would be  difficult,  for  instance,  to 
establish criteria in terms of  percentage or threshold 
•  Finally,  it  is  also  difficult  to  draw  a  line  between  "physiologic  effects"  and 
"effects on Health". 
From the point of view of the Ministries, making a health claim is questionable since 
they could mislead the consumer and even if they are presented as a way of increasing 
consumer  information  and  well-being,  they  may  actually  serve  other  interests. 
Consequently, a health claim becomes a marketing tool.  Moreover, the authorisation 
of such health claims cannot be considered as  the best way of helping a consumer to 
take the right decisions regarding his or her health. One should also consider the fact 
that,  given  the  rapid path of change in  scientific knowledge,  health claims (if they 
were authorised) would have to be constantly changed. 
From the Ministry's point of  view, one solution to the problem of  health claims would 
be to draw-up a positive list of claims, providing clear-cut conditions of  use. In such a 
sensitive  area,  should  any  other  solution  be  chosen,  it  would  be  signify  that  a 
mercantile approach would have overcome public Health policy. 
3.  Ethical Claims 
It is  highly unlikely that  the Government will  begin to  analyse the  issue of ethical 
claims in the near future. However a domino effect from the current Consumer NGOs 
campaign  to  boycott  products  manufactured  by children  or by workers  receiving 
subsidence salaries may speed up the process. 
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issue. Hence, the "Organizacion de consumidores y  Usarios" (Consumers and Users 
Organisation) campaigns. Even if organisations and institutions have not yet received 
responsibilities in this area, this particular consumer organisation has tried to organise 
campaigns  ("ropa  limpia"  i.e  "clean  clothes"),  to  provide  information  on  how  to 
identify the type of enterprises that produces supposedly "dirty" products (a list of 
these firms  is  made available to  the consumer who wishes to know more about the 
issue), and to make the promotion of"el comercio Justo" (i.e fair trade). 
In its May 1999 issue
42
,  the OCU publication Compra Maostra dedicates an article to 
"sellas de comercio Justo" (fair trade labels). It says that "one way to inform consists 
in attributing labels to  the enterprises, which show that they respect human rights in 
the way they treat their employees. Among other conditions are a fair salary; labour 
contract; no children work, etc. In Spain only the so-called "'fair trade" shops sell this 
kind of labelled products. In addition, these specialised shops also sell products that 
have been imported through recognised importers, known for their respect of workers' 
rights.  In  Spain,  these  importers  include  Altemativa  3,  solidaridad  International, 
Intermon and Equimercado e Ideas. 
Moreover, the article mentions the possibility for the OCU to  add to  their traditional 
technical criteria for the analysis of  products, some ethical criteria. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
A Decree from the Minister of Health
43 was published on the 2 August 1996, banning 
any  publicity  of products  (including  food)  related  to  health  benefits.  The  FlAB 
(Federation of Beverage and Agro-Food Industry) asked the Minister of Health for an 
agreement  to  interpret  it  in  a more  flexible  and  appropriate  way,  taking  Directive 
79/112  EEC into  account.  After one and a half years of work, an  agreement
44  was 
finally signed in March 1998. 
This Voluntary Agreement will be applied to the Publicity of Health related foodstuff 
properties. 
a.  Existing  strict  prohibitions  that  will  not  be  covered  by  the  Voluntary 
Agreement 
42 OCU. Compra Maostra, n.225, Mayo 1999 
43  See Annex 5., op.cit. 
44 See Annex 9., op.cit 
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The  ex1stmg  legislation  is  recalled  and,  on  this  basis,  strict  exclusion  from  the 
Voluntary  Agreement's  area  of  application  are  highlighted:  foodstuff  claims 
attributing  preventive,  therapeutic  or curative  properties  as  stated  in  Real  Decree 
21211992
45
;  claims  related  to  special  foodstuff for  diet  (Real  Decreto  2685176
46
), 
special legislation established through technico-sanitary reglementation (Real Decreto 
1809/91
47
;  claims related to mineral water (Real Decreto 1164/91 ), nutritional claims 
already covered by Royal Decrees 930/1992,2685/1976, 180911991, 1426/198
48
. 
b.  Guidelines for assessing authorised health claims 
Other  claims  might  be  allowed  even  it  is  said  that  "there  are  differences  of 
interpretation on where to locate the frontier between this type of allowed claims and 
the strictly forbidden one." 
In order to help in drawing this line, a positive list of forbidden claims is given. This 
list has been drawn up on the basis of the claim contents, and also on the grounds of 
the way they have been formulated (the text states: "the value each word has"). 
The document also gives some conditions that should be fulfilled by the claim.  The 
claim should be backed by scientific proof showing that the information is true and 
accurate.  The  nutrient,  which  is  said  to  possess  virtues,  has  to  be  present  in 
"significant quantities".  The  claim also  has  to be followed  by  a  statement on the 
importance of  a balanced diet. 
These  requirements  are  consistent  with  the  "general principles  for  making  Health 
claims",  established  in  the  Codex  Alimentarius  (1997).  The  Codex  Alimentarius 
defines a health claim as  '"any representation that states,  suggests or implies that a 
relationship exists between a food or nutrient or other substance contained in a food, 
and a disease or health related condition". The Spanish Voluntary Agreement gives a 
very similar definition: "any claim related to the function of a nutrient on the human 
body, on Health; or related to healthy food habits". 
The parallel between the two texts can also be made by comparing the sections on 
"general principles for making Health Claims". The Codex Alimentarius lists the need 
for scientific evidence, states that substantiation should demonstrate efficacy with an 
appropriate amount of intake, that health claims should be justified in the context of 
the whole diet and must be applicable to the amount of  food normally consumed. 
The Voluntary Agreement states that a  "health claim will need to  be supported by 
scientific proof; the nutrient will have to be present in the foodstuff in an appropriate 
quantity; the claim will have to be followed by the mention of the importance of a 
balanced diet;  and it will not be possible to  suggest that a  specific brand produces 
peculiar effects". 
45  See Annex 6., op.cit 
46 See Annex 2., op.cit 
47 See Annex 3., op.cit. 
4s See Annexes 1  ,2,3,4, op.cit 
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Voluntary  Agreement  also  establishes  a  Follow-up  Committee  (Comision  de 
seguimiento) consisting of: 
•  The Director-General of  the Ministry of  Health and Consumer Affairs; 
•  The Sub-Director General for Hygiene and Foodstuffs, of the Ministry of  Health 
and Consumer Affairs; 
•  The Secretary-General of  FlAB and 
•  The Director of  the Department on Foodstuffs Law, of  FlAB. 
Under  a  request  from  a  third  party  (a  consumer  or  industry  representative),  the 
Follow-up Committee will  investigate whether a claim is allowed or not, under the 
rules of the agreement. The holder of the claim can present his arguments justifying 
the claim to the members of the Committee, if he so requests it.  The Committee has 
10  days  to  give  its  verdict  of the  claim.  If after  this  time,  a  conclusion  by  the 
Committee has not been reached, the claim is allowed. 
The agreement will be regularly submitted to  revision "aiming at adapting it  to  the 
experience the following-up committee will have acquired". 
Since its creation, the Follow-up Committee has carried out 50 investigations into the 
acceptability of  various claims. 
3.  Ethical Claims 
There is no Voluntary Agreement on Ethical claims yet. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
Not applicable. 
2.  Health Claims 
Under the Voluntary Agreement, Health Claims are defined as: 
•  any claim, which makes reference to the effects of  one or several of  the nutrients or 
ingredients of  a foodstuffs on the human body; 
•  any claim, which makes reference to a foodstuffs effect on health; and/or 
•  any claim, which refers to healthy eating habits. 
3.  Ethical Claims 
Not applicable. 
c.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
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1.  Nutritional Claims 
Not applicable 
2.  Health Claims 
The following claims are not covered by the voluntary agreement. 
•  Claims,  which  give  a  foodstuff,  disease  prevention,  therapeutic  and  curative 
properties; 
•  Claims, which refer to  weight loss and/or special diets which are regulated under 
Royal Decree 2685/76
49
,  and the Technical-Health Regulations as  laid out under 
Royal Decree 1809/91
50
; 
•  Claims used by the bottled water industry; 
•  Nutritional  Claims  such  as  "contains  vitamin  A,  or,  with  calcium",  which  are 
regulated under Royal Decree 930/92. 
The voluntary agreement also establishes that the words used in health claim should 
not  be  categorical,  given  that  physiological  effects  vary  from  person  to  person. 
However, words such as "facilitates", "favours", "help", etc, are allowed. 
The voluntary agreement also includes a non-exhaustive list of claims, which are not 
allowed. Those words in the claims, which are prohibited, appear in bold. 
•  Regenerating effect or action; 
•  Invigorating effect or action; 
•  Relaxing effect or action; 
•  The routine consumption of  X diminishes the risk of  suffering from ...  ; 
•  A  voids or substitutes the need for medical treatment; 
•  Favors your natural defences; 
•  Protects you from X disease; 
•  Helps avoid or substitutes the need for medicines; 
•  Helps protect you from intestinal infections; 
•  Cures constipation 
•  Helps you fight osteoporosis; 
•  Stimulates the immune system; 
•  Facilitates the elimination of  cholesterol; 
•  Facilities proper bone ossification; 
•  Fibre prevents colon cancer; 
•  X oranges are recommended by the World Health Organisation; 
•  Product X helps you lose weight; 
•  Regular  ingestion of product X  is  recommended  in  the  fight  against  kidney 
gallstones. 
Questions or doubts as  regards the legality of a claim are analysed by the Follow-up 
Committee  established  under  the  Voluntary  Agreement.  The  conclusions  of the 
49 See Annex 2  ..  op.cit 
50 See  Annex 3., op.  cit 
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judiciary system to clarify the legality of a claim. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The  legislation  on  nutritional  claims  (see  part  II)  gives  precise  criteria  for 
substantiating claims (nature, quantity,  name of the  ingredients used,  source of the 
figures used, etc ...  ). 
2.  Health Claims 
As specified in Royal Decrees 212/1992 and 190711996
51
• 
The  second  additional  disposition  of the  royal  Decree  1907/1996  says  that  the 
General  Direction  of Public  Health  will  produce  certifications  or reports  on  diet 
foodstuffs,  foodstuffs  and  other products  of human  use  or consumption  having  a 
sanitary aim. 
It further states that the General Direction of Public Health, having taken into account 
the reports  from  the  ''Sanitary Technology Evaluation Agency" and other relevant 
reports, will be able to say if they constitute technical or scientific proof, recognized 
as such by the sanitary administration of the State, as a consequence of what has been 
established  in  article  4.16  (the  Decree's key article:  it  prohibits  foodstuffs  claims 
attributing  preventive  or  therapeutic  effects  that  are  not  supported  by  enough 
technical or scientific proofs). 
The  Voluntary Agreement
52  also  gives  some  criteria for  substantiating this  type  of 
claim: a health claim will only be possible if there exists scientific proof, showing the 
truth and the accuracy of the objective elements given or suggested in the claim; the 
nutrient has  to  be present in significant quantity.  However,  as  parts of a voluntary 
agreement, these criteria are not binding. 
3.  Ethical Claims 
No criteria. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
51  See Annexes 6 and 5., op.  cit. 
52  See Annex 9., op.  Cit. 
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There are no pre-guidelines for accepting claims, other than the owners' responsibility 
of ensuring that the rules established under the relevant nutritional and health claim 
legislation, are respected.  The legality of claims is monitored at various points of the 
products life cycle: 
•  Manufacturing; 
•  Border controls; 
•  Warehouses and distribution; 
•  Retail and sales and 
•  Advertising. 
2.  Post-Clearance Rules/ Guidelines 
These are established under the relevant legislative rules. 
3.  Civil or criminal law redress procedures 
Individual consumers, consumer associations and individual companies can take legal 
action against a claim through either the regional courts or the federal Supreme Court. 
To date, all  cases have been brought to  the regional courts.  For example, it was the 
Tribunal of  Biscaya, which ruled that the statement "Helps you to regulate the level of 
cholesterol" is allowed, on the basis that "cholesterol" is not a human illness. 
As such it corresponds to the rules established under Royal Decree 212/92
53  and the 
Voluntary Agreement
54between the Health Ministry and FlAB 
At the federal  level, a case is  usually brought first before the Instituto Nacional del 
Consumo (National Institute of  Consumption, see below), which has the power to: 
•  freeze the sales of a product until a decision has been taken, on the basis that the 
products presents a hazard to human health; 
•  ban the claim if  a decision is taken that it is illegal; or 
•  ban the product based on a decision that it is dangerous to human health. 
The  National  Institute of Consumption is  an autonomous organisation, under the 
auspices  of the  Ministry of Health  and  Consumption.  Under  Law  26/84 
55  for  the 
Consumers  and  Users  defence  and  article  51  of the  Spanish  Constitution,  this 
institute's role is to promote the consumers' rights. 
It is  constituted  by  a  president,  a  vice  president,  a  general  secretariat,  and  two 
subdivisions.  The  first  subdivision  is  responsible  for  Education  and  Formation, 
consumers' information, and "arbitrage". The second one is responsible for technical 
assistance to  the Consumption administrations, the administrative co-ordination and 
53  See Annex 6., op.cit. 
54 See Annex 9., op.  cit 
55  Sec Annex8.. op.cit 
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second subdivision comprises the  Investigation and Quality Control Center.  This 
Center undertakes analysis  and tests  on consumption products,  aiming  at  verifying 
their security and commercial quality. These analysis are based on evidence coming 
from  local Consumption Inspection Services, the National Institute for Consumption, 
Municipal Consumer Information Offices, Tribunals, and other official organisations. 
Co-operation with other organisations takes place through the production of reports, 
diffusion of analytical methods, participation in committees and working groups. This 
co-operation  is  established  with  other  control  laboratories,  Institutions  (General 
administration,  "Comunidades  Autonomas",  "Ayuntamientos"),  normalisation 
organisms (CEN, ENAC ...  ),  and other organisations that have the responsibility for 
elaborating legal norms (CIOA). 
The Institute's decision can then be taken before the Supreme Court. 
There have been very few actual court cases regarding claims in Spain, except in the 
area of  "miracle" product claims.  This resulted in the adoption of 1907/96 banning all 
health claims except for those covered by the voluntary agreement with FlAB. 
b.  Specific procedures for claims 
The procedures for both nutritional and health claims are those established under the 
relevant  legislation  for  misleading  advertising.  Law  26/1984  states  that  infractions 
will be submitted to  administrative sanctions and that that the cases will brought to 
Tribunales de Justicias. It then lists the different type of  sanctions. 
c.  Out-of-court procedures 
All  health  claims  are  allowed  if they  follow  the  guidelines  set  in  the  relevant 
legislation  (Royal  Decrees  212/92  and  1907 /96
56
)  and  the  rules  established  in  the 
FlAB voluntary agreement. If doubts exist as to the legality of the claim, the Follow-
up  Committee can be requested to  investigate whether it meets  the  rules set in  the 
agreement,  prior to  the release of the  claim.  In  such a case,  the  Committee has  10 
working days to give its conclusions on the inquiry. The claim is cleared if a decision 
has  not  been taken  by this  deadline,  and/or if the  Committee  approves  the  claim. 
During its investigation, the Follow-up Committee can temporarily ban the use of the 
claim until a decision has been taken. The owner of the claim has the right to request 
that  he/she  be  allowed  to  present  arguments  in  favor  of the  claim,  during  the 
investigation. To date the Follow-up Committee has studied more than 50 cases. 
The Consumer Association, CECU, has also been involved in verifying claims, either 
at  its  own initiative or by request of individual consumers.  In  the  case that CECU 
decides that a claim warrants investigation, it will first carry out its own investigation 
and  then,  if its  decides  sufficient cause  for  further  action  exists,  it  can present  its 
findings  to  the  Consumer  Institute,  requesting  further  investigation  from  the 
Government body. 
56 See Annexes 5 and 6., op.cit 
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C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Federal  and  regional  health  and  consumer  administrations  as  well  as  consumer 
associations,  industry,  and  individual  consumers  are  allowed  to  take  legal  action 
against  claims,  following  the  guidelines  of Law  3411988  on  General  Rules  of 
Advertising (a distinction between advertising and claims does not exist within the 
Spanish  legal  framework).  This  law  is  a  transposition  of Directive  84/450/CEE. 
Consumers also have recourse to Law 26/1984 
57 on the Protection of Consumers and 
Users,  and to Royal  Decree  194511989 on Infractions and Sanctions in  the  areas of 
Consumer Protection and the agro-food industry. 
Legal action can be taken to both the regional  and federal  courts,  and to  date most 
cases have been dealt with by the regional courts. 
D.  BURDEN OF PROOF 
The burden of proof is  on public authorities  to  show that an offence has occurred 
under the legislation. 
Law 26/1984 states in  its chapter "protection of economic and social interests" that 
"doubt in the interpretation will be solved against those who will have written them" 
and, further, that public authorities and the relevant administration bodies competent 
in consumption matters will adopt and promote adequate means in order to  help the 
consumer(s),  individually  or  collectively,  that  will  find  himself  in  situation  of 
inferiority." Chapter 10 states that the State Administration will have to promote and 
develop the consumer's protection and defence. 
Thus,  legislation  on  nutritional  claims  and  health  claims  indicate which  particular 
administration is responsible in particular cases. 
E.  APPLICABLE PENAL  TIES 
The penalties  applied  in  the  event a  claim  is  proven not to  comply with  relevant 
legislation are: 
•  Fines (amount fixed by the court or Consumer Institute); 
•  Destruction of  the merchandise; and 
•  Ban on the sale of  the product. 
V.  CASELAW 
There is no body of  case law in Spain. The only case law that we could find relate to 
the  Tribunal  of Biscaya  ( 19.04.1995)  in  the  "margarine  FLORA"  ruled  that  the 
statement "helps you to  regulate the  level of cholesterol" was allowed, on the basis 
that "cholesterol" was  not a human illness,  and,  as  such,  corresponded to  the  rules 
established under the Royal Decree 212/1992, and the Voluntary Agreement. 
58 
57 See Annex 8., op.cit 
sx  Sec Annexes 6 and 9, op.cit 
Pan- European study on nutritionaL health and ethical claims- 1999.  372 VI.  MEANS OF COMMUNICATION 
For all types of claims, non-compliance with the specific legal requirements on claims 
(see part on legislation) is considered to be misleading publicity, defined by the Law 
34/1.988 as the publicity that "in any way, even through the presentation, induce or 
may induce an error,  influence the  economic behavior, or jeopardize a competitor's 
position" 
Spain introduced a self regulatory body for the media. 
The Association for  Advertising  Self Regulation  (APP)  is  the  only organisation in 
Spain  dealing  with  self-regulation  in  advertising.  It is  composed of the  following 
members: 73  advertisers, 22 agencies,  14 representatives of the media and 6 industry 
organisations (the Spanish Advertiser's association, the Spanish Proprietary Products 
Association, the Spanish Advertising Agencies'  Association, the Advertising Media of 
Spain Association, the Spanish Outdoor Advertising Association, and the Federation 
of  regional Radio and Television Organisations). 
It is  a  private,  non-profit  making  body,  independent  from  the  government.  It is 
composed of a  Board of Directors, and a Director General who together form  the 
governing  body,  a  Secretariat,  and  a  Jury  (made  up  of 4  legal  experts  and  6 
representatives  of business  and  advertising  associations,  presided over by a  senior 
academic and an administrative law specialist). 
It aims  at  ensuring compliance with the legal  and self regulatory provisions, which 
regulate advertising as a form of  commercial communication, and to regulate both the 
form  and content of advertising in all  media.  To this  end,  it considers and resolves 
cases of non-compliance,  provides pre-publication advice  and drafts  guidelines  for 
legal and ethical advertising practices. 
The Codes: 
•  Code of  Advertising Practice (December 1996) 
•  Sector specifics: such as the "rules for the advertising of  food products"(l985). 
The AAP provides copy advice on campaigns, examines advertising for compliance 
with its code, handle complaints, etc. 
A number of sanctions can be proposed (to ask the advertiser to withdraw or modify 
the advertisement, to  request the media to  cease publication of the advertisement, to 
publish the adjudication in the APP's monthly newsletter, which is  sent to  members 
and the media, to expel the advertiser or advertising agency from membership). 
VII.  STATISTICS ON CLAIMS 
There is no information relating to statistics. 
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Legislation 
1) Real Decreto 93011992, 17.07.1992 (on nutritional claims), BOE 187. 
2)  Real  Decreta  268511976,  16.10.1976  (on  technico-sanitary  reglementation  for 
theelaboration, circulation and trade of  diet foodstuffs), BOE 284. 
3)  Real  Decreto  1809/1991,  13.12.1991,  (modification  of the  technico-sanitary 
reglementation. On the elaboration, circulation and trade of diet foodstuffs), BOE 308. 
4) Real Decreto 142611988,25.11.1988, BOE 288 
5) Real  decreta  1907/1998, 02.08.1996, on publicity and commercial promotion on 
products activities or services having a sanitary aim, BOE 189 
6)  Real  Decreto  21211992,  06.03.1992  (General  norm  on  foodstuff  claims, 
presentation and publicity), BOE  72 
7)  Real  Decreto  194511983,  22.06.1983  on  infraction  and  sanctions  regarding  the 
consumer and the agro-alimentarian defence. BOE 168 
8) Law 26/1984, 19.06.1984 for the Consumers and Users defence, BOE 176. 
Other Documents 
9)  Ministerio  de  Sanidad  y  de  Consumo  I  Federacion  espanola  de  Industriales  de 
Alimentacion y Bebidas : 
Acuerdo interpretativo sabre Ia publicidad de  las propiedades de  los alimentos en 
relacion con Ia salud. 
1  0) El Instituo Nacional de Consumo http://www.consumo-inc.es/prescntainc.htm 
11) EASA: The blue Book, Advertising and self-regulation 
12) OCU Compra Maostra, no.225, May 1999. 
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0.  SWEDEN 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This  study on nutritional,  health  and  ethical  claims  has  been well  received  by  all 
interested parties/stakeholders who together have been very co-operative in meeting 
and providing information. 
The issue of food claims has been discussed in Sweden for a longer time than most 
other European countries.  Since 1990, Sweden has had a voluntary code in place - a 
self-regulating programme for health claims - and has therefore gained considerable 
operational experience compared to  other European countries.  At the  present time, 
discussions are  ongoing regarding a potential extension of the  existing code also to 
include product specific  health  claims.  The  outcome of these  discussions  remains 
unclear.  Ethical claims are  about to  gain public interest but have until present only 
received  limited  attention.  Sweden  would  welcome  new  initiatives  from  the  EU 
Commission regarding claims and would like to make the issue a higher priority. 
B.  MEMBER STATE POLICY 
Swedish  policy  thinking  on  nutritional  and  health  claims  is  based  on  consumer 
protection (not misleading of the consumer), combined with consumer safety and the 
promotion of healthy eating habits.  Unlike at the EU  level, the Food Act defines the 
term food as any foodstuff, beverage, stimulant or other product intended for human 
consumption,  with  the  exception  of products  covered  by  the  Act  on  Medicinal 
products.  Consequently, there is  a general prohibition on claims implying that food 
products can prevent or cure a disease. 
1.  Nutritional Claims 
Nutritional claims are defined in Swedish law.  The Swedish definition is in complete 
accordance  with  the  EU  definition  and  with  the  Codex  Alimentarius  definition. 
Furthermore, the Codex '"nutrient content claim", "comparative claim" and ''nutrient 
function claim" are all accepted in Sweden. 
There also exists an ordinance regarding the  use of certain symbols.  Known as  the 
"key hole" symbol, which is a registered trademark, it can be used on a wide range of 
food  products  providing  that  they  have  a  low  fat  content  or  a  high  dietary  fibre 
content.  This allows it to be classified as a nutritional claim, which is  in accordance 
with Codex guidelines. 
2.  Health Claims 
Health claims are not, strictly speaking, defined in the Swedish Food Act.  However, 
an ordinance on the labelling and presentation of foodstuffs states that "labelling and 
methods used must not contain statements that the foodstuff prevents, treats or cures 
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Swedish definition is more medicinal than that which is  currently being elaborated at 
Codex  (April  1999  draft  guidelines).  The  Swedish  Marketing  Act  also  applies  to 
health claims. 
Following an intense national debate in the 1980s, it was considered that health claims 
used in a responsible way might be an important means to  help in implementing the 
dietary recommendations. Consequently, the then Medical Products Agency decided 
in  1989  to  no  longer to  apply medicinal product legislation to  products  commonly 
found on the dinner table.  The condition being that no  dosage is given in marketing 
of the product and that no information is given, which is used for medicinal products. 
This led to the food industry launching a set of  rules for health claims (see below). 
3.  Ethical Claims 
There is no legislation and/or legal definition of ethical claims in Sweden.  However, 
claims  are  subject  to  general  clauses  regarding  correctness,  honesty  and  non-
misleading information in  the  Marketing Act.  The very recent  government study, 
Mark Val (label well), raised the issue of ethical labelling and recommended that with 
EU  co-operation,  work  should  be  carried  out  on  labelling  which  will  enable 
consumers  to  avoid  products which are manufactured by companies  which  behave 
unethically. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Health Claims 
Established in  1990 and recognised by the authorities, Sweden is  home to  the oldest 
industry-led voluntary code, regulating health claims.  A health claim is defined as an 
assessment of  the positive health effect of a foodstuff, i.e., a claim that the nutritional 
composition of the  product can be connected with a reduced risk of a diet-related 
disease. The claim must be based on the importance of  the product in a balanced diet, 
and must be in line with official Swedish dietary recommendations. 
The code is  being "updated'' with a new proposal to  include product-specific claims, 
following the development of functional foods.  Product-specific physiological claims 
must  be  documented  by  human  studies;  the  study  group  must  be  representative; 
normal amounts of the product should be used, and the duration of the studies should 
be sufficient to show lasting effects. A pre-market review of  the studies supporting the 
claim is  to  be carried out by specially selected,  internationally reputed scientists.  A 
special "Assessment Board for Diet-Health Information" will be established to follow 
up  the marketing of every product with different kinds of health claims, having the 
possibility to impose a fine for transgression of  the rules. 
2.  Ethical Claims 
Whilst a number of ethical labelling schemes are  in  operation in  Sweden, only the 
"'Rattvis"  (fairness)  logo  and  organisation  is  generally  recognised:  although  the 
market share of  labelled products is still fairly low (1-2% ), more than 1  Oo/o of Swedish 
consumers are aware of the Rattvis logo  according to  the  organisation.  The Rattvis 
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logo  used  for  coffee,  tea  and  cocoa products  and  the  organisation  is  working  on 
including other product categories such as  honey, bananas, chocolate, orange juice, 
etc.  The logo is recognised by the authorities. 
D.  VERIFICATION SYSTEMS 
In addition to  specific relevant legislation, the Swedish Marketing Act provides the 
necessary legal structure. However, although the National Food Administration, or the 
Swedish  Nutrition  Foundations  or  the  Consumer  Agency  can  provide  advice, 
guidelines, etc, there is no pre-clearance mechanism in place for labelling claims. 
The municipal environmental and health protection administrations undertake post-
clearance. In the large majority of cases, disputes are settled out of court, through the 
issuing of prohibitions or information orders.  Cases can,  nevertheless, be taken  to 
court if  necessary and, under the Marketing Act, a so-called market disturbance fee of 
up to a maximum of 10 percent of the company's turnover can, in theory, be levied. 
Any legal person- consumer or competitor- can take a complaint to the Consumer 
Agency or the relevant municipal authorities, whilst the burden of proof always rests 
with the legal person responsible for the marketing of  the product. 
E.  MEANS OF COMMUNICATION 
There  are  no  differences  in  the  applicability  of the  relevant  legislation/guidelines 
regarding the means of  communication. 
F.  CONSUMER PROTECTION 
Consumer  protection  is  at  the  forefront  of Swedish  policy  as  far  as  labelling  is 
concerned.  There is  generally a  good working relationship between authorities and 
consumer  organisations.  Recently,  the  Swedish  Consumer  Association  filed  a 
complaint to the Consumer Agency (it receives about 200 complaints a year mostly 
related to  dietary supplements and natural  remedies)  regarding  labelling of an ice-
cream product.  It is  expected that such action might take place more frequently in 
light of  new food products entering the market, which make marketing claims. 
G.  BARRIERS TO TRADE 
It is fair to say that this is not a major issue of  contention.  However, it is worth noting 
that the Swedish National Board of  Trade notes that voluntary labelling systems (e.g., 
relating to ethical labelling and the use of  the Rattvis logo) may cause barriers to trade 
and that such systems should be harmonized internationally. 
H.  CASELAW 
Cases are dealt with in the administrative system rather than going to court and, there 
is  very  little  case  law  at  hand.  On  a  number  of occasions  the  National  Food 
Administration and the Medicinal Products Agency have issued administrative orders 
to  change  existing  marketing  practices  with  reference  to  both  misleading 
advertisement and the use of  health claims. 
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1.  Government Authorities 
•  In  essence,  the  authorities  are  not  planning  to  take  any  action  on  nutritional 
claims.  Rather, they recognise and support the voluntary code for health claims. 
Nevertheless,  current  policy thinking  in  Sweden  clearly  favours  an  EU  based 
regulatory framework for health claims as stated in Sweden's comments to the EU 
Green Paper on food law. It has also been suggested that when Sweden takes over 
the  Presidency of the  E U on 2001,  it  will  launch a health claims  initiative.  As 
regards  ethical claims,  there  is  a growing  awareness  that the  issue needs  to  be 
addressed,  but  once  again  the  Government's  latest  reaction  suggests  that  it  is 
looking to the EU to establish a framework. 
2.  Consumer Organisations 
•  The  Swedish  voluntary  code  for  health  claims  is  supported  by the  two  main 
consumer organisations - the Swedish Consumers' Association and the Consumer 
Coalition.  The Consumers'  Association has  also  pronounced its  support for  the 
new proposal concerning product-specific physiological claims, at least for a trial 
period.  The  Association  has  sympathy  for  the  stipulated  rules  relating  to 
documentation for these claims. The Consumer Coalition is very positive towards 
the new proposal since this organisation generally holds the view that more (true) 
information should be passed on to  consumers so  that they can  make informed 
purchasing decisions. 
3.  Industry 
•  There  is  no  indication from  industry that  modifications  are  needed  concerning 
nutritional claims.  As far as  health claims are concerned, the voluntary code is 
proving satisfactory and,  indeed,  a revised  programme  has  been  in  force  since 
January  1997  and  a  new proposal  has  been  tabled  to  include  product-specific 
claims.  The National Food Administration is  considering how it  should react to 
the new proposal. 
* * * 
Pan~  European study on nutritional, health and ethical claims~ 1999.  378 I 
II.  MEMBER STATE POLICY 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
Nutritional claims are defined in the Swedish Ordinance on Nutritional Declaration 
(SL V FS  1993:21:  Statens livsmedelverks kungorelse med foreskrifter ich allmanna 
radom naringsvardes deklaration). 
In § 5 it is said: 
"A  nutritional claim is defined as any representation or message which states, 
implies  or  maintains  that  a  foodstuff  has  special  nutritional  qualities 
regarding the energy it gives, gives in  increases or decreased degree,  or does 
not  give;  or regarding  the  nutrients  it  contains,  contains  in  increased  or 
decreased degree, or does not contain. " 
It is  also  mentioned  that  compulsory  information  on  the  quality  or  quantity  of 
nutrients does not constitute a nutritional claim. 
The Swedish definition of a nutritional claim is  in complete accordance with the EU 
definition and with the Codex Alimentarius definition. The Codex "nutrient content 
claim", "comparative claim" and "nutrient function claim" are all accepted in Sweden. 
2.  Health Claims 
Health claims are not explicitly defined in  the Swedish Food Act, but the National 
Food  Administration's  Ordinance  with  Regulations  and  General  Advice  on  the 
Labelling and Presentation of Foodstuff (SL  V  FS  1998:15:  Statens livsmedelsverks 
kungorelse med foreskrifter om markning och presentaion av livsmedel) states in §6: 
"Labelling and methods used must not contain statements that the foodstuff 
prevents, treats or cures disease." 
This more implicit definition reflects the definition found in Article 2 of  79/112. 
In the latest Codex definitions of health claims from April  1999 (still at discussion 
stage), two different definitions are used.  It is  interesting and important to note that 
neither of  these definitions includes words like "preventing, treating or curing." 
Consequently, a comparative analysis of the Swedish and the EU definition vis-a-vis 
the Codex definitions suggests that these are not really in accordance with each other, 
i.e. the Swedish and EU definitions are more "medicinal" than the Codex definitions. 
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No official definition for ethical claims exists. 
B.  LEGISLATION 
1.  Nutritional Claims 
The regulatory framework for nutritional claims includes primarily: 
•  The  National Food Administration's  Ordinance  with  Regulations  and General 
Advice on the Labelling and Presentation of  Foodstuff (SLV FS 1998: 15) (Statens 
livsmedelsverks  kungorelse  med foreskrifter  om  miirkning och  presentaion  av 
livsmedel), §5 deals with honesty and non-use of  labelling and methods that may 
lead to misunderstanding  ..... , and 
•  The Ordinance on Nutritional Declaration. 
The  Council  Directive  90/496/EEC  on  nutritional  labelling  is  implemented  in  the 
Ordinance on Nutritional Declaration. 
In  a  wider  sense,  the  Swedish  Marketing  Act  logically  also  applies  to  nutritional 
claims. 
The  National  Food  Administration  has,  in  a  separate  piece  of legislation,  The 
Ordinance  with  Regulation  and  General  advice  regarding  application  of a  certain 
symbol (SL  V FS  1989:2), made rules for the use of a so-called "key hole" symbol. 
The symbol  is  registered as  a trademark and may be used on a wide range of food 
products providing they have a low content of fat  or a high content of dietary fibre. 
The use of the keyhole symbol can be classified as a nutritional claim, in accordance 
with the Codex guidelines. 
2.  Health Claims 
Health  claims  legislation  concernmg  food  product  and  dietary  supplements  IS 
contained in: 
•  The  National  Food Administration's  Ordinance  with  Regulations  and General 
Advice on the Labelling and Presentation of  Foodstuff (SLV FS 1998:15: Statens 
livsmedelsverks  kungorelse  med foreskrifter  om  markning och  presentaion  av 
livsmedel), §5 as described above, and 
•  §6,  as mentioned under section II A 2. 
In a general note to  §6, it is  specifically mentioned that the regulations in §6 permit 
the  use  of health claims covered by the rules  in the  food  industry's programme as 
published  in  "Health  Claims  in  the  labelling  and  marketing  of food  products." 
(Amended by Ordinance SLV FS 1995:15). 
The  Council  Directive  79/112  on  Labelling  of Foodstuffs  is  implemented  in  The 
National Food Administration's Ordinance with Regulations and General Advice on 
the Labelling and Presentation of  Foodstuff (SL  V FS 1998: 15) 
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The  Swedish  Marketing  Act  is  equally  applicable  to  health  claims.  Health  claims 
regulation is also in place for other product categories.  For example, natural remedies 
are regulated by The Medicinal Products Act. 
3.  Ethical Claims 
There is no specific legislation in place regarding ethical claims. However, any claim 
-including ethical claims- is subject to general clauses regarding correctness, honesty 
and non-misleading information in The Swedish Marketing Act. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
Nothing to report. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Nutritional Claims 
The essence of policy thinking regarding claims is related to consumer protection and 
non-misleading of the  consumer.  In  relation  to  food  products,  the  policy thinking 
further  includes  consumer  safety,  consumer  health  and  the  overall  promotion  of 
healthy eating habits.  With regard  to ·nutritional claims,  the  Swedish policy has,  in 
general, been coherent with Codex guidelines and EU policies/directives. 
All kinds of claims used, either in labelling or marketing, must be in accordance with 
the  totality  of relevant  legislation  - the  main  laws  being  the  Food  Act  and  The 
Marketing Act.  Expressed in a simplified way, labelling is  covered by The Food Act 
and marketing is covered The Swedish Marketing Act. 
The nutrient content claim, the comparative claim and the nutrient function claim are 
generally administered according to the Codex Guidelines on Nutrition Labelling and 
Nutrition Claims. As such, information on generally accepted nutrient function effects 
may  be  given,  provided  no  connection  is  made  to  disease  and  provided  that  the 
product contains a significant amount of the substance in question - generally 15% of 
the recommended daily intake. 
2.  Health Claims 
As will be demonstrated below, health claims are in use in Sweden. As such, it might 
be useful to outline the historical background and thinking behind such claims. 
The Food Act defines the  term food  as  any foodstuff,  beverage,  stimulant or other 
product intended for human consumption, with the exception of  products to which the 
Act on Medicinal Products (SFS 1992:859) is applicable. 
The term medicinal product is used to describe products intended for administration to 
people or animals to prevent, detect, palliate, or cure disease or symptoms of disease, 
or to be used with similar intent (SFS 1992:859). 
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implying that food  products can prevent or cure a  disease.  On the  other hand,  the 
background of the dietary recommendations is  that certain dietary habits do help to 
prevent  diet-related  diseases.  During  the  1980s,  there  was  an  increasingly  intense 
debate  in  Sweden whether it  was  reasonable  to  have,  on one hand,  official  dietary 
recommendations  aiming  at  preventing  diet-related  diseases  and,  on  the  other,  a 
complete  prohibition  of any  claim  regarding  even  well-established  and  generally 
recognised diet-health relationships. It was also considered that health claims used in 
a responsible way might be an  important means of helping to  implement the dietary 
recommendations. 
With  this  background,  the  National  Board  of Health  and  Welfare  and  the  Drug 
Department (now the Medical Products Agency) decided in 1989 no  longer to  apply 
medicinal product legislation to  products commonly found  on the  dinner table.  The 
condition  being that  no  dosage  is  given  in  marketing of the  product  and  that  no 
information is given, which is used for medicinal products. 
It was against this background that the food industry - encouraged by the authorities -
took the initiative to  create a set of rules for health claims concerning labelling and 
marketing of  food products. 
The current policy thinking in Sweden is clearly in favour of an EU based regulatory 
framework for health claims as  it has also been stated in Swedish comments to  the 
Green  Book on  EU  food  policy/legislation.  It has  also  been  suggested  that  when 
Sweden takes over the Presidency of the EU in 2001, it will launch a health claims 
initiative. 
The  National  Food  Administration  is  considering  how  it  should react  to  the  new 
proposal regarding so-called "'Product-specific physiological claims" which has been 
prepared  by the  parties  behind  the  food  industry's  self-regulation  programme  for 
health  claims.  (More  details  may  be  found  under  the  Section  III  - Voluntary 
Instruments). 
3.  Ethical Claims 
The subject of  ethical labelling is about to receive more public attention. Late in 1997, 
the government decided to carry out a study concerning problems regarding labelling 
and other consumer information in  relation to  consumer goods.  The  study was also 
aimed  at  drawing  up  proposals  regarding principles  for  consumer information and 
labelling of consumer goods.  The  study,  Mark  Val  (label  well),  was  published  in 
February 1999 (SOU 1999:7, further information may be found at www.faktainfo.se  ). 
In  the  study,  ethical  labelling  is  described  as  taking  a  position  in  certain  ethical 
questions. 
The  study contains  no  comprehensive  discussion of ethical  claims/labelling.  In  the 
conclusion,  a  number  of proposals  regarding  future  principles  for  labelling  are 
suggested.  One such proposal is  related to  ethical claims. It is  stated that Sweden -
within the framework of EU co-operation - should work towards a labelling system, 
which  enables  consumers  to  avoid  products,  which are  against their own personal 
ethical convictions. 
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On a general note, the Ministry of Finance, of which the Swedish Consumer Agency 
is  now  a  member,  has  recently  published  a  book "Mark Val"  (label  well)  which 
analyses the entire area of consumer information regarding ordinary consumer goods. 
The analysis has made a list of proposals for further consideration, some of which are 
also  relevant  to  the  present  report;  for  example,  it  recommends  that  all  products 
should be marked with country of  origin and with the date the product was produced. 
It has also been proposed that Sweden within the framework of the EU  should work 
for  the  most  complete  labelling  of ingredients  possible  on  pre-packaged  food 
products. In this way, consumers may avoid products presenting a risk to their health 
or products that go against their ethical convictions. The Food Administration will be 
asked to consider the keyhole labelling and questions in relation to contamination and 
safety. It has further been suggested that the possibility for consumer organisations to 
take part in the work regarding labelling of consumer goods should be strengthened 
and that representatives from these organisations should get on the Board of relevant 
public agencies. 
In  a note  relating to  ethical  labelling and the  use of the  Rattvis  logo  the  Swedish 
National Board of Trade remarks that voluntary labelling systems may cause barriers 
to  trade  and  that  such  voluntary  labelling  systems  should  be  harmonized 
internationally as far as possible. 
III.  VOLUNTARY INSTRUMENTS USED 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional 
No voluntary instruments are in place. 
2.  Health Claims 
The Swedish code "Health Claims in the Labelling and Marketing of Food Products: 
The Food Industry's Rules  (Self-Regulating Programme)" was established in  1990, 
i.e.  five years before Sweden's entry into the European Union. From  I January 1997, 
a revised programme has been applicable. 
A health claim is  defined in the programme as an assessment of the positive health 
effect of a foodstuff, i.e. a claim that the nutritional composition of the product can be 
connected with a reduced risk of a diet-related disease. The claim must be based on 
the  importance of the  product in  a balanced diet,  and must be in  line with official 
Swedish dietary recommendations. The claim must consist of two parts:  information 
on  diet-health  relationships,  followed  by  information  on  the  composition  of the 
product. 
The  two-step  principle  has  been  required  by  the  authorities  to  make  the  code 
compatible  with  the  general  prohibition  of health  claims.  According  to  §6  of the 
Ordinance on Labelling and Presentation of Foodstuffs, the  labelling used must not 
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advice  given  in  §6,  however,  provides scope for  the  use of health  claims:  General 
advice: The regulations in §6 permit use of the health claims that are covered by the 
Food Industry's Self-Regulating Programme. Claims that a certain food product has 
specific health effects in itself are not allowed within the present programme. 
The programme has four parts: 
A.  Rules based on  official guidelines and statements,  subject to  review and update 
following discussion with the relevant authorities 
B.  Expert advice from the Swedish Nutrition Foundation regarding the application of 
the code 
C.  Information activities from  organisations and companies involved,  and from  the 
Swedish Nutrition Foundation; and 
D.  Evaluation. 
The programme is based upon the following eight well-established connections: 
1.  Obesity and energy content 
2.  Cholesterol level in the blood and  fat quality or some types of  soluble, gel-forming 
dietary fibre 
3.  Blood pressure and salt (sodium chloride) 
4.  Atherosclerosis  as  related  to  factors  decreasing  blood  cholesterol  and blood 
pressure, and naturally occurring omega-3-fatty acids in fat fish and  fish products 
5.  Constipation and dietary fibres 
6.  Osteoporosis and calcium 
7.  Caries  and the absence of  sugars and other easily fermentable carbohydrates 
8.  Iron deficiency and iron intake, including bioavailabilty aspects 
The  claim  must  consist  of two  parts:  information  on  diet-health  relationships, 
followed  by  information  on  the  composition  of  the  product.  For  instance,  a 
hypertension-salt claim could be made like this: 
In  high quantities, ordinary salt may increase the risk of  high blood pressure. 
X has a low salt content. 
The parties, which signed the  self-regulating programme, have in co-operation with 
the  Swedish  Nutrition  Foundation  formulated  a  proposal  for  an  extension  of the 
existing code to  include "Product-Specific Claims."  The proposal was published in 
June 1998 and is currently being discussed with authorities, the scientific community 
and consumer organisations. 
The proposal, which can be regarded as an extension of and as a complement to  the 
existing programme on generic claims in  two steps, is  of particular relevance to  so-
called  "functional  foods",  i.e.  foods  with  a  positive  health  effect  beyond  basic 
nutrition. 
According to the proposal, product-specific physiological claims must be documented 
by human studies showing the effects that are going to  be claimed. The study group 
must  be  representative,  normal  amounts  of the  product  should  be  used,  and  the 
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duration  of the  studies  should be  sufficient to  show  lasting effects.  A  pre-market 
review of the studies supporting the claim is  to  be carried out by specially selected, 
internationally well-reputed scientists in the field.  It is suggested that such a group be 
established on the European level. 
A  special  "Assessment  Board for  Diet-Health  Information"  will  be  established  to 
follow up the marketing of every product with different kinds of health claims, having 
the possibility to impose a fine  for transgression of the rules. The Swedish Nutrition 
Foundation should continue its advisory role and may also have an administrative role 
in the pre-market scientific evaluation of studies. 
3.  Ethical Claims 
The International Fair Trade Labelling Organisation (FLO) is represented in Sweden 
by the Rattvis organisation since  1996. "Rattvis" can be translated as  "fairness" and 
the organisation has its own logo. 
As  with all  member organisations of the  FLO,  the Rattvis  organisation has  similar 
principles  and  criteria  for  its  work  and  licensing schemes,  i.e.  for  small  farmers: 
democratic  forms  of organisations,  no  discrimination, political  independence,  good 
product quality; and for employees: fair salaries, the right to  organise itself, no child 
labour, etc. 
The  Rattvis  logo  used  for  coffee,  tea  and  cocoa  products  and  the  organisation  is 
working  on  including other product  categories  such  as  honey,  bananas,  chocolate, 
orange juice,  etc.  The market share of labelled products  is  still  fairly  low  (l-2o/o). 
However, according to  the organisation, more  than  1  Oo/o  of Swedish consumers are 
aware of the Rattvis logo. Some of  the bigger retail chains have started using the logo 
on some of their private brands. 
About  fourteen  organisations  (mainly  NGO  organisations)  back  the  Rattvis 
organisation. The Swedish Development Agency, Sida, also gives financial support. 
Another  voluntary  ethical  label  is  used  in  Sweden,  i.e.  an  "animal/rabbit"  logo 
together with the text ""against animal experiments." This labelling guarantees that the 
products or the ingredients in question have not been tested on animals. The label is 
used - among other things  - on the products manufactured by the retail chain "The 
Body Shop." 
Other ethically based labelling systems, e.g.  the Rugmark, Clean Clothes Campaign 
and others are not really used to any extent. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
1.  Nutritional Claims 
Not relevant. 
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As cited under Section III A, the food industry's self regulating programme defines a 
health claim as  an assessment of the positive health effect of a foodstuff, i.e. a claim 
that  the  nutritional  composition of the  product can be  connected with  prophylactic 
effects or the reduced risk of a diet-related disease. 
3.  Ethical Claims 
Not relevant. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Not relevant. 
2.  Health Claims 
Based on the fact that there is  no consensus and thus no official recommendation on 
the use of probiotic products, claims on probiotic products were explicitly prohibited 
from being included in  the revised programme of 1997 on health claims. Therefore, 
claims  cannot  be  made according  to  the  required  two-step  principle.  Furthermore, 
health effects of  pro  biotic microorganisms are confined to specific species - a fact that 
is frequently pointed out in the marketing of  these products. 
However,  health  benefits  of probiotic  products  may  be  claimed  if the  product  Is 
registered as a natural remedy under the Medicinal Products Agency. 
As an exemption, it is relevant to notice that in spite of  the emerging consensus on the 
decreased risk of several cancers with a diet rich in  vegetables and fruits,  no  diet-
cancer claims are  allowed in  the  Swedish code at  present.  The main reason is  that 
since  the  protective  effects  cannot  be  connected  with  a  certain  component,  such 
claims cannot be made according to the two-step principle. 
3.  Ethical Claims 
Not relevant. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
1.  Nutritional Claims 
Not relevant. 
2.  Health Claims 
The  food  industry's  self-regulating  programme  is  accepted/recognised  by  the 
authorities. In §6 of the Ordinance on Labelling and Presentation of Foodstuffs scope 
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is provided for the legal use of health claims that are covered by the mentioned self-
regulating programme. 
3.  Ethical Claims 
The Rattvis logo/claim is recognised by the authorities. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
The  criteria  for  using nutritional  claims  are  based  on the  relevant  legislation  and 
guidelines mentioned under II C 1, reflecting the 90/496/EEC Directive and Codex. 
As mentioned earlier, any claim appearing on labelling, etc. makes nutrition labelling 
compulsory. As far as the allowed nutritional claims are concerned, i.e.  content and 
comparative  claims,  these  are  based  on  quantitative  criteria  thereby  making  it 
relatively easy to verify if  such claims are justified. 
As far as the mentioned nutrient function claim is concerned these are allowed when 
they refer to generally accepted nutrient function effects (these are defined by a group 
of  experts  on  Diet,  Exercise  and  Health  associated  with  the  National  Food 
Administration) and when they make no reference to disease. 
2.  Health Claims 
Health claims must follow the eight well-established diet-health connections and the 
two-step principle outlined in the self-regulating programme. 
As far as the new proposal (for product-specific physiological claims) is concerned a 
separate verification system is contained in the proposal as discussed under Section III 
A2. 
3.  Ethical Claims 
The  voluntary  scheme  named  Rattvis  has  its  own  set  of principles  and  criteria 
applying  to  the  whole  food  value  chain.  The  scheme  also  operates  its  own 
verification/control system.  The FLO Register Committees monitor compliance. No 
national authorities are involved. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
General rules concerning labelling and marketing including claims are covered by the 
Swedish Marketing Act. The Consumer Agency and the Consumer Ombudsman, who 
also acts as the Director-General of the Consumer Agency, administer this act. 
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relevant in relation to claims. 
As  mentioned  under  Section  II  B,  claims  relating  to  food  products  are  generally 
regulated  by the  Food  Act  and  the  National  Food  Administration  in  relation  to 
labelling  whereas  marketing falls  under the jurisdiction of the  Swedish Marketing 
Act/ the Consumer Agency. 
1.  Pre-Clearance Rules/ Guidelines 
Questions from companies about food legislation including claims may be addressed 
to the company's supervisory authority, which is usually the municipal environmental 
and health protection administration. 
The National Food Administration publishes regulation, general advice, etc. and gives 
answers  to  principally important questions  on interpretation  and application of the 
legislation.  However, no real pre-clearance mechanism exists. 
Advice on claims and,  in particular, on health claims is  available from  the Swedish 
Nutrition Foundation. 
Several  other  central  authorities,  including  the  Consumer  Agency  and  trade 
organisations,  can  also  be  contacted  with  questions  relating  to  labelling  and 
marketing. 
2.  Post-Clearance Rules/ Guidelines 
Both the Swedish Food Act and the Swedish Marketing Act contain rules prohibiting 
incorrect labelling and misleading marketing. 
In most cases where the regulations are not complied with they are settled in out-of-
court procedures.  Otherwise,  cases  can be taken  to  the  civil  court and the  Market 
Court  and  only exceptional  cases  will  invoke  criminal  responsibility.  The  Market 
Court is  regarded as the supreme authority as far as  laws relating to competition and 
marketing are concerned.  It is the last resort. 
Most cases are settled by issuing prohibitions or information orders. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Any legal person including consumers or competitors can complain to  the Consumer 
Agency or the municipal authority regarding labelling or marketing not in accordance 
with the regulations. 
D.  BURDEN OF PROOF 
The burden of proof always rests with the legal person responsible for the marketing 
of the product and no specific kind of  proof is adduced. 
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Applicable penalties when violating claims regulations are usually of a limited size. 
Since  1996, the Marketing Act also includes some detailed rules prohibiting certain 
marketing  activities,  which  in  theory  would  cover claims.  Violations  thereof may 
cause a company to  pay a so-called market disturbance fee  (from a minimum 5.000 
Skr (approx. EUR 800) up to 5 million SKr. (approx. EUR 800 000) or a maximum of 
1  Oo/o of  the company's turnover. 
V.  CASELAW 
Decisions of  the Market Court in 1992, ( 1992: 18): 
•  The decision concerned Sodium reduced salt/Mineral salt (sodium partly replaced 
with potassium), claiming that the product would prevent from CHD.  The Market 
Court judged that it was a forbidden claim 
•  Moreover,  the marketing company was not allowed to claim that ordinary salt has 
a  blood pressure  elevating  effect,  that  potassium  counteracts  blood pressure 
increase,  that potassium  is  healthy,  that  this  particular sodium  reduced salt is 
healthier  than  ordinary  salt,  that  medical  experts  recommend  this  particular 
sodium reduced salt for the prevention of  high blood pressure 
Decision of the Market Court in 1995: 
•  The  decision concerned the company Naturpost AB that was fined 500.000 SKr 
(approx.  EUR  80  000)  for  violating  the  Marketing  Act  and  the  prohibition 
regarding health claims for natural remedies and dietary supplements. 
On  a  number  of occasions  the  National  Food  Administration  and  the  Medicinal 
Products  Agency  have  issued  administrative  orders  to  change  existing  marketing 
practices  with  reference  to  both  misleading  advertisement  and  the  use  of health 
claims. 
One such area has been claims relating mainly to dairy products containing probiotics. 
Overall, cases are dealt with in the administrative system rather than going to court. 
In  May  1999,  the  Swedish  Consumer  Association  filed  a  complaint  with  the 
Consumer Agency regarding the marketing of a new ice-cream product ""godhalsa" 
(good  health).  In  the  complaint,  it  is  stated  that  the  advertising  goes  against  the 
Marketing Act,  the  EU  Labelling  Directive  and  the  food  industry's  self-regulating 
programme.  This  incidence  is  mentioned  here  to  illustrate  that  the  consumer 
organisation is concerned about misleading advertising. 
VI.  MEANS OF COMMUNICATION 
No  differences  exist  in  the  applicability  of  the  relevant  legislation/guidelines 
regarding the means of communication used such as television, Internet, press, labels, 
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the Marketing Act. 
VII.  STATISTICS ON CLAIMS 
The Consumer Agency receives  approximately 200 complaints annually relating to 
claims; mostly these complaints concern dietary supplements and natural remedies. 
No further information is  available.  Out of approximately 200 complaints annually 
approximately 75  concern dietary supplements, approximately 40 slimming products 
and  only  a  limited  number  concern  nutritional/health  claims  for  ordinary  food 
products. 
VIII.  ANNEXES 
1.  Swedish  Ordinance  on  Nutritional  Declaration  (SL  V  FS  1993:21)  (Statens 
livsmedelverks kungorelse med foreskrifter och allmanna n1d  om naringsvardes 
deklaration) 
2.  Ordinance  with  Regulations  and  General  Advice  on  the  Labelling  and 
Presentation of Foodstuff (SLY FS 1998: 15) (Statens livsmedelsverks kungorelse 
med foreskrifter om markning och presentaion av livsmedel) 
3.  Health  claims  in  the  labelling  and  marketing  of food  products,  The  Food 
Industry's Rules (Self-Regulating Programme), Revised Programme, August 28, 
1996, Applicable from January 1,  1997, The Swedish Nutrition Foundation 
4.  Health  claims  in  the  labelling  and  marketing  of food  products,  The  Food 
Industry's  Rules  (Self-Regulating  Programme),  Proposal  for  extension  of the 
programme,  Product-specific  physiological  claims,  The  Swedish  Nutrition 
Foundation 
5.  The Swedish Marketing Act, Ministry of  Public Administration Ds 1996:3 
IX.  DATABASE OF CONTACTS 
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P.  UNITED KINGDOM 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
In  carrying  out  the  necessary  research  for  this  report,  Hill  and  Knowlton  has 
contacted, spoken, met and discussed the development of  public policy on claims with 
a variety of government departments,  industry association,  consumer organisations, 
scientific experts and self-regulatory bodies.  Without exception, the  people that we 
have contacted have been exceptionally helpful in assisting us with our research.  As 
far  as  possible,  we have  sought  to  canvass the  views  of all  organisations  with  an 
interest in these issues. 
The  organisations  we  met  welcomed  DG  XXIV's  initiative  to  undertake  an 
examination  of  the  regulatory  framework  for  claims.  However,  there  exist 
considerable  differences  of attitude  towards  the  Commission  proposing  EU  level 
initiatives.  These are examined further in the report. 
One of the most striking aspects of our research has been the  spirit of co-operation 
and constructive dialogue that exists in the UK.  Despite differing views on claims, 
there appears to be a genuine desire among all the constituents in the debate to reach 
common  accord  on  a  regulatory framework  for  claims.  The  Joint  Health  Claims 
Initiative  is  the  prime  example  of this.  This  can  only  be  seen  as  a  positive 
development and can only lead to the creation of a system where levels of consumer 
protection  are  ensured  whilst  allowing  industry  to  develop  and  market  innovative 
products  within  a  clearly defined  regulatory  framewo~k.  The  involvement of the 
enforcement authorities,  in  particular the  Local  Authorities  Co-ordination  Body on 
Food and Trading Standards (LACOTS), is a groundbreaking step that should, in the 
long term, benefit all interested parties. 
The platform for a frank exchange of views, mixed with a desire to reach agreement 
despite  different  positions,  is  a  model  that  should  be  mirrored  not  only  in  other 
Member Sates but at the EU level as well. 
B.  MEMBER STATE POLICY 
1.  Nutritional Claims 
The definition of nutritional claims in the  UK is  the same as  defined in  EU  law in 
Directive  79/112.  The  UK  authorities  consider  current  nutritional  legislation 
satisfactory and have  no  intention to  amend/update (save  for  issuing guidelines  on 
use). 
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Heath claims are regulated by reference to the various legislative instruments, which 
exist for  food  safety and labelling.  There is  no  specific definition or legislation for 
health claims.  However,  although there are no  plans to  do  so,  the  UK government 
would like  to  see  specific  legislation on health claims.  They would prefer an  EU 
initiative based on the current Codex Alimentarius draft guidelines, and are urging the 
EU  Executive to take action. In the meantime, they have welcomed the Joint Health 
Claims Initiative (JHCI).  However, the government recognises that non-UK products 
would not be covered by the JHCI nor does it believe that self-regulation alone is the 
best approach. It is also sensitive to calls from consumer organisations for a system of 
pre-vetting but equally aware  of the  increased bureaucracy that would  result from 
compulsory pre-vetting. 
Despite  the  lack  of definition,  health  claims  are  generally  understood  to  be  any 
statement, suggestion or implication in food labelling or advertising that a food carries 
a specific health benefit, but not nutrition claims nor medicinal claims (i.e. claims that 
a food is capable of  curing, treating or preventing a human disease or any reference to 
such a property). 
3.  Ethical Claims 
In contrast to the above, the government does not seem under pressure to do anything 
with regard to  ethical claims.  Rather it believes that the current legislation in place 
(rules  on  misleading  advertising  or  on  trade  descriptions)  more  than  suffices. 
Furthermore,  the  Department of Trade and  Industry (DTI)  is  a  strong supporter of 
self-regulation and has thought of  setting-up a self-regulatory code for on-pack ethical 
claims with retailers. However, due to the high level of fragmentation of the industry, 
the practicalities of  enforcing a code would be very difficult. 
C.  VOLUNTARY CODE OF PRACTICE 
Voluntary codes of practice for the means of communication are dealt with under a 
separate section. 
1.  Nutritional Claims 
In  order to  supplement food  labelling legislation, the Food Advisory Committee, an 
independent body which provides government with advice on food regulation, issues 
guidelines on nutritional claims.  These guidelines are updated on a regular basis. 
Industry organisations have also developed their own codes of practice on nutritional 
claims.  The most notable of these is  the  guidelines drawn up  by the  Co-operative 
Wholesale Society (CWS). 
2.  Health Claims 
The Joint Health Claims Initiative (JHCI) is the principle voluntary code of  practice in 
the  UK.  This  has  been  developed  by  industry,  consumer  organisations  and  the 
enforcement authorities. 
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Initiative (JHCI) will provide the necessary framework for regulating health claims. 
However,  a  number of the  participants  believe  that  it  is  a  stopgap  until  a  proper 
legislative framework,  which should emanate at EU  level, is  established. The JHCI 
can claim that all interested parties (government, enforcement authorities, consumers 
and  industry)  participated actively and  they are now  hoping that  it  will  come into 
force in 2000.  A Code Administration body, made up of a Council (representing all 
key  stakeholders),  a  Secretariat  and  an  expert  authority  will  manage  the  JHCI. 
Consumers, especially, hope that the soon to be created Food Standards Agency will 
take  responsibility.  The  initiative promotes a  pre-market advice/pre-vetting system, 
which suggests the exercise of due diligence, applied to health claims in all means of 
communications, with the overriding principle that the likely consumer perception of 
the health claim is  paramount. The Code administration body will develop a list of 
generic  health  claims,  to  be  approved  by  the  Expert  authority,  to  be  reviewed 
regularly. A system of innovative claims will  also be established. Whilst not legally 
binding, it promises to deliver. 
Under the JHCI code, annex  1 (see Section VII) sets out the limits between what is 
considered  to  be a  health  claim  and  a  medicinal  claim.  It also  treats  the  issue  of 
borderline cases. The code, therefore, provides guidance on how a legally acceptable 
claim may be made for a food, which has a role in reducing the risk of  disease. 
In practice, the involvement of the enforcement authorities in the JHCI will give the 
initiative a form of official backing. The enforcement authorities are  represented by 
the Local Authorities Coordinating Body on Trading Standards (LACOTS) and have 
been closely involved in the drafting of the code and will provide representatives for 
the JHCI Council.  However, despite the involvement of LACOTS, it will remain up 
to individual local authorities, which are responsible for enforcing relevant legislation 
to decide whether to prosecute on a case by case basis.  In practical terms, it should be 
noted  that  LACOTS  welcomes  the  JHCI  because  it  will  remove  an  element  of 
subjectivity from  enforcement through the  establishment of a list of generic  health 
claims.  LACOTS will advise Local Authorities to use the JHCI as guidelines for their 
activities.  They also  hope that  the  Code  Administration  Body will,  in  effect,  be a 
substitute for court proceedings, which would only need to be used as a last resort. 
The Co-Operative Wholesale Society (CWS) has developed its own code of practice 
for  labelling of pre-packed foods  for  both nutritional and health claims.  They have 
established a consumer help line, a complaints and disputes structure and a jury. The 
code builds on the Food Labelling Regulations and the FAC guidelines. The views of 
the  CWS  on  nutritional  claims  is  that  the  lack of detailed provisions  has  led to  a 
situation where labelers make factually correct claims, which show their products in 
the best light. However, because different criteria have been used in different product 
sectors, the potential for  misleading consumer arises. Consequently, the CWS Code 
provides  for  a  number of rules.  For health  claims,  the  CWS  states  that  "modern 
technology increasingly allows  foods  to  be manipulated to  deliver health benefits". 
The absolute ban on referring to diseases prohibits effective consumer communication 
by at best, forcing labelers to  adopt less direct messages, at variance with generally 
accepted  health  messages  and  failing  to  capitalize  on  the  benefits  of short,  sharp 
messages often repeated. At worst, it discourages claims all together. 
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In the UK, there are a number of organisations that are involved in ethical trading but 
relatively few, which have specifically established voluntary codes on ethical claims. 
Nevertheless, there could be growing pressure from members of the voluntary codes 
to use these as a basis for making ethical claims. 
The  Fairtrade  mark appears  to  be the  exception  in  the  UK and  is  one of the  few 
examples of a voluntary agreement on ethical claims. The Fairtrade mark provides an 
independent  mechanism  for  assisting  disadvantaged  producers  of  specific 
commodities in  developing countries by defining criteria for eligible producers and 
for  terms  of trade,  establishing a  register of qualifying producers,  and  monitoring 
transactions  so  as  to  provide  a  guarantee  to  consumers  that  products  bearing  a 
Fairtrade Label meet the agreed criteria. The Fairtrade Foundation, which has set up a 
licensing system for companies that wish to use the Fairtrade Mark, grants the right to 
use the Fairtrade mark on or in relation to products subject to the licensee complying 
with the terms and agreement of  the license. 
However, the lack of definition of claims and the ability of  manufacturers of  products 
to place their own claims on products could lead to consumers being misled. The lack 
of  any system of  control leaves the market for ethical claims open to potential abuse. 
D.  VERIFICATION SYSTEMS 
UK law does not as  such provide an inventory of criteria for substantiating nutrition, 
health or ethical claims.  It is  up  to  the courts  to  decide whether or not a particular 
claim  contravenes  the  law.  Responsibility  for  enforcing  the  law  falls  to  the  local 
authorities.  The  Fairtrade  Foundation  does,  however,  have  a  list  of criteria  that  a 
manufacturer must meet in order to qualify for the Fairtrade mark. Once again, there 
are no pre-clearance requirements in law although the JHCI encourages manufacturers 
to  seek  pre-clearance.  All  the  organisations  that  administer  the  means  of 
communication encourage pre-clearance for  all  types of claims. Some do  this more 
than  others;  for  example,  given  the  costs  involved,  it  is  a  normal  procedure  for 
television adverts.  As  to  post-clearance,  the  Director-General of the  Office of Fair 
Trading has  the  power  to  stop  an  advertisement  by  means  of a  court  injunction. 
However,  this  is  only  used  in  exceptional  circumstances  and  once  self-regulatory 
channels have been exhausted. 
As is demonstrated above, the legislative measures in place in the UK all require the 
enforcement  authorities  to  prove  that  any  particular  claim  that  is  being  made  is 
contrary to the provisions of  the various rules in force. 
In  the case of the  Trade Descriptions Act,  the Food Labelling Regulations  and  the 
Food  Safety Act,  the  offences  are  criminal  offences  and,  therefore,  the  burden of 
proof is  "beyond  reasonable  doubt".  In  the  case  of the  Control  of Misleading 
Advertising  Regulations  the  Director-General  would  need to  show  that  a  claim  is 
misleading on the "balance of  probabilities''. 
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This has repercussions for the decision by the enforcement authorities to  take action 
against makers of  claims, in particular where there is contradictory scientific evidence 
on a specific claim. 
E.  CONSUMER PROTECTION 
The  issue  of consumer protection  as  regards  claims  is  a  priority concern of many 
consumer organisations and, indeed, the authorities. This is reflected by the detailed 
and  carefully  worked  out  positions  of the  Consumer  Association  (CA)  and  the 
Consumers in Europe Group (CEG). 
The CA, provides numerous examples of  lack of  consumer protection from nutritional 
claims, e.g.  Hala Caramel Heaven bar claims to be 85% fat free,  which means is still 
contains 15% fat which is still a significant amount of  fat. 
In their opinion, most claims are not regulated and, therefore, their use can often be 
inconsistent,  confusing,  or even misleading.  They have consequently proposed four 
recommendations, which can be summarised as: 
1.  Definitions should provide criteria for  absolute and relative claims for  nutrients 
relevant to dietary guidelines; 
2.  The use of nutrition claims that are not relevant to  the  UK population should be 
prohibited; 
3.  Any nutritional claim should be supported by a full nutrition panel, in the absence 
of  mandatory nutrition labelling; and 
4.  A  set  of standard  criteria for  healthy eating  symbols  should be  developed that 
applies across the board and a nationally agreed set of nutrition criteria should be 
agreed for all healthy eating schemes. 
The CEG have developed three specific recommendations: 
1.  CEG believes that nutrient content claims must be clearly defined in terms of the 
quantitative level of the nutrient present, be consistent between products, and be 
meaningful to consumers. 
2.  The  Scientific  Committee  for  Foods  should  be  responsible  for  drawing  up 
threshold values for individual nutrients based on the most up-to-date research. 
3.  CEG is opposed to the use of implied nutrient content claims. 
As regards health claims, the position of the consumer organisations is  detailed and 
very well documented, reflecting the importance of the issue. There is also a general 
view in government departments that there is  a lack of consumer protection. The CA 
has elaborated four reasons for this, namely: 
1.  An increasing number of products are being marketed on the basis that foods can 
play a role in the protection and promoting of  health. 
2.  These claims are not always explicit, often implying health benefits through the 
use of  packaging and illustrations. 
3.  The  difference between a health and medicinal  claim is  not  always  obvious  to 
consumers. 
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of  complex claims are now being made on product labels. 
Given the above and the fact that research has demonstrated that consumers have little 
faith  in  health claims, the CA concludes that effective legislation is  required.  Such 
legislation  should  address  the  issue  of a  proper  definition  for  health  claims,  the 
conditions  of use,  a  prior approval  system,  rules  relating to  the  required  evidence 
(scientific), and a system of  penalties. 
In the absence of legislation, certain consumer groups welcome the JHCI in the short 
term and acknowledge that the  Code of Practice might provide a basis for control. 
Industry's position on health claims is essentially enshrined in the JHCI, although the 
Food and Drink Federation goes a step further in  calling for  disease risk reduction 
claims  to  be allowed,  pointing out that  Directive 65/65  is  no  longer appropriate in 
today's  environment  when  it  is  acknowledged  that  a  food  can  be  beneficial  to  a 
person's health. 
F.  BARRIERS TO TRADE 
Generally, the problem of barriers to trade is  not associated with claims. There are, 
nevertheless, concerns that if the use of health claims continues to  grow, this might 
accentuate the problem. The Medicines Control Agency did,  however, give specific 
examples of barriers to trade problems in connection with borderline cases between a 
food  and a medicine and on the different interpretations given by Member States to 
65/65.  The  same  applies  to  the  various  interpretations  given  to  79/112  and,  in 
particular,  Article 2.  Some Member States have  a more  liberal view of this  while 
others  adopt  a  more  narrow  interpretation.  This  can  lead  to  differences  between 
Member States and the need for manufacturers to  adapt a claim used in one country 
for  another  market.  However,  can  this  be  seen  as  a .barrier  to  trade?  There  is  an 
industry view, which acknowledges that they have to adapt to each national market -
taking into account national cultural/social differences, just as they have to change the 
language of the claim. 
One of the  objectives _in  the  JHCI  is  "'promoting  consistency  in  the  use  of health 
claims in the UK, Europe and internationally".  The JHCI code has had to be notified 
to  the European Commission under the  Directive 83/189 on national rules affecting 
the  free  movement  of goods.  This  will  provide  both  the  Commission  and  other 
Member  States  an  opportunity to  indicate  whether they believe  that  the  code  will 
result in barriers to trade. 
From our discussion, it appeared more likely that barriers to  trade would arise  from 
claims that are approved under the code in the UK but forbidden elsewhere in Europe. 
There was a general view that mutual recognition of a code would prove difficult and 
the authorities also pointed out that claims from outside the UK would not fall under 
the code. 
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The means of communication in the UK system of  regulation is notable in its reliance 
on  self-regulation.  The  arguments  in  support  of such  an  approach  are  clearly 
demonstrated by the professional and effective system that has been established. 
For  broadcast  communications  claims  are  regulated  through  the  Independent 
Television Commission  (television advertisements)  and  the  Radio  Authority (radio 
advertisements). Both these bodies have been set up under the broadcasting act with a 
requirement to develop and enforce codes of practice.  To  assist them with their task 
clearance bodies have been created for both television (the Broadcasting Advertising 
Clearance Centre) and radio (the Radio Advertising Clearance Centre).  They provide 
pre-market advice to advertisers on the legality of  advertising copy. 
For non-broadcast advertising a similar system exists but takes account of the very 
different  nature  and  scale  of non-broadcast  advertising.  The  British  Codes  of 
Advertising  and  Sales  Promotion  are  drafted  by  the  Committee  on  Advertising 
Practice (CAP).  The Advertising Standards Authority provides independent scrutiny 
of the  self-regulatory  system  administered  by  CAP  and  is  the  responsible  for 
consumer complaints. 
For  both  broadcast  and  non-broadcast  advertising  the  respective  codes  detail 
provisions specifically related to health claims (in the case of the radio, health claims 
must receive pre-clearance). 
H.  CASELAW 
There is a limited amount of case law available on claims in the UK.  The reasons for 
this appear to be threefold: 
•  The UK system of regulation is  heavily based on self-regulation and,  therefore, 
disputes tend to be resolved outside the legal system.  This is particularly the case 
with regard to the regulation of  the means of  communication. 
•  Even where there are specific legislative provisions on claims, the system is such 
that the parties are encouraged to reach an agreement outside the courts. 
•  The  authorities  responsible  for  the  enforcement  of legislation  are  the  local 
authorities. There is  reluctance on the part of the local authorities to  bring cases 
before  the  courts.  This  is  due  to  a  number of reasons  but  the  most  important 
appears to  be cost and the difficulties in securing a judgement as  a result of the 
burden of  proof  being on the plaintiff to show that the claim is not justified. 
There is considerable evidence to suggest that the lack of resources available to  local 
authorities  results  in  a  number  of claims  being  made  that  would  otherwise  be 
unlawful.  We are not in a position to judge whether this has the direct effect of a lack 
of  consumer protection. 
LACOTS has provided us with a summary of a study carried out by local authorities 
in  Wales  that  assess  whether  claims  comply  inter  alia  with  the  Food  Labelling 
Regulations 1996. 
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judgement  of the  local  authorities  are  unlawful.  The  summary  of this  study  is 
provided in annex XII. 
I.  STAKEHOLDER ANALYSIS 
The regulation of claims, and specifically health claims in the UK is  noteworthy in 
that  there  is  heavy  reliance  on  self-regulation  - particularly  in  the  means  of 
communication.  The  Joint  Health  Claims  Initiative  should  also  be  highlighted, 
although the parties concerned are still "wondering" whether it will be successful. 
1.  Government Authorities 
•  On nutrition claims, the government does not perceive the need for a review of  EU 
legislation.  However, the F  AC guidelines are regularly updated. 
•  On health claims, despite the support that the government has expressed for the 
JHCI, they are committed to an EU level initiative in this area. 
•  No  real  position  on  ethical  claims  exists  within  government,  only that  ethical 
claims must comply with rules on misleading trade descriptions. 
•  The enforcement authorities welcome the JHCI as a means to assist them in work 
on  health  claims.  No  specific  positions  on  nutritional  or  ethical  claims  were 
expressed. 
•  The enforcement authorities are hampered by a lack of resources and the current 
structure of the regulatory framework that requires them to prove that a claim is 
not justified.  As a result, they strongly support the Joint Health Claims Initiative, 
as this will act as a filter on claims that are currently made but fall outside the law. 
2.  Consumers 
•  Consumer organisations believe that nutritional claims can still mislead consumers 
and that further regulation is necessary.  In particular, they wish to see criteria for 
absolute  and  relative  claims,  a  full  supporting  nutritional  panel  and  a  set  of 
standard criteria for healthy eating symbols. 
•  Despite  the  JHCI,  consumer  organisations  still  favour  a  legislative  framework 
specific to health claims (some remain opposed health claims in principle).  They 
believe that this should be in the form of a European Union Directive and that pre-
market clearance of  claims is necessary. However, consumer organisations did not 
necessarily  see  the  Misleading  Advertising  Directive  as  the  only  vehicle  to 
regulate  claims.  They  are,  however,  concerned  that  there  is  a  danger  of the 
consumer is being misled in the current regulatory environment. However, in the 
absence of EU legislation they are supporting the Joint Health Claims Initiative. 
3.  Industry 
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regulatory approach and believes that it should be left up to the makers of claims 
to decide whether pre-market clearance is necessary. They believe that makers of 
claims should be allowed to  use claims as  long as these claims may be justified. 
The onus should be on the maker of  the claim to justify. 
•  Under current legislation, the onus is on the enforcement authorities to prove that 
the  claim is  not justified. Industry would also  like  to  see  changes  to  Directive 
65/65  and  791112  to  allow disease risk reduction claims to  be made.  However, 
industry remains skeptical of EU  legislative solutions.  It is concerned that an EU 
directive would result in the lowest common denominator approach and, therefore, 
restrict marketing freedoms. 
4.  Self regulatory bodies 
•  The organisations that regulate the means of communication are firmly opposed to 
EU  legislation and point to  sophisticated and  efficient systems that exist in  the 
UK. 
In summary, the situation in the UK is as follows: 
•  Nutrition  claims  - despite  concerns  from  the  consumer  assoc1atwns,  a  clear 
regulatory framework, which has the support of industry government, is in place. 
The framework is updated to reflect changes in scientific knowledge. 
•  Health claims - if the  JHCI proves  successful  the  need for  legislation may  be 
limited.  However,  both  government  and  consumers  and  the  enforcement 
authorities would welcome, at a minimum, a set of  regulatory principles for health 
claims.  ~ 
•  Ethical claims - there is no comprehensive approach to ethical claims.  There is a 
danger that consumers may be misled.  However, the  solutions  that need to  be 
adopted are likely to be very different from those required for health or nutritional 
claims. 
* * * 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The definition of a nutritional claim is set out in the Food Labelling Regulations 1996 
and is as follows: 
"any statement, suggestion or implication in any labelling, presentation or advertising 
of  a food that a food has particular nutrition properties" 
Nutrition properties is defined as: 
"(a)  the  provision  (including provision at  a reduced  or increased rate),  or lack  of 
provision, of energy" or "(b) the content ((including content in a reduced or increased 
proportion), or lack of  content of  any nutrient (including any substance which belongs 
to, or is a component of, a nutrient)." 
The  definition  of nutritional  claims  is  as  m  the  Directive  on  the  Labelling  of 
Foodstuffs (90/496). 
Article 40(2) of  the Food Labelling Regulations 1996 provides: 
"a claim  of the  type  described  in  part  II  of Schedule  6  shall  not  be  made,  either 
expressly  or  by implication,  in  the  labelling  or advertising  of a  food,  except  in 
accordance with the appropriate conditions set out in that Part of  that schedule." 
Part II of Schedule 6 provides a list of types of claims that can be made.  Alongside 
the types of claims that are allowed the conditions that must be met are listed:  The 
types of  claims that are permitted are defined as follows: 
•  "Claims relating to foods for a particular nutritional uses" - A claims that a food is 
suitable, or has been specifically made, for a nutritional purpose. 
•  "Reduced or low energy value claims"- a claim that a food has a reduced or low 
energy. 
•  "Protein claims" - a claim that a food,  other than a food  intended for  babies or 
young  children  which  satisfies  the  conditions  of item  1  of this  Part  of this 
schedule, is a source of  protein. 
•  ''Vitamin claims"- a claim that a food, other than a food intended for babies or 
young  children  which  satisfies  the  conditions  of item  1  of this  part  of this 
Schedule, is a source of  vitamins. 
•  "Mineral claims" - a claim that a food,  other than a food  intended for babies or 
young  children  which  satisfies  the  conditions  of item  1 of this  Part  of this 
Schedule, is a source of minerals. 
•  "Cholesterol claim" - a claim relating to the presence or absence of cholesterol in 
a food. 
•  "Nutrition claim"- any nutrition claim not dealt with under any other item in this 
part of this schedule. 
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The definition provided in the Food Labelling Regulations 1996 are supplemented by 
guidelines based on recommendations made by the  Food Advisory Committee (see 
Section III.A.1 ). 
2.  Health Claims 
The UK has no legal definition of  a health claim. 
However, for working purposes the government considers that health claims are any 
statement, suggestion or implication in food labelling or advertising that a food carries 
a specific health benefit, but not nutrition claims nor medicinal claims (i.e. claims that 
a food is capable of  curing, treating or preventing a human disease or any reference to 
such a  property).  The  term "health claim"  includes  claims,  which refer to  nutrient 
function  (e.g.  calcium  aids  the  development  of strong  bones  and  teeth)  and  to 
recommended dietary practice (e.g. eat more oily fish for a healthy lifestyle). 
3.  Ethical Claims 
There is no legal definition of  an ethical claim in UK law. 
B.  LEGISLATION IN PLACE 
1.  Nutritional Claims 
The main piece of legislation in place in respect to nutrition claims in the UK are the 
Food Labelling  Regulations  1996  (see  annex  I).  These  include  the  definition  of a 
nutrition claim as provided for in Directive 90/496. 
The Food Labelling Regulations contain the legal definition of a nutrition claim and 
set  out  conditions  for  their  use,  including  the  requirement  to  provide  nutrition 
information if  a claim is made. 
2.  Health Claims 
Although no  specific legisiation exists, health claims must comply with a variety of 
legislative measures including the Food Labelling Regulations, the Food Safety Act 
(see  annex  II),  the  Trade  Descriptions  Act  (see  annex  III)  and  the  Control  of 
Misleading Advertising Regulations (see annex IV). 
The Control of Misleading Advertising Regulations implements Directive 84/450 on 
Misleading Advertising. 
Directive 79/112 on the Labelling of  Foodstuffs is implemented inter alia by the Food 
Labelling Regulations. 
In  particular, Article 2 (para. 2)  of Directive 79/112 is  implemented by Schedule 6 
Part I of  the Food Labelling Regulations 1996. 
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that it is an offence to describe falsely a food or to mislead as to its nature, substance 
or quality. 
3.  Ethical Claims 
There exists no specific legislation in  the UK on ethical claims.  In  a similar way to 
health claims, ethical claims are, therefore, subject to general provisions on claims- in 
particular,  the  Trade  Descriptions  Act  and  the  Control  of Misleading Advertising 
Regulations. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
For each of the types of claims that are listed in Part II  of Schedule 6 of the Food 
Labelling Regulations, specific conditions for their use are set out.  Below we have set 
out the conditions for certain types of  claims.  A full list of the conditions, which each 
type of  claim must meet, is provided in annex I. 
a.  Claims relating to foods for particular nutritional uses: 
"1. The food must be capable of  fulfilling the claim. 
2. The food must be marked or labelled with an indication of the particular aspects of 
its composition or manufacturing process that give the food its particular nutritional 
characteristics. 
3. The food-
(a)  must be marked or labelled with the prescriDed nutrition labelling and may 
be marked or labelled with further information in respect of either or both 
of-
(i) 
(ii) 
any nutrient or component of a nutrient (whether or not a claim is 
made in respect of  such a nutrient or component) or 
any  other  component  or characteristic  which  is  essential  to  the 
food's suitability for its particular nutritional use and 
(b) when sold to  the ultimate consumer, must be pre-packed and completely 
enclosed by its packaging" 
b.  Cholesterol claims 
"I. Subject  to  condition  3  the  food  must  contain no  more  than  0.005  per cent  of 
cholesterol. 
2.  The claim must not be accompanied by a suggestion, whether express or implied, 
that the food is beneficial to human health because of  its level of  cholesterol. 
3. If the claim relates to the removal of cholesterol from, or its reduction in,  the food 
and condition 1 is not met, such claims shall only be made-
(  a)  as part of  an indication of  the true nature of  the food. 
(b)  as part of  an indication of  the treatment of  the food. 
(c)  within the list of  ingredients, or 
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(d) As a footnote in respect of  a prescribed nutrition labelling. 
4. The food shall be marked or labelled with the prescribed nutrition labelling." 
2.  Health Claims 
a.  Food Labelling Regulations 
The Food Labelling Regulations section 40 (1) provides that: 
"A claim  of the  type  described  in  Part  I of schedule  6  shall  not  be  made,  either 
expressly or by implication, in the labelling or advertising of a food." 
Schedule 6 provides the following: 
"1. A claim that food has tonic properties 
2.  A claim that a  food  has the property of preventing,  treating or curing a human 
disease or any reference to such a property." 
b.  Food Safety Act 
In the UK, health claims are also subject to general provisions in the Food Safety Act 
1990 (Section 15). This makes it an offence to describe falsely a food or to mislead as 
to its nature, substance or quality. 
c.  Trade Descriptions Act 
Health claims are also subject to Section 1 of the Trade Descriptions Act 1968 which 
makes it unlawful to apply a false or misleading trade description. 
d.  Control of Misleading Advertising Regulations 
Health  claims  are  also  subject  to  the  Control  of  Misleading  Advertisements 
Regulations 1988 (CMAR). Under CMAR, an advertisement is defined as "any form 
of representation,  which  is  made  in  connection  with  a  trade,  business,  craft  or 
profession in order to promote the supply or transfer of goods or services, immovable 
property, rights or obligations". 
Under CMAR, an advertisement is defined as misleading if in "any way, including its 
presentation, it deceives or is likely to deceive the persons to whom it is addressed or 
whom it reaches and if,  by reason of its deceptive nature,  it is  likely to  affect their 
economic behavior or, for those reasons, injures or is  likely to  injure a competitor of 
the person whose interests the advertisement seeks to promote." 
3.  Ethical Claims 
There are no specific restrictions on ethical claims in the UK.  However ethical claims 
are  subject  to  general  rules  on  misleadingness  in  the  Control  of  Misleading 
Advertising  Regulations  and  the  Trade  Descriptions  Act  and,  where  applied  to 
foodstuff, to rules under the Food Safety Act (discussed above). 
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1.  Nutritional Claims 
In general, the UK authorities consider current legislation on nutritional claims to be 
satisfactory.  They are  happy with the  manner in  which nutritional claims are  dealt 
with under EU law. 
The UK government plans no new policy initiatives on nutritional claims.  However, 
it  should be noted that  the  UK government has  consulted interested parties  on  the 
Food Advisory Committee guidelines.  These will be issued shortly. 
2.  Health Claims 
The UK Government's current policy on health claims is as follows: 
"The UK government takes very seriously the need for accurate and informative food 
labelling.  It therefore  wishes  to  see  claims made  about  health  which  are  soundly 
based and do  not mislead consumers.  It believes that international agreement is  the 
way forward  on both health and nutrition claims,  to  ensure that all  products on our 
shelves  follow  common  standards.  It  supports  the  progress  made  by  Codex 
Alimentarius  and  urges  the  European  Commission  to  work  on  developing  an  EC 
claims policy based on  Codex standards and to  bring forward proposals as  soon as 
possible." 
The  UK  government  cites  two  main reasons  for  the  lack of a  definition  of health 
claims: (I) Health claims are regulated by the Food Safety Act 1990 in so far as they 
may  be  considered  misleading  claims  (2)  Health  claims  are  a  relatively  new 
phenomena. Government policy is therefore still being developed. 
In the UK, the government's policy on health claims is linked to  a number of factors 
among which the most important are: 
•  UK regulation  of food  policy is  undergoing  a  radical  re-structuring.  The  UK 
government  has  decided to  set  up  a  dedicated  Food  Standards Agency (FSA). 
This will bring together different parts of the administration including parts of  the 
Department of Health and parts of the Ministry of Agriculture Food and Fisheries. 
The  FSA  is  expected to  be up  and  running by April  2000.  The FSA will  be 
independent but under the political control of  the Minister of Health. 
•  Medicinal claims for non-medicinal products are banned under UK law. 
•  In  the interim period, and in  the absence of EU  legislation on health claims, the 
government is lending its support to the Joint Health Claims Initiative (JHCI) (see 
section on voluntary instrument for further details). 
The UK government has, in fact, encouraged the development of  the JHCI.  However, 
the  government's  position  remains  that  it  would  like  to  see  legislation  on  health 
claims.  In  particular,  the  government recognizes  that non-UK products will  not be 
covered by the JHCI and believes that a consistent approach must be ensured. 
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and recognises calls from consumer organisations for a system of  pre-vetting of  health 
claims. However, the government is  equally aware of the  increased bureaucracy that 
would result from a system of  compulsory pre-vetting. 
No  new  national  policy initiatives  are  planned on health  claims  in  the  immediate 
future.  However, the UK government has made it clear that it would like to see an EU 
initiative on health claims in the near future. 
3.  Ethical Claims 
Responsibility for ethical claims does not fall under the responsibility of a particular 
department but is  dealt with by both the Department for Trade and Industry and the 
Department for International Development. 
The Department of Trade and  Industry does  not have a particular policy on ethical 
claims.  However, they point out that any claim that is made for any product is subject 
to  legislation  covering  claims  such  as  rules  on  misleading  advertising  or on  trade 
descriptions. 
The UK government points out that it encourages a co-operative approach between 
industry,  consumers  and enforcement authorities.  The  policy of the  Department of 
Trade  and  Industry  is  to  leave  the  market  to  determine  the  regulatory  framework 
subject to high levels of consumer protection and fair competition between providers. 
Regulations should be driven by consumer demand and the need for information and, 
in  any  case,  should  not  be  prescriptive.  As  such,  the  Department  of Trade  and 
Industry  is  a  strong  supporter  of self-regulation.  The  Department  of Trade  and 
Industry has  thought of setting  up  a  self-regulatory code  for  on-pack claims with 
retailers.  However, the industry is  extremely fragmented and it would be extremely 
difficult to effectively enforce a code. 
The Department of Trade and Industry is also responsible for the Internal Market and 
ensuring that there are no barriers to trade between the UK and other Member States. 
They would,  therefore, examine policy developments in other Member States and at 
the European level in this context. 
The Department for  International Development believes that government policy will 
be  dependent  on  consumer  demand.  However  the  Department  for  International 
Development is  also aware that consumers can be very volatile in  their reaction to 
ethical claims. The Department for International Development's priority is for ethical 
claims/standards to  assist in the elimination of the problem identified  (for example, 
poverty) and to educate consumers (for example, about the operation of globalisation) 
and to allow consumers to make informed choices. 
There are  no  new  initiatives planned by the  government on ethical  claims.  At  this 
stage, no  particular government department seems to  have responsibility for ethical 
claims.  There is  mixed responsibly in  that the Department of Trade and Industry is 
responsible  for  advertising  and  consumer  protection,  while  the  Ministry  for 
International Development is responsible for the types of policy issues that might be 
included under ethical claims, such as fairtrade. 
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there are moves by DG VIII to develop a standard for fairtrade. 
E.  REMARKS ABOUT BARRIERS TO TRADE AND LACK OF 
CONSUMER PROTECTION 
1.  Nutritional Claims 
No specific cases ofbarriers to trade as a result of  nutritional claims were identified. 
The Consumer's Association (CA) provides specific examples of a lack of consumer 
protection from nutritional claims.  The CA general policy is that "whilst consumers 
value claims when making food  choices, they expect them to  be trustworthy!  It is 
important that all claims are adequately controlled so that they are consistently used, 
meaningful and do not mislead". 
In respect of nutritional claims they make the following points: 
•  Although some nutrient content claims have quantified legal definitions, the  law 
only requires that the rest be capable of fulfilling the claims they make, and that 
they  give  prescribed  nutrition  labelling.  A  variety  of claims  are  now  made, 
together with retailers' own healthy eating logos and product ranges, promoting a 
healthier  choice.  The  government's  Food  Advisory  Committee  (FAC)  has 
produced guidelines on the use of  terms such as "low fat" but these are not always 
followed. 
•  As  most  claims  are  not  regulated,  their  use  can  often  be  inconsistent  and 
confusing, or may even mislead. 
The Consumer's Association, therefore, makes the following recommendations: 
•  Definitions should provide criteria for  absolute and relative claims for nutrients 
relevant to  dietary guidelines  (including energy,  fat,  saturates, trans  fatty  acids, 
sugars, fibre, sodium, salt and relevant vitamins and minerals). 
•  The use of nutrition claims that are not relevant to the UK population e.g. high in 
thiamin, where there is  no  evidence of a likely deficiency or where these are no 
clear benefits  to  either increasing or reducing intake  of the  nutrient,  should be 
prohibited. 
•  Any nutrition claim should be supported by a full nutrition panel (in the absence 
of mandatory  nutrition  labelling).  Currently,  a  food  carrying  a  claim  that  it  is 
lower in  fat or contains added vitamins or minerals, is  only required to  give the 
basic  four  panels  (i.e.  energy,  carbohydrates,  protein  and  fat).  Full  nutrition 
labelling would ensure that levels of  sugars and sodium were always labelled. 
•  A  set of standard criteria for  healthy eating  symbols  should be  developed that 
applies to all stores and sectors and used on own-label and branded products.  Any 
symbols or logos used on  foods  to  suggest a healthy or healthier product should 
only be used for an all-round healthy product.  A nationally agreed set of nutrition 
criteria should be agreed tor all healthy eating schemes. 
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Finally the CA points out that in the short term, industry should develop guidelines to 
ensure the consistent and responsible use of  nutrition claims. 
The Consumers in Europe Group (CEG), an independent voluntary UK organisation, 
concerned with the effects of EU  legislation on UK consumers, makes the following 
recommendations in respect of  nutrition claims. 
•  CEG believes that nutrient content claims must be clearly defined in terms of the 
quantitative level of the nutrient present, be consistent between products, and be 
meaningful to consumers. 
•  The  Scientific  Committee  for  Foods  should  be  responsible  for  drawing  up 
threshold values for individual nutrients based on the most up-to-date research. 
•  CEG is opposed to the use of  implied nutrient content claims. 
2.  Health Claims 
No  particular  barriers  to  trade  were  identified  by  the  Department  of Agriculture 
Fisheries and Food or by the Department of Health. However, they both recognised 
that barriers to trade could arise as the use of  health claims develops. 
The Medicines Control Agency did, however,  give specific examples of barriers to 
trade.  These barriers refer to borderline cases between food and medicines and focus 
on  differing  interpretations  of Directive 65/65.  A  specific  example  that  was  cited 
concerns the classification of  vitamins.  In Germany, a product that contains one and a 
half the recommended daily allowance is  considered to  be a medicine.  This is  not 
necessarily the case in the UK. The MCA has, therefore, been requested to provide an 
explanation for this situation by the European Commission.  In the UK the criteria for 
whether a product is considered a medicine is consumer safety.  The MCA points out 
that in other Member States other factors are included.  This can, therefore, give rise 
to barriers to trade. 
There is a general feeling in government departments that there is a lack of consumer 
protection  in  health  claims.  This  is  echoed  by  the  Consumer  organisations.  In 
particular,  there  is  concern  that  claims  may  be  misleading  and  may  give  rise  to 
concerns about safety. 
The  Consumer's Association  makes  the  following  points  with  regard  to  consumer 
protection and health claims: 
•  An increasing number of products are being marketed on the basis that foods can 
play a role in protecting and promoting health. 
•  These claims are not always explicit, often implying health benefits through the 
use of  packaging and illustrations. 
•  The  difference  between a health and medicinal  claim  is  not always obvious to 
consumers. 
•  As there are currently no regulations covering health claims an increasing variety 
of  complex claims are now being made on product labels. 
The  Consumer's  Association  makes  the  following  recommendations  m  respect  of 
health claims: 
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products.  This points to the need for effective regulation. 
•  The JHCI (see section on voluntary instruments) should help improve the situation 
in the short term in the absence of legislation. 
Legislation should address the following issues~ 
•  Controls on the use of health claims should be tightened up so that consumers can 
trust valid claims that are made including: 
•  The definition of  a health claim; 
•  Conditions for the use of  a health claim; 
•  Prior approval of  claims before sale; 
•  Rules on the level of  evidence and standard of  proof needed to make a claim; and 
•  Development of a system of quick penalties when unsubstantiated, exaggerated or 
misleading health claims are used on foods. 
•  Health claims should only be used if approved in advance, with approval based on 
an  independent and exhaustive review of scientific literature.  Misleading claims 
need to  be prevented rather than dealt with after products are on the market and 
have in some cases, already been heavily promoted. 
•  An expert Committee should have responsibility for advising on and monitoring 
the use of health claims.  The Committee should consider when it is  appropriate 
for a claim to  be made  e.g.  the  level  of active  ingredients,  and  the  amount of 
product likely to be consumed. 
•  If a health claim is made, the manufacturer should be required to  give additional 
information on the food label, including at least the following and any additional 
information that the expert committee thinks necessary about a specific product: 
•  Amount of active ingredients, and information on how much needs to be taken to 
have the desired effect; 
•  Origin of ingredients; 
•  Warnings on contra-indicators for use if  necessary or appropriate; 
•  Full  nutrition  labelling,  to  ensure  that  consumers  are  given  the  full  nutritional 
context in which the  claim is  made and  are not misled about the  overall health 
benefit of  a product; 
•  A statement of  the role of the food in relation to the overall diet and other factors; 
•  Nutrition criteria for  making health claims should be established e.g.  maximum 
fat, sugars, and sodium content etc. 
The Consumers in  Europe  Group  (CEG)  makes  the  following  recommendations  in 
respect of  health claims. 
•  Health claims include any statement, suggestion or implication in food labelling 
that a food is beneficial to health, other than nutrient content claims and medicinal 
claims. 
•  A  number of different claims  fall  into  this  category including those  describing 
food  as  "natural",  "light/lite",  "fresh"  or  "full  of goodness".  These  can  be 
particularly confusing and in many cases meaningless.  They often imply that the 
product  is  a  healthier  version  of a  standard  one  but  the  difference  is  usually 
unspecified and unclear. 
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•  CEG supports the position that any ambiguous or imprecise claims made in the 
labelling of a food must be explained and justified on the label and be capable of 
substantiation. 
•  There is  no specific legislation on health claims other than the general provision 
that they must not be misleading or falsely describe a product. 
•  For many years, CEG has called for greater control over the use of claims made 
about foodstuffs.  The number and range of these claims has grown in a way that 
has  left  consumers  increasingly  confused  and  without  enough  information  to 
assess the claims objectively.  Current legislation is  inadequate to  deal with the 
variety of claims now made about food and to ensure satisfactory enforcement of 
those claims.  Surveys have shown that consumers are confused about the controls 
of claims on dietary supplements in particular, because these products often have 
the appearance of medicines but do not have to comply with strict regulations of 
medicines. 
•  CEG would prefer all health claims to  be prohibited because they can so  easily 
mislead consumers. They believe that claims should be limited to  information on 
the objective, measurable aspects of a food that could enable consumers to  make 
up their own minds about the health value of a food.  Health claims are hard to 
justify for individual foods when the needs of individual consumers vary greatly 
and  when  diet  and  lifestyle  factors  are  of key  importance  to  health.  The 
potentially useful educational role of health claims could be heavily outweighed 
by their potential to confuse and mislead consumers, who are not generally well 
informed  about  their  individual  health  status.  Ideally,  consumers  should  be 
encouraged to  achieve dietary change by the provision of clear, simple, accurate 
and  comprehensive  information  and  education  about  nutrition  - not  through 
marketing claims. 
•  CEG would prefer all health claims to be banned.  However, if a political decision 
is made to allow them then this must be under very limited and strictly controlled 
conditions. 
If health claims are allowed: 
•  CEG  considers  that  health  claims  should  be  regulated  at  EU  level  to  ensure 
consistency across the Single Market.  In the absence of EU legislation, clear and 
detailed voluntary guidelines, such as  the Code of Practice drafted by the JHCI, 
might provide a basis for control. 
•  Dietary supplements should be considered as foods for marketing purposes; clear 
criteria are needed to clarify the difference between foods and medicines. 
•  Health  claims  must  be  fully  substantiated  by scientific  evidence  that  must  be 
assessed by an independent expert body.  CEG strongly supports the pre-market 
approval of  health claims. 
•  CEG  accepts  that  it  could  be  useful  to  have  a  list  of officially  endorsed  and 
acceptable health claims that are linked to  nutrient function and that command a 
general scientific consensus. 
•  Any  system  for  the  approval  of health  claims  must  be  transparent,  credible, 
accountable and enforceable. 
The  Food  and  Drink  Federation (FDF)  does  not  believe  that  there  are  significant 
barriers  to  trade  as  a  result of the  regulation  of health  claims.  However,  they did 
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interpretation  so  of Directive  79/112.  The  FDF  would  like  to  see  disease  risk 
reduction claims allowed and points out that Directive 65/65 is no longer appropriate 
bearing in mind developments made in food production. 
The FDF welcomes the JHCI and has been closely involved in its establishment and 
points  out  that  failure  to  specify  a  particular  disease  on  a  claim  can  in  itself be 
misleading.  The  FDF  would  welcome  the  JHCI  as  the  only  layer  of regulation. 
However, the FDF is aware that the nature of the European Market will mean that a 
European solution to regulation will be necessary. 
The FDF believes that claims should be an issue of  consumer education not consumer 
safety but agree that the burden of proof should be on the maker of a claim to justify 
it. They also support voluntary systems for pre-marketing approval for claims. 
3.  Ethical Claims 
The  absence  of legislation  on  ethical  claims  does  not  seem  to  have  spurred  any 
problems  in  terms  of  barriers  to  trade.  However,  according  to  the  Fairtrade 
Foundation there is  growing danger that consumers are being misled by the use of 
ethical claims.  This is dealt with further in the section on voluntary instruments. 
III.  VOLUNTARY INSTRUMENTS USED 
Please note that this section should be read in conjunction with the codes developed 
for  the  various  means  of communications,  which  are  dealt  with  separately  under 
Section VII. 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims 
a.  Food Advisory Committee 
The  rules  provided  in  the  Food  Labelling  Regulations  1996  are  supplemented by 
guidelines based on recommendations made by the Food Advisory Committee.  The 
guidelines are advisory and have no legal effect. 
The Food Advisory Committee is  a non-statutory body comprising a chairman and 
fifteen  members  appointed  for  their  personal  expertise.  It does  not  represent  a 
particular interest.  The Committee's main task is to review and prepare reports on all 
matters within its terms of reference (to advise Ministers on the exercise of power in 
the Food Safety Act 1990 and to  assess the risk to  humans of chemicals which are 
used in or on food) 
The most recent guidelines have been notified to  the European Commission and will 
be issued following the notification process. A copy of the guidelines is  provided in 
annex V. 
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b.  Co-operative Wholesale Society Guidelines 
The Co-operative Wholesale Society (CWS) (the owners of the Co-op) has developed 
its own code of practice for the labelling of pre-packed foods.  The code covers both 
nutritional  and  health  claims  (as  well  as  other  types  of  claims  and  labelling 
requirements).  A copy of  the code is provided in annex VI. 
The code was develop in 1997 and is applied to all own label products.  The code is 
complemented  by  the  Co-op's  honest  labelling  campaign.  Under  the  campaign, 
consumers are encouraged to comment on the Co-op labelling policy through the use 
of  free phone and freepost services. 
When a consumer makes a complaint, the Co-op may react to the complaint and make 
appropriate changes to its labelling policy.  When there is dispute between the Co-op 
and a consumer, the complaint will be referred to the Co-op's jury.  The jury is made 
up  of members  of the  Co-op  (the  Co-op  is  a  membership  organisation)  who  are 
selected on the basis of their interest in labelling policy.  The jury will then consider 
the complaint.  The Co-op is bound by the jury's decision. 
The code only applies  to  pre-packed food and addresses labelling from a consumer 
perspective rather than from an industry viewpoint. The code complements the Food 
Labelling Regulations and the Food Advisory Committee Guidelines. 
As regards nutrition claims the CWS makes the following remarks: 
•  There are  only limited criteria for  nutrient content claims in  law;  otherwise the 
regulation on claims relies on general labelling provisions that information should 
not mislead the consumer; 
•  The  lack  of detailed  provisions  has  led  to  a  situation  where  labellers  make 
factually correct claims,  which show their products in the best light.  However, 
because different criteria have been used in different product sectors the potential 
for misleading the consumer arises. 
The code provides for the following rules with regard to nutrition claims: 
•  Compliance with the FAC guidelines as well as the Food Labelling Regulations 
•  Claims  that are  not  meaningful to  the population at  large should be considered 
misleading.  For  example,  there  is  no  protein  deficiency  in  the  UK  thereby 
invalidating a high protein claim. 
•  Alternatively if a product meets the criteria for a reduced nutrient claim but the 
difference in the particular nutrient content maybe insignificant because the level 
in the food of  comparison is itself relatively low. 
•  Certain negative claims can imply naturalness to the consumer and may therefore 
be potentially misleading and must not be used.  Example of these include ( 1)  a 
claim for a food  that is  free from "X" if all foods  in the same category are free 
from  "X" (2)  statements or implications which give undue emphasis to  the  fact 
that a product is free from certain non-natural additives, when the product contains 
other non-natural additives (3) a claim that a food is  "free from" one category of 
additive when a similar additive of another category,  or an  ingredient having a 
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of  additives when the product contains other additives. 
•  The code  also  lays  down detailed  rules  for  nutrient content claims.  These are 
attached in annex VI. 
2.  Health Claims 
b.  Joint Health Claims Initiative 
A copy of  the JHCI code is provided in annex VII. 
i.  Background 
The development of a regulatory framework for health claims in the UK has focused 
on a voluntary initiative that has brought together the majority of interested parties, 
The Joint Health Claim Initiative. 
The  JHCI  was  established  in  June  1997  as  a  joint  venture  between  consumer 
organisations,  enforcement  authorities  and  industry  bodies  to  establish  a  code  of 
practice for the use of  health claims on foods. 
The JHCI was set up  following discussions initiated by the Ministry for Agriculture, 
Food and Fisheries and guidelines drafted by the Food Advisory Committee on health 
claims  in  December  1996.  As  a  result,  of these  initiatives  the  Food  and  Drink 
Federation,  the  National  Food  Alliance  (which  has  subsequently  been  renamed 
Sustain)  and  the  Local  Authority  Coordinating  Body  on  Trading  Standards 
(LA COTS) agreed to work on a voluntary code on health claims. 
Other  interested  parties  were  invited  to  assist  in  drafting  the  code  (a  list  of the 
organisations, which were involved in the initiative, is attached in annex VI). 
ii.  Code administration body 
Although  the  code  has  been  finalised,  the  code  administration  body  is  still  to  be 
finalised. The code administration body will consist of: 
(a)  A Council which will include an  equal number of representatives of consumers, 
industry and enforcement authorities.  The Council's role will be to monitor the 
implementation of  the code. 
(b) A  secretariat.  At the  time  of our discussions  with  interested  parties  it  seemed 
likely that the secretariat would be given to Leatherhead Food RA. 
(c)  An expert authority, which will consist of experts in the field of food and health 
and would provide opinions to anyone requesting a view on the scientific validity 
of  a health claim. 
At this stage, it should be pointed out that a number of interested parties, in particular 
the consumer associations hoped that the administration of the code would eventually 
fall within the competence of the Food Standards Agency once it has been set up. 
Pan- European study on nutritional, health and ethical claims- 1999.  412 I 
iii.  Objectives 
The objectives of  the code are defined as the following: 
(a)  Protecting and promoting public health 
(b) Providing  accurate  and  responsible  information  relating  to  food  to  enable 
consumers to make informed choices 
(c)  Promoting fair trade and innovation in the food industry 
(d) Promoting  consistency  in  the  use  of health  claims  in  the  UK,  Europe  and 
intemationall  y. 
iv.  Legal Status of  the code 
The code makes it clear that it is not legally binding but points out that" compliance 
with  this  code  should  assist  companies  to  establish  a  defence  of due  diligence  if 
prosecuted for making a health claim under the Food Safety Act and other applicable 
laws." 
It further points out that '"providing this  code  is  followed  in  its  entirety,  including 
seeking pre-market advice at an early stage and acting, if necessary on the outcome, 
disputes should not arise over the legality or scientific justification of an innovative 
health claim." 
Despite  these  statements,  it  is  clear  that  following  the  code  will  not  provide  a 
guarantee that a prosecution under the Food Safety Act would not be brought by the 
enforcement authorities.  This is reflected in the code that states '"ultimately it will be 
for the courts to  decide whether or not a health claim is made in accordance with the 
relevant provisions of  existing legislation." 
v.  Scope 
The code applies to the use of  health claims in labelling, advertising and promotion of 
all food as marketed to the general public whether foods, drinks or food supplements. 
However,  the  code  does  not  apply  to  the  safety assessments  of foods,  which  are 
subject to the safety requirements of  the Food Safety Act 1990 and also to novel foods 
if they are subject to the Novel Foods Regulations 1997. 
vi.  General principles for making a health claim 
In  summary,  the  code  states  that  health  claims  should  assists  consumers  to  make 
informed choices and that they expect that health claims have been substantiated by 
independent experts prior to use. 
The overriding principle of the  code  is  that  the  likely  consumer perception of the 
health  claims  is  paramount.  The  factors  used  to  determine  a  consumer perception 
include: 
•  The possibility of  misleading the consumer through marketing imagery 
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or the item itself. 
•  The  manner  in  which  the  product  is  presented  to  the  consumer,  including 
literature,  ingredients  highlighted,  the  form  of the  product,  its  name,  who  is 
promoting it to which group of  people and the media used. 
•  The direct, indirect or implied meaning of  the heath claim. 
The above  factors  where  stressed by Consumer Associations and,  in particular,  by 
independent bodies working in the  field of nutrition.  They pointed out that health 
claims should only be directed at groups who would see an overall health benefit from 
purchasing the product.  It was pointed out that by and large products for which health 
claims were made were relatively more expensive. Therefore, substituting other foods 
for a product on which a health claims is made would have an overall effect on diet. 
vii.  Legal and nutrition principles 
The general principle  is  that  health claims  must be  truthful  and must not mislead, 
exaggerate or deceive either directly or by implication. The claim must also indicate 
to which if  any specific group the claimed benefit refers. 
Other principles include: 
•  Any  reference  to  a  specific  disease  or  to  disease  in  general  terms  should  be 
avoided, as this is likely to imply that food will have a medicinal effect.  It is also 
pointed out that medicinal claims are prohibited by law. 
•  However,  it is  deemed acceptable to  refer to  the  maintenance of good health in 
general or specific organs of  the body. 
•  It is also acceptable to refer to risk factors that may ·adversely affect good health. 
•  However, any such reference must make it clear that the overall benefit is  within 
the context of  a healthy diet. 
•  The claim must not encourage  or condone  excessive  consumption or disparage 
good dietary practice. 
•  The benefit from the claim must be fulfilled by consumption as recommended by 
the company or on the label. 
•  The benefit from the health claim must be derived wholly from the food for which 
the  claim  is  made  and  not  rely on any benefit  derived  from  consumption with 
other foods. 
•  Health  claims  must  be  communicated  in  such  a  way  to  assist  consumer 
understanding of  the basis of  the claim. 
•  Companies  should  take  care  to  ensure  that  any  health  claim  does  not  mislead 
vulnerable sectors of the population. 
viii.  Labelling and other consumer information 
When a health claim is made companies are advised to provide additional information 
to assist consumer's understanding of the significance of the health claim. This is not 
an absolute requirement but companies are advised to include the following: 
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(a)  a full nutrition declaration 
(b)  a quantified serving size 
(c)  the target population and anyone who should avoid using the food 
(d) a statement indicating the quantity and pattern of consumption likely to achieve a 
beneficial effect. 
(e)  A safe maximum intake 
(f)  Wherever a food component provides the basis for a health claim, a declaration of 
the amount of this  functional  ingredient in  1  OOg  and/or one serving of the food 
whichever is the most appropriate. 
ix.  Substantiation of health claims 
All health claims must be capable of substantiation.  The Code Administration Body 
will maintain an updated list of  generic and approved innovative claims. 
x.  Generic Health claims 
In the case of generic health claims no specific substantiation is required. Companies 
wishing to make a generic health claim may do so for complying foods.  Complying 
food comprises or contains the ingredients in sufficient quantity to produce the effects 
claimed or falls within the category of  foods to which the generic health claim applies. 
Any company may use  a generic  health claim  on complying food  without further 
documentation. 
The code administration body is  responsible for  developing a list of generic health 
claims for approval by the Expert authority. The list will be regularly reviewed and 
updated in the light of international scientific consensus and new evidence. 
xi.  Innovative health claims 
Substantiation of  innovative health claims is essential. Companies must show that the 
health claim is likely to be true and that the scientific evidence in support of  the health 
claim  outweighs  opposing  evidence.  Pre-market  advice  is  strongly  recommended 
before making a new health claim. 
xii.  The aims of substantiation 
When using health claims companies must be able to demonstrate the following: 
•  That the food will cause or contribute to  a physiological benefit when consumed 
by the target population as part of  their normal diet. 
•  The claimed benefit can be achieved by consuming a reasonable amount of the 
food 
•  The effect is maintained over a reasonable period of  time 
•  Indicate the target group that can benefit from the food 
•  How the effect is brought about 
xiii.  Source and nature of scientific evidence 
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The conclusions of this review should be based on: 
(a)  The totality of evidence not just data, which support the health claim 
(b) Human studies or evidence 
(c)  Studies which are the most methodologically sound available. 
The conclusions of the  review should be based on  experimental studies in  humans. 
Additional information could be expected from the following sources. 
(a)  Human studies, including epidemiological and clinical studies 
(b) Animal studies 
(c)  Biochemical and cellular studies 
(d) Any other relevant sources 
Research should assess the effects of  foods on the health status ofhuman objects. 
xiv.  Documentation of claims 
Any innovative  health claim must be supported by documentation of the  scientific 
evidence  demonstrating  the  physiological  effect,  which  is  claimed.  Companies 
making an innovative health claim must prepare documentation of  scientific evidence. 
Companies are strongly advised to  seek the advice of the Code Administration body 
and their Home Authority at an early stage prior to making an innovative health claim. 
It is suggested that documentation should include: 
•  Scientific and lay summaries of  the evidence that is the basis of  the claim. 
•  Name and description of  the food. 
•  Identification of the specific component or combinations of  components for which 
the health claim is made. 
•  Details of  the chemical analysis carried out. 
•  A statement of  intended use. 
•  Appropriate warnings 
•  Any advice of the code administration body sought prior to making an innovative 
health claim. 
•  A copy of the product label and samples of  health claims made in advertising and 
other promotions. 
•  Contact  details  of independent  scientific  experts  to  whom  the  full  scientific 
evidence have been referred for review. 
xv.  Pre-market advice for innovative health claims 
Companies  are  strongly  encouraged  to  seek  pre-market  advice  from  the  Code 
Administration body before using an innovative health claim.  The exact procedures 
for seeking pre-market advice and timescales for delivery will be established by the 
Council. 
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Companies may request an independent review by the Council of the advice given by 
the Expert Authority. 
Acting upon pre-market advice suggest the exercise of due diligence. The Courts may 
take this into account in the event of any legal challenge to the health claim under he 
Food Safety Act.  Similarly the Independent Television Commission, the Advertising 
Standards Authority and the  Radio Authority are encouraged to  take this procedure 
into account when deciding if  a breach of  the ITC, CAP or RA codes has occurred. 
Companies  who have  not sought pre-market advice  for  an  innovative health  claim 
have not necessarily failed to exercise due diligence. 
xvi.  Determination of legality of borderline health claims 
In  cases  where  doubts  arise  as  to  the  legality  of  a  health  claim  the  Code 
Administration body will refer the proposed claim to  LACOTS  and  the  Medicines 
Control Agency (MCA) for determination of  its legality. 
LA  COTS and the MCA will jointly assess such claims on a case by case basis. 
xvii.  Access to evidence, information on health claims and confidentiality 
All information held by the Code Administration body is freely available except in the 
following cases: 
•  Where data on innovative health claims is  submitted to  the Code Administration 
body, if such data is commercially sensitive confidence must be fully respected. 
•  The Code Administration body will draw up further guidelines on confidentiality 
and commercial sensitivity. 
xviii.  Suspected breaches of the code 
In the event that the Code Administration body is aware that a health claim is being 
made, which may breach the Code, the Code secretariat may complain to the relevant 
enforcement, regulatory or self-regulatory bodies.  The  Code secretariat may make 
public the details of  the complaint. 
The Code Administration Body may disclose details of an opinion to  enforcement, 
regulatory or self-regulatory bodies. 
xix.  Co-operative Wholesale Society Guidelines 
As  noted  above  in  Section  III.A.l,  the  CWS  has  a  code  of practice  for  labelling 
prepacked foods, which include guidelines on health claims. 
The CWS makes the following remarks about health claims: 
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•  The only constraints on claims are  the  general provision that they must not be 
misleading or falsely describe a product. 
•  Modem technology increasingly allows foods to be manipulated to  deliver health 
benefits.  The absolute ban on referring to  diseases prohibits effective consumer 
communication  by,  at  best,  forcing  labellers  to  adopt  less  direct  messages,  at 
variance with generally accepted health messages and failing to  capitalise on the 
benefits of short, sharp messages often repeated.  At worst, it discourages claims 
all together. 
The code addresses these issues in the following manner: 
•  For generally accepted, well established links between nutrients and disease the 
code  lays  down  a  number  of so-called  medicinal  claim  which  can  be  used, 
provided the associated conditions are met. 
•  For all other health claims the code sets out general criteria which any claim must 
meet  and  requires  each  such  claim  to  be  approved  by  an  authoritative  body 
through  the  submission  of a  dossier  of the  scientific  evidence.  Additional 
labelling requirement for such claim are also laid down. 
The guidelines for health claims are follows: 
•  All health claims must be valid. 
•  A  dossier  of scientific  evidence  supporting  the  claim  must  be  compiled.  The 
dossier, together with an example of the product label, must be submitted to  and 
approved by a designated body.  The dossier must be available to the public and 
enforcement inspection and must be able to stand up to scientific, peer review. 
•  Health  claims must be based on  good  evidence of a  likelihood of need  in  the 
population or of a clear benefit either from reducing or increasing the intake of  the 
particular substance. 
•  No  claims  must  be  made  for  substances  where  there  is  evidence  that  excess 
consumption can be harmful if  this is achievable from readily available foodstuffs 
and supplements. 
•  Claims  must  only be  made  where  the  amount  of the  substance  in  a  serving 
provides a significant contribution to the recommended daily intake. 
•  The  claimed benefit must apply to  the  food  as  eaten and must not rely on  any 
benefit from consuming the food with other foods. 
•  Health claims must only be made on products, which are no  less "healthy" than 
their regular counterparts. 
•  Health claims must not encourage excessive consumption. 
•  Care should be taken not to mislead vulnerable sectors of the population (pregnant 
women, lactating mothers and children). 
•  Claims must be accompanied by an  on-pack guideline of the recommended daily 
amount and must be substantiated by a statement on the pack of the amount in a 
servmg. 
•  Contra indications must also be included in labelling statements 
The code also provides the following guidelines on so-called medicinal claims: 
Pan~  European study on nutritional, health and ethical claims~ 1999.  418 I 
I 
•  A  claim  that  the  consumption  or  reduced  consumption  of food,  nutrient  or 
substance contained in a food, as part of a total dietary pattern, may have an effect 
on a disease or health related claim should only be made where all the conditions 
for  health  claims  are  met.  In  addition,  there  must  be  scientific  consensus; 
supported by the  Chief Medical Officer, the  Committee on Medical Aspects of 
Food Policy or a similarly independent and authoritative source that a relationship 
exists between the food and the health-related condition. 
•  The  wording of the  claim  must be made  within  the  context of a  total  dietary 
pattern  and  include  (1)  amount  serving  per day  (2)  contra-indications  and  (3) 
special dietary regimes on which the claim is dependant. 
•  The following claims may be made where specified conditions are met (see annex 
VI for the conditions under which the claims may be used).  No other claims may 
be made: 
1.  X contains calcium which may reduce the risk of  osteoporosis later in life 
2.  X contains soluble fibre which may reduce the risk of  heart disease 
3.  X is low fat and a source of  fibre, which may reduce the risk of some types of 
cancer. 
4.  X is low in total fat, which may reduce the risk of  some cancers. 
5.  X is low in salt, which may reduce the risk of  high blood pressure. 
6.  X is  rich in folic  acid,  which may reduce a woman's risk of having a child 
with spina bifida or other neural tube defects. 
3.  Ethical Claims 
In the UK, there are a number of organisations that are involved in ethical trading but 
relatively few who have specifically established voluntary codes on ethical claims. 
For example,  the  Ethical Trading Initiative (ETI) promotes ethical  trading but does 
not  include  specific  mention  of ethical  claims  in  its· codes.  According  to  the  UK 
government, ETI members are prohibited from using their membership of the ETI as 
an ethical claim. However, our discussions with interested parties have indicated that 
there is growing pressure for ETI members to be able to make such claims.  A copy of 
the ETI code is attached in annex VIII. 
The Fairtrade mark appears to be the exception to this in the UK and is one of the few 
examples  of a  voluntary  agreement  on  ethical  claims.  The  Fairtrade  mark  is 
administered by the Fairtrade Foundation. Further details  of the  Fairtrade mark are 
attached in the annex. IX. 
The Fairtrade mark provides an independent mechanism for assisting disadvantaged 
producers of specific  commodities  in  developing  countries  by defining  criteria  for 
eligible  producers  and  for  terms  of trade,  establishing  a  register  of qualifying 
producers, and monitoring transactions so as to provide a guarantee to consumers that 
products bearing a Fairtrade Label meet the agreed criteria. 
The criteria used for  defining Fairtrade standards for suppliers of licensed products 
include: 
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standards and environmental standards 
•  For small holders: a genuine democratic producer co-op, a fair price, credit terms 
and a long term trading commitment. 
The  price  paid  includes  a  premium  to  be  used  m  consultation  with  workers  or 
producers to benefit the community. 
The Fairtrade Foundation has set up a licensing system for companies that wish to use 
the  Fairtrade Mark.  The Fairtrade Foundations grants  the  right to  use the  Fairtrade 
mark on or in  relation to  products subject to  the licensee complying with the terms 
and agreement of  the license. 
The  terms  and  conditions  of the  license  specify  how  the  licensee  shall  use  the 
Fairtrade mark.  This  includes the  licensee submitting all  packaging and advertising 
materials using or referring to the mark for approval by the Foundation.  The licensee 
is also prohibited from using other marks denoting ethical trading. 
B.  DEFINITIONS USED IN THE VOLUNTARY INSTRUMENTS 
Please note that the CWS does not include any definitions in its code of  practice. 
1.  Nutritional Claims 
The following definitions are used in the Food Advisory Committee guidelines for the 
use of  certain nutrition claims in food labelling and advertising. 
"Nutrition claim means  any  statement,  suggestion  or  implication  in  any  labelling, 
presentation or advertising of a food that that food has particular nutrition properties, 
but does  not  include a reference  to  any quality or quantity of nutrient where such 
reference is required by law". 
"Sugars means all monosaccharides and disaccharides but excludes polyols" 
'"Fat means total lipids including phospholipids" 
'"Saturates means fatty acids with double bond." 
"Fibre is yet to be defined but we advise that fibre, for claims and nutritional labelling 
purposes, means dietary fibre defined as non starch polysaccharides.  Claims relating 
to fibre should be based on this definition." 
2.  Health Claims 
For the purposes of the JHCI Code, the following definitions are used: 
"Health claim" 
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A direct, indirect or implied claim in food labelling, advertising and promotion 
that consumption of  a food carries a specific health benefit or avoids a specific 
health  detriment.  This  includes  nutrient  function  claims  describing  the 
physiological  role  of the  nutrients  in  growth,  development  and  normal 
functions of the body (e.g. calcium aids in the development of strong teeth and 
bones) but does not include nutrient content claims (e.g. that a food is low in 
fat, has reduced cholesterol or high fibre content). 
"Generic Health Claim" 
A health claim based on well-established, generally accepted knowledge from 
evidence in the  scientific literature and/or to  recommendations from national 
or international public health bodies  such as  the  Committee on the  Medical 
Aspects  of Food  and  Nutrition  Policy  ("COMA"),  the  US  Food and  Drug 
Administration ("FDA") or the EU Scientific Committee for Foods ("SCF"). 
"Innovative Health Claim" 
A health claim other than a generic health claim based on scientific evidence 
applied  to  existing  or  new  foods  and  substantiated  in  accordance  with 
Paragraph  8  of this  Code.  When  the  body  of evidence  in  the  published 
scientific literature is such that the link between the nutrient/ingredient and the 
claimed effect is  generally accepted, the claim meets the criteria identified in 
paragraph 3.2 and the claim will become generic. 
"Medicinal claim" and "human disease" 
A medicinal claim is a health claim, which states or implies that a food has the 
property  of treating,  preventing  or  curing  human  disease  or  makes  any 
reference to such a property.  "Human disease" means any injury, ailment or 
adverse condition, whether of  body or mind. 
"Target Population" 
The full population, sub-sections of the population or vulnerable sub-groups of 
the population to which the health claim applies. 
"Labelling" 
Includes  any words,  particulars,  trademark,  brand name,  pictorial  matter or 
symbol  relating  to  the  food  and/or  appearing  on  the  packaging.  It also 
includes any document, notice, label, ring or collar accompanying the food. 
"Advertising" 
Includes any notice, circular, mailing, invoice, or other document destined to 
be seen  by the  public  and  any public  announcement made orally or by any 
means of producing or transmitting light or sound by any medium including 
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labelling.  "Advertisement" shall be likewise construed. 
'"Promotion'' 
Includes product promotions and any public relations materials used directly 
or in association with the food, including, for example, testimonials and press 
releases, either written or broadcast, or materials provided alongside the food 
where it is displayed for sale where these are clearly a part of the advertising 
for the food and directly related to the food.  It also includes the activities and 
statements of company and sales representatives.  Material exclusively aimed 
at health professionals is  not included provided there is  no  intention to bring 
the content of  such materials to the attention of  the general public.  Promotion 
does not include editorial, opinion or the reporting of statements or activities 
by independent third parties not connected with the companies. 
3.  Ethical claims 
The Fairtrade Foundation uses the following definitions 
"Fairtrade Criteria" means  the  standards  and  terms  of trade  for  specific product 
categories agreed by all the National Initiatives affiliated to FLO, as applicable at the 
Commencement Date and as subsequently revised. 
"Packaging"  means  all  materials  normally  supplied  as  part  of the  Product  and 
includes (among others) all containers, wrappers, labels, and transit packaging. 
"Advertising  &  Promotional  Materials"  means  all  materials  and  statements 
produced  by  the  Licensee  in  the  course  of marketing  the  products  and  includes 
(among others) leaflets, brochures, catalogues, press and broadcast advertising, press 
releases and information published via the internet. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  Nutritional Claims 
Food Advisory Committee Guidelines 
The Food Advisory Committee guidelines for  the  use of certain nutrition claims in 
food labelling and advertising provide for the following criteria: 
""Low:  claims  for  fat  saturates,  sugar(s)  and  salt/sodium  should  conform  to  the 
conditions in the attached annex (see annex V).  Claims for other nutrients are outwith 
these  guidelines,  but reference  should  be  made  to  Schedule  6  part II  of the  Food 
Labelling Regulations for conditions for energy. 
•  Claims for foods naturally low in a nutrient should take the form of  '"a low 
X food". 
•  Information in the nutrition panel on sodium level should be accompanied 
by an equivalent salt figure. 
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•  Since dietary cholesterol is not a major factor in coronary heart disease and 
there  is  a  danger  of  confusion  with  blood  cholesterol  levels,  low 
cholesterol claims should not be made." 
"No Added:  claims  for  sugar(s)  and  salt  should  conform  to  the  conditions  in  the 
attached  annex  (see  annex  V).  Claims  for  other  nutrients  are  outwith  these 
guidelines." 
"X free/without: claims for fat, saturates, sugar(s), and salt/sodium should conform to 
the conditions in the attached Annex (see annex V).  The Food Labelling Schedule 6 
part II  lays  down conditions for cholesterol free  claims.  However,  as  far as  "low" 
cholesterol is concerned, it is recommended that such claims are not made.  Claims 
for other nutrients are outwith these guidelines. 
•  Since  "X%  fat  free"  claims  may  be  misunderstood,  these  should  be 
avoided. 
•  Information in the nutrition panel on sodium levels should be accompanied 
by an equivalent salt figure." 
"Source: claims for fibre should conform to the conditions in the attached annex (see 
annex  V).  Claims  for  other nutrients  are  outwith  these  guidelines,  but  reference 
should be made to the Food Labelling Regulations for conditions for protein, vitamins 
and minerals." 
"Increased:  claims for fibre  should conform to the conditions in the attached annex 
(see  annex  V).  Claims  for  other  nutrients  should  only  be  made  when  there  is  a 
minimum 25% increase of the nutrient contained in the food by comparison with the 
normal product, i.e. the standard version of the product, for which no claim is made. 
'"Reduced:  claims should only be made when there is  a minimum 25% reduction of 
the  nutrient  contained in the  food  by comparison with the  normal product,  i.e.  the 
standard version of  the product, for which no claim is made.  Reference should also be 
made to the Food Labelling Regulations Schedule 6 part II for conditions for energy 
and cholesterol.  Again, it is recommended that cholesterol claims are not made." 
"More/less: claims for food with changes in nutrient content of less that 25% should 
take the form ""contains Yo/o less/more X". 
"High/rich: claims for  fibre  should conform to  the conditions in the  attached annex 
(see annex V).  Claims for other nutrients are outwith these guidelines, but see the 
Food Labelling Regulations Schedule 6 part II for condition for protein, vitamins and 
minerals.  Claims for foods naturally high in a nutrient should take the form "a high X 
food". 
Co-operative Wholesale Society code of practice 
The code defines certain type of  claims, which by their very nature will be considered 
misleading and are therefore prohibited. 
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•  Clams that are not meaningful to the population at large or to a defined group of 
individuals e.g. vegetarians. 
•  A  claim  which  is  factually  correct  but  which  is  insignificant  either  to  the 
population  or to  the  individual  product  (i.e.  high  protein  claims  in  the  UK -
because there  is  no protein deficiency in the UK).  Alternatively,  a  claim that 
implies that a product is in some way different when in reality all products of that 
type are the same. 
2.  Health Claims 
Under the JHCI code,  annex  1 (see annex  VII) sets out the limits between what is 
considered  to  be  a  health  claim  and  a  medicinal  claim  and  treats  the  issue  of 
borderline cases. The code therefore provides guidance on how a legally acceptable 
claim may be made for a food, which has a role in reducing risk of  disease. 
Medicinal claims 
The code points out that there is a general prohibition for medicinal claims for food 
products.  If a food is  intended for a medicinal purpose the making of a claim will 
need to  be approved by the  Medicines  Control  Agency through  the  granting of a 
product license.  Supplying such a product without a medicine license is  a  crin1inal 
offence. 
Use of certain word and phrases in health claims for foods 
The code states that the following could give rise to the impression that a product can 
prevent, treat or cure disease (with the implication that  this  would be a  medicinal 
claim and therefore prohibited under law but not necessarily under the code): 
•  Pictorial or other references to changes in the human body caused by disease. 
•  References to a specific disease. 
•  Non-specific references to disease in general. 
•  References to relief of"symptoms" 
•  Descriptions of particular symptoms which are perceived as signs of a disease (e.g. 
stress, anxiety, aches and pains, tension etc.) 
•  Targeting of  products to sections of  the population suffering from diseases or known 
to be at risk. 
•  Use of, or reference to, associated promotions or literature, which includes mentions 
of  disease. 
•  References to a body function which is  associated with the development of disease 
(such as cholesterol synthesis, formation of fat or body metabolism, immunity from 
infection  etc.)  unless  the  reference  only relates  to  the  continuation of its  normal 
healthy function. 
•  The  use  of medical  terminology and/or images  to  increase the  association of the 
product with medical usage. 
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•  The use of certain words  and phrases which may not,  taken alone,  signify that  a 
product can treat, prevent or cure human disease but may, if presented in a medical 
context, imply that the product can provide a medicinal benefit.  Such words include: 
"restore,  repair,  eliminate,  control,  counteract,  combat,  clear,  stop,  alleviate, 
remove, heal, remedy, avoid, protect, relieve, regenerate, normalise, strengthen, 
check, end, fight, calm, detoxify, reduce or lower". 
The code also gives examples of acceptable words and phrases in health claims and 
words and phrases that are unlikely to imply treatment, prevention or cure of  disease. 
Co-operative Wholesale Society code of practice 
The following type of  health claim are not allowed under the code: 
•  It is  not  appropriate  to  make  a  claim  related  to  the  function  of a  particular 
substance  which,  whilst  true,  could  imply  a  health  benefit  from  additional  or 
reduced intake which could not be justified; 
•  No  health claim can be  made  for  products  where there  is  evidence that  excess 
consumption can be harmful,  if this  is  easily achievable from  readily available 
foodstuff and supplements. 
•  Health claims must only be made on products, which are no  less "healthy" than 
their regular counterparts. 
3.  Ethical Claims 
The Fairtrade Foundation Fairtrade mark can only be used subject to  a contractual 
agreement  between  the  Fairtrade  Foundation  and  the  licensee.  The  contractual 
agreement defines how the Fairtrade mark can be used. 
If packaging or advertising materials are produced without the prior authorization of 
the  Fairtrade  Foundation  and  breach  the  conditions  for  the  use  of the  Mark,  the 
Foundation may require packaging to be reprinted and replaced within three months 
or materials to be withdrawn from circulation immediately. 
The licensee is  also contractually obliged to  observe any other reasonable directions 
given by the Fairtrade Foundation as to the colouring, size, manner and disposition of 
the Mark on packaging and on advertising and promotional materials. 
D.  VOLUNTARY INSTRUMENTS ACCEPTED/RECOGNISED BY 
THE AUTHORITIES 
Although the CWS code does not have any official recognition from the authorities, 
the CWS states that the Department of Health is thinking of  using its code as the basis 
for further work in this area once the Food Standards Agency has been set up. 
1.  Nutritional Claims 
The  Food Advisory Committee's guidelines  are  advisory and have  no  legal  effect. 
However, the government hopes that manufacturers will follow the recommendations 
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manner. 
2.  Health Claims 
The UK government has indicated that it supports the JHCI, although it has not yet 
received  ministerial  approval.  Notwithstanding,  the  government's  position remains 
that it wishes to see EU level legislation on health claims. 
It should also be noted that the European Commission has asked the UK government 
to notify the JHCI (see section on barriers to trade below). 
In practice, the involvement of the enforcement authorities in the JHCI will give the 
initiative a form of official backing. The enforcement authorities are  represented by 
the  Local  Authorities  Coordinating  Body  on  Trading  Standards  (LACOTS). 
LACOTS  has  been  closely involved  in  the  drafting of the  code  and  will  provide 
representatives for the JHCI Council.  However, despite the involvement of  LA  COTS, 
it  will remain up to  individual local authorities, which are responsible for enforcing 
relevant  legislation  to  decide  whether  to  prosecute  on  a  case  by  case  basis.  In 
practical terms, it should be noted that LACOTS welcomes the JHCI because it will 
remove an element of subjectivity from enforcement through the  establishment of a 
list of generic health claims.  LACOTS will advise Local Authorities to use the JHCI 
as  guidelines for their activities. They also hope that the Code Administration Body 
will in effect be a substitute for court proceedings, which would only need to be used 
as a last resort. 
3.  Ethical Claims 
The Fairtrade Foundation does not have any official recognition from the authorities. 
In  contrast,  the  Ethical  Trading  Initiative  outlined  above  does  have  official 
government backing and has been set up with government financial support (  approx. 
EUR 843 750 over three years). 
E.  REMARKS  ABOUT  BARruERS  TO  TRADE  AND  LACK  OF 
CONSUMER PROTECTION 
The  CWS  code is  subject to  a system of complaints from  consumers.  Through the 
CWS' s honest labelling campaign, consumers are encouraged to comment on claims. 
A complaint may result in the CWS changing its policy on claims.  Where there is  a 
dispute, the complaint is  referred to  a membership jury, which will adjudicate.  The 
CWS is bound by the jury's decision. A copy of the Consumer Jury Complaints and 
Adjudication Procedure is provided in Annex X. 
As the code of  practice only applies to own-label products, it is unlikely to give rise to 
barriers to  trade, except in so far as  suppliers from outside the United Kingdom may 
be  required  to  provide  the  Co-op  with  product  information  that  would  not  be 
necessary with other suppliers. 
1.  Nutritional Claims 
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The Food Advisory Committee guidelines are notified to the European Commission in 
accordance  with the  provision of Directive  83/189.  We understand  that  the  UK 
government  has  notified  the  guidelines  and  will  officially  publish  the  guidelines 
shortly.  The  Commission  and  the  other  Member  Sates  have,  therefore,  the 
opportunity to bring to the UK government's attention any potential barriers to trade 
that may arise from the guidelines. 
Concerns about consumer protection are referred to in Section Il.F  .1 
2.  Health Claims 
One of the  objectives  in  the JHCI is  "promoting consistency in  the  use of health 
claims in the UK, Europe and internationally".  The JHCI code has had to be notified 
to  the European Commission under the Directive 83/189 on national rules affecting 
the  free  movement of goods.  This  will  provide  both  the  Commission  and  other 
Member States  an  opportunity to  indicate  whether they believe that  the  code will 
result in barriers to trade. 
From our discussions, it appeared more likely that barriers to trade would arise from 
claims that are approved under the code in the UK but forbidden elsewhere in Europe. 
There was a general view that mutual recognition of  a code would prove difficult and 
the authorities also pointed out that claims from outside the UK would not fall under 
the code. 
Concerns about consumer protection are referred to in Section II. F. 2. 
3.  Ethical Claims 
Under the  contract with the  Fairtrade  Foundation,  the  licensee  is  only allowed to 
market its product primarily in the UK and may not actively market its products in 
those  countries that have their own Fairtrade  Labelling Organisations  International 
(FLO)  affiliated  Fairtrade  Labelling  Initiative.  That  is  unless  a  separate  license 
agreement is entered into with the appropriate Fairtrade Labelling Initiative. 
This provision might give rise to concern to barriers to  trade in the Internal Market. 
However, we understand that the Fairtrade Foundation and its sister organisations are 
moving towards international definitions and consistency.  This is being co-ordinated 
by the FLO. 
The  Fairtrade  Foundation  is  aware  of the  difficulties  that  exist  for  consumer 
protection in ethical claims. This arises from the fact that anyone is free to make an 
ethical claim.  There is no agreed definition of  an ethical claim.  It was suggested that 
ethical  claims  could  include  the  following:  animal  welfare  claims,  social 
standards/employment claims, fairtrade social/marketing claims, or simply claims by 
companies that they are acting ethically.  This can lead to confusion for the consumer. 
An example was cited where two different fairtrade  labels could both claim that a 
minimum  price  was  guaranteed  for  a  producer  of a  certain  product  i.e.  coffee. 
However, because the guaranteed price is  different the consumer may chose to  buy 
the cheaper product even though the guaranteed price for the producer may be lower. 
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that the emphasis should not be on a definition of a claim but agreeing standards for 
certification/justification of  ethical claims/fairtrade. 
The  example  mentioned above  by Fairtrade  Foundation raises  important questions 
relating to  consumer protection.  The lack of definition of claims and the ability of 
manufacturers  of products  to  place  their  own  claims  on  products  could  lead  to 
consumers being misled.  The  lack of any system of control  leaves the market for 
ethical claims wide open to abuse. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims 
According to  the  UK government, UK law does not provide an inventory of criteria 
for substantiating nutrition claims. It is  up  to the courts to decide whether or not a 
particular claim contravenes the law.  Responsibility for enforcing the law is with the 
local authorities. 
2.  Health Claims 
According to  the UK government, UK law does not provide an inventory of criteria 
for  substantiating nutrition claims.  It is  up  to  the courts to  decide whether or not a 
particular claim contravenes the law.  Responsibility for enforcing the law falls to the 
local authorities. 
The  JHCI  code  does,  however,  include  a  section  on  the  substantiation  of Health 
claims. This is discussed in further detail in Section III. A. 2. 
3.  Ethical Claims 
No  legal  provisions  exist  for  the  verification  of ethical  claims  under  UK  law. 
However, the Fairtrade Foundation has a list of  criteria that a manufacturer must meet 
in  order  to  qualify  for  the  Fairtrade  Mark.  These  are  referred  to  as  the  Fairtrade 
Criteria, which mean the standards and terms of trade for a specific product categories 
agreed by all the National Initiative's affiliated to the FLO. The criteria are developed 
for  each  type  of product  for  which  the  Fairtrade  Mark  can  be used.  Criteria  are 
applied to both the importers/packers of the product as well as to "accepted sources" 
of  the product. A full list of  the "tea" criteria is provided in annex XI. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
The system for verifying claims under the  Co-operative Wholesale Society code is 
dealt with in Section V. E. 
1.  Pre-Clearance Rules/ Guidelines 
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various self-regulatory initiatives. 
The JHCI encourages manufacturers to  seek pre-clearance of health claims and,  in 
particular,  innovative  health  claims.  Companies  wishing  to  do  so  can  submit 
substantiating evidence to the Code Administration Body for advice from the Expert 
Authority.  The exact procedures for seeking pre-market advice and timescales for its 
delivery have yet to be established by the Council. 
Further details of  the pre-clearance rules are provided in Section Ill.A.2. 
All the bodies that administer the means of communication encourage pre-clearance 
for all types of  claims.  In some instances, such as for Radio broadcasts, health claims 
must  be  submitted  for  pre-clearance.  In  other  instances,  for  example,  television 
broadcasting this is the normal procedure as the costs involved in producing television 
commercials are such that pre-clearance advice is almost always sought. 
However,  it  must  be  noted  that  none  of the  pre-clearance  systems  provide  the 
manufacturer  with  a  guarantee  that  their  particular  claim  will  comply  with  the 
respective codes or the law. 
In the case of the media, the pre-clearance advice is given by either the Broadcasting 
Advice  Clearance  Centre  (BACC)  or  the  Radio  Advertising  Clearance  Centre 
(RACC)  or in  the  case  of the  non-broadcast  media the  Committee  on  Advertising 
Practice (CAP). 
The role of  these bodies is dealt with separately under Section VI. 
2.  Post-Clearance Rules/Guidelines 
Control of Misleading Advertising Regulations 
Under the Control of  Misleading Advertisements the following rules apply. 
The  Director-General  of the  Office  of Fair  Trading  has  the  power  to  stop  an 
advertisement by means of a court injunction.  The Director-General's powers only 
apply to the following types of  advertisement: 
•  Newspapers and magazines; 
•  Outdoor  advertising  including  bus,  taxi  and  aerial  advertisement,  as  well  as 
posters; 
•  Cinema commercials; 
•  Brochures, leaflets, inserts, point of sale  advertising, display materials, circulars 
and direct mail. 
The  Director-General's  powers  come  into  play  when  a  complaint  about  an 
advertisement is made to him. However, before he considers the complaint he can ask 
the  complainant  to  show  that  the  existing  channels  have  been  given  a  reasonable 
opportunity to deal with the problem. 
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•  Trading Standards Departments who enforce the Trade Descriptions Act. 
•  The  Advertising  Standards  Authority  which  administers  the  British  Codes  of 
Advertising and Sales Promotion. 
The  Director-General  can  only  act  when  a  complaint  has  been  received.  The 
complaint must be about the misleading nature of  the advertisement, which is defined 
in the regulations as: 
"for the purposes of these regulations an advertisement is  misleading if in  any way, 
including it presentation, it deceives or is likely to deceive the persons to whom it is 
addressed or whom it reaches and if, by reason of its deceptive nature, it is  likely to 
affect their economic behaviour or, for those reasons, injures or is  likely to  injure a 
competitor of  the person whose interest the advertisement seeks to promote." 
An advertisement can be deceptive in various ways including where, for example, it: 
•  Contains a false statement of fact - this may be possible to prove or disprove by 
evidence; 
•  Conceals or leaves out important facts; 
•  Promises to do something but there is no intention of  carrying it out; 
•  Creates a false impression, even if  everything stated in it may be literally true. 
If having considered the advertisement, the Director-General thinks it is  misleading, 
then he has to decide whether to  take court action.  In making this decision he must 
have regard to  all the interests involved, particularly the public interest.  This means 
he will assess the gravity of the complaint.  The factors for assessing the gravity of  the 
complaint include: 
•  Health and safety 
•  The nature of  the goods or service advertised 
•  Loss suffered by the complainant 
•  The nature of  the target audience 
•  The likely size of  the target audience 
•  The cost of  products or services advertised. 
•  The need for speed in seeking a ban on the advertisement. 
•  The likely hood of  continued publication if  court proceedings are not started 
The Director-General will  take court action where he  considers it  warranted by the 
gravity of the misleading advertising and no immediate undertaking is given to amend 
or discontinue it.  He will seek a High Court injunction. 
3.  What are the administrative/legal costs 
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There are no  specific  legal and administrative costs for those who wish to make a 
complaint. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Food Safety Act 1990 
Section 6 of the Food Safety provides the following: 
(1) In this act "the enforcement authority", in relation to any provision of this Act or 
any regulations or orders made under it, means the authority by whom they are to 
be enforced and executed. 
(2) Every Food authority shall enforce and execute, within their area, the provisions 
of  this act with respect to which the duty is not imposed expressly or by necessary 
implication on some other authority. 
Section 5 of the Act defines the food authorities as "each London borough, district or 
non-metropolitan county, the council of that borough, district or county" (hereafter 
referred to as local authorities). 
Control of Misleading Advertising Regulations 
Any person may complain to the Director-General of  the Office of Fair Trading under 
the Control of Misleading Advertising Regulations.  Only the Director-General may 
seek an injunction. 
Food Labelling Regulations 1996 
Section 45 of  the Food labelling Regulations 1996 provides the following: 
"each food authority shall enforce and execute these regulations in its area" 
Trade Descriptions Act 1968 
Article  26  of the  Trade  Descriptions  Act  provides  that  Trading  Standards  (or 
Consumer  Protection)  Departments  are  responsible  for  enforcing  the  act.  The 
Departments are part of  the respective local authorities. 
D.  BURDEN OF PROOF 
1.  Burden of proof 
Control of Misleading Advertising Regulations 
The burden of proof is on the Director-General of the Office of Fair Trading to prove 
that the advertisement is misleading. 
The Food Labelling Regulations 1996 
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occurred under the regulations. 
In the case of a claim this is provided under section 44(b) that provides: 
"if any person sells or advertises for sale any food  in  respect of which a claims is 
made, nutrition labelling is given or a description or name is used in contravention of 
the provision of  part III of  these regulations". 
Food Safety Act 1990 
The burden of proof is  on the enforcement authorities to  show that an offence has 
been committed. 
In the case of  claims this is provided under section 15 that provides: 
"Any person who gives with any food sold by him, or displays with any food offered 
or exposed  by him  for  sale  or in  his  possession  for  the  purpose of sale,  a  label, 
whether or not attached to or printed on the wrapper or container, which, 
(a)  falsely describes the food; or 
(b) is likely to mislead a to the nature or substance or quality of  the food 
shall be guilty of  an offence." 
E.  APPLICABLE PENAL  TIES 
Control of Misleading Advertising Regulations 
There are no specific penalties under the Control Misleading Advertising Regulations 
except  in  that  the  Director-General  of the  Office  of Fair  Trading  can  seek  an 
injunction to stop the advertisement. 
Food Safety Act 1990 
Section 35 provides: 
"(2) A person found guilty of  any other offence under this act shall be liable-
(a)  on conviction on indictment, to a fine or to imprisonment for a term not exceeding 
two years or to both". 
(b) on  summary  conviction,  to  a  fine  not  exceeding  the  relevant  amount  or  to 
imprisonment for a term not exceeding six months or to both." 
(3) In subsection (2) above the relevant amount means-
(a)  in  the  case of an offence under section 7,8,  or 14  above £20 000 (EUR 31 
250); 
(b) in any other case, the statutory maximum." 
Note the relevant section for claims is section 15. 
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Food Labelling Regulations 1996 
Section 44 of Food Labelling Regulations provides that if any persons commits an 
offence "he shall be liable on summary conviction to a fine not exceeding level 5 on 
the standard scale £5000 (approx. EUR 7812) ." 
Trade Descriptions Act 1968 
Section 18 provides: 
"a person guilty of an offence under this act for which no other penalty is specified 
shall be liable -
(a)  on summary conviction, to a fine not exceeding £400 (approx. EUR 625).  This 
figure has been raised to£ 5000 (approx. EUR 7812); and 
(b) on conviction or indictment to a fine  or imprisonment for a term not exceeding 
two years or both. 
F.  REMARKS ABOUT BARRIERS TO TRADE AND LACK OF CONSUMER 
PROTECTION 
As is demonstrated above, the legislative measures in place in the UK all require the 
enforcement  authorities  to  prove  that  any  particular  claim  that  is  being  made  is 
contrary to the provisions of  the various rules in force. 
In  the case of the  Trade  Descriptions Act,  the  Food Labelling Regulations and the 
Food Safety Act the offences are criminal offences and therefore the burden of proof 
is  "beyond reasonable doubt".  In the case of the Control of Misleading Advertising 
Regulations,  the  Director-General  would  need  to  show  that  on  the  "balance  of 
probabilities" that a claim is misleading. 
This has repercussions for the decision by the enforcement authorities to  take action 
against makers of  claims, in particular where there is contradictory scientific evidence 
on a specific claim. 
V.  CASELAW 
There is a limited amount of case law available on claims in the UK.  The reasons for 
this appear to be threefold: 
•  The UK system of regulation is  heavily based on self-regulation and,  therefore, 
disputes tend to be resolved outside the legal system.  This is particularly the case 
with regard to the regulation of  the means of  communication. 
•  Even where there are specific legislative provisions on claims, the system is such 
that the parties are encouraged to reach an agreement outside the courts. 
•  The  authorities  responsible  for  the  enforcement  of legislation  are  the  local 
authorities. There is reluctance on  the part of the  local authorities to  bring cases 
before  the  courts.  This  is  due  to  a  number of reasons  but  the  most  important 
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burden ofproofbeing on the plaintiffto show that the claim is not justified. 
In addition to the case law on health claims, the Medicines Control Agency in closely 
involved in regulating borderline cases.  Examples of these are set out below. 
1.  Nutritional Claims 
No cases involving nutritional claims were mentioned to us. 
2.  Health Claims 
Two cases have been drawn to our attention. 
1. Cheshire County Council versus Momflake Oats 
In this case, the defendant used the claim that its product helped to  "reduce excess 
cholesterol levels, cutting down the risk of  heart disease". 
The Divisional Court ruled that this was a medicinal claim, which could not be made 
unless a product license has been issued under the Medicine Act 1968. 
The Court concluded that: 
•  The claim had the inevitable result that the disease would be prevented by being 
eliminated altogether; and 
•  The  words  cutting down had  no  meaning at  all,  unless  those persons suffering 
from  the disease would suffer to  a less acute degree  than they otherwise would 
have done. 
2. In this case the defendant used a claim on a product suggesting that it would raise a 
child's IQ.  The plaintiff was Shropshire County Council and the Court ruled that the 
claim  had  not  being  justified  and  that  the  claim  was  unlawful  under  the  Trade 
Descriptions Act. 
3.  Ethical Claims 
No cases involving ethical claims were mentioned to us. 
4.  Borderline cases 
The example given the MCA of a borderline case is the PrevaCan case.  The MCA 
took the view that the name of the product and the marketing strategy amounted to the 
presentation of it  ''for treating or preventing disease".  Copies of the  some of the 
marketing material are attached in Annex XII. 
The MCA took the view that the claims were medicinal and where therefore in breach 
of medicinal and food legislation.  However, as the product was a food it was up to 
the Food Regulators to take action.  Nevertheless, the food regulators resisted and the 
MCA decided to take its own legal advice.  The advice was supportive the MCA right 
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to take action but pessimistic about the potential outcome of the case.  The MCA was 
advised to continue discussions with the manufacturers alongside the Food regulator. 
The manufacturer has since suggested changing the name and promotional material. 
This is also included in Annex XII. 
B.  REMARKS ABOUT BARRIERS TO TRADE AND LACK OF 
CONSUMER PROTECTION 
There is considerable evidence to suggest that the lack of resources available to local 
authorities  results  in  a  number  of claims  being  made  that  would  otherwise  be 
unlawful.  We are not in a position to judge whether this has the direct effect of  a lack 
of  consumer protection. 
LACOTS has provided us with a summary of a study carried out by local authorities 
in  Wales  that  assess  whether  claims  comply  inter  alia  with  the  Food  Labelling 
Regulations 1996. 
This study would seem to  imply that a number of claims are being made that in the 
judgement  of the  local  authorities  are  unlawful.  The  summary  of this  study  is 
provided in annex XIII. 
However, the local authorities are not in a position to systematically enforce relevant 
legislation 
VI.  MEANS OF COMMUNICATION 
The UK has a sophisticated mix of regulatory and self-regulatory systems in place for 
the control of  claims/advertising in the different forms of  media.  These are dealt with 
here under two categories (broadcast (radio and television) and non-broadcast). 
A.  BROADCAST 
The broadcast sector is  regulated by a  system of statutory bodies (the  Independent 
Television  Commission  and  the  Radio  Authority)  and  a  system  of pre-clearance 
advice given by the Broadcast Advertising Clearance Centre (BACC) and the Radio 
Advertising Clearance Centre (RACC). 
1.  Television 
The Broadcasting Act 1990 makes it the statutory duty of the Independent Television 
Commission (ITC) to draw up and enforce a code governing standards and practice in 
television  advertising  and  the  sponsoring  of programmes.  A  copy of the  code  is 
provided in annex XIV. 
All  holders of relevant lTC licenses are required to ensure that any advertising they 
transmit  complies  with  the  Code  and  to  satisfy  the  ITC  that  they  have  adequate 
procedures to fulfil this requirement.  The lTC itself draws up the Code and revises 
the rules, advises broadcasters on interpretation, monitors compliance and investigates 
complaints. The ITC has statutory powers to  enable advertisements to be withdrawn 
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appropriate cases, impose penalties on the broadcasters, including financial penalties 
and  in  extreme  cases,  the  curtailment  and  eventual  rescinding  of a  broadcaster's 
license. 
2.  lTC Code 
The ITC code provides the following in respect of  health claims: 
"Subject to the generality of the code, health claims and the advertising of medicines, 
treatments and dietary supplements are subject to more detailed rules in Appendix 3." 
The majority of  the Appendix deals with advertising of medicinal products rather that 
health claims in particular. However, section 36 deals with health and nutrition claims 
as follows: 
"(d) specific nutrition claims (e.g. "full of  the goodness of vitamin C) or health claims 
(e.g.  aids a healthy digestion)  must be supported by  sound scientific  evidence and 
must not give a misleading impression of the nutritional or health benefits of the food 
as a whole. More generalized claims or descriptions which imply nutritional or health 
benefits (e.g. "wholesome") without stating the basis for which them explicitly in the 
advertising are acceptable only if there is  in fact a specific basis for  them which is 
similarly supported by sound scientific evidence. Such claims will, where relevant be 
assessed by reference to the concept of a balanced diet." 
In addition, the following general notes are provided 
(i)  Particular  attention  should  also  be  paid  to  the  requirements  of the  Food 
Labelling Regulations 1996, especially the prohibited and restricted claims set 
out in Schedule 6.  Licensees and advertisers are advised to bear in mind that it 
is  illegal  to  make  medicinal  claims  on  behalf of food  products  unless  the 
product has a product license under the Medicines Act.'' 
In order to comply with the code, broadcasters have established a body to  assist with 
pre-clearance  of  television  advertising.  The  Broadcast  Advertising  Clearance 
Centre's  (BACC)  role  is  to  examine  advertisements  before  they are  accepted  for 
broadcasting,  to  decide whether they comply with the  relevant code  and to  handle 
day-to-day negotiations with the advertising agencies and advertisers. 
3.  BACC guidance notes 
The BACC has developed its own guidance notes, which are intended to  be read in 
conjunction with the ITC code, whose rules they supplement and expand.  A copy of 
the  guidance notes is provided in  Annex XV.  Section 5 is dedicated to  Medicines, 
Treatments and Health Claims. 
Section 4.5 states the following: 
"Claims that goods are healthy must be made with proper regard for the interpretation 
likely  to  be  placed upon  the  word by the  lay  person.  Foods  may be  described  as 
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are demonstrably capable of playing a significant role in  a well balanced diet".  The 
word healthy is not acceptable if  used merely as a loose synonym for "wholesome". 
Similarly  terms  such  as  "goodness"  need  to  be  used  with  discretion,  to  avoid 
exaggerating a food's contribution to the diet.  "Goodness" is not acceptable simply as 
a synonym for "wholesomeness". 
Most foods  are wholesome and many are nutritious.  However, the fact  that a food 
product may be a good source of nutrients which, in isolation, are important or even 
essential for  good health is  not of itself a sufficient justification for  promoting that 
product on a platform of general nutritional benefit.  Claims in  this area need to  be 
assessed having regard  to  the  likely dietary requirements  of the  UK population  in 
general. 
For example, although fat  is  essential to  the  well being of the  human metabolism, 
most available evidence suggests that the majority of British people would be well 
advised to reduce the amount of fat in their diet.  In these circumstances, it would be 
inappropriate  to  advertise  a  fat-rich  product  on  the  basis  of a  claim,  express  or 
implied,  that  it  was  "good for  you",  nutritious,  or that  it  had  a  part  to  play  in  a 
"healthy diet", even though these statements might be perfectly justifiable in absolute 
scientific terms. 
The acceptability of claims about a product's nutritional benefits will be assessed on 
this  basis,  with  the  advice,  where  necessary  of BACC's  medical  and  nutritional 
advisors. 
In some foods,  the presence of a nutrient for which a claim of nutritional benefit can 
be  justified  is  offset  by  another,  less  desirable  ingredient.  In  such  cases,  the 
acceptability of a positive nutritional claim for the product as a whole will depend on 
the extent to which the presence of the "negative" ingredient detracts from the benefit 
offered by the "positive" one. 
In  certain circumstances it may be acceptable for a food  product unable to  claim in 
absolute terms to be "healthy" or" good for you", for example because of its fat,  salt, 
or sugar content,  to  make  a justifiable claim  to  be "healthier" or "better for  you" 
because it  contains significantly less  of those  ingredients than  are  commonly to  be 
found  in  such  foods,  so  that  its  substitution  for  them  would  produce  a  positive 
benefit." 
Inter alia, the BACC's code also includes sections on general food law, ingredient and 
additives, creative treatments and descriptions, and dietary aids to slimming. 
According to  the  ITC  and the BACC, 90o/o  of all  broadcast advertisements receive 
pre-clearance from the BACC. 
However it should be pointed out that the ITC has no direct link with the advertiser. 
The only link is with the broadcaster. 
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A similar structure exists for radio. The Statutory body is  the Radio Authority (RA) 
which licenses  and regulates commercial radio in  accordance with the Broadcasting 
Act  1990  and  the  Broadcasting  Act  1996.  The  RA  has  approved  the  Radio 
Advertising  Clearance  Centre  (RACC)  as  responsible  for  clearance  of  radio 
advertising. 
5.  RA Code 
The Radio Authority has developed a code on advertising and sponsorship. A copy of 
the  code  is  provided  in  Annex  XVI.  The  RA  code  provides  that  certain  special 
categories of advertising must be approved by the central clearance authority.  These 
special  categories  include  food  and nutrition claims.  Therefore, any  advertisement, 
which includes a food and nutrition claim, must be approved by the RACC. 
The RA code on advertising and sponsorship includes a section devoted to medicines, 
treatments  and  health,  which  provides  that  ''health  claims  and  the  advertising  of 
medicines and treatments (including veterinary products) are subject to  the  rules  at 
Appendix 4. 
Inter alia Appendix 4 provides the following: 
"Claims  about  any  type  of product  or  treatment  which  fall  within  this  Appendix 
require very close scrutiny.  Whenever a proper assessment of  such claims can only be 
made by a medically qualified expert, appropriate independent medical advice should 
be  sought  before  acceptance.  This  includes  claims  relating  to  the  nutritional, 
therapeutic or prophylactic effects of  products such as food or toilet products." 
The appendix also  includes a specific section on  generalized health claim for  food, 
which provides: 
"Generalised  claims  such  as  "goodness"  or "wholesome"  may  imply  that  a  food 
product or an ingredient has a greater nutritional or health benefit than is actually the 
case.  In  some  instances,  reference to  the  properties of a particular ingredient may 
give a misleading impression of the properties of the product taken as a whole.  Such 
claims are unacceptable unless supported by sound medical evidence. 
Particular attention  should  also  be paid to  the  requirements of the  Food  Labelling 
Regulations especially the prohibited and restricted claims set out in Schedule 6." 
6.  RACC guidelines 
The  RACC  guidelines  provide  that  special  categories  of advertisements  require 
clearance for the RACC.  This list includes food and nutritional claims. 
A copy of the Radio Advertising Clearance Centre Radio copy guidelines is provided 
in annex XVII. 
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B.  NON-BROADCAST MEDIA 
1.  Advertising Standards Authority 
The non-broadcast media in  the  UK is  subject to  a system of self-regulation that is 
administered  by the  Advertising  Standards  Authority  (ASA).  The  ASA  provides 
independent scrutiny of the self-regulatory system administered by the Committee on 
Advertising Practice (CAP).  CAP is responsible for the British Codes of Advertising 
and Sales Promotion. A copy of the British Codes of  Advertising and Sales Promotion 
is provided in annex XVIII. 
Its  chief tasks  are  to  promote  and  enforce  high  standards  in  advertisements,  to 
investigate complaints, to  identify and resolve problems through its own research, to 
ensure  that  the  system  operates  in  the  public  interest  and  to  act  as  a  channel  for 
communications with those who have an interest in advertising standards. 
The  ASA  is  an independent company and  is  independent of both  the  advertising 
industry and the government. 
The ASA's complaint's system has the following steps: 
(i) 
(ii) 
(iii) 
(iv) 
(v) 
(vi) 
(vii) 
(viii) 
complaint received - ASA sends  an  acknowledgement card  and  assess  the 
complaint 
Decision - case needs  investigating or complainant advised that there  is  no 
case to answer under the codes 
Investigation - ASA  asks  the  advertiser  to  comment on  the  complaint  and 
supply evidence for any disputed claims 
Considering  the  complaint  - Advertisement  assessed  in  the  light  of 
advertiser's response 
Decision - ASA Council adjudication 
Taking  Action  - Advertiser  and  complainant  notified  of ruling.  Where 
complaint  is  upheld,  ASA  asks  for  the  advertisement  to  be  amended  or 
withdrawn 
Publication of ruling - ASA publishes  outcome  of the  investigation  in  the 
Monthly report which is circulated to journalists and the industry 
Final  check  - ASA  checks  that  the  advertisement  has  been  changed  or 
withdrawn. 
2.  Committee on Advertising Practice (CAP) 
The Committee on Advertising Practice is the self-regulatory body that devises and 
enforces the British Codes of  Advertising and Sales Promotion. 
CAP  also  administers  the  mandatory  pre-clearance  of cigarette  advertising  and 
provides  free  and confidential  pre-publication advice to  advertisers  and promoters, 
their agencies, the media and produces Advice Notes and Ad Alerts for the industry 
and co-ordinates the sanctions operated by its members. 
Favourable  pre-publication  advice  does  not  automatically  protect  advertisers  or 
promoters from their complaints being investigated by the ASA. 
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3.  British Codes of Advertising and Sales promotion 
The British Codes of  Advertising and Sales Promotion are drafted by the CAP. 
In  its  broadest  sense  the  code  requires  that  advertisements  and  sales  promotions 
should be: 
•  Legal decent, honest and truthful 
•  Prepared with a sense of  responsibility to consumers and to society 
•  In line with the principles of  fair competition and generally accepted in business. 
The  code  also  contains  specific  provisions  on  health  and  beauty  products  and 
therapies: 
•  Medical  and  scientific  claims  made  about  beauty  and  health-related  products 
should be backed by trials, where appropriate conducted on people. Substantiation 
will be assessed by the ASA on the basis of  established scientific knowledge. 
•  Advertisers should not discourage people from having essential treatment; medical 
advice is needed for serious or prolonged ailments and advertisers should not offer 
medicines or therapies for them. 
•  Advice,  diagnosis  or  treatment  of any  serious  medical  condition  should  be 
conducted  face-to-face.  Advertisers  inviting  consumers  to  diagnose  their  own 
minor ailments should not make claims that might lead to a mistaken diagnosis. 
•  Consumers should not be  encouraged to  use products  to  excess and advertisers 
should not suggest that their products or therapies-are guaranteed  to  work,  are 
absolutely safe or without side effects for everyone. 
•  Advertisements should not suggest that  any product is  safe  or  effective merely 
because it is  'natural' or that it is generally safer because it omits an ingredient in 
common use. 
•  Advertisers  offering individual  treatments,  particularly those that  are  physically 
invasive may be asked by the media and the ASAto provide full  details together 
with  information  about  those  who  will  supervise  and  administer  them.  Where 
appropriate,  practitioners  should  have  relevant  and  recognised  qualifications. 
Consumers  should  be  encouraged  to  take  independent  medical  advice  before 
committing themselves to significant treatments. 
•  References  to  the  relief of symptoms  or  the  superficial  signs  of ageing  are 
acceptable  if they  can  be  substantiated.  Unqualified  claims  such  as  'cure'  and 
'rejuvenation' are not generally acceptable. 
•  Claims made for the  treatment of minor addictions and bad habits should make 
clear the vital role of  willpower. 
•  Advertisers should not use unfamiliar scientific words for common conditions. 
•  Advertisers  should hold  scientific  evidence  for  any claim that  their  vitamin or 
mineral product or food supplement is beneficial to health. 
•  A well-balanced diet should provide the vitamins and minerals needed each day 
by  a  normal,  healthy  individuaL  Advertisers  may  offer  supplements  as  a 
safeguard,  but  should  not  suggest  that  there  is  widespread  vitamin  or  mineral 
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Advertisements should not imply that supplements will guard against deficiency, 
elevate mood or enhance performance. Supplements should not be promoted as a 
substitute for a healthy diet. 
•  Certain groups of people may benefit from vitamin and mineral supplementation. 
These include people who eat nutritionally inadequate meals, the elderly, children 
and adolescents, convalescents, athletes in training, those who are physically very 
active, women of child-bearing age, lactating and pregnant women and dieters. In 
assessing  claims  the  ASA  will  bear  in  mind  recommendations  made  by  the 
Department of  Health. 
•  Serious vitamin and mineral depletion caused by illness should be diagnosed and 
treated by a doctor.  Self-medication should not be promoted on the basis that it 
will influence the speed or extent of  recovery. 
VII.  STATISTICS ON CLAIMS 
As  discussed in section V.B  LACOTS  has  provided us  with a summary of a study 
carried out by local authorities in Wales that assess whether claims comply inter alia 
with the Food Labelling Regulations 1996. 
This study would seem to  imply that a number of claims are being made that in the 
judgement  of the  local  authorities  are  unlawful.  The  summary  of this  study  is 
provided in annex XIII. 
Two other studies examining nutritional and health claims have been carried both by 
the Food Commission: 
•  "Functional Foods Examined: the health claims being made for food products and 
the need for regulation" by Jane Bradbury, Tim Lobstein and Vivien Lund, April 
1996. 
•  '"Food Supplement Claims: a survey of over 700 nutritional ad health claims being 
made  by over 300  food  supplements  showing  a  need  for  clearer  and  stronger 
regulations to prevent consumers being misled" by Viv Stein, July 1997 
Full copies of  these studies are provided in annexes XIX and XX. 
VIII. ANNEXES 
I.  Food Labelling Regulations 1996 
II.  Food Safety Act 1990 
III.  Trade Descriptions Act 1968 
IV.  Control of  Misleading Advertising Regulations 1988 
V.  Food Advisory Committee Guidelines for the Use of Certain Nutrition Claims 
in Food Labelling and Advertising 
VI.  Co-operative  Wholesale  Society  Code  of Practice  for  labelling  prepacked 
foods. 
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VIII.  Ethical  Trading  Initiative,  Purpose,  principles  programme  membership 
information. 
IX.  The Fairtrade Foundation; Fairtrade Mark General Criteria 
X.  Co-operative Wholesale Society Consumer Jury Complaints and Adjudication 
Procedure 
XI.  Fairtrade Foundation, Tea Criteria of the International Producer Register- A 
viable alternative for disadvantaged producers. 
XII.  Prevacan promotional material 
XIII.  LA COTS Summary on Evaluation of  Claims 
XIV.  The Independent Television Commission Code of Advertising Standards and 
Practice. 
XV.  Broadcast Advertising Clearance Centre, Guidance notes on pre-transmission 
clearance for Television Advertising. 
XVI.  Radio Authority Advertising and Sponsorship Code 
XVII.  Radio Adverting Clearance Centre radio copy guidelines. 
XVIII.  British Codes of  Advertising and Sale Promotion 
XIX.  Functional Food Examined; the health claims being made for food  products 
and the need for regulation. 
XX.  Food Supplement claims: a survey of over 700 nutritional and health claims 
being made  by over 300  food  supplements  showing a need  for  clearer and 
stronger regulations to prevent consumers being misled. 
IX.  CONTACT DATABASE 
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I Q.  UNITED STATES 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This  study was  greeted with interest by regulatory authorities  and  other interested 
parties  in  the  United  States, where  considerable  experience has  been  gained in  the 
regulatory treatment of nutritional and health claims.  The study has been conducted 
at a time when the U.S. system governing nutritional and health claims has undergone 
substantial changes.  These have had an important impact on the numbers of products 
making  such  claims,  and the  ability of regulators  to  effectively police  and  control 
them. These changes hold potentially important lessons for how this issue should be 
approached in the European Union (EU). 
The following Executive Analysis outlines the main points of  interest in relation to the 
U.S.  system, the major changes it has undergone, and the  principal consequences of 
these changes. 
B.  MEMBER STATE POLICY 
1.  Nutritional and health claims 
The U.S.  Government applies a comprehensive regulatory scheme to  manufacturers 
making health and nutrition claims on labelling and in advertising of food and dietary 
supplement  products.  This  regulatory  scheme  includes  definitions  of health  and 
nutrition claims that are similar to those applied within the EU, and is in many areas 
very specific about the types of claims that can be made, the  specific  language that 
can be used, and even the prominence that the claim can be given in relation to other 
labelling information. 
In  general, these definitions are thought by most parties to  distinguish fairly clearly 
between the claims that are permissible on food products, and those claims that would 
lead  a  product  to  be  classified  as  a  medicinal  product  or drug.  However,  recent 
government  efforts  to  develop  regulations  drawing  a  clearer  line  between  health 
claims  and  certain  nutrition  support  statements  (i.e.,  structure/function  claims), 
especially for dietary supplements, have caused considerable confusion and concern, 
and are still being sorted out. 
The  U.S.  regulatory approach is  designed to  strike a balance between the  need to 
ensure a high level of consumer information and protection on the one hand, and the 
desire  to  allow  the  food  and dietary supplement industries  to  develop  to  their full 
economic potential (and to use valid nutrition and health claims as part of their effort 
to do so) on the other. 
Under  the  U.S.  regulatory  regime  in  the  early  1990s,  the  terms  upon  which 
manufacturers could make nutrition or health claims were quite clear.  Prior approval 
of the  U.S.  Food and  Drug Administration (FDA)  was  generally required,  and  the 
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was, therefore, an  element of certainty in  the  marketplace as  to  which claims were 
permissible and which were not.  Many consumer advocacy groups felt that the prior 
authorization system afforded a relatively high level of consumer protection.  Many 
manufacturers, however, felt that the FDA approach to claims was far too restrictive. 
Reforms adopted between  1994  and 1997 created alternative bases (other than prior 
FDA  approval)  on  which  manufacturers  could  make  claims.  In  1994,  the  U.S. 
Congress  adopted  legislation  allowing  dietary  supplement  manufacturers  to  make 
structure and function claims without prior government approval, a step which led to 
several thousand such claims being notified (as required) to the FDA.  More recently, 
the U.S. Congress adopted legislation allowing nutrition and health claims to be made 
if they were based upon an authoritative statement (e.g., an official report) of one of 
the federal government's scientific bodies. 
2.  Ethical claims 
There is  no regulation in the United States on ethical claims.  Moreover, only a very 
small amount of  activity has taken place in this area. 
C.  VOLUNTARY CODES OF PRACTICE 
1.  Nutritional and health claims 
Partly because of  the pervasive nature ofthe U.S. regulatory regime, there is relatively 
little development on voluntary codes of practice that specifically relate to  nutrition 
and health claims.  Several related sectors have developed codes dealing with other 
aspects  of industry  standards,  such  as  good  manufacturing  practices,  but  these 
generally  do  not  contain  comprehensive  standards  for  claims  that  create  a  real 
alternative to the U.S. regulatory and enforcement regime. 
2.  Ethical Claims 
The U.S. does not have a specific regulatory regime for the making of ethical claims, 
although there has been some activity relating to  claims for environmental or social 
purposes.  The  Federal  Trade  Commission  (FTC),  for  example,  has  adopted 
guidelines governing the use of environmental claims in product marketing, and was 
petitioned  several  years  ago  by  consumer  organizations  to  develop  comparable 
guidelines  governing  the  use  of claims  that  products  were  manufactured  without 
having been tested on animals.  The FTC declined to take up this petition, however, 
and its officials indicate that they have not been pressed to adopt guidelines on social 
or  other  ethical  claims.  Some  consumer  groups  believe  that  U.S.  industry  has 
effectively  quashed  any  consideration  by  government  of  a  regulatory  scheme 
governing such claims. 
D.  VERIFICATION SYSTEMS 
In addition to providing for pre-clearance as one means of making certain claims, the 
U.S. maintains what appears to be a vigorous enforcement scheme aimed at ensuring 
manufacturers'  compliance  with  the  relevant  regulations.  At  federal  level, 
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product advertising).  Enforcement measures are based mainly on these agencies' own 
monitoring of the marketplace, but also on complaints received from consumers and 
competitors.  These measures are  mainly non-judicial,  consisting of warning letters 
that FDA and FTC officials indicate usually produce a corrective action by product 
manufacturers,  but the  government  can  and  does  initiate judicial  action  when  its 
warnings are not met. 
Federal  enforcement  efforts  are  supplemented  by  enforcement  at  other  levels  of 
government, such as the attorneys general of some of  the 50 states and local consumer 
protection bureaus.  In addition, a number of membership-based organisations try to 
perform some monitoring of food and supplement product claims (and whether they 
are valid) as a service to their members. 
The number and strength of the administrative and judicial enforcement mechanisms 
available under the U.S. system would suggest that the level of  consumer protection is 
quite high.  Indeed, the FTC and FDA can bring to bear a wide and impressive range 
of sanctions and leverage against offending companies, and judicial remedies include 
cease-and-desist  orders,  consent  agreements  forcing  the  company  to  refrain  from 
certain action, and even court-ordered compensation to affected consumers. 
However,  partly due  to  resource  limitations,  regulators  tend to  seek  such remedies 
only in cases where a company has demonstrated a pattern of misconduct.  Moreover, 
there is  considerable concern that enforcement authorities' resources are increasingly 
inadequate  to  cope with the  sheer number of products  and  claims  being made  for 
them.  This concern has become especially acute because of a recent upsurge in  the 
marketing of  such products on the Internet, especially dietary supplements. 
E.  MEANS OF COMMUNICATION 
The  two  main  regulatory  authorities  - the  FDA  and  the  FTC  - apply  the  same 
standards to  nutrition and health claims regardless of the means by which they are 
communicated.  It  should  be  noted,  however,  that  much  of  the  FTC's  recent 
enforcement activity (problems) has been directed towards the numerous claims being 
made via Internet marketing sites. 
F.  CONSUMER PROTECTION 
The  U.S.  regulatory  approach  has  evolved  over a  time  frame  in  which  consumer 
knowledge of the health and nutrient value of food  and related products has grown 
substantially.  That knowledge plays an increasingly decisive role in the products that 
consumers select, and where manufacturers recognize the potential value of nutrition 
and  health  claims  in  distinguishing their  products  from  those  of their competitors. 
These  trends  are  reflected  in  the  gradual  movement  towards  mandatory  nutrition 
labelling, and the accompanying concern that consumers should be able to rely on the 
validity and  accuracy of nutrition,  health  and related claims  when  they appear on 
labels or in product advertising. 
As  noted above, many parties agree that the level of consumer protection regarding 
such claims was quite high during the period when prior FDA approval for claims was 
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fallen off in the last several years as Congress has moved to  create alternative bases 
upon  which  claims  can  be  made  without  prior  FDA  approval.  The  dietary 
supplements  industry  is  seen  as  having  been  particularly  assertive  in  making 
structure/function claims for the rapidly growing number of supplements on the U.S. 
market. 
G.  BARRIERS TO TRADE 
Over this same period, industry has been concerned at times that the U.S.  regulatory 
approach failed to allow them sufficient leeway in making nutrition and health claims, 
which  they believe  are of great  value  to  consumers  seeking to  make an  informed 
purchasing  choice.  This  was  particularly true  of the  dietary  supplement  industry, 
which felt  that the overall approach of regulatory authorities in the early 1990s was 
constraining the growth of  an industry in which many Americans see great value. 
The  reforms  adopted  from  1994  to  1997  are  widely  viewed  as  having  helped  to 
engender increased competition in the food and dietary supplement markets.  In many 
respects,  this  has  achieved  the  goal  policymakers  wanted:  to  allow  the  food  and 
supplement industries to  grow, and to  make their products more widely available to 
consumers who may wish to use them. 
To  date,  the  degree  to  which the  U.S.  system might prevent the  fair  marketing  of 
claims-bearing products from elsewhere has not received substantial attention.  On the 
other hand, many of those interviewed suggested that the increasing saturation of the 
U.S.  market,  specifically  for  dietary  supplement  products,  will  soon  lead  to  an 
increase in U.S. exports of such products.  At this point, the claims that such products 
bear could become an issue in several export markets. 
H.  CASELAW 
Jurisprudence  in  the  U.S.  related  to  the  making of nutrition and  health  claims has 
fallen generally into two categories: first, cases challenging broad aspects of the U.S. 
regulatory regime itself, including whether some aspects are constitutional or not, and 
secondly,  cases  involving  administrative  and  court  enforcement  efforts  against 
particular companies thought to be infringing one or more of  the relevant laws. 
I.  STAKEHOLDER ANALYSIS 
1.  Government Authorities 
•  The United States has  one of the world's most detailed regulatory schemes for 
nutritional  and  health  claims.  In  spite of this,  the  U.S.  authorities  continue  to 
struggle to  achieve the ideal balance between ensuring a high level of consumer 
protection  and  giving  industry the  leeway to  make  all  the  valid  claims  that  it 
would like. 
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•  Enforcement responsibilities are split between the Food and Drug Administration 
(FDA)  and  the  Federal  Trade  Commission (FTC).  However,  the  two  agencies 
work in close cooperation on enforcement issues in order to make the enforcement 
system effective. Since 1994, FTC has modeled its advertising enforcement policy 
on the FDA's labelling standards. 
3.  Consumers 
•  Many  consumer groups  have  tried  to  oppose  the  expansion  of the  basis  upon 
which specific health claims may be used in food, but to no avail. Their argument, 
based  on  the  idea  that  consumers  would  be  exposed  to  a  growing  number of 
misleading  or  unsubstantiated  claims,  has  not  been  retained  by  the  US 
government.  Thus,  consumer organizations tend to  believe that  the  government 
favors the industry to the detriment of  consumers. 
4.  Industry 
•  Industry  groups  have  widely supported  the  expansion of the  basis  upon  which 
specific health claims may be used in  food.  They believe that the increase in the 
number of permissible claims was an effective way of providing consumers with 
information on the products that they buy. 
•  To conclude, it should be underlined that there is  considerable concern in the US 
that in allowing legitimate industry greater flexibility to make certain claims with 
no prior approval, some less reputable manufacturers have also been given room 
for  maneuver,  resulting  in  an  increase  in  questionable  claims  (for  sometimes 
questionable products).  This concern is  exacerbated by the increasing use of the 
Internet as  a marketing tool,  especially for  dietary supplements.  The  combined 
effect of more liberal procedures for making claims and a mechanism providing 
vastly  wider  dissemination  of such  claims  has  created  the  risk  that  many 
questionable claims now lie beyond the effective reach of  regulatory authorities. 
*** 
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A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The U.S.  Code of Federal Regulations codifies the definitions and other elements of 
legislation governing the making of  nutritional and health claims.  Title 21  §  101.13 of 
the  Code  of Federal  Regulations  (CFR)  distinguishes  between  expressed  nutrient 
content claims and implied nutrient content claims. 
An expressed nutrient content claim is defined as any direct statement about the level 
(or range) of  a nutrient in the food (e.g.  "low sodium" or "contains 100 calories"). 
59 
An implied nutrient content claim is defined as any claim that 
describes the food or an ingredient therein in  a manner that suggests that 
a  nutrient is  absent or present in  a  certain  amount  (e.g.  "high  in  oat 
bran"), or 
suggests that the food,  because of its  nutrient content,  may be useful in 
maintaining healthy dietary practices and is  made in  association with  an 
explicit  claim  or statement about  a  nutrient  (e.g.  "healthy,  contains  3 
{fi  '')  60  grams~  at  . 
These definitions apply to foods that are intended for human consumption and that are 
offered  for  sale,  including both conventional  foods  and  dietary supplements  (even 
though these two categories are subject to somewhat different regulatory schemes). 
2.  Health Claims 
According to Title 21  §  101.14 CFR, a health claim is any claim made on a label or in 
labelling of  a food,  including a dietary supplement,  that express(y or by implication, 
including "third party" references, written statements (e.g., a brand name including a 
term such as  "heart"), symbols (e.g.,  a heart symbol), or vignettes,  characterizes the 
relationship ~lany  substance to  a disease or health-related condition. Implied health 
claims include those statements, symbols,  vignette or others forms of  communication 
that suggest, within the context in which they are presented, that a relationship exists 
betvveen  the presence or level of  a  substance in  the food and a  disease  or health 
related condition. 
61 
59 Code of Federal Regulations, Title 21  (Food and Drugs), Nutrient Content Claims- general 
principles, Sec.  101.13(b)(l). 
6°  Code of Federal Regulations, Title 21  (Food and Drugs), Nutrient Content Claims-general 
principles, Sec.  10 1.13(b  )(2 ). 
61  Code of Federal Regulations, Title 21  (Food and Drugs), Health Claims- general requirements, Sec. 
1  0 1.14( a)( I ) 
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The U.S.  regulatory scheme also allows a sub-category of claims known as  structure 
and function claims (e.g., "calcium builds strong bones").  These are defined by U.S. 
law as any claim that describes the role of  a nutrient or dietary ingredient intended to 
affect  the  structure  or function  in  humans,  or  that  characterizes  the  documented 
mechanism by which a nutrient or dietary ingredient act to maintain such structure or 
fi 
.  67  unctzon.  ~ 
4.  Ethical Claims 
Because there  is  not  a  comprehensive regime for  regulating the  making of ethical 
claims, these are not specifically defined in U.S. law. 
B.  LEGISLATION IN PLACE 
The  United  States  has  a  comprehensive  and  highly  detailed  regulatory  scheme 
governing the making of nutrition-related claims and health claims on food product 
labelling or in separate advertising.  The U.S. regulatory regime has  long imposed a 
general  obligation  that  label  statements  be  truthful.  More  recent  legislation  has 
clarified substantially the  kinds  of claims  that can be made  for  particular types  of 
products, especially foods and dietary supplements. 
The following are the most relevant statutes on health and nutrition claims made on 
product labels, which represent successive amendments to. the federal Food, Drug and 
Cosmetic  Act.  The  provisions  of these  measures  are  reflected  in  implementing 
regulations that are codified at Section 2I  §I  0 I of the Code of Federal Regulations 
(CFR): 
the Nutrition Labelling and Education Act (NLEA), 1990 
the Dietary Supplements Health and Education Act (OSHEA), I994 
the Food and Drug Administration Modernization Act (FDAMA), 1997 
Taken together, these and other federal statutes give the FDA primary responsibility 
for  regulating  claims  made  on  product  labels,  which  includes  product  packaging, 
inserts, and other promotional materials that are distributed along with the product at 
the point of sale (e.g., informational pamphlets placed alongside the product on retail 
store  shelves).  By law,  the  FDA  also  shares  enforcement  authority  over product 
advertising with the FTC.  In practice, however, the two agencies cooperate based on 
a memorandum of understanding between the two that places primary responsibility 
for enforcement regarding product advertising with the FTC. 
According to  Sections 5,  12  and  15  of the Federal Trade Commission Act, the FTC 
has  responsibility  for  regulating  claims  made  in  food  and  dietary  supplement 
advertising (and, indeed, in product advertising generally). Such advertising includes 
62  21  U.S.C. 4039(R)(6)(a) 
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materials. 
63 
While it appears that regulatory authority is, therefore, split depending on whether the 
claim is  made in product labelling or in product advertising, the two  agencies work 
together closely on enforcement issues.  Indeed, the FTC has modeled its advertising 
enforcement  policy  on  the  FDA's  labelling  standards  (see  Enforcement  Policy 
Statement on Food Advertising, May 1994, annex 1). 
1.  Nutritional Claims 
a.  Nutrient Content Claims 
Under the Nutrition Labelling and Education Act ( 1990), companies could not use a 
nutrient  content  claim  in  food  labelling  unless  the  FDA  published  a  regulation 
specifically  authorizing  such  a  claim.  Consumer  groups  generally  preferred  this 
approach on the  grounds  that  it  set  a high  standard  for  consumer information and 
protection, but many in the food industry viewed this approach as too restrictive. 
It should be noted that an even stricter regime applies to  certain special categories of 
food such as food for infants or children under 2 years of age, where nutrient content 
claims (except for statements regarding the percentage of recommended daily intake 
of vitamins and minerals) are generally not allowed. It should also be noted that the 
NLEA implementing regulations initially exempted restaurant menus from the general 
requirements  applicable  when  a  nutrition  or  health  claim  is  made.  Over  time, 
however, the FDA was persuaded that U.S. consumers' awareness of the relationship 
between diet and health would be improved if menu claims were also covered, and it 
eliminated the restaurant exemption in 1996. 
Two  provisions  of the  1997  Food  and  Drug  Administration  Modernization  Act 
(FDAMA),  Sections  303  and  304,  created  an  alternative  approach  to  authorizing 
nutrition claims.  These allow companies to  use nutrient content claims  if they are 
based on current, published authoritative statements of one or more federal scientific 
bodies  that  have  responsibility  for  public  health  protection  or  research  on  human 
nutrition. 
FDAMA specifically identified the  National Institutes of Health and the Centers for 
Disease Control and Prevention as relevant scientific bodies.  The FDA considers that 
the following federal agencies also qualify: the Office of the Surgeon General in the 
Department of  Health and Human Services, and, in the Department of  Agriculture, the 
Food  and  Nutrition  Service,  the  Food  Safety  and  Inspection  Service,  and  the 
Agricultural Research Service.  Thus, manufacturers may rely on statements made in 
current, published reports by these bodies as the basis for a nutrient content claim. 
Companies must notify FDA of their intent to  use  a claim on the  basis of such an 
authoritative  statement.  The  notification  must  include  the  exact  wording  of the 
proposed claim, a description of why the manufacturer believes the scientific body's 
63  It should be noted that the FTC has asserted jurisdiction over promotional materials on the Internet, 
which the FTC regards as another means of  advertising.  Similarly, the FDA believes that product-
related claims made on the Internet can be considered as another form of  product labelling. 
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statement on which the claim is  based.  For nutrient content claims, the notification 
must also include a balanced representation of the scientific literature relation to  the 
nutrient level to which the claim refers. 
Notification of the  prospective nutrient content claim must be submitted to  FDA at 
least  120  days  before  a  food  bearing the  claim  may be  introduced  into  interstate 
commerce. The claim can then be used if FDA does not modify it or prohibit it within 
this  timeframe.  (FDA  may  prohibit  the  claim  either  by  issuing  a  regulation  or 
obtaining a federal court injunction against its use).  These provisions apply to claims 
made both on conventional food and dietary supplements. 
b.  Comparative Claims 
All comparative claims must be accompanied by a declaration stating the percentage 
or  fraction of change and the  identity of a reference  food  (e.g.  "50% less  fat  than 
potato chips").  The reference food varies depending on the particular claim made.  To 
make use of the terms  "less," "fewer," or "more," for example, the  reference  food 
may be a dissimilar food within a product category that can generally be substituted 
for one another such as potato chips as a reference for pretzels.  To make use of terms 
such as "light," "reduced," "fortified," and "enriched," however, the reference food 
needs  to  be  a  similar one,  such  as  another kind of potato  chips.  The declaration 
stating the percentage or fraction of change, and the  identify of the  reference food, 
must appear in immediate proximity to the most prominent claim. 
c.  Other Nutrient Content Claims 
The  FDA  has  also  specified  in  detail  the  conditions  under  which  other  popular 
labelling terms can be used.  The term "lean," for example, may be used on seafood 
and game meats only if the product contains less than 10  grams of total fat, less than 
4.5  grams of saturated fat,  and less  than 95  milligrams of cholesterol per reference 
amount.  The term "modified" may be used as  a comparative claim in a statement of 
identity of the product (e.~., Modified Fat Cheese Cake- contains 35%>  less fat than 
our regular cheese cake"). 
4 
Similarly, the FDA has established a scale specifying the percentage daily amount of 
protein, vitamins, minerals, dietary fiber and potassium that a product must provide 
before its labelling can contain comparative terms such as  "Rich in" or "Extra."  For 
example, a product must provide more than 20o/o of the daily value of these items to 
be able to use the terms "High," "Rich in," or "Excellent source of," and must provide 
between  1  0-19o/o  of the  daily value  to  be able to  use the  terms "Good source of," 
"Provides," or "Contains."  So  long as  the  labeled food  and the  reference food  can 
both be considered a "good source" of a particular nutrient, the FDA also allows what 
it calls "equivalence" claims (e.g., "contains as much vitamin C as an 8 ounce glass of 
orange juice"). 
64 See "'A Food Labelling Guide,"  Relative (or Comparative) Claims, Annex B, which was published 
in September 1994 and updated in May 1997 by the Center for Food Safety and Applied Nutrition of 
the U.S. Food and Drug Administration, which is attached as Annex II. 
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claims, so long as they are not made in a nutrient context.  These include statements 
enabling consumers to avoid a particular product for religious, food tolerance or other 
non-nutrition related reasons (e.g.,  "100% milk-free), statements about non-nutritive 
substances  (e.g.,  "made  with  no  artificial  colors"),  and  so-called  added  value 
statements (e.g., made with real butter). 
d.  Health Claims 
The  Nutrition  Labelling  and  Education  Act  ( 1990)  directed  the  Food  and  Drug 
Administration  to  promulgate  regulations  establishing  a  regulatory  regime  under 
which FDA had to give prior authorization to health claims before they could be used. 
Until the  1997 Food and Drug Administration Modernization Act, which created an 
alternative  approach based on  authoritative  statements by federal  scientific  bodies, 
this was the only basis on which health claims could be made. 
Under this system (which is  still an option for companies wishing to  make a health 
claim), manufacturers are  obliged to petition the FDA to authorize a specific claim. 
Petitions must include a complete explanation of why the substance qualifies  for  a 
health claim, including a summary of  the scientific data upon which the claim is based 
and a statement of the public health benefit if the  claim is  approved.  The petition 
must also address whether there is an optimum level of the substance that should be 
used,  and  whether the  substance  can cause  adverse  effects  for  any segment of the 
population.  If the substance is intended for a specific segment of the population (e.g., 
adolescents  or the  elderly),  the  dietary evidence  produced must be  specific  to  that 
segment.
65 
If the FDA determines that the claim is valid, it will issue a regulation that allows any 
product of that type to  make the  claim.  (The regulation, therefore, is  generally not 
intended  to  be  specific  to  one  or  several  manufacturers'  products.  However, 
consumer groups have criticized the FDA decision that authorizes a health claim for 
fiber from  whole oats  on  the  grounds  that it would supposedly benefit mainly one 
manufacturer,  and  leveled  a  similar criticism  for  the  authorization  given  to  health 
claims for fiber from psyllium). 
In  making  its  declaration,  FDA  imposes  a  standard  of  "significant  scientific 
agreement" about the claim.  Thus, FDA may issue regulations authorizing a specific 
claim  only  if the  agency  determines,  based on  the  totality  of publicly  available 
evidence  (including  evidence from  well-designed  studies  conducted  in  a  manner 
which  is  consistent with generally recognized scientific procedures and principles), 
that  there  is  sign(ficant scientific agreement among experts  qualified by scientific 
training and experience to  evaluate such claims,  that the claim is supported by such 
evidence. 
66 
The FDA has also made clear that it does not believe this standard would be met by 
any findings that could be characterized as preliminary research results or that suggest 
65  Sec Code ofF  cdcral Regulations,Section 101.70, Petitions for Health Claims. 
nn  See Section 403(r)(3)(B)(i) of  the Food and Drug Administration Modernization Act. 
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the research is less than conclusive.  (As explained below, however, the effectiveness 
of these standards has come into question as a result of  recent court rulings). 
Seven health claims were authorized under this system in 1993, and three others have 
been added since. These claims refer to: 
Calcium and osteoporosis 
Sodium and hypertension 
Dietary lipids and cancer 
Dietary saturated fat and cholesterol and risk of coronary heart disease 
Fruits,  vegetables  and  grain  products  that  contain  fiber  and  risk  of 
coronary heart disease 
Fruits/vegetables and cancer 
Folate and neural tube birth effects 
Dietary sugar alcohol and dental caries 
Dietary soluble fiber from whole oats or psyllium products and coronary 
heart disease 
With respect to  each of the above,  federal  regulations specify in  detail the  types of 
claims that can be made and the limitations to the claim that must be spelled out.  For 
example,  a  claim  associating calcium  with  a  reduced  risk of osteoporosis  may be 
made only if  these conditions are met: 
•  The claim makes clear that there are risk factors  for  this  disease  (e.g.,  heredity, 
gender, race,  age and amount of exercise) other than the amount of the calcium 
intake; 
•  The claim does not suggest that all members of the U.S. population are equally at 
risk from osteoporosis, and identifies the sections of  the population who are; 
•  The claim does not attribute a specific degree of risk reduction to  calcium intake; 
and 
•  The claim states that there is  no  known benefit to  a calcium intake higher than 
200% of  the recommended daily intake. 
Similar conditions and  limitations apply  to  the  nine other health claims mentioned 
above.  These conditions and limitations appear in Annex III. 
As  noted  above,  two  new  provisions  of the  1997  Food  and  Drug  Administration 
Modernization Act (Sections 303 and 304) also allow companies to use health claims 
for foods if they are based on authoritative statements of one or more federal scientific 
bodies.
67  As  with  nutrient  content claims,  the  notification  must include  the  exact 
wording of the proposed claim, a description of why the  manufacturer believes the 
scientific body's authoritative statement justifies making the claim, and a copy of the 
authoritative statement.  In the case of  health claims, the notification must also include 
a  balanced  representation  of the  scientific  literature  relating  to  the  relationship 
between a nutrient and the disease or health-related condition the nutrient is meant to 
affect. 
67  As explained in Section ll.E.2, below, the FDA believes that the Food and Drug Administration 
Modernization Act does not explicitly allow for the use of  health claims based on authoritative 
statements for dietary supplements, but has initiated a rule-making procedure that would accomplish 
this. 
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authoritative statement. Notification of  the prospective health claim must be submitted 
to  FDA at least 120 days before a food bearing the claim may be marketed in more 
than one state.
68  The claim can then be used if FDA does not modify it or prohibit it 
within this timeframe. (FDA may prohibit the claim either by issuing a regulation or 
obtaining a federal court injunction against its use). 
e.  Structure and Function Claims 
Longstanding U.S. regulatory policy had generally permitted the making of structure 
and  function  claims for  food  products.  (Examples of such claims include:  calcium 
builds  strong  bones,  anti-oxidants  maintain  cell  integrity,  fiber  maintains  bowel 
regularity).  In  1994, the Dietary Supplement Health and Education Act was adopted, 
helping to  clarify the circumstances in which "structure and function" claims can be 
made for dietary supplements. 
Under  this  Act,  structure  and  function  claims  may  be  made  without  prior  FDA 
approval, but must be notified to  the FDA within 30 days after the product is  first 
marketed. Manufacturers must be able to substantiate their claims but do not have to 
share the substantiation with FDA or make it publicly available in advance.  When a 
structure or function claim is  made for  foods,  the substance that is  the  basis of the 
claim must contribute to the aroma, taste or nutritive value of the food.  When such a 
claim  is  made  for  a  dietary  supplement,  such  products  must  carry  the  following 
disclaimer on the label:  This treatment has not been evaluated by the Food and Drug 
Administration.  This  product  is  not  intended  to  diagnose,  treat,  cure  or prevent 
disease. 
With  respect to  both foods  and  dietary supplements,  structure  and  function  claims 
must  meet  the  general  statutory requirement  that  they  not  be  false  or misleading. 
Claims  which  pretend  that  a  nutrient  or  dietary  ingredient  contained  in  a  dietary 
supplement can help  to  diagnose,  cure,  mitigate or prevent a disease  are  unlawful, 
unless they are appropriate health claims authorized by FDA (see list above) or if the 
dietary supplement is  marketed as  a drug (in which case the product has  to  comply 
with the more stringent provisions of the Food, Drug and Cosmetic Act).  Examples 
of  illegal claims that are not allowed include: cures cancer or treats arthritis. 
The  FDA initially  issued procedures  for  manufacturers  to  notify the  FDA of their 
intent to make a structure/function claim in October 1997.  Since that time, the FDA 
received more than 3,000 notifications of  structure/function claims. 
D.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
The circumstances in  which nutrition and health claims may be used have been set 
forth in general terms above.  As  explained, the  current U.S.  regulatory framework 
establishes  detailed  procedures  for  obtaining  prior  authorization  for  such  claims 
tiS  In general terms, the authority of  the federal government to regulate trade in goods derives from the 
fact that the goods are marketed across state lines and therefore have an effect on interstate commerce. 
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when prior authorization is not required. 
The main  prohibition in U.S.  law relating to  product labelling specifically prohibits 
the  introduction  of food  products  that  have  been  "misbranded."  A  product  is 
considered  to  have  been  misbranded if its  labelling  is  false  or misleading  in  any 
particular way, or if its advertising is false or misleading in a material respect. 
69  The 
main  prohibition  in  U.S.  law  relating  to  product  advertising  prohibits  unfair  or 
deceptive  practices  in  (or  affecting)  interstate  commerce, 
70  including  the 
dissemination of false  and  misleading advertising intended  to  induce  consumers  to 
purchase particular foods or related products. 
71 
Some  of the  other  specific  prohibitions  ansmg  from  the  current  U.S.  regulatory 
framework include the following. 
1.  Nutritional Claims 
According to Title 21  CFR §101.13: 
nutrient content claims are not allowed on food  intended specifically for 
use by infants and children of less than 2 years of age,  except for claims 
regarding vitamins and minerals or when the claim is specifically provided 
for in parts 101, 1  05 and 1  07 CFR. 
because  the  use  of a  ""free"  or "low" claim .before  the  name  of a  food 
implies that the food differs from other foods of the same type by virtue of 
its  having  a  lower  amount  of the  nutrient,  only  foods  that  have  been 
specially processed, altered, formulated or reformulated so as to lower the 
amount of nutrient in the food,  remove the nutrient from  the food or not 
include the nutrient in the food can bear such a claim. 
to bear a relative claim about the nutrient, the amount of  that nutrient in the 
food  must  be  compared  with  an  amount  of nutrient  in  an  appropriate 
reference food, as specified in 21  CFR §I 0 1.13 U) (1 ). 
nutrient content claims that have not been defined by regulation and that 
are contained in the brand name of a specific product that was the brand 
name in  use on such food  before October 25,  1989  may continue to  be 
used as part of  that brand name for such product, provided that they are not 
false or misleading. 
a soft drink that used the term diet as part of its brand name before October 
25, 1989 may continue to use that term as part of  its brand name, provided 
that it is not false or misleading.  A statement that describes the percentage 
of a vitamin or mineral in the food in reference daily intake may be made 
without  a regulation  authorizing  such  a  claim  for  a  specific  vitamin  or 
69 See the Federal Food, Drug and Cosmetic Act, Sec. 403(a)(l ).  Annex IV. 
70 See the Federal Trade Commission Act, Sec. 5 
71  Sec the Federal Trade Commission Act, Sec. 12 
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section 403(r) (2) (A) (6) 
2.  Health Claims 
The following health claims are not authorized for foods in conventional forms or for 
dietary supplements of  vitamins, minerals, herbs or other similar substances: 
dietary fiber and cancer 
dietary fiber and cardiovascular disease 
antioxidant vitamins and cancer 
zinc and immune function in the elderly 
omega-3 fatty acids and coronary heart disease 
In  addition,  claims made about the use of a  dietary supplement to  diagnose,  cure, 
mitigate or prevent a disease are not allowed (see above C part 2). 
E.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
1.  Evolution of Policies Governing Nutritional Claims and Health Claims 
Over the past three decades, U.S. policy toward the making of nutritional and health 
claims on food products and in related advertising has evolved considerably.  This has 
reflected both the growing desire of consumers to make an informed choice about the 
foods  they select, as  well as a growing recognition by food manufacturers that such 
claims offer a potentially important means of  informing consumers and distinguishing 
their products from those of  their competitors. 
The importance of nutrition, and the contribution that nutrition labelling can make to 
consumers' health, took on a higher visibility in the late 1960s, especially in the wake 
of the  1969 White House Conference on Food, Nutrition and Health.  In the  early 
1970s,  the  U.S.  Food  and  Drug  Administration  began  to  establish  a  regulatory 
framework  governing  nutrition  labelling  on  foods.  In  general  terms,  that  early 
framework allowed food manufacturers to provide nutritional information on product 
labels on a voluntary basis, but established a standard format in which the information 
was  to  be presented when manufacturers  chose to  do  so.  Nutrition  labelling was 
mandatory only in certain cases, such as  when the product made a specific nutrition 
claim or when a nutrient had been added. 
Consumer  awareness  was  further  enhanced  with  the  publication  in  1988  of the 
Surgeon General's "Report on Nutrition and Health", the first comprehensive federal 
chronicle of the importance of diet to health.  In 1989, the Food and Nutrition Board 
of the National Academy of Sciences (NAS) convened a panel to examine how food 
labels could be improved to help consumers move towards healthier diets. 
Based partly on the  NAS  panel findings,  the  United States  moved to  a  system of 
mandatory nutrition labelling with the adoption in  1  990 of the Nutrition Labelling and 
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72  The NLEA required mandatory nutrition labelling for most 
foods and specified the circumstances in which health-related claims could be made 
on food products. 
Adoption of the NLEA reflected a growing awareness of the importance of a healthy 
diet,  and  was  intended  to  help  promote  informed  consumer  choice  about  food 
products.  It  was  also  intended  to  encourage  the  development  of  new  food 
technologies, which legislators felt would lead, in turn, to an increase in claims made 
about  foods  produced  with  those  technologies.  After  a  long  public  consultation 
process, regulations implementing the nutrition labelling provisions of  the NLEA took 
effect in 1994. 
Along with nutrition claims, health claims became a sensitive issue in the U.S. during 
the 1980s, when food marketing strategies began to reflect greater interest in the role 
of nutrition  in  promoting  public  health.  In  the  absence  of regulation,  some 
manufacturers used claims that were considered misleading by consumers.  The 1990 
NLEA  was  partly  designed  to  protect  consumers  by  preventing  deceptive  and 
misleading  health  claims  on  product  labels.  Thus,  the  Act  required  prior  FDA 
approval  for  any health  claims,  and  directed  the  Secretary of Health  and  Human 
Services  (who  oversees  the  FDA)  to  determine  whether  10  specific  health  claims 
should be allowed.  Regulations implementing the NLEA provisions governing health 
claims  took  effect  in  1993,  and  FDA has  gradually  authorized  10  specific  health 
claims. 
In addition to regulating nutrition and health claims, the NLEA had a broader purpose. 
Congress intended health and nutritional claims to  help educate consumers, so  as  to 
assist  them  maintain healthy dietary practices.  Thus,  NLEA mandated  the  FDA to 
undertake a  consumer education effort that incorporates  mandatory nutrition labels 
and emphasizes the importance of  diet to overall health. 
In  1994, the U.S.  Congress adopted legislation devising a new regulatory framework 
for dietary supplements, which had previously been regulated in the U.S. as foods (or 
in some cases as  drugs).  Market research indicates that U.S. consumer spending on 
dietary supplements had grown from $3.3 billion in 1990 to $5 billion by 1994.
73  The 
Dietary  Supplement  Health  and  Education  Act  (DSHEA)
74  was  designed  to  help 
ensure that such products were available to  consumers, many of whom believe that 
such  supplements  offer health benefits,  and  that manufacturers  could  market them 
more freely so long as they could verify the claims made about the product. 
In  1997,  the  U.S.  Congress  adopted  legislation  expanding  the  basis  upon  which 
specific health claims may be used in foods.  As an alternative to obtaining prior FDA 
approval,  the  Food  and  Drug  Administration  Modernization  Act  allowed 
72 Public Law 101-535, the Nutrition Labelling and Education Act, which is attached at Annex V.  This 
act is augmented by roughly I ,000 pages of  implementing regulations published in the Federal Register 
and available from the Government Printing Office.  The full implementing regulations are not 
included in annex to this report, but their content is reflected in the U.S. Code of  Federal Regulations, 
the relevant portions of  which are attached at Annex VI. 
73  A 1998 survey of industry by the National Business Journal suggested that this number had grown to 
$12 billion annually. 
74 Public Law 103-417, the Dietary Supplement Health and Education Act, which is attached at Annex 
VII. 
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statement by one of several federal  scientific bodies (e.g., the National Institutes of 
Health,  the  National  Center  for  Disease  Control,  and  the  National  Academy  of 
Sciences).  In  such cases, the FDA is  given a limited period of time to object to  the 
making of the  claim and  to  demonstrate  why it  should not be  made.  (Because  it 
believes that, for health claims, conventional foods and dietary supplements should be 
subject to  the  same standards,  the  FDA has  made  a  proposal  to  allow  supplement 
manufacturers  to  also  make  health  claims based on  the  authoritative  statements  of 
federal scientific bodies). 
This change was broadly supported by many food manufacturers, which view health 
claims as  an effective way of providing consumers with information on the products 
they buy.  However,  many consumer groups  opposed this  change, believing that it 
would result in consumers being exposed to  a growing number of claims that would 
not be fully substantiated, and that - together with the DSHEA - it represented the 
latest in a series of regulatory changes tilting public policy on food and supplement 
labelling heavily in favor of  industry. 
Partly  as  a  result  of this  evolution  in  policy,  recent  evidence  suggests  that  U.S. 
consumers' interest and awareness of the link between diet and health has reached an 
all  time  high.  An  independent  survey,  conducted  early  this  year  for  the  Food 
Marketing  Institute,  found  that  90%  of consumers  believe  that  a  healthy  diet 
contributes  directly  to  disease  prevention. 
75  More  than  two-thirds  said  that  they 
regularly purchase fortified  foods  to  help  maintain good health,  and one-third said 
that  they bought organic  foods  for  the  same  reason.  Reducing or controlling their 
weight was reported by 72% of those surveyed as the single most important factor in 
their food purchases, while 72% also cited cholesterol as a key concern. 
2.  Ethical Claims 
As  noted  above,  the  U.S.  Government  has  not  adopted  a  regulatory  scheme 
specifically governing the making of ethical claims.  If such claims are made,  they 
would,  of course,  be  subject  to  the  general  requirement  of U.S.  law  that  they  be 
truthful  and  not  misleading.  However,  officials  at  the  U.S.  Federal  Trade 
Commission (FTC),  which  enforces  the  truth-in-advertising law/
6  indicate  that  no 
such cases have arisen. 
There has been a small amount of activity in areas that some believe could fall under a 
very broad definition of ethical claims.  For example, the FTC has adopted guidelines 
governing the use of environmental claims in product marketing, and was petitioned 
several  years  ago  by  consumer  organizations  to  develop  comparable  guidelines 
governing  the  use  of claims  that  products  were  manufactured  without  testing  on 
animals.  The FTC declined to take up this petition, however, and its officials indicate 
they have  not  been  pressed  to  adopt  guidelines  on  social  or  other ethical  claims. 
75  Sec "Shopping For Health:  The Growing Self-Care Movement,"  published jointly by the Food 
Marketing Institute and Prevention magazine, June 1999. 
76 Sec. 5 of  the Federal Trade Commission Act prohibits deceptive practices affecting interstate 
commerce, including deceptive advertising.  Sections 12 and 15 ofthe Federal Trade Commission Act 
prohibit false advertising relating to foods, drugs and medical devises, and this includes advertising that 
is misleading in any material respect. 
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I Some  consumer  groups  believe  that  U.S.  industry  has  effectively  quashed  any 
consideration by government of  a regulatory scheme governing such claims. 
3.  Review of Current Policy Developments 
Recent policy initiatives affecting the U.S. regulatory scheme have mainly been aimed 
at clarifying the regulatory treatment of dietary supplements.  These initiatives have 
focused  on  two  areas:  first,  FDA efforts  to  grant  explicit  authority  for  the  use  in 
dietary  supplements  of health  claims  based  on  authoritative  statements  of federal 
scientific  bodies,  and  second,  on  FDA  efforts  to  clarify  the  difference  between 
structure/function claims and health claims. 
4.  Structure/Function Claims v. Health Claims in Dietary Supplements 
Since the adoption in  1994 of the Dietary Supplement Health and Education Act, the 
FDA has been attempting to devise and clarify implementing regulations.  This is to 
make clear what is permitted as a structure/function claim, and clarify the sometimes 
narrow distinction between structure/function claims and health claims. 
The FDA issued a proposed rule in April 1998 seeking to accomplish these objectives, 
and in particular, to distinguish structure/function claims from regulations suggesting 
disease prevention or cure.  As  part of the proposed rule,  the FDA recommended a 
definition of "disease" that differed from the definition of "disease or health-related 
condition."  This had been in force as a working definition since 1993, when the FDA 
issue regulations implementing the health claims provisions of the Nutrition Labelling 
and Education Act. 
77 
This  proposed  rule  sparked  off a  substantial  reaction  from  industry,  consumer 
organizations, and other interested parties, in the course of which the FDA received 
more  than  100,000  comments.  Among these,  according  to  the  FDA,  three  issues 
received particular attention: 
•  whether  the  FDA  should  retain  the  currently  applied  definition  of "disease  of 
health-related condition" or switch to  the newer one  it has proposed (but which 
generated considerable opposition), 
•  whether certain  common  conditions  associated  with  natural  states  (such  as  hot 
flashes  associated with menopause) should be included in any new definition of 
"disease," and, 
•  whether dietary supplements should be permitted to carry implied disease claims. 
In the wake of the many adverse comments generated by its proposed rule, the FDA 
believes that further public consultation is necessary before settling on a final version. 
To that end, the FDA has engaged in a series of public meetings, in  1999, at which 
stakeholders have been invited to  testify in detail about their views of the proposed 
rule and possible alternatives.  The most recent of these were held in June and August 
77 See ''Regulations on Statements Made for Dietary Supplements Concerning the Effect ofthe Product 
on the Structure or Function of  the Body,"  Food and Drug Administration, Federal Register Vol. 63, 
No. 82, Wednesday, April29, 1998,  p. 23624. Annex VIII. 
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regulatory scheme for dietary supplements. 
5.  Use  in  Dietary  Supplements  of Authoritative  Statements  By  Federal 
Scientific Bodies 
As  noted above,  the  1997  Food and Drug Modernization Act (FDAMA)  permitted 
nutrient content claims based on authoritative statements of federal  scientific bodies 
for  both conventional foods  and  for dietary supplements.  For conventional  foods, 
FDAMA also allowed health claims based on such authoritative statements, but did 
not  explicitly  allow  health  claims  based  on  authoritative  statements  for  dietary 
supplements. 
FDA  believes  that,  with  respect  to  health  claims,  conventional  food  and  dietary 
supplements  should  be  subject  to  the  same  standards  and  procedures.  It therefore 
issued  a  proposed  rule  in  January  1999  that  would  allow  health  claims  based  on 
authoritative statements to be made for dietary supplements. 
In  so  doing,  however,  the  FDA  does  not  believe  that  dietary  supplement 
manufacturers  are  likely  to  make  substantial  use  of  health  claims  based  on 
authoritative  statements.  As  noted  above,  the  FDA  feels  that  supplement 
manufacturers  are  more  likely  to  rely  on  structure/function  claims  than  on  health 
claims.  FDA  estimates,  for  example,  that  12  companies  per year may submit  an 
average of five  notifications each that they plan to  use a health claim based on an 
authoritative  statement.  If the  FDA  estimate  is  correct,  the  resulting  total  of 60 
notifications  per  year  would  be  dwarfed  by  the  3,000  notifications  of 
structure/function claims that the FDA has received in the past two years.
78 
III.  VOLUNTARY INSTRUMENTS 
A.  VOLUNTARY INSTRUMENTS IN PLACE 
1.  Nutritional Claims and Health Claims 
At times during the late 1980s and 1990s, there was some hope on the part of federal 
regulators  that  the  food  industry  and,  also  the  dietary  supplement industry,  would 
launch a comprehensive push towards self-regulation that would include regulation of 
product labelling and advertising.  Self-regulation was not viewed by regulators as  a 
complete  alternative  to  federal  oversight  of the  industry,  but  rather  as  a  possible 
complementary regime that would spread the burden of the oversight role, and lessen 
the load of the regulatory agencies on enforcement. 
A  number  of  consumer  and  membership-based  organisations  perform  some 
monitoring of nutrition and health claims, either as a basis for their lobbying efforts 
on  related policies  or,  in  the  case of certain membership-based organisations,  as  a 
7
R For further detail on the FDA's comparative estimates of  stmcture/function claims versus anticipated 
health claims based on authoritative statements, see "Food Labelling:  Use on Dietary Supplements of 
Health Claims Based on Authoritative Statements, Federal Register VoL 64, No. 13, January 21, 1999. 
Annex IX. 
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have also put into place codes of conduct that deal mainly with such issues as product 
safety and  quality,  and  goods  manufacturing practices.  However,  due  partly to  the 
comprehensive  nature  of the  federal  regulatory  regime  (and  parallel  enforcement 
efforts by attorneys general among the 50 states), the industries have not developed a 
comprehensive, voluntary code of  conduct on nutrition and health claims. 
IV.  VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional Claims and Health Claims 
As explained above, nutrition and health claims for foods  may be based either upon 
prior  approval  of  the  claim  by  the  Food  and  Drug  Administration,  or  upon 
authoritative statements by federal scientific bodies. 
79  Both methods reflect criteria 
that seek to ensure the claims meet a minimum threshold of  scientific support. 
In  the  case  of claims  made  on  the  basis  of authoritative  statements  by  federal 
scientific bodies, the claims must: 
come from  a  "federal  scientific  body of the  United  States  with  official 
responsibility for  public health protection or research  directly related to 
human  nutrition"  or  from  the  National  Academy  of  Science  or  its 
subdivisions. 
be published by the scientific body and be currently in effect. 
identify the nutrient level to which the claim refers. 
reflect  a  consensus  within the  identified  scientific  body.  It cannot be  a 
statement made individually by an employee of a federal scientific body. 
be  based  on  a  deliberative  review  of the  scientific  evidence  by  the 
scientific body. 
In  considering whether to  grant prior approval to  health claims for foods and dietary 
supplements,  the  Food and Drug Administration requires  that  there be "significant 
scientific  agreement''  about  the  claim.  Under  this  standard,  FDA  may  issue 
regulations authorizing a specific claim only if the agency determines,  based on  the 
totality of  publicly available evidence (including evidence from well-designed studies 
conducted  in  a  manner  which  is  consistent  with  generally  recognized  scientific 
procedures  and principles),  that  there  is  sign~ficant scientific  agreement  among 
experts qualified by scientific training and experience to  evaluate such claims,  that 
the claim is supported by such evidence. 
80  The FDA has also made clear that it does 
79 The situation is the same for dietary supplements, except that the FDA is still in the process of 
promulgating regulations allowing claims for supplements to be based on authoritative statements. 
KO  See Section 403(r)(3)(B)(i) of  the Food and Drug Administration Modernization Act. 
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preliminary research results or that suggest the research is less than conclusive. 
However, the FDA standard has recently been called into question by a decision of 
one  of the  nation's most  influential  courts of appeal.
81  The  appeal  court's  ruling 
involved an attempt by dietary supplement manufacturers to reverse an FDA decision 
rejecting four  health claims that the manufacturers had proposed.  In its  ruling,  the 
court held that the FDA had acted arbitrarily in rejecting the proposed claims because 
it  had  failed  to  sufficiently  clarify what was  required by the  standard  "significant 
scientific agreement."
82  As  a result, the FDA could be forced to provide the public 
with substantially greater detail about the quality, amount and conclusiveness of the 
scientific evidence needed to support a health claim. 
Moreover,  the  appeal  court  held  that  the  FDA  decision  had  violated  the 
manufacturers'  right  to  free  speech  (which  includes  the  right  to  lawful  and  non-
misleading commercial speech) by prohibiting the health claims outright instead of 
considering the alternative sought by the plaintiffs.  This would in effect allow claims, 
but would require them to be accompanied by disclaimer statements.  The impact of 
this part of the court ruling is not yet clear, but it creates the possibility that the FDA 
could be  forced to authorize health claims even when its scientific standard has not 
been  fully  met,  so  long  as  the  health  claim  is  accompanied  by a  statement  that 
accurately reflects the level of  scientific uncertainty about the claim. 
2.  Structure and Function Claims 
As explained above,  the FDA has proposed a rule that seeks to  clarify the types of 
statements  that  would qualify as  structure/function claims  for  dietary supplements. 
However,  this  rule  does  not  seek  to  establish  a  standard  for  substantiation  of 
structure/function claims and some consumer groups have complained that the FDA 
has  not done  so  at  all.  The reasoning of the  appeals court ruling described above, 
however, would suggest that the FDA will have to  establish a precise substantiation 
standard. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
As explained in an earlier Section, the U.S. regulatory system contains a detailed pre-
clearance process by which prior approval of the FDA can be obtained for nutrition 
and health claims.  (See that Section of the report for a detailed review of the process 
and  the  supporting  material  that  manufacturers  must  provide  when  seeking  prior 
approval of a claim.)  The FDA has also issued a guidance document setting forth the 
procedures for  manufacturers to  notify the FDA of their intention to  make a claim 
based  on  an  authoritative  statement  by a  federal  scientific  body.  Much  of this 
HI  In the U.S. judicial system, the federal courts of  appeals occupy a middle strata between the federal 
district courts, which is where most cases are initially heard, and the U.S. Supreme Court, which is the 
country's highest judicial body.  The U.S. Court of Appeals for the D.C. Circuit is widely regarded as 
the most authoritative appeals court on issues involving federal legislation and regulation. 
82 Pearson v.  Shalala, 164 F.3d 650 (D.C. Circuit), 1999,  rehearing en bane denied, 172 F.3d 72 (D.C. 
Circuit) 1999. 
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guidance  is  reflected  m  the  earlier  Section,  and  the  guidance  document  itself is 
attached as an annex . 
2.  Post-Clearance Rules/ Guidelines 
The U.S.  regulatory system includes monitoring and enforcement efforts by federal 
agencies of food and dietary supplement manufacturers' compliance with federal law 
and regulations on nutrition and health claims. 
As explained above, the U.S. Food and Drug Administration has primary authority for 
enforcement relating to claims made on product labels.  According to FDA officials, 
most instances involving questionable labelling claims are resolved via informal (i.e., 
non-judicial) means.  Specifically, the FDA regularly sends various types of warning 
letters alerting manufacturers to the possibility that their product labelling may not be 
in compliance with FDA regulations, and that continued use of the label in question 
could result in more formal  enforcement proceedings. 
83  Officials indicate that such 
letters result in corrective action by the manufacturer (either cessation of use of the 
label or modification of its text) about 90% of the time, and that the FDA only rarely 
undertakes judicial enforcement efforts. 
In matters involving product advertising, the Federal Trade Commission has primary 
enforcement authority.  As  with the FDA, officials of the FTC indicate that that the 
vast majority of  instances involving questionable advertising are resolved by informal 
means.  The FTC also regularly sends what it calls "access letters" to manufacturers 
alerting them to  the  possibility that their advertisements may not be in compliance 
with  federal  law  and  regulation.  According  to  the  FTC,  such  letters  result  in 
corrective action about 98% of  the time.  The FTC also enters into consent agreements 
with manufacturers in which they pledge to undertake specific steps conforming their 
behavior  to  FTC  rules.  FTC  officials  indicate  that  they  rarely  undertake judicial 
enforcement proceedings. 
FTC  officials  also  indicate  that  an  important  share  of their  recent  enforcement 
activities have been directed towards claims made in  connection with Internet-based 
advertising.  In November 1998, for example, the FTC helped to organize an "Internet 
Surf Day," in which 80 public and private consumer protection organisations from 25 
countries (including the U.S., Canada and Mexico) examined Internet sites  to  try to 
identify  potentially  false  or  deceptive  advertising  claims  about  the  prevention, 
treatment  or  cure  of six  major  diseases.  About  1,200  sites  were  found  to  have 
potentially unwarranted claims, and were sent e-mail warnings by the FTC reminding 
them that U.S.  and other countries'  laws  prohibit false  and misleading advertising. 
According to the FTC, a follow-up sampling of some of these sites indicated that 28% 
had either modified their sites or taken them down entirely. 
84 
As  noted  in  an  earlier  Section,  the  FTC's  and  FDA's  enforcement  efforts  are 
supplemented by the efforts of many state and local consumer affairs offices, as well 
83  An excerpt from the FDA's Regulatory Procedures Manual containing standard language for such 
letters is attached at annex X. 
84 A copy of the FTC e-mail notice, along with a press release describing this enforcement activity, are 
attached at annex XI. 
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about particular foods and dietary supplements. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
Complaints may be made to  either the FDA or FTC (as  well as  the  state and  local 
authorities and private organisations that make supplementary monitoring efforts) by 
any individual or organization that has reason to  believe a nutrition or health claim 
does not comply with federal law, regulations or policy. 
85 
Such complaints sometimes form the basis of enforcement proceedings by the federal 
regulatory agencies.  This is  especially true when they suggest a pattern of false  or 
misleading claims by one or more manufacturers (which is  where the FTC and FDA 
tend to concentrate their enforcement activities).  In addition, the regulatory agencies 
may introduce enforcement proceedings under their own initiative.  (An FTC official 
has estimated that about 70% of that agency's enforcement efforts are based on their 
own initiative, while 30% stem from consumer complaints). 
The attorney general of the 50  states are also authorized to  bring enforcement suits 
over claims made on products distributed within  their jurisdiction, and many have 
been quite active in enforcement activities. 
D.  BURDEN OF PROOF 
1.  Burden of proof 
Under the U.S. system, it is generally the party making a claim that carries the burden 
of proof for  its  validity.  As  explained above,  for  example,  a manufacturer seeking 
prior FDA  approval  for  a nutrition  or  health  claim  is  required  to  submit evidence 
supporting the claim, including evidence that there is  significant scientific agreement 
that the  claim is  well-founded.  Similarly, a manufacturer seeking to  make a health 
claim based on an  authoritative statement by a federal  scientific body is  required to 
produce evidence supporting the claim, including evidence a copy of  the authoritative 
statement and the reasons that it supports the claim being made. 
In cases such as the latter, because they do not involve prior regulatory approval of a 
claim, the regulatory agency is given a fixed number of days to block the claim, either 
by issuing a regulation against it or obtaining a court order against its use.  Such an 
action would be based upon the FDA's assessment that the necessary scientific proof 
had  not  been  produced  by  the  manufacturer.  However,  the  burden  of proof 
technically  remains  with  the  manufacturer  to  produce  such  evidence,  even  if the 
manufacturer might disagree with the FDA's assessment over whether the  standard 
had been met. 
xs  A copy of the FTC's model claim form, which can be accessed via their web site, is attached as 
annex XII. 
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2.  Proof to be adduced 
A  detailed  summary  is  given  in  an  earlier  Section  of the  type  of proof that 
manufacturers  must  produce  to  support  their  claims  and  recent  court  rulings 
questioning the substantiation standard that the FDA has traditionally applied. 
E.  APPLICABLE PENAL  TIES 
The range of remedies available in cases of false or misleading claims includes both 
criminal and civil penalties, as well as measures calling a halt to the claim in question 
and even providing redress to affected consumers. 
Under the Federal Food, Drug and Cosmetic Act, for example, it is a criminal offense 
to introduce into interstate commerce any food or similar product that is misbranded; 
products are considered to be misbranded if  their labelling or advertising is considered 
false or misleading. 
86  Such offenses are punishable by up to one year in prison and/or 
a fine  of $1,000 per offense, as  well  as  the  possibility of additional civil  penalties. 
These penalties are increased for second and subsequent offenses, or if the violation 
was committed with an explicit intent to defraud or mislead. 
87 
In addition, regulatory authorities may seek numerous other forms of redress, which 
include: seizure (or preventing the importation) of misbranded products, a court order 
forcing  cessation  of the  claim,  a  court  order  forcing  a  company  to  compensate 
consumers  or  to  disgorge  profits  made  from  the  product  carrying  the  claim,  a 
requirement that  a  company having been found  to  have  made  false  or misleading 
claims in  the past post a bond in order to be able to  sell that or other products in a 
given area.  Regulators  may also  arrive  at  consent agreements with manufacturers 
containing one or more of  these elements. 
V.  CASELAW 
Jurisprudence  in  the  U.S.  related  to  the  making of nutrition and  health  claims  has 
fallen generally into two categories: first, cases challenging broad aspects of the U.S. 
regulatory regime itself, including whether some aspects are constitutional or not, and 
secondly,  cases  involving  administrative  and  court  enforcement  efforts  against 
particular companies thought to be infringing one or more of  the relevant laws. 
1.  Court Challenges to the Government's Regulatory Approach 
A review of the recent Court of Appeal ruling is  treated in an earlier Section.  This 
calls  into  question  whether  the  FDA  has  arrived  at  an  adequate  standard  for 
substantiation of claims  or  not.  It also  deals  with  whether the  FDA can prohibit 
claims  outright  (as  opposed  to  allowing  them  to  be  made  with  an  accompanying 
disclaimer  statement)  without violating  companies'  First  Amendment  right  to  free 
commercial speech. 
86 See Section Federal Food, Drug and Cosmetic Act, Sec. 30l(a) 
87 See Section Federal Food, Drug and Cosmetic Act, Sec. 303(a) 
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As noted above, because regulatory authorities are able to settle the vast majority of 
questionable claims via informal proceedings, there are fewer federal court cases than 
might  be  expected,  with  the  regulatory  agencies  instead  relying  heavily  on 
administrative  enforcement  proceedings.  Several  such  cases  and  administrative 
enforcement proceedings, which are illustrative of the federal agencies' enforcement 
approach, are described below. 
3.  FTC Administrative Enforcement Proceedings 
John Sneed and Melinda Sneed d/b/a Arthritis Pain  Care Center.  According to  the 
FTC,  the  Arthritis  Pain  Care  Center marketed  a  product  called  CMO,  which  was 
purportedly a fatty acid derived from beef tallow, with claims that it could cure most 
forms of arthritis by modifying the immune system.  The FTC complained that the 
claims were false and were not supported by authoritative statements of the National 
Institutes  of Health,  as  the  makers  had  claimed.  The  FTC  reached  a  proposed 
settlement  with  the  Center  prohibiting  these  and  future  unsubstantiated  claims  or 
misrepresentation of  scientific data. 
Body Systems  Technology,  Inc.  According to the FTC, this  organisation sold shark 
cartilage  capsules,  as  well  as  capsules  and  liquid  containing  a  Peruvian  plant 
derivative known as Cat's Claw, with claims that they provided effective treatment for 
cancer,  HIV/AIDS and  arthritis.  The  FTC  reached a proposed settlement with the 
organisation under which it  would cease making these or any other unsubstantiated 
claims, and would refund purchasers of  these products within a fixed period of time. 
4.  Judicial Enforcement Cases 
Home  Shopping  Network.  In  1995,  the  FTC  filed  a  lawsuit  against  the  Home 
Shopping  Network,  a  commercial  television  channel  devoted  to  product  sales. 
Among the products promoted by the Network were several vitamin sprays, for which 
the  Network allegedly made claims  that  they  could prevent the  common  cold and 
reduce the risk of infectious diseases.  The Network eventually reached a settlement 
with the  FTC  in which it would refrain from  making any claims for  foods,  dietary 
supplements or other products without reliable scientific evidence. 
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VI.  MEANS OF COMMUNICATION 
The two main regulatory authorities in  the U.S. -the FDA and the FTC- apply the 
same standards to  nutrition and health claims regardless of the means by which they 
are  communicated.  It should  be  noted,  however,  that  much  of the  FTC's recent 
enforcement activity has been directed towards the numerous claims being made via 
Internet  marketing  sites,  which  FTC  officials  indicate  have  largely  replaced 
advertising materials sent via mail as their chief enforcement problem. 
~~ A copy of the consent agreement is attached at annex XIII. 
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U.S. regulatory authorities indicate that they do not, as  a practice, retain a regular set 
of statistics on the numbers of health and nutrition claims being made, how many of 
that number are valid (or not), or how many are the subject of complaints, either to 
regulators  or to  the  private  associations  that  assist  their members  in  dealing  with 
invalid claims.  It is, therefore, difficult to state with any precision how many food or 
supplement manufacturers may currently be making  such claims.  However,  some 
evidence of the FDA's thinking on these points can be gleaned from the background 
information it has published, including as part of  related rule-making efforts. 
In  1995,  for  example,  the  FDA  published  a  survey  of  products  stocked  in 
supermarkets, and found that 24 out of 1  ,030 products contained some kind of health 
claim stating a relationship between a component of  the product and a disease.  While 
only a small percentage (2.3%) of the total number of products, this  could comprise 
several hundred products when considering that a typical U.S.  supermarket contains 
upwards of 15,000 products.  Moreover, the number of such health claims is likely to 
have risen since 1995. 
With regard to  dietary supplements, the FDA has estimated that there are some 850 
companies  currently  marketing  an  estimated  29,000  supplement  products  in  the 
United States.  Of this number, the FDA believes that most manufacturers rely (and 
will continue to rely) on structure/function claims rather than on other kinds of  claims. 
Since  notification  procedures  for  structure/function  claims  were  issued  in  October 
1997,  the  FDA  indicates  it  has  received  more  than  3,000  notifications  of 
manufacturers' intention to use such claims.  This would suggest that more than 1  0% 
of the  supplement  products  currently  in  circulation  are  making  structure/function 
claims. 
In  contrast, the FDA has indicated that it expects only 12  supplement manufacturers 
per year to  seek the use of health claims based on authoritative statements of federal 
scientific bodies, and that these  12 would file  only five notifications each.  As noted 
above, the resulting total of  60 notifications per year would be dwarfed by the number 
of  structure/function claims being made by the supplement industry. 
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R.  CANADA 
I.  EXECUTIVE ANALYSIS 
A.  INTRODUCTION 
This study took place during an important process of  reform in Canada. The Canadian 
authorities  intend  to  review  the  regulatory  framework  governing  claims  on  food 
within the next few months, thus showing the need for change and adaptation in this 
area.  The  reform  is  driven  by  two  inter-related  factors.  One  is  the  growing 
importance,  in  the  eyes  of Canadian  consumers,  of nutritional  information  in  the 
observance of healthy diets. The other is the lack of such information on food labels 
and in advertising in comparison with the United States. 
This  situation is  not  only the  result of a  non-mandatory system of food  labelling 
(compared to the mandatory American system).  It also stems from  the fact that the 
regulatory framework governing food claims is more restrictive in Canada than in the 
United States. 
The current review  is  generally well  received by all  interested  parties  in  Canada, 
including  producers  and  manufacturers.  Some  of  them,  however,  criticise  the 
slowness of the  Canadian government in carrying out changes in the legislation.  It 
should be  stressed  that  the  process  of reform  is  still  ongoing.  Consequently,  the 
outcome remains to be determined. 
B.  MEMBER STATE POLICY 
1.  Nutritional claims 
The  definition  of  a  nutrient  content  claim  is  the  same  as  defined  in  Codex 
Alimentarius.  However,  this  definition  has  no  legal  force  in  Canada  since  it  is 
included in an information document with no legal value (namely the Guide to Food 
Labelling and Advertising). The same document defines comparative claims in a very 
similar way to Codex Alimentarius. 
Changes in the system governing nutrient content claims have been under discussion 
for the last three years in Canada. Specific requirements regarding the use of nutrient 
content claims are spelt out in the Guide to Food Labelling and Advertising. However, 
Health Canada would like to regulate all nutrient content claims in the future.  Food 
industries and manufacturers are reluctant to  see the introduction of new regulatory 
measures:  they  believe  that  non-regulatory  instruments  are  more  flexible  and, 
therefore, more effective. The compositional criteria for nutrient content claims are 
also under review.  Health Canada is  in  the  process of analysing the  stakeholders' 
positions and, on this basis, plans to introduce new regulatory measures by the end of 
the year. 
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The  legislative  framework  governing health  claims  is  also  in  the  process of being 
modified.  Although the  term health claim  is  not defined in  Canadian legislation,  a 
difference is  made in practice between therapeutic claims, risk reduction claims and 
structure/function  claims. 
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currently prohibited in Canada, whereas structure/function claims are allowed under 
specific  conditions,  as  in  the  United  States.  However,  the  Canadian  government 
intends  to  introduce  the  ten  generic  health  claims  authorised  in  the  United  States 
(which are all risk-reduction claims). 
In the longer term, standards of  evidence and a guidance document for the submission 
of new risk reduction claims should be  developed.  Stakeholders are currently being 
consulted on these issues. The Food industry is satisfied with the proposed changes, as 
they would create '"a level-playing field" with the United States in terms of marketing 
opportunities.  Non  governmental  health  organisations  are  also  supporting  the 
government's  positions.  Only  a  minority of consumer  groups  remain  reluctant  to 
changing the  system.  This  is  mainly due  to  fears  of an  increase  in prices.  They 
believe that the  use of health claims will  actually have little impact on the  diet of 
consumers but will serve as an excuse to raise prices on the part of  manufacturers. 
3.  Ethical Claims 
In Canada, the issue of ethical claims has received little attention to date. There is no 
legal definition of an ethical claim and no directly relevantJegislation. Some industry 
groups tend to  explain this general lack of interest for ethical claims by the fact that 
they are harder to make on perishable foods than on manufactured goods. 
C.  VOLUNTARY CODES OF PRACTICE 
In  Canada,  the  only  voluntary  code  of conduct  on  health  or  nutritional  claims 
concerns claims made in  advertising.  The Canadian Code of Advertising standards, 
administered  by  Advertising  standards  Canada  (a  national  industry  association 
independent  from  the  government),  sets  out  guidelines  which,  in  principle,  are 
applicable to  advertisements containing food  claims.  However, these  guidelines  are 
superceded  by  existing  legal  rules  since  both  instruments  spell  out  equivalent 
prohibitions. 
The absence of  voluntary codes of  conduct or self-regulations for labelling claims lies 
in the fact that the Guide to  Food Labelling and Advertising already operates. This is 
a non-binding document, which has been approved by representatives of the industry 
and the consumers during consultations with the government. 
lN The structure/function category used in the  United States and Canada corresponds to  the enhanced 
function  category used in  a few  European countries.  Structure/function claims are defined as  claims 
which describe the role of a nutrient or dietary ingredient intended to affect the structure or function in 
humans, or that characterises the documented mechanism by which a nutrient or dietary ingredient act 
to maintain such structure or function (US definition, taken on by the Canadian authorities). 
470 
I I 
D.  VERIFICATION SYSTEMS 
With regard to  the  issue of verification of claims, there are no  general pre-clearance 
rules  in  Canada.  Only broadcast  advertisements  are  subject  to  a  non-binding pre-
clearance scheme administered by Advertising standards Canada.  ACS  reviews  the 
advertising copies to ensure compliance with the Food and Drugs regulations and the 
Guide to Food Labelling and Advertising. In practice, all advertisements on food and 
beverages are submitted to pre-clearance as  soon as they contain a claim. Otherwise, 
broadcasters refuse to broadcast them. 
As  far  as  post-clearance  is  concerned,  this  comes  under  the  responsibility  of the 
Canadian Food  Inspection Agency (CFIA).  This verification function  is  carried out 
through ad hoc and routine plant inspections. Canadian industries hardly ever break 
the rules.  When they do,  a warning letter is  usually sufficient to  put an  end to  the 
infringement. 
In  cases where a manufacturer does not follow CFIA's injunctions, the Agency can 
take legal action before a criminal court. There are no  examples of cases that were 
brought to Court by CFIA. 
E.  MEANS OF COMMUNICATION 
There is no difference between the means of communication in Canada. The standards 
applicable to claims made in advertisements are the same in all forms of  media. 
F.  CONSUMER PROTECTION 
The  attention  of all  interested  parties  in  Canada  is  focused  on  the  question  of 
consumer  information.  No  particular  remarks  were  made  concerning  consumer 
protection. 
G.  BARRIERS TO TRADE 
The  issue of barriers  to  trade  appears  more  relevant in  the  context of Canada-US 
relations than between Canada and Europe. The United States is Canada's first trading 
partner  and  vice-versa.  In  principle,  Canada's  more  restrictive  framework  of 
regulations on food claims can be considered as an impediment to  American imports. 
However, trade issues are not at the core of the debate.  Health Canada has made  it 
clear that although it takes into account the potential economic and trade implications 
of regulatory decisions, the key issue is health:. 
H.  CASELAW 
There is  very little jurisprudence in Canada in this  area.  There are no  examples of 
cases that were brought to Court by the Canadian Food Inspection Agency (CFIA). 
I.  STAKEHOLDER ANALYSIS 
The  outcome  of the  broad  review  of nutritional  and  health  claims  regulations  in 
Canada remains to  be seen, since no  formal  legislative changes have taken place at 
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follows: 
1.  Government authorities 
•  The  Canadian  government  intends  to  provide  Canadian  consumers  with  the 
nutritional  information  that  they  need  to  make  healthy  food  choices.  In  this 
respect, Health Canada is planning to  regulate all nutrient content claims in the 
future, thus taking a more regulatory approach than in the past. The current reform 
is also aimed at influencing manufacturers to produce more nutritious food. 
•  On health claims, the Canadian authorities recognise that diet may modify the risk 
of developing and exacerbating certain chronic diseases.  They also  believe that 
food can affect certain risk factors for disease. There is a clear will on the part of 
the Canadian government to model Canadian legislation on health claims on the 
American one. Some risk-reduction claims are likely to be authorised in Canada in 
the  future.  In  the  longer  term,  the  Canadian  government  would  like  to  adopt 
standards of evidence and a  guidance document for  the  submission of new risk 
reduction claims. 
•  On ethical claims, the Federal authorities have no real position. 
2.  Consumer Organisations 
•  Consumer groups and non-governmental health organisations were instrumental in 
triggering the current review on nutritional  and health claims  in  Canada.  They 
believe that a  revision of the  compositional  criteria will  allow for more health 
claims  and,  thus,  increase  the  level  of  information  available  to  Canadian 
consumers. 
•  On health claims, only a  minority of organisations  remain reluctant to  see  the 
introduction of the  US  generic health claims in Canada, mainly due to  fears  of 
pnce mcrease. 
3.  Industry 
•  Industry  pressures  were  also  instrumental  in  triggering  the  current  review  on 
nutritional and health claims in Canada. The industry is favourable to the adoption 
of the US  generic health claims  in Canada, as it should create a  '•level  playing 
field" with the United States. It also advocates the revision of the compositional 
criteria for nutrient content claims.  However, it opposes an increase in the number 
of  regulations. For the industry groups, the system should continue to be based on 
the Guide to Food Labelling and Advertising, which is a non-binding instrument. 
•  The current review is generally well received by all interested parties in Canada, 
including  producers  and  manufacturers.  Some  of them,  however,  criticise  the 
slowness of  the Canadian government in carrying out changes in the legislation. It 
should be stressed that the process of reform is  still ongoing.  Consequently, the 
outcome remains to  be determined. We believe, however, that a trend towards a 
more liberal system is clearly visible in Canada. 
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II. MEMBER STATE POLICY 
A.  DEFINITIONS OF CLAIMS 
1.  Nutritional Claims 
The Canadian Food Inspection Agency's Guide to  Food Labelling and Advertising 
defines a nutrient content claim as follows: 
"any  statement  or  expression  which  describes,  directly  or  indirectly,  the  level  of 
nutrient(s) in a food." 
In addition, comparative claims are defined as: 
"claims which compare directly or indirectly the nutritional properties of  two or more 
foods." 
a.  Health Claims 
The term health claim is not defined in Canadian legislation. 
However,  an  internal  working  group  of Health  Canada  (the  Federal  Department 
responsible for health policy) has identified three types of  health claims: 
therapeutic claims: claims that a product can cure, treat, mitigate or 
prevent a disease or condition. 
risk reduction  claims:  claims that a product significantly alters  a 
major  risk  factor  or  factors  recognized  to  be  involved  in  the 
development  of  a  chronic  disease  or  abnormal  physiological 
condition through product use. 
structure/function  claims:  claims  which  describe  the  role  of a 
nutrient  or dietary  ingredient  intended  to  affect  the  structure  or 
function in humans (US definition). This includes claims about the 
biological role of  a nutrient generally recognized as an aid or factor 
in  maintaining  the  functions  of the  body,  or necessary  for  the 
maintenance of  good health and normal growth and development. 
Claims within each of these  categories may be product specific or generic. Product 
specific claims are made for a single commercial product and cannot be generalised to 
other similar products  unless  acceptable  supporting  evidence  is  provided.  Generic 
claims can be applied to any food, provided that it meets the criteria for the claim. 
b.  Ethical Claims 
There is no legal definition of  ethical or social claims in Canadian law. 
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Health  and  nutritional  claims  are  regulated  by  the  Food  and  Drugs  Act  and 
Regulations (Annex 1  ).  The main provision consists of a general prohibition to  label, 
package,  treat,  process,  sell  or  advertise  any  food  in  a  manner  that  is  false, 
misleading or deceptive or is  likely to  create an erroneous impression regarding its 
character, value, quantity, merit or safety  (Food and Drugs Act, section 5.1). 
In addition,  a Guide to  Food Labelling and Advertising published by the  Canadian 
Food  Inspection  Agency  (CFIA)  provides  a  summary of labelling  and  advertising 
requirements, policies and guidelines which deal with statements and claims for foods 
(Annex 2).  The Guide is an information document based on the Food and Drugs Act 
and Regulations. Although it has no  legal value, it helps to determine which claims 
are false,  misleading or deceptive as  defined by section 5.1  of the Food and Drugs 
Act.  Food  claims  which  comply  with  the  guidelines  described  in  the  Guide  are 
deemed to comply with the legal texts the Guide is based on. 
1.  Nutritional Claims 
a.  Nutrient content claims 
Canadian legislation provides compositional criteria for nutrient content claims using 
terms such as:  "free", '"low", "'lean", "extra lean'', "light", "source", "good source'', 
"high in", "more" and "reduced/less''. These criteria are either spelt out in the Food 
and Drug Regulations or based on the general prohibition in section 5.1  of the Food 
and  Drugs  Act  against  false  and  misleading  representations  on  labels  and 
advertisements  for  food.  These  requirements  are  compiled  by type  of nutrients  in 
CFIA's Guide to Food Labelling and Advertising, Sections 6.2.1 to 6.2.6. 
The use of a nutrient content claim is subject to a declaration of  the particular nutrient 
claimed  in  the  nutrition  information panel  and,  in  the  case  of sodium,  potassium, 
cholesterol  and  fatty  acid  claims,  declaration  of  additional  nutrients.  These 
declarations must be based on a serving of a stated size of the food as sold. Specific 
labelling requirements exist for claims for special dietary use such as "low sodium", 
"low calorie" and "sugar free". 
b.  Comparative claims 
In Canada, comparative claims may refer to positive characteristics of food - such as 
"contains 50o/o more protein than", "contains as much as" - or the potentially negative 
characteristics- such as "contains 20% less fat than", '"reduced in", "lower in". 
According to  the  Guide to  Food Labelling and Advertising, comparative claims are 
potentially misleading unless they: 
involve similar foods; 
clearly  identify  the  foods  being  compared  and  the  differences  between 
them; 
are  based  on  ditTerences  which  are  both  nutritionally  and  analytically 
significant~ or 
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are  accompanied  by  other  relevant  nutrition  information  regarding  the 
compared foods. 
Comparative claims can, therefore, be made under the following conditions only: 
the reference food must be a similar food:  the reference food must either 
be another brand of the same food, a different version of the same food,  a 
substitute food or at  minimum a food  belonging to  the same food  group 
according to Canada's Food Guide to Healthy eating; 
the reference food and the amount of  difference must be clearly identified: 
the  claim  must  be  accompanied  by the  amount  of difference  and  the 
identity of the reference food.  Incomplete comparisons such as  "less fat" 
or "less salt" are considered misleading; 
the comparison is to be based on a significant difference with the reference 
food:  differences in energy value or nutrient content should be more than 
25o/o per serving from the reference value; and 
relevant  nutrition  information  regarding  the  compared  foods  must  be 
provided. 
2.  Health Claims 
Canadian  law  restricts  the  nature  and  extent  of health  information  that  can  be 
communicated  on  food  labels  and  in  advertising.  A  distinction  is  made  between 
structure/function claims, on the one hand, and therapeutic claims and risk reduction 
claims, on the other. 
a.  Structure/function claims 
According  to  the  Food  and  Drug  Regulations,  some  structure/function  claims  are 
permitted on foods. 
The Food and Drugs Act and Regulations (Sections D.Ol.006 and D.02.004) authorize 
labelling or advertising claims concerning the action or effects of  a vitamin or mineral 
nutrient contained in  the food,  such as:  protein,  fat,  carbohydrates,  sugars,  sorbitol, 
mannitol,  xylitol,  starch,  dietary  fibers,  amino-acids,  linoleic  acid,  cis-methylene 
interrupted  polyunsaturated  acids,  cis-monounsaturated  fatty  acids,  saturated  fatty 
acids, vitamins and mineral nutrients, listed in Tables 1 and 2 of the Food and Drugs 
regulations. 
The following conditions apply: 
the claim may not refer directly or indirectly to  the treatment, mitigation, 
or  prevention  of any  disease,  disorder  or  abnormal  physical  state,  or 
symptoms of  the same, nor may it refer directly or indirectly to correcting, 
restoring or modifying organic functions; 
the claim may not refer directly or indirectly to the treatment, prevention, 
or cure  of diseases  listed  in  Schedule  A  of the  Food  and  Drugs  Act, 
Section 3.1; and 
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made is generally recognized as  an aid in maintaining the functions of the 
body necessary for the maintenance of good health and normal growth and 
development. 
The following examples of acceptable claims are given by Health Canada: 
"calcium aids in the growth and maintenance of  bones and teeth", "protein 
is needed for the maintenance and repair of  body tissues" 
The  following  examples  of unacceptable  claims  are  given  by  Health 
Canada:  '"calcium  fights  bone  disease  such  as  osteoporosis",  "protein 
builds muscles and makes you stronger" 
The claim triggers a declaration of  the nutrient content in a food serving of 
stated size; 
a minimum level of  nutrient is present in the food; 
The claim should not imply that consumption of the food,  by itself, will 
have the effect attributed to the nutrient; 
The  following  example  of an  acceptable  claim  is  given  by 
Health Canada: "milk is an excellent source of calcium, which 
helps build strong bones and teeth". 
The following  example of an unacceptable claim  is  given by 
Health Canada: "milk helps build strong bones and teeth". 
The  following  general  claims  are  generally-recognized  functions  of all 
nutrients  and are permissible:  "X is  a factor in the maintenance of good 
health", "Y is a factor in normal growth and development" 
Wellness claims,  such as "promotes a  good night's sleep",  "helps relieve  fatigue", 
"encourages energy during the day", or other physiological states not associated with 
a disease, are reviewed on a case by case basis. In most cases, the use of such claims 
is discouraged. 
b.  Therapeutic claims 
Under the Food and Drugs Act, therapeutic claims are prohibited on food products. 
Otherwise, these products are classified as  drugs. 
90  This prohibition also  applies  to 
90  The Food and Drugs Act defines food as any article manufactured, sold or represented for use as 
food or drink for human beings.  chewing gum and any ingredient that may be mixed with food for any 
purpose tt'lwtever. A drug is defined as any substance or mixture of  substances manufactured, sold or 
represented for use in  (a)  the diagnosis,  treatment,  mitigation or prevention of  a disease,  disorder or 
ahnormal physical state,  or its /):vmptoms,  in  human  beings or animals;  (b)  restoring,  correcting or 
mod~fying organic fimctions in human beings or animals or (c)  disinfection in premises in which food is 
mam!lactured, prepared or kept.  In Canada, all dmgs are submitted to  pre-market approval and can be 
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foods and Health claims on foods,  Annex 3) 
The Food and Drugs Act (part I, section 3.1) prohibits the sale or advertisement to the 
general  public  of "any food,  drug,  cosmetic  or device  to  the  general public as  a 
treatment,  preventative  or  cure  for  any  of the  diseases,  disorders  or  abnormal 
physical states referred to in Schedule A" of the Food and Drugs Act (Annex 4). This 
list  covers  a  wide  range of diseases,  including not only many chronic  diet  linked 
diseases such as  cancer, diabetes, heart disease and obesity, but also other diseases 
such as alcoholism, hair loss and impotence. Therapeutic health claims are, therefore, 
prohibited in Canada. The rationale behind this prohibition, which was introduced in 
Canadian legislation  in  1934,  is  that the  46 diseases  listed  in  Schedule A  require 
medical diagnosis or treatment:  the general public should not be self-medicating for 
these conditions. 
c.  Risk-reduction claims 
Risk-reduction claims are not allowed on foods in Canada. However, a shift in policy 
development is taking place (see Section D.2). 
3.  Ethical Claims 
There is no specific legislation on ethical claims in Canada. However, section 5.1  of 
the  Food  and  Drugs  Act  on  false  and  misleading  representations  on  labels  and 
advertisements applies to ethical claims. 
C.  EXISTING PROHIBITIONS, RESTRICTIONS AND EXEMPTIONS 
1.  General prohibition 
Section 5.1  of the Food and Drugs Act prohibits claims which are false, misleading or 
deceptive and which are likely to create an erroneous impression regarding the food's 
character,  value,  quantity,  composition  merit  or  safety.  This  general  prohibition 
applies to nutritional claims, health claims and ethical claims. 
Specific conditions for the use of  nutrient content claims and health-related claims are 
set out in the Guide to Nutrition Labelling and Advertising. The conditions for certain 
types of claims are presented below. A full  list of the conditions which each type of 
claim must meet may be found  in  the Guide to Food Labelling and Advertising in 
Annex 2. 
sold only with a Drug Identification Number; they must also comply with testing procedures and arc 
submitted to post-market surveillance. 
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a.  Claims regarding content 
Claims on labels or in advertisements relating to  the content in the food of a number 
of substances are subject to conditions spelt out in Sections B.O 1.300 to  B.O 1.311  of 
the  Food and Drug Regulations.  These  conditions vary according to  the  substance 
concerned. 
For  instance,  claims  about  protein,  fat,  carbohydrate,  sugars,  sorbitol,  mannitol, 
xylitol, starch, dietary fibre and amino acids are allowed under the condition that the 
content of  the substance to which the claim relates is declared in grams per serving of 
a stated size (this does not apply to formulated liquid diets, human milk substitutes or 
foods represented as containing a human milk substitute). Claims that a food is low in 
fat  or is  a  low-fat food  are  prohibited unless the  food  contains no more than 0.15 
grams of fat per gram of dry matter and a serving of stated size of the food contains 
no more than 3 grams of fat  (this does not apply to  formulated liquid diets,  human 
milk substitutes or foods represented as containing a human milk substitute). 
b.  Claims regarding energy value 
Claims relating to the energy value of  the food are allowed under the condition that a 
declaration of the energy value, preceded by the word "energy", expressed in calories 
and kilojoules per serving of a stated size, is made (this does not apply to formulated 
liquid diets, human milk substitutes or foods represented as containing a human milk 
substitute). 
c.  Claims regarding fatty acids 
Claims regarding the presence in the food of a specific fatty acid other than linoleic 
acid,  or  of a  specific  group  of fatty  acids  other  than  cis-methylene  interrupted 
polyunsaturated fatty acids, cis-monounsaturated fatty acids and saturated fatty acids 
are prohibited (this does not apply to  formulated liquid diets,  foods  represented for 
use  in  a  very  low-energy diet,  meal  replacements,  nutritional  supplements, human 
milk substitutes or foods represented as containing a human milk substitute). 
3.  Health Claims 
a.  Claims regarding the action or effects of specific substances 
According to  section  B.O 1.311  of the Food and Drugs  Act,  claims  concerning  the 
action  or effects of any of the  following  substances  contained in the  food  are  not 
allowed: 
linoleic acid 
cis-methylene interrupted polyunsaturated fatty acids 
cis-monounsaturated fatty acids 
saturated  fatty  acids  a  substance  referred  to  in  any  of  paragraphs 
B.01.300(1 )(a) to U).(2) 
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I However,  such claims may be  made to  the  effect that the  substance  (in respect of 
which  the  claim  is  made)  is  generally  recognized  as  an  aid  in  maintaining  the 
functions of the body necessary to the maintenance of good health and normal growth 
and development. 
4.  Ethical Claims 
There is no specific restriction on ethical claims in Canada. However, ethical claims 
are subject to  the general prohibition spelt out in Section 5.1  of the Food and Drugs 
Act. 
D.  POLICY DEVELOPMENTS AND STAKEHOLDERS' POSITIONS 
Canadian policies regarding food labelling and advertising are designed to: 
protect  health  and  safety and  to  prevent product  misrepresentation  and 
fraud; 
promote an informed food  choice,  by providing consumers with reliable 
and  comparable information;  the  Canadian government is  committed to 
developing  policies  that  reflect  current  food  technology  and  nutrition 
recommendations; 
support market place equity and fair competition; and 
respect obligations under international and provincial trade agreements. 
The Canadian food and beverage industry, for its part, is committed to: 
maintaining truth and integrity in consumer communications; 
strive  to  ensure  that  product  communications  comply  with  the  food 
regulations, practices and policies; and 
allow  consumers  to  make  informed  choices  by  stnvmg  to  promote 
messages in advertising and  labelling that reflect consumer requirements 
for  food  consistent  with  current  health,  safety  and  nutntwn 
recommendations;  reflect  current  technological  advancement;  do  not 
mislead the consumer; and promote fair competition in the marketplace. 
All interested parties work in close partnership with the Federal government through a 
consultation  mechanism  designed  to  ensure  that  regulations  and  policies  are 
responsive to stakeholders needs. 
In this respect, the Canadian government has recently launched an  important review 
process to reform the regulatory framework governing claims on food products. The 
first aim of this review is  to give Canadians the nutritional information they need to 
make healthy food choices;  it  should also influence manufacturers to  produce more 
nutritious foods. The second objective is  to harmonize Canadian law with American 
legislation, whenever possible. 
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consultations on nutrition labelling, nutrient content claims and health claims. Thus, 
the  Canadian  system of food  labelling  and  advertising  is  undergoing  an  important 
reform, whose outcome will only be determined during 2000. 
1.  Nutritional Claims 
a.  Nutrient content claims review 
In  January 1996, Health Canada and Agriculture and Agri-Food Canada published a 
consultation  document  on  nutrient  content  claims,  which  proposed  that  the 
compositional criteria for nutrient content claims be harmonized, where feasible, with 
those of the United States. This change was triggered by growing dissatisfaction on 
the part of Canadian consumers, who felt they were provided with little information 
compared to  the American consumers and  did not have the ability to  make healthy 
food choices. 
Following this  first  consultation,  the  compositional criteria for the  claim '"fat  free" 
was revised in  1997.  The previous definition was considered restrictive because few 
foods qualified for that nutrient content claim. The claim "fat free" was dealt with on 
a priority basis because it related to  both health and trade.  The economic and trade 
impact analysis carried out by Agriculture and Agri-Food Canada, indeed, indicated 
that aligning the Canadian criteria to US standards would result in increasing two-way 
trade  between  the  US  and  Canada.  Consequently,  the  definition  for  fat  free  was 
therefore  changed  from  "not  more  than  0, 1  grams  of fat  par  100  grams  or  100 
millilitres  of food''  to  "less  than  0,5  grams  of fat  per  reference  amount  and  per 
labelled serving of a food. 
In  the  meantime, Health  Canada has  indicated its  intention  to  regulate  all  nutrient 
content  claims  in  the  future,  in  order  to  ensure  consistency  in  their  application. 
Revised  proposals  on  compositional  criteria  for  nutrient  content  claims  were  put 
forward in March 1998 (Annex 5) and a second consultation of the various interested 
parties was held between April and June 1999. 
Industries  and  manufacturers  consider  that  there  should  be  no  new  regulatory 
measures: the system should continue to be regulated under the non-binding Guide to 
Food Labelling and Advertising. 
Stakeholders'  positions  are  currently being  considered  by Health  Canada  and  not 
available to  the  public.  They will  serve as  a  basis  for  regulatory measures,  which 
Health Canada hopes to introduce by the end of 1999. 
2.  Health Claims 
Health  Canada  recognises  that  diet  may  modify  the  risk  of  developing  and 
exacerbating  certain  chronic  diseases.  It  also  acknowledges  that  individual 
components of  food can affect certain risk factors for disease. 
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currently not in line with this global policy thinking.  Consequently, Health Canada 
has  indicated  its  intention  to  remove  unduly  restrictive  regulatory  barriers  to 
communicate scientifically valid health information on food labels and in advertising. 
In  this respect, the Canadian government is  considering adopting the generic health 
claims,  which are  authorized  in  the  United  States.  There  are  currently  10  generic 
health claims allowed in the US, which are all risk reduction claims. 
91  They could be 
introduced as  such  in  Canada, but a Canadian regulatory approach is  advocated in 
their  implementation  (see  discussion  paper:  US  generic  health  claims  in  Canada: 
background and implementation issues in the Canadian context, June 1999, annex 6) 
This position is  a response to industry group pressures to  allow US  based claims in 
Canada, in order to have a level playing field with the United States. Industries would 
like  to  go  even further by creating a  system which allows  product-specific  health 
claims. Health Canada's move also satisfies the demands of non governmental health 
organizations. However, there seems to be no consensus among consumers on what 
claims,  if any,  should  be  allowed.  Some  consumer  organizations,  although  quite 
isolated, are reluctant to allow health claims on products because they believe it may 
add  to  cost of the  product  without overall  health  benefit to  the  consumer.  Others 
advocate the use of health claims to allow Canadian consumers to make healthy food 
choices. 
In the longer term (two to three years), Health Canada therefore intends to develop a 
regulatory framework to  allow for new  generic  and product-specific risk reduction 
and structure/function health claims for foods. It also aims at developing Standards of 
Evidence  and  a  Guidance  document  for  submission  of new  generic  and  product-
specific risk reduction claims. 
In  June  1999,  Health Canada called on stakeholders  to  give  their opinion on four 
issues that will affect the successful adoption of  US generic claims in Canada: 
the  appropriateness  of the  US  general  requirements  for  genenc  health 
claims in Canada; 
the  appropriateness  of the  US  specific  requirements  for  generic  health 
claims in Canada; 
Canadian format issues around generic health claims; 
Canadian credibility issues around generic health claims. 
Comments will be analysed later this autumn. No position paper has been received by 
Health Canada to this date. 
91  The health  claims allowed  in  the  US  are  the  following:  Calcium and osteoporosis;  Sodium and 
hypertension:  Dietary fat and cancer; Dietary saturated fat  and cholesterol and risk of coronary heart 
disease;  Fruits,  vegetables  and  grain products that  contain fiber and  risk of coronary heart  disease; 
Fruits/vegetables and  cancer;  Folate and neural  tube  birth effects;  Dietary sugar alcohol  and dental 
caries; Dietary soluble fiber and coronary heart disease. 
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Canada's  attention  is  focused  away from  ethical  claims.  They are  not  part  of the 
current policy review  on claims  and the  Canadian government has  no  intention to 
develop  legislation in  this  field.  Industry and  consumer groups  are  not focused  on 
ethical  claims either.  The main reason seems to  be that  it  is  harder to  make ethical 
claims on foods than on other manufactured products. 
E.  REMARKS ABOUT BARRIERS TO TRADE AND LACK OF CONSUMER 
PROTECTION 
While Health Canada takes into account the potential economic and trade implications 
of regulatory  decisions,  its  position  is  that  health  and  safety  issues  must  take 
precedence. This position is consistent with the provisions of  the Technical Barriers to 
Trade  (TBT)  agreements  under  both  the  WTO  and  NAFTA,  wherein  members 
maintain  their  rights  to  establish  standards  to  ensure  an  adequate  level  of health 
protection. 
III. VOLUNTARY INSTRUMENTS 
A.  ADVERTISING CLAIMS 
Advertising  standards Canada (ASC),  a  national  industry association committed to 
assuring  the  integrity  and  viability  of advertising,  has  developed  and  administers 
instruments for the  self-regulation of advertising which,  in  principle, apply to  food 
claims. 
1.  Canadian Code of Advertising Standards (Annex 7) 
Section 1 of  the Canadian Code of  Advertising Standards states: 
"advertisements  must  not  contain  inaccurate  or  deceptive  claims,  statements, 
illustrations  or  representations,  either  direct  or  implied,  with  regard  to  price, 
availability or pelformance of  a product or service". 
Section 8 provides: 
"advertisements  must  not  distort  the  true  meaning  of statements  made  by 
professionals or  scient~fic authorities.  Advertising claims  must not imply  that they 
have a scientific basis which they do  not truly possess. Any scientific, professional or 
authoritative claims or statements must be applicable to the Canadian context, unless 
otherwise clearly stated". 
In  addition,  the  Canadian Code  of Advertising  Standards  sets  out  a  procedure  for 
consumers  wishing  to  complain  to  Advertising  Standards  Canada  (ASC)  that  an 
advertisement contravenes the Code. 
In  theory,  these provisions are applicable to  advertisements containing food claims. 
However,  they overlap with the  existing legal rules,  since the  Food and Drugs Act 
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the Canadian Food Inspection Agency the responsibility to  apply the rules. Potential 
complaints from consumers concerning a food claim in an advertisement would be re-
directed  to  CFIA.  This  is,  however,  a  very  theoretical  situation,  as  no  individual 
consumer or company has ever tried to  challenge a claim through ASC 's complaint 
mechanism. 
a.  Advertising clearance guidelines 
ASC administers a clearance system for food and beverage broadcast advertising. It is 
a non-mandatory mechanism set up by broadcasters and advertisers (see Section V.B). 
2.  Labelling claims 
There  are  no  voluntary instruments  in  place  for  self-regulation  of claims  on  food 
labels.  In  fact,  the  Guide to  Food Labelling and advertising replaces potential self-
regulations.  It already reflects the  needs  of industries  and  consumers,  since  it  was 
drafted in close cooperation with all interested parties. 
IV. VERIFICATION SYSTEMS 
A.  CRITERIA FOR SUBSTANTIATING CLAIMS 
1.  Nutritional claims 
See Section II.B.l. 
2.  Health Claims 
See Section ll.B.2. 
3.  Ethical claims 
There is no provision for the verification of ethical claims under Canadian law. 
B.  LEGAL/ADMINISTRATIVE SYSTEMS FOR VERIFYING CLAIMS 
1.  Pre-Clearance Rules/ Guidelines 
a.  Labelling claims/claims in printed advertising 
In  Canada,  there  are  no  pre-clearance rules  or guidelines  for  claims  on  labels  and 
claims in printed advertising. 
In order to  preclude potential compliance problems, which could occur without pre-
market review,  manufacturers may voluntarily submit their claims  to  the  Canadian 
Food  Inspection Agency for  compliance evaluation.  If the  claim complies with  all 
regulations, a '"letter of  no objection" is issued to the petitioner. 
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A  self-regulated pre-clearance system  for  food  claims in  broadcast advertising has 
been  set  up  by  broadcasters  and  advertisers.  It  is  administered  by  Advertising 
Standards  Canada  on  the  basis  of a  "No  claim" Food and Beverage  Broadcast 
Advertising Clearance Exemption Policy Document provided in Annex 8. 
Advertising  Standards  Canada's  Food  Section  staff has  responsibility  to  review 
advertising  copies  to  ensure  that  opinions  pertaining  to  nutrition  or  composition 
comply  with  the  Food  and  Drugs  Act  and  Regulations  and  the  Guide  to  Food 
Labelling and Advertising. 
The following rules are applied by ACS: 
A broadcast advertisement for a food advertiser or for a food product is exempt from 
clearance requirement if the advertisement makes no "Food and Beverage" claim in 
the  context  of the  Food  and  Drugs  act  and  Regulations  and  the  Guide  to  Food 
Labelling and Advertising. In this context, "food claim" means any direct or indirect 
visual  (including  legible  visuals of labels)  or auditory reference  with respect  to  a 
specific  brand  name,  trade  name  or  product/food  category  relating  to:  quality; 
ingredient/composition;  nutrition/nutrition  properties;  health/safety/weight 
management; or production/processing. A food claim may also refer to market share 
claims,  research  and  survey  claims  and  direct  or indirect  comparative  statements 
(including taste claims) regarding other foods or other establishments. 
The following are examples of  food claims for which clearance is required: 
specific  terms,  such  as:  fresh,  improved,  natural,  new,  pure, 
real/true/  genuine, etc. 
descriptions relating to quality: better/best, better tasting/best tasting, finest 
tasting, higher/highest, larger/largest, premium, superior/top/choice, etc. 
ingredient/composition: pure, organic, pesticide free, natural, etc. 
nutrition/nutrition  properties:  calories/low  calorie/calorie-reduced, 
diet/dietetic, energy, enriched, fat free/low fat/less fat, light, lean, etc. 
health/safety/weight management:  brain  food,  choice-wise/smart,  weight 
loss/gain, health/healthy eating, etc. 
production/processing: home-made, made by hand, stone ground, etc. 
Pre-clearance of food and beverage advertising is  not a legal obligation. In practice, 
however, broadcasters require the pre-clearance of food and beverage advertisements 
whenever they contain a food claim. Otherwise, they refuse to put them on the air. 
2.  Post-Clearance Rules/ Guidelines 
a.  Control of compliance 
Verification  of compliance  of food  claims  with  the  Food  and  Drugs  Act  and 
Regulations  and  the  Guide  to  Food  Labelling  and  Advertising  falls  under  the 
responsibility  of the  Canadian  Food  Inspection  Agency  (CFIA).  This  function  is 
carried out through routine or ad hoc plant inspections by CFIA'  s regional inspectors. 
484 Non-compliance with existing rules is rare as  there is  a mistaken impression in parts 
of the industrial sector that the guidelines provided for in the Guide to Food Labelling 
and  Advertising  have  regulatory  status.  The  policy  of Health  Canada's  Health 
Protection  Branch  has  always  been  to  promote  voluntary  compliance.  In  case  of 
infringement,  CFIA  sends  a  warning  letter  to  inform  the  manufacturer  that  it 
contravenes the Canadian legislation.
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claim and is given a deadline to regularize his situation. This procedure is brought to a 
successful end in most instances. 
In  instances  where  the  manufacturer does  not comply with CFIA's injunction,  the 
Agency is  entitled to  bring the case before a criminal court.  However, there are no 
examples of  cases which were brought to court by CFIA. 
C.  LEGAL PERSONS ENTITLED TO TAKE LEGAL ACTION 
As indicated above, CFIA is allowed to take legal action, but this instrument remains 
very theoretical. 
Individual  consumers,  consumer  groups  and  industry  groups  could  potentially 
challenge  a  claim directly before. a  criminal  court.  However,  all  interested parties 
indicate that this is very unlikely to happen because legal action is not in the Canadian 
mindset. Indeed, no example of  such direct action has been brought to our knowledge. 
In  some cases, however, consumers and industries have drawn CFIA's attention on 
what they considered were illegal practices 
D.  BURDEN OF PROOF 
It is the responsibility of the Federal Government to prove beyond a reasonable doubt 
that a person violated a specific section of  the Act. 
E.  APPLICABLE PENAL  TIES 
Section 31.1  of the Food and Drugs Act provides: 
"Every person who contravenes any provision of  the Act or Regulations, as it relates 
to food, is guilty of  an offense and liable 
(a)  on  summary conviction  to  a fine  not exceeding $CAN 50,000 (approx. 
31,600 EUR) or to imprisonment for a term not exceeding six months or to 
both,· 
or 
(b) on conviction by indictment to a fine not exceeding $CAN 250,000 (approx. 
158,000 EUR) or to imprisonment for a term not exceeding three years, or to 
both." 
1)
2  The  manufacturer  is  liable  for  claims  made  on  labels  or  in  advertisements  for  his  product. 
Exceptionally,  the  retailer  can  bear the  responsibility  if it  makes  a  claim  independently  from  the 
manufacturer (in an advertisement displayed in the store for instance). 
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be instituted at  any  time  within  two  years  after the  time  the  subject matter of the 
prosecution becomes known to the Minister of  Agriculture and Agri-Food. 
This applies to  the violations of Sections 3.1  and 5.1  applicable to claims. However, 
the  Canadian  government  rarely  prosecutes  a  company  contravening  the  law  in 
making a claim on food.  CFIA tries to resolve all cases through direct dialogue with 
the company, aiming at voluntary withdrawal of  the claim. 
F.  CASELAW 
Our  research  indicates  that  there  have  been  very  few  challenges  in  court  about 
labelling and advertising claims. Thus, there is  very little jurisprudence in Canada in 
this area. 
V. MEANS OF COMMUNICATION 
In Canada, there is  no difference between the standards applicable to claims made in 
advertisements in different forms of  media. 
VI.  STATISTICS ON CLAIMS 
There are no statistics available in Canada with regards to food claims. 
VII. ANNEXES 
1.  Food and Drugs Act and Regulations 
2.  Guide  to  Food  Labelling  and  Advertising  (Canadian  Food  Inspection 
Agency) 
3.  Neutraceutical/functional foods and health claims on foods --Policy paper 
(Health Canada) 
4.  Schedule A of  the Food and Drugs Act 
5.  Proposed revisions to the compositional criteria for nutrient content claims 
(Health Canada) 
6.  US  generic  health  claims  in  Canada:  background  and  implementation 
issues in the Canadian context-- Discussion paper (Health Canada) 
7.  Canadian Code of  Advertising Standards (Advertising Standards Canada) 
8.  "'No Claim" food and beverage broadcast advertising clearance exemption 
policy document (Advertising Standards Canada) 
VIII.  DATABASE OF CONTACTS 
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I 